PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Reimer, J; Haasen, C				Reimer, Jens; Haasen, Christian			Need-adapted HCV-treatment setting for injection drug users	LANCET			English	Editorial Material							HEPATITIS-C; PREVENTION; VIRUS; CARE		[Reimer, Jens; Haasen, Christian] Univ Hamburg, Ctr Interdisciplinary Addict Res, D-20246 Hamburg, Germany	University of Hamburg	Reimer, J (corresponding author), Univ Hamburg, Ctr Interdisciplinary Addict Res, Martinistr 52, D-20246 Hamburg, Germany.	reimer@uke.de						Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; Edlin BR, 2005, CLIN INFECT DIS, V40, pS276, DOI 10.1086/427441; Jack K, 2009, ALIMENT PHARM THER, V29, P38, DOI 10.1111/j.1365-2036.2008.03872.x; Laine C, 2001, JAMA-J AM MED ASSOC, V285, P2355, DOI 10.1001/jama.285.18.2355; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; NEUMAN MG, 2003, ALCOHOL CLIN EXP S1, V25, pS215; Paterson BL, 2007, INT J DRUG POLICY, V18, P364, DOI 10.1016/j.drugpo.2007.02.004; Stoove MA, 2005, DRUG ALCOHOL DEPEN, V77, P81, DOI 10.1016/j.drugalcdep.2004.07.002; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wilkinson M, 2009, ALIMENT PHARM THER, V29, P29, DOI 10.1111/j.1365-2036.2008.03834.x; Wong JB, 2006, PHARMACOECONOMICS, V24, P661, DOI 10.2165/00019053-200624070-00005; Wright C, 2003, BRIT J PSYCHIAT, V183, P132, DOI 10.1192/bjp.183.2.132; Wright TL, 2007, HEPATOL RES, V37, pS294, DOI 10.1111/j.1872-034X.2007.00200.x	13	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2090	2091		10.1016/S0140-6736(09)60347-0	http://dx.doi.org/10.1016/S0140-6736(09)60347-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19376573				2022-12-24	WOS:000267229700007
J	Harnden, A				Harnden, Anthony			Practice Easily Missed? Whooping cough	BRITISH MEDICAL JOURNAL			English	Editorial Material							BORDETELLA-PERTUSSIS; PERSISTENT COUGH; INFECTION; CHILDREN; DIAGNOSIS; ADULTS; TOXIN		Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk						Cagney M, 2005, RESPIROLOGY, V10, P359, DOI 10.1111/j.1440-1843.2005.00722.x; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; Dodhia H, 2002, J PUBLIC HEALTH MED, V24, P200, DOI 10.1093/pubmed/24.3.200; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; Levenson R, 2007, BRIT MED J, V334, P532, DOI 10.1136/bmj.39120.556296.AE; Litt DJ, 2006, J MED MICROBIOL, V55, P1223, DOI 10.1099/jmm.0.46543-0; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044	10	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 21	2009	338								b1772	10.1136/bmj.b1772	http://dx.doi.org/10.1136/bmj.b1772			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NT	19460804				2022-12-24	WOS:000266270000003
J	Bhattacharya, S; Black, R; Bourgeois, L; Clemens, J; Cravioto, A; Deen, JL; Dougan, G; Glass, R; Grais, RF; Greco, M; Gust, I; Holmgren, J; Kariuki, S; Lambert, PH; Liu, MA; Longini, I; Nair, GB; Norrby, R; Nossal, GJV; Ogra, P; Sansonetti, P; von Seidlein, L; Songane, F; Svennerholm, AM; Steele, D; Walker, R				Bhattacharya, S.; Black, R.; Bourgeois, L.; Clemens, J.; Cravioto, A.; Deen, J. L.; Dougan, Gordon; Glass, R.; Grais, R. F.; Greco, M.; Gust, I.; Holmgren, J.; Kariuki, S.; Lambert, P. -H.; Liu, M. A.; Longini, I.; Nair, G. B.; Norrby, R.; Nossal, G. J. V.; Ogra, P.; Sansonetti, P.; von Seidlein, L.; Songane, F.; Svennerholm, A. -M.; Steele, D.; Walker, R.			The Cholera Crisis in Africa	SCIENCE			English	Editorial Material							VACCINATION; VACCINES		[Cravioto, A.; Deen, J. L.; von Seidlein, L.] Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Bhattacharya, S.] Indian Council Med Res, New Delhi, India; [Black, R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Bourgeois, L.; Steele, D.; Walker, R.] PATH, Enter Vaccine Initiat, Seattle, WA 98107 USA; [Clemens, J.] Int Vaccine Inst, Seoul 151600, South Korea; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England; [Glass, R.] NIH, Fogarty Inst, Bethesda, MD 20892 USA; [Grais, R. F.] Epictr, FR-75011 Paris, France; [Gust, I.; Nossal, G. J. V.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Gust, I.; Nossal, G. J. V.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Holmgren, J.; Svennerholm, A. -M.] Univ Gothenburg, SE-40530 Gothenburg, Sweden; [Kariuki, S.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Lambert, P. -H.] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Liu, M. A.] Karolinska Inst, SE-17177 Stockholm, Sweden; [Longini, I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Longini, I.] Univ Washington, Seattle, WA 98109 USA; [Nair, G. B.] Natl Inst Cholera & Infect Dis, Kolkata 700010, India; [Norrby, R.] Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; [Ogra, P.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Sansonetti, P.] Inst Pasteur, INSERM, U786, Unite Pathogenie Microbienne Mol, FR-75724 Paris 15, France; [Songane, F.] Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva, Switzerland	Indian Council of Medical Research (ICMR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Vaccine Institute; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; University of Melbourne; University of Melbourne; University of Gothenburg; Kenya Medical Research Institute; University of Geneva; Karolinska Institutet; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Swedish Institute for Infectious Disease Control; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Deen, JL (corresponding author), Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh.	jdeen@ivi.int		Black, Robert/0000-0001-9926-7984; Holmgren, Jan/0000-0003-1784-5918; Freeman Grais, Rebecca/0000-0002-5037-8218				Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; [Anonymous], 1995, Lancet, V345, P339; [Anonymous], 2009, B WORLD HEALTH ORGAN, V87, P85, DOI 10.2471/BLT.09.010209; Chaignat CL, 2008, EXPERT REV VACCINES, V7, P431, DOI 10.1586/14760584.7.4.431; Fleck F, 2009, B WORLD HEALTH ORGAN, V87, P6, DOI 10.2471/BLT.09.020109; *GOV ZIMB WHO, 2009, ZIMB DAIL CHOL UPD A; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Kapp C, 2009, LANCET, V373, P447, DOI 10.1016/S0140-6736(09)60151-3; Koenig R, 2009, SCIENCE, V323, P860, DOI 10.1126/science.323.5916.860; Legros D, 1999, B WORLD HEALTH ORGAN, V77, P837; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; Naficy A, 1998, JAMA-J AM MED ASSOC, V279, P521, DOI 10.1001/jama.279.7.521; *NAT OUTBR COMM, 2009, CHOL OUTBR S AFR NAT; *PROMED MAIL, 2009, INT SOC INF DIS; *WHO, 2006, WHOCDSNTDIDM20062	16	30	31	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					885	885		10.1126/science.1173890	http://dx.doi.org/10.1126/science.1173890			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443768				2022-12-24	WOS:000266048800018
J	Wilson, JM				Wilson, James M.			A History Lesson for Stem Cells	SCIENCE			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Wilson, JM (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; [Anonymous], 1996, B MED ETHICS; [Anonymous], [No title captured]; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Friedmann T, 2005, PERSPECT BIOL MED, V48, P585, DOI 10.1353/pbm.2005.0089; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Thompson L, 2000, FDA Consum, V34, P19; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; 2009, ABC NEWS        0123	13	83	85	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					727	728		10.1126/science.1174935	http://dx.doi.org/10.1126/science.1174935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423804				2022-12-24	WOS:000265832400023
J	Bockenhauer, D; Feather, S; Stanescu, HC; Bandulik, S; Zdebik, AA; Reichold, M; Tobin, J; Lieberer, E; Sterner, C; Landoure, G; Arora, R; Sirimanna, T; Thompson, D; Cross, JH; van't Hoff, W; Al Masri, O; Tullus, K; Yeung, S; Anikster, Y; Klootwijk, E; Hubank, M; Dillon, MJ; Heitzmann, D; Arcos-Burgos, M; Knepper, MA; Dobbie, A; Gahl, WA; Warth, R; Sheridan, E; Kleta, R				Bockenhauer, Detlef; Feather, Sally; Stanescu, Horia C.; Bandulik, Sascha; Zdebik, Anselm A.; Reichold, Markus; Tobin, Jonathan; Lieberer, Evelyn; Sterner, Christina; Landoure, Guida; Arora, Ruchi; Sirimanna, Tony; Thompson, Dorothy; Cross, J. Helen; van't Hoff, William; Al Masri, Omar; Tullus, Kjell; Yeung, Stella; Anikster, Yair; Klootwijk, Enriko; Hubank, Mike; Dillon, Michael J.; Heitzmann, Dirk; Arcos-Burgos, Mauricio; Knepper, Mark A.; Dobbie, Angus; Gahl, William A.; Warth, Richard; Sheridan, Eamonn; Kleta, Robert			Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISTAL CONVOLUTED TUBULE; WIDE LINKAGE ANALYSIS; BARTTERS-SYNDROME; K+ CHANNEL; POTASSIUM CHANNEL; BLOOD-PRESSURE; HYPOKALEMIC ALKALOSIS; BASOLATERAL MEMBRANE; KNOCK-OUT; GENE	Background: Five children from two consanguineous families presented with epilepsy beginning in infancy and severe ataxia, moderate sensorineural deafness, and a renal salt-losing tubulopathy with normotensive hypokalemic metabolic alkalosis. We investigated the genetic basis of this autosomal recessive disease, which we call the EAST syndrome (the presence of epilepsy, ataxia, sensorineural deafness, and tubulopathy). Methods: Whole-genome linkage analysis was performed in the four affected children in one of the families. Newly identified mutations in a potassium-channel gene were evaluated with the use of a heterologous expression system. Protein expression and function were further investigated in genetically modified mice. Results: Linkage analysis identified a single significant locus on chromosome 1q23.2 with a lod score of 4.98. This region contained the KCNJ10 gene, which encodes a potassium channel expressed in the brain, inner ear, and kidney. Sequencing of this candidate gene revealed homozygous missense mutations in affected persons in both families. These mutations, when expressed heterologously in xenopus oocytes, caused significant and specific decreases in potassium currents. Mice with Kcnj10 deletions became dehydrated, with definitive evidence of renal salt wasting. Conclusions: Mutations in KCNJ10 cause a specific disorder, consisting of epilepsy, ataxia, sensorineural deafness, and tubulopathy. Our findings indicate that KCNJ10 plays a major role in renal salt handling and, hence, possibly also in blood-pressure maintenance and its regulation. N Engl J Med 2009;360:1960-70.	[Bockenhauer, Detlef; Stanescu, Horia C.; Zdebik, Anselm A.; Tobin, Jonathan; Landoure, Guida; Arora, Ruchi; Sirimanna, Tony; Thompson, Dorothy; Cross, J. Helen; van't Hoff, William; Tullus, Kjell; Klootwijk, Enriko; Hubank, Mike; Dillon, Michael J.; Kleta, Robert] UCL, Great Ormond St Hosp, London NW3 2PF, England; [Feather, Sally; Yeung, Stella; Dobbie, Angus; Sheridan, Eamonn] Univ Leeds, Leeds Hosp, Leeds, W Yorkshire, England; [Feather, Sally; Yeung, Stella; Dobbie, Angus; Sheridan, Eamonn] Univ Leeds, Bradford Teaching Hosp, Leeds, W Yorkshire, England; [Stanescu, Horia C.; Landoure, Guida; Anikster, Yair; Klootwijk, Enriko; Arcos-Burgos, Mauricio; Knepper, Mark A.; Gahl, William A.; Kleta, Robert] NIH, Bethesda, MD 20892 USA; [Bandulik, Sascha; Reichold, Markus; Lieberer, Evelyn; Sterner, Christina; Heitzmann, Dirk; Warth, Richard] Univ Regensburg, Inst Physiol, Regensburg, Germany; [Landoure, Guida] Univ Bamako, Dept Neurol, Bamako, Mali; [Al Masri, Omar] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Anikster, Yair] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Arcos-Burgos, Mauricio] Univ Miami, Miami, FL USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Leeds; University of Leeds; National Institutes of Health (NIH) - USA; University of Regensburg; University of Bamako; Chaim Sheba Medical Center; University of Miami	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Bockenhauer, Detlef/C-5951-2008; Warth, Richard/N-7119-2014; Reichold, Markus/J-9933-2015; Cross, J. Helen/ACK-3032-2022; Tullus, Kjell/C-6589-2008; Knepper, Mark/AAF-8412-2020; Hubank, Michael JF/C-1837-2008; Bockenhauer, Detlef/AAF-6495-2020; Bandulik, Sascha/L-7365-2015; Arcos-Burgos, Mauricio/H-1326-2017	Bockenhauer, Detlef/0000-0001-5878-941X; Warth, Richard/0000-0001-6084-0659; Cross, J. Helen/0000-0001-7345-4829; Hubank, Michael JF/0000-0002-2901-0742; Bockenhauer, Detlef/0000-0001-5878-941X; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Thompson, Dorothy/0000-0001-5491-3911	Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HL001285-24, Z01 HL001285-22, Z99 HL999999, ZIA HL001285-23, Z01 HL001285-21] Funding Source: Medline	Great Ormond Street Hospital Childrens Charity; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bilusic M, 2004, HYPERTENSION, V44, P695, DOI 10.1161/01.HYP.0000144542.57306.5e; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bleich M, 1999, PFLUG ARCH EUR J PHY, V438, P245, DOI 10.1007/s004240050906; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; DAWSON DC, 1990, AM J PHYSIOL, V259, pC181, DOI 10.1152/ajpcell.1990.259.2.C181; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kleta R, 2000, NEW ENGL J MED, V343, P661, DOI 10.1056/NEJM200008313430915; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Kuffer S. W., 1966, Ergebnisse der Physiologie, V57, P1; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC2001, DOI 10.1152/ajpcell.zh0-5456-corr.2007; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; TANIGUCHI J, 1989, AM J PHYSIOL, V256, pF246, DOI 10.1152/ajprenal.1989.256.2.F246; Thiel BA, 2003, AM J HYPERTENS, V16, P151, DOI 10.1016/S0895-7061(02)03246-6; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; TSUCHIYA K, 1992, P NATL ACAD SCI USA, V89, P6418, DOI 10.1073/pnas.89.14.6418; Vallon V, 2001, J AM SOC NEPHROL, V12, P2003, DOI 10.1681/ASN.V12102003; WEST ML, 1986, MINER ELECTROL METAB, V12, P226; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200	41	380	390	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					1960	1970		10.1056/NEJMoa0810276	http://dx.doi.org/10.1056/NEJMoa0810276			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420365	Bronze, Green Accepted			2022-12-24	WOS:000265784400006
J	Wilson, CW; Nguyen, CT; Chen, MH; Yang, JH; Gacayan, R; Huang, J; Chen, JN; Chuang, PT				Wilson, Christopher W.; Nguyen, Catherine T.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Huang, Jie; Chen, Jau-Nian; Chuang, Pao-Tien			Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis	NATURE			English	Article							KINESIN-RELATED PROTEIN; TRANSDUCTION; DROSOPHILA; HOMOLOG; MECHANISM; DEFECTS; COSTAL2; PRODUCT; COMPLEX; GROWTH	Hedgehog (Hh) signalling is essential for several aspects of embryogenesis(1,2). In Drosophila, Hh transduction is mediated by a cytoplasmic signalling complex(3-5) that includes the putative serine-threonine kinase Fused (Fu) and the kinesin Costal 2 (Cos2, also known as Cos), yet Fu does not have a conserved role in Hh signalling in mammals(6,7). Mouse Fu (also known as Stk36) mutants are viable and seem to respond normally to Hh signalling. Here we show that mouse Fu is essential for construction of the central pair apparatus of motile, 912 cilia and offers a new model of human primary ciliary dyskinesia. We found that mouse Fu physically interacts with Kif27, a mammalian Cos2 orthologue(8), and linked Fu to known structural components of the central pair apparatus, providing evidence for the first regulatory component involved in central pair construction. We also demonstrated that zebrafish Fu is required both for Hh signalling and cilia biogenesis in Kupffer's vesicle. Mouse Fu rescued both Hh-dependent and-independent defects in zebrafish. Our results delineate a new pathway for central pair apparatus assembly, identify common regulators of Hh signalling and motile ciliogenesis, and provide insights into the evolution of the Hh cascade.	[Wilson, Christopher W.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Catherine T.; Huang, Jie; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu	Chen, Jau-Nian/AAM-7808-2020	Chen, Jau-Nian/0000-0001-8807-3607; Chen, Miao-Hsueh/0000-0002-9715-3067; YANG, JEHN-HSIAHN/0000-0001-8648-0882	National Institutes of Health; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bourne, C. C. Hui, Z. Zhang, J. Strauss III and W. Hwang for constructs, antibodies and sharing of unpublished results; R. Harland and T. Mikawa for X. tropicalis and chicken tissue; K. Thorn and S. Dandekar for assistance with microscopy and ciliary beat frequency analysis; M.-L. Cheong and Y. Nozawa for technical assistance; and D. Casso, S. Coughlin, T. Kornberg, W. Marshall, T. Mikawa, K. Wemmer and members of the Chen and Chuang laboratories for discussion and critical reading of the manuscript. Some data for this study were acquired at the Nikon Imaging Center at UCSF/QB3. This work was supported by grants from the National Institutes of Health to J.-N. C. and P.-T. C., and a Career Investigator Award from the American Lung Association to P.-T. C.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Katoh Y, 2004, INT J ONCOL, V25, P1875; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; McKean PG, 2003, CURR BIOL, V13, P598, DOI 10.1016/S0960-9822(03)00174-X; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nagy A., 2003, MANIPULATING MOUSE E; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; Oh SA, 2005, CURR BIOL, V15, P2107, DOI 10.1016/j.cub.2005.10.044; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sambrook J, 2001, MOL CLONING LAB MANU; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002	37	107	114	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					98	U105		10.1038/nature07883	http://dx.doi.org/10.1038/nature07883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19305393	Green Accepted			2022-12-24	WOS:000265801300037
J	Coumailleau, F; Furthauer, M; Knoblich, JA; Gonzalez-Gaitan, M				Coumailleau, F.; Fuerthauer, M.; Knoblich, J. A.; Gonzalez-Gaitan, M.			Directional Delta and Notch trafficking in Sara endosomes during asymmetric cell division	NATURE			English	Article							RECEPTOR ACTIVATION; DROSOPHILA EMBRYOS; DOMAIN PROTEIN; FYVE DOMAIN; ENDOCYTOSIS; LOCALIZATION; SUPPRESSOR; PRESENILIN; SANPODO; FATE	Endocytosis has a crucial role during Notch signalling after the asymmetric division of fly sensory organ precursors (SOPs): directional signalling is mediated by differential endocytosis of the ligand Delta and the Notch effector Sanpodo in one of the SOP daughters, pIIb(1-3). Here we show a new mechanism of directional signalling on the basis of the trafficking of Delta and Notch molecules already internalized in the SOP and subsequently targeted to the other daughter cell, pIIa. Internalized Delta and Notch traffic to an endosome marked by the protein Sara(4,5). During SOP mitosis, Sara endosomes containing Notch and Delta move to the central spindle and then to pIIa. Subsequently, in pIIa (but not in pIIb) Notch appears cleaved in Sara endosomes in a gamma-secretase-and Delta internalization-dependent manner, indicating that the release of the intracellular Notch tail to activate Notch target genes has occurred. We thus uncover a new mechanism to bias signalling even before asymmetric endocytosis of Sanpodo and Delta takes place in the daughter cells: already during SOP mitosis, asymmetric targeting of Delta and Notch-containing Sara endosomes will increase Notch signalling in pIIa and decrease it in pIIb.	[Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Knoblich, J. A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Geneva; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Furthauer, M (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Maximilian.Fuerthauer@unige.ch; Marcos.Gonzalez@unige.ch	FÃrthauer, Maximilian/AAY-4516-2020; Knoblich, Juergen A/C-2974-2015	FÃrthauer, Maximilian/0000-0001-6344-6585; Knoblich, Juergen A/0000-0002-6751-3404; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; COUMAILLEAU, Franck/0000-0002-1392-5665	EMBO; Human Frontier Science Program (HFSP); Fondation pour la recherche medicale (FRM); Max Planck Society; Volkswagen; FP6 Strep (ONCASYM); Swiss National Science Foundation (SNF); SystemsX (LipidX); HFSP	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagen(Volkswagen); FP6 Strep (ONCASYM)(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SystemsX (LipidX); HFSP(Human Frontier Science Program)	We thank S. Bray, P. Bryant, D. Glover, C. Gonzalez, E. Lai, C. Micchelli, M. Muskavitch, M. O'Connor, J. Posakony, F. Schweisguth, J. Skeath and A. Wodarz for providing reagents, and the M. G.-G. laboratory members, A. Martinez-Arias and F. Schweisguth for critically reading the manuscript. We thank S. Sigrist and W. Fouquet for providing us the opportunity to perform stimulated emission depletion (STED) microscopy. We thank A. Schwabedissen, D. Backash, C. Alliod and A. Beguin for technical assistance. M. F. thanks M. P. Euzenot for support. M. F. has benefited from EMBO and Human Frontier Science Program (HFSP) long-term postdoctoral fellowships and F. C. from a Fondation pour la recherche medicale (FRM) postdoctoral fellowship. This work was supported by the Max Planck Society, Volkswagen, an FP6 Strep (ONCASYM), the Swiss National Science Foundation (SNF), SystemsX (LipidX) and HFSP.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Cournailleau F, 2008, CURR OPIN CELL BIOL, V20, P462, DOI 10.1016/j.ceb.2008.03.007; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gho M, 1999, DEVELOPMENT, V126, P3573; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	28	137	138	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1051	1055		10.1038/nature07854	http://dx.doi.org/10.1038/nature07854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295516				2022-12-24	WOS:000265412900048
J	Mikucki, JA; Pearson, A; Johnston, DT; Turchyn, AV; Farquhar, J; Schrag, DP; Anbar, AD; Priscu, JC; Lee, PA				Mikucki, Jill A.; Pearson, Ann; Johnston, David T.; Turchyn, Alexandra V.; Farquhar, James; Schrag, Daniel P.; Anbar, Ariel D.; Priscu, John C.; Lee, Peter A.			A Contemporary Microbially Maintained Subglacial Ferrous "Ocean"	SCIENCE			English	Article							TAYLOR GLACIER; DRY VALLEYS; SULFUR; OXYGEN; SULFATE; EXCHANGE; REDOX; WATER; MODEL; ICE	An active microbial assemblage cycles sulfur in a sulfate-rich, ancient marine brine beneath Taylor Glacier, an outlet glacier of the East Antarctic Ice Sheet, with Fe(III) serving as the terminal electron acceptor. Isotopic measurements of sulfate, water, carbonate, and ferrous iron and functional gene analyses of adenosine 5'-phosphosulfate reductase imply that a microbial consortium facilitates a catalytic sulfur cycle. These metabolic pathways result from a limited organic carbon supply because of the absence of contemporary photosynthesis, yielding a subglacial ferrous brine that is anoxic but not sulfidic. Coupled biogeochemical processes below the glacier enable subglacial microbes to grow in extended isolation, demonstrating how analogous organic-starved systems, such as Neoproterozoic oceans, accumulated Fe(II) despite the presence of an active sulfur cycle.	[Mikucki, Jill A.; Pearson, Ann; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Johnston, David T.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Priscu, John C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Lee, Peter A.] Coll Charleston, Hollings Marine Lab, Charleston, SC 29412 USA	Harvard University; Harvard University; University of Cambridge; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; College of Charleston	Mikucki, JA (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.	jill.a.mikucki@dartmouth.edu	Johnston, David/A-9796-2010; Pearson, Ann/A-6723-2009	Johnston, David/0000-0002-2487-1084; Pearson, Ann/0000-0003-2785-8405	NSF Polar postdoctoral fellowship [OPP-0528710]; NSF [EAR-0311937, OPP-432595, OPP-0631494, OPP-0338097, OCE-0728683]; Canadian Institute for Advanced Research; Harvard Microbial Sciences Initiative; NASA [NNX07AV51G]	NSF Polar postdoctoral fellowship; NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard Microbial Sciences Initiative; NASA(National Aeronautics & Space Administration (NASA))	G. Eischeld and S. Fawcett assisted with oxygen isotope measurements, A. Masterson assisted with sulfur isotope measurements, and G. Gordon assisted with iron isotope measurements. We are grateful for assistance from the Crary Laboratory, Petroleum Helicopters Incorporated, and S. Carter. We would like to extend a special thanks to McMurdo personnel B. Peace and W. Hayworth. Discussions with H. Keys, M. Tranter, K. Welch, W. B. Lyons, W. Hamilton, F. MacDonald, S. Shah, and A. Knoll were helpful in formulating the ideas presented. The comments of three anonymous reviewers and A. J. Kaufman greatly improved the manuscript. This research was funded by an NSF Polar postdoctoral fellowship (OPP-0528710) to J.A.M. Additional support was provided by NSF grants EAR-0311937 (A.P.), OPP-432595 and OPP-0631494 (J.C.P.), and OPP-0338097 and OCE-0728683 (awarded to G. R. DiTullio) (P.A.L.); Canadian Institute for Advanced Research (A.V.T.); Harvard Microbial Sciences Initiative; and NASA (NNX07AV51G) (D.T.J.). DNA sequences have been submitted to GenBank with accession numbers FJ389341 to FJ389351.	Aciego SM, 2007, QUATERNARY RES, V68, P303, DOI 10.1016/j.yqres.2007.07.013; BETTS RH, 1970, CAN J CHEMISTRY, V48, P2035, DOI 10.1139/v70-339; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Black R.F., 1965, J GEOL, V73, P175, DOI [10.1086/627053, DOI 10.1086/627053]; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4773, DOI 10.1016/j.gca.2005.04.017; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; CHIBA H, 1985, GEOCHIM COSMOCHIM AC, V49, P993, DOI 10.1016/0016-7037(85)90314-X; COX SC, 1991, ANTARCT SCI, V3, P405, DOI 10.1017/S0954102091000500; ELSTON DP, 1981, ANTARCT RES SER, V33, P413, DOI DOI 10.1029/AR033P0413; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; HAMILTON W, 1965, 456B GEOL SURV; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hubbard A, 2004, ANN GLACIOL-SER, V39, P79, DOI 10.3189/172756404781813970; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lyons WB, 2005, GEOCHIM COSMOCHIM AC, V69, P305, DOI 10.1016/j.gca.2004.06.040; MIKUCKI JA, 2005, THESIS MONTANA STATE; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Priscu J. C, 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Schink B, 2006, ENG LIFE SCI, V6, P228, DOI 10.1002/elsc.200620130; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Tranter M, 2005, HYDROL PROCESS, V19, P995, DOI 10.1002/hyp.5854; Turchyn AV, 2006, GEOBIOLOGY, V4, P191, DOI 10.1111/j.1472-4669.2006.00079.x; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; Wilch T. M., 1993, GEOGR ANN A, V75, P331, DOI DOI 10.1080/04353676.1993.11880399	32	175	182	0	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					397	400		10.1126/science.1167350	http://dx.doi.org/10.1126/science.1167350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372431				2022-12-24	WOS:000265221600045
J	Lin, YY; Lu, JY; Zhang, JM; Walter, W; Dang, WW; Wan, J; Tao, SC; Qian, J; Zhao, YM; Boeke, JD; Berger, SL; Zhu, H				Lin, Yu-yi; Lu, Jin-ying; Zhang, Junmei; Walter, Wendy; Dang, Weiwei; Wan, Jun; Tao, Sheng-Ce; Qian, Jiang; Zhao, Yingming; Boeke, Jef D.; Berger, Shelley L.; Zhu, Heng			Protein Acetylation Microarray Reveals that NuA4 Controls Key Metabolic Target Regulating Gluconeogenesis	CELL			English	Article							SISTER-CHROMATID COHESION; LIFE-SPAN EXTENSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; CALORIE RESTRICTION; MOUSE-LIVER; HEPATIC GLUCONEOGENESIS; FUNCTIONAL DISSECTION; LYSINE ACETYLATION	Histone acetyltransferases (HATs) and histone deacetylases (HDACs) conduct many critical functions through nonhistone substrates in metazoans, but only chromatin-associated nonhistone substrates are known in Saccharomyces cerevisiae. Using yeast proteome microarrays, we identified and validated many nonchromatin substrates of the essential nucleosome acetyltransferase of H4 (NuA4) complex. Among these, acetylation sites (Lys19 and 514) of phosphoenolpyruvate carboxykinase (Pck1p) were determined by tandem mass spectrometry. Acetylation at Lys514 was crucial for enzymatic activity and the ability of yeast cells to grow on nonfermentable carbon sources. Furthermore, Sir2p deacetylated Pck1p both in vitro and in vivo. Loss of Pck1p activity blocked the extension of yeast chronological life span caused by water starvation. In human hepatocellular carcinoma (HepG2) cells, human Pck1 acetylation and glucose production were dependent on TIP60, the human homolog of ESA1. Our findings demonstrate a regulatory function for the NuA4 complex in glucose metabolism and life span by acetylating a critical metabolic enzyme.	[Lin, Yu-yi; Lu, Jin-ying; Tao, Sheng-Ce; Boeke, Jef D.; Zhu, Heng] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Mol Sci, Baltimore, MD 21205 USA; [Wan, Jun; Qian, Jiang] Johns Hopkins Univ, Sch Med, Wilmer Eye Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Zhang, Junmei; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Walter, Wendy; Dang, Weiwei; Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Taiwan University; National Taiwan University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu; berger@wistar.org; heng.zhu@jhmi.edu	Wan, Jun/AAN-1337-2020; Wan, Jun/H-7132-2013; Wan, Jun/A-2177-2014; Tao, Sheng-ce/A-5833-2012	Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Tao, Sheng-ce/0000-0002-9210-1823; Boeke, Jef/0000-0001-5322-4946; Dang, Weiwei/0000-0002-6931-4636; Berger, Shelley/0000-0001-5398-4400	National Institutes of Health [U54 RR 020839, R01CA126832, R01EY017589]; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. M. Cooper, L. Dai, A. Norris, and K. A. O'Donnell for gifts of reagents; J. Liu, J. T. Stivers, H. Takahashi, S. Taverna, J. Zhang, and members of the Zhu and Boeke labs for valuable discussions throughout the course of the work. This work was supported in part by National Institutes of Health Roadmap Grant U54 RR 020839, "Technology Center for Networks and Pathways'' (to J.D.B., S.L.B., and H.Z.); the Keck Foundation (H.Z.); and National Institutes of Health Grants R01CA126832 (to Y.Z.) and R01EY017589 (to J. Q.).	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ashrafi K, 2000, GENE DEV, V14, P1872; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; BALY DL, 1985, J NUTR, V115, P872, DOI 10.1093/jn/115.7.872; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Delbaere LTJ, 2004, BBA-PROTEINS PROTEOM, V1697, P271, DOI 10.1016/j.bbapap.2003.11.030; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2008, BIOSCIENCE REP, V28, P107, DOI 10.1042/BSR20080015; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lardy H, 1972, ENZYMES, P117; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; Permutt MA, 2000, TRENDS ENDOCRIN MET, V11, P383, DOI 10.1016/S1043-2760(00)00329-5; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Raab RM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-40; Ravanal MC, 2003, J PROTEIN CHEM, V22, P311, DOI 10.1023/A:1025306105105; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin ZK, 2000, MOL MICROBIOL, V35, P553, DOI 10.1046/j.1365-2958.2000.01723.x; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	74	240	252	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1073	1084		10.1016/j.cell.2009.01.033	http://dx.doi.org/10.1016/j.cell.2009.01.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303850	Green Accepted, Bronze			2022-12-24	WOS:000264403900013
J	Kearney, MK; Weininger, RB; Vachon, MLS; Harrison, RL; Mount, BM				Kearney, Michael K.; Weininger, Radhule B.; Vachon, Mary L. S.; Harrison, Richard L.; Mount, Balfour M.			Self-care of Physicians Caring for Patients at the End of Life "Being Connected ... A Key to My Survival"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WRITTEN EMOTIONAL EXPRESSION; STRESS REDUCTION; MENTAL-HEALTH; OF-LIFE; SURGICAL ONCOLOGISTS; HOSPITAL CONSULTANTS; PERSONAL WELLNESS; CONTROLLED-TRIAL; PALLIATIVE CARE; IMMUNE FUNCTION	Physicians providing end-of-life care are subject to a variety of stresses that may lead to burnout and compassion fatigue at both individual and team levels. Through the story of an oncologist, we discuss the prodromal symptoms and signs leading to burnout and compassion fatigue and present the evidence for prevention. We define and discuss factors that contribute to burnout and compassion fatigue and consider factors that may mitigate burnout. We explore the practice of empathy and discuss an approach for physicians to maximize wellness through self-awareness in the setting of caring for patients with end-stage illness. Finally, we discuss some practical applications of self-care in the workplace.	[Kearney, Michael K.] Santa Barbara Cottage Hosp, Palliat Care Serv, Santa Barbara, CA 93102 USA; [Kearney, Michael K.] Visiting Nurse & Hosp Care Santa Barbara, Santa Barbara, CA USA; [Weininger, Radhule B.] La Casa de Maria Retreat & Conf Ctr, Santa Barbara, CA USA; [Vachon, Mary L. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Vachon, Mary L. S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Harrison, Richard L.] Univ British Columbia, Counseling Psychol Program, Vancouver, BC V5Z 1M9, Canada; [Mount, Balfour M.] McGill Univ, Dept Med, Montreal, PQ, Canada	Santa Barbara Cottage Hospital; University of Toronto; University of Toronto; University of British Columbia; McGill University	Kearney, MK (corresponding author), Santa Barbara Cottage Hosp, Palliat Care Serv, POB 689,Pueblo Bath St, Santa Barbara, CA 93102 USA.	mkearney@sbch.org						Allegra CJ, 2005, J ONCOL PRACT, V1, P140, DOI 10.1200/jop.2005.1.4.140; Armstrong J, 2004, J CLIN ONCOL, V22, P4425, DOI 10.1200/JCO.2004.07.138; Arnold D, 2005, J HUMANIST PSYCHOL, V45, P239, DOI 10.1177/0022167805274729; Asai M, 2007, PSYCHO-ONCOLOGY, V16, P421, DOI 10.1002/pon.1066; Balch CM, 2007, ANN SURG ONCOL, V14, P3029, DOI 10.1245/s10434-007-9588-0; BARNARD D, 2000, CROSSING OVER NARRAT; Beddoe AE, 2004, J NURS EDUC, V43, P305; Boston PH, 2006, J PAIN SYMPTOM MANAG, V32, P13, DOI 10.1016/j.jpainsymman.2006.01.009; Brady DW, 2002, ANN INTERN MED, V137, P220, DOI 10.7326/0003-4819-137-3-200208060-00025; Bressi C, 2008, BRIT J CANCER, V98, P1046, DOI 10.1038/sj.bjc.6604270; Calhoun L., 1999, FACILITATING POSTTRA; Calhoun LG, 1998, LEA SER PER CLIN PSY, P215; Cepeda MS, 2008, J PAIN SYMPTOM MANAG, V35, P623, DOI 10.1016/j.jpainsymman.2007.08.011; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; CHARON R, 2008, NARRATIVE MED HONORI, P156; Cohen-Katz Joanne, 2004, Holist Nurs Pract, V18, P302; Coster JS, 1997, PROF PSYCHOL-RES PR, V28, P5, DOI 10.1037/0735-7028.28.1.5; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Desalvo Louise, 1999, WRITING WAY HEALING; Elit L, 2004, GYNECOL ONCOL, V94, P134, DOI 10.1016/j.ygyno.2004.04.014; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; *EUR COMM, 2004, PROM DEV INT PALL CA; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Figley C.R., 2002, TREATING COMPASSION; Figley C.R., 1995, COMPASSION FATIGUE C, DOI 10.1192/bjp.bp.114.150078; Fillion L, 2009, PSYCHO-ONCOLOGY, V18, P1300, DOI 10.1002/pon.1513; Frisina PG, 2004, J NERV MENT DIS, V192, P629, DOI 10.1097/01.nmd.0000138317.30764.63; GARFIELD C, 1995, SOMETIMES MY HEART G; Gentry J., 2002, TREATING COMPASSION; Graham J, 1996, PALLIATIVE MED, V10, P185, DOI 10.1177/026921639601000302; Graham J, 2002, EUR J CANCER CARE, V11, P188, DOI 10.1046/j.1365-2354.2002.00338.x; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Harris AHS, 2006, J CONSULT CLIN PSYCH, V74, P243, DOI 10.1037/0022-006X.74.2.243; HARRISON RL, PSYCHOTHERA IN PRESS; Haward R, 2003, BRIT J CANCER, V89, P15, DOI 10.1038/sj.bjc.6601073; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; HUGGARD PK, 2008, MANAGING COMPASSION; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Johnson T.A., 2006, PROFESSIONALS WEEP E, P3; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kash KM, 2000, ONCOLOGY-NY, V14, P1621; Kearney M, 2009, PLACE HEALING WORKIN; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Kjeldmand D, 2004, PATIENT EDUC COUNS, V55, P230, DOI 10.1016/j.pec.2003.09.009; KOBASA SC, 1982, J PERS SOC PSYCHOL, V42, P168, DOI 10.1037/0022-3514.42.1.168; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Kornfield Jack, 2008, WISE HEART GUIDE UNI; Kuerer HM, 2007, ANN SURG ONCOL, V14, P3043, DOI 10.1245/s10434-007-9579-1; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Le Blanc PM, 2007, J APPL PSYCHOL, V92, P213, DOI 10.1037/0021-9010.92.1.213; Leiter MP, 2005, NEW HORIZ MANAG, P544; Linley PA, 2005, PSYCHOTHER PSYCHOSOM, V74, P185, DOI 10.1159/000084004; Mackereth Peter A, 2005, Eur J Oncol Nurs, V9, P147, DOI 10.1016/j.ejon.2004.04.006; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C., 1996, MASLACH BURNOUT INVE; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Morgan Nancy P, 2008, Oncologist, V13, P196, DOI 10.1634/theoncologist.2007-0147; Mount BM, 2007, J PAIN SYMPTOM MANAG, V33, P372, DOI 10.1016/j.jpainsymman.2006.09.014; Muscatello MRA, 2006, PSYCHOL REP, V99, P641, DOI 10.2466/PR0.99.2.641-650; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; O'Cleirigh C, 2008, BRIT J HEALTH PSYCH, V13, P81, DOI 10.1348/135910707X250884; Pearlman L. A., 1999, SECONDARY TRAUMATIC, P51; Pennebaker JW, 1997, OPENING HEALING POWE; Perry Beth, 2008, Can Oncol Nurs J, V18, P87; Petrie KJ, 2004, PSYCHOSOM MED, V66, P272, DOI 10.1097/01.psy.0000116782.49850.d3; Pierce B, 2007, J PALLIAT CARE, V23, P32, DOI 10.1177/082585970702300105; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rabinowitz S, 1996, AAOHN J, V44, P28; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Robinson Katya, 2004, J Palliat Med, V7, P637, DOI 10.1089/jpm.2004.7.637; ROHAN EA, 2005, EXLPORATION VICARIOU; Saakvitne, 1995, TRAUMA THERAPIST COU, P31; Salston M, 2003, J TRAUMA STRESS, V16, P167, DOI 10.1023/A:1022899207206; Shanafelt T, 2006, J CLIN ONCOL, V24, P4020, DOI 10.1200/JCO.2006.05.8248; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; SHAPIRO S, 2008, MINDFULNESS THERAPEU; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; SHAPIRO SL, CASS SEM JUN 27 2008; Siegal Dan, 2017, DR DAN SIEGALS HAND; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SPANN C, 2004, POET HEALER CONT POE; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; Stamm B.H., 2002, PSYCHOSOCIAL STRESS, P107; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; TEDESCHI RG, 1995, TRAUMA TRANSFORMATIO, P43; Travado L, 2005, PSYCHO-ONCOLOGY, V14, P661, DOI 10.1002/pon.890; Vachon M., 2007, PRINCIPLES PRACTICE, V3rd, P667; VACHON MLS, 1995, PALLIATIVE MED, V9, P91, DOI 10.1177/026921639500900202; Vachon MLS, 2009, HDB PSYCHIAT PALLIAT; Vachon MLS., 1987, OCCUPATIONAL STRESS; VACHON MLS, 2008, PALLIATIVE MED, P75; VACHON MLS, PSYCHOONCOL IN PRESS; Valent P., 2002, TREATING COMPASSION, P17; Wallace BA, 2006, AM PSYCHOL, V61, P690, DOI 10.1037/0003-066X.61.7.690; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Whippen DA, 2004, J CLIN ONCOL, V22, p532S; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Wright B, 2004, PALLIATIVE MED, V18, P3, DOI 10.1191/0269216304pm866ed	111	257	262	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1155	1164		10.1001/jama.2009.352	http://dx.doi.org/10.1001/jama.2009.352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419UC	19293416				2022-12-24	WOS:000264244200021
J	Shi, YM; Tyson, GW; DeLong, EF				Shi, Yanmei; Tyson, Gene W.; DeLong, Edward F.			Metatranscriptomics reveals unique microbial small RNAs in the ocean's water column	NATURE			English	Article							NONCODING RNAS; GENES; EXPRESSION; IDENTIFICATION; RIBOSWITCHES; PREDICTION; SEQUENCES; ALIGNMENT; DATABASE	Microbial gene expression in the environment has recently been assessed via pyrosequencing of total RNA extracted directly from natural microbial assemblages. Several such 'metatranscriptomic' studies(1,2) have reported that many complementary DNA sequences shared no significant homology with known peptide sequences, and so might represent transcripts from uncharacterized proteins. Here we report that a large fraction of cDNA sequences detected in microbial metatranscriptomic data sets are comprised of well-known small RNAs ( sRNAs) 3, as well as new groups of previously unrecognized putative sRNAs ( psRNAs). These psRNAs mapped specifically to intergenic regions of microbial genomes recovered from similar habitats, displayed characteristic conserved secondary structures and were frequently flanked by genes that indicated potential regulatory functions. Depth-dependent variation of psRNAs generally reflected known depth distributions of broad taxonomic groups(4), but fine-scale differences in the psRNAs within closely related populations indicated potential roles in niche adaptation. Genome-specific mapping of a subset of psRNAs derived from predominant planktonic species such as Pelagibacter revealed recently discovered as well as potentially new regulatory elements. Our analyses show that metatranscriptomic data sets can reveal new information about the diversity, taxonomic distribution and abundance of sRNAs in naturally occurring microbial communities, and indicate their involvement in environmentally relevant processes including carbon metabolism and nutrient acquisition.	[Shi, Yanmei; Tyson, Gene W.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu	Tyson, Gene W/C-6558-2013	Tyson, Gene W/0000-0001-8559-9427	Craig Venter Institute; Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter [HTCC7211]; Gordon and Betty Moore Foundation; National Science Foundation Microbial Observatory [MCB-0348001]; Department of Energy Genomics GTL Program; Department of Energy Microbial Genomics Program; NSF Science and Technology award; C-MORE	Craig Venter Institute; Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation Microbial Observatory(National Science Foundation (NSF)); Department of Energy Genomics GTL Program(United States Department of Energy (DOE)); Department of Energy Microbial Genomics Program(United States Department of Energy (DOE)); NSF Science and Technology award(National Science Foundation (NSF)); C-MORE	We are grateful to the University of Hawaii HOT team, and the captain and crew of the RV Kilo Moana for their expert assistance at sea. We also thank S. Schuster for collaboration and advice on pyrosequencing, J. Eppley for help with computational analyses and discussion, and J. Maresca, A. Martinez, J. McCarren and V. Rich for their comments on this manuscript. We thank S. Giovannoni, J. Tripp and M. Schwalbach for sharing their in press manuscript on Pelagibacter riboswitches, and S. Giovannoni, U. Stingl, the J. Craig Venter Institute and the Gordon and Betty Moore Foundation for the genome sequence of Pelagibacter strain HTCC7211. This work was supported by the Gordon and Betty Moore Foundation, National Science Foundation Microbial Observatory Award MCB-0348001, the Department of Energy Genomics GTL Program, the Department of Energy Microbial Genomics Program, and an NSF Science and Technology award, C-MORE. This article is a contribution from the NSF Science and Technology Center for Microbial Oceanography: Research and Education (C- MORE).	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Bruttin A, 1996, VIROLOGY, V219, P96, DOI 10.1006/viro.1996.0226; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; EDDY S, 2007, INFERNAL USERS GUIDE; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Holste D, 2000, J MOL EVOL, V51, P353, DOI 10.1007/s002390010097; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; JASON S, 2000, SIGBIO NEWSL, V20, P13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Re M, 2007, LECT NOTES ARTIF INT, V4578, P544; Rudd KE, 2000, NUCLEIC ACIDS RES, V28, P60, DOI 10.1093/nar/28.1.60; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schattner P, 2002, NUCLEIC ACIDS RES, V30, P2076, DOI 10.1093/nar/30.9.2076; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Storz G, 2007, CURR OPIN MICROBIOL, V10, P93, DOI 10.1016/j.mib.2007.03.017; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wendisch VF, 2001, ANAL BIOCHEM, V290, P205, DOI 10.1006/abio.2000.4982; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126	46	192	202	3	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					266	U154		10.1038/nature08055	http://dx.doi.org/10.1038/nature08055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444216				2022-12-24	WOS:000266036100044
J	Livingston, DM				Livingston, David M.			Complicated Supercomplexes	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; FANCONI-ANEMIA; PALB2; MUTATIONS; PARTNER		[Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu						Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Goggins M, 1996, CANCER RES, V56, P5360; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	14	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					602	603		10.1126/science.1174839	http://dx.doi.org/10.1126/science.1174839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407191				2022-12-24	WOS:000265608800031
J	Grigoryan, G; Reinke, AW; Keating, AE				Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.			Design of protein-interaction specificity gives selective bZIP-binding peptides	NATURE			English	Article							COILED-COIL; PDZ DOMAIN; COMPUTATIONAL REDESIGN; PREDICTION; STABILITY; INTERFACES; AFFINITY; ENERGY	Interaction specificity is a required feature of biological networks and a necessary characteristic of protein or small-molecule reagents and therapeutics. The ability to alter or inhibit protein interactions selectively would advance basic and applied molecular science. Assessing or modelling interaction specificity requires treating multiple competing complexes, which presents computational and experimental challenges. Here we present a computational framework for designing protein-interaction specificity and use it to identify specific peptide partners for human basic-region leucine zipper (bZIP) transcription factors. Protein microarrays were used to characterize designed, synthetic ligands for all but one of 20 bZIP families. The bZIP proteins share strong sequence and structural similarities and thus are challenging targets to bind specifically. Nevertheless, many of the designs, including examples that bind the oncoproteins c-Jun, c-Fos and c-Maf (also called JUN, FOS and MAF, respectively), were selective for their targets over all 19 other families. Collectively, the designs exhibit a wide range of interaction profiles and demonstrate that human bZIPs have only sparsely sampled the possible interaction space accessible to them. Our computational method provides a way to systematically analyse trade-offs between stability and specificity and is suitable for use with many types of structure-scoring functions; thus, it may prove broadly useful as a tool for protein design.	[Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Reinke, Aaron/0000-0001-7612-5342; Keating, Amy/0000-0003-4074-8980	NIH [GM67681]; NSF [0216437]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH award GM67681 and used computer equipment purchased under the NSF award 0216437. We thank the MIT BioMicro center for arraying instrumentation and R. T. Sauer, M. Singh, B. Tidor, M. Laub, T. A. Baker, J. H. Davis, M. S. Kay, J. R. S. Newman, W. F. DeGrado and members of the Keating laboratory, especially O. Ashenberg and T. C. S. Chen, for comments on the manuscript.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Ali MH, 2005, STRUCTURE, V13, P225, DOI 10.1016/j.str.2004.12.009; APGAR JR, J COMPUT CH IN PRESS; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Grigoryan G, 2006, J MOL BIOL, V355, P1125, DOI 10.1016/j.jmb.2005.11.036; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kangas E, 2000, J CHEM PHYS, V112, P9120, DOI 10.1063/1.481522; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhou F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.148103; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	38	275	281	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					859	U2		10.1038/nature07885	http://dx.doi.org/10.1038/nature07885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370028	Green Accepted			2022-12-24	WOS:000265182500036
J	MacGregor, GA; de Wardener, HE				MacGregor, Graham A.; de Wardener, Hugh E.			The French salt industry in court	LANCET			English	Editorial Material							RISK		[MacGregor, Graham A.] Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England; [de Wardener, Hugh E.] Univ London Imperial Coll Sci Technol & Med, London, England	St Georges University London; University of London; Imperial College London	MacGregor, GA (corresponding author), Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England.	g.macgregor@sgul.ac.uk						ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; de Wardener HE, 1999, J HUM HYPERTENS, V13, P1, DOI 10.1038/sj.jhh.1000759; *FDN SCI CIT, 2008, NOT LIB ACT BROUGHT; *FRENCH FOOD SAF A, 2002, REP SALT EV REC; *NAT AC MED, 2004, REP SALT INT BLOOD P; 2008, LIBERATION FR   0313; 2006, SALT SKIP NEWS, V140, P4	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					990	992		10.1016/S0140-6736(09)60589-4	http://dx.doi.org/10.1016/S0140-6736(09)60589-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304002				2022-12-24	WOS:000264398200010
J	Slade, D; Lindner, AB; Paul, G; Radman, M				Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav			Recombination and Replication in DNA Repair of Heavily Irradiated Deinococcus radiodurans	CELL			English	Article							BREAK-INDUCED REPLICATION; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; TARGETED MUTAGENESIS; MICROCOCCUS; POLYMERASE; RADIATION; PROTEIN; DAMAGE; RADIORESISTANCE	Deinococcus radiodurans' extreme resistance to ionizing radiation, desiccation, and DNA-damaging chemicals involves a robust DNA repair that reassembles its shattered genome. The repair process requires diploidy and commences with an extensive exonucleolytic erosion of DNA fragments. Liberated single-stranded overhangs prime strand elongation on overlapping fragments and the elongated complementary strands reestablish chromosomal contiguity by annealing. We explored the interdependence of the DNA recombination and replication processes in the reconstitution of the D. radiodurans genome disintegrated by ionizing radiation. The priming of extensive DNA repair synthesis involves RecA and RadA proteins. DNA polymerase III is essential for the initiation of repair synthesis, whereas efficient elongation requires DNA polymerases I and III. Inactivation of both polymerases leads to degradation of DNA fragments and rapid cell death. The present in vivo characterization of key recombination and replication processes dissects the mechanism of DNA repair in heavily irradiated D. radiodurans.	[Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav] Univ Paris 05, Fac Med, INSERM, U571, F-75015 Paris, France; [Radman, Miroslav] Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), Univ Paris 05, Fac Med, INSERM, U571, 156 Rue Vaugirard, F-75015 Paris, France.	miroslav.radman@inserm.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; Radman, Miroslav/0000-0002-7034-4365; Slade, Dea/0000-0002-0052-5910; Radman, Miroslav/0000-0003-0216-3148	Institut National de la Sante et de la Recherche Medicale (INSERM); Boehringer Ingelheim Fonds	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	D. S. wishes to thank Dragana Ahel and Rupert Thorough for revision and editing of the manuscript. We thank Marina Elez and Dennis R. Harris for comments pertaining to the manuscript. We acknowledge generous gifts: Mary E. Lidstrom for pRAD1, John R. Battista for the polA mutant, and Suzanne Sommer for the recA mutant. We also thank Sophie Viel at Institut Curie in Paris for using <SUP>137</SUP>Cs gamma-ray source, Kathleen Smith of Eucodis for lending the PFGE equipment, and Gely Chantal of INSERM unit 876 for using the scintillation counter. This work was funded by Institut National de la Sante et de la Recherche Medicale (INSERM). D. S. is a Boehringer Ingelheim Fonds Ph. D. fellow. D. S. carried out all the experiments. D. S. and M. R. designed the experiments. D. S., A. B. L., and M. R. interpreted the results. G. P. computed an algorithm for quantitative analysis of PFGE gels. D. S. and M. R. wrote the manuscript.	ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; DRIEDGER A A, 1970, Radiation Research, V44, P835, DOI 10.2307/3573160; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HARSOJO KS, 1981, J BIOCH, V90, P877; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kornberg A., 1992, DNA REPLICATION; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; LETT JT, 1970, J MOL BIOL, V48, P395, DOI 10.1016/0022-2836(70)90053-7; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MOSELEY BEB, 1975, J BACTERIOL, V121, P422, DOI 10.1128/JB.121.2.422-428.1975; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Vandewiele D, 2002, MUTAT RES-FUND MOL M, V499, P85, DOI 10.1016/S0027-5107(01)00268-8; VUKOVICNAGY B, 1974, INT J RADIAT BIOL, V25, P329, DOI 10.1080/09553007414550401; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Xu WL, 2001, MOL MICROBIOL, V39, P286, DOI 10.1046/j.1365-2958.2001.02267.x; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou Q, 2006, CHINESE SCI BULL, V51, P2993, DOI 10.1007/s11434-006-2209-7	42	177	191	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1044	1055		10.1016/j.cell.2009.01.018	http://dx.doi.org/10.1016/j.cell.2009.01.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303848	Bronze			2022-12-24	WOS:000264403900011
J	Caplan, AL; Patrizio, P				Caplan, Arthur L.; Patrizio, Pasquale			The beginning of the end of the embryo wars	LANCET			English	Editorial Material									[Caplan, Arthur L.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; [Patrizio, Pasquale] Yale Univ, Fertil Ctr, New Haven, CT USA	University of Pennsylvania; Yale University	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu	Patrizio, Pasquale/AGO-0674-2022					Caplan AL, 2007, SOCIETY, V44, P26, DOI 10.1007/BF02919513; George R.P., 2008, EMBRYO DEFENSE HUMAN; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; Guenin LM, 2008, MORALITY OF EMBRYO USE, P1; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Ord T, 2008, AM J BIOETHICS, V8, P12, DOI 10.1080/15265160802248146; Quinn B., 2009, GUARDIAN	7	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1074	1075		10.1016/S0140-6736(09)60638-3	http://dx.doi.org/10.1016/S0140-6736(09)60638-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19338071				2022-12-24	WOS:000264773600015
J	Park, S; Roelofs, J; Kim, W; Robert, J; Schmidt, M; Gygi, SP; Finley, D				Park, Soyeon; Roelofs, Jeroen; Kim, Woong; Robert, Jessica; Schmidt, Marion; Gygi, Steven P.; Finley, Daniel			Hexameric assembly of the proteasomal ATPases is templated through their C termini	NATURE			English	Article							19S REGULATORY PARTICLE; 26 S-PROTEASOME; 20S PROTEASOMES; STRUCTURAL BASIS; COMPLEX; YEAST; PROTEINS; SUBUNITS; PATHWAY; DEGRADATION	Substrates of the proteasome are recognized and unfolded by the regulatory particle, and then translocated into the core particle (CP) to be degraded(1). A hetero-hexameric ATPase ring, containing subunits Rpt1-6, is situated within the base subassembly of the regulatory particle(1). The ATPase ring sits atop the CP, with the Rpt carboxy termini inserted into pockets in the CP2-6. Here we identify a previously unknown function of the Rpt proteins in proteasome biogenesis through deleting the C-terminal residue from each Rpt in the yeast Saccharomyces cerevisiae. Our results indicate that assembly of the hexameric ATPase ring is templated on the CP. We have also identified an apparent intermediate in base assembly, BP1, which contains Rpn1, three Rpts and Hsm3, a chaperone for base assembly. The Rpt proteins with the strongest assembly phenotypes, Rpt4 and Rpt6, were absent from BP1. We propose that Rpt4 and Rpt6 form a nucleating complex to initiate base assembly, and that this complex is subsequently joined by BP1 to complete the Rpt ring. Our studies show that assembly of the proteasome base is a rapid yet highly orchestrated process.	[Park, Soyeon; Roelofs, Jeroen; Kim, Woong; Robert, Jessica; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465	US National Institutes of Health (NIH) [GM043601, GM67945]; EMBO; NIH NRSA [5F32GM75737-2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084228, R37GM043601, R01GM067945, F32GM075737, R01GM043601] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. D. Orth for discussion and technical assistance, and C. Hill for discussions. We also thank J. W. Hanna, S. Elsasser and all members of Finley laboratory for comments on the manuscript. The work was supported by grants from US National Institutes of Health (NIH) to D. F. (GM043601) and S. P. G. (GM67945), an EMBO long-term fellowship to J. R. and an NIH NRSA postdoctoral fellowship (5F32GM75737-2) to S. P.	Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guthrie C, 1991, GUIDE YEAST GENETICS; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	30	105	110	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					866	U9		10.1038/nature08065	http://dx.doi.org/10.1038/nature08065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19412160	Green Accepted			2022-12-24	WOS:000267084500044
J	Guerin, E; Cambray, G; Sanchez-Alberola, N; Campoy, S; Erill, I; Da Re, S; Gonzalez-Zorn, B; Barbe, J; Ploy, MC; Mazel, D				Guerin, Emilie; Cambray, Guillaume; Sanchez-Alberola, Neus; Campoy, Susana; Erill, Ivan; Da Re, Sandra; Gonzalez-Zorn, Bruno; Barbe, Jordi; Ploy, Marie-Cecile; Mazel, Didier			The SOS Response Controls Integron Recombination	SCIENCE			English	Article							ANTIBIOTIC-RESISTANCE		[Cambray, Guillaume; Mazel, Didier] CNRS, URA 2171, Inst Pasteur, F-75015 Paris, France; [Guerin, Emilie; Da Re, Sandra; Ploy, Marie-Cecile] Univ Limoges, Fac Med, EA3175, INSERM,Equipe Avenir, F-87000 Limoges, France; [Sanchez-Alberola, Neus; Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Erill, Ivan] CSIC, CNM, IMB, Biomed Applicat Grp, Barcelona 08193, Spain; [Gonzalez-Zorn, Bruno] Univ Complutense Madrid, Dept Sanidad Anim, E-28040 Madrid, Spain; [Gonzalez-Zorn, Bruno] Univ Complutense Madrid, VISAVET Ctr Vigilancia Sanitaria Vet, E-28040 Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); Complutense University of Madrid; Complutense University of Madrid	Mazel, D (corresponding author), CNRS, URA 2171, Inst Pasteur, F-75015 Paris, France.	mazel@pasteur.fr	Mazel, Didier/F-9200-2013; Sanz, Mar/G-2116-2011; Barbe, Jordi/G-5212-2015; campoy, susana/E-4346-2010; Cambray, Guillaume/A-9476-2015; Campoy, Susana/C-7335-2008; Da Re, Sandra/F-6383-2011; studies, IT VISAVET Account for bibliometric/C-3115-2014; Erill, Ivan/H-9405-2015; Ploy, Marie-Cécile/O-7501-2016	Mazel, Didier/0000-0001-6482-6002; Barbe, Jordi/0000-0003-4408-013X; campoy, susana/0000-0003-1369-0197; Cambray, Guillaume/0000-0003-0087-2469; Campoy, Susana/0000-0003-1369-0197; Da Re, Sandra/0000-0003-3579-9185; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Erill, Ivan/0000-0002-7280-7191; 	Ministere de l Enseignement Superieur et de la Recherche; Conseil Regional du Limousin; Fondation pour la Recherche Medicale (FRM); Institut National de la Sante et de la Recherche Medicale; Institut Pasteur; Centre National de la Recherche Scientifique; European Union [STREP CRAB, LSHM-CT-2005-019023, MED-VET-NET, FOOD-CT-2004-506122]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-01078/BMC, GEN2006-27767-E/PAT]; Catalunya Generalitat [2005SGR-533]	Ministere de l Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalunya Generalitat	M.-C.P. acknowledges support by grants from the Ministere de l Enseignement Superieur et de la Recherche, the Conseil Regional du Limousin, the Fondation pour la Recherche Medicale (FRM), and Institut National de la Sante et de la Recherche Medicale; D.M. from the Institut Pasteur, the Centre National de la Recherche Scientifique, the FRM, and the European Union (STREP CRAB, LSHM-CT-2005-019023); J.B. from the Spanish Ministerio de Ciencia e Innovacion (MICINN) (BFU2008-01078/BMC) and the Catalunya Generalitat (2005SGR-533); and B.G.Z. from the MICINN (GEN2006-27767-E/PAT) and European Union (MED-VET-NET and FOOD-CT-2004-506122). The GenBank accessions for the sequences shown in Fig. 1 are AF055586 [GenBank] (Vch CI), AY014398 [GenBank] (Vme CI), AY014399 [GenBank] (Vpa CI), AY181034 [GenBank] (Vna CI), AF034958 [GenBank] (cl1-MI), AJ001816 [GenBank] (cl2-MI), AB070224 [GenBank] (cl3-MI), and AJ277063 [GenBank] (cl5-MI).	Aertsen A, 2006, TRENDS MICROBIOL, V14, P421, DOI 10.1016/j.tim.2006.08.006; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462	5	286	306	9	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1034	1034		10.1126/science.1172914	http://dx.doi.org/10.1126/science.1172914			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460999				2022-12-24	WOS:000266246700032
J	Fairen, AG; Davila, AF; Gago-Duport, L; Amils, R; McKay, CP				Fairen, Alberto G.; Davila, Alfonso F.; Gago-Duport, Luis; Amils, Ricardo; McKay, Christopher P.			Stability against freezing of aqueous solutions on early Mars	NATURE			English	Article							CARBON-DIOXIDE CLOUDS; WATER; ATMOSPHERES; CLIMATE; EARTH	Many features of the Martian landscape are thought to have been formed by liquid water flow(1,2) and water-related mineralogies on the surface of Mars are widespread and abundant(3). Several lines of evidence, however, suggest that Mars has been cold with mean global temperatures well below the freezing point of pure water(4). Martian climate modellers(5,6) considering a combination of greenhouse gases at a range of partial pressures find it challenging to simulate global mean Martian surface temperatures above 273 K, and local thermal sources(7,8) cannot account for the widespread distribution of hydrated and evaporitic minerals throughout the Martian landscape(3). Solutes could depress the melting point of water(9,10) in a frozen Martian environment, providing a plausible solution to the early Mars climate paradox. Here we model the freezing and evaporation processes of Martian fluids with a composition resulting from the weathering of basalts, as reflected in the chemical compositions at Mars landing sites. Our results show that a significant fraction of weathering fluids loaded with Si, Fe, S, Mg, Ca, Cl, Na, K and Al remain in the liquid state at temperatures well below 273 K. We tested our model by analysing the mineralogies yielded by the evolution of the solutions: the resulting mineral assemblages are analogous to those actually identified on the Martian surface. This stability against freezing of Martian fluids can explain saline liquid water activity on the surface of Mars at mean global temperatures well below 273 K.	[Fairen, Alberto G.; Davila, Alfonso F.; McKay, Christopher P.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA; [Gago-Duport, Luis] Univ Vigo, Dept Geociencias Marinas, Vigo 36200, Spain; [Amils, Ricardo] CSIC INTA, Ctr Astrobiol, Madrid 28850, Spain; [Amils, Ricardo] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Fairen, AG (corresponding author), NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA.	alberto.g.fairen@nasa.gov	Davila, Alfonso/A-2198-2013; Gago-Duport, Luis/ABG-3623-2020; Amils, Ricardo/X-2706-2019	Davila, Alfonso/0000-0002-0977-9909; Gago-Duport, Luis/0000-0002-5536-2565; 	ORAU-NPP	ORAU-NPP	Work by A. G. F. and A. F. D. was supported by ORAU-NPP. We thank J. Kasting and J. Kargel for reviews that significantly improved the paper.	Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Chevrier V, 2007, NATURE, V448, P60, DOI 10.1038/nature05961; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001967; Debye P, 1923, PHYS Z, V24, P185; Fairen AG, 2009, PLANET SPACE SCI, V57, P276, DOI 10.1016/j.pss.2008.11.008; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Gaidos E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002000; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Johnson SS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002962; Karunatillake S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002859; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Kasting JF, 1997, SCIENCE, V276, P1213, DOI 10.1126/science.276.5316.1213; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; Kuz'min R. O., 1998, Solar System Research, V32, P187; Marion GM, 2008, GEOCHIM COSMOCHIM AC, V72, P242, DOI 10.1016/j.gca.2007.10.012; Marion GM, 2008, ADV ASTROBIOL BIOGEO, P101; Osterloo MM, 2008, SCIENCE, V319, P1651, DOI 10.1126/science.1150690; PARKHURST DL, 1999, 994259 US GEOL RES I; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pitzer KS., 1995, THERMODYNAMICS; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432	30	96	97	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					401	404		10.1038/nature07978	http://dx.doi.org/10.1038/nature07978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458717	Green Published			2022-12-24	WOS:000266243700040
J	Cole, DG; Snell, WJ				Cole, Douglas G.; Snell, William J.			SnapShot: Intraflagellar Transport	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS; CHLAMYDOMONAS; IFT		[Cole, Douglas G.] Univ Idaho, Moscow, ID 83843 USA; [Snell, William J.] UT SW Med Ctr, Dallas, TX USA	Idaho; University of Idaho; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cole, DG (corresponding author), Univ Idaho, Moscow, ID 83843 USA.				NIGMS NIH HHS [R01 GM025661] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Harris E.H., 2009, CHLAMYDOMONAS SOURCE, V1; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044	10	52	58	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					784	U202		10.1016/j.cell.2009.04.053	http://dx.doi.org/10.1016/j.cell.2009.04.053			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450523	Bronze			2022-12-24	WOS:000266114100025
J	McSween, HY; Taylor, GJ; Wyatt, MB				McSween, Harry Y., Jr.; Taylor, G. Jeffrey; Wyatt, Michael B.			Elemental Composition of the Martian Crust	SCIENCE			English	Review							THERMAL EMISSION-SPECTROSCOPY; CHEMICAL-COMPOSITION; MARS; TERRESTRIAL; ROCKS; CONSTRAINTS; ACCRETION; ORIGIN; SOILS	The composition of Mars' crust records the planet's integrated geologic history and provides clues to its differentiation. Spacecraft and meteorite data now provide a global view of the chemistry of the igneous crust that can be used to assess this history. Surface rocks on Mars are dominantly tholeiitic basalts formed by extensive partial melting and are not highly weathered. Siliceous or calc-alkaline rocks produced by melting and/or fractional crystallization of hydrated, recycled mantle sources, and silica-poor rocks produced by limited melting of alkali-rich mantle sources, are uncommon or absent. Spacecraft data suggest that martian meteorites are not representative of older, more voluminous crust and prompt questions about their use in defining diagnostic geochemical characteristics and in constraining mantle compositional models for Mars.	[McSween, Harry Y., Jr.] Univ Tennessee, Planetary Geosci Inst, Knoxville, TN 37996 USA; [McSween, Harry Y., Jr.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Taylor, G. Jeffrey] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Wyatt, Michael B.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Hawaii System; University of Hawaii Manoa; Brown University	McSween, HY (corresponding author), Univ Tennessee, Planetary Geosci Inst, Knoxville, TN 37996 USA.	mcsween@utk.edu						[Anonymous], 2005, ANTARCTIC METEORITE; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2005, NATURE, V436, P504, DOI 10.1038/nature03639; CHRISTENSEN PR, 1992, J GEOPHYS RES-PLANET, V97, P7719, DOI 10.1029/92JE00453; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Filiberto J, 2008, ICARUS, V197, P52, DOI 10.1016/j.icarus.2008.04.016; FOLEY CN, 2003, J GEOPHYS RES, V108; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Greeley R, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002401; Halliday AN, 2001, SPACE SCI REV, V96, P197, DOI 10.1023/A:1011997206080; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002515; LONGHI J, 1991, P LUNAR PLANET SCI, V21, P695; McBirney A.R., 2007, IGNEOUS PETROLOGY, V3rd; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; McSween HY, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002970; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; MCSWEEN HY, 1998, REV MINERAL, V36; Meyer C, 2006, 27672 JSC NASA; Michalski JR, 2005, ICARUS, V174, P161, DOI 10.1016/j.icarus.2004.10.022; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; *NASA, NNG06GG36G NASA; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; OURI Y, 2003, ANTARC MET RES, V16, P80; PAPIKE JJ, 1998, REV MINERAL, V36; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Wyatt MB, 2004, GEOLOGY, V32, P645, DOI 10.1130/G20527.1; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356; Zipfel J, 2004, METEORIT PLANET SCI, V39, pA118	36	315	319	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					736	739		10.1126/science.1165871	http://dx.doi.org/10.1126/science.1165871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423810				2022-12-24	WOS:000265832400029
J	Omabegho, T; Sha, R; Seeman, NC				Omabegho, Tosan; Sha, Ruojie; Seeman, Nadrian C.			A Bipedal DNA Brownian Motor with Coordinated Legs	SCIENCE			English	Article							DOUBLE-CROSSOVER MOLECULES; SINGLE-STRANDED-DNA; FLEXIBILITY; TRANSPORT; KINETICS	A substantial challenge in engineering molecular motors is designing mechanisms to coordinate the motion between multiple domains of the motor so as to bias random thermal motion. For bipedal motors, this challenge takes the form of coordinating the movement of the biped's legs so that they can move in a synchronized fashion. To address this problem, we have constructed an autonomous DNA bipedal walker that coordinates the action of its two legs by cyclically catalyzing the hybridization of metastable DNA fuel strands. This process leads to a chemically ratcheted walk along a directionally polar DNA track. By covalently cross-linking aliquots of the walker to its track in successive walking states, we demonstrate that this Brownian motor can complete a full walking cycle on a track whose length could be extended for longer walks. We believe that this study helps to uncover principles behind the design of unidirectional devices that can function without intervention. This device should be able to fulfill roles that entail the performance of useful mechanical work on the nanometer scale.	[Sha, Ruojie; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Omabegho, Tosan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	New York University; Harvard University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			National Institute of General Medical Sciences; NSF; Army Research Office; Office of Naval Research; New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Army Research Office; Office of Naval Research(Office of Naval Research); New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mao, H. Yan, and N. Jonoska for critical reading of the manuscript. This research has been supported by grants to N.C.S. from the National Institute of General Medical Sciences, NSF, the Army Research Office, the Office of Naval Research, the New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy, and the W. M. Keck Foundation.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; GIA O, 1992, BIOCHEMISTRY-US, V31, P11818, DOI 10.1021/bi00162a021; Green SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238101; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Shapiro E, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0506-44; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	24	453	467	3	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					67	71		10.1126/science.1170336	http://dx.doi.org/10.1126/science.1170336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342582	Green Accepted			2022-12-24	WOS:000264802100032
J	Francis, NJ; Follmer, NE; Simon, MD; Aghia, G; Butler, JD				Francis, Nicole J.; Follmer, Nicole E.; Simon, Matthew D.; Aghia, George; Butler, Jeffrey D.			Polycomb Proteins Remain Bound to Chromatin and DNA during DNA Replication In Vitro	CELL			English	Article							GENOME-WIDE ANALYSIS; SIMIAN VIRUS-40 DNA; EARLY MOUSE EMBRYOS; HISTONE H3; TRANSCRIBING POLYMERASE; DROSOPHILA-MELANOGASTER; POLYTENE CHROMOSOMES; H2A UBIQUITYLATION; REPRESSIVE COMPLEX; CELLS	The transcriptional status of a gene can be maintained through multiple rounds of cell division during development. This epigenetic effect is believed to reflect heritable changes in chromatin folding and histone modifications or variants at target genes, but little is known about how these chromatin features are inherited through cell division. A particular challenge for maintaining transcription states is DNA replication, which disrupts or dilutes chromatin-associated proteins and histone modifications. PRC1-class Polycomb group protein complexes are essential for development and are thought to heritably silence transcription by altering chromatin folding and histone modifications. It is not known whether these complexes and their effects are maintained during DNA replication or subsequently re-established. We find that when PRC1-class Polycomb complex-bound chromatin or DNA is replicated in vitro, Polycomb complexes remain bound to replicated templates. Retention of Polycomb proteins through DNA replication may contribute to maintenance of transcriptional silencing through cell division.	[Francis, Nicole J.; Follmer, Nicole E.; Aghia, George; Butler, Jeffrey D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, Matthew D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Francis, NJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	francis@mcb.harvard.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	National Institutes of Health [GM078456-01]; Searle Scholar award; March of Dimes Basil O'Connor Scholar award; Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; March of Dimes Basil O'Connor Scholar award(March of Dimes); Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kingston, T. Maniatis, W. M. Michael, N. Kleckner, A. Murray, A. Mazo, L. Kobrossy, B. Lengsfeld, and S. Lo for advice and support throughout the project and J. Muller, R. Jones, B. Stillman, and W. M. Michael for reagents. This work was supported by the National Institutes of Health (GM078456-01), a Searle Scholar award and a March of Dimes Basil O'Connor Scholar award to N.J.F., and a Helen Hay Whitney fellowship to M.D.S.	Abmayr S. M., 2006, CURRENT PROTOCOLS MO, P1211; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Azuara V, 2006, NAT PROTOC, V1, P2171, DOI 10.1038/nprot.2006.353; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Beuchle D, 2001, DEVELOPMENT, V128, P993; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; JACKMAN J, 2003, METHODS SYNCHRONIZIN; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kohn KW, 2008, MOL BIOL CELL, V19, P1, DOI 10.1091/mbc.E07-06-0528; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moshkin YM, 2001, P NATL ACAD SCI USA, V98, P570, DOI 10.1073/pnas.021353598; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Poux S, 2001, DEVELOPMENT, V128, P75; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009	71	133	134	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					110	122		10.1016/j.cell.2009.02.017	http://dx.doi.org/10.1016/j.cell.2009.02.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19303136	Green Accepted, Bronze			2022-12-24	WOS:000264813300018
J	Weijers, D; Friml, J				Weijers, Dolf; Friml, Jiri			SnapShot: Auxin Signaling and Transport	CELL			English	Editorial Material							PLANT DEVELOPMENT; RECEPTORS; TIR1		[Weijers, Dolf] Wageningen Univ, NL-6703 HA Wageningen, Netherlands; VIB, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent, B-9052 Ghent, Belgium	Wageningen University & Research; Flanders Institute for Biotechnology (VIB); Ghent University	Weijers, D (corresponding author), Wageningen Univ, NL-6703 HA Wageningen, Netherlands.		Friml, Jiri/D-9511-2012; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Friml, Jiri/0000-0002-8302-7596; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X				Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006	8	33	37	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 20	2009	136	6					1172	U200	1172.e1	10.1016/j.cell.2009.03.009	http://dx.doi.org/10.1016/j.cell.2009.03.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303857	Green Published, Bronze			2022-12-24	WOS:000264403900021
J	Wong, RHF; Chang, I; Hudak, CSS; Hyun, S; Kwan, HY; Sul, HS				Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook			A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin	CELL			English	Article							FATTY-ACID SYNTHASE; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEPENDENT PROTEIN-KINASE; UPSTREAM STIMULATORY FACTORS; HORMONAL-REGULATION; IN-VIVO; NUTRITIONAL REGULATION; TRANSGENIC MICE; E-BOX; PROMOTER	Fatty acid synthase (FAS) is a central enzyme in lipogenesis and transcriptionally activated in response to feeding and insulin signaling. The transcription factor USF is required for the activation of FAS transcription, and we show here that USF phosphorylation by DNA-PK, which is dephosphorylated by PP1 in response to feeding, triggers a switch-like mechanism. Under fasting conditions, USF-1 is deacetylated by HDAC9, causing promoter inactivation. In contrast, feeding induces the recruitment of DNA-PK to USF-1 and its phosphorylation, which then allows recruitment of P/CAF, resulting in USF-1 acetylation and FAS promoter activation. DNA break/repair components associated with USF induce transient DNA breaks during FAS activation. In DNA-PK-deficient SCID mice, feeding-induced USF-1 phosphorylation/acetylation, DNA breaks, and FAS activation leading to lipogenesis are impaired, resulting in decreased triglyceride levels. Our study demonstrates that a kinase central to the DNA damage response mediates metabolic gene activation.	[Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Wong, Roger H. F.; Sul, Hei Sook] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Han, Zaiqi/AAI-2233-2019; Wong, Hoi Fung Roger/F-2044-2013	KWAN, Hiu Yee/0000-0002-6088-7323	NIH [DK81098, DK75682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081098, T32DK061918, R01DK075682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK81098 and DK75682 to H. S. S. We are grateful to Drs. Tony Kouzarides, Kathy Meek, Arthur Zelent, Angus Lamond, Moshe Oren, and Jerry Shay for various HAT, DNA-PK, HDAC9, PP1, -0.7 p53-Luc and Kus constructs, respectively. We thank YongEun Lee, Shelley Ling, Nicole Cho, Eunice Kim, Philip Lee, JiHyun (Amy) Cho, Aabid Farukhi, Sue Lee, and Helen Wong for excellent technical assistance; Jenny Huang, Aditi Ananth, Melanie Ma, Fanny Yan, and Nayoung Bae for assistance; and Drs. Mary Ann Williams, Jen-Chywan (Wally) Wang, and Maryam Ahmadian for critical reading of the manuscript. We also thank Dr. Donald Scott for nuclear run-on protocol, and we thank Dr. Daniel P. Cashman for critical discussions of the data and review of the manuscript.	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Griffin MJ, 2007, J BIOL CHEM, V282, P5453, DOI 10.1074/jbc.M610566200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hashimoto M, 2003, J RADIAT RES, V44, P151, DOI 10.1269/jrr.44.151; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.38.22135; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Moon YS, 2000, J BIOL CHEM, V275, P10121, DOI 10.1074/jbc.275.14.10121; MOUSTAID N, 1991, J BIOL CHEM, V266, P18550; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029	42	179	186	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1056	1072		10.1016/j.cell.2008.12.040	http://dx.doi.org/10.1016/j.cell.2008.12.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303849	Bronze, Green Accepted			2022-12-24	WOS:000264403900012
J	Zebker, HA; Stiles, B; Hensley, S; Lorenz, R; Kirk, RL; Lunine, J				Zebker, Howard A.; Stiles, Bryan; Hensley, Scott; Lorenz, Ralph; Kirk, Randolph L.; Lunine, Jonathan			Size and Shape of Saturn's Moon Titan	SCIENCE			English	Article							RADAR; ORIGIN; PLANETS; LAKES	Cassini observations show that Saturn's moon Titan is slightly oblate. A fourth-order spherical harmonic expansion yields north polar, south polar, and mean equatorial radii of 2574.32 +/- 0.05 kilometers (km), 2574.36 +/- 0.03 km, and 2574.91 +/- 0.11 km, respectively; its mean radius is 2574.73 +/- 0.09 km. Titan's shape approximates a hydrostatic, synchronously rotating triaxial ellipsoid but is best fit by such a body orbiting closer to Saturn than Titan presently does. Titan's lack of high relief implies that most-but not all-of the surface features observed with the Cassini imaging subsystem and synthetic aperture radar are uncorrelated with topography and elevation. Titan's depressed polar radii suggest that a constant geopotential hydrocarbon table could explain the confinement of the hydrocarbon lakes to high latitudes.	[Zebker, Howard A.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Zebker, Howard A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Stiles, Bryan; Hensley, Scott] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lorenz, Ralph] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Lunine, Jonathan] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Lunine, Jonathan] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Stanford University; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona	Zebker, HA (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	zebker@stanford.edu	Lorenz, Ralph D/B-8759-2016	Lorenz, Ralph D/0000-0001-8528-4644; zebker, howard/0000-0001-9931-5237; Lunine, Jonathan/0000-0003-2279-4131	Cassini Project; NASA	Cassini Project; NASA(National Aeronautics & Space Administration (NASA))	We thank the Cassini Radar Team for detailed planning of these observations. This work was supported by the Cassini Project and by NASA as part of the Cassini Data Analysis Program. We also thank the reviewers for many constructive comments on our error analysis and data interpretation. The Cassini Project is a joint endeavor of NASA, the European Space Agency, and the Italian Space Agency. Cassini is managed by JPL, California Institute of Technology, under a contract with NASA.	ALBERS S, MAP TITAN DERIVED IM; ANTREASIAN PG, 2008, AM I AER ASTR AAS AS; Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Castillo-Rogez JC, 2007, ICARUS, V190, P179, DOI 10.1016/j.icarus.2007.02.018; DERMOTT SF, 1979, ICARUS, V37, P310, DOI 10.1016/0019-1035(79)90137-4; DERMOTT SF, 1988, ICARUS, V73, P25, DOI 10.1016/0019-1035(88)90084-X; ELACHI C, 1991, P IEEE, V79, P867, DOI 10.1109/5.90164; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Mitri G, 2007, ICARUS, V186, P385, DOI 10.1016/j.icarus.2006.09.004; MOORE RK, 1981, IEEE T AERO ELEC SYS, V17, P410, DOI 10.1109/TAES.1981.309069; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rhodes D. R., 1959, INTRO MONOPULSE; Stiles BW, 2009, ICARUS, V202, P584, DOI 10.1016/j.icarus.2009.03.032; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Zebker HA, 2009, ICARUS, V200, P240, DOI 10.1016/j.icarus.2008.10.023	19	80	80	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					921	923		10.1126/science.1168905	http://dx.doi.org/10.1126/science.1168905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19342551				2022-12-24	WOS:000266048800033
J	Bowler, C; Karl, DM; Colwell, RR				Bowler, Chris; Karl, David M.; Colwell, Rita R.			Microbial oceanography in a sea of opportunity	NATURE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; GENE-EXPRESSION; DEEP-SEA; OCEAN; GENOME; BIODIVERSITY; BIOGEOGRAPHY; BIOSPHERE; FIXATION; ATLANTIC		[Bowler, Chris] Ecole Normale Super, Dept Biol, CNRS, UMR8186, Paris, France; [Bowler, Chris] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Karl, David M.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [Colwell, Rita R.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; University of Hawaii System; University System of Maryland; University of Maryland College Park	Bowler, C (corresponding author), Ecole Normale Super, Dept Biol, CNRS, UMR8186, 46 Rue Ulm, Paris, France.	cbowler@biologie.ens.fr	Bowler, Chris/AAC-6256-2019; Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721; Bowler, Chris/0000-0003-3835-6187	Div Of Molecular and Cellular Bioscience [0753659] Funding Source: National Science Foundation; PHS HHS [1R01A139129-01] Funding Source: Medline	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Colwell RR, 1998, SCIENCE, V279, P968, DOI 10.1126/science.279.5353.963g; Curtin TB, 2008, OCEANOGRAPHY, V21, P44, DOI 10.5670/oceanog.2008.34; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Kolber Z, 2007, OCEANOGRAPHY, V20, P79, DOI 10.5670/oceanog.2007.51; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Murray AE, 2007, PHILOS T R SOC B, V362, P2259, DOI 10.1098/rstb.2006.1944; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Prasady PWC, 2008, INT J ELECTRON, V95, P111, DOI 10.1080/00207210701828770; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Short SM, 2007, ENVIRON MICROBIOL, V9, P1591, DOI 10.1111/j.1462-2920.2007.01258.x; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	39	67	76	3	69	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					180	184		10.1038/nature08056	http://dx.doi.org/10.1038/nature08056			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19444203				2022-12-24	WOS:000266036100027
J	Kimura, Y; Yashiroda, H; Kudo, T; Koitabashi, S; Murata, S; Kakizuka, A; Tanaka, K				Kimura, Yoko; Yashiroda, Hideki; Kudo, Tai; Koitabashi, Sumiko; Murata, Shigeo; Kakizuka, Akira; Tanaka, Keiji			An Inhibitor of a Deubiquitinating Enzyme Regulates Ubiquitin Homeostasis	CELL			English	Article							MULTIVESICULAR BODY PATHWAY; YEAST 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; POLYUBIQUITIN GENE; PROTEIN-DEGRADATION; GLOBAL ANALYSIS; IN-VIVO; DOA4; ISOPEPTIDASE; MECHANISMS	The dynamic and reversible process of ubiquitin modification controls various cellular activities. Ubiquitin exists as monomers, unanchored chains, or protein-conjugated forms, but the regulation of these interconversions remains largely unknown. Here, we identified a protein designated Rfu1 (regulator of free ubiquitin chains 1), which regulates intracellular concentrations of monomeric ubiquitins and free ubiquitin chains in Saccharomyces cerevisiae. Rfu1 functions as an inhibitor of Doa4, a deubiquitinating enzyme. Rapid loss of free ubiquitin chains upon heat shock, a condition in which more proteins require ubiquitin conjugation, was mediated in part by Doa4 and Rfu1. Thus, regulation of ubiquitin homeostasis is controlled by a balance between a deubiquitinating enzyme and its inhibitor. We propose that free ubiquitin chains function as a ubiquitin reservoir that allows maintenance of monomeric ubiquitins at adequate levels under normal conditions and rapid supply for substrate conjugation under stress conditions.	[Kimura, Yoko; Yashiroda, Hideki; Kudo, Tai; Koitabashi, Sumiko; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan; [Kakizuka, Akira] Kyoto Univ, JST, Lab Funct Biol, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Kyoto 6068501, Japan; [Yashiroda, Hideki; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo 1130033, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Kyoto University; University of Tokyo	Kimura, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	kimura-yk@igakuken.or.jp	Yashiroda, Hideki/Y-7641-2019; Murata, Shigeo/A-1426-2010; Kimura, Yoko/E-6845-2013	Murata, Shigeo/0000-0002-3177-3503; Kimura, Yoko/0000-0002-3054-9753	Research on Priority Area; Ministry of Education, Culture, Science and Technology of Japan; Target Protein Project of MEXT; Takeda Science Foundation	Research on Priority Area; Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank T. Fujita for his initial support and C. Takahashi, H. Ueno, and T. Hasegawa for technical support. We also thank D. Botstein, K. Matsumoto, K. Umebayashi, R. Hirata, A. Nakano, Y. Saeki, S. Ito, and A. Amerik for materials, Y. Saeki, K. Umebayashi, R. Hirata, A. Nakano, A. Toh-e, Y. Yoshida, and N. Matsuda for discussion, and A. Toh- e for comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research on Priority Area (to Y.K.), Specially Promoted Research (to K.T.) from the Ministry of Education, Culture, Science and Technology of Japan, the Target Protein Project of MEXT (to K.T.), and Takeda Science Foundation (to K.T.).	Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; CHEN YP, 1995, BBA-MOL CELL RES, V1268, P59, DOI 10.1016/0167-4889(95)00044-S; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; JOHNSON ES, 1995, J BIOL CHEM, V270, P17422; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Singer JD, 1996, MOL CELL BIOL, V16, P1356; Stryer L, 1981, BIOCHEMISTRY; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Woolford Jr JL, 1991, MOL CELLULAR BIOL YE, P587; Xu P, 2008, ANAL CHEM, V80, P3438, DOI 10.1021/ac800016w	48	68	71	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					549	559		10.1016/j.cell.2009.02.028	http://dx.doi.org/10.1016/j.cell.2009.02.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410548	Bronze			2022-12-24	WOS:000265677200023
J	Dong, XH; Biswas, A; Suel, KE; Jackson, LK; Martinez, R; Gu, HM; Chook, YM				Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min			Structural basis for leucine-rich nuclear export signal recognition by CRM1	NATURE			English	Article							PROTEIN EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; SEQUENCE REQUIREMENTS; IMPORTIN-BETA; T-ANTIGEN; LOCALIZATION; PREDICTION; PATHWAY; COMPLEX; SYSTEM	CRM1 (also known as XPO1 and exportin 1) mediates nuclear export of hundreds of proteins through the recognition of the leucine-rich nuclear export signal (LR-NES). Here we present the 2.9 angstrom structure of CRM1 bound to snurportin 1 (SNUPN). Snurportin 1 binds CRM1 in a bipartite manner by means of an amino-terminal LR-NES and its nucleotide-binding domain. The LR-NES is a combined alpha-helical-extended structure that occupies a hydrophobic groove between two CRM1 outer helices. The LR-NES interface explains the consensus hydrophobic pattern, preference for intervening electronegative residues and inhibition by leptomycin B. The second nuclear export signal epitope is a basic surface on the snurportin 1 nucleotide-binding domain, which binds an acidic patch on CRM1 adjacent to the LR-NES site. Multipartite recognition of individually weak nuclear export signal epitopes may be common to CRM1 substrates, enhancing CRM1 binding beyond the generally low affinity LR-NES. Similar energetic construction is also used in multipartite nuclear localization signals to provide broad substrate specificity and rapid evolution in nuclear transport.	[Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019		National Institute of Health (NIH) [R01GM069909, R01GM069909-03S1, 5-T32-GM008297]; Welch Foundation [I-1532]; UT Southwestern Endowed Scholars Program; US Department of Energy; Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008297, R01GM069909] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern Endowed Scholars Program; US Department of Energy(United States Department of Energy (DOE)); Office of Energy Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Sheng, C. Kong, D. Tomchick and C. Dann for assistance during data collection and structure determination, S. Padrick for advice on fluorescence binding assays, G. Suel and T. Cagatay for help with microscopy, K. Weis for yeast strains and constructs, X. Zhang, L. Rice and M. Rosen for discussion. This work is funded by National Institute of Health (NIH) grants R01GM069909, R01GM069909-03S1, 5-T32-GM008297, Welch Foundation grant I-1532 and the UT Southwestern Endowed Scholars Program. Use of the Argonne National Laboratory Stuctural Biology Center beamlines at the Advanced Photon Source, was supported by the US Department of Energy, Office of Energy Research, under contract no. W-31-109-ENG-38.	Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DONG X, NATURE STRU IN PRESS, DOI DOI 10.1038/NSMB.1585; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; NISHI K, 1994, J BIOL CHEM, V269, P6320; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIKORSKI RS, 1989, GENETICS, V122, P19; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Swanton E, 2006, CELL, V127, P877, DOI 10.1016/j.cell.2006.11.018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	50	238	243	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1136	U71		10.1038/nature07975	http://dx.doi.org/10.1038/nature07975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339969	Green Accepted			2022-12-24	WOS:000265754600040
J	Parry, M; Lowe, J; Hanson, C				Parry, Martin; Lowe, Jason; Hanson, Clair			Overshoot, adapt and recover	NATURE			English	Editorial Material									[Parry, Martin] IPCCs 2007 Working Grp II Assessment, London, England; [Lowe, Jason] Met Off, Exeter EX1 3PB, Devon, England; [Hanson, Clair] 2007 IPCC Working Grp II Tech Support Unit, Norwich, Norfolk, England; [Hanson, Clair] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	Met Office - UK; Met Office - UK; Hadley Centre; University of East Anglia	Parry, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London SW7 2AR, England.	martin@mlparry.com	Lowe, Jason/GQI-4036-2022	Aerts, Jeroen/0000-0002-2162-5814				ACKERMAN F, ENERGY POLI IN PRESS; European Commission, 2007, LIM GLOB CLIM CHANG; IPCC, 2007, CLIMATE CHANGE 2007; Lowe JA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014012; Parry M., 2008, NATURE REPORTS CLIMA, DOI [DOI 10.1038/CLIMATE.2008.50, 10.1038/climate.2008.50]; Stern Nicholas, 2006, STERN REV EC CLIMATE; UNFCC, 2007, INV FIN FLOWS ADDR C	7	95	98	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1102	1103		10.1038/4581102a	http://dx.doi.org/10.1038/4581102a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441FL	19407775				2022-12-24	WOS:000265754600018
J	Subramanian, SV; Ackerson, LK; Smith, GD; John, NA				Subramanian, S. V.; Ackerson, Leland K.; Smith, George Davey; John, Neetu A.			Association of Maternal Height With Child Mortality, Anthropometric Failure, and Anemia in India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT; RISK-FACTORS; NUTRITIONAL-STATUS; MALNUTRITION; DETERMINANTS; GROWTH; OLD	Context Prior research on the determinants of child health has focused on contemporaneous risk factors such as maternal behaviors, dietary factors, and immediate environmental conditions. Research on intergenerational factors that might also predispose a child to increased health adversity remains limited. Objective To examine the association between maternal height and child mortality, anthropometric failure, and anemia. Design, Setting, and Population We retrieved data from the 2005-2006 National Family Health Survey in India ( released in 2008). The study population constitutes a nationally representative cross-sectional sample of singleton children aged 0 to 59 months and born after January 2000 or January 2001 (n=50 750) to mothers aged 15 to 49 years from all 29 states of India. Information on children was obtained by a face-to-face interview with mothers, with a response rate of 94.5%. Height was measured with an adjustable measuring board calibrated in millimeters. Demographic and socioeconomic variables were considered as covariates. Modified Poisson regression models that account for multistage survey design and sampling weights were estimated. Main Outcome Measures Mortality was the primary end point; underweight, stunting, wasting, and anemia were included as secondary outcomes. Results In adjusted models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality (relative risk [RR], 0.978; 95% confidence interval [CI], 0.970-0.987; P < .001), underweight (RR, 0.971; 95% CI, 0.968-0.974; P < .001), stunting (RR, 0.971; 95% CI, 0.968-0.0973; P < .001), wasting (RR, 0.989; 95% CI, 0.984-0.994; P < .001), and anemia (RR, 0.998; 95% CI, 0.997-0.999; P=.02). Children born to mothers who were less than 145 cm in height were 1.71 times more likely to die (95% CI, 1.37-2.13) (absolute probability, 0.09; 95% CI, 0.07-0.12) compared with mothers who were at least 160 cm in height (absolute probability, 0.05; 95% CI, 0.04-0.07). Similar patterns were observed for anthropometric failure related to underweight and stunting. Paternal height was not associated with child mortality or anemia but was associated with child anthropometric failure. Conclusion In a nationally representative sample of households in India, maternal height was inversely associated with child mortality and anthropometric failure.	[Subramanian, S. V.; John, Neetu A.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts, Sch Hlth & Environm, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell; University of Bristol	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; John, Neetu/0000-0001-8983-1211; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health Career Development Award [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275).	Alasfoor D, 2007, J HEALTH POPUL NUTR, V25, P359; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; [Anonymous], 2008, WORLDW PREV AN 1993; Back S, 2004, POINT CARE, V3, P60, DOI DOI 10.1097/01.poc.0000127152.03809.87; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Bhalotra S, 2008, J ECONOMETRICS, V143, P274, DOI 10.1016/j.jeconom.2007.10.005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLOSSNER M, 2007, WHO ANTHRO PERSONAL; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Cohen JC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-1; Faber M, 2007, J HEALTH POPUL NUTR, V25, P285; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hirve S S, 1994, Indian Pediatr, V31, P1221; Huntsman AC, 2007, ANN HUM BIOL, V34, P411, DOI 10.1080/03014460701366373; International Institute for Population Sciences, 2006, ANTHR AN HIV TEST FI; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Malik Sushma, 1997, Indian Journal of Pediatrics, V64, P373, DOI 10.1007/BF02845207; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mavalankar D V, 1994, Indian Pediatr, V31, P1205; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; *ORC MACR, 2005, HIV TEST LAB MAN DEM; PANANDIKER VAP, 1997, POLITICS BACKWARDNES, P88; Rikimaru T, 1998, J NUTR SCI VITAMINOL, V44, P391, DOI 10.3177/jnsv.44.391; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Uchimura TT, 2003, REV SAUDE PUBL, V37, P397, DOI 10.1590/S0034-89102003000400002; United Nations Children's Fund, 2008, STAT WORLDS CHILDR 2; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; Webb E, 2008, J EPIDEMIOL COMMUN H, V62, P351, DOI 10.1136/jech.2006.056457; WHO, 2006, WHO CHILD GROWTH STA; Zhang X, 2007, J PEDIATR-US, V150, P603, DOI 10.1016/j.jpeds.2007.01.048; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	163	164	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1691	1701		10.1001/jama.2009.548	http://dx.doi.org/10.1001/jama.2009.548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383960	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000265350700025
J	Gelbart, WM; Knobler, CM				Gelbart, William M.; Knobler, Charles M.			Pressurized Viruses	SCIENCE			English	Editorial Material							EJECTION FORCES; DNA EJECTION; MOTOR		[Gelbart, William M.; Knobler, Charles M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	gelbart@chem.ucla.edu						EARNSHAW WC, 1977, NATURE, V268, P598, DOI 10.1038/268598a0; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Gaussier H, 2006, J MOL BIOL, V357, P1154, DOI 10.1016/j.jmb.2006.01.013; Grayson P, 2006, VIROLOGY, V348, P430, DOI 10.1016/j.virol.2006.01.003; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; RAU DC, 1992, BIOPHYS J, V61, P246, DOI 10.1016/S0006-3495(92)81831-3; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Tzlil S, 2003, BIOPHYS J, V84, P1616, DOI 10.1016/S0006-3495(03)74971-6	15	76	76	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1682	1683		10.1126/science.1170645	http://dx.doi.org/10.1126/science.1170645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325104				2022-12-24	WOS:000264559800026
J	Lerner, BH				Lerner, Barron H.			The art of medicine Complicated lessons: Lorenzo Odone and medical miracles	LANCET			English	Editorial Material							OIL		Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA.	bhl5@columbia.edu						Jones AH, 2000, ANN INTERN MED, V133, P567, DOI 10.7326/0003-4819-133-7-200010030-00030; Lerner B.H., 2006, ILLNESS GOES PUBLIC; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; ODONE C, 2008, DAILY MAIL      0601; Rettig R. A., 2007, FALSE HOPE BONE MARR	5	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					888	889		10.1016/S0140-6736(09)60534-1	http://dx.doi.org/10.1016/S0140-6736(09)60534-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19291841				2022-12-24	WOS:000264158700014
J	Kim, N; Jinks-Robertson, S				Kim, Nayun; Jinks-Robertson, Sue			dUTP incorporation into genomic DNA is linked to transcription in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLESION SYNTHESIS; REPAIR; DAMAGE; RECOMBINATION; SPECIFICITIES; PROTEINS	Highly activated transcription is associated with eukaryotic genome instability, resulting in increased rates of mitotic recombination and mutagenesis. The association between high transcription and genome stability is probably due to a variety of factors including an enhanced accumulation of DNA damage, transcription-associated supercoiling, collision between replication forks and the transcription machinery, and the persistence of RNA-DNA hybrids(1). In the case of transcription-associated mutagenesis, we previously showed that there is a direct proportionality between the level of transcription and themutation rate in the yeast Saccharomyces cerevisiae(2), and that the molecular nature of the mutations is affected by highly activated transcription(2,3). Here we show that the accumulation of apurinic/apyrimidinic sites is greatly enhanced in highly transcribed yeast DNA. We further demonstrate that most apurinic/apyrimidinic sites in highly transcribed DNA are derived from the removal of uracil, the presence of which is linked to direct incorporation of dUTP in place of dTTP. These results show an unexpected relationship between transcription and the fidelity of DNA synthesis, and raise intriguing cell biological issues with regard to nucleotide pool compartmentalization.	[Kim, Nayun; Jinks-Robertson, Sue] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Jinks-Robertson, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	sue.robertson@duke.edu			National Institutes of Health [R01 GM038464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Boiteux for providing the p424-GAL-DUT1 plasmid. We thank members of the laboratory and T. Petes for discussions and comments on the manuscript. This work was supported by a grant from the National Institutes of Health ( R01 GM038464).	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Lippert MJ, 2004, MOL CELL BIOL, V24, P4801, DOI 10.1128/MCB.24.11.4801-4809.2004; Minesinger BK, 2005, GENETICS, V169, P1939, DOI 10.1534/genetics.104.033894; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; Senturker S, 1998, NUCLEIC ACIDS RES, V26, P5270, DOI 10.1093/nar/26.23.5270; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i	15	54	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1150	1153		10.1038/nature08033	http://dx.doi.org/10.1038/nature08033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19448611	Green Accepted			2022-12-24	WOS:000267636700048
J	Lim, B; Jiang, MJ; Camargo, PHC; Cho, EC; Tao, J; Lu, XM; Zhu, YM; Xia, YN				Lim, Byungkwon; Jiang, Majiong; Camargo, Pedro H. C.; Cho, Eun Chul; Tao, Jing; Lu, Xianmao; Zhu, Yimei; Xia, Younan			Pd-Pt Bimetallic Nanodendrites with High Activity for Oxygen Reduction	SCIENCE			English	Article							PLATINUM NANOPARTICLES; CRYSTAL-SURFACES; FACILE SYNTHESIS; NANOCRYSTALS; ELECTROCATALYSTS; ALLOYS; CARBON	Controlling the morphology of Pt nanostructures can provide a great opportunity to improve their catalytic properties and increase their activity on a mass basis. We synthesized Pd-Pt bimetallic nanodendrites consisting of a dense array of Pt branches on a Pd core by reducing K2PtCl4 with L-ascorbic acid in the presence of uniform Pd nanocrystal seeds in an aqueous solution. The Pt branches supported on faceted Pd nanocrystals exhibited relatively large surface areas and particularly active facets toward the oxygen reduction reaction (ORR), the rate-determining step in a proton-exchange membrane fuel cell. The Pd-Pt nanodendrites were two and a half times more active on the basis of equivalent Pt mass for the ORR than the state-of-the-art Pt/C catalyst and five times more active than the first-generation supportless Pt-black catalyst.	[Lim, Byungkwon; Camargo, Pedro H. C.; Cho, Eun Chul; Lu, Xianmao; Xia, Younan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Jiang, Majiong] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Tao, Jing; Zhu, Yimei] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Brookhaven National Laboratory	Xia, YN (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	xia@biomed.wustl.edu	Lu, Xianmao/E-4622-2010; Camargo, Pedro H. C./D-9547-2011; Jiang, Maijong/E-3794-2012; Xia, Younan/E-8499-2011; Camargo, Pedro HC/L-3773-2019; Jiang, Majiong/I-3630-2013	Lu, Xianmao/0000-0002-7422-2867; Camargo, Pedro H. C./0000-0002-7815-7919; Camargo, Pedro HC/0000-0002-7815-7919; 	Washington University in St. Louis; Korea Government [KRF-2006-352-D00067, KRF-2007-357-D00070]; Fulbright Program; Brazilian Ministry of Education; U.S. DOE Basic Energy Sciences [DEAC02-98CH10886]	Washington University in St. Louis; Korea Government(Korean Government); Fulbright Program; Brazilian Ministry of Education; U.S. DOE Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by startup funds from Washington University in St. Louis. B.L. was also partially supported by postdoctoral fellowships from the Korea Research Foundation funded by the Korean Government (KRF-2006-352-D00067). P.H.C.C. was also supported in part by the Fulbright Program and the Brazilian Ministry of Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). E.C.C. was also partially supported by postdoctoral fellowships from the Korea Research Foundation funded by the Korean Government (KRF-2007-357-D00070). J.T. and Y.Z. were supported by the U.S. DOE/Basic Energy Sciences (DEAC02-98CH10886). We thank H. Yang for technical assistance with the electrochemical measurements.	Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; BLAKELY DW, 1977, SURF SCI, V65, P419, DOI 10.1016/0039-6028(77)90457-5; Bratlie KM, 2007, NANO LETT, V7, P3097, DOI 10.1021/nl0716000; Chen JY, 2005, ANGEW CHEM INT EDIT, V44, P2589, DOI 10.1002/anie.200462668; Chen W, 2008, J PHYS CHEM C, V112, P3891, DOI 10.1021/jp7110204; Ciacchi LC, 2003, J PHYS CHEM B, V107, P1755, DOI 10.1021/jp026698f; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Habas SE, 2007, NAT MATER, V6, P692, DOI 10.1038/nmat1957; Kuzume A, 2007, J ELECTROANAL CHEM, V599, P333, DOI 10.1016/j.jelechem.2006.05.006; Lee HJ, 2008, J AM CHEM SOC, V130, P5406, DOI 10.1021/ja800656y; Lim BW, 2008, NANO LETT, V8, P4043, DOI 10.1021/nl802959b; Lim B, 2008, NANO LETT, V8, P2535, DOI 10.1021/nl8016434; MALLOUK TE, 1990, NATURE, V343, P515, DOI 10.1038/343515b0; Markovic N, 1997, J ELECTROCHEM SOC, V144, P1591, DOI 10.1149/1.1837646; Markovic NM, 2001, FUEL CELLS, V1, P105, DOI 10.1002/1615-6854(200107)1:2<105::AID-FUCE105>3.0.CO;2-9; Markovic NM, 2002, SURF SCI REP, V45, P121, DOI 10.1016/S0167-5729(01)00022-X; MARKOVIC NM, 1994, J ELECTROANAL CHEM, V377, P249, DOI 10.1016/0022-0728(94)03467-2; Mayrhofer KJJ, 2008, ELECTROCHIM ACTA, V53, P3181, DOI 10.1016/j.electacta.2007.11.057; MUKERJEE S, 1995, J ELECTROCHEM SOC, V142, P1409, DOI 10.1149/1.2048590; MUKERJEE S, 1993, J ELECTROANAL CHEM, V357, P201, DOI 10.1016/0022-0728(93)80380-Z; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Perry ML, 2002, J ELECTROCHEM SOC, V149, pS59, DOI 10.1149/1.1488651; Schmidt TJ, 1998, J ELECTROCHEM SOC, V145, P2354, DOI 10.1149/1.1838642; Song H, 2005, J PHYS CHEM B, V109, P188, DOI 10.1021/jp0464775; Song YJ, 2004, J AM CHEM SOC, V126, P635, DOI 10.1021/ja037474t; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Teng XW, 2006, SMALL, V2, P249, DOI 10.1002/smll.200500244; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Vielstich W, 2003, HDB FUEL CELLS FUNDA; Wang C, 2008, ANGEW CHEM INT EDIT, V47, P3588, DOI 10.1002/anie.200800073; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569	33	2586	2627	62	3088	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2009	324	5932					1302	1305		10.1126/science.1170377	http://dx.doi.org/10.1126/science.1170377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453TF	19443738				2022-12-24	WOS:000266635100038
J	Doyal, L				Doyal, Len			Personal View Euthanasia and free speech in Ireland	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Doyal, L (corresponding author), Univ London, London WC1E 7HU, England.	l.doyal@qmul.ac.uk						Battin MP, 2007, J MED ETHICS, V33, P591, DOI 10.1136/jme.2007.022335; Doyal L, 2001, BMJ-BRIT MED J, V323, P1079, DOI 10.1136/bmj.323.7321.1079; DOYAL L, 2009, IRISH TIMES     0424; DOYAL L, 2006, 1 DO NO HARM, P461; Doyal Len., 2006, CLIN ETHICS, V1, P65, DOI DOI 10.1258/147775006777254579; Lewis P, 2007, J LAW MED ETHICS, V35, P197, DOI 10.1111/j.1748-720X.2007.00124.x; MINIHAN M, 2009, IRISH TIMES     0418; 2009, PRIME TIME      0428	8	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b2109	10.1136/bmj.b2109	http://dx.doi.org/10.1136/bmj.b2109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	451WT	19474015				2022-12-24	WOS:000266502300015
J	Western, D; Behrensmeyer, AK				Western, David; Behrensmeyer, Anna K.			Bone Assemblages Track Animal Community Structure over 40 Years in an African Savanna Ecosystem	SCIENCE			English	Article							DEATH ASSEMBLAGES; FIDELITY; PRESERVATION; ABUNDANCE; CLIMATE; SIZE	Reconstructing ancient communities depends on how accurately fossil assemblages retain information about living populations. We report a high level of fidelity between modern bone assemblages and living populations based on a 40-year study of the Amboseli ecosystem in southern Kenya. Relative abundance of 15 herbivorous species recorded in the bone assemblage accurately tracks the living populations through major changes in community composition and habitat over intervals as short as 5 years. The aggregated bone sample provides an accurate record of community structure time-averaged over four decades. These results lay the groundwork for integrating paleobiological and contemporary ecological studies across evolutionary and ecological time scales. Bone surveys also provide a useful method of assessing population changes and community structure for modern vertebrates.	[Western, David] African Conservat Ctr, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Western, D (corresponding author), African Conservat Ctr, Box 62844, Nairobi, Kenya.	dwestern@africaonline.co.ke; behrensa@si.edu			Ford Foundation; Wildlife Conservation Society; Liz Claiborne Art Ortenberg Foundation; National Geographic Society [1508, 4339-90, 7525-03]; Simithsonian Institution	Ford Foundation; Wildlife Conservation Society; Liz Claiborne Art Ortenberg Foundation; National Geographic Society(National Geographic Society); Simithsonian Institution	D.W.'s ecological studies have been supported by the Ford Foundation, Wildlife Conservation Society, and Liz Claiborne Art Ortenberg Foundation. We acknowledge the statistical assistance of V. Mose, T. Faith, G. Hunt, S. Kidwell, and A. Tomasovych and the field support of D. Maitumo. A.K.B.'s taphonomic research has been supported by the National Geographic Society (grants 1508, 4339-90, and 7525-03) and the Simithsonian Institution. Particular thanks are due to D.D. Boaz, J. Altmann, E. Kanga, F. Odock, and many other individuals who provided essential advice and help with the bone surveys. Permission for the studies was granted by the Office of the President, Kenya, and institutional support over the years was provided by the Kenya Wildlife Service and the National Museums of Kenya.	Altmann J, 2002, AFR J ECOL, V40, P248, DOI 10.1046/j.1365-2028.2002.00366.x; BADGLEY C, 1986, Palaios, V1, P328, DOI 10.2307/3514695; Behrensmeyer A.K., 1980, P72; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Behrensmeyer Anna K., 1992, P15; Brown J. H., 1995, MACROECOLOGY; Damuth J., 1990, BODY SIZE MAMMALIAN; FAITH JT, 2008, BIENN M PAL SOC S AF; Hadly EA, 1999, PALAEOGEOGR PALAEOCL, V149, P389, DOI 10.1016/S0031-0182(98)00214-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Kidwell SM, 2007, P NATL ACAD SCI USA, V104, P17701, DOI 10.1073/pnas.0707194104; Miller J, 2008, J VERTEBR PALEONTOL, V28, p116A; Pennycuick C.J., 1972, East African Wildlife Journal, V10, P175; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; POWELL EN, 1992, PALAEOGEOGR PALAEOCL, V95, P209, DOI 10.1016/0031-0182(92)90142-R; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sokal RR, 1995, BIOMETRY; Terry RC, 2008, PALAIOS, V23, P402, DOI 10.2110/palo.2007.p07-071r; Tomasovych A, 2009, PALEOBIOLOGY, V35, P94, DOI 10.1666/08024.1; Western D, 2004, AFR J ECOL, V42, P111, DOI 10.1111/j.1365-2028.2004.00506.x; Western D., 1980, P41; WESTERN D, 1975, East African Wildlife Journal, V13, P265; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; WESTERN D, 1973, NATURE, V241, P104, DOI 10.1038/241104a0; Western D., 2006, AFRICAN J ECOLOGY, V45, P302, DOI DOI 10.1111/J.1365-2028.2006	30	69	71	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1061	1064		10.1126/science.1171155	http://dx.doi.org/10.1126/science.1171155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461002				2022-12-24	WOS:000266246700039
J	Campbell-Lendrum, D; Bertollini, R; Neira, M; Ebi, K; McMichael, A				Campbell-Lendrum, Diarmid; Bertollini, Roberto; Neira, Maria; Ebi, Kristie; McMichael, Anthony			Health and climate change: a roadmap for applied research	LANCET			English	Editorial Material									[Campbell-Lendrum, Diarmid; Bertollini, Roberto; Neira, Maria] WHO, Publ Hlth & Environm Dept, CH-1277 Geneva, Switzerland; [Ebi, Kristie] Carnegie Inst, Intergovernmental Panel Climate Change Tech Suppo, Stanford, CA USA; [McMichael, Anthony] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	World Health Organization; Carnegie Institution for Science; Australian National University	Campbell-Lendrum, D (corresponding author), WHO, Publ Hlth & Environm Dept, CH-1277 Geneva, Switzerland.	campbelllendrumd@who.int						[Anonymous], 2008, LANCET, V372, P1855, DOI 10.1016/S0140-6736(08)61789-4; [Anonymous], 2009, PROT HLTH CLIM CHANG; WHO, 2008, 61 WORLD HLTH ASS	3	41	42	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 16	2009	373	9676					1663	1665		10.1016/S0140-6736(09)60926-0	http://dx.doi.org/10.1016/S0140-6736(09)60926-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447RP	19447242				2022-12-24	WOS:000266209800006
J	Mobbs, D; Yu, RJ; Meyer, M; Passamonti, L; Seymour, B; Calder, AJ; Schweizer, S; Frith, CD; Dalgleish, T				Mobbs, Dean; Yu, Rongjun; Meyer, Marcel; Passamonti, Luca; Seymour, Ben; Calder, Andrew J.; Schweizer, Susanne; Frith, Chris D.; Dalgleish, Tim			A Key Role for Similarity in Vicarious Reward	SCIENCE			English	Article							OTHERS		[Mobbs, Dean; Yu, Rongjun; Meyer, Marcel; Passamonti, Luca; Calder, Andrew J.; Schweizer, Susanne; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Meyer, Marcel] Univ Birmingham, Dept Psychol, Birmingham B15 2TT, W Midlands, England; [Passamonti, Luca] ISN, CNR, I-87050 Cosenza, Italy; [Seymour, Ben; Frith, Chris D.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Seymour, Ben] ESRC Ctr Econ Learning & Social Evolut UCL, London WC1H OAN, England; [Frith, Chris D.] Aarhus Univ, Ctr Funct Integrat Neurosci, DK-800 Aarhus, Denmark	University of Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of London; University College London; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London; Aarhus University	Mobbs, D (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England.	dean.mobbs@mrc-cbu.cam.ac.uk	Frith, Chris D/A-2171-2009; Yu, Rongjun/AAV-2615-2020; Schweizer, Susanne/X-4313-2018; Passamonti, Luca/I-7057-2019; Dalgleish, Tim/E-8341-2010	Frith, Chris D/0000-0002-8665-0690; Yu, Rongjun/0000-0003-0123-1524; Schweizer, Susanne/0000-0001-6153-8291; Passamonti, Luca/0000-0002-7937-0615; Dalgleish, Tim/0000-0002-7304-2231; Seymour, Ben/0000-0003-1724-5832	MRC; MRC [MC_U105579214] Funding Source: UKRI; Economic and Social Research Council [RES-538-28-1001] Funding Source: researchfish; Medical Research Council [MC_U105579214, MC_U105579215] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Ewbank, R. Henson, and E. Hill for their help. This work was conducted at the Cognition and Brain Sciences Unit and supported by the MRC.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Park JH, 2005, EVOL HUM BEHAV, V26, P158, DOI 10.1016/j.evolhumbehav.2004.08.013; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022	9	199	204	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					900	900		10.1126/science.1170539	http://dx.doi.org/10.1126/science.1170539			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443777	Green Accepted			2022-12-24	WOS:000266048800027
J	Malone, CD; Brennecke, J; Dus, M; Stark, A; McCombie, WR; Sachidanandam, R; Hannon, GJ				Malone, Colin D.; Brennecke, Julius; Dus, Monica; Stark, Alexander; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.			Specialized piRNA Pathways Act in Germline and Somatic Tissues of the Drosophila Ovary	CELL			English	Article							GYPSY ENDOGENOUS RETROVIRUS; SELFISH GENETIC ELEMENTS; MELANOGASTER GERMLINE; INFECTIOUS RETROVIRUS; TRANSPOSABLE ELEMENTS; CELL MAINTENANCE; FEMALE GERMLINE; POLAR GRANULES; STEM-CELLS; PIWI	In Drosophila gonads, Piwi proteins and associated piRNAs collaborate with additional factors to form a small RNA-based immune system that silences mobile elements. Here, we analyzed nine Drosophila piRNA pathway mutants for their impacts on both small RNA populations and the subcellular localization patterns of Piwi proteins. We find that distinct piRNA pathways with differing components function in ovarian germ and somatic cells. In the soma, Piwi acts singularly with the conserved flamenco piRNA cluster to enforce silencing of retroviral elements that may propagate by infecting neighboring germ cells. In the germline, silencing programs encoded within piRNA clusters are optimized via a slicer-dependent amplification loop to suppress a broad spectrum of elements. The classes of transposons targeted by germline and somatic piRNA clusters, though not the precise elements, are conserved among Drosophilids, demonstrating that the architecture of piRNA clusters has coevolved with the transposons that they are tasked to control.	[Malone, Colin D.; Brennecke, Julius; Dus, Monica; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Brennecke, Julius; Dus, Monica; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Stark, Alexander/D-1473-2012; Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019; Brennecke, Julius/C-1626-2015	Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; Brennecke, Julius/0000-0002-5141-0814; McCombie, W. Richard/0000-0003-1899-0682	Watson School of Biological Sciences; National Science Foundation Graduate Research Fellowship; Ernst Schering foundation; Human Frontier Science Program; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ernst Schering foundation; Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hannon laboratory for helpful discussions and Oliver Tam for computational assistance. We are grateful to Michelle Rooks, Emily Hodges, Danea Rebolini, Laura Cardone, and Mike Regulski ( Cold Spring Harbor Laboratory) for help with deep sequencing. We also thank Attilio Pane and Trudi Schupbach for providing the zuc and squ fly stocks. C. D. M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by a National Science Foundation Graduate Research Fellowship. J.B. is supported by a fellowship from the Ernst Schering foundation. M. D. is an Engelhorn fellow of the Watson School of Biological Sciences. A. S. is supported by a Human Frontier Science Program postdoctoral fellowship. This work was supported in part from grants from the National Institutes of Health to G.J.H. and W.R.M. and a kind gift from Kathryn W. Davis ( G.J.H.).	ALMUKHTAR KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lecher P, 1997, J GEN VIROL, V78, P2379; LI C, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin HF, 1997, DEVELOPMENT, V124, P2463; LUNING KG, 1981, HEREDITAS, V95, P181; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Murchison EP, 2008, GENOME RES, V18, P995, DOI 10.1101/gr.073056.107; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, MOL BIOL EVOL, V24, P498, DOI 10.1093/molbev/msl176; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shpiz S, 2007, MOL BIOL EVOL, V24, P2535, DOI 10.1093/molbev/msm205; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Song SU, 1997, DEVELOPMENT, V124, P2789; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Styhler S, 1998, DEVELOPMENT, V125, P1569; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wilson JE, 1996, DEVELOPMENT, V122, P1631	58	594	613	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					522	535		10.1016/j.cell.2009.03.040	http://dx.doi.org/10.1016/j.cell.2009.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395010	Bronze, Green Accepted			2022-12-24	WOS:000265677200021
J	Ford, N; Mills, E; Calmy, A				Ford, Nathan; Mills, Edward; Calmy, Alexandra			GLOBAL HEALTH Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUB-SAHARAN AFRICA		[Ford, Nathan] MSF, Med Unit, Cape Town, South Africa; [Ford, Nathan] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Mills, Edward] Univ Ottawa, Canada Res Chair Global Hlth, Ottawa, ON, Canada; [Calmy, Alexandra] Univ Hosp Geneva, Infect Dis Serv, HIV Unit, Geneva, Switzerland; [Calmy, Alexandra] MSF Int, MSF Access Campaign, Geneva, Switzerland	Doctors Without Borders; University of Cape Town; University of Ottawa; University of Geneva; Doctors Without Borders	Ford, N (corresponding author), MSF, Med Unit, Cape Town, South Africa.							Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Moreno S, 2009, INT J TUBERC LUNG D, V13, P150; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1808	1810		10.1056/NEJMp0902820	http://dx.doi.org/10.1056/NEJMp0902820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19403900				2022-12-24	WOS:000265560300002
J	Barraclough, K				Barraclough, Kevin			Diagnosis in General Practice Chronic cough in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERTUSSIS; ASTHMA; MANAGEMENT; DISEASE				Barraclough, K (corresponding author), Hoyland House, Painswick GL6 6RD, Stroud, England.	k.barraclough@btinternet.com						Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cockcroft DW, 1997, ANN ALLERG ASTHMA IM, V79, P226, DOI 10.1016/S1081-1206(10)63006-2; CULLINAN P, 1992, RESP MED, V86, P143, DOI 10.1016/S0954-6111(06)80231-3; Dicpinigaitis PV, 2006, CHEST, V129, p169S, DOI 10.1378/chest.129.1_suppl.169S; Dicpinigaitis PV, 2004, THORAX, V59, P71; Glasziou P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1312; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Kardos P, 1996, Pneumologie, V50, P437; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2003, THORAX, V58, P901, DOI 10.1136/thorax.58.10.901; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Thomas PF, 2000, MED J AUSTRALIA, V173, P74, DOI 10.5694/j.1326-5377.2000.tb139246.x; *WHO, 2008, ALL RH ITS IMP ASTHM; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704	18	3	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2009	338								b1218	10.1136/bmj.b1218	http://dx.doi.org/10.1136/bmj.b1218			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OR	19395418				2022-12-24	WOS:000265497300002
J	Justman, QA; Serber, Z; Ferrell, JE; El-Samad, H; Shokat, KM				Justman, Quincey A.; Serber, Zach; Ferrell, James E., Jr.; El-Samad, Hana; Shokat, Kevan M.			Tuning the Activation Threshold of a Kinase Network by Nested Feedback Loops	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE; SWITCH; MATURATION; OOCYTES; MODULE; MEMORY	Determining proper responsiveness to incoming signals is fundamental to all biological systems. We demonstrate that intracellular signaling nodes can tune a signaling network's response threshold away from the basal median effective concentration established by ligand-receptor interactions. Focusing on the bistable kinase network that governs progesterone-induced meiotic entry in Xenopus oocytes, we characterized glycogen synthase kinase-3b (GSK-3 beta) as a dampener of progesterone responsiveness. GSK-3 beta engages the meiotic kinase network through a double-negative feedback loop; this specific feedback architecture raises the progesterone threshold in correspondence with the strength of double-negative signaling. We also identified a marker of nutritional status, L-leucine, which lowers the progesterone threshold, indicating that oocytes integrate additional signals into their cell-fate decisions by modulating progesterone responsiveness.	[El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Serber, Zach; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	helsamad@biochem.ucsf.edu; shokat@cmp.ucsf.edu			NIH [AI49006, GM46383]; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI049006, R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Yue for providing Mos and cyclin protein; N. L. Salimi for help with statistics; J. J. Fleming and P. M. England for help with oocytes; and A. W. Murray, R. D. Mullins, J. A. Blair, and E. C. Garner for critical reading of the manuscript. Funding from NIH grant AI49006 (to K.M.S.), the Sandler Family Supporting Foundation (to H.E.), and NIH grant GM46383 (to J.E.F.).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fisher DL, 1999, DEVELOPMENT, V126, P567; FORTUNE JE, 1983, DEV BIOL, V99, P502, DOI 10.1016/0012-1606(83)90299-3; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; O'Neill DJ, 2004, BIOORGAN MED CHEM, V12, P3167, DOI 10.1016/j.bmc.2004.04.010; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	21	40	40	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					509	512		10.1126/science.1169498	http://dx.doi.org/10.1126/science.1169498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390045	Green Accepted			2022-12-24	WOS:000265411200046
J	Bostrom, J; Yu, SF; Kan, D; Appleton, BA; Lee, CV; Billeci, K; Man, W; Peale, F; Ross, S; Wiesmann, C; Fuh, G				Bostrom, Jenny; Yu, Shang-Fan; Kan, David; Appleton, Brent A.; Lee, Chingwei V.; Billeci, Karen; Man, Wenyan; Peale, Franklin; Ross, Sarajane; Wiesmann, Christian; Fuh, Germaine			Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATIC HYPERMUTATION; BREAST-CANCER; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; RECEPTOR; COMPLEX; XENOGRAFTS; DIVERSITY	The interface between antibody and antigen is often depicted as a lock and key, suggesting that an antibody surface can accommodate only one antigen. Here, we describe an antibody with an antigen binding site that binds two distinct proteins with high affinity. We isolated a variant of Herceptin, a therapeutic monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), on the basis of its ability to simultaneously interact with vascular endothelial growth factor (VEGF). Crystallographic and mutagenesis studies revealed that distinct amino acids of this antibody, called bH1, engage HER2 and VEGF energetically, but there is extensive overlap between the antibody surface areas contacting the two antigens. An affinity-improved version of bH1 inhibits both HER2-and VEGF-mediated cell proliferation in vitro and tumor progression in mouse models. Such "two-in-one" antibodies challenge the monoclonal antibody paradigm of one binding site, one antigen. They could also provide new opportunities for antibody-based therapy.	[Bostrom, Jenny; Appleton, Brent A.; Lee, Chingwei V.; Man, Wenyan; Wiesmann, Christian; Fuh, Germaine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Yu, Shang-Fan; Kan, David; Ross, Sarajane] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Billeci, Karen] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Peale, Franklin] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fuh, G (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	gml@gene.com		Appleton, Brent/0000-0003-1136-5649; Wiesmann, Christian/0000-0002-4092-9880	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank the Protein Engineering structure group, L. Haber, and D. McMahon for technical consultation and C. Eigenbrot for helpful advice. We also thank members of the DNA synthesis, DNA sequencing, in vivo cell culture, and protein chemistry groups at Genentech. We are grateful for the support of R. Neutze and Chalmers University of Technology, Sweden. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The atomic coordinates of the bH1/HER2 and bH1/VEGF were deposited in the Protein Data Bank with accession numbers 3BDY and 3BE1, respectively. G.F. and J.B. are inventors of the patent application "Multispecific Antibodies" (Pub. App. No. 20080069820), which relates to this work. All authors are or were under the employment of Genentech and declare competing financial interests.	Baselga J, 1998, CANCER RES, V58, P2825; Bernard-Marty C, 2006, DRUGS, V66, P1577, DOI 10.2165/00003495-200666120-00004; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clark LA, 2006, J IMMUNOL, V177, P333, DOI 10.4049/jimmunol.177.1.333; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Mylvaganam SE, 1998, J MOL BIOL, V281, P301, DOI 10.1006/jmbi.1998.1942; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pegram MD, 2002, SEMIN ONCOL, V29, P29, DOI 10.1053/sonc.2002.34053; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Senn BM, 2003, EUR J IMMUNOL, V33, P950, DOI 10.1002/eji.200323340; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0	27	266	381	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1610	1614		10.1126/science.1165480	http://dx.doi.org/10.1126/science.1165480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299620				2022-12-24	WOS:000264342300040
J	Vano-Galvan, S; Jaen, P				Vano-Galvan, Sergio; Jaen, Pedro			Extravasation of Epirubicin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vano-Galvan, Sergio; Jaen, Pedro] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Vano-Galvan, S (corresponding author), Hosp Ramon & Cajal, E-28034 Madrid, Spain.	sergiovano@yahoo.es		Vano-Galvan, Sergio/0000-0003-2773-7494					0	3	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2117	2117		10.1056/NEJMicm0800614	http://dx.doi.org/10.1056/NEJMicm0800614			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444WN	19439746				2022-12-24	WOS:000266011200010
J	Stegemann, S; Bock, R				Stegemann, Sandra; Bock, Ralph			Exchange of Genetic Material Between Cells in Plant Tissue Grafts	SCIENCE			English	Article								Tissue grafting includes applications ranging from plant breeding to animal organ transplantation. Donor and recipient are generally believed to maintain their genetic integrity, in that the grafted tissues are joined but their genetic materials do not mix. We grafted tobacco plants from two transgenic lines carrying different marker and reporter genes in different cellular compartments, the nucleus and the plastid. Analysis of the graft sites revealed the frequent occurrence of cells harboring both antibiotic resistances and both fluorescent reporters. Our data demonstrate that plant grafting can result in the exchange of genetic information via either large DNA pieces or entire plastid genomes. This observation of novel combinations of genetic material has implications for grafting techniques and also provides a possible path for horizontal gene transfer.	[Stegemann, Sandra; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany	Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940	Bundesministerium fur Bildung und Forschung	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank M. Lohse and D. Karcher for providing transgenic lines, Y. Weber for technical assistance, and D. Karcher for help with identifying markers. This research was financed by the Bundesministerium fur Bildung und Forschung.	Beddie A. D., 1942, T P R SOC NZ, V71, P199; BRABEC F, 1954, PLANTA, V44, P562, DOI 10.1007/BF01937601; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Lucas WJ, 2004, NAT REV MOL CELL BIO, V5, P712, DOI 10.1038/nrm1470; OHTA Y, 1975, EUPHYTICA, V24, P355, DOI 10.1007/BF00028201; Stange C, 2004, FUNCT PLANT BIOL, V31, P149, DOI 10.1071/FP03160	7	202	236	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					649	651		10.1126/science.1170397	http://dx.doi.org/10.1126/science.1170397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407205				2022-12-24	WOS:000265608800046
J	Dobson, JE				Dobson, Jerome E.			Big Brother has evolved	NATURE			English	Editorial Material									Univ Kansas, Dept Geog, Lawrence, KS 66045 USA	University of Kansas	Dobson, JE (corresponding author), Univ Kansas, Dept Geog, Lawrence, KS 66045 USA.	dobson@ku.edu						Dobson JE, 2007, GEOGR REV, V97, P307, DOI 10.1111/j.1931-0846.2007.tb00508.x; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958	2	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					968	968		10.1038/458968a	http://dx.doi.org/10.1038/458968a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396123	Bronze			2022-12-24	WOS:000265412900017
J	Sainz, M; del Pozo, JG; Arias, LHM; Carvajal, A				Sainz, Maria; Garcia del Pozo, Javier; Martin Arias, Luis H.; Carvajal, Alfonso			Drug Point Strontium ranelate may cause alopecia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATES		[Carvajal, Alfonso] Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, E-47005 Valladolid, Spain	Universidad de Valladolid	Carvajal, A (corresponding author), Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, Ramon & Cajal 7, E-47005 Valladolid, Spain.	carvajal@ife.uva.es	MARTIN ARIAS, LUIS/H-6438-2015; Sainz-Gil, María/V-5390-2017	MARTIN ARIAS, LUIS/0000-0002-3815-8781; Sainz-Gil, María/0000-0002-4353-055X				Hunt N, 2005, BRIT MED J, V331, P951, DOI 10.1136/bmj.331.7522.951; Lenzer J, 2008, BRIT MED J, V336, P117, DOI 10.1136/bmj.39461.527650.4E; POWIS SJA, 1976, BRIT MED J, V2, P1166, DOI 10.1136/bmj.2.6045.1166; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	4	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2009	338								b1494	10.1136/bmj.b1494	http://dx.doi.org/10.1136/bmj.b1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OP	19386675				2022-12-24	WOS:000265497100005
J	Nicholson, M; Hoye, R				Nicholson, Matthew; Hoye, Russell			Reducing Adolescents' Exposure to Alcohol Advertising and Promotion During Televised Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUTH		[Hoye, Russell] La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia; [Nicholson, Matthew] Univ Ballarat, Sch Human Movement & Sport Sci, Ballarat, Vic 3353, Australia	La Trobe University; Federation University Australia	Hoye, R (corresponding author), La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia.	r.hoye@latrobe.edu.au	Hoye, Russell/AAW-5890-2020	Hoye, Russell/0000-0001-9000-1848; Nicholson, Matthew/0000-0002-7229-6037				*ALC OTH DRUGS COU, 2005, SUBM NAT ALC STRAT 2; *AM MED ASS OFF AL, 2002, PARTN FOE ALC IND YO; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; *CTR ALC MARK YOUT, 2008, YOUTH EXP ALC ADV TE; Federal Trade Commission, 2008, SELF REG ALC IND; Fortin RB, 2005, EFFECTIVENESS REGULA; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Jernigan DH, 2005, J PUBLIC HEALTH POL, V26, P287, DOI 10.1057/palgrave.jphp.3200042; *NAT AC SCI NAT AC, 2003, RED UND DRINK COLL R; Ringel JS, 2006, J ADOLESCENT HEALTH, V39, P473, DOI 10.1016/j.jadohealth.2006.02.006; *SEN STAND COMM CO, 2008, ALC TOLL RED BILL 20, P75; Shifrin DL, 2006, PEDIATRICS, V118, P2563, DOI 10.1542/peds.2006-2698; Statistical Research Inc., 2001, AAF ESPN CHILDR SPOR; *WHO DEP MENT HLTH, 2004, GLOB STAT REP ALC PO; Winter MV, 2008, J STUD ALCOHOL DRUGS, V69, P676, DOI 10.15288/jsad.2008.69.676	15	6	6	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1479	1482		10.1001/jama.2009.469	http://dx.doi.org/10.1001/jama.2009.469			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429MN	19351947				2022-12-24	WOS:000264924900030
J	Yamanaka, S				Yamanaka, Shinya			A Fresh Look at iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; GENERATION; MOUSE; DIFFERENTIATION; EXPRESSION; INDUCTION; THERAPY; NEURONS; ALS	The potential of induced pluripotent stem (iPS) cells is enormous, but many obstacles remain before their medical and pharmaceutical applications can be fully realized.	Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; KAJI K, 2009, NATURE, DOI DOI 10.1038/NA-TURE07864; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	517	566	9	186	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					13	17		10.1016/j.cell.2009.03.034	http://dx.doi.org/10.1016/j.cell.2009.03.034			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345179	Bronze			2022-12-24	WOS:000264813300006
J	Feachem, RGA; Phillips, AA				Feachem, Richard G. A.; Phillips, Allison A.			Malaria: 2 years in the fast lane	LANCET			English	Editorial Material									[Feachem, Richard G. A.; Phillips, Allison A.] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Feachem, RGA (corresponding author), UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA.	feachemr@globalhealth.ucsf.edu						[Anonymous], GLOB MAL ACT PLAN MA; BARRETT C, 2009, BRISBANE TIMES  0210; *EXXONMOBIL, AFR HLTH IN; Feachem RGA, 2009, SHRINKING MALARIA MA; GATES B, 2007, BILL M GAT MAL FOR S; *GLOB FUND FIGHT A, GRANT PORTF FUND DEC; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; *PATH, MACEPA MAL CONTR PAR; PAYNE DM, 2008, 1 LADY L BUSH RAISE; *USAID, 2008, PRES MAL IN PROGR PA; *WORLD BANK BOOST, 2007, SCAL UP IMP SUFI 2 Y; World Health Organization, 2009, FIN CRIS GLOB HLTH, DOI 10.1186/1744-8603-5-17	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1409	1411		10.1016/S0140-6736(09)60801-1	http://dx.doi.org/10.1016/S0140-6736(09)60801-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19394520				2022-12-24	WOS:000265501900009
J	Sandman, PM				Sandman, Peter M.			Pandemics: good hygiene is not enough	NATURE			English	Editorial Material											Sandman, PM (corresponding author), 59 Ridgeview Rd, Princeton, NJ 08540 USA.	peter@psandman.com							0	27	27	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 21	2009	459	7245					322	323		10.1038/459322a	http://dx.doi.org/10.1038/459322a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458694	Green Published			2022-12-24	WOS:000266243700017
J	Gostin, LO				Gostin, Lawrence O.			Regulating the Safety of Pharmaceuticals The FDA, Preemption, and the Public's Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TORT LITIGATION; LIABILITY		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V300, P1939, DOI 10.1001/jama.2008.513; *FOOD DRUG ADM SCI, 2007, SCI MISS RISK REP SU; Gostin L., 2008, PUBLIC HLTH LAW POWE; Gostin LO, 2008, JAMA-J AM MED ASSOC, V299, P2313, DOI 10.1001/jama.299.19.2313; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Kesselheim AS, 2009, NEW ENGL J MED, V360, P559, DOI 10.1056/NEJMp0809403; Kessler DA, 2008, GEORGETOWN LAW J, V96, P461; MCGARITY THOMAS O., 2008, PREEMPTION WAR FEDER; *US HR, 2008, FDA CAR STAFF OBJ AG; 2006, FED REG, V71, P3922	10	5	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2036	2037		10.1001/jama.2009.680	http://dx.doi.org/10.1001/jama.2009.680			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454642				2022-12-24	WOS:000266159600028
J	Kelly, JX; Smilkstein, MJ; Brun, R; Wittlin, S; Cooper, RA; Lane, KD; Janowsky, A; Johnson, RA; Dodean, RA; Winter, R; Hinrichs, DJ; Riscoe, MK				Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.			Discovery of dual function acridones as a new antimalarial chemotype	NATURE			English	Article							CHLOROQUINE RESISTANCE TRANSPORTER; TRANSMEMBRANE PROTEIN PFCRT; PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; BETA-HEMATIN; IN-VITRO; DRUG; MALARIA; MUTATIONS; MECHANISM	Preventing and delaying the emergence of drug resistance is an essential goal of antimalarial drug development. Monotherapy and highly mutable drug targets have each facilitated resistance, and both are undesirable in effective long-term strategies against multi-drug-resistant malaria. Haem remains an immutable and vulnerable target, because it is not parasite-encoded and its detoxification during haemoglobin degradation, critical to parasite survival, can be subverted by drug-haem interaction as in the case of quinolines and many other drugs(1-5). Here we describe a new antimalarial chemotype that combines the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs. Beyond the essential intrinsic characteristics common to deserving candidate antimalarials ( high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favourable physicochemical properties), our initial lead, T3.5 (3-chloro-6-(2-diethylamino-ethoxy)-10-(2-diethylamino-ethyl)acridone), demonstrates unique synergistic properties. In addition to 'verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, T3.5 also results in an apparently mechanistically distinct synergism with quinine and with piperaquine. This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, has been demonstrated both in vitro and in vivo. In summary, this innovative acridone design merges intrinsic potency and resistance-counteracting functions in one molecule, and represents a new strategy to expand, enhance and sustain effective antimalarial drug combinations.	[Kelly, Jane X.; Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.] Portland VA Med Ctr, Portland, OR 97239 USA; [Kelly, Jane X.; Smilkstein, Martin J.; Dodean, Rozalia A.; Winter, Rolf; Riscoe, Michael K.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Hinrichs, David J.; Riscoe, Michael K.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Brun, Reto; Wittlin, Sergio] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Cooper, Roland A.; Lane, Kristin D.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Portland State University; Oregon Health & Science University; University of Basel; Swiss Tropical & Public Health Institute; Old Dominion University	Kelly, JX (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	kellyja@ohsu.edu; riscoem@ohsu.edu	Lane, Kristin D./AAS-3596-2020	Lane, Kristin D./0000-0002-4352-0562; Dodean, Rozalia/0000-0001-5002-4607	Merit Review Program of the Department of Veterans Affairs	Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	We thank D. Kyle for the gift of P. falciparum parasite Tm90-C2B, and the Malaria Research and Reference Resource Center for supplying P. falciparum parasites D6, Dd2 and 7G8. We thank A. P. Waters and C. J. Janse for the donation of GFP- labelled P. berghei strain ANKA. We thank L. Jones- Brando and R. Yolken for the cytotoxicity (HFF) data. We are grateful to A. Cornea for the confocal imaging. We thank K. Liebman, C. Hudson, S. Burgess and D. Peyton for compound characterization. We acknowledge financial support from the Merit Review Program of the Department of Veterans Affairs. United States patent applications have been filed by the US Department of Veterans Affairs to protect the intellectual property described in this report.	Bhattacharjee AK, 2002, J CHEM INF COMP SCI, V42, P1212, DOI 10.1021/ci0200265; Bhattacharjee AK, 2001, ANTIMICROB AGENTS CH, V45, P2655, DOI 10.1128/AAC.45.9.2655-2657.2001; Biot Christophe, 2006, Infectious Disorders - Drug Targets, V6, P173, DOI 10.2174/187152606784112155; Biot C, 2005, MOL PHARMACEUT, V2, P185, DOI 10.1021/mp0500061; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Foley M, 1997, INT J PARASITOL, V27, P231, DOI 10.1016/S0020-7519(96)00152-X; Kelly JX, 2007, ANTIMICROB AGENTS CH, V51, P4133, DOI 10.1128/AAC.00669-07; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kumar S, 2007, LIFE SCI, V80, P813, DOI 10.1016/j.lfs.2006.11.008; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; Wellems TE, 2002, SCIENCE, V298, P124, DOI 10.1126/science.1078167; *WHO, 2006, WHOHTMMAL20061108; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	28	146	150	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					270	273		10.1038/nature07937	http://dx.doi.org/10.1038/nature07937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	445FR	19357645	Green Accepted			2022-12-24	WOS:000266036100045
J	Mummery-Widmer, JL; Yamazaki, M; Stoeger, T; Novatchkova, M; Bhalerao, S; Chen, D; Dietzl, G; Dickson, BJ; Knoblich, JA				Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Chen, Doris; Dietzl, Georg; Dickson, Barry J.; Knoblich, Juergen A.			Genome-wide analysis of Notch signalling in Drosophila by transgenic RNAi	NATURE			English	Article							CELL-FATE; PROTEIN TRAFFICKING; BOUNDARY FORMATION; GENE; HAIRLESS; LOCALIZATION; NUMB; INTEGRATION; SUPPRESSOR; ENDOCYTOSIS	Genome-wide RNA interference (RNAi) screens have identified near-complete sets of genes involved in cellular processes. However, this methodology has not yet been used to study complex developmental processes in a tissue-specific manner. Here we report the use of a library of Drosophila strains expressing inducible hairpin RNAi constructs to study the Notch signalling pathway during external sensory organ development. We assigned putative loss-of-function phenotypes to 21.2% of the protein-coding Drosophila genes. Using secondary assays, we identified 6 new genes involved in asymmetric cell division and 23 novel genes regulating the Notch signalling pathway. By integrating our phenotypic results with protein interaction data, we constructed a genome-wide, functionally validated interaction network governing Notch signalling and asymmetric cell division. We used clustering algorithms to identify nuclear import pathways and the COP9 signallosome as Notch regulators. Our results show that complex developmental processes can be analysed on a genome-wide level and provide a unique resource for functional annotation of the Drosophila genome.	[Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Novatchkova, Maria; Bhalerao, Sheetal; Dietzl, Georg; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Chen, Doris] MFPL, Dept Biochem, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Dickson, Barry/AAE-7632-2019	Knoblich, Juergen A/0000-0002-6751-3404; Dickson, Barry/0000-0003-0715-892X; Chen, Doris/0000-0001-8835-0280; Stoeger, Thomas/0000-0002-5540-4278	Austrian Science Fund FWF [P 16629] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BANG AG, 1991, DEVELOPMENT, V111, P89; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Calleja M, 2000, DEVELOPMENT, V127, P3971; Cavodeassi F, 2002, DEVELOPMENT, V129, P3815; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gho M, 1996, DEVELOPMENT, V122, P1673; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Pi HW, 2004, P NATL ACAD SCI USA, V101, P8378, DOI 10.1073/pnas.0306010101; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Tekotte H, 2002, DEV BIOL, V244, P396, DOI 10.1006/dbio.2002.0612; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	54	234	245	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					987	U59		10.1038/nature07936	http://dx.doi.org/10.1038/nature07936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19363474	Green Accepted			2022-12-24	WOS:000265412900033
J	Kiser, AK; Pronovost, PJ				Kiser, Ava K.; Pronovost, Peter J.			Management of Diseases Without Current Treatment Options Something Can Be Done	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; RETINITIS-PIGMENTOSA; SURVIVORS		[Kiser, Ava K.] Johns Hopkins Univ, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kiser, AK (corresponding author), 550 N Broadway,6th Floor, Baltimore, MD 21205 USA.	abittne1@jhmi.edu	Bittner, Ava/AAK-8778-2021	Bittner, Ava/0000-0002-9498-2230	NEI NIH HHS [K23 EY018356-02, K23 EY018356] Funding Source: Medline; NINR NIH HHS [P30 NR008995-05, P30 NR008995] Funding Source: Medline; NATIONAL EYE INSTITUTE [K23EY018356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR008995] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kiser AK, 2008, CLIN EXP OPTOM, V91, P166, DOI 10.1111/j.1444-0938.2007.00224.x; Ormel J, 1997, PSYCHOL MED, V27, P1065, DOI 10.1017/S0033291797005321; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	10	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1708	1709		10.1001/jama.2009.506	http://dx.doi.org/10.1001/jama.2009.506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383962	Green Accepted			2022-12-24	WOS:000265350700027
J	McWilliams, JM; Meara, E; Zaslavsky, AM; Ayanian, JZ				McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.			Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U. S. Trends From 1999 to 2006 and Effects of Medicare Coverage	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; NUTRITION EXAMINATION SURVEY; ACUTE MYOCARDIAL-INFARCTION; PAY-FOR-PERFORMANCE; RACIAL DISPARITIES; NATIONAL-HEALTH; HYPERTENSION PREVALENCE; UNINSURED ADULTS; UNITED-STATES; US ADULTS	Background: Efforts to improve the care of cardiovascular disease and diabetes or expand insurance coverage for adults with these conditions may reduce differences in clinical outcomes. Objective: To assess recent national trends in disease control, trends in sociodemographic differences in control, and changes in sociodemographic differences after age 65 years associated with near-universal Medicare coverage. Design: Observational and quasi-experimental analyses of repeated cross-sectional data. Setting: National Health and Nutrition Examination Survey, 1999 to 2006. Participants: Adults age 40 to 85 years with relevant clinical conditions. Measurements: Blood pressure control (< 140/90 mm Hg) and mean systolic blood pressure among adults with hypertension (n = 4521); glycemic control (hemoglobin A(1c) levels < 7.0%) and mean hemoglobin A1c levels among those with diabetes (n = 1733); and total cholesterol level control (< 5.2 mmol/L [< 200 mg/dL]) and mean total cholesterol levels among those with coronary heart disease, stroke, or diabetes (n = 2928). Temporal trends in these measures were compared by race, ethnicity, and education, and sociodemographic differences were compared above and below eligibility for Medicare at age 65 years. Results: Disease control improved significantly between 1999 and 2006 for all 6 measures ( P < 0.001). These trends did not differ by race or ethnicity or by education ( P >= 0.185 for group-time interactions), except that white-Hispanic differences in glycemic control widened (P = 0.042). Black-white differences in systolic blood pressure were smaller among adults age 65 to 85 years than among adults age 40 to 64 years (reduction in difference, 4.2 mm Hg; P = 0.009). Black-white differences in hemoglobin A(1c) levels were also smaller after age 65 years (reduction in difference, 0.7%; P = 0.005), as were Hispanic-white differences (reduction in difference, 0.7%; P = 0.007) and differences between less and more educated adults (reduction in difference, 0.5%; P = 0.033). Limitation: Data were cross-sectional, and estimates may have been biased by coincidental events at age 65 years, such as retirement, that may affect disease control. Conclusion: Control of blood pressure and glucose and cholesterol levels has improved since 1999 for adults with cardiovascular disease and diabetes, but racial, ethnic, or socioeconomic differences have not narrowed significantly. Medicare coverage after age 65 years is associated with reductions in these differences.	[McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Bureau of Economic Research	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970	Commonwealth Fund [20060485]	Commonwealth Fund	By The Commonwealth Fund (grant no. 20060485).	ABRAIDOLANZA AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI DOI 10.2105/AJPH.89.10.1543; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; [Anonymous], 2004, 10365 NBER; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Blustein J, 2008, JAMA-J AM MED ASSOC, V299, P814, DOI 10.1001/jama.299.7.814; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CARD D, 2007, 3668 NAT BUR EC RES; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Decker SL, 2005, J HUM RESOUR, V40, P948, DOI 10.3368/jhr.XL.4.948; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fiscella K, 2008, ANN FAM MED, V6, P497, DOI 10.1370/afm.873; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; *I MED, 2002, UN TREATM CONFR RAC; *I MED, 2004, INS AM HLTH PRINC R; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2001, COV MATT INS HLTH CA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Landon BE, 2008, MED CARE RES REV, V65, P167, DOI 10.1177/1077558707310208; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McGuire TG, 2006, HEALTH SERV RES, V41, P1979, DOI 10.1111/j.1475-6773.2006.00583.x; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; *NAT CTR HLTH STAT, 2007, DHHS PUBL; *NCHS, 2003, NAT HLTH NUTR EX SUR; [NCHS] National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR; *NHANES, 2006, AN REP GUID 2006; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Simantov E, 2001, HEALTH AFFAIR, V20, P139, DOI 10.1377/hlthaff.20.4.139; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US PREV SERV TASK, 2007, AHRQ PUBL; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1575, DOI 10.1377/hlthaff.26.6.1575; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yusuf S, 2000, NEW ENGL J MED, V342, P145	79	263	264	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					505	W90		10.7326/0003-4819-150-8-200904210-00005	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437AD	19380852				2022-12-24	WOS:000265457000001
J	Narimatsu, M; Bose, R; Pye, M; Zhang, L; Miller, B; Ching, P; Sakuma, R; Luga, V; Roncari, L; Attisano, L; Wrana, JL				Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Miller, Bryan; Ching, Peter; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Attisano, Liliana; Wrana, Jeffrey L.			Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases	CELL			English	Article							NEURAL-TUBE DEFECTS; INNER-EAR; HAIR-CELLS; LOOP-TAIL; SIGNALING SPECIFICITY; CONVERGENT EXTENSION; STRABISMUS/VAN-GOGH; FLOOR PLATE; PCP PATHWAY; DROSOPHILA	Planar cell polarity (PCP) is critical for morphogenesis in metazoans. PCP in vertebrates regulates stereocilia alignment in neurosensory cells of the cochlea and closure of the neural tube through convergence and extension movements (CE). Noncanonical Wnt morphogens regulate PCP and CE in vertebrates, but the molecular mechanisms remain unclear. Smurfs are ubiquitin ligases that regulate signaling, cell polarity and motility through spatiotemporally restricted ubiquitination of diverse substrates. Here, we report an unexpected role for Smurfs in controlling PCP and CE. Mice mutant for Smurf1 and Smurf2 display PCP defects in the cochlea and CE defects that include a failure to close the neural tube. Further, we show that Smurfs engage in a non-canonical Wnt signaling pathway that targets the core PCP protein Prickle1 for ubiquitin-mediated degradation. Our work thus uncovers ubiquitin ligases in a mechanistic link between noncanonical Wnt signaling and PCP/CE.	[Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Bose, Rohit; Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Wrana, Jeffrey L.] Mt Sinai Hosp, Ctr Syst Biol, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Attisano, L (corresponding author), Univ Toronto, Dept Biochem, 160 Coll St, Toronto, ON M5S 3E1, Canada.	liliana.attisano@utoronto.ca; wrana@mshri.on.ca	Bose, Rohit/O-9825-2018; Wrana, Jeffrey/F-8857-2013	Bose, Rohit/0000-0002-6785-0697; ZHANG, Liang/0000-0003-3100-8593	Canadian Institutes of Health Research (CIHR) [77690, 74692, 12860]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank Dr. W. Rod Hardy and the ES and transgenic core facilities at Samuel Lunenfeld Research Institute/Toronto Centre for Phenogenomics for supporting generation of ES clones and diploid/tetraploid chimeras. We thank Siyuan Song for technical assistance, Dr. H. McNeill and the members of Drs. Wrana's and Attisano's labs for helpful comments and discussion. This work was supported by grants to L.A. (#77690) and J.L.W. (#74692, #12860) from the Canadian Institutes of Health Research (CIHR). L.A. and J.L.W. hold Canadian Research Chairs, and J.L.W. is an International Scholar of the Howard Hughes Medical Institute.	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lewis J, 2002, J NEUROBIOL, V53, P190, DOI 10.1002/neu.10124; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Penton A, 2002, GENETICS, V161, P747; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2008, MECH DEVELOP, V125, P30, DOI 10.1016/j.mod.2007.10.006; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	45	249	255	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					295	307		10.1016/j.cell.2009.02.025	http://dx.doi.org/10.1016/j.cell.2009.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379695	Bronze			2022-12-24	WOS:000265456800022
J	Campbell, BH				Campbell, Bruce H.			The Code	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bcampbel@mcw.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1415	1416		10.1001/jama.2009.459	http://dx.doi.org/10.1001/jama.2009.459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351928				2022-12-24	WOS:000264924900001
J	Jung, HW; Tschaplinski, TJ; Wang, L; Glazebrook, J; Greenberg, JT				Jung, Ho Won; Tschaplinski, Timothy J.; Wang, Lin; Glazebrook, Jane; Greenberg, Jean T.			Priming in Systemic Plant Immunity	SCIENCE			English	Article							ACQUIRED-RESISTANCE; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; SIGNAL; ACCUMULATION; PATHOGEN; TOBACCO	Plants possess inducible systemic defense responses when locally infected by pathogens. Bacterial infection results in the increased accumulation of the mobile metabolite azelaic acid, a nine-carbon dicarboxylic acid, in the vascular sap of Arabidopsis that confers local and systemic resistance against the pathogen Pseudomonas syringae. Azelaic acid primes plants to accumulate salicylic acid (SA), a known defense signal, upon infection. Mutation of the AZELAIC ACID INDUCED 1 (AZI1) gene, which is induced by azelaic acid, results in the specific loss of systemic immunity triggered by pathogen or azelaic acid and of the priming of SA induction in plants. Furthermore, the predicted secreted protein AZI1 is also important for generating vascular sap that confers disease resistance. Thus, azelaic acid and AZI1 are components of plant systemic immunity involved in priming defenses.	[Jung, Ho Won; Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tschaplinski, Timothy J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Wang, Lin; Glazebrook, Jane] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	University of Chicago; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Greenberg, JT (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 1103 E 57th St EBC410, Chicago, IL 60637 USA.	jgreenbe@midway.uchicago.edu	Tschaplinski, Timothy/D-6382-2018; Wang, Lin/D-4021-2009	Tschaplinski, Timothy/0000-0002-9540-6622; Greenberg, Jean/0000-0002-7213-7618; Glazebrook, Jane/0000-0001-5167-736X	NSF [IOB-0450207, IOB-0419648]; Korea Research Foundation fellowship; Office of Biological and Environmental Research of the U.S. Department of Energy; U.S. Department of Energy [DE-AC05-00OR22725]	NSF(National Science Foundation (NSF)); Korea Research Foundation fellowship(National Research Foundation of Korea); Office of Biological and Environmental Research of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by NSF grants to J.T.G. (IOB-0450207) and J.G. (IOB-0419648) and by a fellowship from Korea Research Foundation to H.W.J., and T.J.T. was supported by the Office of Biological and Environmental Research of the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle for the U.S. Department of Energy under contract DE-AC05-00OR22725. We thank J. Bergelson and L. Mets for the use of their high-performance liquid chromatographys, F. Katagiri and J. Malamy for useful discussions, R. Cameron for sharing her detailed exudate collection protocol, and N. Engle for analysis of exudates. A patent application related to this work has been filed by the University of Chicago and UT-Battelle on behalf of inventors J.T.G., H.W.J., and T.J.T. on the use of azelaic acid to confer protection in crop plants against infection.	Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; DEAN RA, 1986, PHYTOPATHOLOGY, V76, P966, DOI 10.1094/Phyto-76-966; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x	13	563	591	6	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					89	91		10.1126/science.1170025	http://dx.doi.org/10.1126/science.1170025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342588				2022-12-24	WOS:000264802100038
J	Jeong, H; Then, F; Melia, TJ; Mazzulli, JR; Cui, L; Savas, JN; Voisine, C; Paganetti, P; Tanese, N; Hart, AC; Yamamoto, A; Krainc, D				Jeong, Hyunkyung; Then, Florian; Melia, Thomas J., Jr.; Mazzulli, Joseph R.; Cui, Libin; Savas, Jeffrey N.; Voisine, Cindy; Paganetti, Paolo; Tanese, Naoko; Hart, Anne C.; Yamamoto, Ai; Krainc, Dimitri			Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation	CELL			English	Article							INCLUSION-BODY FORMATION; CAENORHABDITIS-ELEGANS; POLYGLUTAMINE EXPANSIONS; IN-VITRO; DISEASE; PROTEIN; DYSFUNCTION; MODEL; AGGREGATION; NEURODEGENERATION	Huntington's disease (HD) is an incurable neurodegenerative disease caused by neuronal accumulation of the mutant protein huntingtin. Improving clearance of the mutant protein is expected to prevent cellular dysfunction and neurodegeneration in HD. We report here that such clearance can be achieved by posttranslational modification of the mutant Huntingtin (Htt) by acetylation at lysine residue 444 (K444). Increased acetylation at K444 facilitates trafficking of mutant Htt into autophagosomes, significantly improves clearance of the mutant protein by macroautophagy, and reverses the toxic effects of mutant huntingtin in primary striatal and cortical neurons and in a transgenic C. elegans model of HD. In contrast, mutant Htt that is rendered resistant to acetylation dramatically accumulates and leads to neurodegeneration in cultured neurons and in mouse brain. These studies identify acetylation as a mechanism for removing accumulated protein in HD, and more broadly for actively targeting proteins for degradation by autophagy.	[Jeong, Hyunkyung; Then, Florian; Mazzulli, Joseph R.; Cui, Libin; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA; [Voisine, Cindy; Hart, Anne C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Ctr Canc Res, Charlestown, MA 02129 USA; [Melia, Thomas J., Jr.] Yale Univ, Dept Cell Biol, New Haven, CT 06519 USA; [Savas, Jeffrey N.; Tanese, Naoko] New York Univ, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.] New York Univ, Sch Med, NYU & NIH Grad Partnership Program Struct Biol, New York, NY 10016 USA; [Paganetti, Paolo] Novartis Pharma AG, NIBR Basel, Neurosci Dis, CH-4002 Basel, Switzerland; [Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; New York University; National Institutes of Health (NIH) - USA; New York University; Novartis; Columbia University	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu	Yamamoto, Ai/D-1100-2011; Paganetti, Paolo/AAF-8039-2020; Voisine, Cindy/AAG-9045-2019	Paganetti, Paolo/0000-0003-1896-6324; Tanese, Naoko/0000-0002-1946-3211; Voisine, Cindy/0000-0001-7165-9636	DFG;  [R01NS050352];  [R01 NS051303];  [R01 NS050199]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050352, R01NS063973, R01NS051303, R01NS050199] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Drs. K. Kegel, M. DiFiglia, C. D. Allis, A. Basu, H. Park, and A.B. Young and members of the Krainc laboratory for helpful suggestions and comments on the manuscript. We also thank Drs. D. Sarracino, B. Krastins, J. Kowalak, S. Markey, and A. Makusky for help with mass spectrometry; B. Hyman, W. Stoothoff, and C. Lill for help with live-cell imaging; E. Regulier for help with lentiviral transductions; A. Weiss and A. Roscic for help with HN10 cells; H. Ischiropoulos for use of HPLC system; N. Mizushima for Atg5-deficient cells; A. Kazantsev for CBP and CBP Delta Q constructs; Y. Yoshimori for GFP-LC3; G.A. Fitzgerald for p300 and P/CAF; P.W. Faber for osm::Htt564-150Q; and the New York Structural Biology Center for the EM facilities. This work was supported by R01NS050352 and R01 NS051303 (to D.K.) and R01 NS050199 (to A.Y.). F.T. is a fellow of the DFG. Author contributions: H.J. and F.T. contributed equally to this work.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hart AC, 1999, J NEUROSCI, V19, P1952; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Regulier E, 2003, HUM MOL GENET, V12, P2827, DOI 10.1093/hmg/ddg305; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Voisine Cindy, 2004, V277, P141; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	48	296	306	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					60	72		10.1016/j.cell.2009.03.018	http://dx.doi.org/10.1016/j.cell.2009.03.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345187	Bronze, Green Accepted			2022-12-24	WOS:000264813300014
J	Macdonald, S; Dixit, A; Wyatt, MG				Macdonald, S.; Dixit, A.; Wyatt, M. G.			Picture quiz "Brain attack"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; CAROTID STENOSIS; SYMPTOMATIC PATIENTS; ENDARTERECTOMY; STROKE; TRIAL; RISK		[Macdonald, S.; Dixit, A.; Wyatt, M. G.] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Wyatt, MG (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England.	mike.wyatt@nuth.nhs.uk		Wyatt, Michael G/0000-0002-9144-4437				[Anonymous], 1994, STROKE, V25, P2523; Corriveau MM, 2004, J VASC SURG, V39, P735, DOI 10.1016/j.jvs.2003.12.017; DEANE C, 2007, SOC VASC TECHN GREAT; Halliday A, 2004, LANCET, V363, P1491; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; *NAT I HLTH CLIN E, 2007, 233 IPG NAT I HLTH C; National Institutes of Health and Clinical Excellence, 2008, NIC CLIN GUID; OATES CP, 2008, EUR J VASC ENDO 1127; Schulz UG, 2004, STROKE, V35, P2459, DOI 10.1161/01.STR.0000143455.55877.b9; Sen S, 2000, CEREBROVASC DIS, V10, P102, DOI 10.1159/000016038; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vidjak V, 2007, COLLEGIUM ANTROPOL, V31, P775; Wardlaw JM, 2006, HEALTH TECHNOL ASSES, V10, P1; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2009	338								a3109	10.1136/bmj.a3109	http://dx.doi.org/10.1136/bmj.a3109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AM	19359302				2022-12-24	WOS:000264893200001
J	O'Rourke, MF				O'Rourke, Michael F.			Should doctors recommend automated external defibrillators for use at home after myocardial infarction? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CARDIAC-ARREST		[O'Rourke, Michael F.] Univ New S Wales, Darlinghurst, NSW 2010, Australia; [O'Rourke, Michael F.] St Vincents Clin, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney	O'Rourke, MF (corresponding author), Univ New S Wales, 438 Victoria St, Darlinghurst, NSW 2010, Australia.	m.orourke@unsw.edu.au		Hutchinson, Mathew/0000-0002-8286-0113				Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; HAYES DL, 2008, BRAUNWALDS HEART DIS, P831; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; O'Rourke MF, 2005, HEART, V91, P1505, DOI 10.1136/hrt.2005.061572; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; Whitfield R, 2005, RESUSCITATION, V64, P269, DOI 10.1016/j.resuscitation.2005.01.003	8	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 23	2009	338								b874	10.1136/bmj.b874	http://dx.doi.org/10.1136/bmj.b874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307277				2022-12-24	WOS:000264639400018
J	Brown, CJ; Roth, DL; Allman, RM; Sawyer, P; Ritchie, CS; Roseman, JM				Brown, Cynthia J.; Roth, David L.; Allman, Richard M.; Sawyer, Patricia; Ritchie, Christine S.; Roseman, Jeffrey M.			Trajectories of Life-Space Mobility After Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL DECLINE; OLDER-ADULTS; MULTICOMPONENT INTERVENTION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ACUTE-CARE; OUTCOMES; DELIRIUM; PREVALENCE; DISABILITY	Background: Life space is a measure of where a person goes, the frequency of going there, and the dependency in getting there. It may be a more accurate measure of mobility in older adults because it reflects participation in society as well as physical ability. Objective: To assess effects of hospitalization on life space in older adults, and to compare life-space trajectories associated with surgical and nonsurgical hospitalizations. Design: Prospective observational study. Setting: Central Alabama. Participants: 687 community-dwelling Medicare beneficiaries at least 65 years of age with surgical (n = 44), nonsurgical (n = 167), or no (n = 476) hospitalizations. Measurements: Life-Space Assessment (LSA) scores before and after hospitalization (range, 0 to 120; higher scores reflect greater mobility). Results: Mean age of participants was 74.6 years (SD, 6.3). Fifty percent were black, and 46% were male. Before hospitalization, adjusted LSA scores were similar in participants with surgical and nonsurgical admissions. Life-space assessment scores decreased in both groups immediately after hospitalization; however, participants with surgical hospitalizations had a greater decrease in scores (12.1 more points [95% CI, 3.6 to 20.7 points]; P = 0.005) than those with nonsurgical hospitalizations. However, participants with surgical hospitalizations recovered more rapidly over time (gain of 4.7 more points [CI, 2.0 to 7.4 points] per ln [week after discharge]; P < 0.001). Score recovery for participants with nonsurgical hospitalizations did not significantly differ from the null (average recovery, 0.7 points [CI,-0.6 to 1.9 points] per ln [week after discharge]). Limitation: Life space immediately before and after hospitalization was self-reported, often after hospital discharge. Conclusion: Hospitalization decreases life space in older adults. Surgical hospitalizations are associated with immediate marked life-space declines followed by rapid recovery, in contrast to nonsurgical hospitalizations, which are associated with more modest immediate declines and little evidence of recovery after several years of follow-up.	Birmingham & Atlanta Vet Affairs Geriatr Res, Birmingham, AL USA; Ctr Clin, Birmingham, AL USA; Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Brown, CJ (corresponding author), Birmingham Vet Affairs Med Ctr, 11G,700 S 19th St, Birmingham, AL 35233 USA.	cbrown@aging.uab.edu; droth@uab.edu	Allman, Richard M./O-1693-2019	Allman, Richard M./0000-0002-1850-6515; Brown, Cynthia J/0000-0002-1629-5507	National Institute on Aging [R01 AG015062]; Veterans Affairs Research Career Development Award [E4-3842VA]; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING [R01AG015062] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Research Career Development Award(US Department of Veterans Affairs); John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: National Institute on Aging.; Grant Support: By a Veterans Affairs Research Career Development Award (E4-3842VA) (Dr. Brown) and a John A. Hartford Foundation-funded Southeast Center of Excellence in Geriatric Medicine Special Fellows grant (Dr. Brown). The UAB Study of Aging is funded through a grant from the National Institute on Aging (R01 AG015062).	Ahmed A, 2007, AM J CARDIOL, V99, P549, DOI 10.1016/j.amjcard.2006.08.065; *AL RUR HLTH ASS, 1998, HLTH STAT RUR AL; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Dubois MF, 2007, J CLIN EPIDEMIOL, V60, P1040, DOI 10.1016/j.jclinepi.2006.12.011; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; *I MED, 2006, FUT DIS AM; Incalzi RA, 1996, ARCH INTERN MED, V156, P425, DOI 10.1001/archinte.156.4.425; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; JETTE AM, 2006, PHYS THER, V86, P726, DOI DOI 10.1093/PTJ/86.5.726; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LAZARUS BA, 1991, ARCH INTERN MED, V151, P2452, DOI 10.1001/archinte.151.12.2452; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; MARGITIC SE, 1993, J AM GERIATR SOC, V41, P258, DOI 10.1111/j.1532-5415.1993.tb06703.x; McAvay GJ, 2006, J AM GERIATR SOC, V54, P1245, DOI 10.1111/j.1532-5415.2006.00815.x; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; MCVEY LJ, 1989, ANN INTERN MED, V110, P79, DOI 10.7326/0003-4819-110-1-79; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Parker M, 2002, J GERONTOL NURS, V35, P35, DOI DOI 10.1300/J083V35N04_04; Peak EL, 2005, J BONE JOINT SURG AM, V87A, P247, DOI 10.2106/JBJS.C.01513; Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008; Roseman, 2006, AGING HLTH, V2, P417, DOI [10.2217/1745509x.2.3.417, DOI 10.2217/1745509X.2.3.417]; RUEL M, 2005, SABISTON SPENCER SUR, P1476; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Sager MA, 1998, CLIN GERIATR MED, V14, P669; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; VAITKEVICUS VP, 2003, PRINCIPLES GERIATRIC, P361; WARSHAW GA, 1982, JAMA-J AM MED ASSOC, V248, P847, DOI 10.1001/jama.248.7.847; WHO, 2001, WHO INT CLASS FUNCT	40	131	131	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					372	W67		10.7326/0003-4819-150-6-200903170-00005	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293070	Green Accepted			2022-12-24	WOS:000264468500002
J	Liu, J; Cao, L; Chen, JC; Song, SW; Lee, IH; Quijano, C; Liu, HJ; Keyvanfar, K; Chen, HQ; Cao, LY; Ahn, BH; Kumar, NG; Rovira, II; Xu, XL; van Lohuizen, M; Motoyama, N; Deng, CX; Finkel, T				Liu, Jie; Cao, Liu; Chen, Jichun; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Keyvanfar, Keyvan; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Xu, Xiao-Ling; van Lohuizen, Maarten; Motoyama, Noboru; Deng, Chu-Xia; Finkel, Toren			Bmi1 regulates mitochondrial function and the DNA damage response pathway	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; REPAIR; PROLIFERATION; SENESCENCE; INK4A; MICE; P16(INK4A); TARGET; GROWTH	Mice deficient in the Polycomb repressor Bmi1 develop numerous abnormalities including a severe defect in stem cell self-renewal, alterations in thymocyte maturation and a shortened lifespan. Previous work has implicated de-repression of the Ink4a/Arf (also known as Cdkn2a) locus as mediating many of the aspects of the Bmi1(-/-) phenotype. Here we demonstrate that cells derived from Bmi1(-/-) mice also have impaired mitochondrial function, a marked increase in the intracellular levels of reactive oxygen species and subsequent engagement of the DNA damage response pathway. Furthermore, many of the deficiencies normally observed in Bmi1(-/-) mice improve after either pharmacological treatment with the antioxidant N-acetylcysteine or genetic disruption of the DNA damage response pathway by Chk2 (also known as Chek2) deletion. These results demonstrate that Bmi1 has an unexpected role in maintaining mitochondrial function and redox homeostasis and indicate that the Polycomb family of proteins can coordinately regulate cellular metabolism with stem and progenitor cell function.	[Liu, Jie; Cao, Liu; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu; Keyvanfar, Keyvan] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Kumar, Neil G.] NIH, Howard Hughes Med Inst, Res Scholar Program, Bethesda, MD 20892 USA; [Xu, Xiao-Ling; Deng, Chu-Xia] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Netherlands Cancer Institute; National Center for Geriatrics & Gerontology	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Liu.Cao@nih.gov; finkelt@nih.gov	deng, chuxia/N-6713-2016; LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 HL005012-11] Funding Source: Medline; NIA NIH HHS [R00 AG032356] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037, ZICHL005906, ZIAHL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG032356] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Smith AL, 2005, J GERONTOL A-BIOL, V60, P448, DOI 10.1093/gerona/60.4.448; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	38	368	381	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					387	U100		10.1038/nature08040	http://dx.doi.org/10.1038/nature08040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404261	Green Accepted			2022-12-24	WOS:000266243700037
J	Esslinger, C; Walter, H; Kirsch, P; Erk, S; Schnell, K; Arnold, C; Haddad, L; Mier, D; von Boberfeld, CO; Raab, K; Witt, SH; Rietschel, M; Cichon, S; Meyer-Lindenberg, A				Esslinger, Christine; Walter, Henrik; Kirsch, Peter; Erk, Susanne; Schnell, Knut; Arnold, Claudia; Haddad, Leila; Mier, Daniela; von Boberfeld, Carola Opitz; Raab, Kyeon; Witt, Stephanie H.; Rietschel, Marcella; Cichon, Sven; Meyer-Lindenberg, Andreas			Neural Mechanisms of a Genome-Wide Supported Psychosis Variant	SCIENCE			English	Article							SCHIZOPHRENIA		[Esslinger, Christine; Kirsch, Peter; Haddad, Leila; Mier, Daniela; Raab, Kyeon; Meyer-Lindenberg, Andreas] Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Walter, Henrik; Schnell, Knut] Univ Bonn, Div Med Psychol, D-53105 Bonn, Germany; [Walter, Henrik; Erk, Susanne; Schnell, Knut; Arnold, Claudia; von Boberfeld, Carola Opitz] Univ Bonn, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany; [Witt, Stephanie H.; Rietschel, Marcella] Univ Heidelberg, Dept Genet Epidemiol Psychiat, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53105 Bonn, Germany; [Cichon, Sven] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn	Meyer-Lindenberg, A (corresponding author), Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, J5, D-68159 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Walter, Henrik/O-2612-2013; Cichon, Sven/H-8803-2013; Kirsch, Peter/C-2499-2008; Cichon, Sven/B-9618-2014; Meyer-Lindenberg, Andreas/H-1076-2011	Cichon, Sven/0000-0002-9475-086X; Kirsch, Peter/0000-0002-0817-1248; Cichon, Sven/0000-0002-9475-086X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Erk, Susanne/0000-0003-0961-3543; Mier, Daniela/0000-0003-2518-7492; Walter, Henrik/0000-0002-9403-6121	Bundesministerium fur Bildung und Forschung; Deutsche Forschungemeinschaft [SFB 636-B7]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungemeinschaft(German Research Foundation (DFG))	Funding was provided by Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz plus MooDs) and Deutsche Forschungemeinschaft (SFB 636-B7). We thank T. Paul, B. Newport, D. Gass, O. Grimm, and C. Sauer for data acquisition; T. Demirakca and M. Ruf for technical support; and T. Schulze and M. Nothen for helpful discussion.	Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005	6	319	339	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					605	605		10.1126/science.1167768	http://dx.doi.org/10.1126/science.1167768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407193				2022-12-24	WOS:000265608800033
J	Nishikimi, A; Fukuhara, H; Su, WJ; Hongu, T; Takasuga, S; Mihara, H; Cao, QH; Sanematsu, F; Kanai, M; Hasegawa, H; Tanaka, Y; Shibasaki, M; Kanaho, Y; Sasaki, T; Frohman, MA; Fukui, Y				Nishikimi, Akihiko; Fukuhara, Hideo; Su, Wenjuan; Hongu, Tsunaki; Takasuga, Shunsuke; Mihara, Hisashi; Cao, Qinhong; Sanematsu, Fumiyuki; Kanai, Motomu; Hasegawa, Hiroshi; Tanaka, Yoshihiko; Shibasaki, Masakatsu; Kanaho, Yasunori; Sasaki, Takehiko; Frohman, Michael A.; Fukui, Yoshinori			Sequential Regulation of DOCK2 Dynamics by Two Phospholipids During Neutrophil Chemotaxis	SCIENCE			English	Article							PHOSPHATIDIC-ACID; CELL-MIGRATION; DOWNSTREAM ACTIVATION; RAC ACTIVATION; MOTILITY; POLARITY; PROTEINS; COMPLEX; ROLES; ARF6	During chemotaxis, activation of the small guanosine triphosphatase Rac is spatially regulated to organize the extension of membrane protrusions in the direction of migration. In neutrophils, Rac activation is primarily mediated by DOCK2, an atypical guanine nucleotide exchange factor. Upon stimulation, we found that DOCK2 rapidly translocated to the plasma membrane in a phosphatidylinositol 3,4,5-trisphosphate-dependent manner. However, subsequent accumulation of DOCK2 at the leading edge required phospholipase D-mediated synthesis of phosphatidic acid, which stabilized DOCK2 there by means of interaction with a polybasic amino acid cluster, resulting in increased local actin polymerization. When this interaction was blocked, neutrophils failed to form leading edges properly and exhibited defects in chemotaxis. Thus, intracellular DOCK2 dynamics are sequentially regulated by distinct phospholipids to localize Rac activation during neutrophil chemotaxis.	[Nishikimi, Akihiko; Fukuhara, Hideo; Cao, Qinhong; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan; [Nishikimi, Akihiko; Tanaka, Yoshihiko; Fukui, Yoshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Su, Wenjuan; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Takasuga, Shunsuke; Sasaki, Takehiko] Akita Univ, Sch Med, Dept Pathol & Immunol, Div Microbiol, Akita 0108543, Japan; [Mihara, Hisashi; Kanai, Motomu; Shibasaki, Masakatsu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Kyushu University; Japan Science & Technology Agency (JST); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tsukuba; Akita University; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Kanai, Motomu/J-6807-2016; Nishikimi, Akihiko/I-4692-2018	Kanai, Motomu/0000-0003-1977-7648; Nishikimi, Akihiko/0000-0001-9497-7557; TANAKA, Yoshihiko/0000-0002-6458-5082; Fukui, Yoshinori/0000-0003-2335-8745; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; Global Center of Excellence program of the Japan Society for the Promotion of Science; NIH [R01GM71520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251, R01GM071520] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); CREST program of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Global Center of Excellence program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants for Targeted Proteins Research Project, Genome Network Project, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; the Global Center of Excellence program of the Japan Society for the Promotion of Science; and NIH award R01GM71520.	ALA A, 2009, MOL PHARM, V75, P437; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	24	204	211	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					384	387		10.1126/science.1170179	http://dx.doi.org/10.1126/science.1170179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19325080	Green Accepted			2022-12-24	WOS:000265221600041
J	Burlingham, WJ				Burlingham, William J.			A Lesson in Tolerance - Maternal Instruction to Fetal Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIGENS		Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Burlingham, WJ (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066219] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066219, R01 AI066219-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Molitor-Dart ML, 2007, J IMMUNOL, V179, P6749, DOI 10.4049/jimmunol.179.10.6749; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572	5	35	36	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1355	1357		10.1056/NEJMcibr0810752	http://dx.doi.org/10.1056/NEJMcibr0810752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321873	Green Accepted			2022-12-24	WOS:000264524100015
J	Fuentes, R; Petersson, P; Siesser, WB; Caron, MG; Nicolelis, MAL				Fuentes, Romulo; Petersson, Per; Siesser, William B.; Caron, Marc G.; Nicolelis, Miguel A. L.			Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease	SCIENCE			English	Article							TRIGEMINAL NERVE-STIMULATION; DEEP BRAIN-STIMULATION; L-DOPA; SUBTHALAMIC NUCLEUS; MOTOR; RAT; MOVEMENT; NEURONS; CORTEX	Dopamine replacement therapy is useful for treating motor symptoms in the early phase of Parkinson's disease, but it is less effective in the long term. Electrical deep-brain stimulation is a valuable complement to pharmacological treatment but involves a highly invasive surgical procedure. We found that epidural electrical stimulation of the dorsal columns in the spinal cord restores locomotion in both acute pharmacologically induced dopamine-depleted mice and in chronic 6-hydroxydopamine-lesioned rats. The functional recovery was paralleled by a disruption of aberrant low-frequency synchronous corticostriatal oscillations, leading to the emergence of neuronal activity patterns that resemble the state normally preceding spontaneous initiation of locomotion. We propose that dorsal column stimulation might become an efficient and less invasive alternative for treatment of Parkinson's disease in the future.	[Fuentes, Romulo; Petersson, Per; Caron, Marc G.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Petersson, Per] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, BMC F10, S-22184 Lund, Sweden; [Siesser, William B.; Caron, Marc G.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] ELS IINN, BR-59066060 Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Duke University; Lund University; Duke University; Duke University; Duke University; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fuentes, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fuentes@neuro.duke.edu	Petersson, Per/P-1878-2019; Fuentes, Romulo/AFR-1296-2022; Fuentes, Romulo/N-4258-2019; Petersson, Per/A-5740-2010	Petersson, Per/0000-0001-6697-0171; Fuentes, Romulo/0000-0002-6282-7287; Fuentes, Romulo/0000-0002-6282-7287; Petersson, Per/0000-0001-6697-0171	National Institute of Neurological Disorders and Stroke (NINDS) [R33NS049534]; International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC; Knut and Alice Wallenberg Foundation;  [R01NS019576];  [R01MH073853]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS049534, R21NS049534, R01NS019576] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC(National Research Centre (NRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. M. Chan, G. Lehew, and J. Meloy for outstanding technical assistance; R. Gainetdinov, S.-C. Lin, H. Zhang, and K. Dzirasa for valuable comments; and S. Halkiotis for proofreading the manuscript. This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) R33NS049534 and the International Neuroscience Network Foundation to M.A.L.N., R01NS019576 and R01MH073853 to M.G.C., Ruth K. Broad Postdoctoral Award to R.F., and NRC and Knut and Alice Wallenberg Foundation to P.P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health. M.A.L.N. dedicates this paper to Lily Safra for her continuing support and to the memory of his grandfather, Angelo Nicolelis, who suffered from Parkinson's disease. M.A.L.N. acknowledges a visiting professorship, Chaire Blaise Pascal, from the Region Ile de France at the Ecole Superieure de Physique et de Chimie Industrielles, Paris.	Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; BRUDZYNSKI SM, 1993, CAN J PHYSIOL PHARM, V71, P394, DOI 10.1139/y93-060; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; DeGiorgio CM, 2006, EPILEPSIA, V47, P1213, DOI 10.1111/j.1528-1167.2006.00594.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fanselow EE, 2000, J NEUROSCI, V20, P8160; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hornykiewicz O, 2002, AMINO ACIDS, V23, P65, DOI 10.1007/s00726-001-0111-9; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Schlesinger I, 2007, MOVEMENT DISORD, V22, P2394, DOI 10.1002/mds.21739; SHAW KM, 1980, Q J MED, V49, P283; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; WALL PD, 1970, BRAIN, V93, P505, DOI 10.1093/brain/93.3.505; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499	28	189	223	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1578	1582		10.1126/science.1164901	http://dx.doi.org/10.1126/science.1164901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299613	Green Accepted			2022-12-24	WOS:000264342300031
J	Mao, YW; Ge, XC; Frank, CL; Madison, JM; Koehler, AN; Doud, MK; Tassa, C; Berry, EM; Soda, T; Singh, KK; Biechele, T; Petryshen, TL; Moon, RT; Haggarty, SJ; Tsai, LH				Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Madison, Jon M.; Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Petryshen, Tracey L.; Moon, Randall T.; Haggarty, Stephen J.; Tsai, Li-Huei			Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3 beta/beta-Catenin Signaling	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; DISC1; BRAIN; MICE; LITHIUM; CELLS; DISRUPTED-IN-SCHIZOPHRENIA-1; EXPRESSION	The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scottish family with a high incidence of major depression, schizophrenia, and bipolar disorder. Subsequent studies provided indications that DISC1 plays a role in brain development. Here, we demonstrate that suppression of DISC1 expression reduces neural progenitor proliferation, leading to premature cell cycle exit and differentiation. Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3 beta. First, DISC1 inhibits GSK3 beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin. Importantly, expression of stabilized beta-catenin overrides the impairment of progenitor proliferation caused by DISC1 loss of function. Furthermore, GSK3 inhibitors normalize progenitor proliferation and behavioral defects caused by DISC1 loss of function. Together, these results implicate DISC1 inGSK3 beta/beta-catenin signaling pathways and provide a framework for understanding how alterations in this pathway may contribute to the etiology of psychiatric disorders.	[Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Moon, Randall T.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mao, Yingwei] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Soda, Takahiro] Harvard Univ, Sch Med, Phd Program, Boston, MA 02115 USA; [Soda, Takahiro] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] MIT, Cambridge, MA 02139 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Soda, Takahiro/AHC-3347-2022; Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; Petryshen, Tracey/X-5850-2019; Haggarty, Stephen J/M-9495-2016	Soda, Takahiro/0000-0001-6268-2965; Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Petryshen, Tracey/0000-0002-7972-4612; Haggarty, Stephen J/0000-0002-7872-168X; Mao, Yingwei/0000-0001-7339-1565	National Alliance for Research on Schizophrenia and Depression Young Investigator Award; Natural Sciences and Engineering Research Council Postdoctoral Award; National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); Natural Sciences and Engineering Research Council Postdoctoral Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Sawa for providing the human DISC1 cDNA construct, C. Lois for the FUGW construct, X. He for FLAG-Dvl2, HA-GSK3 beta, FLAG-WT-beta-catenin, and SA-beta-catenin constructs, Y. Ma and M. Greenberg for Ngn2 antibodies, and F. Gage for the AHP cells. We acknowledge E. Scolnick, B. A. Samuels, Z. Xie, D. Meletis, M. Carlen, C. Bragg, J. Buchman, P. Thanawala, and M. Dobbin for technical support, helpful discussion, and critical reading of the manuscript. L.-H. T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research. Y. M. is a recipient of the National Alliance for Research on Schizophrenia and Depression Young Investigator Award. K. K. S. is a recipient of a Natural Sciences and Engineering Research Council Postdoctoral Award and a Human Frontiers Science Program Research Fellowship. T. S. is a recipient of the Singleton Fellowship. This work was partially supported by a National Institutes of Health grant (NS37007) to L.-H. T.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Newton SS, 2007, CNS DRUGS, V21, P715, DOI 10.2165/00023210-200721090-00002; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	46	601	635	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1017	1031		10.1016/j.cell.2008.12.044	http://dx.doi.org/10.1016/j.cell.2008.12.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303846	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000264403900009
J	Wang, RH; Farrona, S; Vincent, C; Joecker, A; Schoof, H; Turck, F; Alonso-Blanco, C; Coupland, G; Albani, MC				Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Alonso-Blanco, Carlos; Coupland, George; Albani, Maria C.			PEP1 regulates perennial flowering in Arabis alpina	NATURE			English	Article							ARABIDOPSIS-THALIANA; VERNALIZATION; GENE; FLC; PROTEIN; EVOLUTION; REPRESSOR; TRIMETHYLATION; BRASSICACEAE; METHYLATION	Annual plants complete their life cycle in one year and initiate flowering only once, whereas perennials live for many years and flower repeatedly. How perennials undergo repeated cycles of vegetative growth and flowering that are synchronized to the changing seasons has not been extensively studied(1). Flowering is best understood in annual Arabidopsis thaliana 2,3, but many closely related species, such as Arabis alpina(4,5), are perennials. We identified the A. alpina mutant perpetual flowering 1 (pep1), and showed that PEP1 contributes to three perennial traits. It limits the duration of flowering, facilitating a return to vegetative development, prevents some branches from undergoing the floral transition allowing polycarpic growth habit, and confers a flowering response to winter temperatures that restricts flowering to spring. Here we show that PEP1 is the orthologue of the A. thaliana gene FLOWERING LOCUS C (FLC). The FLC transcription factor inhibits flowering until A. thaliana is exposed to winter temperatures(6,7), which trigger chromatin modifications that stably repress FLC transcription(8-11). In contrast, PEP1 is only transiently repressed by low temperatures, causing repeated seasonal cycles of repression and activation of PEP1 transcription that allow it to carry out functions characteristic of the cyclical life history of perennials. The patterns of chromatin modifications at FLC and PEP1 differ correlating with their distinct expression patterns. Thus we describe a critical mechanism by which flowering regulation differs between related perennial and annual species, and propose that differences in chromatin regulation contribute to this variation.	[Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Coupland, George; Albani, Maria C.] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de; albani@mpiz-koeln.mpg.de	Turck, Franziska/G-1240-2013; Schoof, Heiko/Y-7073-2018; Alonso-Blanco, Carlos/F-8864-2016; Coupland, George/AAP-8609-2020	Turck, Franziska/0000-0002-4982-5949; Schoof, Heiko/0000-0002-1527-3752; Alonso-Blanco, Carlos/0000-0002-4738-5556; Coupland, George/0000-0001-6988-4172; Albani, Maria/0000-0002-8215-020X; Farrona, Sara/0000-0002-6855-2237	Max Planck Society	Max Planck Society(Max Planck Society)	The authors would like to thank P. Sharma for growing plants and R. Bruggmann for running the gene prediction pipeline. The laboratories of H. S. and G. C. are partly funded by a core grant from the Max Planck Society.	Ansell SW, 2008, MOL ECOL, V17, P2245, DOI 10.1111/j.1365-294X.2008.03739.x; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Battey NH, 2000, J EXP BOT, V51, P1769, DOI 10.1093/jexbot/51.352.1769; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Bena G, 1998, P ROY SOC B-BIOL SCI, V265, P1141, DOI 10.1098/rspb.1998.0410; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Aloia M, 2008, NEW PHYTOL, V178, P755, DOI 10.1111/j.1469-8137.2008.02404.x; DIOMAIUTO J, 1988, Phytomorphology, V38, P163; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schranz ME, 2002, GENETICS, V162, P1457; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	41	263	269	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					423	U138		10.1038/nature07988	http://dx.doi.org/10.1038/nature07988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19369938	Green Published			2022-12-24	WOS:000266243700045
J	Ntoukakis, V; Mucyn, TS; Gimenez-lbanez, S; Chapman, HC; Gutierrez, JR; Balmuth, AL; Jones, AME; Rathjen, JP				Ntoukakis, Vardis; Mucyn, Tatiana S.; Gimenez-lbanez, Selena; Chapman, Helen C.; Gutierrez, Jose R.; Balmuth, Alexi L.; Jones, Alexandra M. E.; Rathjen, John P.			Host Inhibition of a Bacterial Virulence Effector Triggers Immunity to Infection	SCIENCE			English	Article							E3 UBIQUITIN LIGASE; PROGRAMMED CELL-DEATH; SYRINGAE PV. TOMATO; PLANT IMMUNITY; III EFFECTOR; NEGATIVE REGULATION; PROTEIN-KINASE; PTO KINASE; AVRPTOB; PHOSPHORYLATION	Plant pathogenic bacteria secrete effector proteins that attack the host signaling machinery to suppress immunity. Effectors can be recognized by hosts leading to immunity. One such effector is AvrPtoB of Pseudomonas syringae, which degrades host protein kinases, such as tomato Fen, through an E3 ligase domain. Pto kinase, which is highly related to Fen, recognizes AvrPtoB in conjunction with the resistance protein Prf. Here we show that Pto is resistant to AvrPtoB-mediated degradation because it inactivates the E3 ligase domain. AvrPtoB ubiquitinated Fen within the catalytic cleft, leading to its breakdown and loss of the associated Prf protein. Pto avoids this by phosphorylating and inactivating the AvrPtoB E3 domain. Thus, inactivation of a pathogen virulence molecule is one mechanism by which plants resist disease.	[Ntoukakis, Vardis; Mucyn, Tatiana S.; Gimenez-lbanez, Selena; Chapman, Helen C.; Gutierrez, Jose R.; Balmuth, Alexi L.; Jones, Alexandra M. E.; Rathjen, John P.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Rathjen, JP (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	john.rathjen@tsl.ac.uk	Gutierrez-Pulgar, Jose/AAC-1281-2020; Jones, Alexandra/B-5227-2009; Ntoukakis, Vardis/C-6296-2012; rathjen, john p/C-9327-2009; Gimenez-Ibanez, Selena/B-1172-2017	Jones, Alexandra/0000-0003-2571-8708; Ntoukakis, Vardis/0000-0003-0069-6004; rathjen, john p/0000-0003-4073-8088; Gimenez-Ibanez, Selena/0000-0002-5453-8565	Biotechnology and Biological Science Research Council [BB/D00456X/1]; Gatsby Charitable foundation; Biotechnology and Biological Sciences Research Council [BB/D00456X/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Serazetdinova for help with mass spectroscopy and G. Martin (Cornell University) for bacterial strains and RG-pto11 mutant seeds. Part of this work was funded by a Biotechnology and Biological Science Research Council grant BB/D00456X/1 to J.P.R. We gratefully acknowledge the support of the Gatsby Charitable foundation.	Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2005, FEMS MICROBIOL LETT, V245, P1, DOI 10.1016/j.femsle.2005.02.025; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Andriotis VME, 2006, J BIOL CHEM, V281, P26578, DOI 10.1074/jbc.M603197200; Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Lin NC, 2006, APPL ENVIRON MICROB, V72, P702, DOI 10.1128/AEM.72.1.702-712.2006; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; SALMERON JM, 1994, PLANT CELL, V6, P511, DOI 10.1105/tpc.6.4.511; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tatematsu K, 2008, J BIOL CHEM, V283, P11575, DOI 10.1074/jbc.M706961200; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2	24	92	94	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					784	787		10.1126/science.1169430	http://dx.doi.org/10.1126/science.1169430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423826				2022-12-24	WOS:000265832400046
J	Rout, ME; Callaway, RM				Rout, Marnie E.; Callaway, Ragan M.			An Invasive Plant Paradox	SCIENCE			English	Editorial Material							ECOSYSTEM CARBON; SOIL BIOTA		[Rout, Marnie E.; Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Rout, ME (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	marnie.rout@mso.umt.edu						Blank RR, 2008, INVAS PLANT SCI MANA, V1, P226, DOI 10.1614/IPSM-07-026.1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Gomez-Aparicio L, 2008, ECOL MONOGR, V78, P69, DOI 10.1890/06-2036.1; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Liao CZ, 2007, ECOSYSTEMS, V10, P1351, DOI 10.1007/s10021-007-9103-2; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Vanderhoeven S, 2005, PLANT SOIL, V275, P169, DOI 10.1007/s11104-005-1257-0; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	16	89	93	7	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					734	735		10.1126/science.1173651	http://dx.doi.org/10.1126/science.1173651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423809				2022-12-24	WOS:000265832400028
J	Saudek, CD				Saudek, Christopher D.			Can Diabetes Be Cured? Potential Biological and Mechanical Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ISLET TRANSPLANTATION; BETA-CELLS; MELLITUS; TRIAL; INSULIN		Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD 21287 USA	Johns Hopkins University	Saudek, CD (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Osler 575,700 N Wolfe St, Baltimore, MD 21287 USA.	csaudek@jhu.edu						Bollyky J, 2008, MT SINAI J MED, V75, P385, DOI 10.1002/msj.20054; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Waki Kayo, 2007, Clin Transpl, P9; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	17	17	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1588	1590		10.1001/jama.2009.508	http://dx.doi.org/10.1001/jama.2009.508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366779				2022-12-24	WOS:000265137900030
J	Kim, J; Ashenhurst, JA; Movassaghi, M				Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad			Total Synthesis of (+)-11,11 '-Dideoxyverticillin A	SCIENCE			English	Article							CONCISE TOTAL-SYNTHESIS; PERMANGANATE; OXIDATION; ACID; EPIDITHIODIOXOPIPERAZINES; BIOSYNTHESIS; CONSTRUCTION; VERTICILLIN; DERIVATIVES; EXPRESSION	The fungal metabolite (+)-11,11'-dideoxyverticillin A, a cytotoxic alkaloid isolated from a marine Penicillium sp., belongs to a fascinating family of densely functionalized, stereochemically complex, and intricate dimeric epidithiodiketopiperazine natural products. Although the dimeric epidithiodiketopiperazines have been known for nearly 4 decades, none has succumbed to total synthesis. We report a concise enantioselective total synthesis of (+)-11,11'- dideoxyverticillin A via a strategy inspired by our biosynthetic hypothesis for this alkaloid. Highly stereo- and chemoselective advanced-stage tetrahydroxylation and tetrathiolation reactions, as well as a mild strategy for the introduction of the epidithiodiketopiperazine core in the final step, were developed to address this highly sensitive substructure. Our rapid functionalization of the advanced molecular framework aims to mimic plausible biosynthetic steps and offers an effective strategy for the chemical synthesis of other members of this family of alkaloids.	[Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Movassaghi, M (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	movassag@mit.edu			Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; Lilly; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089732] Funding Source: NIH RePORTER	Amgen(Amgen); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Lilly(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.M. is an Alfred P. Sloan Research Fellow and a Beckman Young Investigator. J.K. and J.A.A. acknowledge predoctoral (National Defense Science and Engineering Graduate) and postdoctoral [Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)] fellowships, respectively. We thank P. Muller for assistance with x-ray structures of (+)-1 and (+)-14. We acknowledge generous support from Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, and Lilly. Structural parameters for (+)-1 and (+)-14 are freely available from the Cambridge Crystallographic Data Centre under CCDC-719219 and CCDC-719218, respectively.	Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen Y, 2005, FEBS LETT, V579, P3683, DOI 10.1016/j.febslet.2005.05.053; Chen Y, 2005, BIOCHEM BIOPH RES CO, V329, P1334, DOI 10.1016/j.bbrc.2005.02.115; CUTHBERTSON E, 1975, TETRAHEDRON LETT, V16, P1345; FIROUZABADI H, 1982, TETRAHEDRON LETT, V23, P1847, DOI 10.1016/S0040-4039(00)86758-1; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; GARDNER KA, 1995, SCIENCE, V269, P1849, DOI 10.1126/science.7569922; HAUSER D, 1970, HELV CHIM ACTA, V53, P1061, DOI 10.1002/hlca.19700530521; HERSCHEID JDM, 1980, J ORG CHEM, V45, P1880, DOI 10.1021/jo01298a023; KATAGIRI K, 1970, J ANTIBIOT, V23, P420, DOI 10.7164/antibiotics.23.420; KIRBY GW, 1980, BIOSYNTH MYCOTOX, P301; KISHI Y, 1973, J AM CHEM SOC, V95, P6490, DOI 10.1021/ja00800a077; Movassaghi M, 2008, ANGEW CHEM INT EDIT, V47, P1485, DOI 10.1002/anie.200704960; Movassaghi M, 2007, ANGEW CHEM INT EDIT, V46, P3725, DOI 10.1002/anie.200700705; Overman LE, 2007, ORG LETT, V9, P5267, DOI 10.1021/ol702518t; Rauk A, 1999, BIOCHEMISTRY-US, V38, P9089, DOI 10.1021/bi990249x; Ruble JC, 1998, J AM CHEM SOC, V120, P11532, DOI 10.1021/ja982890c; SALA T, 1978, J CHEM SOC CHEM COMM, P253, DOI 10.1039/c39780000253; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; SEEBACH D, 1983, J AM CHEM SOC, V105, P5390, DOI 10.1021/ja00354a034; Son BW, 1999, NAT PROD LETT, V13, P213, DOI 10.1080/10575639908048788; Strassner T, 2000, J AM CHEM SOC, V122, P7821, DOI 10.1021/ja000981f; WILLIAMS RM, 1980, J ORG CHEM, V45, P2625, DOI 10.1021/jo01301a017; WOODWARD RB, 1958, J AM CHEM SOC, V80, P209, DOI 10.1021/ja01534a053; Wu ZC, 2000, ANGEW CHEM INT EDIT, V39, P3866, DOI 10.1002/1521-3773(20001103)39:21<3866::AID-ANIE3866>3.0.CO;2-E; Zhang YX, 2005, ANTI-CANCER DRUG, V16, P515, DOI 10.1097/00001813-200506000-00007	29	250	256	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					238	241		10.1126/science.1170777	http://dx.doi.org/10.1126/science.1170777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	430WX	19359584	Green Accepted, Green Submitted			2022-12-24	WOS:000265024400043
J	Sun, YX; Kucej, M; Fan, HY; Yu, H; Sun, QY; Zou, H				Sun, Yuxiao; Kucej, Martin; Fan, Heng-Yu; Yu, Hong; Sun, Qing-Yuan; Zou, Hui			Separase Is Recruited to Mitotic Chromosomes to Dissolve Sister Chromatid Cohesion in a DNA-Dependent Manner	CELL			English	Article							CELL-CYCLE; CLEAVAGE; ANAPHASE; SECURIN; PHOSPHORYLATION; COMPLEX; PROTEIN; ARMS; CTCF; LOCALIZATION	Sister chromatid separation is triggered by the separase-catalyzed cleavage of cohesin. This process is temporally controlled by cell-cycle-dependent factors, but its biochemical mechanism and spatial regulation remain poorly understood. We report that cohesin cleavage by human separase requires DNA in a sequence-nonspecific manner. Separase binds to DNA in vitro, but its proteolytic activity, measured by its autocleavage, is not stimulated by DNA. Instead, biochemical characterizations suggest that DNA mediates cohesin cleavage by bridging the interaction between separase and cohesin. In human cells, a fraction of separase localizes to the mitotic chromosome. The importance of the chromosomal DNA in cohesin cleavage is further demonstrated by the observation that the cleavage of the chromosome-associated cohesins is sensitive to nuclease treatment. Our observations explain why chromosome-associated cohesins are specifically cleaved by separase and the soluble cohesins are left intact in anaphase.	[Sun, Yuxiao; Kucej, Martin; Zou, Hui] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yu, Hong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Fan, Heng-Yu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Zou, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	hui.zou@utsouthwestern.edu		Kucej, Martin/0000-0001-9129-4216	Damon Runyon Cancer Foundation (DRS) [35-03]; American Cancer Society [RSG-04-171-01-CCG]; Welch Foundation [I-1594]; NIH [R01GM081466-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081466] Funding Source: NIH RePORTER	Damon Runyon Cancer Foundation (DRS); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lydia Chiu and Julie Covino for technical support, Hongtao Yu for helpful discussions, and Eric Olson for critical reading and comments of the manuscript. We also thank Hongtao Yu, David Pellman, and Stephen Taylor for generously providing the myc<INF>6</INF>-SCC1, separase-V5, and myc-separase stable cell lines, respectively. H.Z. is the Kenneth G. and Elaine A. Langone Scholar supported by the Damon Runyon Cancer Foundation (DRS-#35-03). This work is also supported by a Research Scholar Grant from the American Cancer Society (RSG-04-171-01-CCG), a research grant from the Welch Foundation (I-1594), and a NIH R01 grant (R01GM081466-02) to H.Z.	Akhmedov AT, 1999, J BIOL CHEM, V274, P38216, DOI 10.1074/jbc.274.53.38216; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Fan HY, 2006, CELL CYCLE, V5, P198, DOI 10.4161/cc.5.2.2321; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Rollins RA, 1999, GENETICS, V152, P577; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zou H, 2002, FEBS LETT, V528, P246, DOI 10.1016/S0014-5793(02)03238-6; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	38	44	45	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					123	132		10.1016/j.cell.2009.01.040	http://dx.doi.org/10.1016/j.cell.2009.01.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345191	Green Accepted, Bronze			2022-12-24	WOS:000264813300019
J	Kizhatil, K; Baker, SA; Arshavsky, VY; Bennett, V				Kizhatil, Krishnakumar; Baker, Sheila A.; Arshavsky, Vadim Y.; Bennett, Vann			Ankyrin-G Promotes Cyclic Nucleotide-Gated Channel Transport to Rod Photoreceptor Sensory Cilia	SCIENCE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MEMBRANE-PROTEINS; LATERAL MEMBRANE; INITIAL SEGMENTS; SPECTRIN; REQUIRES; SUBUNIT; AXON; BETA(2)-SPECTRIN; CARDIOMYOCYTES	Cyclic nucleotide-gated (CNG) channels localize exclusively to the plasma membrane of photosensitive outer segments of rod photoreceptors where they generate the electrical response to light. Here, we report the finding that targeting of CNG channels to the rod outer segment required their interaction with ankyrin-G. Ankyrin-G localized exclusively to rod outer segments, coimmunoprecipitated with the CNG channel, and bound to the C-terminal domain of the channel beta 1 subunit. Ankyrin-G depletion in neonatal mouse retinas markedly reduced CNG channel expression. Transgenic expression of CNG channel beta-subunit mutants in Xenopus rods showed that ankyrin-G binding was necessary and sufficient for targeting of the beta 1 subunit to outer segments. Thus, ankyrin-G is required for transport of CNG channels to the plasma membrane of rod outer segments.	[Kizhatil, Krishnakumar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Baker, Sheila A.; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	benne012@mc.duke.edu	Kizhatil, Krish/AAR-5868-2021	Kizhatil, Krishnakumar/0000-0003-3755-6101; Baker, Sheila/0000-0002-0259-0652	NIH [EY12859]; Howard Hughes Medical Institute (HHMI); NATIONAL EYE INSTITUTE [P30EY005722, R01EY012859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Hoffman for constructing the plasmids used in the study. V.Y.A. was funded by NIH grant EY12859. V.B. is an investigator of Howard Hughes Medical Institute (HHMI) and was funded by HHMI.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MADREPERLA SA, 1989, J CELL BIOL, V109, P1483, DOI 10.1083/jcb.109.4.1483; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; WOHLFART P, 1992, J BIOL CHEM, V267, P644; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	29	58	62	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1614	1617		10.1126/science.1169789	http://dx.doi.org/10.1126/science.1169789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299621	Green Accepted			2022-12-24	WOS:000264342300041
J	Stein, RA				Stein, Richard A.			Lessons From Outbreaks of H1N1 Influenza	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; PANDEMIC INFLUENZA; TRANSMISSION; INFECTION; VIRUS; SARS; TRAVEL; PIGS	A new H1N1 triple-reassortant "swine" influenza virus was recently described in individuals from the United States and Mexico who presented with respiratory symptoms, and the same virus was subsequently confirmed in patients from several countries around the world. The circumstances surrounding the emergence of this pathogen, and the factors that facilitated the initial cross-species transmission, are still incompletely understood. It became apparent in the early days of the outbreak that the virus can be directly transmitted between humans. Pathogens that originate in animal reservoirs and subsequently acquire the potential for human-to-human transmission have caused outbreaks throughout human history. Although each outbreak is marked by its own particularities, it is important to remember the teachings that emerge from previous epidemics and pandemics. Integrating the important lessons of the past will provide the best opportunity to understand host-pathogen interaction and the most powerful approach to implementing effective prophylactic and therapeutic measures.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ras2@princeton.edu						[Anonymous], PREPARING INFLUENZA; Bassetti S, 2005, EMERG INFECT DIS, V11, P637, DOI 10.3201/eid1104.040639; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; *CDC, 1988, MMWR-MORBID MORTAL W, V37, P661; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; MACKENZIE D, 2009, DEADLY NEW FLU VIRUS; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Oxford JS, 2005, VACCINE, V23, P940, DOI 10.1016/j.vaccine.2004.06.035; Pascoe Neil, 2006, Tex Nurs, V80, P6; ROSENTHAL E, 2003, NY TIMES        0410, pA8; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08; Wenzel RP, 2005, ARCH MED RES, V36, P610, DOI 10.1016/j.arcmed.2005.03.040; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Wu W, 2004, CHINESE MED J-PEKING, V117, P14; 2003, WKLY EPIDEMIOL REC, V78, P145	25	18	20	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2009	151	1					59	62		10.7326/0003-4819-151-1-200907070-00123	http://dx.doi.org/10.7326/0003-4819-151-1-200907070-00123			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	470BF	19470591				2022-12-24	WOS:000267946100007
J	Shinde, V; Bridges, CB; Uyeki, TM; Shu, B; Balish, A; Xu, XY; Lindstrom, S; Gubareva, LV; Deyde, V; Garten, RJ; Harris, M; Gerber, S; Vagasky, S; Smith, F; Pascoe, N; Martin, K; Dufficy, D; Ritger, K; Conover, C; Quinlisk, P; Klimov, A; Bresee, JS; Finelli, L				Shinde, Vivek; Bridges, Carolyn B.; Uyeki, Timothy M.; Shu, Bo; Balish, Amanda; Xu, Xiyan; Lindstrom, Stephen; Gubareva, Larisa V.; Deyde, Varough; Garten, Rebecca J.; Harris, Meghan; Gerber, Susan; Vagasky, Susan; Smith, Forrest; Pascoe, Neal; Martin, Karen; Dufficy, Deborah; Ritger, Kathy; Conover, Craig; Quinlisk, Patricia; Klimov, Alexander; Bresee, Joseph S.; Finelli, Lyn			Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JANUARY-FEBRUARY 1976; FORT-DIX; VIRUS-INFECTION; TRANSMISSION; RESISTANCE; WORLDWIDE; WORKERS; SPREAD; PIGS	Background Triple-reassortant swine influenza A (H1) viruses - containing genes from avian, human, and swine influenza viruses - emerged and became enzootic among pig herds in North America during the late 1990s. Methods We report the clinical features of the first 11 sporadic cases of infection of humans with triple-reassortant swine influenza A (H1) viruses reported to the Centers for Disease Control and Prevention, occurring from December 2005 through February 2009, until just before the current epidemic of swine-origin influenza A (H1N1) among humans. These data were obtained from routine national influenza surveillance reports and from joint case investigations by public and animal health agencies. Results The median age of the 11 patients was 10 years (range, 16 months to 48 years), and 4 had underlying health conditions. Nine of the patients had had exposure to pigs, five through direct contact and four through visits to a location where pigs were present but without contact. In another patient, human-to-human transmission was suspected. The range of the incubation period, from the last known exposure to the onset of symptoms, was 3 to 9 days. Among the 10 patients with known clinical symptoms, symptoms included fever (in 90%), cough (in 100%), headache (in 60%), and diarrhea (in 30%). Complete blood counts were available for four patients, revealing leukopenia in two, lymphopenia in one, and thrombocytopenia in another. Four patients were hospitalized, two of whom underwent invasive mechanical ventilation. Four patients received oseltamivir, and all 11 recovered from their illness. Conclusions From December 2005 until just before the current human epidemic of swine-origin influenza viruses, there was sporadic infection with triple-reassortant swine influenza A (H1) viruses in persons with exposure to pigs in the United States. Although all the patients recovered, severe illness of the lower respiratory tract and unusual influenza signs such as diarrhea were observed in some patients, including those who had been previously healthy.	[Shinde, Vivek; Bridges, Carolyn B.; Uyeki, Timothy M.; Shu, Bo; Balish, Amanda; Xu, Xiyan; Lindstrom, Stephen; Gubareva, Larisa V.; Deyde, Varough; Garten, Rebecca J.; Klimov, Alexander; Bresee, Joseph S.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Shinde, Vivek; Dufficy, Deborah] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA 30333 USA; [Shinde, Vivek] Ctr Dis Control & Prevent, Prevent Med Residency Program, Atlanta, GA 30333 USA; [Harris, Meghan; Quinlisk, Patricia] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA; [Gerber, Susan; Ritger, Kathy] Chicago Dept Publ Hlth, Chicago, IL USA; [Vagasky, Susan] Michigan Dept Community Hlth, Lansing, MI USA; [Smith, Forrest] Ohio Dept Hlth, Columbus, OH 43266 USA; [Pascoe, Neal] Texas Dept State Hlth Serv, Austin, TX USA; [Martin, Karen] Minnesota Dept Hlth, St Paul, MN USA; [Conover, Craig] Illinois Dept Publ Hlth, Springfield, IL 62761 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; MDHHS - Michigan Department of Health & Human Services; Texas Department of State Health Services; Minnesota Department of Health (MHD)	Finelli, L (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd,NE Mailstop A-32, Atlanta, GA 30333 USA.	lfinelli@cdc.gov	Finelli, Lyn/AAK-2360-2020					Adiego Sancho B., 2009, EURO SURVEILL, V14; BASTIEN N, 2009, J CLIN MICROBIO 0401; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CSTE, 2007, COUNC STAT TERR EP P; DACSO CC, 1984, J CLIN MICROBIOL, V20, P833, DOI 10.1128/JCM.20.4.833-835.1984; GAYDOS JC, 1977, J INFECT DIS, V136, pS363, DOI 10.1093/infdis/136.Supplement_3.S363; GAYDOS JC, 1977, J INFECT DIS, V136, pS356, DOI 10.1093/infdis/136.Supplement_3.S356; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gregg M B, 1980, Ann N Y Acad Sci, V353, P45, DOI 10.1111/j.1749-6632.1980.tb18904.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HINSHAW VS, 1978, VIROLOGY, V84, P51, DOI 10.1016/0042-6822(78)90217-9; HODDER RA, 1977, J INFECT DIS, V136, pS369, DOI 10.1093/infdis/136.Supplement_3.S369; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KENDAL AP, 1983, J CLIN MICROBIOL, V18, P930, DOI 10.1128/JCM.18.4.930-934.1983; Kendal AP, 1982, CONCEPTS PROCEDURES; Kimura K, 1998, MAYO CLIN PROC, V73, P243, DOI 10.4065/73.3.243; Ma W, 2009, J MOL GENET MED, V3, P158; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; *NAT AGR STAT SERV, 2008, USDA Q HOGS PIGS REP; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; OBRIEN RJ, 1977, J INFECT DIS, V136, pS390, DOI 10.1093/infdis/136.Supplement_3.S390; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Olsen CW, 2006, DIS SWINE, V9, P469; PATRIARCA PA, 1984, AM J EPIDEMIOL, V119, P152, DOI 10.1093/oxfordjournals.aje.a113733; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Robinson JL, 2007, EMERG INFECT DIS, V13, P1865, DOI 10.3201/eid1312.070615; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; SMITH TF, 1976, NEW ENGL J MED, V294, P708, DOI 10.1056/NEJM197603252941308; THOMPSON RL, 1976, NEW ENGL J MED, V295, P714, DOI 10.1056/NEJM197609232951307; TOP FH, 1977, J INFECT DIS, V136, pS376, DOI 10.1093/infdis/136.Supplement_3.S376; VINCENT AL, 2009, VET MICROBIOL   0106; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; WELLS DL, 1991, JAMA-J AM MED ASSOC, V265, P478, DOI 10.1001/jama.265.4.478; Wentworth DE, 1997, J INFECT DIS, V175, P7, DOI 10.1093/infdis/175.1.7; WENTWORTH DE, 1994, J VIROL, V68, P2051, DOI 10.1128/JVI.68.4.2051-2058.1994	43	433	490	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2616	2625		10.1056/NEJMoa0903812	http://dx.doi.org/10.1056/NEJMoa0903812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19423871				2022-12-24	WOS:000267060000006
J	Wang, GG; Song, JK; Wang, ZX; Dormann, HL; Casadio, F; Li, HT; Luo, JL; Patel, DJ; Allis, CD				Wang, Gang G.; Song, Jikui; Wang, Zhanxin; Dormann, Holger L.; Casadio, Fabio; Li, Haitao; Luo, Jun-Li; Patel, Dinshaw J.; Allis, C. David			Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger	NATURE			English	Article							HISTONE H3; DEVELOPMENTAL REGULATORS; LYSINE-4 TRIMETHYLATION; PROTEIN STRUCTURES; PLANT HOMEODOMAIN; METHYLATION; TRANSCRIPTION; POLYCOMB; DIFFERENTIATION; MACROPHAGES	Histone H3 lysine 4 methylation (H3K4me) has been proposed as a critical component in regulating gene expression, epigenetic states, and cellular identities(1). The biological meaning of H3K4me is interpreted by conserved modules including plant homeodomain (PHD) fingers that recognize varied H3K4me states(1,2). The dysregulation of PHD fingers has been implicated in several human diseases, including cancers and immune or neurological disorders(3). Here we report that fusing an H3K4-trimethylation (H3K4me3)binding PHD finger, such as the carboxy-terminal PHD finger of PHF23 or JARID1A (also known as KDM5A or RBBP2), to a common fusion partner nucleoporin-98 (NUP98) as identified in human leukaemias(4,5), generated potent oncoproteins that arrested haematopoietic differentiation and induced acute myeloid leukaemia in murine models. In these processes, a PHD finger that specifically recognizes H3K4me3/2 marks was essential for leukaemogenesis. Mutations in PHD fingers that abrogated H3K4me3 binding also abolished leukaemic transformation. NUP98-PHD fusion prevented the differentiation-associated removal of H3K4me3 at many loci encoding lineage-specific transcription factors (Hox(s), Gata3, Meis1, Eya1 and Pbx1), and enforced their active gene transcription in murine haematopoietic stem/progenitor cells. Mechanistically, NUP98-PHD fusions act as 'chromatin boundary factors', dominating over polycomb-mediated gene silencing to 'lock' developmentally critical loci into an active chromatin state (H3K4me3 with induced histone acetylation), a state that defined leukaemia stem cells. Collectively, our studies represent, to our knowledge, the first report that deregulation of the PHD finger, an 'effector' of specific histone modification, perturbs the epigenetic dynamics on developmentally critical loci, catastrophizes cellular fate decision-making, and even causes oncogenesis during mammalian development.	[Wang, Gang G.; Dormann, Holger L.; Casadio, Fabio; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Song, Jikui; Wang, Zhanxin; Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Luo, Jun-Li] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; State University System of Florida; University of Florida	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Wang, G Greg/L-6666-2014; Li, Haitao/B-2668-2012; Hu, Ruogu/B-2203-2008	Wang, G Greg/0000-0002-7210-9940; Li, Haitao/0000-0001-6741-293X; 	Leukemia & Lymphoma Society Fellow award; Choh-Hao Li Memorial Fund Scholar award; Boehringer Ingelheim Foundation; National Institutes of Health (NIH); Rockefeller University; Abby RockefellerMauze Trust; Dewitt Wallace and Maloris Foundations; US Department of Defense CDMRP; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE [K99CA151683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society Fellow award; Choh-Hao Li Memorial Fund Scholar award; Boehringer Ingelheim Foundation(Boehringer Ingelheim); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Abby RockefellerMauze Trust; Dewitt Wallace and Maloris Foundations; US Department of Defense CDMRP(United States Department of Defense); Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Baker, P. Chi, A. Ruthenberg and A. Xiao for critical reading and help in manuscript preparation, C. Hughes for antibodies, and other Allis laboratory members for their advice. We are extremely grateful to M. Kamps and S. Rafii for shared plasmids and expert advice. Thanks to E. Coutavas, W. Chen, E. Ezhkova and the R. Roeder laboratory for help on cell and animal work. G. G. W. is supported by a Leukemia & Lymphoma Society Fellow award and a Choh-Hao Li Memorial Fund Scholar award; H. L. D. is supported by a predoctoral Boehringer Ingelheim Foundation fellowship; This research was supported by the National Institutes of Health (NIH) grant and funds of Rockefeller University to C. D. A., funds of Abby RockefellerMauze Trust and the Dewitt Wallace and Maloris Foundations to D. J. P., US Department of Defense CDMRP grant to J.-L. L., and a joint Starr Foundation Cancer Consortium grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; BOITE S, 2006, J MICROSC-OXFORD, V224, P213; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	53	318	322	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					847	U6		10.1038/nature08036	http://dx.doi.org/10.1038/nature08036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19430464	Green Accepted			2022-12-24	WOS:000267084500040
J	Mehta, R; Steinkraus, KA; Sutphin, GL; Ramos, FJ; Shamieh, LS; Huh, A; Davis, C; Chandler-Brown, D; Kaeberlein, M				Mehta, Ranjana; Steinkraus, Katherine A.; Sutphin, George L.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt			Proteasomal Regulation of the Hypoxic Response Modulates Aging in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN; DIETARY RESTRICTION; LONGEVITY; PROTEOTOXICITY; PROTEIN; DAF-16; FAMILY; ADAPTATION; EXTENSION	The Caenorhabditis elegans von Hippel-Lindau tumor suppressor homolog VHL-1 is a cullin E3 ubiquitin ligase that negatively regulates the hypoxic response by promoting ubiquitination and degradation of the hypoxic response transcription factor HIF-1. Here, we report that loss of VHL-1 significantly increased life span and enhanced resistance to polyglutamine and beta-amyloid toxicity. Deletion of HIF-1 was epistatic to VHL-1, indicating that HIF-1 acts downstream of VHL-1 to modulate aging and proteotoxicity. VHL-1 and HIF-1 control longevity by a mechanism distinct from both dietary restriction and insulin-like signaling. These findings define VHL-1 and the hypoxic response as an alternative longevity and protein homeostasis pathway.	[Mehta, Ranjana; Steinkraus, Katherine A.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sutphin, George L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu	Sutphin, George L./AAE-6151-2020	Sutphin, George/0000-0002-3659-4678	Alzheimers Association [IIRG-07-60158]; Glenn/AFAR (American Federation for Aging Research) award; NIH [1R01AG031108-01, P30AG013280]; Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG031108] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Glenn/AFAR (American Federation for Aging Research) award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank B. Kennedy and P. Kapahi for helpful discussion. Strains were provided by the Caenorhabditis Genetics Center. This work was supported by Alzheimers Association grant IIRG-07-60158, a Glenn/AFAR (American Federation for Aging Research) Breakthroughs in Gerontology award, and NIH grant 1R01AG031108-01 to M.K. R.M. and K.A.S. were supported by postdoctoral fellowships from the Hereditary Disease Foundation. G.L.S., L.S.S., and F.J.R. were supported by NIH grant P30AG013280. M.K. is an Ellison Medical Foundation New Scholar in Aging.	Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	25	168	210	5	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1196	1198		10.1126/science.1173507	http://dx.doi.org/10.1126/science.1173507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19372390	Green Accepted			2022-12-24	WOS:000266410100045
J	Sotelo, J; Perez-Padilla, R				Sotelo, Julio; Perez-Padilla, Rogelio			Personal View The flu epidemic in Mexico: the challenges for doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sotelo, Julio] Inst Hlth & Specialty Hosp Mexico, Mexico City, DF, Mexico; [Perez-Padilla, Rogelio] Natl Inst Resp Dis Mexico, Mexico City, DF, Mexico		Sotelo, J (corresponding author), Inst Hlth & Specialty Hosp Mexico, Mexico City, DF, Mexico.	jsotelo@unam.mx							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2009	338								b1820	10.1136/bmj.b1820	http://dx.doi.org/10.1136/bmj.b1820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GT	19416996				2022-12-24	WOS:000265969400007
J	Rybczynski, N; Dawson, MR; Tedford, RH				Rybczynski, Natalia; Dawson, Mary R.; Tedford, Richard H.			A semi-aquatic Arctic mammalian carnivore from the Miocene epoch and origin of Pinnipedia	NATURE			English	Article							PHYLOGENY; IMPACT	Modern pinnipeds (seals, sea lions and the walrus) are semi-aquatic, generally marine carnivores the limbs of which have been modified into flippers. Recent phylogenetic studies using morphological and molecular evidence support pinniped monophyly, and suggest a sister relationship with ursoids(1,2) (for example bears) or musteloids(3-7) (the clade that includes skunks, badgers, weasels and otters). Although the position of pinnipeds within modern carnivores appears moderately well resolved, fossil evidence of the morphological steps leading from a terrestrial ancestor to the modern marine forms has been weak or contentious. The earliest well-represented fossil pinniped is Enaliarctos, a marine form with flippers, which had appeared on the northwestern shores of North America by the early Miocene epoch(8,9). Here we report the discovery of a nearly complete skeleton of a new semi-aquatic carnivore from an early Miocene lake deposit in Nunavut, Canada, that represents a morphological link in early pinniped evolution. The new taxon retains a long tail and the proportions of its fore-and hindlimbs are more similar to those of modern terrestrial carnivores than to modern pinnipeds. Morphological traits indicative of semi-aquatic adaptation include a forelimb with a prominent deltopectoral ridge on the humerus, a posterodorsally expanded scapula, a pelvis with relatively short ilium, a shortened femur and flattened phalanges, suggestive of webbing. The new fossil shows evidence of pinniped affinities and similarities to the early Oligocene Amphicticeps from Asia and the late Oligocene and Miocene Potamotherium from Europe. The discovery suggests that the evolution of pinnipeds included a freshwater transitional phase, and may support the hypothesis that the Arctic was an early centre of pinniped evolution.	[Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Dawson, Mary R.] Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; [Tedford, Richard H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Rybczynski, N (corresponding author), Canadian Museum Nat, POB 3443 STN D, Ottawa, ON K1P 6P4, Canada.	nrybczynski@mus-nature.ca						Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Baskin Jon A., 1998, P152, DOI 10.1017/CBO9780511529924.011; Bebej RM, 2009, J MAMM EVOL, V16, P77, DOI 10.1007/s10914-008-9099-1; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; DARWIN C, 1880, ORIGIN SPECIES MEANS, P180; DAVIES JL, 1958, GEOGR REV, V48, P474, DOI 10.2307/211670; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; FISH FE, 1994, J MAMMAL, V75, P989, DOI 10.2307/1382481; Fish Frank E., 2001, P261; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FLYNN JJ, 1988, PHYLOGENY CLASSIFICA, V2, P73; Hunt Robert M. Jr, 1994, Proceedings of the San Diego Society of Natural History, V29, P57; JESSBERGER EK, 1988, METEORITICS, V23, P233, DOI 10.1111/j.1945-5100.1988.tb01285.x; Matthew W. D., 1915, Annals of the New York Academy of Sciences, V24; Mitchell E., 1973, Bulletin Am Mus nat Hist, V151, P203; Mors Thomas, 2000, Senckenbergiana Lethaea, V80, P257; Orlov J. A., 1933, Travaux de l'Institut Paleozoologique Acad Sci URSS, V2, P165; Sato JJ, 2006, ZOOL SCI, V23, P125, DOI 10.2108/zsj.23.125; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; SCHMIDT-KITTLER N, 1981, Eclogae Geologicae Helvetiae, V74, P753; Sherlock SC, 2005, METEORIT PLANET SCI, V40, P1777, DOI 10.1111/j.1945-5100.2005.tb00146.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Tedford Richard H., 2004, P169; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; WHITLOCK C, 1990, ARCTIC, V43, P324; WOLSAN M, 1993, ACTA THERIOL, V38, P345, DOI 10.4098/AT.arch.93-29; [No title captured]	30	76	79	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1021	1024		10.1038/nature07985	http://dx.doi.org/10.1038/nature07985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396145				2022-12-24	WOS:000265412900041
J	Wieffer, M; Maritzen, T; Haucke, V				Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker			SnapShot: Endocytic Trafficking	CELL			English	Editorial Material							MEMBRANE		[Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Free Univ Berlin, D-1000 Berlin, Germany; [Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Charite Univ Med Berlin, D-13353 Berlin, Germany; [Haucke, Volker] Leibniz Inst Mol Pharmacol, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wieffer, M (corresponding author), Free Univ Berlin, D-1000 Berlin, Germany.			Haucke, Volker/0000-0003-3119-6993; Maritzen, Tanja/0000-0003-4993-0340				Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Puertollano R, 2004, EMBO REP, V5, P942, DOI 10.1038/sj.embor.7400249; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003	10	45	45	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2							382.e1	10.1016/j.cell.2009.04.012	http://dx.doi.org/10.1016/j.cell.2009.04.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379701	Bronze			2022-12-24	WOS:000265456800030
J	Turnipseed, M; Crowder, LB; Sagarin, RD; Roady, SE				Turnipseed, Mary; Crowder, Larry B.; Sagarin, Raphael D.; Roady, Stephen E.			Legal Bedrock for Rebuilding America's Ocean Ecosystems	SCIENCE			English	Editorial Material									[Turnipseed, Mary; Roady, Stephen E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Crowder, Larry B.] Duke Univ, Nicholas Sch Environm, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Sagarin, Raphael D.] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA; [Roady, Stephen E.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Roady, Stephen E.] Earthjustice, Washington, DC 20036 USA	Duke University; Duke University; Duke University; Duke University	Turnipseed, M (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	mary.turnipseed@duke.edu						[Anonymous], 1983, FED REGISTER, V48; Archer J. H., 1994, PUBLIC TRUST DOCTRIN; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; McLeod K.L., 2005, SCI CONSENSUS STATEM; PARENTEAU PA, 2008, OCEAN COASTAL LAW PO, pCH19; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Ruhl J. B., 2006, SE ENV LAW J, V15, P223; SHACKEROFF JS, ECOSYSTEM B IN PRESS; Turnipseed M, 2009, ECOL LAW QUART, V36, P1; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; 2007, GLOBAL MARITIME BOUN; [No title captured]	14	30	32	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					183	184		10.1126/science.1170889	http://dx.doi.org/10.1126/science.1170889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	430WX	19359567	Green Submitted			2022-12-24	WOS:000265024400023
J	West, SD; McBeath, HA; Stradling, JR				West, Sophie D.; McBeath, Helen A.; Stradling, John R.			Easily Missed? Obstructive sleep apnoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE AIRWAY PRESSURE; PREVALENCE; RISK; MEN		[West, Sophie D.; Stradling, John R.] Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England; [McBeath, Helen A.] St Clements Surg, Oxford OX4 1JS, England	University of Oxford	West, SD (corresponding author), Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England.	sophie@west66.freeserve.co.uk		Stradling, John/0000-0003-4971-5018				[Anonymous], 2008, BBC NEWS; Cross MD, 2008, THORAX, V63, P578, DOI 10.1136/thx.2007.081877; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; *NIH CLIN EXC, 2008, COST TEMPL CONT POS; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	17	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1165	10.1136/bmj.b1165	http://dx.doi.org/10.1136/bmj.b1165			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351671				2022-12-24	WOS:000265102800001
J	Hulme, PE; Pysek, P; Nentwig, W; Vila, M				Hulme, Philip E.; Pysek, Petr; Nentwig, Wolfgang; Vila, Montserrat			Will Threat of Biological Invasions Unite the European Union?	SCIENCE			English	Editorial Material							PATHWAYS		[Hulme, Philip E.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CZ-25243 Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Dept Ecol, CZ-12801 Vinicna 7, Czech Republic; [Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Vila, Montserrat] CSIC, EBD, E-41092 Seville, Spain	Lincoln University - New Zealand; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; University of Bern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hulme, PE (corresponding author), Lincoln Univ, Bioprotect Res Ctr, POB 84, Canterbury, New Zealand.	philip.hulme@lincoln.ac.nz	Hulme, Philip/F-7454-2011; Vila, Montserrat/D-9339-2013; Nentwig, Wolfgang/A-6624-2011; Pysek, Petr/B-1957-2012	Hulme, Philip/0000-0001-5712-0474; Vila, Montserrat/0000-0003-3171-8261; 				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; *CZ PRES EU GOV CZ, WORK PROGR PRIOR CZ; DAISIE, 2009, HDB AL SPEC EUR; *EC, 2008, 789 COM EC; EEA (EEA European Enviroment Agency), 2007, HALT LOSS BIOD 2010; *EUR COMM, 2007, SINGL MARK GOODS; Flash Eurobarometer 219, 2007, ATT EUR ISS BIOD; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hulme Philip E., 2007, V25, P56; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; McGeoch MA, 2006, CONSERV BIOL, V20, P1635, DOI 10.1111/j.1523-1739.2006.00579.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; 2007, EFSAJ, V468, P1; 2007, EFSAJ, V539, P1	17	247	257	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					40	41		10.1126/science.1171111	http://dx.doi.org/10.1126/science.1171111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427TN	19342572	Green Submitted			2022-12-24	WOS:000264802100020
J	Watson, M; McPherson, A; Murray, SA				Watson, Max; McPherson, Alan; Murray, Scott A.			Should hospices be exempt from following national cardiopulmonary resuscitation guidelines? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Watson, Max] No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland; [Watson, Max] Univ Ulster, Coleraine, Ireland; [Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9YL, Midlothian, Scotland	Ulster University; University of Edinburgh	Watson, M (corresponding author), No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland.	max.watson@nihospicec.org						[Anonymous], NAT SURV PAT ACT DAT; *ROYAL COLL NURS B, 2007, DEC REL CARD RES JOI; Twycross R, 2003, INTRO PALLIATIVE CAR	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 26	2009	338								b965	10.1136/bmj.b965	http://dx.doi.org/10.1136/bmj.b965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LR	19325181				2022-12-24	WOS:000264639700005
J	Maisel, WH				Maisel, William H.			Left Atrial Appendage Occlusion - Closure or Just the Beginning?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA.							Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; *FOOD DRUG ADM, 2009, CIRC DEV PAN M APR 2; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Halperin JL, 2003, J AM COLL CARDIOL, V42, P1259, DOI 10.1016/S0735-1097(03)00958-6; NIH, CLINICALTRIALS GOV	5	47	54	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2601	2603		10.1056/NEJMp0903763	http://dx.doi.org/10.1056/NEJMp0903763			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19474420				2022-12-24	WOS:000267060000004
J	Wild, G; Gardner, A; West, SA				Wild, Geoff; Gardner, Andy; West, Stuart A.			Adaptation and the evolution of parasite virulence in a connected world	NATURE			English	Article							INCLUSIVE FITNESS; GROUP SELECTION; SOCIAL SEMANTICS; MODELS; COOPERATION; BEHAVIOUR; ALTRUISM	Adaptation is conventionally regarded as occurring at the level of the individual organism, where it functions to maximize the individual's inclusive fitness(1-3). However, it has recently been argued that empirical studies on the evolution of parasite virulence in spatial populations show otherwise(4-7). In particular, it has been claimed that the evolution of lower virulence in response to limited parasite dispersal(8,9) provides proof of Wynne-Edwards's(10) idea of adaptation at the group level. Although previous theoretical work has shown that limited dispersal can favour lower virulence, it has not clarified why, with five different suggestions having been given(6,8,11-15). Here we show that the effect of dispersal on parasite virulence can be understood entirely within the framework of inclusive fitness theory. Limited parasite dispersal favours lower parasite growth rates and, hence, reduced virulence because it (1) decreases the direct benefit of producing offspring(dispersers are worth more than non-dispersers, because they can go to patches with no or fewer parasites), and (2) increases the competition for hosts experienced by both the focal individual ('self-shading') and their relatives ('kin shading'). This demonstrates that reduced virulence can be understood as an individual-level adaptation by the parasite to maximize its inclusive fitness, and clarifies the links with virulence theory more generally(16).	[Wild, Geoff] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada; [Gardner, Andy] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Western University (University of Western Ontario); University of Edinburgh; University of Oxford	Wild, G (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B7, Canada.	gwild@uwo.ca	West, Stuart A/M-3608-2014; Wild, Geoff/AAG-1232-2019; Gardner, Andy/K-5353-2013	West, Stuart A/0000-0003-2152-3153; Wild, Geoff/0000-0001-7821-7304; Gardner, Andy/0000-0002-1304-3734	Natural Sciences and Engineering Research Council of Canada; UK Natural Environmental Research Council; Royal Society; Leverhulme Trust; European Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	We thank M. Boots, S. Brown, A. Buckling, A. Fernandes, S. Gandon, A. Griffin and S. Lion for discussions, and the Natural Sciences and Engineering Research Council of Canada, the UK Natural Environmental Research Council, the Royal Society, the Leverhulme Trust, and the European Research Council for funding.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Day T, 2007, ECOL LETT, V10, P876, DOI 10.1111/j.1461-0248.2007.01091.x; FISHER RA, 1930, GENETICAL THEORY NAT, DOI [10.5962/bhl.title.27468, DOI 10.5962/BHL.TITLE.27468]; FRANK SA, 1986, THEOR POPUL BIOL, V29, P312, DOI 10.1016/0040-5809(86)90013-4; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Goodnight C, 2008, COMPLEXITY, V13, P23, DOI 10.1002/cplx.20209; Grafen A, 2007, J EVOLUTION BIOL, V20, P1243, DOI 10.1111/j.1420-9101.2007.01321.x; Grafen A, 2006, J THEOR BIOL, V238, P541, DOI 10.1016/j.jtbi.2005.06.009; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Haraguchi Y, 1996, J THEOR BIOL, V183, P121, DOI 10.1006/jtbi.1996.9999; Holldobler B, 2008, SUPERORGANISM BEAUTY; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rousset F, 2004, THEOR POPUL BIOL, V65, P127, DOI 10.1016/j.tpb.2003.09.003; ROUSSET F, 2004, GENETIC STRUCTURE SE; Sober Elliott, 1998, OTHERS EVOLUTION PSY; Stearns S.C., 1992, pi; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Wilson DS, 2008, J EVOLUTION BIOL, V21, P368, DOI 10.1111/j.1420-9101.2007.01396.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wynne-Edwards V. C., 1962, pUnpaginated	30	100	101	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					983	986		10.1038/nature08071	http://dx.doi.org/10.1038/nature08071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19474791	Green Submitted			2022-12-24	WOS:000267063500042
J	Guo, P; Hirano, M; Herrin, BR; Li, JX; Yu, CL; Sadlonova, A; Cooper, MD				Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.			Dual nature of the adaptive immune system in lampreys	NATURE			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; MIGRATION-INHIBITORY FACTOR; T-CELL REPERTOIRE; DIFFERENTIATION; EVOLUTION; RESPONSES; DIVERSITY; THYMUS; GENES; DIVERSIFICATION	Jawless vertebrates use variable lymphocyte receptors (VLR) comprised of leucine-rich-repeat (LRR) segments as counterparts of the immunoglobulin-based receptors that jawed vertebrates use for antigen recognition. Highly diverse VLR genes are somatically assembled by the insertion of variable LRR sequences into incomplete germline VLRA and VLRB genes. Here we show that in sea lampreys (Petromyzon marinus) VLRA and VLRB anticipatory receptors are expressed by separate lymphocyte populations by monoallelic VLRA or VLRB assembly, together with expression of cytosine deaminase 1 (CDA1) or 2 (CDA2), respectively. Distinctive gene expression profiles for VLRA(+) and VLRB+ lymphocytes resemble those of mammalian T and B cells. Although both the VLRA and the VLRB cells proliferate in response to antigenic stimulation, only the VLRB lymphocytes bind native antigens and differentiate into VLR antibody-secreting cells. Conversely, VLRA lymphocytes respond preferentially to a classical T-cell mitogen and upregulate the expression of the pro-inflammatory cytokine genes interleukin-17 (IL-17) and macrophage migration inhibitory factor (MIF). The finding of T-like and B-like lymphocytes in lampreys offers new insight into the evolution of adaptive immunity.	[Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Guo, Peng; Hirano, Masayuki; Herrin, Brantley R.; Li, Jianxu; Yu, Cuiling; Sadlonova, Andrea; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University	Cooper, MD (corresponding author), Emory Univ, Emory Vaccine Ctr, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.	max.cooper@emory.edu	Li, Jianxu/I-5723-2013; Yu, Cuiling/E-6254-2011	Herrin, Brantley/0000-0002-1842-6806	National Institutes of Health; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI072435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. N. Alder and G. R. A. Ehrhardt for suggestions and discussion; C. L. Turnbough, Jr for providing B. anthracis spores and exosporium; D. E. Briles and W. H. Benjamin, Jr for E. coli, S. pneumoniae and S. typhimurium; H. Yi for help with electron microscopy; S. A. Durham and R. E. Karaffa, II for help with cell sorting; M. Flurry for help with preparation of figures. This work is supported by the National Institutes of Health and the Georgia Research Alliance.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; ARDAVIN CF, 1988, THYMUS, V11, P59; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; BLOOM BR, 1975, J EXP MED, V142, P1306, DOI 10.1084/jem.142.5.1306; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Lippert U, 2004, EXP DERMATOL, V13, P520, DOI 10.1111/j.0906-6705.2004.00182.x; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Paul W.E, 2008, FUNDAMENTAL IMMUNOLO; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; ROITT IM, 1969, LANCET, V2, P367; Sims-Mourtada JC, 2003, IMMUNOLOGY, V110, P296, DOI 10.1046/j.1365-2567.2003.01745.x; Suzuki T, 2004, DEV COMP IMMUNOL, V28, P993, DOI 10.1016/j.dci.2004.04.005; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Uinuk-ool T, 2002, P NATL ACAD SCI USA, V99, P14356, DOI 10.1073/pnas.212527699; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; Yu CL, 2009, EUR J IMMUNOL, V39, P571, DOI 10.1002/eji.200838846; ZINKERNA.RM, 1973, J EXP MED, V138, P1266, DOI 10.1084/jem.138.5.1266	50	254	276	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					796	U1		10.1038/nature08068	http://dx.doi.org/10.1038/nature08068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474790	Green Accepted			2022-12-24	WOS:000267084500029
J	Tamborlane, WV; Beck, RW				Tamborlane, William V.; Beck, Roy W.			Continuous glucose monitoring in type 1 diabetes mellitus	LANCET			English	Editorial Material							PEDIATRIC-PATIENTS		[Tamborlane, William V.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL USA	Yale University; JAEB Center For Health Research	Tamborlane, WV (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	william.tamborlane@yale.edu						Diabetes Research in Children Network (DIRECNET) Study Group, 2003, Diabetes Technol Ther, V5, P781; Diabetes Research in Children Network (DIRECNET) Study Group, 2003, Diabetes Technol Ther, V5, P791; Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P377, DOI 10.1089/dia.2008.0068; *JUV DIAB RES FDN, DIABETES CA IN PRESS; *JUV DIAB RES FDN, DIABETES IN PRESS; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967	9	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2009	373	9677					1744	1746		10.1016/S0140-6736(09)60962-4	http://dx.doi.org/10.1016/S0140-6736(09)60962-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449NM	19465217				2022-12-24	WOS:000266337300009
J	Thompson, MJ; Harnden, A; Del Mar, C				Thompson, Matthew J.; Harnden, Anthony; Del Mar, Chris			Diagnosis in General Practice Excluding serious illness in feverish children in primary care: restricted rule-out method for diagnosis	BRITISH MEDICAL JOURNAL			English	Article							RECOGNIZING MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; SIGNS; INFECTIONS; SYMPTOMS; RASH		[Thompson, Matthew J.; Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England; [Del Mar, Chris] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	University of Oxford; Bond University	Thompson, MJ (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	matthew.thompson@dphpc.ox.ac.uk	Del Mar, Chris/B-1136-2008	Del Mar, Chris/0000-0003-3821-8163				Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Brogan PA, 2000, ARCH DIS CHILD, V83, P506, DOI 10.1136/adc.83.6.506; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Granier S, 1998, BRIT J GEN PRACT, V48, P1167; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Inkelis SH, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e3; Kai J, 1996, BRIT MED J, V313, P983; Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308; MARZOUK O, 1991, ARCH DIS CHILD, V66, P485, DOI 10.1136/adc.66.4.485; Murtagh J, 1990, Aust Fam Physician, V19, P733; Nadel S, 1998, J ACCID EMERG MED, V15, P298; *SIGN, 2008, SIGN GUID, V102; SORENSEN HT, 1992, J CLIN EPIDEMIOL, V45, P1289; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; VALMARI P, 1987, EUR J PEDIATR, V146, P515, DOI 10.1007/BF00441607; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; VOSS L, 1989, NEW ZEAL MED J, V102, P243	20	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 20	2009	338								b1187	10.1136/bmj.b1187	http://dx.doi.org/10.1136/bmj.b1187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437ON	19380412				2022-12-24	WOS:000265496900001
J	Purnell, JQ; Flum, DR				Purnell, Jonathan Q.; Flum, David R.			Bariatric Surgery and Diabetes Who Should Be Offered the Option of Remission?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS		[Purnell, Jonathan Q.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Flum, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Purnell, JQ (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Mailstop L481,3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	purnellj@ohsu.edu	Flum, David/GPX-7976-2022		NIDDK NIH HHS [U01 DK066568] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; *DARTM HITCHC MED, WEIGHT MAN; *DEP HLTH HUM SERV, CMS PROGR INF; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Tarnoff M, 2009, SURG ENDOSC, V23, P650, DOI 10.1007/s00464-008-0125-4; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	13	17	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1593	1595		10.1001/jama.2009.541	http://dx.doi.org/10.1001/jama.2009.541			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366781	Green Accepted			2022-12-24	WOS:000265137900032
J	Cyranoski, D				Cyranoski, David			Retracted paper rattles Korean science	NATURE			English	News Item																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					561	561		10.1038/458561b	http://dx.doi.org/10.1038/458561b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340046	Bronze			2022-12-24	WOS:000264796200012
J	Trabucchi, M; Briata, P; Garcia-Mayoral, M; Haase, AD; Filipowicz, W; Ramos, A; Gherzi, R; Rosenfeld, MG				Trabucchi, Michele; Briata, Paola; Garcia-Mayoral, MariaFlor; Haase, Astrid D.; Filipowicz, Witold; Ramos, Andres; Gherzi, Roberto; Rosenfeld, Michael G.			The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs	NATURE			English	Article							POSTTRANSCRIPTIONAL REGULATION; DICER; EXPRESSION; MIRNAS; LIN-28; TRBP	Consistent with the role of microRNAs (miRNAs) in down-regulating gene expression by reducing the translation and/or stability of target messenger RNAs1, the levels of specific miRNAs are important for correct embryonic development and have been linked to several forms of cancer(2-4). However, the regulatory mechanisms by which primary miRNAs (pri-miRNAs) are processed first to precursor miRNAs (pre-miRNAs) and then to mature miRNAs by the multiprotein Drosha and Dicer complexes(5-8), respectively, remain largely unknown. The KH-type splicing regulatory protein (KSRP, also known as KHSRP) interacts with single-strand AU-rich-element-containing mRNAs and is a key mediator of mRNA decay(9,10). Here we show in mammalian cells that KSRP also serves as a component of both Drosha and Dicer complexes and regulates the biogenesis of a subset of miRNAs. KSRP binds with high affinity to the terminal loop of the target miRNA precursors and promotes their maturation. This mechanism is required for specific changes in target mRNA expression that affect specific biological programs, including proliferation, apoptosis and differentiation. These findings reveal an unexpected mechanism that links KSRP to the machinery regulating maturation of a cohort of miRNAs that, in addition to its role in promoting mRNA decay, independently serves to integrate specific regulatory programs of protein expression.	[Trabucchi, Michele; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept & Sch Med, La Jolla, CA 92093 USA; [Briata, Paola; Gherzi, Roberto] Ist Nazl Ric Canc IST, I-16132 Genoa, Italy; [Garcia-Mayoral, MariaFlor; Ramos, Andres] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Haase, Astrid D.; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Genoa; IRCCS AOU San Martino IST; MRC National Institute for Medical Research; Friedrich Miescher Institute for Biomedical Research	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept & Sch Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	aramos@nimr.mrc.ac.uk; rgherzi@ucsd.edu; mrosenfeld@ucsd.edu	Briata, Paola/AAC-6039-2020; Trabucchi, Michele/O-1755-2018; @haase_astrid, Astrid D/HHS-1635-2022; Gherzi, Roberto/AAA-7256-2020	Briata, Paola/0000-0003-3470-0454; @haase_astrid, Astrid D/0000-0003-1120-9013; Gherzi, Roberto/0000-0001-8654-0611; Trabucchi, Michele/0000-0001-6885-5628	Italian ISS [527B/2B/6]; AIRC; CIPE; ISS [526D/39]; EC; NIH [DK018477, DK39949, HL065445]; AICF; Wellcome Trust [WT022088MA]; Novartis Research Foundation; MRC [MC_U117574558, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574558] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	Italian ISS; AIRC(Fondazione AIRC per la ricerca sul cancro); CIPE; ISS; EC(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICF; Wellcome Trust(Wellcome TrustEuropean Commission); Novartis Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondazione Telethon(Fondazione Telethon)	We thank V. Narry Kim, T. C. Hobman, I. G. Macara, D. Srivastava and J. G. Belasco for reagents, G. Corte for sharing laboratory facilities and critical reading, Y. T. Liu for use of the microarray facility, M. Ponassi and C. Nelson for technical assistance, I. Diaz-Moreno, M. Doyle, S. Martin and D. Hollingworth for discussions and reagents, and A. Pasquinelli and A. De Flora for comments and discussions. Part of the studies has been conducted in the laboratories and facilities of the Centro Biotecnologie Avanzate (CBA, Genova, Italy). M. G. R. is an investigator with the Howard Hughes Medical Institute. M. T. is supported by a post-doctoral fellowship from the Italian Telethon Foundation. This work has been partly supported by grants from Italian ISS (527B/2B/6), AIRC and CIPE 2007 to R. G., ISS (526D/39) to P. B., the EC FP6 Program Sirocco to W. F. and NIH grants DK018477, DK39949 and HL065445 to M. G. R. P. B. is recipient of a Senior Scholar Consultancy grant from AICF. Structural work on KSRP-RNA interaction is supported by grant WT022088MA from the Wellcome Trust. NMR spectra were recorded at the MRC Biomedical NMR Centre, London. The Friedrich Miescher Institute is supported by the Novartis Research Foundation.	Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dorin D, 2003, J BIOL CHEM, V278, P4440, DOI 10.1074/jbc.M208954200; Garcia-Mayoral MF, 2008, NUCLEIC ACIDS RES, V36, P5290, DOI 10.1093/nar/gkn509; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Martin SR, 2004, FEBS LETT, V577, P284, DOI 10.1016/j.febslet.2004.10.023; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schrimpf SP, 2001, ELECTROPHORESIS, V22, P1224, DOI 10.1002/1522-2683()22:6&lt;1224::AID-ELPS1224&gt;3.0.CO;2-I; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	40	489	498	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1010	U144		10.1038/nature08025	http://dx.doi.org/10.1038/nature08025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19458619	Green Accepted			2022-12-24	WOS:000267063500048
J	O'Hare, AM; Kaufman, JS; Covinsky, KE; Landefeld, CS; McFarland, LV; Larson, EB				O'Hare, Ann M.; Kaufman, James S.; Covinsky, Kenneth E.; Landefeld, C. Seth; McFarland, Lynne V.; Larson, Eric B.			Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II-Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GLOMERULAR-FILTRATION-RATE; LEFT-VENTRICULAR HYPERTROPHY; DEPENDENT DIABETES-MELLITUS; NONDIABETIC RENAL-DISEASE; URINARY ALBUMIN EXCRETION; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; SERUM CREATININE; DOUBLE-BLIND	Angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists are recommended for patients with chronic kidney disease because these drugs can slow disease progression. Older adults account for a large and growing number of patients with chronic kidney disease. The authors evaluated the relevance to adults older than 70 years of the evidence base for major U. S. practice guidelines for the use of these agents in chronic kidney disease. The authors first examined the representation of older adults in randomized trials that underpin these guidelines, then compared the characteristics of participants in these trials with those of a representative sample of older adults with chronic kidney disease in the general population. The authors found that current guidelines for the use of angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease are based on evidence with limited relevance to most persons older than 70 years with this condition.	[O'Hare, Ann M.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98108 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Grp Hlth Ctr Hlth Studies, Seattle, WA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	O'Hare, AM (corresponding author), Univ Washington, Dept Med, Div Nephrol, Bldg 100,Room 5B113,1660 S Columbian Way, Seattle, WA 98108 USA.	ann.ohare@va.gov			National Institute on Aging [K 1K23AG28980]; NATIONAL INSTITUTE ON AGING [K23AG028980] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a Beeson Career Development Award from the National Institute on Aging to Dr. O'Hare (K 1K23AG28980).	Agardh CD, 1996, J HUM HYPERTENS, V10, P185; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Bakris GL, 1996, KIDNEY INT, V50, P1641, DOI 10.1038/ki.1996.480; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chan JCN, 2000, KIDNEY INT, V57, P590, DOI 10.1046/j.1523-1755.2000.t01-1-00879.x; CHAN JCN, 1992, BRIT MED J, V305, P981, DOI 10.1136/bmj.305.6860.981; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cinotti GA, 2001, NEPHROL DIAL TRANSPL, V16, P961, DOI 10.1093/ndt/16.5.961; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; DeCesaris R, 1996, CLIN PHARMACOL THER, V60, P472, DOI 10.1016/S0009-9236(96)90204-0; Dyadyk AI, 1997, NEPHROL DIAL TRANSPL, V12, P945, DOI 10.1093/ndt/12.5.945; Esnault VLM, 2008, CLIN THER, V30, P482, DOI 10.1016/j.clinthera.2008.03.006; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gullion CM, 2006, AM J KIDNEY DIS, V48, P212, DOI 10.1053/j.ajkd.2006.04.083; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; *K DOQI, 2004, AM J KIDNEY DIS S, V43, pS1; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2006, ANN INTERN MED, V144, P213, DOI 10.7326/0003-4819-144-3-200602070-00011; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MATHIESEN ER, 1991, BMJ-BRIT MED J, V303, P81, DOI 10.1136/bmj.303.6794.81; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Remuzzi G, 2002, ANN INTERN MED, V136, P604, DOI 10.7326/0003-4819-136-8-200204160-00010; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Sarnak MJ, 2008, ARCH INTERN MED, V168, P147, DOI 10.1001/archinternmed.2007.40; Sawicki PT, 1997, NEPHROL DIAL TRANSPL, V12, P1890, DOI 10.1093/ndt/12.9.1890; Schnack C, 1996, DIABETOLOGIA, V39, P1611, DOI 10.1007/s001250050623; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Suzuki H, 2001, HYPERTENS RES, V24, P153, DOI 10.1291/hypres.24.153; Tarnow L, 2000, DIABETES CARE, V23, P1725, DOI 10.2337/diacare.23.12.1725; TREVISAN R, 1995, AM J HYPERTENS, V8, P876, DOI 10.1016/0895-7061(95)00162-I; vanEssen GG, 1997, KIDNEY INT, pS58; Velussi M, 1996, DIABETES, V45, P216, DOI 10.2337/diabetes.45.2.216; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Vogt L, 2005, J HYPERTENS, V23, P2055, DOI 10.1097/01.hjh.0000186829.56372.04; Winkelmayer WC, 2006, DIABETES CARE, V29, P2210, DOI 10.2337/dc06-0570; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolf G, 2008, FRONT BIOSCI-LANDMRK, V13, P4993, DOI 10.2741/3058; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang ZX, 2005, J AM SOC NEPHROL, V16, P1775, DOI 10.1681/ASN.2004080632; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	72	92	101	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					717	U12		10.7326/0003-4819-150-10-200905190-00010	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19451579				2022-12-24	WOS:000266285300008
J	Cripe, LD				Cripe, Larry D.			Giving Up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lcripe@iupui.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1747	1748		10.1001/jama.2009.550	http://dx.doi.org/10.1001/jama.2009.550			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417181				2022-12-24	WOS:000265742500001
J	Mahmoodi, BK; Gansevoort, RT; Veeger, NJGM; Matthews, AG; Navis, G; Hillege, HL; van der Meer, J				Mahmoodi, Bakhtawar K.; Gansevoort, Ron T.; Veeger, Nic J. G. M.; Matthews, Abigail G.; Navis, Gerjan; Hillege, Hans L.; van der Meer, Jan		PREVEND Study Grp	Microalbuminuria and Risk of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							URINARY ALBUMIN EXCRETION; HEMOSTATIC FACTORS; CARDIOVASCULAR EVENTS; THROMBOSIS; POPULATION; ARTERIAL; INFLAMMATION; ASSOCIATION; PREDICTOR; DAMAGE	Context Microalbuminuria (albuminuria 30-300 mg per 24-hour urine collection) is a well-known risk marker for arterial thromboembolism. It is assumed that microalbuminuria reflects generalized endothelial dysfunction. Hence, microalbuminuria may also predispose for venous thromboembolism (VTE). Objective To assess whether microalbuminuria is associated with VTE. Design, Setting, and Participants Prevention of Renal and Vascular End-stage Disease (PREVEND) study, an ongoing community-based prospective cohort study initiated in 1997. All inhabitants of Groningen, the Netherlands, aged 28 through 75 years (n=85 421) were sent a postal questionnaire and a vial to collect a first morning urine sample for measurement of urinary albumin concentration. Of those who responded (40 856), a cohort (8592 participants) including more participants with higher levels of urinary albumin concentration completed screening at an outpatient clinic. Screening data were collected on urinary albumin excretion (UAE) and risk factors for cardiovascular and renal disease. Main Outcome Measure Symptomatic and objectively verified VTE (ie, deep vein thrombosis, pulmonary embolism, or both) between study initiation and June 1, 2007. Results Of 8574 evaluable participants (mean [SD] age, 49 [13] years; 50% men), 129 experienced VTE during a mean (SD) follow-up period of 8.6 (1.8) years, corresponding to overall annual incidence of 0.14% (95% confidence interval [CI], 0.11%-0.19%). Annual incidences were 0.12%, 0.20%, 0.40%, and 0.56% in participants with UAE of less than 15 (n=6013), 15-29 (n=1283), 30-300 (n=1144), and greater than 300 (n=134) mg per 24-hour urine collection, respectively (P for trend <.001). When adjusted for age, cancer, use of oral contraceptives, and atherosclerosis risk factors, hazard ratios associated with UAE levels of 15-29, 30-300, and greater than 300 mg/24 h were 1.40 (95% CI, 0.86-2.35), 2.20 (95% CI, 1.44-3.36), and 2.82 (95% CI, 1.21-6.61), respectively, compared with participants with UAE of less than 15 mg/24 h (global P=.001). Adjusted hazard ratio for microalbuminuria vs normoalbuminuria (UAE<30 mg/24 h) was 2.00 (95% CI, 1.34-2.98; P<.001). Microalbuminuria-related number needed to harm was 388 per year. Conclusion Microalbuminuria is independently associated with an increased risk for VTE.	[Mahmoodi, Bakhtawar K.; Veeger, Nic J. G. M.; van der Meer, Jan] Univ Groningen, Univ Med Ctr Groningen, Div Hemostasis Thrombosis & Rheol, Dept Hematol, NL-9713 GZ Groningen, Netherlands; [Gansevoort, Ron T.; Navis, Gerjan] Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Veeger, Nic J. G. M.; Hillege, Hans L.] Univ Med Ctr Groningen, Trial Coordinat Ctr, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands; [Matthews, Abigail G.] Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	University of Groningen; University of Groningen; University of Groningen; Rockefeller University	Mahmoodi, BK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Hemostasis Thrombosis & Rheol, Dept Hematol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	b.k.mahmoodi@int.umcg.nl	Veeger, Nic JGM/F-2966-2013; Mahmoodi, Bakhtawar/ABA-7050-2020	Veeger, Nic JGM/0000-0002-1492-7937; 	Dutch Kidney Foundation	Dutch Kidney Foundation	The PREVEND Study has been made possible by grants from the Dutch Kidney Foundation.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; AGEWALL S, 1995, J INTERN MED, V237, P195, DOI 10.1111/j.1365-2796.1995.tb01161.x; Agewall S, 2001, ATHEROSCLEROSIS, V157, P197, DOI 10.1016/S0021-9150(00)00706-1; [Anonymous], 2007, SURVEY DATA REFERENC; [Anonymous], 2007, SURVIVAL ANAL EPIDEM; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Borch-Johnsen K, 1999, ARTERIOSCL THROM VAS, V19, P1992, DOI 10.1161/01.ATV.19.8.1992; Clausen P, 1999, CLIN SCI, V97, P37, DOI 10.1042/CS19990002; COLLIER A, 1992, DIABETES, V41, P909, DOI 10.2337/diabetes.41.8.909; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; Festa A, 2000, KIDNEY INT, V58, P1703, DOI 10.1046/j.1523-1755.2000.00331.x; Franchini M, 2008, THROMB RES, V122, P727, DOI 10.1016/j.thromres.2007.09.010; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GRUDEN G, 1994, DIABETES, V43, P426, DOI 10.2337/diabetes.43.3.426; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hansson PO, 1999, ARCH INTERN MED, V159, P1886, DOI 10.1001/archinte.159.16.1886; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P455, DOI 10.1161/01.ATV.16.3.455; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; Migliacci R, 2007, HAEMATOLOGICA, V92, P812, DOI 10.3324/haematol.10872; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ray JG, 2007, QJM-INT J MED, V100, P679, DOI 10.1093/qjmed/hcm083; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Virchow RLK., 1856, GESAMMELTE ABH; Yuyun MF, 2004, J INTERN MED, V255, P247, DOI 10.1046/j.1365-2796.2003.01264.x	39	148	152	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 6	2009	301	17					1790	1797		10.1001/jama.2009.565	http://dx.doi.org/10.1001/jama.2009.565			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441AU	19417196	Bronze			2022-12-24	WOS:000265742500028
J	Meinshausen, M; Meinshausen, N; Hare, W; Raper, SCB; Frieler, K; Knutti, R; Frame, DJ; Allen, MR				Meinshausen, Malte; Meinshausen, Nicolai; Hare, William; Raper, Sarah C. B.; Frieler, Katja; Knutti, Reto; Frame, David J.; Allen, Myles R.			Greenhouse-gas emission targets for limiting global warming to 2 degrees C	NATURE			English	Article							CLIMATE SENSITIVITY; TEMPERATURE; UNCERTAINTIES; PROJECTIONS; INCREASE; CYCLE	More than 100 countries have adopted a global warming limit of 2 degrees C or below ( relative to pre-industrial levels) as a guiding principle for mitigation efforts to reduce climate change risks, impacts and damages(1,2). However, the greenhouse gas (GHG) emissions corresponding to a specified maximum warming are poorly known owing to uncertainties in the carbon cycle and the climate response. Here we provide a comprehensive probabilistic analysis aimed at quantifying GHG emission budgets for the 2000-50 period that would limit warming throughout the twenty-first century to below 2 degrees C, based on a combination of published distributions of climate system properties and observational constraints. We show that, for the chosen class of emission scenarios, both cumulative emissions up to 2050 and emission levels in 2050 are robust indicators of the probability that twenty-first century warming will not exceed 2 degrees C relative to pre-industrial temperatures. Limiting cumulative CO2 emissions over 2000-50 to 1,000 Gt CO2 yields a 25% probability of warming exceeding 2 degrees C-and a limit of 1,440 Gt CO2 yields a 50% probability - given a representative estimate of the distribution of climate system properties. As known 2000-06 CO2 emissions(3) were similar to 234 Gt CO2, less than half the proven economically recoverable oil, gas and coal reserves(4-6) can still be emitted up to 2050 to achieve such a goal. Recent G8 Communiques(7) envisage halved global GHG emissions by 2050, for which we estimate a 12-45% probability of exceeding 2 degrees C-assuming 1990 as emission base year and a range of published climate sensitivity distributions. Emissions levels in 2020 are a less robust indicator, but for the scenarios considered, the probability of exceeding 2 degrees C rises to 53-87% if global GHG emissions are still more than 25% above 2000 levels in 2020.	[Meinshausen, Malte; Hare, William; Frieler, Katja] Telegraphenberg, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Meinshausen, Nicolai] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hare, William] Telegraphenberg, Climate Analyt, D-14412 Potsdam, Germany; [Raper, Sarah C. B.] Manchester Metropolitan Univ, Ctr Air Transport & Environm, Manchester M1 5GD, Lancs, England; [Knutti, Reto] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Frame, David J.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford OX1 2BQ, England; [Frame, David J.; Allen, Myles R.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England	Potsdam Institut fur Klimafolgenforschung; University of Oxford; Manchester Metropolitan University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Oxford	Meinshausen, M (corresponding author), Telegraphenberg, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany.	malte.meinshausen@pik-potsdam.de	Frame, Dave/A-8918-2014; Frame, Dave/R-6169-2016; Meinshausen, Malte/AAG-6505-2019; Allen, Myles R/A-5172-2012; Knutti, Reto/B-8763-2008; Meinshausen, Malte/A-7037-2011; Hare, Bill/A-8527-2013	Frame, Dave/0000-0002-0949-3994; Meinshausen, Malte/0000-0003-4048-3521; Knutti, Reto/0000-0001-8303-6700; Meinshausen, Malte/0000-0003-4048-3521; Hare, Bill/0000-0003-1242-8250; Frieler, Katja/0000-0003-4869-3013	DAAD; German Ministry of Environment; Natural Environment Research Council [NE/C515747/1] Funding Source: researchfish	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Ministry of Environment; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank T. Wigley, M. Schaeffer, K. Briffa, R. Schofield, T. S., von Deimling, J. Nabel, J. Rogelj, V. Huber and A. Fischlin for discussions and comments on earlier manuscripts and our code, J. Gregory for AOGCM diagnostics, D. Giebitz-Rheinbay and B. Kriemann for IT support and the EMF- 21 modelling groups for providing their emission scenarios. M. M. thanks DAAD and the German Ministry of Environment for financial support. We acknowledge the modelling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) and the WCRP's Working Group on Coupled Modelling (WGCM) for their roles in making available the WCRP CMIP3 multi-model data set. Support of this data set is provided by the Office of Science, US Department of Energy.	ABRAHAM K, 2007, WORLD OIL, V228; Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; BP, 2008, BP STAT REV WORLD EN; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CLARKE AW, 2007, SURVEY ENERGY RESOUR; CLARKE AW, 2007, 2007 SURVEY ENERGY R; Council of the European Union, 2005, PRES CONCL BRUSS 22; den Elzen M, 2006, CLIM POLICY, V6, P545; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; EGGELSTON HS, 2006, 2006 GUIDELINES NATL; ENTING IG, 1994, 31 CSIRO DIV ATM RES; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Forest CE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL023977; FORSTER P, 2007, IPCC CLIMATE CHANGE, P129; Frame DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025801; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; *G8, 2008, HOKK TOY SUMM LEAD D; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; HOUGHTON JT, 1996, IPPC CLIMATE CHANGE; Knutti R, 2003, CLIM DYNAM, V21, P257, DOI 10.1007/s00382-003-0345-1; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Knutti R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032904; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Knutti R, 2006, J CLIMATE, V19, P4224, DOI 10.1175/JCLI3865.1; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M., 2008, ATMOS CHEM PHYS DISC, V8, P6153, DOI DOI 10.5194/ACPD-8-6153-2008; Meinshausen M, 2006, CLIMATIC CHANGE, V75, P151, DOI 10.1007/s10584-005-9013-2; Metz B., 2007, IPCC CLIMATE CHANGE; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Piani C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024452; Radler M, 2006, OIL GAS J, V104, P20; REMPE H, 2007, RESERVES RESOURCES A; SCHELLNHUBER JS, 2006, AVOIDING DANGEROUS C; Solomon S., 2007, CONTRIBUTION WORKING, P996; Van Vuuren DP, 2008, P NATL ACAD SCI USA, V105, P15258, DOI 10.1073/pnas.0711129105; WATKINS K, 2007, FIGHTING CLIMATE CHA; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	44	1668	1726	37	3670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1158	U96		10.1038/nature08017	http://dx.doi.org/10.1038/nature08017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407799				2022-12-24	WOS:000265754600045
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man The death of DNR	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOW NATURAL DEATH; CARDIOPULMONARY-RESUSCITATION		Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						Adams DH, 2006, J AM OSTEOPATH ASSOC, V106, P402; Chen YY, 2008, J MED ETHICS, V34, P887, DOI 10.1136/jme.2008.024570; Chessa F, 2004, HASTINGS CENT REP, V34, P4, DOI 10.2307/3527579; Cohen RW, 2004, HASTINGS CENT REP, V34, P4; Conroy SP, 2006, BRIT MED J, V332, P479, DOI 10.1136/bmj.332.7539.479; Jones GK, 2000, ACAD EMERG MED, V7, P48, DOI 10.1111/j.1553-2712.2000.tb01891.x; Jonsen AR, 2006, CLIN ETHICS; Venneman SS, 2008, J MED ETHICS, V34, P2, DOI 10.1136/jme.2006.018317	8	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2009	338								b1723	10.1136/bmj.b1723	http://dx.doi.org/10.1136/bmj.b1723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JY	19406889				2022-12-24	WOS:000265697800010
J	Iversen, A; Rushforth, B; Forrest, K				Iversen, Amy; Rushforth, Bruno; Forrest, Kirsty			Practice The Competent Novice How to handle stress and look after your mental health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CONSULTANTS; DOCTORS; BURNOUT; PRACTITIONERS; SATISFACTION; DEPRESSION; DISTRESS; GENDER; RISK		[Iversen, Amy] Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; [Rushforth, Bruno] Dewsbury & Dist Hosp, Dewsbury WF13 4HS, England; [Forrest, Kirsty] Leeds Gen Infirm, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England	University of London; King's College London; Leeds General Infirmary; University of Leeds	Iversen, A (corresponding author), Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	a.iversen@iop.kcl.ac.uk	Iversen, Amy/D-1112-2011					[Anonymous], 1987, EUR J PERSONALITY, V1, P141, DOI DOI 10.1002/PER.2410010304; Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Firth-Cozens J, 2003, BRIT MED J, V326, P670, DOI 10.1136/bmj.326.7391.670; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Firth-Cozens J., 1999, STRESS HLTH PROFESSI; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; General Medical Council, 2006, GOOD MED PRACT; GHODSE H, 2000, DOCTORS THEIR HLTH; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; JONES P, 2005, DOCTORS PATIENTS; Kjeldmand D, 2008, ANN FAM MED, V6, P138, DOI 10.1370/afm.813; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; MANN MP, 1992, MED TEACH, V14, P311, DOI 10.3109/01421599209018849; McCray LW, 2008, FAM MED, V40, P626; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V23; Ospina-Kammerer Veronika, 2003, Int J Emerg Ment Health, V5, P29; Paice E, 2002, MED EDUC, V36, P56, DOI 10.1046/j.1365-2923.2002.01101.x; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Whelan P, 2008, J ROY SOC MED, V101, P313, DOI 10.1258/jrsm.2008.070449	33	10	10	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2009	338								b1368	10.1136/bmj.b1368	http://dx.doi.org/10.1136/bmj.b1368			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JR	19398476				2022-12-24	WOS:000265697100009
J	Cohen, D				Cohen, Deborah			Medicine and the Media PSA testing: press coverage in UK and US is an ocean apart	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 27	2009	338								b1287	10.1136/bmj.b1287	http://dx.doi.org/10.1136/bmj.b1287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	425LS	19329514				2022-12-24	WOS:000264639800004
J	Phipps, RJ; Gaunt, MJ				Phipps, Robert J.; Gaunt, Matthew J.			A Meta-Selective Copper-Catalyzed C-H Bond Arylation	SCIENCE			English	Article							FUNCTIONALIZATION; ARENES; ALKENYLATION; METALATION; MECHANISM; EFFICIENT; INDOLES	For over a century, chemical transformations of benzene derivatives have been guided by the high selectivity for electrophilic attack at the ortho/para positions in electron-rich substrates and at the meta position in electron-deficient molecules. We have developed a copper-catalyzed arylation reaction that, in contrast, selectively substitutes phenyl electrophiles at the aromatic carbon-hydrogen sites meta to an amido substituent. This previously elusive class of transformation is applicable to a broad range of aromatic compounds.	[Phipps, Robert J.; Gaunt, Matthew J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Gaunt, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjg32@cam.ac.uk		Gaunt, Matthew/0000-0002-7214-608X	Biotechnology and Biological Sciences Research Council [Industrial Case Award]; GlaxoSmithKline [Industrial Case Award]; Royal Society [University Research Fellowship];  [Next Generation Fellowship]; Engineering and Physical Sciences Research Council [EP/D074487/1] Funding Source: researchfish; EPSRC [EP/D074487/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Royal Society(Royal Society of London); ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline for an Industrial Case Award to R.J.P., the Royal Society for a University Research Fellowship to M.J.G., and Philip and Patricia Brown for a Next Generation Fellowship to M.J.G. We also thank S. Peace (GSK Medicines Research Center, UK) for useful discussion.	Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; BARTON DHR, 1987, TETRAHEDRON LETT, V28, P887, DOI 10.1016/S0040-4039(01)81015-7; Beck EM, 2006, J AM CHEM SOC, V128, P2528, DOI 10.1021/ja058141u; Bielawski M, 2007, ADV SYNTH CATAL, V349, P2610, DOI 10.1002/adsc.200700373; Brasche G, 2008, ORG LETT, V10, P2207, DOI 10.1021/ol800619c; Campeau LC, 2008, J AM CHEM SOC, V130, P3266, DOI 10.1021/ja710451s; Chen X, 2006, J AM CHEM SOC, V128, P6790, DOI 10.1021/ja061715q; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Daugulis O, 2005, ANGEW CHEM INT EDIT, V44, P4046, DOI 10.1002/anie.200500589; Davies DL, 2005, J AM CHEM SOC, V127, P13754, DOI 10.1021/ja052047w; Deprez NR, 2006, J AM CHEM SOC, V128, P4972, DOI 10.1021/ja060809x; Desai LV, 2008, J AM CHEM SOC, V130, P13285, DOI 10.1021/ja8045519; Evindar G, 2006, J ORG CHEM, V71, P1802, DOI 10.1021/jo051927q; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Friedel C., 1877, CR HEBD ACAD SCI, V84, P1392; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Grimster NP, 2005, ANGEW CHEM INT EDIT, V44, P3125, DOI 10.1002/anie.200500468; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2008, SYNLETT, P949, DOI 10.1055/s-2008-1042907; Mulvey RE, 2007, ANGEW CHEM INT EDIT, V46, P3802, DOI 10.1002/anie.200604369; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; OLAH GA, 1963, FRIEDELCRAFTS RELATE; Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s; Rohbogner CJ, 2008, ANGEW CHEM INT EDIT, V47, P1503, DOI 10.1002/anie.200703382; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Stuart DR, 2007, J AM CHEM SOC, V129, P12072, DOI 10.1021/ja0745862; Thalji RK, 2004, J AM CHEM SOC, V126, P7192, DOI 10.1021/ja0394986; WANG DH, 2008, J AM CHEM SOC, V130, P14082	32	806	806	8	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1593	1597		10.1126/science.1169975	http://dx.doi.org/10.1126/science.1169975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	421EN	19299616				2022-12-24	WOS:000264342300035
J	Cole, A				Cole, Andrew			Feature Environment Saving the planet as well as lives	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.cole71@ntlworld.com						Hutchins DCJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b609; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH N	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2009	338								b933	10.1136/bmj.b933	http://dx.doi.org/10.1136/bmj.b933			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NT	19289415				2022-12-24	WOS:000264435700004
J	Santra, MK; Wajapeyee, N; Green, MR				Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.			F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage	NATURE			English	Article							CANCER; PHOSPHORYLATION; HETEROZYGOSITY; SENESCENCE; ATM; CHECKPOINTS; PATHWAY; KINASE; GENE	In response to DNA damage, eukaryotic cells initiate a complex signalling pathway, termed the DNA damage response (DDR), which coordinates cell cycle arrest with DNA repair. Studies have shown that oncogene-induced senescence, which provides a barrier to tumour development, involves activation of the DDR1-3. Using a genome-wide RNA interference (RNAi) screen, we have identified 17 factors required for oncogenic BRAF to induce senescence in primary fibroblasts and melanocytes(4). One of these factors is an F-box protein, FBXO31, a candidate tumour suppressor encoded in 16q24.3, a region in which there is loss of heterozygosity in breast, ovarian, hepatocellular and prostate cancers(5-9). Here we study the cellular role of FBXO31, identify its target substrate and determine the basis for its growth inhibitory activity. We show that ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1. Cyclin D1 degradation results from a direct interaction with FBXO31 and is dependent on the F-box motif of FBXO31 and phosphorylation of cyclin D1 at Thr 286, which is known to be required for cyclin D1 proteolysis. The involvement of the DDR in oncogene-induced senescence prompted us to investigate the role of FBXO31 in DNA repair. We find that DNA damage induced by gamma-irradiation results in increased FBXO31 levels, which requires phosphorylation of FBXO31 by the DDR-initiating kinase ATM. RNAi-mediated knockdown of FBXO31 prevents cells from undergoing efficient arrest in G1 after gamma-irradiation and markedly increases sensitivity to DNA damage. Finally, we show that a variety of DNA damaging agents all result in a large increase in FBXO31 levels, indicating that induction of FBXO31 is a general response to genotoxic stress. Our results reveal FBXO31 as a regulator of the G1/S transition that is specifically required for DNA damage-induced growth arrest.	[Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Santra, Manas K.; Wajapeyee, Narendra; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012		Our Danny Cancer Fund; Howard Hughes Medical Institute	Our Danny Cancer Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank S. Cook, O. Tetsu, M. Kastan and R. Kumar for reagents; M. Pagano for reagents and advice; L. Chamberlain for technical assistance; and S. Evans for editorial assistance. N. W. is supported in part by a fellowship from the Our Danny Cancer Fund. M. R. G. is an investigator of the Howard Hughes Medical Institute.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Harkonen P, 2005, PROSTATE, V62, P267, DOI 10.1002/pros.20147; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Kumar R, 2005, CANCER RES, V65, P11304, DOI 10.1158/0008-5472.CAN-05-0936; Launonen V, 2000, CANCER GENET CYTOGEN, V122, P49, DOI 10.1016/S0165-4608(00)00279-X; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin YW, 2001, INT J CANCER, V93, P74, DOI 10.1002/ijc.1287; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	201	212	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					722	U129		10.1038/nature08011	http://dx.doi.org/10.1038/nature08011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412162	Green Accepted			2022-12-24	WOS:000266608600048
J	Riviere, S; Challet, L; Fluegge, D; Spehr, M; Rodriguez, I				Riviere, Stephane; Challet, Ludivine; Fluegge, Daniela; Spehr, Marc; Rodriguez, Ivan			Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; MAMMALS; INDIVIDUALS; RECOGNITION; NEURONS; GENES	Mammals rely heavily on olfaction to interact adequately with each other and with their environment(1). They make use of seven-transmembrane G-protein-coupled receptors to identify odorants and pheromones. These receptors are present on dendrites of olfactory sensory neurons located in the main olfactory or vomeronasal sensory epithelia, and pertain to the odorant(2), trace amine-associated receptor(3) and vomeronasal type 1 (ref. 4) or 2 (refs 5-7) receptor superfamilies. Whether these four sensor classes represent the complete olfactory molecular repertoire used by mammals to make sense of the outside world is unknown. Here we report the expression of formyl peptide receptor-related genes by vomeronasal sensory neurons, in multiple mammalian species. Similar to the four known olfactory receptor gene classes, these genes encode seven-transmembrane proteins, and are characterized by monogenic transcription and a punctate expression pattern in the sensory neuroepithelium. In vitro expression of mouse formyl peptide receptor-like 1, 3, 4, 6 and 7 provides sensitivity to disease/inflammation-related ligands. Establishing an in situ approach that combines whole-mount vomeronasal preparations with dendritic calcium imaging in the intact neuroepithelium, we show neuronal responses to the same molecules, which therefore represent a new class of vomeronasal agonists. Taken together, these results suggest that formyl peptide receptor-like proteins have an olfactory function associated with the identification of pathogens, or of pathogenic states.	[Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; [Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Natl Ctr Competence Frontiers Genet, CH-1205 Geneva, Switzerland; [Fluegge, Daniela; Spehr, Marc] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany	University of Geneva; University of Geneva; Ruhr University Bochum	Rodriguez, I (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland.	ivan.rodriguez@unige.ch	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation; Claraz, Schmidheiny; Volkswagen; Schlumberger Foundations; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Claraz, Schmidheiny; Volkswagen(Volkswagen); Schlumberger Foundations(Schlumberger); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C.-D. K. Ballif, C. Engelhardt and H. Bartel for technical help, and C. Bauer and P. Descombes for assistance on the NCCR 'Frontiers in Genetics' bioimaging and genomic platforms, respectively. We also thank H. Hatt for unlimited access to departmental infrastructure, and P. Vassalli for comments on the manuscript. This work was supported by the Swiss National Science Foundation, the Claraz, Schmidheiny, Volkswagen and Schlumberger Foundations, and the Emmy Noether program of the Deutsche Forschungsgemeinschaft.	BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Casella R, 2002, CANCER, V95, P2494, DOI 10.1002/cncr.10989; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Kelliher KR, 2007, HORM BEHAV, V52, P561, DOI 10.1016/j.yhbeh.2007.08.012; Le YY, 2007, PROTEIN PEPTIDE LETT, V14, P846, DOI 10.2174/092986607782110211; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Spehr M, 2002, J NEUROSCI, V22, P8429; Takata M, 2008, NEUROSCI LETT, V435, P126, DOI 10.1016/j.neulet.2008.02.019	20	247	264	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					574	577		10.1038/nature08029	http://dx.doi.org/10.1038/nature08029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387439				2022-12-24	WOS:000266370500040
J	Jack, A				Jack, Andrew			Governments must be pulled up for failings over flu	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 15	2009	338								b2019	10.1136/bmj.b2019	http://dx.doi.org/10.1136/bmj.b2019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446JB	19447826				2022-12-24	WOS:000266116800004
J	Moloney, A				Moloney, Anastasia			Questions raised over response to influenza A outbreak	LANCET			English	Editorial Material																			0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1591	1592		10.1016/S0140-6736(09)60868-0	http://dx.doi.org/10.1016/S0140-6736(09)60868-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19437600	Green Published, Bronze			2022-12-24	WOS:000266066300012
J	Bolhuis, JJ; Wynne, CDL				Bolhuis, Johan J.; Wynne, Clive D. L.			Can evolution explain how minds work?	NATURE			English	Editorial Material									[Bolhuis, Johan J.] Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands; [Wynne, Clive D. L.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Bolhuis, Johan J.] Univ Utrecht, Helmholtz Inst, NL-3508 TC Utrecht, Netherlands	Utrecht University; State University System of Florida; University of Florida; Utrecht University	Bolhuis, JJ (corresponding author), Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands.	j.j.bolhuis@uu.nl; wynne@ufl.edu	Bolhuis, Johan J/B-9080-2011; Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378; Wynne, Clive/0000-0001-8408-1466				Bolhuis J., 2009, TINBERGENS LEGACY FU; Cosmides L., 1997, EVOLUTIONARY PSYCHOL; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; PINKER S, 1994, LANGUAGE INSTINCT MI; Richardson R. C, 2007, EVOLUTIONARY PSYCHOL; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	6	68	70	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					832	833		10.1038/458832a	http://dx.doi.org/10.1038/458832a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433CS	19370014				2022-12-24	WOS:000265182500022
J	Bethke, A; Fielenbach, N; Wang, Z; Mangelsdorf, DJ; Antebi, A				Bethke, Axel; Fielenbach, Nicole; Wang, Zhu; Mangelsdorf, David J.; Antebi, Adam			Nuclear Hormone Receptor Regulation of MicroRNAs Controls Developmental Progression	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; DAUER FORMATION; DAF-12; IDENTIFICATION; MUTATIONS; ENCODES; MIR-48; LARVAL; LIN-14	In response to small-molecule signals such as retinoids or steroids, nuclear receptors activate gene expression to regulate development in different tissues. MicroRNAs turn off target gene expression within cells by binding complementary regions in messenger RNA transcripts, and they have been broadly implicated in development and disease. Here we show that the Caenorhabditis elegans nuclear receptor DAF-12 and its steroidal ligand directly activate promoters of let-7 microRNA family members to down-regulate the microRNA target hbl-1, which drives progression of epidermal stem cells from second to third larval stage patterns of cell division. Conversely, the receptor without the ligand represses microRNA expression during developmental arrest. These findings identify microRNAs as components of a hormone-coupled molecular switch that shuts off earlier developmental programs to allow for later ones.	[Bethke, Axel; Fielenbach, Nicole; Antebi, Adam] Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA; [Bethke, Axel] Univ Osnabruck, Fachbereich Biol Chem, D-49069 Osnabruck, Germany; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	Baylor College of Medicine; University Osnabruck; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Antebi, A (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	aantebi@bcm.edu	Wang, Zhu/H-3844-2013	Mangelsdorf, David/0000-0002-4355-0796	NIH [GM077201]; Ellison Medical Foundation; Howard Hughes Medical Institute; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our thanks go to G. Hayes, G. Ruvkun, V. Ambros, and A. Rougvie for strains; N. Timchenko for gel shift support; and D. Magner, S. Greene, and F. Schroeder for manuscript comments. This work was supported by NIH grant GM077201 and the Ellison Medical Foundation (A.A.), and the Howard Hughes Medical Institute and the Robert A. Welch Foundation (D.J.M.).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; Jia KL, 2002, DEVELOPMENT, V129, P221; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	21	122	134	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					95	98		10.1126/science.1164899	http://dx.doi.org/10.1126/science.1164899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342589	Green Accepted			2022-12-24	WOS:000264802100040
J	Jack, A				Jack, Andrew			Feature Pandemic Flu The problem with flu vaccines	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				WHO, 2009, REC STRAT ADV GROUP; WYMAN O, 2009, INFLUENZA VACCINE SU	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 21	2009	338								b2065	10.1136/bmj.b2065	http://dx.doi.org/10.1136/bmj.b2065			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NT	19460800				2022-12-24	WOS:000266270000009
J	Gehring, NH; Lamprinaki, S; Kulozik, AE; Hentze, MW				Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.			Disassembly of Exon Junction Complexes by PYM	CELL			English	Article							NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; MOLECULAR INSIGHTS; MAMMALIAN-CELLS; TRANSLATION; PROTEIN; REVEALS; INHIBITION; INTRONS; NUCLEUS	Exon junction complexes (EJCs) are deposited onto mRNAs during splicing, serve as positional landmarks for the intron exon structure of genes, and direct posttranscriptional processes in the cytoplasm. EJC removal and recycling by translation are ill understood and have been attributed to ribosomal passage. This work identifies the ribosome-associated protein PYM as an EJC disassembly factor and defines its mechanism of function. Whereas EJC assembly intermediates are resistant to PYM, fully assembled EJCs are dissociated from spliced mRNAs by PYM. This disassembly involves PYM binding to the EJC proteins MAGOH-Y14. PYM overexpression in cells disrupts EJC association with spliced mRNA and inhibits nonsense-mediated mRNA decay. In cells depleted of PYM, EJCs accumulate on spliced mRNAs and EJC protein recycling is impaired. Hence, PYM is an EJC disassembly factor that acts both in vitro and in living cells, and that antagonizes important EJC functions.	[Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.] Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Lamprinaki, Styliani; Kulozik, Andreas E.; Hentze, Matthias W.] European Mol Biol Lab, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Kulozik, Andreas E.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Gehring, Niels H.; Lamprinaki, Styliani; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Gehring, NH (corresponding author), Heidelberg Univ, Mol Med Partnership Unit, D-69120 Heidelberg, Germany.	niels.gehring@med.uni.heidelberg.de; hentze@embl.de	Hentze, Matthias W/V-3980-2017; Kulozik, Andreas/AAO-2432-2020	Hentze, Matthias W/0000-0002-4023-7876; 	EMBL International PhD Programme; Deutsche Forschungsgemeinschaft [KU563/11-1]; Manfred Lautenschlarger Research Prize	EMBL International PhD Programme; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Manfred Lautenschlarger Research Prize	We thank Nicole Echner for excellent technical assistance, Pavel Ivanov and Kent Duncan for critical reading of the manuscript, and members of our laboratories for advice and discussion. We are grateful to Elisa Izaurralde and Yanping Zhang for the kind gift of antibodies, and Miles Wilkinson for kindly providing TCR-beta expression plasmids. S.L. acknowledges a fellowship from the EMBL International PhD Programme. This work was funded by a grant (KU563/11-1) from the Deutsche Forschungsgemeinschaft (to N.H.G. and A.E.K.), and by funds from the Manfred Lautenschlarger Research Prize (to A.E.K. and M.W.H.).	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DeLano Scientific, 2002, PYMOL MOL GRAPH SYST; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	36	131	134	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					536	548		10.1016/j.cell.2009.02.042	http://dx.doi.org/10.1016/j.cell.2009.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410547	Bronze			2022-12-24	WOS:000265677200022
J	Spizzo, R; Nicoloso, MS; Croce, CM; Calin, GA				Spizzo, Riccardo; Nicoloso, Milena S.; Croce, Carlo M.; Calin, George A.			SnapShot: MicroRNAs in Cancer	CELL			English	Editorial Material									[Spizzo, Riccardo] MD Anderson Canc Ctr, Houston, TX 77030 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Spizzo, R (corresponding author), MD Anderson Canc Ctr, Houston, TX 77030 USA.		Young, Richard A/F-6495-2012; Calin, George/E-9390-2011; Nicoloso, Milena S/K-6411-2012; Spizzo, Riccardo/V-1057-2019	Young, Richard A/0000-0001-8855-8647; Nicoloso, Milena S/0000-0003-4231-9303; Spizzo, Riccardo/0000-0001-7772-0960; Calin, George/0000-0001-6704-5615				Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347	9	203	210	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					586	U204		10.1016/j.cell.2009.04.040	http://dx.doi.org/10.1016/j.cell.2009.04.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410551	Bronze			2022-12-24	WOS:000265677200026
J	Klionsky, DJ				Klionsky, Daniel J.			Crohn's Disease, Autophagy, and the Paneth Cell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATG16L1		Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053396, R01 GM053396-19] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383	5	38	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1785	1786		10.1056/NEJMcibr0810347	http://dx.doi.org/10.1056/NEJMcibr0810347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369659	Green Accepted			2022-12-24	WOS:000265377800015
J	Kaddis, JS; Olack, BJ; Sowinski, J; Cravens, J; Contreras, JL; Niland, JC				Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Contreras, Juan L.; Niland, Joyce C.			Human Pancreatic Islets and Diabetes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; QUALITY-OF-LIFE; BETA-CELL; TRANSPLANTATION; LANGERHANS; XENOTRANSPLANTATION; INFLAMMATION; APOPTOSIS; VARIABLES; MODELS	Human islet research is crucial to understanding the cellular biology of the pancreas in developing therapeutic options for diabetes patients and in attempting to prevent the development of this disease. The national Islet Cell Resource Center Consortium provides human pancreatic islets for diabetes research while simultaneously addressing the need to improve islet isolation and transplantation technologies. Since its inception in 2001, the consortium has supplied 297.6 million islet equivalents to 151 national and international scientists for use in clinical and laboratory projects. Data on the volume, quality, and frequency of shipments substantiate the importance of human islets for diabetes research, as do the number of funded grants for beta-cell projects and publications produced as a direct result of islets supplied by this resource. Limitations in using human islets are discussed, along with the future of islet distribution centers. The information presented here is instructive to clinicians, basic science investigators, and policy makers who determine the availability of funding for such work. Organ procurement coordinators also may find the information useful in explaining to donor families why research consent is so valuable.	[Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Niland, Joyce C.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA; [Contreras, Juan L.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA	City of Hope; University of Alabama System; University of Alabama Birmingham	Kaddis, JS (corresponding author), City Hope Natl Med Ctr, Dept Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jkaddis@coh.org		Olack, Barbara/0000-0001-6645-8215; Kaddis, John/0000-0002-6752-7670	National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases; US National Institutes of Health (NIH); NCRR [U42 RR 017673, U42 RR 023246]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR023246, U42RR017673] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding/Support: This work was funded by the cooperative efforts of the National Center for Research Resources (NCRR) and the National Institute of Diabetes and Digestive and Kidney Diseases, a component of the US National Institutes of Health (NIH), in conjunction with the generous contributions of the Juvenile Diabetes Research Foundation. Messrs Kaddis and Cravens, Mss Olack and Sowinski, and Dr Niland are supported by grants U42 RR 017673 (J.C.N.) and U42 RR 023246 (J.L.C.) from the NCRR.	Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a; Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8; BALLINGER WF, 1972, SURGERY, V72, P175; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bhonde R, 2007, INDIAN J MED RES, V125, P425; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cure P, 2008, TRANSPLANTATION, V85, P801, DOI 10.1097/TP.0b013e318166a27b; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dufrane D, 2006, XENOTRANSPLANTATION, V13, P204, DOI 10.1111/j.1399-3089.2006.00275.x; Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616; Goss JA, 2004, TRANSPLANTATION, V77, P462, DOI 10.1097/01.TP.0000100397.86756.A3; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Hanley SC, 2008, TRANSPLANTATION, V85, P950, DOI 10.1097/TP.0b013e3181683df5; Hering BJ, 2007, AM J TRANSPLANT, V7, P205; Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Huang XL, 2008, ENDOCR REV, V29, P603, DOI 10.1210/er.2008-0006; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; *INT SOC CELL THER, RISK BOV SPONG ENC B; *ISI WEB KNOWL, WEB SCI J IMP REP TO; *JUV DIAB RES FDN, JUV DIAB RES FDN INT; Knazek Richard A, 2002, Diabetes Technol Ther, V4, P551, DOI 10.1089/152091502760306652; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; LAKEY JR, 2006, HUM ISL IS TRANSP TE; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; Markmann JF, 2008, AM J TRANSPLANT, V8, P1588, DOI 10.1111/j.1600-6143.2008.02305.x; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; *NAT SCI FDN, NAT SCI FDN AW SEARC; NIH RePORTER, NIH RES PORTF ONL RE; O'Neil JJ, 2003, CELL TRANSPLANT, V12, P883, DOI 10.3727/000000003771000110; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; *OPTN, OPTN NAT DAT REP; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059; Qian D, 2007, COMPUT STAT DATA AN, V51, P5494, DOI 10.1016/j.csda.2007.02.030; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Ryan EA, 2004, DIABETES, V53, P955, DOI 10.2337/diabetes.53.4.955; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Toso C, 2007, TRANSPLANTATION, V84, P664, DOI 10.1097/01.tp.0000280550.01028.89; Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Yang Z, 2004, TRANSPL P, V36, P1532, DOI 10.1016/j.transproceed.2004.04.075; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; ZOON KC, LETT TRANSPLANT CTR	56	44	46	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1580	1587		10.1001/jama.2009.482	http://dx.doi.org/10.1001/jama.2009.482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366778	Green Accepted			2022-12-24	WOS:000265137900029
J	Knops, A; Thirion, B; Hubbard, EM; Michel, V; Dehaene, S				Knops, Andre; Thirion, Bertrand; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas			Recruitment of an Area Involved in Eye Movements During Mental Arithmetic	SCIENCE			English	Article							HUMAN BRAIN ACTIVITY; PARIETAL CORTEX; NUMBER LINE; SPACE; REPRESENTATION; PERCEPTION; ATTENTION; PATTERNS; IMAGES	Throughout the history of mathematics, concepts of number and space have been tightly intertwined. We tested the hypothesis that cortical circuits for spatial attention contribute to mental arithmetic in humans. We trained a multivariate classifier algorithm to infer the direction of an eye movement, left or right, from the brain activation measured in the posterior parietal cortex. Without further training, the classifier then generalized to an arithmetic task. Its left versus right classification could be used to sort out subtraction versus addition trials, whether performed with symbols or with sets of dots. These findings are consistent with the suggestion that mental arithmetic co-opts parietal circuitry associated with spatial coding.	[Knops, Andre; Hubbard, Edward M.; Dehaene, Stanislas] INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Knops, Andre; Thirion, Bertrand; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas] CEA, I2BM, F-91191 Gif Sur Yvette, France; [Knops, Andre; Hubbard, Edward M.; Michel, Vincent; Dehaene, Stanislas] Univ Paris 11, F-91405 Orsay, France; [Thirion, Bertrand; Michel, Vincent] Inst Natl Rech Informat & Automat Saclay Ile Fran, Orsay, France; [Dehaene, Stanislas] Coll France, F-75231 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Knops, A (corresponding author), INSERM, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France.	knops.andre@gmail.com	Hubbard, Edward/N-2931-2019; Knops, André/D-5457-2013; Jovicich, Jorge/D-2293-2010; Hubbard, Edward/C-1770-2012	Hubbard, Edward/0000-0002-2701-415X; Knops, André/0000-0001-6357-9951; 	INSERM; CEA; McDonnell Foundation centennial fellowship; Volkswagen Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); McDonnell Foundation centennial fellowship; Volkswagen Foundation(Volkswagen)	The fMRI experiment was part of a general research program on functional neuroimaging of the human brain that was sponsored by the Atomic Energy Commission (D. Le Bihan). We thank L. Hertz-Pannier, A. Jobert, and the NeuroSpin staff for their help. Supported by INSERM, CEA, a McDonnell Foundation centennial fellowship (S.D.), and a Volkswagen Foundation grant (S.D. and A.K.).	Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Changizi MA, 2006, AM NAT, V167, pE117, DOI 10.1086/502806; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eger E, 2008, J COGNITIVE NEUROSCI, V20, P356, DOI 10.1162/jocn.2008.20019; Fischer MH, 2004, EXP PSYCHOL, V51, P91, DOI 10.1027/1618-3169.51.2.91; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gallistel C. R., 1990, ORG LEARNING; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Goldstone RL, 1998, COGNITION, V65, P231, DOI 10.1016/S0010-0277(97)00047-4; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Lakoff G., 2000, MATH COMES EMBODIED; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; McCrink K, 2007, PERCEPT PSYCHOPHYS, V69, P1324, DOI 10.3758/BF03192949; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	31	267	269	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 19	2009	324	5934					1583	1585		10.1126/science.1171599	http://dx.doi.org/10.1126/science.1171599			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19423779	Green Submitted			2022-12-24	WOS:000267130600050
J	Compagno, M; Lim, WK; Grunn, A; Nandula, SV; Brahmachary, M; Shen, Q; Bertoni, F; Ponzoni, M; Scandurra, M; Califano, A; Bhagat, G; Chadburn, A; Dalla-Favera, R; Pasqualucci, L				Compagno, Mara; Lim, Wei Keat; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Bertoni, Francesco; Ponzoni, Maurilio; Scandurra, Marta; Califano, Andrea; Bhagat, Govind; Chadburn, Amy; Dalla-Favera, Riccardo; Pasqualucci, Laura			Mutations of multiple genes cause deregulation of NF-kappa B in diffuse large B-cell lymphoma	NATURE			English	Article							HODGKIN LYMPHOMA; EXPRESSION; RECEPTOR; CD40; TRANSDUCTION; RESPONSES; FAMILY; CANCER; BCL6; A20	Diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma in adulthood, comprises multiple biologically and clinically distinct subtypes including germinal centre B-cell-like (GCB) and activated B-cell-like (ABC) DLBCL1. Gene expression profile studies have shown that its most aggressive subtype, ABC-DLBCL, is associated with constitutive activation of the NF-kappa B transcription complex(2). However, except for a small fraction of cases(3), it remains unclear whether NF-kappa B activation in these tumours represents an intrinsic program of the tumour cell of origin or a pathogenetic event. Here we show that >50% of ABC-DLBCL and a smaller fraction of GCB- DLBCL carry somatic mutations in multiple genes, including negative (TNFAIP3, also called A20) and positive (CARD11, TRAF2, TRAF5, MAP3K7 (TAK1) and TNFRSF11A ( RANK)) regulators of NF-kappa B. Of these, the A20 gene, which encodes a ubiquitin-modifying enzyme involved in termination of NF-kappa B responses, is most commonly affected, with similar to 30% of patients displaying biallelic inactivation by mutations and/or deletions. When reintroduced in cell lines carrying biallelic inactivation of the gene, A20 induced apoptosis and cell growth arrest, indicating a tumour suppressor role. Less frequently, missense mutations of TRAF2 and CARD11 produce molecules with significantly enhanced ability to activate NF-kappa B. Thus, our results demonstrate that NF-kappa B activation in DLBCL is caused by genetic lesions affecting multiple genes, the loss or activation of which may promote lymphomagenesis by leading to abnormally prolonged NF-kappa B responses.	[Compagno, Mara; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Califano, Andrea; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Compagno, Mara; Grunn, Adina; Nandula, Subhadra V.; Brahmachary, Manisha; Shen, Qiong; Califano, Andrea; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Lim, Wei Keat; Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY 10032 USA; [Nandula, Subhadra V.; Bhagat, Govind; Dalla-Favera, Riccardo; Pasqualucci, Laura] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bertoni, Francesco; Scandurra, Marta] Oncol Inst So Switzerland IOSI, Expt Oncol Lab, CH-6500 Bellinzona, Switzerland; [Bertoni, Francesco; Scandurra, Marta] Oncol Inst So Switzerland IOSI, Lymphoma Unit, CH-6500 Bellinzona, Switzerland; [Ponzoni, Maurilio] Ist Sci San Raffaele, Unit Lymphoid Malignancies, Pathol Unit, I-20132 Milan, Italy; [Chadburn, Amy] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Institute of Oncology Research (IOR); Institute of Oncology Research (IOR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Cornell University; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	lp171@columbia.edu	Bertoni, Francesco/G-6922-2014; Bhagat, Govind/AAE-9493-2021	Bertoni, Francesco/0000-0001-5637-8983; Bhagat, Govind/0000-0001-6250-048X; Califano, Andrea/0000-0003-4742-3679	NIH [P01 CA92625-07]; NIAID [R01AI066116]; National Centers for Biomedical Computing NIH Roadmap [U54CA121852]; Leukemia and Lymphoma Society SCOR; NATIONAL CANCER INSTITUTE [U54CA121852, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Centers for Biomedical Computing NIH Roadmap; Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Smith, P. Chadwick and the Molecular Pathology Facility of the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center for histology service; V. V. V. Murty and the HICCC Molecular Cytogenetics Service for assistance on the FISH analysis; the HICCC Flow Cytometry Facility for fluorescence-activated cell sorting; V. Miljkovic and J. Pack for help with the Affymetrix gene expression hybridization; U. Klein and D. Dominguez-Sola for suggestions; L. Menard for help with the mutation analysis; and G. Inghirami for the pWPI lentiviral vector. Automated DNA sequencing was performed at Genewiz Inc. L. P. is on leave from the Institute of Hematology, University of Perugia Medical School, Perugia, Italy. This work was supported by NIH grants P01 CA92625-07 (R. D.-F.), NIAID R01AI066116, the National Centers for Biomedical Computing NIH Roadmap initiative U54CA121852 (A. Ca.), and a Leukemia and Lymphoma Society SCOR grant (R. D.- F.). L. P. would like to dedicate this work to the memory of Enrico Pasqualucci.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; SCHMITZ R, J EXP MED IN PRESS; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	35	778	809	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					717	U124		10.1038/nature07968	http://dx.doi.org/10.1038/nature07968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412164	Green Accepted			2022-12-24	WOS:000266608600047
J	Odd, DE; Lewis, G; Whitelaw, A; Gunnell, D				Odd, David E.; Lewis, Glyn; Whitelaw, Andrew; Gunnell, David			Resuscitation at birth and cognition at 8 years of age: a cohort study	LANCET			English	Article							RISK-FACTORS; NEWBORN ENCEPHALOPATHY; APGAR-SCORE; CHILDREN; INFANTS; TERM	Background Mild cerebral injury might cause subtle defects in cognitive function that are only detectable as the child grows older. Our aim was to determine whether infants receiving resuscitation after birth, but with no symptoms of encephalopathy, have reduced intelligence quotient (IQ) scores in childhood. Methods Three groups of infants were selected from the Avon Longitudinal Study of Parents and Children: infants who were resuscitated at birth but were asymptomatic for encephalopathy and had no further neonatal care (n=815), those who were resuscitated and had neonatal care for symptoms of encephalopathy (n=58), and the reference group who were not resuscitated, were asymptomatic for encephalopathy, and had no further neonatal care (n=10609). Cognitive function was assessed at a mean age of 8.6 years (SD 0.33); a low IQ score was defined as less than 80. IQ scores were obtained for 5953 children with a shortened version of the Weschler intelligence scale for children (WISC-III), the remaining 5529 were non-responders. All children did not complete all parts of the test, and therefore multiplied IQ values comparable to the full-scale test were only available for 5887 children. Results were adjusted for clinical and social covariates. Chained equations were used to impute missing values of covariates. Findings In the main analysis at 8 years of age (n=5887), increased risk of a low IQ score was recorded in both resuscitated infants asymptomatic for encephalopathy (odds ratio 1.65 [95% Cl 1.13-2.43]) and those with symptoms of encephalopathy (6.22 [1.57-24.65]). However, the population of asymptomatic infants was larger than that of infants with encephalopathy, and therefore the population attributable risk fraction for an IQ score that might be attributable to the need for resuscitation at birth was 3.4% (95% CI 0.5-6.3) for asymptomatic infants and 1.2% (0.2-2.2) for those who developed encephalopathy. Interpretation Infants who were resuscitated had increased risk of a low IQ score, even if they remained healthy during the neonatal period. Resuscitated infants asymptomatic for encephalopathy might result in a larger proportion of adults with low IQs than do those who develop neurological symptoms consistent with encephalopathy.	[Lewis, Glyn] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bristol; University of Bristol	Odd, DE (corresponding author), Southmead Hosp, Neonatal Intens Care Unit, Bristol BS10 5NB, Avon, England.	david.odd@nbt.nhs.uk	Lewis, Glyn/E-9944-2012; Gunnell, David/ABE-6653-2020; Odd, David/G-8418-2016	Lewis, Glyn/0000-0001-5205-8245; Gunnell, David/0000-0002-0829-6470; Odd, David/0000-0002-6416-4966	Wellcome Trust [077036]; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. This research was funded by a fellowship award (077036) to DO from the Wellcome Trust. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC.	*AM AC PED COMM OB, 1996, OBSTET GYNECOL, V107, P1209; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Baskett TF, 2006, BJOG-INT J OBSTET GY, V113, P769, DOI 10.1111/j.1471-0528.2006.00987.x; Blackman J A, 1988, J Perinatol, V8, P206; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Kaufman A.S., 1994, INTELLIGENT TESTING; KROLL L, 1994, EUR J OBSTET GYN R B, V55, P175, DOI 10.1016/0028-2243(94)90034-5; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V1-3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V2; PALMEKILANDER C, 1992, ACTA PAEDIATR, V81, P739, DOI 10.1111/j.1651-2227.1992.tb12094.x; PASAMANICK B, 1956, AM J PSYCHIAT, V112, P613, DOI 10.1176/ajp.112.8.613; PASQUIER F, 1995, J NEUROL NEUROSUR PS, V58, P81, DOI 10.1136/jnnp.58.1.81; PETERS TJ, 1984, EARLY HUM DEV, V9, P225, DOI 10.1016/0378-3782(84)90033-1; *RES COUNC UK, 2001, RES BIRTH NEWB LIF S; ROYSTON P, 2005, STATA J, V5, P681; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Saugstad OD, 2007, ACTA PAEDIATR, V96, P798, DOI 10.1111/j.1651-2227.2006.00348.x; Tan A, 2005, COCHRANE DB SYST REV, V2; Veltman DJ, 2005, PSYCHOL MED, V35, P175, DOI 10.1017/S0033291704002971; Viggedal G, 2002, ACTA PAEDIATR, V91, P1218, DOI 10.1080/080352502320777469; VILLAR J, 1990, AM J OBSTET GYNECOL, V163, P151, DOI 10.1016/S0002-9378(11)90690-5; Wechsler D., 1991, MANUAL WECHSLER INTE; WECHSLER D, 2004, WECHSLER INTELIGENCE	32	91	94	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1615	1622		10.1016/S0140-6736(09)60244-0	http://dx.doi.org/10.1016/S0140-6736(09)60244-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19386357	Green Published, Bronze			2022-12-24	WOS:000266066300032
J	Koeller, P; Fuentes-Yaco, C; Platt, T; Sathyendranath, S; Richards, A; Ouellet, P; Orr, D; Skuladottir, U; Wieland, K; Savard, L; Aschan, M				Koeller, P.; Fuentes-Yaco, C.; Platt, T.; Sathyendranath, S.; Richards, A.; Ouellet, P.; Orr, D.; Skuladottir, U.; Wieland, K.; Savard, L.; Aschan, M.			Basin-Scale Coherence in Phenology of Shrimps and Phytoplankton in the North Atlantic Ocean	SCIENCE			English	Article							PANDALUS-BOREALIS; RECRUITMENT; BLOOM; SEA	Climate change could lead to mismatches between the reproductive cycles of marine organisms and their planktonic food. We tested this hypothesis by comparing shrimp (Pandalus borealis) egg hatching times and satellite-derived phytoplankton bloom dynamics throughout the North Atlantic. At large spatial and long temporal (10 years or longer) scales, hatching was correlated with the timing of the spring phytoplankton bloom. Annual egg development and hatching times were determined locally by bottom water temperature. We conclude that different populations of P. borealis have adapted to local temperatures and bloom timing, matching egg hatching to food availability under average conditions. This strategy is vulnerable to interannual oceanographic variability and long-term climatic changes.	[Koeller, P.; Fuentes-Yaco, C.; Platt, T.; Sathyendranath, S.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada; [Fuentes-Yaco, C.; Sathyendranath, S.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Platt, T.; Sathyendranath, S.] Plymouth Marine Lab, Plymouth PL1 3, Devon, England; [Richards, A.] Natl Marine Fisheries Serv, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Ouellet, P.; Savard, L.] Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Orr, D.] Fisheries & Oceans Canada, Dept Fisheries & Oceans, St John, NF A1C 5X1, Canada; [Skuladottir, U.] Marine Res Inst, IS-121 Reykjavik, Iceland; [Wieland, K.] Tech Univ Denmark, Natl Inst Aquat Resources, DK-9850 Hirtshals, Denmark; [Aschan, M.] Univ Tromso, Norwegian Coll Fisheries Sci, N-9037 Tromso, Norway	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Plymouth Marine Laboratory; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Marine & Freshwater Research Institute (MFRI); Technical University of Denmark; UiT The Arctic University of Tromso	Koeller, P (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	koellerp@mar.dfo-mpo.gc.ca		Wieland, Kai/0000-0003-1481-7743; Aschan, Michaela/0000-0002-9276-9321	Government Related Initiatives Program; Natural Sciences and Engineering Research Council of Canada; National Centre for Earth Observation; Natural Environment Research Council of the UK; NERC [earth010003, pml010007] Funding Source: UKRI; Natural Environment Research Council [earth010003, pml010007] Funding Source: researchfish	Government Related Initiatives Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Centre for Earth Observation; Natural Environment Research Council of the UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This analysis was made possible by the satellite data provided by NASA and the efforts of the technical personnel in six countries whose efforts at sea and in the laboratory provided the biological and physical oceanographic data. We also thank G. White III for extensive data preparation. This work was supported by the Canadian Space Agency through the Government Related Initiatives Program and by the Natural Sciences and Engineering Research Council of Canada through research grants to T.P. and S.S. This work is a contribution to the National Centre for Earth Observation and the Oceans 2025 programs of the Natural Environment Research Council of the UK.	BERGSTROM B I, 1991, Journal of Shellfish Research, V10, P327; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Clark Stephen H., 2000, Journal of Northwest Atlantic Fishery Science, V27, P193, DOI 10.2960/J.v27.a18; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Koeller P.A., 2000, Journal of Northwest Atlantic Fishery Science, V27, P21, DOI 10.2960/J.v27.a3; Lilly G.R., 2000, Journal of Northwest Atlantic Fishery Science, V27, P45, DOI 10.2960/J.v27.a5; Ouellet P, 2007, MAR ECOL PROG SER, V339, P229, DOI 10.3354/meps339229; Parsons D.G., 1998, Journal of Northwest Atlantic Fishery Science, V24, P1, DOI 10.2960/J.v24.a1; Parsons D.G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P11, DOI 10.2960/J.v27.a2; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Platt T, 2007, ICES J MAR SCI, V64, P863, DOI 10.1093/icesjms/fsm072; Platt T, 2009, ECOL MODEL, V220, P3057, DOI 10.1016/j.ecolmodel.2008.11.022; SHUMWAY SE, 1985, FAO FISH SYNOP, V144, P57; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Wieland K, 2005, ICES J MAR SCI, V62, P1454, DOI 10.1016/j.icesjms.2005.02.012; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Wu YS, 2008, MAR ECOL PROG SER, V355, P9, DOI 10.3354/meps07233	20	149	156	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					791	793		10.1126/science.1170987	http://dx.doi.org/10.1126/science.1170987			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423827				2022-12-24	WOS:000265832400048
J	Hautier, Y; Niklaus, PA; Hector, A				Hautier, Yann; Niklaus, Pascal A.; Hector, Andy			Competition for Light Causes Plant Biodiversity Loss After Eutrophication	SCIENCE			English	Article							SPECIES RICHNESS; GRASSLAND; PRODUCTIVITY; DIVERSITY; RESOURCES	Human activities have increased the availability of nutrients in terrestrial and aquatic ecosystems. In grasslands, this eutrophication causes loss of plant species diversity, but the mechanism of this loss has been difficult to determine. Using experimental grassland plant communities, we found that addition of light to the grassland understory prevented the loss of biodiversity caused by eutrophication. There was no detectable role for competition for soil resources in diversity loss. Thus, competition for light is a major mechanism of plant diversity loss after eutrophication and explains the particular threat of eutrophication to plant diversity. Our conclusions have implications for grassland management and conservation policy and underscore the need to control nutrient enrichment if plant diversity is to be preserved.	[Hautier, Yann; Niklaus, Pascal A.; Hector, Andy] Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland; [Niklaus, Pascal A.] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hautier, Y (corresponding author), Univ Zurich, Inst Environm Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	yhautier@uwinst.uzh.ch	Hector, Andrew/H-4199-2011; Hautier, Yann/D-5426-2015; Niklaus, Pascal A/G-5786-2010; Hautier, Yann/I-2526-2019; Carneiro, Fernanda/E-9513-2013	Hector, Andrew/0000-0002-1309-7716; Hautier, Yann/0000-0003-4347-7741; Niklaus, Pascal A/0000-0002-2360-1357; Hautier, Yann/0000-0003-4347-7741; Carneiro, Fernanda/0000-0001-6389-4564	Swiss National Foundation [3100A0-107572]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	We thank E.D. Schulze and C. Korner for discussion of light manipulation, B. Schmid and L. Turnbull for comments on the manuscript, and L. Wacker, E. Vojtech, G. Feichtinger, and T. Zwimpfer for helpful suggestions and field work assistance. Y.H. is funded by Swiss National Foundation grant 3100A0-107572 to A.H. The project was conceived by A.H., designed by A.H., P.A.N., and Y.H., conducted by Y.H., analyzed by Y.H. and A.H., and written up by Y.H. and A.H. with input from P.A.N.	Berendse F, 1999, TRENDS ECOL EVOL, V14, P4, DOI 10.1016/S0169-5347(98)01451-7; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grime J.P., 2002, PLANT STRATEGIES VEG; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.2307/176991; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 2004, J ECOL, V92, P339, DOI 10.1111/j.0022-0477.2004.00866.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Wacker L, 2008, BASIC APPL ECOL, V9, P467, DOI 10.1016/j.baae.2007.08.003; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950	26	845	916	50	831	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					636	638		10.1126/science.1169640	http://dx.doi.org/10.1126/science.1169640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407202	Green Accepted			2022-12-24	WOS:000265608800042
J	Bakker, M; Boon, D				Bakker, Martijn; Boon, Diederik			Practice 10-Minute Consultation Haematuria	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bakker, Martijn] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; [Boon, Diederik] Dept Nephrol, NL-1620 AR Hoorn, Netherlands	Vrije Universiteit Amsterdam	Bakker, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Postbus 7057, NL-1007 MB Amsterdam, Netherlands.	mbakker72@gmail.com							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2009	338								b1324	10.1136/bmj.b1324	http://dx.doi.org/10.1136/bmj.b1324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TL	19376797				2022-12-24	WOS:000265296900001
J	Steemans, P; Le Herisse, A; Melvin, J; Miller, MA; Paris, F; Verniers, J; Wellman, CH				Steemans, Philippe; Le Herisse, Alain; Melvin, John; Miller, Merrell A.; Paris, Florentin; Verniers, Jacques; Wellman, Charles H.			Origin and Radiation of the Earliest Vascular Land Plants	SCIENCE			English	Article									[Wellman, Charles H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Steemans, Philippe] Univ Liege, B-4000 Liege, Belgium; [Le Herisse, Alain] Univ Brest, UMR 6538, CNRS, Inst Univ Europeen Mer, F-29238 Brest 3, France; [Melvin, John; Miller, Merrell A.] Saudi Aramco, Dhahran 31311, Saudi Arabia; [Paris, Florentin] Univ Rennes 1, CNRS, UMR 6118, F-35042 Rennes, France; [Verniers, Jacques] Univ Ghent, Res Unit Palaentol, B-9000 Ghent, Belgium	University of Sheffield; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Ghent University	Wellman, CH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	c.wellman@sheffield.ac.uk	Verniers, Jacques/B-8024-2009; Paris, francois E/L-4915-2015	Verniers, Jacques/0000-0002-2939-7684; Paris, francois E/0000-0002-0176-7348; Steemans, Philippe/0000-0003-1183-6324	NERC [NE/E006612/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006612/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		EDWARDS D, 2001, PLANTS INVADE LAND, pCH2; GRAY J, 1985, PHILOS T ROY SOC B, V309, P167, DOI 10.1098/rstb.1985.0077; RICHARDSON JB, 1996, PALYNOLOGY PRINCIPLE, V2, pCHA18; Steemans P, 2000, REV PALAEOBOT PALYNO, V113, P189, DOI 10.1016/S0034-6667(00)00059-2; Strother P.K., 2000, PHANEROZOIC TERRESTR, P3; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	6	189	202	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					353	353		10.1126/science.1169659	http://dx.doi.org/10.1126/science.1169659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372423	Green Published			2022-12-24	WOS:000265221600032
J	Pryke, SR; Griffith, SC				Pryke, Sarah R.; Griffith, Simon C.			Genetic Incompatibility Drives Sex Allocation and Maternal Investment in a Polymorphic Finch	SCIENCE			English	Article							MALE ATTRACTIVENESS; NATURAL-SELECTION; COLOR MORPHS; RATIO; BIRDS; EGGS; CHOICE	Genetic compatibility may drive individual mate choice decisions because of predictable fitness effects associated with breeding with incompatible partners. In Gouldian finches (Erythrura gouldiae), females paired with genetically incompatible males of alternative color morphs overproduce sons, presumably to reduce investment in inviable daughters. We also observed a reduced overall investment in clutch size, egg size, and care to offspring resulting from incompatible matings. Within-female experimental pairings demonstrate that female birds have the ability to adaptively adjust the sex of their eggs and allocate resources on the basis of partner quality. Female Gouldian finches thus make cumulative strategic allocation decisions to minimize the costs of poor-quality pairings when faced with a genetically incompatible partner.	[Pryke, Sarah R.; Griffith, Simon C.] Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia	Macquarie University	Pryke, SR (corresponding author), Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia.	sarah.pryke@mq.edu.au	Griffith, Simon/A-1996-2010; Pryke, Sarah/G-7484-2011; Griffith, Simon/AAH-3706-2021	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999	Australian Research Council; L'Oreal [Women in Science Fellowship]; Save The Gouldian Fund;  [New South Global Postdoctoral Fellowship]	Australian Research Council(Australian Research Council); L'Oreal(L'Oreal Group); Save The Gouldian Fund; 	We thank A. Badyaev, R. Montgomerie, T. Price, A. Russell, and B. Sinervo for comments; D. Briscoe, R. Brooks, R. Bonduriansky, T. Burke, and M. Olsson for discussion; and R. Merrill, J. Brazill-Boast, and L. A. Rollins for technical help. Funded by the Australian Research Council (grants awarded to S.R.P. and S.C.G.), a New South Global Postdoctoral Fellowship (to S.R.P.), a L'Oreal For Women in Science Fellowship (to S.R.P.), and the Save The Gouldian Fund. The Animal Care and Ethics Committee of the University of New South Wales and Macquarie University approved this research.	BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; CHARNOV E L, 1982; Cordero PJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P353, DOI 10.1007/s002650000252; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.1111/j.1558-5646.1993.tb02142.x; Ewen JG, 2004, P ROY SOC B-BIOL SCI, V271, P1277, DOI 10.1098/rspb.2004.2735; Fawcett TW, 2007, BEHAV ECOL, V18, P71, DOI 10.1093/beheco/arl052; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; PETRIE M, 1993, P ROY SOC B-BIOL SCI, V251, P127, DOI 10.1098/rspb.1993.0018; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; SOUTHERN HN, 1945, J GENET, V47, P51, DOI 10.1007/BF02989037; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	23	77	80	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1605	1607		10.1126/science.1168928	http://dx.doi.org/10.1126/science.1168928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299618	Green Submitted			2022-12-24	WOS:000264342300038
J	Fazel, S; Langstrom, N; Hjern, A; Grann, M; Lichtenstein, P				Fazel, Seena; Langstrom, Niklas; Hjern, Anders; Grann, Martin; Lichtenstein, Paul			Schizophrenia, Substance Abuse, and Violent Crime	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR MENTAL-DISORDERS; BIRTH COHORT; FOLLOW-UP; ILLNESS; BEHAVIOR; COMMUNITY; HEALTH; MULTICENTER; MEDICATION; REGISTER	Context Persons with schizophrenia are thought to be at increased risk of committing violent crime 4 to 6 times the level of general population individuals without this disorder. However, risk estimates vary substantially across studies, and considerable uncertainty exists as to what mediates this elevated risk. Despite this uncertainty, current guidelines recommend that violence risk assessment should be conducted for all patients with schizophrenia. Objective To determine the risk of violent crime among patients diagnosed as having schizophrenia and the role of substance abuse in mediating this risk. Design, Setting, and Participants Longitudinal designs were used to link data from nationwide Swedish registers of hospital admissions and criminal convictions in 1973-2006. Risk of violent crime in patients after diagnosis of schizophrenia (n = 8003) was compared with that among general population controls (n = 80 025). Potential confounders (age, sex, income, and marital and immigrant status) and mediators (substance abuse comorbidity) were measured at baseline. To study familial confounding, we also investigated risk of violence among unaffected siblings (n = 8123) of patients with schizophrenia. Information on treatment was not available. Main Outcome Measure Violent crime (any criminal conviction for homicide, assault, robbery, arson, any sexual offense, illegal threats, or intimidation). Results In patients with schizophrenia, 1054 (13.2%) had at least 1 violent offense compared with 4276 (5.3%) of general population controls (adjusted odds ratio [OR], 2.0; 95% confidence interval [CI], 1.8-2.2). The risk was mostly confined to patients with substance abuse comorbidity (of whom 27.6% committed an offense), yielding an increased risk of violent crime among such patients (adjusted OR, 4.4; 95% CI, 3.9-5.0), whereas the risk increase was small in schizophrenia patients without substance abuse comorbidity (8.5% of whom had at least 1 violent offense; adjusted OR, 1.2; 95% CI, 1.1-1.4; P<.001 for interaction). The risk increase among those with substance abuse comorbidity was significantly less pronounced when unaffected siblings were used as controls (28.3% of those with schizophrenia had a violent offense compared with 17.9% of their unaffected siblings; adjusted OR, 1.8; 95% CI, 1.4-2.4; P<.001 for interaction), suggesting significant familial (genetic or early environmental) confounding of the association between schizophrenia and violence. Conclusions Schizophrenia was associated with an increased risk of violent crime in this longitudinal study. This association was attenuated by adjustment for substance abuse, suggesting a mediating effect. The role of risk assessment, management, and treatment in individuals with comorbidity needs further examination.	[Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Grann, Martin] Univ Stockholm, Dept Psychol, S-10691 Stockholm, Sweden; [Fazel, Seena; Langstrom, Niklas; Grann, Martin] Univ Stockholm, Ctr Violence Prevent, Stockholm, Sweden; [Langstrom, Niklas; Lichtenstein, Paul] Univ Stockholm, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hjern, Anders] Univ Stockholm, Karolinska Inst, Ctr Epidemiol, Natl Board Hlth & Welf, Stockholm, Sweden; [Hjern, Anders] Uppsala Univ, Dept Childrens & Womens Hlth, Uppsala, Sweden	University of Oxford; Stockholm University; Stockholm University; Stockholm University; Karolinska Institutet; National Board of Health & Welfare; Stockholm University; Uppsala University	Fazel, S (corresponding author), Warneford Hosp, Univ Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Langstrom, Niklas/C-5615-2009; Fazel, Seena/B-5307-2008	Langstrom, Niklas/0000-0002-2686-6799; Fazel, Seena/0000-0002-5383-5365; lichtenstein, paul/0000-0003-3037-5287; Hjern, Anders/0000-0002-1645-2058	Swedish Research Council Medicine; Swedish Council for Working Life and Social Research	Swedish Research Council Medicine(Swedish Research Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The Swedish Research Council Medicine and the Swedish Council for Working Life and Social Research funded the study.	American Psychiatric Association, 2004, PRACT GUID TREATM PA; Angermeyer MC, 1996, SOC SCI MED, V43, P1721, DOI 10.1016/S0277-9536(96)00065-2; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Arseneault L, 2003, BRIT J PSYCHIAT, V183, P520, DOI 10.1192/bjp.183.6.520; Bergman B, 1999, AM J FORENSIC PSYCH, V20, P27; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Brewer RD, 2005, JAMA-J AM MED ASSOC, V294, P616, DOI 10.1001/jama.294.5.616; Chen Xiao, 2003, REGRESSION STATA; Cole TB, 2005, JAMA-J AM MED ASSOC, V294, P623, DOI 10.1001/jama.294.5.623; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; Eisenberger NI, 2007, BIOL PSYCHIAT, V61, P1100, DOI 10.1016/j.biopsych.2006.08.007; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Farnham FR, 2001, LANCET, V358, P1926, DOI 10.1016/S0140-6736(01)06977-X; FARRINGTON D, 2004, CROSS NATL STUDIES C; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Gosden NP, 2005, SCHIZOPHRENIA BULL, V31, P759, DOI 10.1093/schbul/sbi015; Grann M, 2004, BRIT MED J, V328, P1233, DOI 10.1136/bmj.328.7450.1233; GRANN M, 1998, SCANDINAVIAN J FOREN, V3, P78; Gunnell D, 2003, BRIT J PSYCHIAT, V182, P164, DOI 10.1192/bjp.182.2.164; Hansson L, 2001, ACTA PSYCHIAT SCAND, V103, P45, DOI 10.1034/j.1600-0447.2001.00083.x; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hodgins S, 2001, INT J LAW PSYCHIAT, V24, P427, DOI 10.1016/S0160-2527(01)00077-2; James A, 1998, LANCET, V352, P1048; Johnson JG, 2000, AM J PSYCHIAT, V157, P1406, DOI 10.1176/appi.ajp.157.9.1406; Joyal CC, 2007, CURR PSYCHIATRY REV, V3, P33, DOI 10.2174/157340007779815628; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008; LANDIS JR, 1977, BIOMETRICS, V33, P174; Langstrom N, 1999, NORD J PSYCHIAT, V53, P61; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; Mullen P. E., 2006, ADV PSYCHIAT TREATME, V12, P239, DOI DOI 10.1192/APT.12.4.239; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Rasanen P, 1998, SCHIZOPHRENIA BULL, V24, P437, DOI 10.1093/oxfordjournals.schbul.a033338; Satcher D, 2001, JAMA-J AM MED ASSOC, V285, P1697, DOI 10.1001/jama.285.13.1697; Statistics Sweden, 2005, FLERG 2004 BESKR INN; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Svensson AC, 2007, SCHIZOPHR RES, V91, P238, DOI 10.1016/j.schres.2006.12.002; Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Swartz MS, 1998, AM J PSYCHIAT, V155, P226; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Walsh E, 2004, SCHIZOPHR RES, V67, P247, DOI 10.1016/S0920-9964(03)00091-4; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; Williams J, 1996, PSYCHOL MED, V26, P775, DOI 10.1017/S003329170003779X	49	400	417	7	105	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					2016	2023		10.1001/jama.2009.675	http://dx.doi.org/10.1001/jama.2009.675			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	446YU	19454640	Green Accepted, Bronze			2022-12-24	WOS:000266159600026
J	Scott, TF; Kowalski, BA; Sullivan, AC; Bowman, CN; McLeod, RR				Scott, Timothy F.; Kowalski, Benjamin A.; Sullivan, Amy C.; Bowman, Christopher N.; McLeod, Robert R.			Two-Color Single-Photon Photoinitiation and Photoinhibition for Subdiffraction Photolithography	SCIENCE			English	Article							2-PHOTON RADICAL-PHOTOINITIATOR; POLYMERIZATION; SYSTEM; PHOTOPOLYMERIZATION; BENZOSPIROPYRANS; MICROFABRICATION; LITHOGRAPHY; WAVELENGTH; RESOLUTION	Controlling and reducing the developed region initiated by photoexposure is one of the fundamental goals of optical lithography. Here, we demonstrate a two-color irradiation scheme whereby initiating species are generated by single-photon absorption at one wavelength while inhibiting species are generated by single-photon absorption at a second, independent wavelength. Co-irradiation at the second wavelength thus reduces the polymerization rate, delaying gelation of the material and facilitating enhanced spatial control over the polymerization. Appropriate overlapping of the two beams produces structures with both feature sizes and monomer conversions otherwise unobtainable with use of single- or two-photon absorption photopolymerization. Additionally, the generated inhibiting species rapidly recombine when irradiation with the second wavelength ceases, allowing for fast sequential exposures not limited by memory effects in the material and thus enabling fabrication of complex two- or three-dimensional structures.	[Kowalski, Benjamin A.; Sullivan, Amy C.; McLeod, Robert R.] Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA; [Scott, Timothy F.; Bowman, Christopher N.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McLeod, RR (corresponding author), Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA.	robert.mcleod@colorado.edu	Bowman, Christopher N/B-1490-2008; McLeod, Robert R/R-2569-2019; Scott, Timothy/AAV-5819-2021	Bowman, Christopher N/0000-0001-8458-7723; Scott, Timothy/0000-0002-5893-3140; MCLEOD, ROBERT/0000-0001-6354-0168	NSF [IIP-0750506, IIP-0822695, ECS-0636650]; NIH [DE10959]; University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010959, R29DE010959] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by NSF programs IIP-0750506, IIP-0822695, and ECS-0636650, NIH grant DE10959, and the University of Colorado Innovative Seed Grant Program. A preliminary patent based on this technology has been filed by T.F.S., A.C.S., C.N.B., and R.R.M.	Arlt J, 2000, OPT LETT, V25, P191, DOI 10.1364/OL.25.000191; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Flory P. J, 1953, PRINCIPLES POLYM CHE; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; ICHIMURA K, 1988, J POLYM SCI POL LETT, V26, P185, DOI 10.1002/pol.1988.140260403; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; LEE SK, 1991, CHEM MATER, V3, P852, DOI 10.1021/cm00017a021; LEE SK, 1991, CHEM MATER, V3, P858, DOI 10.1021/cm00017a022; LOUGNOT DJ, 1988, J APPL PHYS, V63, P4841, DOI 10.1063/1.340477; Lovell LG, 2001, POLYMER, V42, P421, DOI 10.1016/S0032-3861(00)00386-4; SOH SK, 1982, J POLYM SCI POL CHEM, V20, P1299, DOI 10.1002/pol.1982.170200513; Strandwitz NC, 2008, J AM CHEM SOC, V130, P8280, DOI 10.1021/ja711295k; Sullivan AC, 2007, APPL OPTICS, V46, P295, DOI 10.1364/AO.46.000295; Sun HB, 2000, OPT LETT, V25, P1110, DOI 10.1364/OL.25.001110; Sun HB, 2004, ADV POLYM SCI, V170, P169, DOI 10.1007/b94405; Tanaka T, 2002, APPL PHYS LETT, V80, P312, DOI 10.1063/1.1432450	17	318	338	11	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					913	917		10.1126/science.1167610	http://dx.doi.org/10.1126/science.1167610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359546				2022-12-24	WOS:000266048800031
J	Matsushita, K; Takeuchi, O; Standley, DM; Kumagai, Y; Kawagoe, T; Miyake, T; Satoh, T; Kato, H; Tsujimura, T; Nakamura, H; Akira, S				Matsushita, Kazufumi; Takeuchi, Osamu; Standley, Daron M.; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Tsujimura, Tohru; Nakamura, Haruki; Akira, Shizuo			Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay	NATURE			English	Article							AUTOIMMUNITY; RECOGNITION; ACTIVATION; CLEAVAGE; INNATE	Toll-like receptors (TLRs) recognize microbial components, and evoke inflammation and immune responses(1-3). TLR stimulation activates complex gene expression networks that regulate the magnitude and duration of the immune reaction. Here we identify the TLR-inducible gene Zc3h12a as an immune response modifier that has an essential role in preventing immune disorders. Zc3h12a-deficient mice suffered from severe anaemia, and most died within 12 weeks. Zc3h12a(-/-) mice also showed augmented serum immunoglobulin levels and autoantibody production, together with a greatly increased number of plasma cells, as well as infiltration of plasma cells to the lung. Most Zc3h12a(-/-) splenic T cells showed effector/memory characteristics and produced interferon-gamma in response to T-cell receptor stimulation. Macrophages from Zc3h12a (-/-) mice showed highly increased production of interleukin (IL)-6 and IL-12p40 (also known as IL12b), but not TNF, in response to TLR ligands. Although the activation of TLR signalling pathways was normal, Il6 messenger RNA decay was severely impaired in Zc3h12a (-/-) macrophages. Overexpression of Zc3h12a accelerated Il6 mRNA degradation via its 3'-untranslated region (UTR), and destabilized RNAs with 3'-UTRs for genes including Il6, Il12p40 and the calcitonin receptor gene Calcr. Zc3h12a contains a putative amino-terminal nuclease domain, and the expressed protein had RNase activity, consistent with a role in the decay of Il6 mRNA. Together, these results indicate that Zc3h12a is an essential RNase that prevents immune disorders by directly controlling the stability of a set of inflammatory genes.	[Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Host Def Lab, Suita, Osaka 5650871, Japan; [Standley, Daron M.] Osaka Univ, Lab Syst Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Nakamura, Haruki] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Hyogo College of Medicine; Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009; Standley, Daron/D-2343-2009; Kumagai, Yutaro/L-7732-2018	Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Miyake, Toru/0000-0003-0947-0116	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Global Center of Excellence Program of Japan; NIH [P01 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all colleagues in our laboratory, E. Kamada for secretarial assistance, and Y. Fujiwara, M. Kumagai and R. Abe for technical assistance. We thank S. Sato for discussions and W. Zhao and K. Kirkwood for plasmids. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants from the Ministry of Health, Labour and Welfare in Japan, the Global Center of Excellence Program of Japan, and the NIH (P01 AI070167).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	22	452	469	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1185	U124		10.1038/nature07924	http://dx.doi.org/10.1038/nature07924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19322177				2022-12-24	WOS:000265754600050
J	Armstrong, N; Vale, L; Deverill, M; Nabi, G; McClinton, S; N'Dow, J; Pickard, R				Armstrong, Nigel; Vale, Luke; Deverill, Mark; Nabi, Ghulam; McClinton, Samuel; N'Dow, James; Pickard, Robert		BPE Study Grp	Surgical treatments for men with benign prostatic enlargement: cost effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSURETHRAL MICROWAVE THERMOTHERAPY; URINARY-TRACT SYMPTOMS; PHOTOSELECTIVE VAPORIZATION; RANDOMIZED-TRIAL; HYPERPLASIA; PROSTATECTOMY; RESECTION; MORTALITY	Objective To determine which surgical treatment for lower urinary tract symptoms suggestive of benign prostate enlargement is cost effective. Design Care pathways describing credible treatment strategies were decided by consensus. Cost-utility analysis used Markov modelling and Monte Carlo simulation. Data sources Clinical effectiveness data came from a systematic review and an individual level dataset. Utility values came from previous economic evaluations. Costs were calculated from National Health Service (NHS) and commercial sources. Methods The Markov model included parameters with associated measures of uncertainty describing health states between which individuals might move at three monthly intervals over 10 years. Successive annual cohorts of 25 000 men were entered into the model and the probability that treatment strategies were cost effective was assessed with Monte Carlo simulation with 10 000 iterations. Results A treatment strategy of initial diathermy vaporisation of the prostate followed by endoscopic holmium laser enucleation of the prostate in case of failure to benefit or subsequent relapse had an 85% probability of being cost effective at a willingness to pay value of 20 pound 000 ((sic)21 595, $28 686)/quality adjusted life year (QALY) gained. Other strategies with diathermy vaporisation as the initial treatment were generally cheaper and more effective than the current standard of transurethral resection repeated once if necessary. The use of potassium titanyl phosphate laser vaporisation incurred higher costs and was less effective than transurethral resection, and strategies involving initial minimally invasive treatment with microwave thermotherapy were not cost effective. Findings were unchanged by wide ranging sensitivity analyses. Conclusion The outcome of this economic model should be interpreted cautiously because of the limitations of the data used. The finding that initial vaporisation followed by holmium laser enucleation for failure or relapse might be advantageous both to men with lower urinary tract symptoms and to healthcare providers requires confirmation in a good quality prospective clinical trial before any change in current practice. Potassium titanyl phosphate laser vaporisation was unlikely to be cost effective in our model, which argues against its unrestricted use until further evidence of effectiveness and cost reduction is obtained.	[Pickard, Robert] Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Armstrong, Nigel] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Vale, Luke] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland; [Vale, Luke] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Nabi, Ghulam; McClinton, Samuel; N'Dow, James] Univ Aberdeen, Inst Appl Hlth Sci, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	Newcastle University - UK; Newcastle University - UK; University of Aberdeen; University of Aberdeen; University of Aberdeen	Pickard, R (corresponding author), Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.s.pickard@ncl.ac.uk		Nabi, Ghulam/0000-0002-4864-9445; Vale, Luke/0000-0001-8574-8429	Health Technology Assessment Programme [04/38/03]; National Institute for Health Research [04/38/03] Funding Source: researchfish; Chief Scientist Office [HERU2, HSRU1, HERU1] Funding Source: researchfish	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	This study was funded by the Health Technology Assessment Programme (project No 04/38/03). The views expressed in this paper are those of the authors not the institutions providing funding. An extensive monograph describing the whole project of which this analysis is a part is available for open access (Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008; 12: 1516).	Ackerman SJ, 2000, UROLOGY, V56, P972, DOI 10.1016/S0090-4295(00)00828-1; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; *AM UR ASS, 2003, GUID MAN BEN PROST H; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Blute M, 2000, UROLOGY, V56, P981, DOI 10.1016/S0090-4295(00)00829-3; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Briggs A., 2001, EC EVALUATION HLTH C; *DEP HLTH, 2005, NHS REF COSTS NHS TR; DiSantostefano RL, 2006, PHARMACOECONOMICS, V24, P171, DOI 10.2165/00019053-200624020-00006; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Francisca EAE, 1999, J UROLOGY, V161, P486, DOI 10.1016/S0022-5347(01)61930-X; Harding C, 2007, EUR UROL, V52, P186, DOI 10.1016/j.eururo.2006.11.009; Horasanli K, 2008, UROLOGY, V71, P247, DOI 10.1016/j.urology.2007.09.017; HOWARD K, 2002, MSAC APPL, V1014; Kok ET, 2002, EUR UROL, V42, P491, DOI 10.1016/S0302-2838(02)00403-7; Lourenco T, 2008, HEALTH TECHNOL ASSES, V12, P1; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; Lourenco T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1662; Madersbacher S, 2005, EUR UROL, V47, P499, DOI 10.1016/j.eururo.2004.12.010; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; *NIH CLIN EXC, GUID MAN 2007; Noble SM, 2002, J UROLOGY, V168, P2476, DOI 10.1016/S0022-5347(05)64172-9; Norby B, 2002, SCAND J UROL NEPHROL, V36, P286, DOI 10.1080/003655902320248263; SEAGROATT V, 1995, LANCET, V346, P1521, DOI 10.1016/S0140-6736(95)92052-8; Stafinski T, 2008, CUAJ-CAN UROL ASSOC, V2, P124; Stovsky MD, 2006, J UROLOGY, V176, P1500, DOI 10.1016/j.juro.2006.06.064; Tooher R, 2004, J UROLOGY, V171, P1773, DOI 10.1097/01.ju.0000113494.03668.6d; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Watson V, 2004, J UROLOGY, V172, P2321, DOI 10.1097/01.ju.0000140957.31325.7f	29	16	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2009	338								b1288	10.1136/bmj.b1288	http://dx.doi.org/10.1136/bmj.b1288			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TK	19372131	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000265296800003
J	Hoge, CW; Goldberg, HM; Castro, CA				Hoge, Charles W.; Goldberg, Herb M.; Castro, Carl A.			Care of War Veterans with Mild Traumatic Brain Injury - Flawed Perspectives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hoge, Charles W.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA; [Goldberg, Herb M.] Walter Reed Army Inst Res, Battlemind Training Off, Silver Spring, MD USA; [Castro, Carl A.] USA, Med Res & Mat Command, Mil Operat Med Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hoge, CW (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA.							Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; McCrea M., 2008, MILD TRAUMATIC BRAIN; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	5	200	202	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1588	1591		10.1056/NEJMp0810606	http://dx.doi.org/10.1056/NEJMp0810606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433BH	19369664				2022-12-24	WOS:000265178000002
J	Jugdutt, BI				Jugdutt, Bodh I.			Limiting Fibrosis after Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRIZZLED-RELATED PROTEIN-2		[Jugdutt, Bodh I.] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada; [Jugdutt, Bodh I.] Univ Alberta, Fac Med, Cardiovasc Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta	Jugdutt, BI (corresponding author), Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada.							Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104	5	21	24	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1567	1569		10.1056/NEJMcibr0810801	http://dx.doi.org/10.1056/NEJMcibr0810801			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357414				2022-12-24	WOS:000264976800017
J	Shimoyama, T; Kato, S; Ishii, S; Watanabe, K				Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya			Flagellum Mediates Symbiosis	SCIENCE			English	Article									[Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya] Marine Biotechnol Inst, Lab Appl Microbiol, Kamaishi, Iwate 0260001, Japan; [Shimoyama, Takefumi; Watanabe, Kazuya] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Kato, Souichiro; Watanabe, Kazuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Hashimoto Light Energy Convers Project, Bunkyo Ku, Tokyo 1138656, Japan; [Ishii, Shun'ichi] J Craig Venter Inst, San Diego, CA 92121 USA	University of Tokyo; Japan Science & Technology Agency (JST); J. Craig Venter Institute	Watanabe, K (corresponding author), Marine Biotechnol Inst, Lab Appl Microbiol, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	watanabe@light.t.u-tokyo.ac.jp	Kato, Souichiro/M-4151-2018; Albers, Pieter/I-2563-2017	Kato, Souichiro/0000-0002-2527-7730; Ishii, Shun'ichi/0000-0002-0203-8569	New Energy Development Organization of Japan; JST; Japan Society for Promotion of Science	New Energy Development Organization of Japan; JST(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Nealson for the critical reading of the manuscript, T. Kosaka for microarray setup, and F. Numazaki and M. Sato for technical assistance. This work was supported by the New Energy Development Organization of Japan, JST, and the Japan Society for Promotion of Science.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997	4	88	97	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1574	1574		10.1126/science.1170086	http://dx.doi.org/10.1126/science.1170086			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299611				2022-12-24	WOS:000264342300029
J	Pecho-Vrieseling, E; Sigrist, M; Yoshida, Y; Jessell, TM; Arber, S				Pecho-Vrieseling, Eline; Sigrist, Markus; Yoshida, Yutaka; Jessell, Thomas M.; Arber, Silvia			Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition	NATURE			English	Article							SYNAPTIC CONNECTIONS; SPINAL-CORD; MOTONEURONS; AFFERENTS; NEURONS; PROTEINS; AXONS; PEA3	Spinal reflexes are mediated by synaptic connections between sensory afferents and motor neurons(1-3). The organization of these circuits shows several levels of specificity. Only certain classes of proprioceptive sensory neurons make direct, monosynaptic connections with motor neurons(4). Those that do are bound by rules of motor pool specificity: they form strong connections with motor neurons supplying the same muscle, but avoid motor pools supplying antagonistic muscles(1,5-7). This pattern of connectivity is initially accurate and is maintained in the absence of activity(8), implying that wiring specificity relies on the matching of recognition molecules on the surface of sensory and motor neurons. However, determinants of fine synaptic specificity here, as in most regions of the central nervous system, have yet to be defined. To address the origins of synaptic specificity in these reflex circuits we have used molecular genetic methods to manipulate recognition proteins expressed by subsets of sensory and motor neurons. We show here that a recognition system involving expression of the class 3 semaphorin Sema3e by selected motor neuron pools, and its high-affinity receptor plexin D1 (Plxnd1) by proprioceptive sensory neurons, is a critical determinant of synaptic specificity in sensory-motor circuits in mice. Changing the profile of Sema3e-Plxnd1 signalling in sensory or motor neurons results in functional and anatomical rewiring of monosynaptic connections, but does not alter motor pool specificity. Our findings indicate that patterns of monosynaptic connectivity in this prototypic central nervous system circuit are constructed through a recognition program based on repellent signalling.	[Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, Kavli Inst Brain Sci, New York, NY 10032 USA; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Kavli Inst Brain Sci, New York, NY 10032 USA; [Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Cincinnati Children's Hospital Medical Center	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.	tmj1@columbia.edu; silvia.arber@unibas.ch	Pecho-Vrieseling, Eline/AAP-7239-2020	Pecho-Vrieseling, Eline/0000-0001-6712-775X; Arber, Silvia/0000-0002-6261-250X	Swiss National Science Foundation; NCCR Frontiers in Genetics; Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation; NIH [RO1NS065048]; NINDS; Harold and Leila Mathers Foundation; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harold and Leila Mathers Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ladle for help in analysis of electrophysiological data, J. Livet and C. Henderson for discussions, and P. Schwarb, A. Ponti and M. Stadler for help in image and statistical analysis. M. Mendelsohn, J. Kirkland and B. Han helped in the generation of Plxnd1<SUP>cond</SUP> mice and J. F. Spetz, P. Kopp and B. Kuchemann in the generation of Sema3e mutant and MN:: Sema3e mice. R. Axel, P. Caroni, E. Frank, A. Hantman, C. Henderson, D. Ladle and A. Luethi provided comments on the manuscript. E. P.-V., M. S. and S. A. are supported by the Swiss National Science Foundation, NCCR Frontiers in Genetics, the Kanton Basel-Stadt, EU Framework Program 7 and the Novartis Research Foundation. Y. Y. is supported by NIH grant RO1NS065048. T. M. J. is an HHMI Investigator, and is supported by grants from NINDS, EU Framework Program 7, Project ALS, The Harold and Leila Mathers Foundation, and The Wellcome Trust.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BALDISSERA F, 1981, HDB PHYSL INTEGRATIO, V509; Brown AG, 1981, ORG SPINAL CORD; Burke RE, 1996, J COMP NEUROL, V372, P465; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; FRANK E, 1990, J NEUROSCI, V10, P2250; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOLSTEGE G, 1987, EXP BRAIN RES, V67, P179, DOI 10.1007/BF00269465; Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Mears SC, 1997, J NEUROSCI, V17, P3128; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463, DOI 10.1152/jn.1988.60.2.463; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031	30	131	135	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					842	846		10.1038/nature08000	http://dx.doi.org/10.1038/nature08000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19421194	Green Accepted			2022-12-24	WOS:000267084500039
J	Poland, GA; Barry, MA				Poland, Gregory A.; Barry, Michael A.			Common Cold, Uncommon Variation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN RHINOVIRUSES		[Poland, Gregory A.; Barry, Michael A.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Poland, Gregory A.; Barry, Michael A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Dept Med, Rochester, MN 55905 USA.							Kirchberger S, 2007, INT ARCH ALLERGY IMM, V142, P1, DOI 10.1159/000095993; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; PALMENBERG AC, 2009, SCIENCE         0212; Stone JK, 2008, ANTIMICROB AGENTS CH, V52, P1970, DOI 10.1128/AAC.00011-08; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080	5	5	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2245	2246		10.1056/NEJMcibr0902053	http://dx.doi.org/10.1056/NEJMcibr0902053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19458372				2022-12-24	WOS:000266206000015
J	Bendavid, E; Bhattacharya, J				Bendavid, Eran; Bhattacharya, Jayanta			The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							HIV/AIDS	Background: Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has been the most ambitious initiative to address the global HIV epidemic. However, the effect of PEPFAR on HIV-related outcomes is unknown. Objective: To assess the effect of PEPFAR on HIV-related deaths, the number of people living with HIV, and HIV prevalence in sub-Saharan Africa. Design: Comparison of trends before and after the initiation of PEPFAR's activities. Setting: 12 African focus countries and 29 control countries with a generalized HIV epidemic from 1997 to 2007 ( 451 country-year observations). Intervention: A 5-year, $15 billion program for HIV treatment, prevention, and care that started in late 2003. Measurements: HIV-related deaths, the number of people living with HIV, and HIV prevalence. Results: Between 2004 and 2007, the difference in the annual change in the number of HIV-related deaths was 10.5% lower in the focus countries than in the control countries ( P = 0.001). The difference in trends between the groups before 2003 was not significant. The annual growth in the number of people living with HIV was 3.7% slower in the focus countries than in the control countries from 1997 to 2002 ( P = 0.05), but during PEPFAR's activities, the difference was no longer significant. The difference in the change in HIV prevalence did not significantly differ throughout the study period. These estimates were stable after sensitivity analysis. Limitation: The selection of the focus countries was not random, which limits the generalizability of the results. Conclusion: After 4 years of PEPFAR activity, HIV-related deaths decreased in sub-Saharan African focus countries compared with control countries, but trends in adult prevalence did not differ. Assessment of epidemiologic effectiveness should be part of PEPFAR's evaluation programs. Primary Funding Source: Agency for Healthcare Research and Quality.			Bendavid, E (corresponding author), 117 Encina Commons, Stanford, CA 94305 USA.	ebd@stanford.edu			Agency for Healthcare Research and Quality; National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253, K02AG024237, R21AG041112] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a training grant from the Agency for Healthcare Research and Quality ( Dr. Bendavid) and the National Institute on Aging ( Dr. Bhattacharya).	ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bristol N, 2008, LANCET, V372, P277, DOI 10.1016/S0140-6736(08)61093-4; COHEN C, 2008, DESIGN CONSIDERATION; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Duflo Esther, 2005, EVALUATING DEV EFFEC; Easterly W, 2007, J DEV ECON, V84, P755, DOI 10.1016/j.jdeveco.2006.11.002; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; Ghys PD, 2008, SEX TRANSM INFECT, V84, pI1, DOI 10.1136/sti.2008.032573; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; *GLOB FUND, 2008, PLEDG CONTR; GORGENSALBINO M, 2000, INT BANK RECONSTRUCT; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Joint United Nations Programme on HIV/AIDS (UNAIDS), JOINT UN PROGR HIV A; *OFF US GLOB AIDS, POW PARTN PRES EM PL; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; *PRES EM PLAN AIDS, US 5 YEAR GLOB HIV A; Sachs JD, 2004, BROOKINGS PAP ECO AC, P117; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; STOLBERG SG, 2008, NY TIMES        0105; *UN, 2001, DECL COMM HIV AIDS P; *UNAIDS, 2008, REP GLOB AIDS EP EP; UNAIDS, MON DECL COMM HIV AI; UNAIDS, 2007, FIN RES REQ ACH UN A; *US CENS BUR, INT DAT BAS POP PYR; *US DEP STAT, PRES EM PLAN AIDS RE; *US PRES EM PLAN A, MAK DIFF FUND; *WORLD BANK, GOV MATT 2008 WORLDW	30	110	112	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					688	U5		10.7326/0003-4819-150-10-200905190-00117	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00117			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19349625	Green Accepted			2022-12-24	WOS:000266285300004
J	Riccio, A; Li, Y; Moon, J; Kim, KS; Smith, KS; Rudolph, U; Gapon, S; Yao, GL; Tsvetkov, E; Rodig, SJ; Van't Veer, A; Meloni, EG; Carlezon, WA; Bolshakov, VY; Clapham, DE				Riccio, Antonio; Li, Yan; Moon, Jisook; Kim, Kwang-Soo; Smith, Kiersten S.; Rudolph, Uwe; Gapon, Svetlana; Yao, Gui Lan; Tsvetkov, Evgeny; Rodig, Scott J.; Van't Veer, Ashlee; Meloni, Edward G.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.; Clapham, David E.			Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior	CELL			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; SYNAPTIC PLASTICITY; CONDITIONING PATHWAYS; GROWTH CONES; MEMORY; CHANNELS; RATS; ANXIETY; BRAIN	The transient receptor potential channel 5 (TRPC5) is predominantly expressed in the brain where it can form heterotetrameric complexes with TRPC1 and TRPC4 channel subunits. These excitatory, nonselective cationic channels are regulated by G protein, phospholipase C-coupled receptors. Here, we show that TRPC5(-/-) mice exhibit diminished innate fear levels in response to innately aversive stimuli. Moreover, mutant mice exhibited significant reductions in responses mediated by synaptic activation of Group I metabotropic glutamate and cholecystokinin 2 receptors in neurons of the amygdala. Synaptic strength at afferent inputs to the amygdala was diminished in P10-P13 null mice. In contrast, baseline synaptic transmission, membrane excitability, and spike timing-dependent long-term potentiation at cortical and thalamic inputs to the amygdala were largely normal in older null mice. These experiments provide genetic evidence that TRPC5, activated via G protein-coupled neuronal receptors, has an essential function in innate fear.	[Li, Yan; Moon, Jisook; Kim, Kwang-Soo; Smith, Kiersten S.; Rudolph, Uwe; Tsvetkov, Evgeny; Van't Veer, Ashlee; Meloni, Edward G.; Carlezon, William A., Jr.; Bolshakov, Vadim Y.] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; [Riccio, Antonio; Gapon, Svetlana; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Manton Ctr Orphan Dis, Boston, MA 02115 USA; [Riccio, Antonio; Yao, Gui Lan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu; dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Tsvetkov, Evgeny/C-1085-2016; Van't Veer, Ashlee/GOV-5648-2022; Tsvetkov, Evgeny A/B-6573-2016; Clapham, David/R-5974-2019; Rodig, Scott/Y-3889-2019	Clapham, David/0000-0002-4459-9428; Tsvetkov, Evgeny/0000-0001-9339-1677; Van't Veer, Ashlee/0000-0003-4920-447X; Tsvetkov, Evgeny A/0000-0002-6784-0907; /0000-0002-4162-3947	National Institutes of Health [P30-HD18655]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Whitehall Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Lin Lin Zhao for her help with maintaining the TRPC5 mouse colony and Kenneth Law for help with immunostaining. We also thank the Gene Manipulation Facility of the Children's Hospital Mental Retardation and Developmental Disabilities Research Center (National Institutes of Health grant P30-HD18655). This work was supported by grants from the National Institutes of Health (NIH), the National Alliance for Research on Schizophrenia and Depression (NARSAD), and the Whitehall Foundation (to V. Y. B.).	Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frankland PW, 1997, J NEUROSCI, V17, P1838; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Meis S, 2007, MOL CELL NEUROSCI, V35, P356, DOI 10.1016/j.mcn.2007.03.012; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; de la Mora MP, 2006, EUR J NEUROSCI, V23, P2749, DOI 10.1111/j.1460-9568.2006.04798.x; Pietraszek M, 2005, EUR J PHARMACOL, V514, P25, DOI 10.1016/j.ejphar.2005.03.028; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, J BIOL CHEM, V277, P12302, DOI 10.1074/jbc.M112313200; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Royer S, 2000, J NEUROPHYSIOL, V83, P3509, DOI 10.1152/jn.2000.83.6.3509; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	45	202	204	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					761	772		10.1016/j.cell.2009.03.039	http://dx.doi.org/10.1016/j.cell.2009.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450521	Bronze, Green Accepted			2022-12-24	WOS:000266114100023
J	Wan, XH; O'Quinn, RP; Pierce, HL; Joglekar, AP; Gall, WE; DeLuca, JG; Carroll, CW; Liu, ST; Yen, TJ; McEwen, BF; Stukenberg, T; Desai, A; Salmon, ED				Wan, Xiaohu; O'Quinn, Ryan P.; Pierce, Heather L.; Joglekar, Ajit P.; Gall, Walt E.; DeLuca, Jennifer G.; Carroll, Christopher W.; Liu, Song-Tao; Yen, Tim J.; McEwen, Bruce F.; Stukenberg, Todd; Desai, Arshad; Salmon, E. D.			Protein Architecture of the Human Kinetochore Microtubule Attachment Site	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CENP-E; OUTER PLATE; MOLECULAR ARCHITECTURE; CHROMOSOME CONGRESSION; HIGH-RESOLUTION; NDC80 COMPLEX; LIVING CELLS; LOCALIZATION; SEGREGATION	Chromosome segregation requires assembly of kinetochores on centromeric chromatin to mediate interactions with spindle microtubules and control cell-cycle progression. To elucidate the protein architecture of human kinetochores, we developed a two-color fluorescence light microscopy method that measures average label separation, Delta, at < 5 nm accuracy. Delta analysis of 16 proteins representing core structural complexes spanning the centromeric chromatin-microtubule interface, when correlated with mechanical states of spindle-attached kinetochores, provided a nanometer-scale map of protein position and mechanical properties of protein linkages. Treatment with taxol, which suppresses microtubule dynamics and activates the spindle checkpoint, revealed a specific switch in kinetochore architecture. Cumulatively, Delta analysis revealed that compliant linkages are restricted to the proximity of chromatin, suggested a model for how the KMN (KNL1/Mis12 complex/Ndc80 complex) network provides microtubule attachment and generates pulling forces from depolymerization, and identified an intrakinetochore molecular switch that may function in controlling checkpoint activity.	[Wan, Xiaohu; O'Quinn, Ryan P.; Pierce, Heather L.; Joglekar, Ajit P.; Gall, Walt E.; Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Wan, Xiaohu] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [O'Quinn, Ryan P.] NIH, NIH UNC Grad Partnerships Program Cytoskeleton &, Bethesda, MD 20892 USA; [DeLuca, Jennifer G.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carroll, Christopher W.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Liu, Song-Tao; Yen, Tim J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [McEwen, Bruce F.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Stukenberg, Todd] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; Colorado State University; Stanford University; Fox Chase Cancer Center; State University of New York (SUNY) System; Wadsworth Center; University of Virginia; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	tsalmon@email.unc.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579; Joglekar, Ajit/0000-0002-0607-5332; Yen, Tim/0000-0003-2159-0997; Stukenberg, Todd/0000-0002-6788-2111	NIH [GM24364, GM60678, GM06627, GM86877, GM44762, GM074215]; Burroughs-Wellcome Fund; Leukemia and Lymphoma Society [CA06927]; PA Tobacco Fund; NATIONAL CANCER INSTITUTE [K01CA125051, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, R01GM044762, R01GM086877, R37GM024364, R01GM060678, R01GM024364] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); PA Tobacco Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to a number of scientists who provided well-characterized reagents including Dr. Steve Taylor, Dr. Mitsuhiro Yanagida, Dr. Tomomi Kiyomitsu, Dr. Aaron Straight, and Dr. Jan Ellenberg. The authors would like to thank J. Hittle for expert technical assistance in generating antibodies. We also thank Dr. Kerry Bloom, Dr. Andrea Musacchio, and members of the Salmon and Desai labs for their critiques of early versions of this manuscript. Funded by NIH GM24364 and GM60678 (E. D. S.); GM06627 (B. F. M.); GM86877 and GM44762 (T. J. Y.); and GM074215 (A. D.). A. P. J. holds a Career Award at the Scientific Interface from the Burroughs-Wellcome Fund. T. J. Y. is also supported by the Leukemia and Lymphoma Society, a core grant (CA06927), the PA Tobacco Fund, and an appropriation from the Commonwealth of Pennsylvania.	Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Asbury CL, 2008, STRUCTURE, V16, P834, DOI 10.1016/j.str.2008.05.005; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Brinkley B R, 1992, Trends Cell Biol, V2, P15, DOI 10.1016/0962-8924(92)90139-E; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2003, METHOD ENZYMOL, V360, P597; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiato H, 2006, CHROMOSOMA, V115, P469, DOI 10.1007/s00412-006-0076-2; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; McIntosh JR, 2005, NAT STRUCT MOL BIOL, V12, P210, DOI 10.1038/nsmb0305-210; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Politi V, 2002, J CELL SCI, V115, P2317; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	59	271	277	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 15	2009	137	4					672	684		10.1016/j.cell.2009.03.035	http://dx.doi.org/10.1016/j.cell.2009.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450515	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000266114100016
J	Xu, N; Papagiannakopoulos, T; Pan, GJ; Thomson, JA; Kosik, KS				Xu, Na; Papagiannakopoulos, Thales; Pan, Guangjin; Thomson, James A.; Kosik, Kenneth S.			MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells	CELL			English	Article							SELF-RENEWAL; MOUSE; DIFFERENTIATION; CIRCUITRY; EXPRESSION; GENES; NANOG; FIBROBLASTS; BIOGENESIS; LINEAGES	MicroRNAs (miRNAs) are posttranscriptional modulators of gene expression and play an important role in many developmental processes. We report here that expression of microRNA-145 (miR-145) is low in self-renewing human embryonic stem cells (hESCs) but highly upregulated during differentiation. We identify the pluripotency factors OCT4, SOX2, and KLF4 as direct targets of miR-145 and show that endogenous miR-145 represses the 3' untranslated regions of OCT4, SOX2, and KLF4. Increased miR-145 expression inhibits hESC self-renewal, represses expression of pluripotency genes, and induces lineage-restricted differentiation. Loss of miR-145 impairs differentiation and elevates OCT4, SOX2, and KLF4. Furthermore, we find that the miR-145 promoter is bound and repressed by OCT4 in hESCs. This work reveals a direct link between the core reprogramming factors and miR-145 and uncovers a double-negative feedback loop involving OCT4, SOX2, KLF4, and miR-145.	[Xu, Na; Papagiannakopoulos, Thales; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Pan, Guangjin; Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of California System; University of California Santa Barbara; University of Wisconsin System; University of Wisconsin Madison	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu			W. M. Keck Foundation; California Institute for Regenerative Medicine (CIRM)	W. M. Keck Foundation(W.M. Keck Foundation); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by W. M. Keck Foundation. N. X. is funded by a Postdoctoral Fellowship from California Institute for Regenerative Medicine (CIRM). We thank Sherry Hikita for valuable discussions and Cecilia Conaco and MinJeong Kye for critical reviews of the manuscript. Kai Lao from Applied Biosystems provided the miRNA real-time RT-PCR detection reagents. J. A. T. is a founder of Cellular Dynamics International. He owns stock in the company and serves on its board of directors. K. S. K. owns stock in and serves on the board of Minerva Biotechnologies corporation.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gropp M, 2006, METHOD ENZYMOL, V420, P64, DOI 10.1016/S0076-6879(06)20005-3; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	48	885	950	3	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					647	658		10.1016/j.cell.2009.02.038	http://dx.doi.org/10.1016/j.cell.2009.02.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19409607	Bronze			2022-12-24	WOS:000266114100014
J	Anderson, T				Anderson, Tatum			Global Fund looks to boost private sector contributions	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1594	1594		10.1016/S0140-6736(09)60890-4	http://dx.doi.org/10.1016/S0140-6736(09)60890-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19437602				2022-12-24	WOS:000266066300014
J	Grant, MR; Jones, JDG				Grant, Murray R.; Jones, Jonathan D. G.			Hormone (Dis)harmony Moulds Plant Health and Disease	SCIENCE			English	Editorial Material							PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; ABSCISIC-ACID; DEFENSE RESPONSES; ARABIDOPSIS-THALIANA; BOTRYTIS-CINEREA; SIGNALING PATHWAY; ESCHERICHIA-COLI; JASMONATE; AUXIN	Diseased plants often display phenotypes consistent with hormone perturbations. We review recent data that have revealed roles in plant-microbe interactions for cellular components and signaling molecules that previously were associated only with hormone signaling. A better understanding of cross-talk between hormonal and defense signaling pathways should reveal new potential targets for microbial effectors that attenuate host resistance mechanisms.	[Jones, Jonathan D. G.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Grant, Murray R.] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Exeter	Jones, JDG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	jonathan.jones@tsl.ac.uk	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X	Biotechnology and Biological Sciences Research Council [BB/C514115/1, BB/E010334/1] Funding Source: Medline; BBSRC [BB/E010334/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABEL S, 1995, J BIOL CHEM, V270, P19093, DOI 10.1074/jbc.270.32.19093; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Christmann A, 2005, PLANT PHYSIOL, V137, P209, DOI 10.1104/pp.104.053082; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Inomata M, 2004, PHYTOCHEMISTRY, V65, P2667, DOI 10.1016/j.phytochem.2004.08.025; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaliff M, 2007, MOL PLANT MICROBE IN, V20, P335, DOI 10.1094/MPMI-20-4-0335; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tiryaki I, 2002, PLANT PHYSIOL, V130, P887, DOI 10.1104/pp.005272; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021	50	306	320	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					750	752		10.1126/science.1173771	http://dx.doi.org/10.1126/science.1173771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423816				2022-12-24	WOS:000265832400035
J	Wilson, JF				Wilson, Jennifer Fisher			Cancer Care: A Microcosm of the Problems Facing All of Health Care	ANNALS OF INTERNAL MEDICINE			English	News Item							LIFE; END; CHEMOTHERAPY; DEATH					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Avorn J, 2009, ANN INTERN MED, V150, P563, DOI 10.7326/0003-4819-150-8-200904210-00012; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; *MED PAYM ADV COMM, 2003, REP C VAR INN MED JU; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Miksad RA, 2007, J CLIN ONCOL, V25, P4506, DOI 10.1200/JCO.2007.13.0401; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; OGLESBY P, 1991, CARING PHYS LIFE FRA; Pollak KI, 2007, J CLIN ONCOL, V25, P5748, DOI 10.1200/JCO.2007.12.4180; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	13	8	8	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					573	576		10.7326/0003-4819-150-8-200904210-00024	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380865				2022-12-24	WOS:000265457000017
J	Doksani, Y; Bermejo, R; Fiorani, S; Haber, JE; Foiani, M				Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Haber, James E.; Foiani, Marco			Replicon Dynamics, Dormant Origin Firing, and Terminal Fork Integrity after Double-Strand Break Formation	CELL			English	Article							DNA-DAMAGE RESPONSE; STALLED REPLICATION FORKS; HUMAN-CELLS; CHECKPOINT ACTIVATION; GENOMIC INSTABILITY; CHROMOSOME-III; YEAST; ATR; COMPLEX; ARREST	In response to replication stress, the Mec1/ATR and SUMO pathways control stalled-and damaged-fork stability. We investigated the S phase response at forks encountering a broken template (termed the terminal fork). We show that double-strand break (DSB) formation can locally trigger dormant origin firing. Irreversible fork resolution at the break does not impede progression of the other fork in the same replicon (termed the sister fork). The Mre11-Tel1/ATM response acts at terminal forks, preventing accumulation of cruciform DNA intermediates that tether sister chromatids and can undergo nucleolytic processing. We conclude that sister forks can be uncoupled during replication and that, after DSB-induced fork termination, replication is rescued by dormant origin firing or adjacent replicons. We have uncovered a Tel1/ATM- and Mre11-dependent response controlling terminal fork integrity. Our findings have implications for those genome instability syndromes that accumulate DNA breaks during S phase and for forks encountering eroding telomeres.	[Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, I-20139 Milan, Italy; [Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy; [Haber, James E.] Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02254 USA; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; Brandeis University; Brandeis University	Foiani, M (corresponding author), Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, Via Adamello 16, I-20139 Milan, Italy.	marco.foiani@ifom-ieo-campus.it	Bermejo, Rodrigo/K-6613-2014; Bermejo, Rodrigo/AAG-7830-2019; Foiani, Marco/M-8234-2014; Bermejo, Rodrigo/S-2445-2019	Bermejo, Rodrigo/0000-0002-2692-7045; Foiani, Marco/0000-0003-4795-834X; Doksani, Ylli/0000-0002-2392-5722; Haber, James/0000-0002-1878-0610	Italian Association for Cancer Research; Telethon-Italy; European Community; Italian Ministry of Health; Regione Lombardia; National Institutes of Health [GM20056, 61766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R01GM020056, R01GM061766, R37GM020056] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); European Community(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank D. Branzei, F. d'Adda di Fagagna, A. Pellicioli, D. Sherratt, and all members of our laboratories for helpful comments and F. Vanoli for technical suggestions. We are grateful to D. Agostini, E. Nezi, and R. Zonda for artwork. Work in the M. F. laboratory is supported by grants from Italian Association for Cancer Research, Telethon-Italy, European Community, Italian Ministry of Health, and Regione Lombardia. Work in the J.E.H. laboratory is supported by National Institutes of Health grants GM20056 and 61766.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1993, SCIENCE, V262, P1728, DOI 10.1126/science.8259517; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; Grenon M, 2006, FEMS YEAST RES, V6, P836, DOI 10.1111/j.1567-1364.2006.00076.x; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaplun L, 2000, P NATL ACAD SCI USA, V97, P10077, DOI 10.1073/pnas.97.18.10077; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOSTRIKEN R, 1984, COLD SPRING HARB SYM, V49, P89, DOI 10.1101/SQB.1984.049.01.012; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marheineke K, 2005, NUCLEIC ACIDS RES, V33, P6931, DOI 10.1093/nar/gki994; Moreau S, 2001, GENETICS, V159, P1423; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RAGHURAMAN MK, 1994, GENE DEV, V8, P554, DOI 10.1101/gad.8.5.554; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	93	81	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					247	258		10.1016/j.cell.2009.02.016	http://dx.doi.org/10.1016/j.cell.2009.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19361851	Green Accepted, Bronze			2022-12-24	WOS:000265456800018
J	Koehn, EM; Fleischmann, T; Conrad, JA; Palfey, BA; Lesley, SA; Mathews, II; Kohen, A				Koehn, Eric M.; Fleischmann, Todd; Conrad, John A.; Palfey, Bruce A.; Lesley, Scott A.; Mathews, Irimpan I.; Kohen, Amnon			An unusual mechanism of thymidylate biosynthesis in organisms containing the thyX gene	NATURE			English	Article							CATALYTIC MECHANISM; ESCHERICHIA-COLI; ACTIVE-SITE; SYNTHASE-X; FLAVIN; ENZYME; DNA	Biosynthesis of the DNA base thymine depends on activity of the enzyme thymidylate synthase to catalyse the methylation of the uracil moiety of 2'-deoxyuridine-5'-monophosphate. All known thymidylate synthases rely on an active site residue of the enzyme to activate 2'-deoxyuridine-5'-monophosphate(1,2). This functionality has been demonstrated for classical thymidylate synthases, including human thymidylate synthase, and is instrumental in mechanism-based inhibition of these enzymes. Here we report an example of thymidylate biosynthesis that occurs without an enzymatic nucleophile. This unusual biosynthetic pathway occurs in organisms containing the thyX gene, which codes for a flavin-dependent thymidylate synthase (FDTS), and is present in several human pathogens(3-5). Our findings indicate that the putative active site nucleophile is not required for FDTS catalysis, and no alternative nucleophilic residues capable of serving this function can be identified. Instead, our findings suggest that a hydride equivalent (that is, a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring, followed by an isomerization of the intermediate to form the product, 2'-deoxythymidine-5'-monophosphate. These observations indicate a very different chemical cascade than that of classical thymidylate synthases or any other known biological methylation. The findings and chemical mechanism proposed here, together with available structural data, suggest that selective inhibition of FDTSs, with little effect on human thymine biosynthesis, should be feasible. Because several human pathogens depend on FDTS for DNA biosynthesis, its unique mechanism makes it an attractive target for antibiotic drugs.	[Koehn, Eric M.; Fleischmann, Todd; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Conrad, John A.; Palfey, Bruce A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Joint Ctr Struct Genom, San Diego, CA 92121 USA; [Mathews, Irimpan I.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Iowa; University of Michigan System; University of Michigan; Novartis; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu		Palfey, Bruce/0000-0001-5098-259X; Koehn, Eric/0000-0001-8195-9595	NIH [R01 GM065368, R01 GM61087, GM08270]; NSF [CHE 0715448]; JCSG [U54GM074898]; DOE; OBER; NCRR; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM061087, U54GM074898, R01GM065368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); JCSG; DOE(United States Department of Energy (DOE)); OBER; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM065368 and NSF CHE 0715448 to A. K., the Iowa Center for Biocatalysis and Bioprocessing to E. M. K., NIH R01 GM61087 to B. A. P., NIH training grant GM08270 to J.A.C., and JCSG grant U54GM074898 to S. A. L. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of DOE, OBER. The SSRL Structural Molecular Biology Program is supported by DOE, OBER and by NIH, NCRR, Biomedical Technology Program and NIGMS.	Agrawal N, 2004, BIOCHEMISTRY-US, V43, P10295, DOI 10.1021/bi0490439; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Gattis SG, 2005, J AM CHEM SOC, V127, P832, DOI 10.1021/ja0432214; Graziani S, 2006, J BIOL CHEM, V281, P24048, DOI 10.1074/jbc.M600745200; Hong B, 2005, J LABELLED COMPD RAD, V48, P759, DOI 10.1002/jlcr.993; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Hyatt DC, 1997, BIOCHEMISTRY-US, V36, P4585, DOI 10.1021/bi962936j; KLOTZER W, 1973, MONATSH CHEM, V104, P415, DOI 10.1007/BF00903105; Leduc D, 2004, BIOCHEM SOC T, V32, P231, DOI 10.1042/BST0320231; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Sampathkumar P, 2005, J MOL BIOL, V352, P1091, DOI 10.1016/j.jmb.2005.07.071; Sundberg R, 2000, ADV ORGANIC CHEM; WALDMAN AS, 1983, J BIOL CHEM, V258, P1571; WATAYA Y, 1975, BIOCHEM BIOPH RES CO, V67, P818, DOI 10.1016/0006-291X(75)90886-4	24	65	66	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					919	U13		10.1038/nature07973	http://dx.doi.org/10.1038/nature07973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370033	Green Accepted			2022-12-24	WOS:000265182500049
J	Sakuno, T; Tada, K; Watanabe, Y				Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori			Kinetochore geometry defined by cohesion within the centromere	NATURE			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; FISSION YEAST CENTROMERE; 1ST MEIOTIC DIVISION; MEIOSIS-I; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; MONOPOLAR ATTACHMENT; SISTER KINETOCHORES; BI-ORIENTATION; BUDDING YEAST	During cell division microtubules capture chromosomes by binding to the kinetochore assembled in the centromeric region of chromosomes. In mitosis sister chromatids are captured by microtubules emanating from both spindle poles, a process called bipolar attachment, whereas in meiosis I sisters are attached to microtubules originating from one spindle pole, called monopolar attachment. For determining chromosome orientation, kinetochore geometry or structure might be an important target of regulation. However, the molecular basis of this regulation has remained elusive. Here we show the link between kinetochore orientation and cohesion within the centromere in fission yeast Schizosaccharomyces pombe by strategies developed to visualize the concealed cohesion within the centromere, and to introduce artificial tethers that can influence kinetochore geometry. Our data imply that cohesion at the core centromere induces the mono-orientation of kinetochores whereas cohesion at the peri-centromeric region promotes bi-orientation. Our study may reveal a general mechanism for the geometric regulation of kinetochores, which collaborates with previously defined tension-dependent reorientation machinery.	[Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo GRAD SCH SC, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Special Coordination Funds for Promoting Science and Technology; MEXT, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript. We thank H. Matsuzaki, A. Yamamoto, R. Allshire, K. Nasmyth and the Yeast Genetic Resource Center (YGRC) for yeast strains. We also thank all the members of our laboratory for their support and discussion, especially S. Yokobayashi for materials and assistance in the initial stage of this project. This work was supported in part by Special Coordination Funds for Promoting Science and Technology (to T. S.), the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan, and a Grant- in- Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. W.).	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee J, 2000, MOL REPROD DEV, V56, P51, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;51::AID-MRD7&gt;3.0.CO;2-N; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; OSTERGREN G, 1951, HEREDITAS, V37, P85; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamamoto A, 2008, J CELL BIOL, V182, P277, DOI 10.1083/jcb.200802053; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	50	127	127	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					852	U1		10.1038/nature07876	http://dx.doi.org/10.1038/nature07876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370027				2022-12-24	WOS:000265182500035
J	Christakis, NA				Christakis, Nicholas A.			Observations Only Connect The anthroposphere is changing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2009	338								b1534	10.1136/bmj.b1534	http://dx.doi.org/10.1136/bmj.b1534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369280				2022-12-24	WOS:000265296700006
J	Eichler, HG; Abadie, E; Raine, JM; Salmonson, T				Eichler, Hans-Georg; Abadie, Eric; Raine, June M.; Salmonson, Tomas			Safe Drugs and the Cost of Good Intentions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eichler, Hans-Georg; Abadie, Eric] EMEA, Comm Med Prod Human Use CHMP, London, England; [Abadie, Eric] Agence Francaise Secur Sanitaire Prod Sante, St Denis, France; [Raine, June M.] Med Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London, England; [Salmonson, Tomas] Lakemedelsverket Med Prod Agcy, Uppsala, Sweden	The Medicines & Healthcare Products Regulatory Agency; Medical Products Agency	Eichler, HG (corresponding author), EMEA, Comm Med Prod Human Use CHMP, London, England.							Calfee J., 2006, REPRESENTATIVE SURVE; FISCHHOFF B, OXFORD TXB IN PRESS; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Thompson JP, 2008, NEUROLOGY, V71, P357, DOI 10.1212/01.wnl.0000319648.65173.7a; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067	5	50	50	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1378	1380		10.1056/NEJMp0900092	http://dx.doi.org/10.1056/NEJMp0900092			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339718				2022-12-24	WOS:000264751800002
J	Pan, DN; Fujimoto, M; Lopes, A; Wang, YX				Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu			Twist-1 Is a PPAR delta-Inducible, Negative-Feedback Regulator of PGC-1 alpha in Brown Fat Metabolism	CELL			English	Article							ACTIVATED RECEPTOR-DELTA; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; ADAPTIVE THERMOGENESIS; GAMMA COACTIVATOR-1; UNCOUPLING PROTEIN; INSULIN-RESISTANCE; GENE-EXPRESSION; ADULT HUMANS; ERR-ALPHA	Brown fat is specialized for energy expenditure, a process that is principally controlled by the transcriptional coactivator PGC-1 alpha. Here, we describe a molecular network important for PGC-1 alpha function and brown fat metabolism. We find that twist-1 is selectively expressed in adipose tissue, interacts with PGC-1 alpha, and is recruited to the promoters of PGC-1 alpha's target genes to suppress mitochondrial metabolism and uncoupling. In vivo, transgenic mice expressing twist-1 in the adipose tissue are prone to high-fat-diet-induced obesity, whereas twist-1 heterozygous knockout mice are obesity resistant. These phenotypes are attributed to their altered mitochondrial metabolism in the brown fat. Interestingly, the nuclear receptor PPAR delta not only mediates the actions of PGC-1 alpha but also regulates twist-1 expression, suggesting a negative-feedback regulatory mechanism. These findings reveal an unexpected physiological role for twist-1 in the maintenance of energy homeostasis and have important implications for understanding metabolic control and metabolic diseases.	[Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Wang, YX (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	yongxu.wang@umassmed.edu	Pan, Dongning/P-6523-2019	Pan, Dongning/0000-0001-5463-8155	American Diabetes Association; Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R56DK076118, R01DK076118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076118, R56DK076118] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Michael Green, Michael Czech, and Silvia Corvera for insightful comments on this work; Drs. Ron Evans, Marc Montminy, Heonjoong Kang, and Brian Lewis for reagents; Drs. Hong-Ping Guan, Yasuyuki Okawa, and Claude Gazin for help on CHIP assays; Dr. Greg Hendricks and Tracy Levin for electron microscopy; Alison Burkart for help on oxygen consumption, Drs. Matthew Paul and Robert Dallmann for help on the use of iButtons; and Sue Wheeler, Heidi Chandler, and Dr. Denice Godfrey for animal surgery. These studies were funded by grants from the American Diabetes Association, the Smith Family Foundation, and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R56DK076118 and R01DK076118).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; GARRUTI G, 1992, INT J OBESITY, V16, P383; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang XJ, 2005, MOL CELL ENDOCRINOL, V238, P1, DOI 10.1016/j.mce.2005.04.009; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	50	167	174	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					73	86		10.1016/j.cell.2009.01.051	http://dx.doi.org/10.1016/j.cell.2009.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345188	Green Accepted, Bronze			2022-12-24	WOS:000264813300015
J	Teis, D; Saksena, S; Emr, SD				Teis, David; Saksena, Suraj; Emr, Scott D.			SnapShot: The ESCRT Machinery	CELL			English	Editorial Material							III COMPLEX		[Teis, David; Saksena, Suraj; Emr, Scott D.] Cornell Univ, Ithaca, NY 14853 USA; [Teis, David] Innsbruck Med Univ, Innsbruck, Austria	Cornell University; Medical University of Innsbruck	Teis, D (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.			Teis, David/0000-0002-8181-0253	HFSP [LT00634/2006-L]; American Heart Association [AHA 0826060D]; Weill Institute for Cell and Molecular Biology	HFSP(Human Frontier Science Program); American Heart Association(American Heart Association); Weill Institute for Cell and Molecular Biology	D.T. is funded by HFSP (LT00634/2006-L). S.S. is supported by a fellowship of the American Heart Association (AHA 0826060D). We are grateful to E.V. MacGurn for assistance with graphics. S.D.E. is supported by funds from the Weill Institute for Cell and Molecular Biology. We also thank Z. Yu and G. Jensen for providing the image of the Vps/Vta1 complex.	Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	10	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1							182.e1	10.1016/j.cell.2009.03.027	http://dx.doi.org/10.1016/j.cell.2009.03.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345195	Bronze			2022-12-24	WOS:000264813300024
J	Guerrini, I; Jackson, S; Keaney, F				Guerrini, Irene; Jackson, Siobhan; Keaney, Francis			Practice Pregnancy Plus Pregnancy and alcohol misuse	BRITISH MEDICAL JOURNAL			English	Article							BRIEF INTERVENTION; YOUNG-WOMEN; BRAIN; WITHDRAWAL; RISK		[Guerrini, Irene] S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England; [Jackson, Siobhan] S London & Maudsley NHS Fdn Trust, Queen Elizabeth Hosp Woolwich, Greenwich & Antenatal Clin, Beresford Project, London SE18 6LZ, England; [Keaney, Francis] Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Fdn Trust, London SE5 8AZ, England	South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; University of London; King's College London	Guerrini, I (corresponding author), S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England.	irene.guerrini@slam.nhs.uk						Chang G, 2005, OBSTET GYNECOL, V105, P991, DOI 10.1097/01.AOG.0000157109.05453.84; Chang G, 2001, ALCOHOL RES HEALTH, V25, P204; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Department of Health, 2007, UPD ALC ADV PREGN WO; Gilmore IT, 2008, BRIT MED J, V336, P952, DOI 10.1136/bmj.39520.716863.94; Goransson M, 2003, ADDICTION, V98, P1513, DOI 10.1046/j.1360-0443.2003.00498.x; Guerrini I, 2007, NEUROSCI BIOBEHAV R, V31, P212, DOI 10.1016/j.neubiorev.2006.06.022; HENDERSON J, 2006, BJOG, V114, P243; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Myrick H, 1998, ALCOHOL HEALTH RES W, V22, P38; *NAT I HLTH CLIN E, 2005, PREV RED ALC MIS ED; *NAT TREATM AG SUB, 2006, REV EFF TREATM ALC P; *NAT TREATM AG SUB, 2007, GUID CLIN MAN DRUG M; National Institute for Health and Clincial Excellence, 2008, ANT CAR; NORA AH, 1977, LANCET, V2, P664; O'Connor MJ, 2007, AM J PUBLIC HEALTH, V97, P252, DOI 10.2105/AJPH.2005.077222; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; *ROYAL COLL OBST G, 2006, RCOG STAT, V5; RUSSELL M, 1988, ALCOHOL CLIN EXP RES, V12, P824, DOI 10.1111/j.1530-0277.1988.tb01354.x; Thomas JD, 1998, ALCOHOL HEALTH RES W, V22, P47; *US DEP HLTH, TIP SER US DEP HLTH, V2; *WHO, 2001, BRIEF INT HAZ HARMF; Young C, 2006, NEUROBIOL DIS, V22, P548, DOI 10.1016/j.nbd.2005.12.015	24	1	1	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 30	2009	338								b845	10.1136/bmj.b845	http://dx.doi.org/10.1136/bmj.b845			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AK	19332453				2022-12-24	WOS:000264893000012
J	Li, QS; Skinner, PJ; Ha, SJ; Duan, LJ; Mattila, TL; Hage, A; White, C; Barber, DL; O'Mara, L; Southern, PJ; Reilly, CS; Carlis, JV; Miller, CJ; Ahmed, R; Haase, AT				Li, Qingsheng; Skinner, Pamela J.; Ha, Sang-Jun; Duan, Lijie; Mattila, Teresa L.; Hage, Aaron; White, Cara; Barber, Daniel L.; O'Mara, Leigh; Southern, Peter J.; Reilly, Cavan S.; Carlis, John V.; Miller, Christopher J.; Ahmed, Rafi; Haase, Ashley T.			Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; CD8(+) T-CELLS; SIV INFECTION; PERSISTENCE; TRANSMISSION; GLYCOPROTEIN; REPLICATION; RESPONSES; EPITOPES	In the early stages of viral infection, outcomes depend on a race between expansion of infection and the immune response generated to contain it. We combined in situ tetramer staining with in situ hybridization to visualize, map, and quantify relationships between immune effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the establishment of an excess of effector cells versus targets were found to correlate with the extent of control and the infection outcome (i.e., control and clearance versus partial or poor control and persistent infection). This method highlights the importance of the location, timing, and magnitude of the immune response needed for a vaccine to be effective against agents of persistent infection, such as HIV-1.	[Li, Qingsheng; Duan, Lijie; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Skinner, Pamela J.; Mattila, Teresa L.; Hage, Aaron; White, Cara] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Ha, Sang-Jun; O'Mara, Leigh; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Barber, Daniel L.] NIAID, Immunobiol Sect, Bethesda, MD 20892 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Ctr Comparat Med, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	haase001@umn.edu	Barber, Daniel L./V-1190-2019	Skinner, Pamela/0000-0003-3388-1687; Ha, Sang-Jun/0000-0002-1192-6031	NIH [AI48484, AI20048, AI066314]; National Center for Research Resources [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314, R01AI048484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Immunology Core Laboratory and Primate Services Unit of the California National Primate Research Center (CNPRC); D. Lu, T. Rourke, R. Dizon, and B. Vang for technical assistance; J. Sedgewick for assistance in setting up the confocal microscope to capture images of silver grains; D. Masopust for helpful discussion; and C. O'Neill and T. Leonard for help in preparing the manuscript and figures. Supported in part by NIH research grants AI48484 (A.T.H.), AI20048 (R.A.), and AI066314 (C.J.M.); National Center for Research Resources grant RR00169 (CNPRC, University of California, Davis); and a gift from the James B. Pendleton Charitable Trust (C.J.M.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; Doherty PC, 1998, SCIENCE, V280, P227, DOI 10.1126/science.280.5361.227; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	18	155	169	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1726	1729		10.1126/science.1168676	http://dx.doi.org/10.1126/science.1168676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325114	Green Submitted, Green Accepted			2022-12-24	WOS:000264559800039
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The papal position on condoms and HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 25	2009	338								b1217	10.1136/bmj.b1217	http://dx.doi.org/10.1136/bmj.b1217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LQ	19321547				2022-12-24	WOS:000264639600004
J	Daley, AC; Budd, GE; Caron, JB; Edgecombe, GD; Collins, D				Daley, Allison C.; Budd, Graham E.; Caron, Jean-Bernard; Edgecombe, Gregory D.; Collins, Desmond			The Burgess Shale Anomalocaridid Hurdia and Its Significance for Early Euarthropod Evolution	SCIENCE			English	Article							GREAT-APPENDAGE ARTHROPOD; OPABINIA; FAUNA	As the largest predators of the Cambrian seas, the anomalocaridids had an important impact in structuring the first complex marine animal communities, but many aspects of morphology, diversity, ecology, and affinity remain unclear owing to a paucity of specimens. Here we describe the anomalocaridid Hurdia, based on several hundred specimens from the Burgess Shale in Canada. Hurdia possesses a general body architecture similar to those of Anomalocaris and Laggania, including the presence of exceptionally well-preserved gills, but differs from those anomalocaridids by possessing a prominent anterior carapace structure. These features amplify and clarify the diversity of known anomalocaridid morphology and provide insight into the origins of important arthropod features, such as the head shield and respiratory exites.	[Daley, Allison C.; Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Uppsala University; Royal Ontario Museum; Natural History Museum London	Daley, AC (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	allison.daley@geo.uu.se	Daley, Allison/A-3117-2015	Daley, Allison/0000-0001-5369-5879; Caron, Jean-Bernard/0000-0002-1670-5502; Edgecombe, Gregory/0000-0002-9591-8011	European Union Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]; Swedish Research Council (Vetenskapsradet)	European Union Marie Curie Research Training Network ZOONET(European Commission); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	We thank J. Bergstrom for discussion. Comments from D. E. G. Briggs, B. S. Lieberman, and anonymous reviewers improved the manuscript. J. Dougherty and F. Collier provided access to specimens at GSC and MCZ, respectively, and D. Erwin and J. Thompson provided access to specimens at NMNH. Permission to collect Burgess Shale specimens was given by Parks Canada to D.C. Funding was provided by European Union Marie Curie Research Training Network ZOONET (grant MRTN-CT-2004-005624) to G.E.B. and A.C.D. and the Swedish Research Council (Vetenskapsradet) to G.E.B. This is ROM Burgess Shale Project number 8.	BERGSTROM J, 1987, LETHAIA, V20, P187, DOI 10.1111/j.1502-3931.1987.tb00777.x; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Briggs D.E.G., 1979, Palaeontology (Oxford), V22, P631; Briggs DEG, 2008, J PALEONTOL, V82, P238, DOI 10.1666/06-086.1; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; CHLUPAC I, 2002, B CZECH GEOLOGICAL S, V77, P167; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; COLLINS D, 1999, ROTUNDA, V32, P25; COLLINS D, 1992, PALEONTOLOGICAL SOC, V6, P66; CUI Z, 1990, ACTA PALAEONTOL SIN, V29, P328; Dewel R.A., 1998, Systematics Association Special Volume Series, V55, P109; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou XG, 2006, GEOL J, V41, P259, DOI 10.1002/gj.1050; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Lieberman BS, 2003, J PALEONTOL, V77, P674, DOI 10.1017/S0022336000044413; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; ROLFE W. D. IAN, 1962, BREVIORA MUS COMP ZOOL [HARVARD], V160, P1; Simonetta A.M, 1975, Palaeontographia Italica, V69, P1; Walcott Charles D., 1912, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles D., 1911, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Whiteaves J. F., 1892, CANADIAN RECORD SCI, V5, P205; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Wolff C, 2008, P ROY SOC B-BIOL SCI, V275, P1023, DOI 10.1098/rspb.2007.1327; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	30	138	138	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1597	1600		10.1126/science.1169514	http://dx.doi.org/10.1126/science.1169514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299617				2022-12-24	WOS:000264342300036
J	Koder, RL; Anderson, JLR; Solomon, LA; Reddy, KS; Moser, CC; Dutton, PL				Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie			Design and engineering of an O-2 transport protein	NATURE			English	Article							CYTOCHROME-C-OXIDASE; HEME-PROTEINS; LIGAND-BINDING; COMPUTATIONAL DESIGN; ELECTRON-TRANSFER; ENZYME CATALYSIS; 4-HELIX BUNDLE; HEMOGLOBIN; MAQUETTE; MECHANISM	The principles of natural protein engineering are obscured by overlapping functions and complexity accumulated through natural selection and evolution. Completely artificial proteins offer a clean slate on which to define and test these protein engineering principles, while recreating and extending natural functions. Here we introduce this method with the design of an oxygen transport protein, akin to human neuroglobin. Beginning with a simple and unnatural helix-forming sequence with just three different amino acids, we assembled a four-helix bundle, positioned histidines to bis-histidine ligate haems, and exploited helical rotation and glutamate burial on haem binding to introduce distal histidine strain and facilitate O-2 binding. For stable oxygen binding without haem oxidation, water is excluded by simple packing of the protein interior and loops that reduce helical-interface mobility. O-2 affinities and exchange timescales match natural globins with distal histidines, with the remarkable exception that O-2 binds tighter than CO.	[Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu	Koder, Ronald L/A-6089-2008; Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Anderson, Ross/0000-0002-6796-0482; Koder, Ronald/0000-0003-0868-4972; Solomon, Lee/0000-0003-1471-9510	US Department of Energy; US National Institute of Health; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. J. Wand for assistance in NMR measurements, P. R. Rich for FTIR measurements, M. S. Hargrove for neuroglobin reference spectra and discussions, and D. Hilvert for suggestions. This work was supported by grants from US Department of Energy, US National Institute of Health and US National Science Foundation as detailed in Supplementary Information.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Borovik AS, 2005, ACCOUNTS CHEM RES, V38, P54, DOI 10.1021/ar030160q; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; CHANCE B, 1975, P NATL ACAD SCI USA, V72, P1635, DOI 10.1073/pnas.72.4.1635; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Collman JP, 2004, CHEM REV, V104, P561, DOI 10.1021/cr0206059; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Gibney BR, 1999, J AM CHEM SOC, V121, P4952, DOI 10.1021/ja9833117; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Goldberg DE, 1999, CHEM REV, V99, P3371, DOI 10.1021/cr970152l; Grosset AM, 2001, BIOCHEMISTRY-US, V40, P5474, DOI 10.1021/bi002504f; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Huang SS, 2003, J MOL BIOL, V326, P1219, DOI 10.1016/S0022-2836(02)01441-9; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2006, J AM CHEM SOC, V128, P14450, DOI 10.1021/ja064883r; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Marshall SA, 2001, J MOL BIOL, V305, P619, DOI 10.1006/jmbi.2000.4319; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MCLENDON G, 1991, STRUCT BOND, V75, P159; Moffet DA, 2001, J AM CHEM SOC, V123, P2109, DOI 10.1021/ja0036007; Moffet DA, 2000, J AM CHEM SOC, V122, P7612, DOI 10.1021/ja001198q; Monien BH, 2007, J MOL BIOL, V371, P739, DOI 10.1016/j.jmb.2007.05.047; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SHARMA VS, 1976, J BIOL CHEM, V251, P4267; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; SMITH KM, 1986, J ORG CHEM, V51, P666, DOI 10.1021/jo00355a016; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; WANG JH, 1958, J AM CHEM SOC, V80, P3168, DOI 10.1021/ja01545a072; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; Zhuang JY, 2004, INORG CHEM, V43, P8218, DOI 10.1021/ic048502r	54	184	195	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					305	U64		10.1038/nature07841	http://dx.doi.org/10.1038/nature07841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295603	Green Accepted			2022-12-24	WOS:000264285600034
J	West, JB				West, John B.			Arterial blood measurements in climbers on Mount Everest	LANCET			English	Editorial Material							EXTREME ALTITUDE; GAS-EXCHANGE		Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jwest@ucsd.edu						Catron Thomas F, 2006, BMC Physiol, V6, P3, DOI 10.1186/1472-6793-6-3; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Peacock AJ, 1997, EUR RESPIR J, V10, P1439, DOI 10.1183/09031936.97.10071439; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; WEST JB, 1983, J APPL PHYSIOL, V55, P678, DOI 10.1152/jappl.1983.55.3.678; West John B., 1998, HIGH LIFE HIST HIGH; WINSLOW RM, 1984, J APPL PHYSIOL, V56, P109, DOI 10.1152/jappl.1984.56.1.109	8	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1589	1590		10.1016/S0140-6736(09)60888-6	http://dx.doi.org/10.1016/S0140-6736(09)60888-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427943				2022-12-24	WOS:000266066300010
J	Korb, J; Weil, T; Hoffmann, K; Foster, KR; Rehli, M				Korb, Judith; Weil, Tobias; Hoffmann, Katharina; Foster, Kevin R.; Rehli, Michael			A Gene Necessary for Reproductive Suppression in Termites	SCIENCE			English	Article							DIVISION-OF-LABOR		[Korb, Judith; Hoffmann, Katharina] Univ Osnabruck, D-49076 Osnabruck, Germany; [Korb, Judith; Weil, Tobias] Univ Regensburg, D-93040 Regensburg, Germany; [Weil, Tobias; Rehli, Michael] Univ Hosp Regensburg, Dept Hematol, D-93042 Regensburg, Germany; [Foster, Kevin R.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA	University Osnabruck; University of Regensburg; University of Regensburg; Harvard University	Korb, J (corresponding author), Univ Osnabruck, Barbarastr 11, D-49076 Osnabruck, Germany.	judith.korb@biologie.uni-osnabrueck.de; weil.tobias@web.de	Rehli, Michael/E-9093-2011	Rehli, Michael/0000-0003-3992-932X; Foster, Kevin/0000-0003-4687-6633	Deutsche Forschungsgemeinschaft (DFG) [KO1895/6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank S. Schneuwly and J. Landskron for micromanipulator help and K. Merches and K. Borner for laboratory support. Supported by a Deutsche Forschungsgemeinschaft (DFG) grant to J.K. and M.R. (KO1895/6).	Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Cornette R, 2003, BIOCHEM J, V372, P535, DOI 10.1042/BJ20030025; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Plettner E, 1996, SCIENCE, V271, P1851, DOI 10.1126/science.271.5257.1851; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Terra W. R., 1996, P153; Weil T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-198	8	82	83	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					758	758		10.1126/science.1170660	http://dx.doi.org/10.1126/science.1170660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423819				2022-12-24	WOS:000265832400038
J	Adams, GB; Alley, IR; Chung, U; Chabner, KT; Jeanson, NT; Lo Celso, C; Marsters, ES; Chen, M; Weinstein, LS; Lin, CP; Kronenberg, HM; Scadden, DT				Adams, Gregor B.; Alley, Ian R.; Chung, Ung-il; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Chen, Min; Weinstein, Lee S.; Lin, Charles P.; Kronenberg, Henry M.; Scadden, David T.			Haematopoietic stem cells depend on G alpha(s)-mediated signalling to engraft bone marrow	NATURE			English	Article							IN-VIVO; CHOLERA-TOXIN; MICE; DIFFERENTIATION; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; SELECTINS; CXCR4	Haematopoietic stem and progenitor cells (HSPCs) change location during development(1) and circulate in mammals throughout life(2), moving into and out of the bloodstream to engage bone marrow niches in sequential steps of homing, engraftment and retention(3-5). Here we show that HSPC engraftment of bone marrow in fetal development is dependent on the guanine-nucleotide-binding protein stimulatory a subunit (G alpha(s)). HSPCs from adult mice deficient in G alpha(s) (G alpha(-/-)(s)) differentiate and undergo chemotaxis, but also do not home to or engraft in the bone marrow in adult mice and demonstrate a marked inability to engage the marrow microvasculature. If deleted after engraftment, G alpha(s) deficiency did not lead to lack of retention in the marrow, rather cytokine-induced mobilization into the blood was impaired. Testing whether activation of G alpha(s) affects HSPCs, pharmacological activators enhanced homing and engraftment in vivo. G alpha(s) governs specific aspects of HSPC localization under physiological conditions in vivo and may be pharmacologically targeted to improve transplantation efficiency.	[Adams, Gregor B.; Alley, Ian R.; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Scadden, David T.] Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Chung, Ung-il; Kronenberg, Henry M.] Harvard Univ, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Adams, Gregor B.; Lo Celso, Cristina; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Chen, Min; Weinstein, Lee S.] NIDDKD, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu	Weinstein, Lee S/I-5575-2015	Weinstein, Lee/0000-0002-1899-5152; Lo Celso, Cristina/0000-0002-1163-4207	Burroughs Wellcome Fund, Doris Duke Charitable Trust; Harvard Stem Cell Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Burroughs Wellcome Fund, Doris Duke Charitable Trust(Burroughs Wellcome FundDoris Duke Charitable Foundation (DDCF)); Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for this work was provided by the Burroughs Wellcome Fund, Doris Duke Charitable Trust (D. T. S.), the Harvard Stem Cell Institute (C. P. L.) and the National Institutes of Health (G. B. A., C. P. L., H. M. K., D. T. S.).	Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DEXTER TM, 1985, BLOOD, V65, P1544, DOI 10.1182/blood.V65.6.1544.bloodjournal6561544; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; LONG MW, 1988, EXP HEMATOL, V16, P195; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	21	53	59	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 7	2009	459	7243					103	U111		10.1038/nature07859	http://dx.doi.org/10.1038/nature07859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19322176	Green Accepted			2022-12-24	WOS:000265801300038
J	Srivastava, R				Srivastava, Ranjana			Denial	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1174	1177		10.1056/NEJMp0809399	http://dx.doi.org/10.1056/NEJMp0809399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	420IU	19297570				2022-12-24	WOS:000264283400003
J	Pollock, JD; Koustova, E; Hoffman, A; Shurtleff, D; Volkow, ND				Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.			Treatments for nicotine addiction should be a top priority	LANCET			English	Editorial Material									[Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.] NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Pollock, JD (corresponding author), NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA.	jpollock@mail.nih.gov	Pollock, Jonathan D/B-1554-2009		Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; *CDCP, 1965, SMOK TOB US PERC AD; *INF HEALTHC, 2007, THER AN PHARM R D AN; Richard JBonnie, 2007, ENDING TOBACCO PROBL; SACHS DP, 2008, CHEST, V134; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	8	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					513	514		10.1016/S0140-6736(09)60352-4	http://dx.doi.org/10.1016/S0140-6736(09)60352-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19394686	Green Accepted			2022-12-24	WOS:000269019400010
J	Ziegler, AD; Fox, JM; Xu, JC				Ziegler, Alan D.; Fox, Jefferson M.; Xu, Jianchu			The Rubber Juggernaut	SCIENCE			English	Editorial Material							FOREST		[Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore; [Fox, Jefferson M.] East West Ctr, Honolulu, HI 96848 USA; [Xu, Jianchu] Kunming Inst Bot, World Agroforestry Ctr, Kunming, Peoples R China	National University of Singapore; East West Center; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ziegler, AD (corresponding author), Natl Univ Singapore, Dept Geog, Singapore 117570, Singapore.	adz@nus.edu.sg	Xu, Jianchu/Y-2890-2019; , dr dr/AAA-5406-2022; ZIEGLER, ALAN/A-5463-2012	ZIEGLER, ALAN/0000-0001-5305-2136; Fox, Jefferson/0000-0002-0508-654X				Cyranoski D, 2008, NATURE, V451, P871, DOI 10.1038/451871a; Douglas I, 2006, GEOGR RES-AUST, V44, P123, DOI 10.1111/j.1745-5871.2006.00373.x; Forsyth Tim, 2008, FOREST GUARDIANS FOR; Fox J, 2000, BIOSCIENCE, V50, P521, DOI 10.1641/0006-3568(2000)050[0521:SCANOP]2.0.CO;2; Guardiola-Claramonte M, 2008, ECOHYDROLOGY, V1, P13, DOI 10.1002/eco.3; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Manivong V, 2008, AGROFOREST SYST, V74, P113, DOI 10.1007/s10457-008-9136-3; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Qiu J, 2009, NATURE, V457, P246, DOI 10.1038/457246a; Schmidt-Vogt D., 2001, Journal of Tropical Forest Science, V13, P748; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019	14	297	329	9	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1024	1025		10.1126/science.1173833	http://dx.doi.org/10.1126/science.1173833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460994				2022-12-24	WOS:000266246700027
J	Detsky, AS				Detsky, Allan S.			My Father's Voice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												adetsky@mtsinai.on.ca							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					1968	1969		10.1001/jama.2009.601	http://dx.doi.org/10.1001/jama.2009.601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454627				2022-12-24	WOS:000266159600001
J	Brownell, KD; Frieden, TR				Brownell, Kelly D.; Frieden, Thomas R.			Ounces of Prevention - The Public Policy Case for Taxes on Sugared Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; CONSUMPTION		[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA	Yale University	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.			Frieden, Thomas/0000-0002-4759-2256				Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Nielson SJ, 2005, AM J PREV MED, V28, P413, DOI 10.1016/j.amepre.2005.03.007; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; 2008, BEVERAGE DIGEST 1121, P3	6	303	309	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1805	1808		10.1056/NEJMp0902392	http://dx.doi.org/10.1056/NEJMp0902392			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19357400	Bronze			2022-12-24	WOS:000265560300001
J	Gupta, A; Urquhart, DS; Donovan, S; Bush, A				Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew			Picture quiz A 4 year old boy with recurrent wheeze and chest infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NORTH-AMERICAN-SOCIETY; GASTROESOPHAGEAL-REFLUX; PEDIATRIC-GASTROENTEROLOGY; INFANTS; CHILDREN; PREVALENCE; DIAGNOSIS; ASTHMA		[Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England	Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 1992, J PEDIAT GASTROENTER, V14, P467; BLACK DD, 1990, GASTROENTEROLOGY, V98, P1408, DOI 10.1016/0016-5085(90)91069-I; BUTS JP, 1986, EUR J PEDIATR, V145, P396, DOI 10.1007/BF00439246; Chang AB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004823.pub3; CHEN PH, 1991, J PEDIATR GASTR NUTR, V13, P16, DOI 10.1097/00005176-199107000-00003; Chernick V, 2006, KENDIGS DISORDERS RE; COLLETTI RB, 1995, J PEDIATR GASTR NUTR, V21, P253, DOI 10.1097/00005176-199510000-00002; CUCCHIARA S, 1990, GUT, V31, P129, DOI 10.1136/gut.31.2.129; Dhillon AS, 2004, ACTA PAEDIATR, V93, P88, DOI 10.1080/08035250310007934; EKSTROM T, 1989, THORAX, V44, P19, DOI 10.1136/thx.44.1.19; EULER AR, 1981, GASTROENTEROLOGY, V80, P957; Gibson PG, 2003, COCHRANE DATABASE SY, pCD001496, DOI DOI 10.1002/14651858.CD001496; Keady S, 2007, ARCH DIS CHILDHOOD-E, V92, pEP114, DOI 10.1136/adc.2006.106328; Little JP, 1997, ANN OTO RHINOL LARYN, V106, P1; Lopez-Alonso M, 2006, PEDIATRICS, V118, pE299, DOI 10.1542/peds.2005-3140; Mahajan L, 1998, PEDIATRICS, V101, P260, DOI 10.1542/peds.101.2.260; MALFROOT A, 1987, PEDIATR PULM, V3, P208, DOI 10.1002/ppul.1950030403; Mattioli G, 2006, DIGEST DIS SCI, V51, P2341, DOI 10.1007/s10620-006-9374-z; McGovern MC, 2004, ARCH DIS CHILD, V89, P1043, DOI 10.1136/adc.2003.031740; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Sifrim D, 2008, DIGEST LIVER DIS, V40, P161, DOI 10.1016/j.dld.2007.10.023; Tighe MP, 2009, ARCH DIS CHILDHOOD-E, V94, P18, DOI 10.1136/adc.2008.145169; TOLIA V, 1990, J PEDIATR GASTR NUTR, V10, P426, DOI 10.1097/00005176-199005000-00002; TUCCI F, 1993, J PEDIATR GASTR NUTR, V17, P265, DOI 10.1097/00005176-199310000-00006; Washington N, 1999, ARCH DIS CHILD, V81, P309, DOI 10.1136/adc.81.4.309	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2009	338								b1255	10.1136/bmj.b1255	http://dx.doi.org/10.1136/bmj.b1255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JW	19403569				2022-12-24	WOS:000265697600002
J	Lee, GM; Craik, CS				Lee, Gregory M.; Craik, Charles S.			Trapping Moving Targets with Small Molecules	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; HIGH-AFFINITY LIGANDS; NMR-SPECTROSCOPY; ALLOSTERIC REGULATION; BINDING MODES; IN-VITRO; DYNAMICS; ANTAGONISTS; INHIBITORS; MECHANISM	Structure-based drug design traditionally uses static protein models as inspirations for focusing on "active" site targets. Allosteric regulation of biological macromolecules, however, is affected by both conformational and dynamic properties of the protein or protein complex and can potentially lead to more avenues for therapeutic development. We discuss the advantages of searching for molecules that conformationally trap a macromolecule in its inactive state. Although multiple methodologies exist to probe protein dynamics and ligand binding, our current discussion highlights the use of nuclear magnetic resonance spectroscopy in the drug discovery and design process.	[Lee, Gregory M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St,Box 2280, San Francisco, CA 94158 USA.	craik@cgl.ucsf.edu			NIH [1R01A1067423]; HIV Accessory and Regulatory Complex Center [P50 GM082250]; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067423, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Accessory and Regulatory Complex Center; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from the NIH (grant 1R01A1067423) and the HIV Accessory and Regulatory Complex Center (grant P50 GM082250). G.M.L. is a recipient of the 2007 2008 UCSF-Gladstone Institute for Virology & Immunology Center for AIDS Research Clinical Science Pilot Award (grant P30-AI027763). We also thank K. Dill, J. Gross, D. Hostetter, and T. Shahian for discussion and proofreading of this manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Babe LM, 1997, CELL, V91, P427, DOI 10.1016/S0092-8674(00)80426-2; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Caskey CT, 2007, ANNU REV MED, V58, P1, DOI 10.1146/annurev.med.58.042705.124037; D'Silva L, 2005, J AM CHEM SOC, V127, P13220, DOI 10.1021/ja052143x; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; DILL K, 1R01A1067423 NIH; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Golovanov AP, 2007, J AM CHEM SOC, V129, P6528, DOI 10.1021/ja070505q; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hornak V, 2007, DRUG DISCOV TODAY, V12, P132, DOI 10.1016/j.drudis.2006.12.011; Hu CQ, 2008, CURR MED CHEM, V15, P1720, DOI 10.2174/092986708784872375; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Martinez-Cajas JL, 2008, DRUGS, V68, P43, DOI 10.2165/00003495-200868010-00004; Martins S, 2008, CURR MED CHEM, V15, P1083, DOI 10.2174/092986708784221467; Masterson LR, 2008, J AM CHEM SOC, V130, P7818, DOI 10.1021/ja802701w; MOBLEY DL, STRUCTURE IN PRESS; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nomura AM, 2005, NAT STRUCT MOL BIOL, V12, P1019, DOI 10.1038/nsmb1006; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Schanda P, 2008, J MOL BIOL, V380, P726, DOI 10.1016/j.jmb.2008.05.040; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Volkman HM, 2005, J AM CHEM SOC, V127, P4649, DOI 10.1021/ja042761y; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	41	131	135	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					213	215		10.1126/science.1169378	http://dx.doi.org/10.1126/science.1169378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359579	Green Accepted			2022-12-24	WOS:000265024400035
J	Bonauer, A; Carmona, G; Iwasaki, M; Mione, M; Koyanagi, M; Fischer, A; Burchfield, J; Fox, H; Doebele, C; Ohtani, K; Chavakis, E; Potente, M; Tjwa, M; Urbich, C; Zeiher, AM; Dimmeler, S				Bonauer, Angelika; Carmona, Guillaume; Iwasaki, Masayoshi; Mione, Marina; Koyanagi, Masamichi; Fischer, Ariane; Burchfield, Jana; Fox, Henrik; Doebele, Carmen; Ohtani, Kisho; Chavakis, Emmanouil; Potente, Michael; Tjwa, Marc; Urbich, Carmen; Zeiher, Andreas M.; Dimmeler, Stefanie			MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice	SCIENCE			English	Article							ENDOTHELIAL-CELL MIGRATION; VASCULAR INTEGRITY; EXPRESSION; DICER; FIBRONECTIN; POLYCISTRON; ALPHA(5); GENE	MicroRNAs (miRs) are small noncoding RNAs that regulate gene expression by binding to target messenger RNAs (mRNAs), leading to translational repression or degradation. Here, we show that the miR-17 similar to 92 cluster is highly expressed in human endothelial cells and that miR-92a, a component of this cluster, controls the growth of new blood vessels (angiogenesis). Forced overexpression of miR-92a in endothelial cells blocked angiogenesis in vitro and in vivo. In mouse models of limb ischemia and myocardial infarction, systemic administration of an antagomir designed to inhibit miR-92a led to enhanced blood vessel growth and functional recovery of damaged tissue. MiR-92a appears to target mRNAs corresponding to several proangiogenic proteins, including the integrin subunit alpha5. Thus, miR-92a may serve as a valuable therapeutic target in the setting of ischemic disease.	[Bonauer, Angelika; Carmona, Guillaume; Iwasaki, Masayoshi; Koyanagi, Masamichi; Fischer, Ariane; Burchfield, Jana; Fox, Henrik; Doebele, Carmen; Ohtani, Kisho; Chavakis, Emmanouil; Potente, Michael; Urbich, Carmen; Dimmeler, Stefanie] Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Mione, Marina] Mol Oncol Fdn, Italian Fdn Canc Res Inst, I-02139 Milan, Italy; [Fox, Henrik; Chavakis, Emmanouil; Potente, Michael; Zeiher, Andreas M.] Univ Frankfurt, Dept Med 3, Div Cardiol, D-60590 Frankfurt, Germany; [Tjwa, Marc] Univ Frankfurt, Leibniz AG, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Dimmeler, S (corresponding author), Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Fox, Henrik/AAG-9968-2019; Mione, Maria Caterina/ABG-9926-2021; Mione, Maria Caterina/I-3073-2013	Fox, Henrik/0000-0002-2187-8715; Mione, Maria Caterina/0000-0002-9040-3705; Dimmeler, Stefanie/0000-0002-1045-2436; Potente, Michael/0000-0002-5689-0036	Deutsche Forschungsgemeinschaft [Di 600/6-3, Exc 147/1]; Alfried Krupp Foundation; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); European Research Council (Angiomir); Leducq Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfried Krupp Foundation; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); European Research Council (Angiomir)(European Research Council (ERC)); Leducq Foundation(Leducq Foundation)	We thank M. Muhly-Reinholz, T. Roxe, N. Reinfeld, and F. Pezzimenti for expert technical assistance and W.-K. Hofmann for performing the mRNA array. This work is supported by the Deutsche Forschungsgemeinschaft (Di 600/6-3, Exc 147/1), the Alfried Krupp Foundation (A.B.), the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) (C.D.), the European Research Council (Angiomir), and the Leducq Foundation (J.B. and M.K.). A.B., C.U., A.M.Z., and S.D. have applied for a patent relating to this work.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Urbich C, 2002, ARTERIOSCL THROM VAS, V22, P69, DOI 10.1161/hq0102.101518; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	28	958	1062	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1710	1713		10.1126/science.1174381	http://dx.doi.org/10.1126/science.1174381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19460962				2022-12-24	WOS:000267338200040
J	Chen, L; Jiao, ZH; Zheng, LS; Zhang, YY; Xie, ST; Wang, ZX; Wu, JW				Chen, Lei; Jiao, Zhi-Hao; Zheng, Li-Sha; Zhang, Yuan-Yuan; Xie, Shu-Tao; Wang, Zhi-Xin; Wu, Jia-Wei			Structural insight into the autoinhibition mechanism of AMP-activated protein kinase	NATURE			English	Article							CRYSTAL-STRUCTURE; ALPHA-SUBUNITS; RAT-LIVER; ENERGY; PHOSPHORYLATION; DOMAIN; IDENTIFICATION; SEQUENCE; BINDING; BETA	The AMP-activated protein kinase (AMPK) is characterized by its ability to bind to AMP, which enables it to adjust enzymatic activity by sensing the cellular energy status and maintain the balance between ATP production and consumption in eukaryotic cells(1,2). It also has important roles in the regulation of cell growth and proliferation, and in the establishment and maintenance of cell polarity(3). These important functions have rendered AMPK an important drug target for obesity, type 2 diabetes and cancer treatments(4). However, the regulatory mechanism of AMPK activity by AMP binding remains unsolved. Here we report the crystal structures of an unphosphorylated fragment of the AMPK alpha-subunit (KD-AID) from Schizosaccharomyces pombe that contains both the catalytic kinase domain and an autoinhibitory domain (AID), and of a phosphorylated kinase domain from Saccharomyces cerevisiae (Snf1-pKD). The AID binds, from the 'backside', to the hinge region of its kinase domain, forming contacts with both amino-terminal and carboxy-terminal lobes. Structural analyses indicate that AID binding might constrain the mobility of helix alpha C, hence resulting in an autoinhibited KD-AID with much lower kinase activity than that of the kinase domain alone. AMP activates AMPK both allosterically and by inhibiting dephosphorylation(5,6). Further in vitro kinetic studies demonstrate that disruption of the KD-AID interface reverses the autoinhibition and these AMPK heterotrimeric mutants no longer respond to the change in AMP concentration. The structural and biochemical data have shown the primary mechanism of AMPK autoinhibition and suggest a conformational switch model for AMPK activation by AMP.	[Chen, Lei; Jiao, Zhi-Hao; Zhang, Yuan-Yuan; Xie, Shu-Tao; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zheng, Li-Sha; Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Zheng, Li-Sha; Wang, Zhi-Xin] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, JW (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022	Chen, Lei/0000-0002-7619-8311	MOST [2006CB503900, 2007CB914400]; NSFC [30425005, 30770476]	MOST; NSFC(National Natural Science Foundation of China (NSFC))	We thank Y. Shi and S. C. Lin for critical discussions and reading of the manuscript; J. Chai and Y. Dong for help with data collection and processing; L. Gu and J. Wang for advice on structure determination. This work is supported in part by MOST grants 2006CB503900 and 2007CB914400, and by NSFC grants 30425005 and 30770476.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; YEH LA, 1980, J BIOL CHEM, V255, P2308	39	152	163	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1146	U139		10.1038/nature08075	http://dx.doi.org/10.1038/nature08075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19474788				2022-12-24	WOS:000267636700047
J	Richey, R; Howdle, P; Shaw, E; Stokes, T				Richey, Roberta; Howdle, Peter; Shaw, Elizabeth; Stokes, Tim		Guideline Dev Grp	Guidelines Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howdle, Peter] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Richey, Roberta; Shaw, Elizabeth; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Ctr Clin Practice Short Clin Guidelines, Manchester M1 4BD, Lancs, England	Saint James's University Hospital; University of Leeds; National Institute for Health & Care Excellence	Howdle, P (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	p.d.howdle@leeds.ac.uk	Stokes, Tim/M-9420-2018; Burden, Sorrel/C-6101-2015	Stokes, Tim/0000-0002-1127-1952; Burden, Sorrel/0000-0002-4967-647X				Bottaro G, 1999, AM J GASTROENTEROL, V94, P691, DOI 10.1111/j.1572-0241.1999.00938.x; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; *NAT I HLTH CLIN E, 2009, COELL DIS REC ASS CO; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119	4	21	21	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 27	2009	338								b1684	10.1136/bmj.b1684	http://dx.doi.org/10.1136/bmj.b1684			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	451WT	19474030				2022-12-24	WOS:000266502300002
J	Shinoda, T; Ogawa, H; Cornelius, F; Toyoshima, C				Shinoda, Takehiro; Ogawa, Haruo; Cornelius, Flemming; Toyoshima, Chikashi			Crystal structure of the sodium-potassium pump at 2.4 angstrom resolution	NATURE			English	Article							NA,K-ATPASE BETA-SUBUNIT; CALCIUM-PUMP; CATION-BINDING; RECTAL GLANDS; PROTEIN; DOMAIN; ATP; IDENTIFICATION; NA+,K+-ATPASE; CHOLESTEROL	Sodium-potassium ATPase is an ATP-powered ion pump that establishes concentration gradients for Na+ and K+ ions across the plasma membrane in all animal cells by pumping Na+ from the cytoplasm and K+ from the extracellular medium(1,2). Such gradients are used in many essential processes, notably for generating action potentials. Na+, K+-ATPase is a member of the P-type ATPases, which include sarcoplasmic reticulum Ca2+-ATPase and gastric H+, K+-ATPase, among others, and is the target of cardiac glycosides. Here we describe a crystal structure of this important ion pump, from shark rectal glands, consisting of alpha- and beta-subunits and a regulatory FXYD protein(3,4), all of which are highly homologous to human ones. The ATPase was fixed in a state analogous to E2 center dot 2K(+)center dot P-i, in which the ATPase has a high affinity for K+ and still binds P-i, as in the first crystal structure of pig kidney enzyme at 3.5 angstrom resolution(5). Clearly visualized now at 2.4 angstrom resolution are coordination of K+ and associated water molecules in the transmembrane binding sites and a phosphate analogue (MgF42-) in the phosphorylation site. The crystal structure shows that the beta-subunit has a critical role in K+ binding (although its involvement has previously been suggested(6-8)) and explains, at least partially, why the homologous Ca2+-ATPase counter-transports H+ rather than K+, despite the coordinating residues being almost identical.	[Shinoda, Takehiro; Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Cornelius, Flemming] Univ Aarhus, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark	University of Tokyo; Aarhus University	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778; Shinoda, Takehiro/0000-0003-0297-2471	Ministry of Education, Culture, Sports, Science and Technology of Japan; Danish Medical Research Council	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kawamoto and N. Shimizu for their help in data collection at BL41XU, SPring-8, and T. Tsuda for many aspects of this work. We are grateful to D. B. McIntosh for his help in improving the manuscript and H. R. Z. Christensen for technical assistance. Thanks are also due to G. Cramb for sharing sequencing results of the beta-subunit with us before publication. This work was supported by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to C. T., and grants from the Danish Medical Research Council, to F. C.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Hasler U, 2001, J BIOL CHEM, V276, P16356, DOI 10.1074/jbc.M008778200; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; JONES LR, 1988, METHOD ENZYMOL, V157, P85; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pietrobon D, 2007, NEUROTHERAPEUTICS, V4, P274, DOI 10.1016/j.nurt.2007.01.008; POST RL, 1972, J BIOL CHEM, V247, P6530; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SKOU JC, 1988, METHOD ENZYMOL, V156, P43; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sotomayor CP, 2000, BIOCHEMISTRY-US, V39, P10928, DOI 10.1021/bi000717z; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; UENO T, 1978, J BIOCHEM, V84, P787, DOI 10.1093/oxfordjournals.jbchem.a132190; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925	40	466	478	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					446	U167		10.1038/nature07939	http://dx.doi.org/10.1038/nature07939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458722				2022-12-24	WOS:000266243700050
J	Phelps, RA; Chidester, S; Dehghanizadeh, S; Phelps, J; Sandoval, IT; Rai, K; Broadbent, T; Sarkar, S; Burt, RW; Jones, DA				Phelps, Reid A.; Chidester, Stephanie; Dehghanizadeh, Somaye; Phelps, Jason; Sandoval, Imelda T.; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Burt, Randall W.; Jones, David A.			A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC Loss	CELL			English	Article							RETINOIC ACID BIOSYNTHESIS; TERMINAL-BINDING-PROTEIN; BETA-CATENIN; POLYPOSIS-COLI; COLORECTAL-CANCER; K-RAS; INTESTINAL DEVELOPMENT; REGULATES EXPRESSION; SPLICE VARIANT; IN-VIVO	Aberrant Wnt/beta-catenin signaling following loss of the tumor suppressor adenomatous polyposis coli (APC) is thought to initiate colon adenoma formation. Using zebrafish and human cells, we show that homozygous loss of APC causes failed intestinal cell differentiation but that this occurs in the absence of nuclear beta-catenin and increased intestinal cell proliferation. Therefore, loss of APC is insufficient for causing beta-catenin nuclear localization. APC mutation-induced intestinal differentiation defects instead depend on the transcriptional corepressor C-terminal binding protein-1 (CtBP1), whereas proliferation defects and nuclear accumulation of beta-catenin require the additional activation of KRAS. These findings suggest that, following APC loss, CtBP1 contributes to adenoma initiation as a first step, whereas KRAS activation and beta-catenin nuclear localization promote adenoma progression to carcinomas as a second step. Consistent with this model, human FAP adenomas showed robust upregulation of CtBP1 in the absence of detectable nuclear beta-catenin, whereas nuclear beta-catenin was detected in carcinomas.	[Phelps, Reid A.; Chidester, Stephanie; Dehghanizadeh, Somaye; Phelps, Jason; Sandoval, Imelda T.; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Burt, Randall W.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Phelps, Reid A.; Dehghanizadeh, Somaye; Rai, Kunal; Broadbent, Talmage; Sarkar, Sharmistha; Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Sandoval, Imelda T.; Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Burt, Randall W.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jones, DA (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu		Rai, Kunal/0000-0003-2321-6894; Chidester, Stephanie/0000-0003-4163-3480	National Cancer Institute [CA073992, CA96934]; Huntsman Cancer Foundation; Cancer Center Support [CA042014]; University of Utah MD/PHD program; NATIONAL CANCER INSTITUTE [R01CA116468, P01CA073992, P30CA042014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Foundation; Cancer Center Support; University of Utah MD/PHD program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Richard Dorsky (University of Utah) for providing the TOPGFP zebrafish. This work is supported by grants from the National Cancer Institute (CA073992 and CA96934) and the Huntsman Cancer Foundation awarded to D. A. J. The work was also supported by access to technical cores supported by a Cancer Center Support Grant (CA042014). We thank Dr. Diana Stafforini for helpful discussions. R. A. P. and T. B. are supported in part by the University of Utah MD/PHD program.	Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bienz M, 2004, CURR OPIN CELL BIOL, V16, P528, DOI 10.1016/j.ceb.2004.08.001; Blaker H, 2003, AM J CLIN PATHOL, V120, P418, DOI 10.1309/4E4WG3AYGJNCD11P; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Eisinger AL, 2007, J BIOL CHEM, V282, P29394, DOI 10.1074/jbc.M609768200; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Gripp KW, 2007, AM J MED GENET A, V143A, P1472, DOI 10.1002/ajmg.a.31815; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwao K, 1998, CANCER RES, V58, P1021; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kongkanuntn R, 1999, ONCOGENE, V18, P7219, DOI 10.1038/sj.onc.1203181; Moran AE, 2004, J BIOL CHEM, V279, P43261, DOI 10.1074/jbc.M404276200; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nadauld LD, 2005, J BIOL CHEM, V280, P30490, DOI 10.1074/jbc.M504973200; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nadauld LD, 2006, P NATL ACAD SCI USA, V103, P13409, DOI 10.1073/pnas.0601634103; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2002, CURR BIOL, V12, pR499, DOI 10.1016/S0960-9822(02)00969-7; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Romagnolo B, 1999, CANCER RES, V59, P3875; Samowitz WS, 1999, CANCER RES, V59, P1442; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sparks AB, 1998, CANCER RES, V58, P1130; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052	48	220	226	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					623	634		10.1016/j.cell.2009.02.037	http://dx.doi.org/10.1016/j.cell.2009.02.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450512	Bronze, Green Accepted			2022-12-24	WOS:000266114100012
J	He, XJ; Hsu, YF; Zhu, SH; Wierzbicki, AT; Pontes, O; Pikaard, CS; Liu, HL; Wang, CS; Jin, HL; Zhu, JK				He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Wierzbicki, Andrzej T.; Pontes, Olga; Pikaard, Craig S.; Liu, Hai-Liang; Wang, Co-Shine; Jin, Hailing; Zhu, Jian-Kang			An Effector of RNA-Directed DNA Methylation in Arabidopsis Is an ARGONAUTE 4-and RNA-Binding Protein	CELL			English	Article							GLYCOSYLASE/LYASE ROS1; POLYMERASE-II; TRANSCRIPTION; HETEROCHROMATIN; ROLES; SPT5; IV; MAINTENANCE; SUBUNIT; RITS	DNA methylation is a conserved epigenetic mark in plants and mammals. In Arabidopsis, DNA methylation can be triggered by small interfering RNAs (siRNAs) through an RNA-directed DNA methylation (RdDM) pathway. Here, we report the identification of an RdDM effector, KTF1. Loss-of-function mutations in KTF1 reduce DNA methylation and release the silencing of RdDM target loci without abolishing the siRNA triggers. KTF1 has similarity to the transcription elongation factor SPT5 and contains a C-terminal extension rich in GW/WG repeats. KTF1 colocalizes with ARGONAUTE 4 (AGO4) in punctate nuclear foci and binds AGO4 and RNA transcripts. Our results suggest KTF1 as an adaptor protein that binds scaffold transcripts generated by Pol V and recruits AGO4 and AGO4-bound siRNAs to form an RdDM effector complex. The dual interaction of an effector protein with AGO and small RNA target transcripts may be a general feature of RNA-silencing effector complexes.	[He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Liu, Hai-Liang; Jin, Hailing; Zhu, Jian-Kang] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [He, Xin-Jian; Hsu, Yi-Feng; Zhu, Shihua; Liu, Hai-Liang; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; [Hsu, Yi-Feng; Wang, Co-Shine] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Zhu, Shihua] Ningbo Univ, Coll Sci & Technol, Ningbo 315211, Zhejiang, Peoples R China; [Wierzbicki, Andrzej T.; Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Chung Hsing University; Ningbo University; Washington University (WUSTL)	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Jin, Hailing/Z-1168-2019; Zhu, Jian-Kang/F-7658-2011; Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012; Hsu, Yi Feng/P-7737-2014; hsu, yifeng/GPW-9650-2022	Jin, Hailing/0000-0001-5778-5193; Zhu, Jian-Kang/0000-0001-5134-731X; Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459; hsu, yifeng/0000-0001-6070-9925; Wang, Co-Shine/0000-0002-1668-2750; Zhu, Shihua/0000-0002-8046-6825	National Institutes of Health [R01GM070795, R01GM059138, GM077590]; National Science Foundation [MCB-0642843]; Edward Mallinckrodt Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM070795, R01GM077590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Edward Mallinckrodt Foundation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xuemei Chen and Shou-Wei Ding for helpful discussion. This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 to J.-K.Z., GM077590 to C.S.P., and National Science Foundation grant MCB-0642843 to H.J.O.P. was supported by an Edward Mallinckrodt Foundation Award.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Huang LF, 2009, NAT STRUCT MOL BIOL, V16, P91, DOI 10.1038/nsmb.1539; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Partridge JF, 2007, MOL CELL, V26, P593, DOI 10.1016/j.molcel.2007.05.004; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Winston F, 2001, GENOME BIOL, V2; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	43	178	198	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					498	508		10.1016/j.cell.2009.04.028	http://dx.doi.org/10.1016/j.cell.2009.04.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410546	Green Accepted, Bronze			2022-12-24	WOS:000265677200019
J	Lee, SM; Pippel, E; Gosele, U; Dresbach, C; Qin, Y; Chandran, CV; Brauniger, T; Hause, G; Knez, M				Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Dresbach, Christian; Qin, Yong; Chandran, C. Vinod; Braeuniger, Thomas; Hause, Gerd; Knez, Mato			Greatly Increased Toughness of Infiltrated Spider Silk	SCIENCE			English	Article							MECHANICAL-PROPERTIES; MOLECULAR-ORIENTATION; INSECT MANDIBLES; POLYCHAETE JAWS; ZINC; PROTEIN; METAL; MANGANESE; COMPLEX; DESIGN	In nature, tiny amounts of inorganic impurities, such as metals, are incorporated in the protein structures of some biomaterials and lead to unusual mechanical properties of those materials. A desire to produce these biomimicking new materials has stimulated materials scientists, and diverse approaches have been attempted. In contrast, research to improve the mechanical properties of biomaterials themselves by direct metal incorporation into inner protein structures has rarely been tried because of the difficulty of developing a method that can infiltrate metals into biomaterials, resulting in a metal-incorporated protein matrix. We demonstrated that metals can be intentionally infiltrated into inner protein structures of biomaterials through multiple pulsed vapor-phase infiltration performed with equipment conventionally used for atomic layer deposition (ALD). We infiltrated zinc (Zn), titanium (Ti), or aluminum (Al), combined with water from corresponding ALD precursors, into spider dragline silks and observed greatly improved toughness of the resulting silks. The presence of the infiltrated metals such as Al or Ti was verified by energy-dispersive x-ray (EDX) and nuclear magnetic resonance spectra measured inside the treated silks. This result of enhanced toughness of spider silk could potentially serve as a model for a more general approach to enhance the strength and toughness of other biomaterials.	[Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Qin, Yong; Knez, Mato] Max Planck Inst Microstruct Phys, D-06120 Halle, Germany; [Dresbach, Christian] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany; [Chandran, C. Vinod; Braeuniger, Thomas] Univ Halle Wittenberg, Inst Phys, Nucl Magnet Resonance Grp, D-06108 Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Microscopy Unit Bioctr, D-06120 Halle, Germany	Max Planck Society; Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Lee, SM (corresponding author), Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany.	smlee@mpi-halle.de; mknez@mpi-halle.de	Qin, Yong/D-9716-2011; Knez, Mato/F-9287-2014	Knez, Mato/0000-0002-9850-1035; Chandran, C. Vinod/0000-0003-4074-8833	Bundesministerium fur Bildung und Forschung [FKZ 03X5507]; Deutsche Forschungsgemeinschaft [BR 3370/3-1, Mi 390/17-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Lee from the Korea Research Institute of Standards and Science in Daejeon, Korea; H. Han from the Department of Material Science and Engineering, Pohang University of Science and Technology in Pohang, Korea; and G.-M. Kim from the Department of Physics, Martin-Luther-University Halle-Wittenberg in Merseburg, Germany, for their helpful discussions on physical and chemical interpretations of mechanical properties, WAXS, NMR spectra, Raman spectra, energy-filtered TEM (EFTEM), and time-of-flight secondary ion mass spectroscopy (TOF-SIMS) data. We also thank J. Woltersdorf, M. Becker, and J. Liu from the Max Planck Institute of Microstructure Physics in Halle, Germany, for EFTEM and Raman measurements. We appreciate TOF-SIMS measurement by M. Krause and help and support in arranging the mechanical properties measurements and TOF-SIMS measurement by M. Petzold from the Fraunhofer Institute for Mechanics of Materials in Halle, Germany. This work has received financial support from the Bundesministerium fur Bildung und Forschung (grant FKZ 03X5507) and Deutsche Forschungsgemeinschaft (grants BR 3370/3-1 and Mi 390/17-1).	ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Chang CY, 2008, ORG ELECTRON, V9, P667, DOI 10.1016/j.orgel.2008.04.009; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144; Edwards Ashley J., 1993, Cell Biology International, V17, P697, DOI 10.1006/cbir.1993.1125; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; FORNES RE, 1983, J POLYM SCI POL PHYS, V21, P1163, DOI 10.1002/pol.1983.180210715; GIBBS PE, 1980, J MAR BIOL ASSOC UK, V60, P205, DOI 10.1017/S0025315400024267; Gosline JM, 1999, J EXP BIOL, V202, P3295; GROSSKREUTZ JC, 1969, J ELECTROCHEM SOC, V116, P1232, DOI 10.1149/1.2412286; Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344; GURD FRN, 1956, ADV PROTEIN CHEM, V11, P311, DOI 10.1016/S0065-3233(08)60424-6; GUSTAVSON KH, 1958, NATURE, V182, P1125, DOI 10.1038/1821125a0; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; HILLERTON JE, 1982, J EXP BIOL, V101, P333; HILLERTON JE, 1984, J STORED PROD RES, V20, P133, DOI 10.1016/0022-474X(84)90020-1; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Let AL, 2008, J NON-CRYST SOLIDS, V354, P1801, DOI 10.1016/j.jnoncrysol.2007.09.005; Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Morgan TD, 2003, J STORED PROD RES, V39, P65, DOI 10.1016/S0022-474X(02)00019-X; Pontin MG, 2007, P NATL ACAD SCI USA, V104, P13559, DOI 10.1073/pnas.0702034104; Quicke DLJ, 1998, ZOOL J LINN SOC-LOND, V124, P387, DOI 10.1006/zjls.1997.0146; RAO KSJ, 1994, MOL CELL BIOCHEM, V137, P61; SCHOFIELD R, 1989, J EXP BIOL, V144, P577; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sun HZ, 1998, ANGEW CHEM INT EDIT, V37, P1577, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1577::AID-ANIE1577>3.0.CO;2-M; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wilson CA, 2005, CHEM MATER, V17, P5625, DOI 10.1021/cm050704d	39	287	290	12	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					488	492		10.1126/science.1168162	http://dx.doi.org/10.1126/science.1168162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390040				2022-12-24	WOS:000265411200040
J	Kraft, P; Hunter, DJ				Kraft, Peter; Hunter, David J.			Genetic Risk Prediction - Are We There Yet?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kraft, P (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.							Couzin J, 2008, SCIENCE, V322, P357, DOI 10.1126/science.322.5900.357; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Katsanis SH, 2008, SCIENCE, V320, P316; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	5	307	317	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1701	1703		10.1056/NEJMp0810107	http://dx.doi.org/10.1056/NEJMp0810107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435XY	19369656				2022-12-24	WOS:000265377800004
J	Wallace, GG; Moulton, SE; Clark, GM				Wallace, G. G.; Moulton, S. E.; Clark, G. M.			Electrode-Cellular Interface	SCIENCE			English	Editorial Material							NEURAL STIMULATION; CONDUCTING POLYMER; POLYPYRROLE; BIOCOMPATIBILITY; OSTEOBLASTS; COMPOSITE; RELEASE; CELLS		[Wallace, G. G.; Moulton, S. E.; Clark, G. M.] Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia	University of Wollongong	Wallace, GG (corresponding author), Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.	gwallace@uow.edu.au	Moulton, Simon/AAS-1452-2021; Moulton, Simon E/G-1031-2011; Wallace, Gordon G/H-1123-2011	Moulton, Simon/0000-0002-8320-3852; Moulton, Simon E/0000-0002-8320-3852; Wallace, Gordon G/0000-0002-0381-7273				Boockvar JA, 2000, J NEUROSURG, V93, P140, DOI 10.3171/jns.2000.93.1.0140; Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#; Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Czarnecki JS, 2008, TISSUE ENG PT A, V14, P255, DOI 10.1089/tea.2007.0169; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Hodgson A. J., 1994, SUPRAMOL SCI, V1, P77; Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a; LIN Y, 1994, J CONTROL RELEASE, V30, P137, DOI 10.1016/0168-3659(94)90260-7; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015; Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004; Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t; Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065; Widge AS, 2007, BIOSENS BIOELECTRON, V22, P1723, DOI 10.1016/j.bios.2006.08.011; Wong YT, 2007, IEEE T NEUR SYS REH, V15, P425, DOI 10.1109/TNSRE.2007.903958	20	85	87	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					185	186		10.1126/science.1168346	http://dx.doi.org/10.1126/science.1168346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359568	Green Submitted			2022-12-24	WOS:000265024400024
J	Di Sabatino, A; Corazza, GR				Di Sabatino, Antonio; Corazza, Gino Roberto			Coeliac disease	LANCET			English	Review							STEM-CELL TRANSPLANTATION; INTESTINAL T-CELLS; GLUTEN-FREE DIET; TERM-FOLLOW-UP; TISSUE TRANSGLUTAMINASE; VILLOUS ATROPHY; INTRAEPITHELIAL LYMPHOCYTES; CLINICAL PRESENTATION; SPLENIC HYPOFUNCTION; GLIADIN PEPTIDES	Coeliac disease is a chronic inflammatory disorder of the small bowel induced in genetically susceptible people by the irritant gluten and possibly other environmental cofactors. The disorder is characterised by a diverse clinical heterogeneity that ranges from asymptomatic to severely symptomatic, and it manifests with frank malabsorption, an increased morbidity attributable to the frequent association with autoimmune disorders and increased mortality resulting from the emergence of T-cell clonal proliferations that predispose the patient to enteropathy-type T-cell lymphoma. Our understanding of the molecular basis for this disorder has improved and enabled the identification of targets for new therapies, although a strict gluten-free diet remains the mainstay of safe and effective treatment. In this Seminar we critically reassess the clinical and diagnostic aspects of this disease and new perspectives in its pathogenesis and treatment.	[Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	CORAZZA, GINO ROBERTO/K-8500-2016; Di Sabatino, Antonio/K-8015-2016	CORAZZA, GINO ROBERTO/0000-0001-9532-0573; Di Sabatino, Antonio/0000-0002-0302-8645				Al-Toma A, 2007, GUT, V56, P1373, DOI 10.1136/gut.2006.114512; Al-Toma A, 2007, BLOOD, V109, P2243, DOI 10.1182/blood-2006-08-042820; Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P1322, DOI 10.1016/j.cgh.2006.07.007; Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; AshtonKey M, 1997, AM J PATHOL, V151, P493; Bardella MT, 2000, GASTROINTEST ENDOSC, V51, P714, DOI 10.1067/mge.2000.104653; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bishton MJ, 2007, BRIT J HAEMATOL, V136, P111, DOI 10.1111/j.1365-2141.2006.06371.x; Bonamico M, 2008, J PEDIATR GASTR NUTR, V47, P618, DOI 10.1097/MPG.0b013e3181677d6e; Brar P, 2007, DIGEST LIVER DIS, V39, P26, DOI 10.1016/j.dld.2006.07.014; BROCCHI E, 1988, NEW ENGL J MED, V319, P741, DOI 10.1056/NEJM198809223191202; Brown I, 2006, ARCH PATHOL LAB MED, V130, P1020; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Cammarota G, 2000, LANCET, V356, P1494, DOI 10.1016/S0140-6736(00)02880-4; Cammarota G, 2006, ALIMENT PHARM THER, V23, P61, DOI 10.1111/j.1365-2036.2006.02732.x; Carroccio A, 2002, CLIN CHEM, V48, P1546; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Ciccocioppo R, 2005, LAB INVEST, V85, P397, DOI 10.1038/labinvest.3700225; COLLIN P, 1993, SCAND J GASTROENTERO, V28, P595, DOI 10.3109/00365529309096094; CORAZZA G, 1992, GASTROENTEROLOGY, V103, P1517, DOI 10.1016/0016-5085(92)91172-Z; Corazza GR, 2007, CLIN GASTROENTEROL H, V5, P838, DOI 10.1016/j.cgh.2007.03.019; Corazza GR, 1997, LANCET, V350, P106, DOI 10.1016/S0140-6736(97)01042-8; CORAZZA GR, 1993, J CLIN GASTROENTEROL, V16, P16, DOI 10.1097/00004836-199301000-00006; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; CORAZZA GR, 1995, GASTROENTEROLOGY, V109, P122, DOI 10.1016/0016-5085(95)90276-7; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Dewar DH, 2006, EUR J GASTROEN HEPAT, V18, P483, DOI 10.1097/00042737-200605000-00005; Dewar DH, 2005, GASTROENTEROLOGY, V128, pS19, DOI 10.1053/j.gastro.2005.02.010; Di Cagno R, 2004, APPL ENVIRON MICROB, V70, P1088, DOI 10.1128/AEM.70.2.1088-1096.2004; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Di Sabatino A, 2006, CLIN GASTROENTEROL H, V4, P179, DOI 10.1016/S1542-3565(05)00982-1; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fabbro E, 2008, CLIN CHIM ACTA, V390, P134, DOI 10.1016/j.cca.2008.01.015; Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Fine KD, 1997, GASTROENTEROLOGY, V112, P1830, DOI 10.1053/gast.1997.v112.pm9178673; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Gale J, 2000, J CLIN ONCOL, V18, P795, DOI 10.1200/JCO.2000.18.4.795; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guidetti CS, 2001, GUT, V49, P502, DOI 10.1136/gut.49.4.502; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Holopainen P, 2004, TISSUE ANTIGENS, V63, P212, DOI 10.1111/j.1399-0039.2004.00189.x; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JABBARI M, 1988, GASTROENTEROLOGY, V95, P1518, DOI 10.1016/S0016-5085(88)80071-4; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Jantunen E, 2003, LEUKEMIA LYMPHOMA, V44, P2163, DOI 10.1080/1042819031000123456; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Kemppainen T, 1999, BONE, V24, P249, DOI 10.1016/S8756-3282(98)00178-1; Kemppainen T, 2007, SCAND J GASTROENTERO, V42, P54, DOI 10.1080/00365520600842245; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Korponay-Szabo IR, 2007, BMJ-BRIT MED J, V335, P1244, DOI 10.1136/bmj.39405.472975.80; KUMAR PJ, 1988, ARCH DIS CHILD, V63, P916, DOI 10.1136/adc.63.8.916; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lee A, 2003, J AM DIET ASSOC, V103, P1533, DOI 10.1016/j.jada.2003.08.027; Lewis NR, 2008, ALIMENT PHARM THER, V27, P1140, DOI 10.1111/j.1365-2036.2008.03660.x; Lewis NR, 2005, EUR J GASTROEN HEPAT, V17, P1065, DOI 10.1097/00042737-200510000-00009; Losowsky MS, 2008, DIGEST DIS, V26, P112, DOI 10.1159/000116768; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2007, ALIMENT PHARM THER, V25, P273, DOI 10.1111/j.1365-2036.2006.03203.x; Lundin KEA, 2003, GUT, V52, P1649, DOI 10.1136/gut.52.11.1649; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MAKI M, 1990, ARCH DIS CHILD, V65, P1137, DOI 10.1136/adc.65.10.1137; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; MANN NS, 2006, INTERN MED J, V13, P3; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4; Monteleone I, 2004, GUT, V53, P1090, DOI 10.1136/gut.2003.030551; Mora S, 2001, J PEDIATR-US, V139, P516, DOI 10.1067/mpd.2001.116298; MORTIMER PE, 1968, BRIT MED J, V3, P7, DOI 10.1136/bmj.3.5609.7; Mulder CJJ, 2005, BEST PRACT RES CL GA, V19, P479, DOI 10.1016/j.bpg.2005.01.007; Murray JA, 2008, CLIN GASTROENTEROL H, V6, P186, DOI 10.1016/j.cgh.2007.10.012; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; O'Leary C, 2004, AM J GASTROENTEROL, V99, P2437, DOI 10.1111/j.1572-0241.2004.40182.x; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Obermann EC, 2004, J PATHOL, V202, P252, DOI 10.1002/path.1506; Pais WP, 2008, GASTROINTEST ENDOSC, V67, P1082, DOI 10.1016/j.gie.2007.10.015; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Pietzak MM, 2005, GASTROENTEROLOGY, V128, pS135, DOI 10.1053/j.gastro.2005.02.025; PRZEMIOSLO RT, 1994, GUT, V35, P1398, DOI 10.1136/gut.35.10.1398; Pyle GG, 2005, CLIN GASTROENTEROL H, V3, P687, DOI 10.1016/S1542-3565(05)00366-6; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Rashtak S, 2007, ANN INTERN MED, V147, P339, DOI 10.7326/0003-4819-147-5-200709040-00009; Rostami K, 2001, EUR J OBSTET GYN R B, V96, P146, DOI 10.1016/S0301-2115(00)00457-7; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; SategnaGuidetti C, 1996, J CLIN GASTROENTEROL, V23, P101, DOI 10.1097/00004836-199609000-00006; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Thomas HJ, 2008, EUR J GASTROEN HEPAT, V20, P624, DOI 10.1097/MEG.0b013e3282f45764; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI [10.1016/S0002-9270(02)06006-9, 10.1111/j.1572-0241.2003.07284.x]; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verkarre V, 2003, GASTROENTEROLOGY, V125, P40, DOI 10.1016/S0016-5085(03)00692-9; Vivas S, 2006, NEW ENGL J MED, V354, P2514, DOI 10.1056/NEJMc053129; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Wolters VM, 2008, AM J GASTROENTEROL, V103, P190, DOI 10.1111/j.1572-0241.2007.01471.x; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	155	464	492	1	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1480	1493		10.1016/S0140-6736(09)60254-3	http://dx.doi.org/10.1016/S0140-6736(09)60254-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394538				2022-12-24	WOS:000265501900037
J	Gilman, M; Gilman, SL; Johns, MM				Gilman, Marina; Gilman, Sander L.; Johns, Michael M., III			The art of medicine Human papillomavirus, abstinence, and the other risks	LANCET			English	Editorial Material									[Gilman, Sander L.] Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA; [Gilman, Sander L.] Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA; [Gilman, Marina; Johns, Michael M., III] Emory Univ, Emory Voice Clin, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Gilman, SL (corresponding author), Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA.	sander.gilman@emory.edu	Gilman, Marina/AAI-8144-2021					[Anonymous], 2006, Lancet, V368, P1212; Chan JK, 2007, J CLIN ONCOL, V25, P2975, DOI 10.1200/JCO.2007.10.8662; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Trenholm C, 2008, J POLICY ANAL MANAG, V27, P255, DOI 10.1002/pam.20324; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1420	1421		10.1016/S0140-6736(09)60810-2	http://dx.doi.org/10.1016/S0140-6736(09)60810-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19400001				2022-12-24	WOS:000265501900016
J	Chen, M; Briscoe, WH; Armes, SP; Klein, J				Chen, Meng; Briscoe, Wuge H.; Armes, Steven P.; Klein, Jacob			Lubrication at Physiological Pressures by Polyzwitterionic Brushes	SCIENCE			English	Article							BOUNDARY LUBRICATION; FRICTIONAL FORCES; POLYMER; SURFACE; LAYERS; HYDRATION; QUALITY; CHAINS	The very low sliding friction at natural synovial joints, which have friction coefficients of mu < 0.002 at pressures up to 5 megapascals or more, has to date not been attained in any human-made joints or between model surfaces in aqueous environments. We found that surfaces in water bearing polyzwitterionic brushes that were polymerized directly from the surface can have m values as low as 0.0004 at pressures as high as 7.5 megapascals. This extreme lubrication is attributed primarily to the strong hydration of the phosphorylcholine-like monomers that make up the robustly attached brushes, and may have relevance to a wide range of human-made aqueous lubrication situations.	[Chen, Meng; Briscoe, Wuge H.; Klein, Jacob] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Klein, Jacob] Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Oxford; University of Sheffield; Weizmann Institute of Science	Klein, J (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	jacob.klein@weizmann.ac.il	Briscoe, Wuge H/H-5435-2018	Briscoe, Wuge H/0000-0001-8025-960X; Chen, Meng/0000-0001-6553-0799; Armes, Steven/0000-0002-8289-6351	Engineering and Physical Sciences Research Council; Petroleum Research Fund [45694-AC7]; Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council [EP/C535421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Petroleum Research Fund(American Chemical Society); Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. L. Lewis (Biocompatibles Ltd.) for kind donation of the MPC monomer; X. Y. Chen for synthesis of the macroinitiator; I. E. Dunlop, S. Perkin, and W. Feng for help and advice; and P. Pincus for a discussion. S.P.A. is the recipient of a Royal Society Research Merit Award. W.H.B. thanks the Taiho Kogyo Tribology Research Foundation for support. This work was supported by the Engineering and Physical Sciences Research Council, the Petroleum Research Fund (grant 45694-AC7), the Charles McCutchen Foundation, and the Minerva Foundation at the Weizmann Institute.	Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; CHAN DYC, 1980, J COLLOID INTERF SCI, V77, P283, DOI 10.1016/0021-9797(80)90445-2; Chen M, 2007, CHEMPHYSCHEM, V8, P1303, DOI 10.1002/cphc.200700131; COTTON FA, 1998, ADV INORG CHEM, P1288; Feng W, 2007, BIOINTERPHASES, V2, P34, DOI 10.1116/1.2711705; Forster AM, 2006, J POLYM SCI POL PHYS, V44, P649, DOI 10.1002/polb.20701; Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hills BA, 2002, J RHEUMATOL, V29, P200; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; LIS LJ, 1982, BIOPHYS J, V37, P657; MCCUTCHEN CW, 1966, FED PROC, V25, P1061; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Rappolt M, 2001, COLLOID SURFACE A, V183, P171, DOI 10.1016/S0927-7757(01)00568-4; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Schorr PA, 2003, MACROMOLECULES, V36, P389, DOI 10.1021/ma011207v; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Tadmor R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115503; WITTEN TA, 1990, MACROMOLECULES, V23, P824, DOI 10.1021/ma00205a022; Yaseen M, 2006, LANGMUIR, V22, P5825, DOI 10.1021/la053316z; [No title captured]	28	511	539	23	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1698	1701		10.1126/science.1169399	http://dx.doi.org/10.1126/science.1169399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325108	Green Accepted			2022-12-24	WOS:000264559800031
J	Hill, MN; Gorzalka, BB				Hill, Matthew N.; Gorzalka, Boris B.			Impairments in Endocannabinoid Signaling and Depressive Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS-INDUCED ACTIVATION; PITUITARY-ADRENAL AXIS; ANANDAMIDE HYDROLYSIS; HIPPOCAMPUS; MODULATION; BLOCKADE; SYSTEM; BRAIN		[Hill, Matthew N.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; [Gorzalka, Boris B.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Rockefeller University; University of British Columbia	Hill, MN (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave, New York, NY 10021 USA.	mhill@rockefeller.edu	Hill, Matthew N/J-4610-2013					Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Hill MN, 2008, PHARMACOPSYCHIATRY, V41, P48, DOI 10.1055/s-2007-993211; Hill MN, 2007, J NEUROCHEM, V103, P47, DOI 10.1111/j.1471-4159.2007.04688.x; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Justinova Z, 2008, BIOL PSYCHIAT, V64, P930, DOI 10.1016/j.biopsych.2008.08.008; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; who, DEPR; *ZIM AC REP, PFIZ KILLS DIET DRUG	13	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1165	1166		10.1001/jama.2009.369	http://dx.doi.org/10.1001/jama.2009.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293417				2022-12-24	WOS:000264244200022
J	Wilson, JF				Wilson, Jennifer Fisher			More Cases of Drug-Resistant Tuberculosis Complicate Care but Spur Global Research and Innovation	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P245; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721	7	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					433	436		10.7326/0003-4819-150-6-200903170-00031	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293087				2022-12-24	WOS:000264468500025
J	Chen, K; Baran, PS				Chen, Ke; Baran, Phil S.			Total synthesis of eudesmane terpenes by site-selective C-H oxidations	NATURE			English	Article							ENZYMES; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; SESQUITERPENOIDS; BIOSYNTHESIS; HYDROCARBONS; ACTIVATION; EFFICIENT; TAXOL	From menthol to cholesterol to Taxol, terpenes are a ubiquitous group of molecules (over 55,000 members isolated so far) that have long provided humans with flavours, fragrances, hormones, medicines and even commercial products such as rubber(1). Although they possess a seemingly endless variety of architectural complexities, the biosynthesis of terpenes often occurs in a unified fashion as a 'two-phase' process(2,3). In the first phase (the cyclase phase), simple linear hydrocarbon phosphate building blocks are stitched together by means of 'prenyl coupling', followed by enzymatically controlled molecular cyclizations and rearrangements. In the second phase (the oxidase phase), oxidation of alkenes and carbon-hydrogen bonds results in a large array of structural diversity. Although organic chemists have made great progress in developing the logic(3-5) needed for the cyclase phase of terpene synthesis, particularly in the area of polyene cyclizations(6), much remains to be learned if the oxidase phase is to be mimicked in the laboratory. Here we show how the logic of terpene biosynthesis has inspired the highly efficient and stereocontrolled syntheses of five oxidized members of the eudesmane family of terpenes in a modicum of steps by a series of simple carbocycle-forming reactions followed by multiple site-selective inter-and intramolecular carbon-hydrogen oxidations. This work establishes an intellectual framework in which to conceive the laboratory synthesis of other complex terpenes using a 'two-phase' approach.	[Chen, Ke; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	We are grateful to A. Eschenmoser for discussions and to Bristol-Myers Squibb for financial support. M. Moron Galan and Y. Ishihara are acknowledged for technical contributions to the early stages of this project. We are grateful to B. Shi and A. Reingold for assistance with high-performance liquid chromatography and X-ray crystallographic analyses, respectively.	Betancort JM, 2001, ORG LETT, V3, P3737, DOI 10.1021/ol0167006; Brodsky BH, 2005, J AM CHEM SOC, V127, P15391, DOI 10.1021/ja055549i; CARDONA L, 1992, TETRAHEDRON, V48, P851, DOI 10.1016/S0040-4020(01)88189-8; Chen K, 2008, J AM CHEM SOC, V130, P7247, DOI 10.1021/ja802491q; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chi YG, 2005, ORG LETT, V7, P4253, DOI 10.1021/ol0517729; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davis EM, 2000, TOP CURR CHEM, V209, P53; De Marino S, 2005, PLANTA MED, V71, P706, DOI 10.1055/s-2005-864191; DENIS JN, 1988, J AM CHEM SOC, V110, P5917, DOI 10.1021/ja00225a063; Eschenmoser A, 2005, HELV CHIM ACTA, V88, P3011, DOI 10.1002/hlca.200590245; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; Groves JT, 1996, J AM CHEM SOC, V118, P8961, DOI 10.1021/ja9542092; IRWIN MA, 1973, PHYTOCHEMISTRY, V12, P849, DOI 10.1016/0031-9422(73)80689-2; Jennewein S, 2001, P NATL ACAD SCI USA, V98, P13595, DOI 10.1073/pnas.251539398; Levine SR, 2009, ORG LETT, V11, P289, DOI 10.1021/ol802409h; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Nicolaou K.C., 2008, MOL CHANGED WORLD; PAKNIKAR SK, 1977, INDIAN J CHEM B, V15, P86; RUZICKA L, 1953, EXPERIENTIA, V9, P357, DOI 10.1007/BF02167631; SCHREIBER J, 1955, HELV CHIM ACTA, V38, P1529, DOI 10.1002/hlca.19550380627; Wender PA, 2005, ORG LETT, V7, P79, DOI 10.1021/ol047859w; Wilson RM, 2007, J ORG CHEM, V72, P4293, DOI 10.1021/jo070871s; Wu QX, 2006, NAT PROD REP, V23, P699, DOI 10.1039/b606168k; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhao PJ, 2006, CHEM BIODIVERS, V3, P337, DOI 10.1002/cbdv.200690036	30	306	307	2	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					824	828		10.1038/nature08043	http://dx.doi.org/10.1038/nature08043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	459EV	19440196				2022-12-24	WOS:000267084500035
J	Andrew, TL; Tsai, HY; Menon, R				Andrew, Trisha L.; Tsai, Hsin-Yu; Menon, Rajesh			Confining Light to Deep Subwavelength Dimensions to Enable Optical Nanopatterning	SCIENCE			English	Article							MICROSCOPY; RESOLUTION; MEMORIES	In the past, the formation of microscale patterns in the far field by light has been diffractively limited in resolution to roughly half the wavelength of the radiation used. Here, we demonstrate lines with an average width of 36 nanometers (nm), about one-tenth the illuminating wavelength lambda(1) = 325 nm, made by applying a film of thermally stable photochromic molecules above the photoresist. Simultaneous irradiation of a second wavelength, lambda(2) = 633 nm, renders the film opaque to the writing beam except at nodal sites, which let through a spatially constrained segment of incident lambda(1) light, allowing subdiffractional patterning. The same experiment also demonstrates a patterning of periodic lines whose widths are about one-tenth their period, which is far smaller than what has been thought to be lithographically possible.	[Tsai, Hsin-Yu; Menon, Rajesh] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Menon, Rajesh] LumArray, Somerville, MA 02143 USA; [Tsai, Hsin-Yu] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Andrew, Trisha L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Menon, R (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	rmenon@mit.edu			LumArray [6916866]; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award [W31P4Q-05-C-R156]	LumArray; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank F. Stellacci and T. Swager for advice on synthesis of the photochromic molecules, H. Koh for the ellipsometric measurements, T. OReilly for assistance with the Lloyds-mirror interferometer, and H. Smith for suggestions on the manuscript. T.L.A. was partially funded by a subcontract (6916866) from LumArray. H.Y.T. was partially funded by an ignition grant from the MIT Deshpande Center for Technological Innovation. R.M. was partially funded by a Defense Advanced Research Projects Agency Small Business Innovation Research award (W31P4Q-05-C-R156). Three patents have been filed through MIT based on the work presented herein.	Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI 10.1007/ BF02956173; ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; Chovin A, 2004, NANO LETT, V4, P1965, DOI 10.1021/nl048824s; Crano JC, 1999, T APPL CHEM, P1; DARCY PJ, 1981, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19810000202; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Frey HG, 2002, APPL PHYS LETT, V81, P5030, DOI 10.1063/1.1530736; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Ito T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2227633; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Menon R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043905; Menon R, 2006, J OPT SOC AM A, V23, P2290, DOI 10.1364/JOSAA.23.002290; Menon R, 2009, J OPT SOC AM A, V26, P297, DOI 10.1364/JOSAA.26.000297; Murooka K, 2003, J VAC SCI TECHNOL B, V21, P2668, DOI 10.1116/1.1627803; Novotny L, 1998, ULTRAMICROSCOPY, V71, P341, DOI 10.1016/S0304-3991(97)00066-1; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Pease RF, 2005, MICROELECTRON ENG, V78-79, P381, DOI 10.1016/j.mee.2005.01.009; TAFLOVE A, 2000, COPUTATION ELECTRODY; Tsai HY, 2008, OPT LETT, V33, P2916, DOI 10.1364/OL.33.002916; Tsai HY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775092; Yin XB, 2002, APPL PHYS LETT, V81, P3663, DOI 10.1063/1.1519329; Yokoyama Y, 2000, CHEM REV, V100, P1717, DOI 10.1021/cr980070c	24	191	211	6	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					917	921		10.1126/science.1167704	http://dx.doi.org/10.1126/science.1167704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359545				2022-12-24	WOS:000266048800032
J	Simonetta, KR; Kazmirski, SL; Goedken, ER; Cantor, AJ; Kelch, BA; McNally, R; Seyedin, SN; Makino, DL; O'Donnell, M; Kuriyan, J				Simonetta, Kyle R.; Kazmirski, Steven L.; Goedken, Eric R.; Cantor, Aaron J.; Kelch, Brian A.; McNally, Randall; Seyedin, Steven N.; Makino, Debora L.; O'Donnell, Mike; Kuriyan, John			The Mechanism of ATP-Dependent Primer-Template Recognition by a Clamp Loader Complex	CELL			English	Article							DNA-POLYMERASE-III; REPLICATION FACTOR-C; CELL NUCLEAR ANTIGEN; ESCHERICHIA-COLI SSB; CRYSTAL-STRUCTURE; SLIDING CLAMP; GAMMA-COMPLEX; DELTA-SUBUNIT; STRUCTURAL-ANALYSIS; ACCESSORY PROTEINS	Clamp loaders load sliding clamps onto primer-template DNA. The structure of the E. coli clamp loader bound to DNA reveals the formation of an ATP-dependent spiral of ATPase domains that tracks only the template strand, allowing recognition of both RNA and DNA primers. Unlike hexameric helicases, in which DNA translocation requires distinct conformations of the ATPase domains, the clamp loader spiral is symmetric and is set up to trigger release upon DNA recognition. Specificity for primed DNA arises from blockage of the end of the primer and accommodation of the emerging template along a surface groove. A related structure reveals how the c protein, essential for coupling the clamp loader to single-stranded DNA-binding protein (SSB), binds to the clamp loader. By stabilizing a conformation of the clamp loader that is consistent with the ATPase spiral observed upon DNA binding, c binding promotes the clamp-loading activity of the complex.	[Simonetta, Kyle R.; Kazmirski, Steven L.; Goedken, Eric R.; Cantor, Aaron J.; Kelch, Brian A.; McNally, Randall; Seyedin, Steven N.; Makino, Debora L.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		McNally, Randall/0000-0002-1919-2466; O'Donnell, Michael/0000-0001-9002-4214; Cantor, Aaron/0000-0002-2158-6253; Seyedin, Steven/0000-0002-6841-968X	NIH [GM45547, GM38839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839, R01GM045547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank James Berger and members of the Kuriyan Lab, in particular Meindert Lamers, for helpful discussions. We are also thankful to David King for synthesis of the c peptide and to the staff at beamlines 8.2.1, 8.2.2, and 5.0.1 of the Advanced Light Source (Berkeley, CA) for their help and technical support. This work was supported in part by grants from the NIH to J. K. (GM45547) and M. O. (GM38839).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Ason B, 2003, J BIOL CHEM, V278, P10033, DOI 10.1074/jbc.M211741200; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Bowman GD, 2005, FEBS LETT, V579, P863, DOI 10.1016/j.febslet.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chen S, 2008, NUCLEIC ACIDS RES, V36, P3274, DOI 10.1093/nar/gkn157; Coman MM, 2004, J MOL BIOL, V342, P1457, DOI 10.1016/j.jmb.2004.07.097; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Goedken ER, 2004, J MOL BIOL, V336, P1047, DOI 10.1016/j.jmb.2003.12.074; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 2004, EUR J BIOCHEM, V271, P439, DOI 10.1046/j.1432-1033.2003.03944.x; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Jarvis TC, 2005, J BIOL CHEM, V280, P40465, DOI 10.1074/jbc.M508310200; Jarvis TC, 2005, J BIOL CHEM, V280, P7890, DOI 10.1074/jbc.M412263200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Ozawa K, 2005, J BIOMOL NMR, V32, P235, DOI 10.1007/s10858-005-7946-4; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	56	100	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					659	671		10.1016/j.cell.2009.03.044	http://dx.doi.org/10.1016/j.cell.2009.03.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450514	Green Accepted, Bronze			2022-12-24	WOS:000266114100015
J	Jankowska, EA; Rozentryt, P; Ponikowska, B; Hartmann, O; Kustrzycka-Kratochwil, D; Reczuch, K; Nowak, J; Borodulin-Nadzieja, L; Polonski, L; Banasiak, W; Poole-Wilson, PA; Anker, SD; Ponikowski, P				Jankowska, Ewa A.; Rozentryt, Piotr; Ponikowska, Beata; Hartmann, Oliver; Kustrzycka-Kratochwil, Dorota; Reczuch, Krzysztof; Nowak, Jolanta; Borodulin-Nadzieja, Ludmila; Polonski, Lech; Banasiak, Waldemar; Poole-Wilson, Philip A.; Anker, Stefan D.; Ponikowski, Piotr			Circulating Estradiol and Mortality in Men With Systolic Chronic Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOGENOUS SEX-HORMONES; ENDOTHELIAL PROGENITOR CELLS; TUMOR-NECROSIS-FACTOR; CARDIOVASCULAR-DISEASE; GENE VARIATION; BLOOD-FLOW; RISK; ASSOCIATION; DEFICIENCY	Context Androgen deficiency is common in men with chronic heart failure (HF) and is associated with increased morbidity and mortality. Estrogens are formed by the aromatization of androgens; therefore, abnormal estrogen metabolism would be anticipated in HF. Objective To examine the relationship between serum concentration of estradiol and mortality in men with chronic HF and reduced left ventricular ejection fraction (LVEF). Design, Setting, and Participants A prospective observational study at 2 tertiary cardiology centers (Wroclaw and Zabrze, Poland) of 501 men (mean [SD] age, 58 [ 12] years) with chronic HF, LVEF of 28% (SD, 8%), and New York Heart Association [NYHA] classes 1, 2, 3, and 4 of 52, 231, 181, and 37, respectively, who were recruited between January 1, 2002, and May 31, 2006. Cohort was divided into quintiles of serum estradiol (quintile 1, < 12.90 pg/mL; quintile 2, 12.90-21.79 pg/mL; quintile 3, 21.80-30.11 pg/mL; quintile 4, 30.12-37.39 pg/mL; and quintile 5, >= 37.40 pg/mL). Quintile 3 was considered prospectively as the reference group. Main Outcome Measures Serum concentrations of estradiol and androgens (total testosterone and dehydroepiandrosterone sulfate [DHEA-S]) were measured using immunoassays. Results Among 501 men with chronic HF, 171 deaths (34%) occurred during the 3-year follow-up. Compared with quintile 3, men in the lowest and highest estradiol quintiles had increased mortality (adjusted hazard ratio [HR], 4.17; 95% confidence interval [CI], 2.33-7.45 and HR, 2.33; 95% CI, 1.30-4.18; respectively; P < .001). These 2 quintiles had different clinical characteristics (quintile 1: increased serum total testosterone, decreased serum DHEA- S, advanced NYHA class, impaired renal function, and decreased total fat tissue mass; and quintile 5: increased serum bilirubin and liver enzymes, and decreased serum sodium; all P < .05 vs quintile 3). For increasing estradiol quintiles, 3-year survival rates adjusted for clinical variables and androgens were 44.6% ( 95% CI, 24.4%-63.0%), 65.8% (95% CI, 47.3%-79.2%), 82.4% (95% CI, 69.4%-90.2%), 79.0% ( 95% CI, 65.5%-87.6%), and 63.6% (95% CI, 46.6%-76.5%); respectively (P < .001). Conclusion Among men with chronic HF and reduced LVEF, high and low concentrations of estradiol compared with the middle quintile of estradiol are related to an increased mortality. JAMA. 2009;301(18):1892-1901 www.jama.com	[Jankowska, Ewa A.; Kustrzycka-Kratochwil, Dorota; Reczuch, Krzysztof; Banasiak, Waldemar; Ponikowski, Piotr] Mil Hosp, Dept Cardiol, Ctr Heart Dis, PL-50981 Wroclaw, Poland; [Jankowska, Ewa A.] Polish Acad Sci, Inst Anthropol, Wroclaw, Poland; [Jankowska, Ewa A.; Reczuch, Krzysztof; Ponikowski, Piotr] Wroclaw Med Univ, Dept Heart Dis, Wroclaw, Poland; [Ponikowska, Beata; Borodulin-Nadzieja, Ludmila] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Rozentryt, Piotr; Nowak, Jolanta; Polonski, Lech] Silesian Ctr Heart Dis, Dept Cardiol 2, Zabrze, Poland; [Hartmann, Oliver; Anker, Stefan D.] Charite, Dept Cardiol, Div Appl Cachexia Res, Berlin, Germany; [Anker, Stefan D.] Ist Ricovero & Cura Carattere Sci, Ctr Clin & Basic Res, Rome, Italy; [Poole-Wilson, Philip A.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England	Polish Academy of Sciences; Wroclaw Medical University; Wroclaw Medical University; Silesian Center for Heart Diseases; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; Imperial College London; Royal Brompton Hospital	Jankowska, EA (corresponding author), Mil Hosp, Dept Cardiol, Ctr Heart Dis, Ul Weigla 5, PL-50981 Wroclaw, Poland.	jankowska@antro.pan.wroc.pl	Ponikowski, Piotr/O-6454-2015; Jankowska, Ewa A/AAY-3040-2020; Reczuch, Krzysztof/ABI-1216-2020; Jankowska, Ewa A/G-7960-2011; Jankowska, Ewa A/O-6358-2015; Jankowska, Ewa/ABD-4073-2021	Ponikowski, Piotr/0000-0002-3391-7064; Jankowska, Ewa A/0000-0002-9202-432X; Reczuch, Krzysztof/0000-0002-1699-739X; Jankowska, Ewa A/0000-0002-9202-432X; Nowak, Jolanta/0000-0003-0462-0154; Rozentryt, Piotr/0000-0002-8979-2205	Polish Ministry of Science and Higher Education [3 T11F 008 30]; Polish Science Foundation	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Science Foundation(Foundation for Polish Science)	This research was supported by grant 3 T11F 008 30 from the Polish Ministry of Science and Higher Education (costs of the laboratory assessments). Dr Jankowska was supported by a Postdoctoral Research Fellowship from the Polish Science Foundation.	Abbott RD, 2007, NEUROLOGY, V68, P563, DOI 10.1212/01.wnl.0000254473.88647.ca; Adamopoulos S, 2002, EUR J HEART FAIL, V4, P719, DOI 10.1016/S1388-9842(02)00170-8; Angstwurm MWA, 2005, CRIT CARE MED, V33, P2786, DOI 10.1097/01.CCM.0000190242.24410.17; Anker SD, 1997, EUR HEART J, V18, P259; Anker SD, 1997, J AM COLL CARDIOL, V30, P997, DOI 10.1016/S0735-1097(97)00262-3; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Anker SD, 1997, CIRCULATION, V96, P526; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Cavasin MA, 2003, AM J PHYSIOL-HEART C, V284, pH1560, DOI 10.1152/ajpheart.01087.2002; Forster C, 2004, P NATL ACAD SCI USA, V101, P14234, DOI 10.1073/pnas.0405571101; FRIEDMAN HS, 1995, ALCOHOL CLIN EXP RES, V19, P123, DOI 10.1111/j.1530-0277.1995.tb01479.x; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Harrell FE, 2001, REGRESSION MODELING; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jankowska EA, 2006, CIRCULATION, V114, P1829, DOI 10.1161/CIRCULATIONAHA.106.649426; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Kadokami T, 2005, J INTERF CYTOK RES, V25, P254, DOI 10.1089/jir.2005.25.254; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Komesaroff PA, 2001, HYPERTENSION, V38, P1011, DOI 10.1161/hy1101.095006; Kunnas TA, 2000, BRIT MED J, V321, P273, DOI 10.1136/bmj.321.7256.273; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li J, 2008, STEROIDS, V73, P720, DOI 10.1016/j.steroids.2008.02.011; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; Muller M, 2003, J CLIN ENDOCR METAB, V88, P5076, DOI 10.1210/jc.2003-030611; Murata Y, 2002, MOL CELL ENDOCRINOL, V193, P7, DOI 10.1016/S0303-7207(02)00090-4; Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51; Rochira V, 2002, MOL CELL ENDOCRINOL, V193, P19, DOI 10.1016/S0303-7207(02)00092-8; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Shearman AM, 2005, STROKE, V36, P2281, DOI 10.1161/01.STR.0000181088.76518.ec; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Song WC, 1998, J PHARMACOL EXP THER, V284, P1197; Spratt DI, 2006, AM J PHYSIOL-ENDOC M, V291, pE631, DOI 10.1152/ajpendo.00467.2005; Sudhir K, 1999, J CLIN ENDOCR METAB, V84, P3411, DOI 10.1210/jc.84.10.3411; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yoshioka J, 2004, NUCL MED COMMUN, V25, P557, DOI 10.1097/01.mnm.0000126624.79048.70; Yu AM, 2005, ENDOCRINOLOGY, V146, P2911, DOI 10.1210/en.2004-1248; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047	43	69	73	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 13	2009	301	18					1892	1901		10.1001/jama.2009.639	http://dx.doi.org/10.1001/jama.2009.639			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444JX	19436016				2022-12-24	WOS:000265978400027
J	Sharma, G; Fletcher, KE; Zhang, D; Kuo, YF; Freeman, JL; Goodwin, JS				Sharma, Gulshan; Fletcher, Kathlyn E.; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.			Continuity of Outpatient and Inpatient Care by Primary Care Physicians for Hospitalized Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROVIDER CONTINUITY; UNITED-STATES; INFORMATION-TECHNOLOGY; PATIENT RELATIONSHIP; PREVENTIVE SERVICES; FAMILY PHYSICIANS; HEALTH-CARE; CLAIMS DATA; QUALITY; CANCER	Context Little is known about the extent of continuity of care across the transition from outpatient care to hospitalization. Objectives To describe continuity of care in older hospitalized patients, change in continuity over time, and factors associated with discontinuity. Design, Setting, and Participants A retrospective cohort study of 3 020 770 hospital admissions between 1996 and 2006 using enrollment and claims data for a 5% national sample of Medicare beneficiaries older than 66 years. Data files were constructed to include the patients' demographic and enrollment information (denominator file) and claims for hospital stays (MEDPAR file) and physician services (carrier claims file). Characteristics of the hospitals were included in annual provider of services files. Being seen by a physician was defined as when a physician had submitted a bill for evaluation and management services for that patient. Main Outcome Measures Percentage of patients who during hospitalization were seen by any outpatient physician they had visited in the year before hospitalization ( continuity with any outpatient physician) or by their primary care physician (PCP) (continuity with a PCP). Results In 1996, 50.5% (95% confidence interval [CI], 50.3%-50.7%) of hospitalized patients were seen by at least 1 physician that they had visited in an outpatient setting in the prior year, and 44.3% (95% CI, 44.1%-44.6%) of patients with an identifiable PCP were seen by that physician while hospitalized. These percentages decreased to 39.8% ( 95% CI, 39.6%-40.0%) and 31.9% (95% CI, 31.6%-32.1%), respectively, in 2006. Greater absolute decreases in continuity with any outpatient physician between 1996 and 2006 occurred in patients admitted on weekends (13.9%; 95% CI, 12.9%-14.7%) and those living in large metropolitan areas (11.7%; 95% CI, 11.1%12.3%) and in New England (16.2%; 95% CI, 14.4%-18.0%). In multivariable multilevel models, increasing involvement of hospitalists was associated with approximately one-third of the decrease in continuity of care between 1996 and 2006. Conclusion Between 1996 and 2006, physician continuity from outpatient to inpatient settings decreased in the Medicare population.	[Sharma, Gulshan; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sharma, Gulshan; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Dept Gen Internal Med, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Medical College of Wisconsin; Medical College of Wisconsin	Sharma, G (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd,JSA 5-112, Galveston, TX 77555 USA.	gulshan.sharma@utmb.edu			National Cancer Institute [P50 CA 105631]; National Institute on Aging [K-08 AG 031583, P60 AG 17231]; NATIONAL CANCER INSTITUTE [K05CA134923, P50CA105631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG017231, K08AG031583, P30AG024832] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P50 CA 105631 from the National Cancer Institute and grants K-08 AG 031583 and P60 AG 17231 from the National Institute on Aging.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Arora V, 2009, ARCH INTERN MED, V169, P199, DOI 10.1001/archinternmed.2008.565; Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; Bach PB, 2002, MED CARE, V40, P19; Baldwin LM, 2002, MED CARE, V40, P82; Bates DW, 2005, HEALTH AFFAIR, V24, P1180, DOI 10.1377/hlthaff.24.5.1180; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1976, J HEALTH SOC BEHAV, V17, P339, DOI 10.2307/2136712; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Burge Frederick, 2003, J Palliat Med, V6, P911, DOI 10.1089/109662103322654794; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; Citro R, 1997, IEEE Trans Inf Technol Biomed, V1, P189, DOI 10.1109/4233.654862; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; *COMM FUT PRIM CAR, 1996, PRIM CAR AM HLTH NEW; *CTR MED MED SERV, NON DAT FIL PROV SER; *CTR MED MED SERV, STAND AN FIL; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Finison K S, 1999, Eff Clin Pract, V2, P120; Freese RB, 1999, ANN INTERN MED, V130, P350, DOI 10.7326/0003-4819-130-4-199902161-00004; Gallagher TC, 2001, MED CARE, V39, P1086, DOI 10.1097/00005650-200110000-00006; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Love MM, 2000, J FAM PRACTICE, V49, P998; Mainous AG, 2001, FAM MED, V33, P22; Mainous AG, 2004, ANN FAM MED, V2, P452, DOI 10.1370/afm.84; Mainous AG, 2004, FAM MED, V36, P35; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Moore Kent J, 2005, Fam Pract Manag, V12, P29; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Pantilat SZ, 2001, AM J MED, V111, P15, DOI 10.1016/S0002-9343(01)00964-0; Parchman ML, 2004, FAM MED, V36, P22; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Research Data Assistance Center, MED DAT FIL DESCR; Riall TS, 2007, J GASTROINTEST SURG, V11, P1242, DOI 10.1007/s11605-007-0245-5; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1499, DOI 10.1007/s11606-008-0692-z; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Scholle SH, 2009, AM J MANAG CARE, V15, P67; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Shahinian VB, 2007, J CLIN ONCOL, V25, P5359, DOI 10.1200/JCO.2006.09.9580; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; SHEAR CL, 1983, MED CARE, V21, P1204, DOI 10.1097/00005650-198312000-00007; Slater B, 1996, Int J Health Care Qual Assur, V9, P34, DOI 10.1108/09526869610109143; SMEDBY O, 1986, MED CARE, V24, P511; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Stokes T, 2005, ANN FAM MED, V3, P353, DOI 10.1370/afm.351; US Census Bureau, CENS REG DIV US; Weiner M, 2006, J GEN INTERN MED, V21, pS35, DOI 10.1111/j.1525-1497.2006.00307.x; Weiner M, 2003, ANN INTERN MED, V139, P430, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00010; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	64	85	85	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1671	1680		10.1001/jama.2009.517	http://dx.doi.org/10.1001/jama.2009.517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383958	Bronze, Green Accepted			2022-12-24	WOS:000265350700023
J	Reithinger, R; Tarleton, RL; Urbina, JA; Kitron, U; Gurtler, RE				Reithinger, Richard; Tarleton, Rick L.; Urbina, Julio A.; Kitron, Uriel; Guertler, Ricardo E.			Eliminating Chagas disease: challenges and a roadmap	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRYPANOSOMA-CRUZI; TRANSMISSION		[Reithinger, Richard] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England; [Tarleton, Rick L.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Urbina, Julio A.] Inst Venezolano Invest Cient, Caracas, Venezuela; [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Guertler, Ricardo E.] Univ Buenos Aires, Dept Ecol Genet & Evolut, Buenos Aires, DF, Argentina	University of London; London School of Hygiene & Tropical Medicine; University System of Georgia; University of Georgia; Venezuelan Institute Science Research; Emory University; University of Buenos Aires	Reithinger, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	rreithinger@yahoo.co.uk	Tarleton, Rick/AES-8572-2022	Kitron, Uriel/0000-0003-0493-2043; Reithinger, Richard/0000-0001-5710-1556; Tarleton, Rick/0000-0002-9589-5243	FOGARTY INTERNATIONAL CENTER [R01TW005836] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW005836-01, R01 TW005836] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Attaran A, 2006, LANCET, V368, P1768, DOI 10.1016/S0140-6736(06)69730-4; Beard CB, 2003, EMERG INFECT DIS, V9, P103, DOI 10.3201/eid0901.020217; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; *CAMP ACC ESS MED, 2008, REV SOC BREAS MED TR, V41, P315; *COMM DIS CTR, PAR HLTH TRYP; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Diaz JH, 2008, J TRAVEL MED, V15, P184, DOI 10.1111/j.1708-8305.2008.00205.x; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Kroeger A, 2003, AM J TROP MED HYG, V68, P307, DOI 10.4269/ajtmh.2003.68.307; Leiby DA, 2008, J INFECT DIS, V198, P609, DOI 10.1086/590159; Lescure FX, 2008, EMERG INFECT DIS, V14, P644, DOI 10.3201/eid1404.070489; *MIN SAL, 2006, GUIAS AT PAC INF TRY; Pirard M, 2005, TRANSFUSION, V45, P554, DOI 10.1111/j.0041-1132.2005.04214.x; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Reithinger R, 2006, AM J TROP MED HYG, V74, P766, DOI 10.4269/ajtmh.2006.74.766; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; *SCR SAL, INF EP MOB 2005 VERS; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; *WHO, NEW GLOB EFF EL CHAN; *WHO, STRAT DIR RES DIS BU; *WHO, 2004, WHO REP 2004 CHANG H; WHO Expert Committee, 2002, CONTR CHAG DIS; World Health Organization, 2007, WHO CONS INT BIOL RE; Yabsley MJ, 2002, J WILDLIFE DIS, V38, P75, DOI 10.7589/0090-3558-38.1.75; YADON ZE, 2006, DECENTRALIZACION GES; [No title captured]; [No title captured]	30	39	39	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1283	10.1136/bmj.b1283	http://dx.doi.org/10.1136/bmj.b1283			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TI	19366739	Green Accepted, Green Published			2022-12-24	WOS:000265296600003
J	Konhauser, KO; Pecoits, E; Lalonde, SV; Papineau, D; Nisbet, EG; Barley, ME; Arndt, NT; Zahnle, K; Kamber, BS				Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.; Papineau, Dominic; Nisbet, Euan G.; Barley, Mark E.; Arndt, Nicholas T.; Zahnle, Kevin; Kamber, Balz S.			Oceanic nickel depletion and a methanogen famine before the Great Oxidation Event	NATURE			English	Article							RISE; NI; GEOCHEMISTRY; TECTONICS; CHEMISTRY; SULFUR; GROWTH; CRUST; IRON; PB	It has been suggested that a decrease in atmospheric methane levels triggered the progressive rise of atmospheric oxygen, the so-called Great Oxidation Event, about 2.4 Gyr ago(1). Oxidative weathering of terrestrial sulphides, increased oceanic sulphate, and the ecological success of sulphate-reducing microorganisms over methanogens has been proposed as a possible cause for the methane collapse(1), but this explanation is difficult to reconcile with the rock record(2,3). Banded iron formations preserve a history of Precambrian oceanic elemental abundance and can provide insights into our understanding of early microbial life and its influence on the evolution of the Earth system(4,5). Here we report a decline in the molar nickel to iron ratio recorded in banded iron formations about 2.7 Gyr ago, which we attribute to a reduced flux of nickel to the oceans, a consequence of cooling upper-mantle temperatures and decreased eruption of nickel-rich ultramafic rocks at the time. We measured nickel partition coefficients between simulated Precambrian sea water and diverse iron hydroxides, and subsequently determined that dissolved nickel concentrations may have reached similar to 400nM throughout much of the Archaean eon, but dropped below similar to 200nM by 2.5 Gyr ago and to modern day values(6) (similar to 9 nM) by similar to 550 Myr ago. Nickel is a key metal cofactor in several enzymes of methanogens(7) and we propose that its decline would have stifled their activity in the ancient oceans and disrupted the supply of biogenic methane. A decline in biogenic methane production therefore could have occurred before increasing environmental oxygenation and not necessarily be related to it. The enzymatic reliance of methanogens on a diminishing supply of volcanic nickel links mantle evolution to the redox state of the atmosphere.	[Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Papineau, Dominic] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Nisbet, Euan G.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Arndt, Nicholas T.] Univ Grenoble 1, Lab Geodynam Chaine Alpines Maison Geosci, F-38041 Grenoble, France; [Zahnle, Kevin] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Kamber, Balz S.] Laurentian Univ, Dept Earth Sci, Sudbury, ON P3E 2C6, Canada	University of Alberta; Carnegie Institution for Science; University of London; Royal Holloway University London; University of Western Australia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Laurentian University	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Papineau, Dominic/AAD-6366-2019; Kamber, Balz/A-1823-2008	Konhauser, Kurt/0000-0001-7722-7068; Kamber, Balz/0000-0002-8720-0608; Papineau, Dominic/0000-0003-0063-7514	Natural Science and Engineering Research Council of Canada (NSERC); Australian Research Council (ARC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council (ARC)(Australian Research Council)	We thank M. Labbe for sample preparation, G. Chen and A. Simonetti for assistance with LA-ICP-MS analyses in the Radiogenic Isotope Facility at the University of Alberta, and S. Matveev for assistance with electron microprobe analyses. Field assistance by W. Mueller is acknowledged for Hunter Mine Group samples. Samples from the Loch Maree Group were provided by A. Wright. Funding was provided by the Natural Science and Engineering Research Council of Canada (NSERC) to K. O. K., the Canada Research Chairs Program to B. S. K., the Australian Research Council (ARC) to M. E. B., and NASA Exobiology and Evolutionary Biology Program individually to D. P. and K. Z. This manuscript was improved by discussions with R. Buick, J. Kasting and M. Lesher, and reviews by R. Frei and M. Saito.	Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; ARNDT NT, 1991, TECTONOPHYSICS, V187, P411, DOI 10.1016/0040-1951(91)90479-C; Barley ME, 1998, PRECAMBRIAN RES, V91, P65, DOI 10.1016/S0301-9268(98)00039-4; Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Basiliko N, 2001, BIOGEOCHEMISTRY, V52, P133, DOI 10.1023/A:1006461803585; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Catling DC, 2007, PHILOS T R SOC A, V365, P1867, DOI 10.1098/rsta.2007.2047; Chester R., 2000, MARINE GEOCHEMISTRY; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; DIEKERT G, 1980, ARCH MICROBIOL, V127, P273, DOI 10.1007/BF00427204; Drever J.I., 1988, GEOCHEMISTRY NATURAL; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; Hannington MD, 2003, MINER DEPOSITA, V38, P393, DOI 10.1007/s00126-002-0298-z; Hausrath EM, 2007, GEOBIOLOGY, V5, P49, DOI 10.1111/j.1472-4669.2007.00095.x; JARRELL KF, 1982, J BACTERIOL, V149, P346, DOI 10.1128/JB.149.1.346-353.1982; JAUN B, 2007, METAL IONS LIFE SCI, V0002, P00323; Kamber BS, 2005, EARTH PLANET SC LETT, V240, P276, DOI 10.1016/j.epsl.2005.09.037; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; KEAYS RR, 1995, LITHOS, V34, P1; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kida K, 2001, J BIOSCI BIOENG, V91, P590, DOI 10.1263/jbb.91.590; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MCLENNAN SM, 1983, GEOCHIM COSMOCHIM AC, V47, P1211, DOI 10.1016/0016-7037(83)90063-7; Nisbet E.G., 1982, KOMATIITES, P501; OZTURK M, 1995, MAR CHEM, V48, P329, DOI 10.1016/0304-4203(95)92785-Q; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Saito MA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002216; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Taylor S.R., 1985, CONTINENTAL CRUST IT, DOI DOI 10.1002/GJ.3350210116; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TRENDALL AF, 2002, SPECIAL PUBLICATION, V33, P33, DOI DOI 10.1016/J.PRECAMRES.2016.04.016; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	40	304	323	8	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					750	U85		10.1038/nature07858	http://dx.doi.org/10.1038/nature07858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360085				2022-12-24	WOS:000265193600038
J	TaufiqUrRahman; Skupin, A; Falcke, M; Taylor, CW				TaufiqUrRahman; Skupin, Alexander; Falcke, Martin; Taylor, Colin W.			Clustering of InsP(3) receptors by InsP(3) retunes their regulation by InsP(3) and Ca2+	NATURE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; CHANNELS RYANODINE RECEPTORS; CALCIUM-RELEASE CHANNELS; IP3 RECEPTORS; SPATIAL-DISTRIBUTION; XENOPUS OOCYTES; INACTIVATION; MEMBRANE; PATTERNS; KINETICS	The versatility of Ca2+ signals derives from their spatio-temporal organization(1,2). For Ca2+ signals initiated by inositol-1,4,5-trisphosphate (InsP(3)), this requires local interactions between InsP(3) receptors (InsP(3)Rs)(3,4) mediated by their rapid stimulation and slower inhibition(4) by cytosolic Ca2+. This allows hierarchical recruitment of Ca2+ release events as the InsP(3) concentration increases(5). Single InsP(3)Rs respond first, then clustered InsP(3)Rs open together giving a local 'Ca2+ puff', and as puffs become more frequent they ignite regenerative Ca2+ waves(1,5-9). Using nuclear patch-clamp recording(10), here we demonstrate that InsP(3)Rs are initially randomly distributed with an estimated separation of similar to 1 mu m. Low concentrations of InsP(3) cause InsP(3)Rs to aggregate rapidly and reversibly into small clusters of about four closely associated InsP(3)Rs. At resting cytosolic [Ca2+], clustered InsP(3)Rs open independently, but with lower open probability, shorter open time, and less InsP(3) sensitivity than lone InsP(3)Rs. Increasing cytosolic [Ca2+] reverses the inhibition caused by clustering, InsP(3)R gating becomes coupled, and the duration of multiple openings is prolonged. Clustering both exposes InsP(3)Rs to local Ca2+ rises and increases the effects of Ca2+. Dynamic regulation of clustering by InsP(3) retunes InsP(3)R sensitivity to InsP(3) and Ca2+, facilitating hierarchical recruitment of the elementary events that underlie all InsP(3)-evoked Ca2+ signals(3,5).	[TaufiqUrRahman; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Skupin, Alexander; Falcke, Martin] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Falcke, Martin] Helmholtz Ctr Berlin Mat & Energy, D-14109 Berlin, Germany	University of Cambridge; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114; SKUPIN, Alexander/0000-0002-8955-8304	The Wellcome Trust; The Biotechnology and Biological Sciences Research Council; Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft	The Wellcome Trust(Wellcome TrustEuropean Commission); The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by The Wellcome Trust ( C. W. T.), The Biotechnology and Biological Sciences Research Council ( C. W. T.), a scholarship from the Jameel Family Trust (T.-U.-R.), and the IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft ( A. S.). We thank S. Dedos for help with DT40 cells, D. Prole and B. Billups for advice, and T. Kurosaki for providing DT40-KO cells.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Katayama E, 1996, EMBO J, V15, P4844, DOI 10.1002/j.1460-2075.1996.tb00865.x; Mak DOD, 1998, AM J PHYSIOL-CELL PH, V275, pC179, DOI 10.1152/ajpcell.1998.275.1.C179; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Prole DL, 2003, J GEN PHYSIOL, V122, P775, DOI 10.1085/jgp.200308897; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Sneyd J, 2005, PROG BIOPHYS MOL BIO, V89, P207, DOI 10.1016/j.pbiomolbio.2004.11.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002	26	107	108	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					655	659		10.1038/nature07763	http://dx.doi.org/10.1038/nature07763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19348050	Green Accepted			2022-12-24	WOS:000264796200046
J	Moorthy, V; Smith, PG; Kieny, MP				Moorthy, Vasee; Smith, Peter G.; Kieny, Marie-Paule			A vaccine against malaria: a substantial step forward	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM INFECTION; RANDOMIZED CONTROLLED-TRIAL; EFFICACY; CHILDREN; PROTECTION; DISEASE		[Moorthy, Vasee; Kieny, Marie-Paule] WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland; [Moorthy, Vasee] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Smith, Peter G.] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Moorthy, V (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland.	vasee.moorthy@gmail.com	Kieny, Marie-Paule/Q-1238-2019; smith, peter/ABH-9627-2020; Kieny, Marie-Paule/N-3914-2017	smith, peter/0000-0003-0080-7560; Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy, Vasee/0000-0002-6535-2854	MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Epstein JE, 2007, LANCET, V370, P1523, DOI 10.1016/S0140-6736(07)61642-0; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Smith PG, 2005, LANCET, V365, P472	10	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1411	1412		10.1016/S0140-6736(09)60802-3	http://dx.doi.org/10.1016/S0140-6736(09)60802-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394521				2022-12-24	WOS:000265501900010
J	Trivedi, V; Boire, A; Tchemychev, B; Kaneider, NC; Leger, AJ; O'Callaghan, K; Covic, L; Kuliopulos, A				Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan			Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site	CELL			English	Article							TISSUE FACTOR; THROMBIN RECEPTOR; CLEAVAGE SITE; INHIBITION; COLLAGEN; RELEASE; HEMOSTASIS; FAMILY; GROWTH; BLOOD	Matrix metalloproteases (MMPs) play important roles in normal and pathological remodeling processes including atherothrombotic disease, inflammation, angiogenesis, and cancer. MMPs have been viewed as matrix-degrading enzymes, but recent studies have shown that they possess direct signaling capabilities. Platelets harbor several MMPs that modulate hemostatic function and platelet survival; however their mode of action remains unknown. We show that platelet MMP-1 activates protease-activated receptor-1 (PAR1) on the surface of platelets. Exposure of platelets to fibrillar collagen converts the surface-bound proMMP-1 zymogen to active MMP-1, which promotes aggregation through PAR1. Unexpectedly, MMP-1 cleaves PAR1 at a distinct site that strongly activates Rho-GTP pathways, cell shape change and motility, and MAPK signaling. Blockade of MMP1-PAR1 curtails thrombogenesis under arterial flow conditions and inhibits thrombosis in animals. These studies provide a link between matrix-dependent activation of metalloproteases and platelet-G protein signaling and identify MMP1-PAR1 as a potential target for the prevention of arterial thrombosis.	[Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, Boston, MA 02111 USA; [Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Biochem,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Boire, Adrienne/AAA-3578-2022; Boire, Adrienne/AAJ-9352-2021	Boire, Adrienne/0000-0002-9029-1248; Boire, Adrienne/0000-0002-9029-1248	NIH [R01 HL-57905, R01 HL-64701, R01 CA-122992]; NATIONAL CANCER INSTITUTE [R01CA122992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701, R01HL057905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support from NIH R01 HL-57905, R01 HL-64701, and R01 CA-122992 (to A. K.) is gratefully acknowledged. A. K. and L. C. are founders of Ascent Therapeutics and are members of its scientific advisory board. Ascent Therapeutics has licensed the pepducins used in this study.	Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; BERMAN J, 1992, J BIOL CHEM, V267, P1434; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; CHESNEY CM, 1974, J CLIN INVEST, V53, P1647, DOI 10.1172/JCI107715; Conant K, 2004, J BIOL CHEM, V279, P8056, DOI 10.1074/jbc.M307051200; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; FRESSINAUD E, 1992, BLOOD, V80, P988; Galt SW, 2002, CIRC RES, V90, P1093, DOI 10.1161/01.RES.0000019241.12929.EB; GAST A, 1994, ARTERIOSCLER THROMB, V14, P1466, DOI 10.1161/01.ATV.14.9.1466; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Huebner JL, 1998, ARTHRITIS RHEUM-US, V41, P877, DOI 10.1002/1529-0131(199805)41:5<877::AID-ART16>3.0.CO;2-#; INAUEN W, 1990, ARTERIOSCLEROSIS, V10, P607, DOI 10.1161/01.ATV.10.4.607; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kazes I, 2000, BLOOD, V96, P3064, DOI 10.1182/blood.V96.9.3064.h8003064_3064_3069; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mann KG, 2007, J THROMB HAEMOST, V5, P2055, DOI 10.1111/j.1538-7836.2007.02710.x; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sawicki G, 1997, NATURE, V386, P616, DOI 10.1038/386616a0; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Stephens G, 2005, BLOOD, V105, P186, DOI 10.1182/blood-2004-07-2842; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Suzuki H, 2008, EUR J CLIN INVEST, V38, P166, DOI 10.1111/j.1365-2362.2007.01919.x; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	43	194	200	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					332	343		10.1016/j.cell.2009.02.018	http://dx.doi.org/10.1016/j.cell.2009.02.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379698	Green Accepted, Bronze			2022-12-24	WOS:000265456800025
J	Whitehouse, PJ; George, D				Whitehouse, Peter J.; George, Daniel			The art of medicine Banking on stories for healthier cognitive ageing	LANCET			English	Editorial Material									[Whitehouse, Peter J.] Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA; Univ Oxford Hertford Coll, Oxford, England	Case Western Reserve University; University of Oxford	Whitehouse, PJ (corresponding author), Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA.	peter.whitehouse@case.edu						Ballenger JF, 2006, SELF SENILITY ALZHEI; Kleinman A., 1988, ILLNESS NARRATIVES; Stein J, 2008, ENV THREATS HLTH AGI; Whitehouse P, 2008, MYTH ALZHEIMERS WHAT; WHITEHOUSE PJ, 1997, CONCEPTS ALZHEIMER D	5	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1166	1167		10.1016/S0140-6736(09)60672-3	http://dx.doi.org/10.1016/S0140-6736(09)60672-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19350706				2022-12-24	WOS:000264940600014
J	Matsumoto-Miyai, K; Sokolowska, E; Zurlinden, A; Gee, CE; Luscher, D; Hettwer, S; Wolfel, J; Ladner, AP; Ster, J; Gerber, U; Rulicke, T; Kunz, B; Sonderegger, P				Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Gee, Christine E.; Luescher, Daniel; Hettwer, Stefan; Woelfel, Jens; Ladner, Ana Paula; Ster, Jeanne; Gerber, Urs; Ruelicke, Thomas; Kunz, Beat; Sonderegger, Peter			Coincident Pre- and Postsynaptic Activation Induces Dendritic Filopodia via Neurotrypsin-Dependent Agrin Cleavage	CELL			English	Article							LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; HIPPOCAMPAL-NEURONS; SPINE FORMATION; NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; NERVOUS-SYSTEM; AREA CA1; GROWTH	The synaptic serine protease neurotrypsin is essential for cognitive function, as its deficiency in humans results in severe mental retardation. Recently, we demonstrated the activity-dependent release of neurotrypsin from presynaptic terminals and proteolytical cleavage of agrin at the synapse. Here we show that the activity-dependent formation of dendritic filopodia is abolished in hippocampal neurons from neurotrypsin-deficient mice. Administration of the neurotrypsin-dependent 22 kDa fragment of agrin rescues the filopodial response. Detailed analyses indicated that presynaptic action potential firing is necessary for the release of neurotrypsin, whereas postsynaptic NMDA receptor activation is necessary for the neurotrypsin-dependent cleavage of agrin. This contingency characterizes the neurotrypsinagrin system as a coincidence detector of pre-and postsynaptic activation. As the resulting dendritic filopodia are thought to represent precursors of synapses, the neurotrypsin-dependent cleavage of agrin at the synapse may be instrumental for a Hebbian organization and remodeling of synaptic circuits in the CNS.	[Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Luescher, Daniel; Woelfel, Jens; Ladner, Ana Paula; Kunz, Beat; Sonderegger, Peter] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Gee, Christine E.; Ster, Jeanne; Gerber, Urs] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Ruelicke, Thomas] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Hettwer, Stefan] Neurotune AG, CH-8952 Schlieren, Switzerland	University of Zurich; University of Zurich; University of Zurich	Sonderegger, P (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	peter.sonderegger@bioc.uzh.ch	Gee, Christine E/E-9241-2013	Gee, Christine E/0000-0003-0345-3665; Ster, Jeanne/0000-0002-7277-9135	Swiss National Science Foundation; Olga Mayenfisch Stiftung; Neurotune AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Olga Mayenfisch Stiftung; Neurotune AG	We thank P. Caroni for the mouse line L15 expressing membrane-targeted GFP in sparse neurons, G. Miesenbock for the cDNA of superecliptic pHluorin, D. Blaser for mouse husbandry, and B. Gahwiler for critical reading of the manuscript. This work was supported by grants of the Swiss National Science Foundation, the National Center of Competence in Research "Brain Plasticity and Repair'' of the Swiss National Science Foundation, and the Olga Mayenfisch Stiftung. P. S. is a cofounder and minor shareholder (<1%) of Neurotune AG. Part of this work (<10%) was financially supported by Neurotune AG.	Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; HANSE E, 1994, J NEUROSCI, V14, P5028; Hebb Donald O., 1949, ORG BEHAV; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Knott G, 2008, BRAIN RES REV, V58, P282, DOI 10.1016/j.brainresrev.2008.01.002; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Koulen P, 1999, EUR J NEUROSCI, V11, P4188, DOI 10.1046/j.1460-9568.1999.00848.x; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Li J, 2001, NEUROSCIENCE, V105, P589, DOI 10.1016/S0306-4522(01)00204-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Saito Y, 1997, J NEUROSCI, V17, P8792; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	54	83	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1161	1171		10.1016/j.cell.2009.02.034	http://dx.doi.org/10.1016/j.cell.2009.02.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303856	Bronze, Green Accepted			2022-12-24	WOS:000264403900020
J	Katz, PR; Karuza, J; Intrator, O; Mor, V				Katz, Paul R.; Karuza, Jurgis; Intrator, Orna; Mor, Vincent			Nursing Home Physician Specialists: A Response to the Workforce Crisis in Long-Term Care	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL MEDICINE; INTERNAL-MEDICINE; RESIDENTS; QUALITY; PATTERNS; STATE; STAFF	Marginalization of physicians in the nursing home threatens the overall care of increasingly frail nursing home residents who have medically complex illnesses. The authors propose that creating a nursing home medicine specialty, which recognizes the nursing home as a unique practice site, would go a long way toward remedying existing problems with care in skilled nursing facilities and would best serve the needs of the 1.6 million nursing home residents in the United States. Reviewing what is known about physician practice in nursing homes and hospitals, and taking a lead from the hospitalist movement, the specialty would be characterized in 3 dimensions: the degree of physicians' commitment, physicians' practice competencies, and the structure of the medical staff organization in which they practice. Challenges to the adoption of a nursing home specialist model include mainstream medicine's failure to recognize the nursing home as a legitimate medical practice, the need for the nursing home industry and policymakers to appreciate the links between physician practice and quality, and assurance of financial viability. Implications for quality of care, health policy, and research needs are discussed in this article.	[Katz, Paul R.] Univ Rochester, Sch Med & Dent, Rochester, NY 14620 USA; SUNY Buffalo, Buffalo, NY 14260 USA; Brown Univ, Providence, RI 02912 USA	University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Brown University	Katz, PR (corresponding author), Univ Rochester, Sch Med & Dent, 435 E Henrietta Rd, Rochester, NY 14620 USA.	Paul_Katz@urmc.rochester.edu			National Institute on Aging [R21 AG025246]; NATIONAL INSTITUTE ON AGING [R21AG025246] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: Dr. Katz was supported by the National Institute on Aging (grant R21 AG025246).	*AM MED DIR ASS, CMS IMPL REV SURV GU; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Borger C, 2006, HEALTH AFFAIR, V25, pW61, DOI 10.1377/hlthaff.25.w61; Caprio T. V., 2006, ANNALS OF LONG TERM, V14, P17; Caprio TV, 2009, J AM MED DIR ASSOC, V10, P93, DOI 10.1016/j.jamda.2008.07.007; DeFrances C. J, 2007, 2005 NATL HOSP DISCH, V385; FLOOD AB, 1978, J HEALTH SOC BEHAV, V19, P240, DOI 10.2307/2136557; Glasheen JJ, 2008, J GEN INTERN MED, V23, P1110, DOI 10.1007/s11606-008-0646-5; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Intrator O, 1999, MED CARE, V37, P228, DOI 10.1097/00005650-199903000-00003; Jones Adrienne, 2002, Vital Health Stat 13, P1; KARUZA J, 1994, J AM GERIATR SOC, V42, P787, DOI 10.1111/j.1532-5415.1994.tb06543.x; Kasper J, 2007, CHANGES CHARACTERIST; Katz PR, 2006, J AM MED DIR ASSOC, V7, P394, DOI 10.1016/j.jamda.2006.05.003; Katz Paul R, 2003, J Am Med Dir Assoc, V4, P115, DOI 10.1016/S1525-8610(04)70288-1; Katz PR, 1997, J AM GERIATR SOC, V45, P911, DOI 10.1111/j.1532-5415.1997.tb02958.x; KATZ PR, 1993, J GEN INTERN MED, V8, P691, DOI 10.1007/BF02598291; Katz PR, 2005, J AM GERIATR SOC, V53, P1826, DOI 10.1111/j.1532-5415.2005.53509.x; Kirch DG, 2008, JAMA-J AM MED ASSOC, V299, P2680, DOI 10.1001/jama.299.22.2680; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Leibovitz A, 2004, AGING CLIN EXP RES, V16, P314; *MED PAYM ADV COMM, 2008, DAT BOOK HLTH CAR SP; Medina-Walpole A, 2002, J AM GERIATR SOC, V50, P949, DOI 10.1046/j.1532-5415.2002.50225.x; Roemer M., 1971, DOCTORS HOSP MED STA; Schmidt IK, 2002, SOC SCI MED, V54, P1767, DOI 10.1016/S0277-9536(01)00146-0; Schols J M G A, 2004, J Am Med Dir Assoc, V5, P207, DOI 10.1097/01.JAM.0000123031.43619.60; SHORTELL S, 1976, ORG RES HOSP; SHORTELL SM, 1981, MED CARE, V19, P1041, DOI 10.1097/00005650-198110000-00006; Shortell SM, 2005, MED CARE RES REV, V62, P407, DOI 10.1177/1077558705277389; Sloane PD, 2003, J AM GERIATR SOC, V51, P1587, DOI 10.1046/j.1532-5415.2003.51511.x; Spillman BC, 2000, NEW ENGL J MED, V342, P1409, DOI 10.1056/NEJM200005113421906; Spillman BC, 2002, MED CARE, V40, P965, DOI 10.1097/00005650-200210000-00013; *US, 1987, ANN REV POPUL LAW, V14, P473; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008; Zimmerman S, 2002, J AM GERIATR SOC, V50, P1987, DOI 10.1046/j.1532-5415.2002.50610.x; CERTIFIED MED DIRECT	39	81	81	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					411	W73		10.7326/0003-4819-150-6-200903170-00010	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293074	Green Accepted			2022-12-24	WOS:000264468500007
J	Yang, L; Garbe, DS; Bashaw, GJ				Yang, Long; Garbe, David S.; Bashaw, Greg J.			A Frazzled/DCC-Dependent Transcriptional Switch Regulates Midline Axon Guidance	SCIENCE			English	Article							CNS MIDLINE; GROWTH CONE; DROSOPHILA-MIDLINE; COMMISSURAL AXONS; RECEPTOR; ATTRACTION; ROUNDABOUT; OUTGROWTH; SLIT; ROBO	Precise wiring of the nervous system depends on coordinating the action of conserved families of proteins that direct axons to their appropriate targets. Slit-roundabout repulsion and netrin-deleted in colorectal cancer (DCC) (frazzled) attraction must be tightly regulated to control midline axon guidance in vertebrates and invertebrates, but the mechanism mediating this regulation is poorly defined. Here, we show that the Fra receptor has two genetically separable functions in regulating midline guidance in Drosophila. First, Fra mediates canonical chemoattraction in response to netrin, and, second, it functions independently of netrin to activate commissureless transcription, allowing attraction to be coupled to the down-regulation of repulsion in precrossing commissural axons.	[Yang, Long; Garbe, David S.; Bashaw, Greg J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1113 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu			NIH [NS054739, NS046333]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS046333, R01NS054739, R01NS046333] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS054739 and NS046333 to G.J.B.	Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gong QZ, 1999, DEVELOPMENT, V126, P1451; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Murray MJ, 1999, J NEUROSCI, V19, P7901; *NIH, NS054739 NIH; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445	25	62	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					944	947		10.1126/science.1171320	http://dx.doi.org/10.1126/science.1171320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19325078	Green Accepted			2022-12-24	WOS:000266048800041
J	Chandramohanadas, R; Davis, PH; Beiting, DP; Harbut, MB; Darling, C; Velmourougane, G; Lee, MY; Greer, PA; Roos, DS; Greenbaum, DC				Chandramohanadas, Rajesh; Davis, Paul H.; Beiting, Daniel P.; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Lee, Ming Yeh; Greer, Peter A.; Roos, David S.; Greenbaum, Doron C.			Apicomplexan Parasites Co-Opt Host Calpains to Facilitate Their Escape from Infected Cells	SCIENCE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITE; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; EMBRYONIC-DEVELOPMENT; PROTEASE INHIBITORS; ERYTHROCYTE; CALPASTATIN; DISRUPTION; MEMBRANE	Apicomplexan parasites, including Plasmodium falciparum and Toxoplasma gondii (the causative agents of malaria and toxoplasmosis, respectively), are responsible for considerable morbidity and mortality worldwide. These pathogenic protozoa replicate within an intracellular vacuole inside of infected host cells, from which they must escape to initiate a new lytic cycle. By integrating cell biological, pharmacological, and genetic approaches, we provide evidence that both Plasmodium and Toxoplasma hijack host cell calpain proteases to facilitate parasite egress. Immunodepletion or inhibition of calpain-1 in hypotonically lysed and resealed erythrocytes prevented the escape of P. falciparum parasites, which was restored by adding purified calpain-1. Similarly, efficient egress of T. gondii from mammalian fibroblasts was blocked by either small interfering RNA-mediated suppression or genetic deletion of calpain activity and could be restored by genetic complementation.	[Chandramohanadas, Rajesh; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; McMaster University; Queens University - Canada	Greenbaum, DC (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	dorong@upenn.edu	Chandramohanadas, Rajesh/GLT-0218-2022; Davis, Paul H/J-6141-2012; Beiting, Daniel/AAG-6275-2019	Davis, Paul H/0000-0002-0526-3841; Chandramohanadas, Rajesh/0000-0002-8760-0396; Roos, David Siker/0000-0001-6725-4089	National Research Service Awards; Ellison Medical Foundation; NIH; Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077268, R37AI028724, F32AI075846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER	National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. W. Doms, M. Marti, and M. Klemba for critical discussions; the Penn Proteomics Core for mass spectrometry; and M. A. Lampson for help with imaging. P. falciparum expressing GFP were provided by O. S. Harb. P.H.D. and D.P.B. are funded by National Research Service Awards, and D.S.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Disease, supported by grants from NIH. D.C.G. was supported by the Ritter Foundation, the Penn Genome Frontiers Institute, and the Penn Institute for Translational Medicine and Therapeutics.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BIANCO AE, 1986, EXP PARASITOL, V62, P275, DOI 10.1016/0014-4894(86)90032-9; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Gil-Parrado S, 2003, BIOL CHEM, V384, P395, DOI 10.1515/BC.2003.045; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; WEISS L, 1989, AM J TROP MED HYG, V41, P135, DOI 10.4269/ajtmh.1989.41.135; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	29	118	125	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					794	797		10.1126/science.1171085	http://dx.doi.org/10.1126/science.1171085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19342550	Green Accepted			2022-12-24	WOS:000265832400049
J	Mello, MM				Mello, Michelle M.			New York City's War on Fat.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PUBLIC-HEALTH; CALORIC INFORMATION; OBESITY EPIDEMIC; FAST-FOOD; BEHAVIOR		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				ALLDAY E, 2008, SAN FRANCISCO C 0312, pC1; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973; *CTR SCI PUBL INT, 2008, NUTR LAB CHAIN REST; *CTR SCI PUBL INT, 2008, TRANS FAT BANS REST; DUBBERT PM, 1984, J APPL BEHAV ANAL, V17, P85, DOI 10.1901/jaba.1984.17-85; Food and Drug Administration, 2004, CAL COUNT REP WORK G; Frieden TR, 2004, AM J PUBLIC HEALTH, V94, P2059, DOI 10.2105/AJPH.94.12.2059; Kim SY, 2001, J CONSUM AFF, V35, P346, DOI 10.1111/j.1745-6606.2001.tb00118.x; Koplan J., 2005, PREVENTING CHILDHOOD; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; *NAT C STAT LEG, 2008, TRANS FAT MEN LAB LE; *NEW YORK CIT DEP, 2006, EPIQUERY COMM HLTH S; *NEW YORK CIT DEP, 2007, DIAB NEW YORK CIT PU; *NEW YORK CIT DEP, 2005, HLTH DEP ASKS REST F; *NEW YORK CIT DEP, 2008, CARD DIS PREV PROGR; *NEW YORK CIT OFF, 2007, M BLOOMB AC JB RICHM; NEWMAN M, 2007, NY TIMES        1011; *PAN MICR FOOD NUT, 2005, DIET REF INT EN CARB; Pomeranz JL, 2008, AM J PUBLIC HEALTH, V98, P1578, DOI 10.2105/AJPH.2007.128488; RABIN RC, 2007, NY TIMES        0717, pF6; RIVERA R, 2007, NY TIMES        1025, pB1; Rutkow L, 2008, J LAW MED ETHICS, V36, P772, DOI 10.1111/j.1748-720X.2008.00337.x; SILVER LD, 2006, RESULTS PUBLIC HEARI; Stubenitsky K, 2000, PUBLIC HEALTH NUTR, V3, P201; *TECHN, 2008, CONS REACT CAL DISCL; WOO S, 2008, WALL STREET J   0611, pA2; Yamamoto JA, 2005, J ADOLESCENT HEALTH, V37, P397, DOI 10.1016/j.jadohealth.2004.10.002; *ZOGB INT, 2008, RES NEW YORK SURV	31	29	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2015	2020		10.1056/NEJMhle0806121	http://dx.doi.org/10.1056/NEJMhle0806121			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	441QN	19420372				2022-12-24	WOS:000265784400014
J	Aouadi, M; Tesz, GJ; Nicoloro, SM; Wang, MX; Chouinard, M; Soto, E; Ostroff, GR; Czech, MP				Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.			Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; IN-VIVO DELIVERY; NONHUMAN-PRIMATES; RNA INTERFERENCE; GENE-EXPRESSION; ADULT MICE; GALACTOSAMINE; INHIBITION; RESISTANCE; LETHALITY	Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design(1). However, the transformative therapeutic potential of short interfering RNA ( siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo(2). Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes(3). Here we report the engineering of beta 1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo. Oral gavage of mice with GeRPs containing as little as 20 mu g kg(-1) siRNA directed against tumour necrosis factor alpha (Tnf-alpha) depleted its messenger RNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-a levels. Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression. Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-alpha and interleukin-1 beta production. This technology defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.	[Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	gary.ostroff@umassmed.edu; michael.czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	The University of Massachusetts Diabetes and Endocrinology Center [DK 32520]; Diabetes Genome Anatomy Project [DK 60837]; Commonwealth Medicine; NIH [DK 30898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060837, R37DK030898, R01DK030898, P30DK032520] Funding Source: NIH RePORTER	The University of Massachusetts Diabetes and Endocrinology Center; Diabetes Genome Anatomy Project; Commonwealth Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate critical reading of the manuscript and suggestions by C. Mello, V. Ambros, G. Hannon, S. Corvera and J. Sullivan. We thank P. Zamore for advice on methods. We also appreciate the technical help of P. Furcinitti, A. Burkhart and A. Goller. This work was supported by The University of Massachusetts Diabetes and Endocrinology Center (DK 32520), including its Genomics, Bioinformatics and Imaging Cores, the Diabetes Genome Anatomy Project ( DK 60837), Commonwealth Medicine and NIH grant DK 30898.	Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Endo Y, 1999, BRIT J PHARMACOL, V128, P5, DOI 10.1038/sj.bjp.0702747; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Filleur S, 2003, CANCER RES, V63, P3919; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Shealy D. J., 2008, V181, P101; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorensen DR, 2003, J MOL BIOL, V327, P761, DOI 10.1016/S0022-2836(03)00181-5; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	30	415	450	6	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1180	U116		10.1038/nature07774	http://dx.doi.org/10.1038/nature07774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19407801	Green Accepted			2022-12-24	WOS:000265754600049
J	Roberts, RM; Smith, GW; Bazer, FW; Cibelli, J; Seidel, GE; Bauman, DE; Reynolds, LP; Ireland, JJ				Roberts, R. M.; Smith, G. W.; Bazer, F. W.; Cibelli, J.; Seidel, G. E., Jr.; Bauman, D. E.; Reynolds, L. P.; Ireland, J. J.			Farm Animal Research in Crisis	SCIENCE			English	Editorial Material							BIOMEDICAL-RESEARCH; DOMESTIC-ANIMALS; RESOURCES		[Smith, G. W.; Cibelli, J.; Ireland, J. J.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Roberts, R. M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Bazer, F. W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Seidel, G. E., Jr.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Bauman, D. E.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Reynolds, L. P.] N Dakota State Univ, Dept Anim Sci, Fargo, ND 58105 USA	Michigan State University; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Colorado State University; Cornell University; North Dakota State University Fargo	Ireland, JJ (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	lreland@msu.edu	Reynolds, Lawrence P/I-5267-2015; Seidel, George/AAE-2371-2019; Bazer, Fuller/AAF-4317-2021	Reynolds, Lawrence P/0000-0002-6838-7809; Bazer, Fuller/0000-0002-5823-5086; Cibelli, Jose/0000-0002-2176-3854				BROOKS DL, 2006, LAB ANIMAL MED, P273; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; *FDN BIOM RES, NOB PRIZ; *FOOD AGR ED INF S, 2007, AN SCI GRAD ENR; Fulton JE, 2003, SCIENCE, V300, P1667, DOI 10.1126/science.1085407; GIBBS R, 2004, BOVINE GENOMIC SEQUE; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huffman WE, 2006, AM J AGR ECON, V88, P783, DOI 10.1111/j.1467-8276.2006.00898.x; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; King AJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1837, DOI 10.1152/ajpendo.00668.2006; Mirando MA, 2006, BIOL REPROD, V74, P459, DOI 10.1095/biolreprod.105.048686; NRC, 1989, INV RES PROP STRENGT; NRC, 2000, NAT RES IN VIT COMP; NRC (National Research Council), 1972, REP COMM RES ADV US; Padmanabhan V, 2007, REV ENDOCR METAB DIS, V8, P67, DOI 10.1007/s11154-007-9051-3; Reynolds LP, 2008, J ANIM SCI, V86, P2445, DOI 10.2527/jas.2008-1387; Reynolds LP, 2009, J NUTR, V139, P427, DOI 10.3945/jn.108.103564; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; *US DHHS, BUDG BRIEF; *USDA, USDA FY2007 BUDG SUM; *USDA RES ED EC IN, 2007, USDA RES ED EC INF S; 2007 CENSUS AGR EC	22	61	63	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					468	469		10.1126/science.1168521	http://dx.doi.org/10.1126/science.1168521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390030				2022-12-24	WOS:000265411200029
J	Brenner, MJ				Brenner, Michael J.			Collateral Damage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mbrenner@siumed.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1637	1638		10.1001/jama.2009.543	http://dx.doi.org/10.1001/jama.2009.543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383945				2022-12-24	WOS:000265350700001
J	Zhu, M; Zhao, WJ; Jia, LT; Lu, J; Qiao, T; Qu, QM				Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming			The oldest articulated osteichthyan reveals mosaic gnathostome characters	NATURE			English	Article							BONY FISHES; INTERRELATIONSHIPS	The evolutionary history of osteichthyans (bony fishes plus tetrapods) extends back to the Ludlow epoch of the Silurian period. However, these Silurian forms have been documented exclusively by fragmentary fossils. Here we report the discovery of an exceptionally preserved primitive fish from the Ludlow of Yunnan, China, that represents the oldest near-complete gnathostome (jawed vertebrate). The postcranial skeleton of this fish includes a primitive pectoral girdle and median fin spine as in non-osteichthyan gnathostomes, but a derived macromeric squamation as in crown osteichthyans, and substantiates the unexpected mix of postcranial features in basal sarcopterygians, previously restored from the disarticulated remains of Psarolepis. As the oldest articulated sarcopterygian, the new taxon offers insights into the origin and early divergence of osteichthyans, and indicates that the minimum date for the actinopterygian-sarcopterygian split was no later than 419 million years ago.	[Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, M (corresponding author), Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, POB 643, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Qu, Qingming/R-7194-2016; Qiao, Tuo/AAJ-6317-2021; min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012	Qu, Qingming/0000-0002-8291-8493; Qiao, Tuo/0000-0002-0488-7265; Zhu, Min/0000-0002-4786-0898; Zhao, Wenjin/0000-0002-9649-2171	MST of China [2006CB806400]; Chinese Academy of Sciences; National Natural Science Foundation of China; CAS/SAFEA International Partnership Program for Creative Research Teams; Australian Research Council Discovery [DP0772138]	MST of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Australian Research Council Discovery(Australian Research Council)	We thank M.-M. Chang, P. Janvier, J. Long, P. Ahlberg, X.-B. Yu and B. Choo for discussions, X.-B. Yu and B. Choo for improving the manuscript, J. Zhang and C.-H. Xiong for field work, X.-F. Lu and C.-H. Xiong for specimen preparation, W.-D. Zhang and W. Wang for making thin sections, B. Choo for life restoration, J.-L. Huang for illustrations, and J. Zhang for photography. This work was supported by the Major State Basic Research Projects (2006CB806400) of MST of China, the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the CAS/SAFEA International Partnership Program for Creative Research Teams. M. Z., J. L. and T. Q. thank G. Young and J. Long for the examination of Australian specimens with the support of an Australian Research Council Discovery Grant (DP0772138).	Andrews S. M., 2006, T ROY SOC EDINBURGH, V96, P197, DOI DOI 10.1017/S0263593300001309; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P25, DOI 10.1023/A:1007370213924; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Cumbaa SL, 2002, CAN J EARTH SCI, V39, P1457, DOI 10.1139/E02-047; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; DENISON R H, 1968, Fieldiana Geology, V17, P353; Fang R.S., 1985, MIDDLE SILURIAN EARL; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Gagnier P.-Y., 1989, Courier Forschungsinstitut Senckenberg, V110, P123; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grande L., 1991, J VERTEBR PALEONTOL, V11, P1, DOI [DOI 10.1080/02724634.1991.10011424, 10.1080/02724634.1991.10011424]; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Janvier P., 1978, Eesti NSV Teaduste Akadeemia Toimetised Geoloogia, V27, P88; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 1999, Geodiversitas, V21, P33; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Long M., 1988, U HAWAII WORKING PAP, V7, P1; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Min Z, 1997, LETHAIA, V30, P293; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nelson JS, 1984, FISHES WORLD; PAN J, 1986, B CHINESE ACAD GEOLO, V15, P227; PEARSON D M, 1979, Transactions of the Royal Society of Edinburgh, V70, P337; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Rong J.-y., 1990, Journal of Stratigraphy, V14, P161; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Schultze H. P., 1968, Bulletin of the British Museum (Natural History) Geology, V16, P341; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1992, FOSSIL FISHES LIVING, P233; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Ting V. K., 1937, Bulletin of the Geological Society of China, V16, P1; Walliser O.H., 1989, Courier Forschungsinstitut Senckenberg, V110, P111; Wang Cheng-yuan, 2001, Journal of Stratigraphy, V25, P125; Wang N.-z., 1989, Acta Palaeontologica Sinica, V28, P192; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhang YT, 2001, INT J ENG SCI, V39, P1, DOI 10.1016/S0020-7225(00)00013-6; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271	50	163	181	7	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					469	474		10.1038/nature07855	http://dx.doi.org/10.1038/nature07855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325627				2022-12-24	WOS:000264532400036
J	Good, M; Tang, G; Singleton, J; Remenyi, A; Lim, WA				Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.			The Ste5 Scaffold Directs Mating Signaling by Catalytically Unlocking the Fus3 MAP Kinase for Activation	CELL			English	Article							PHEROMONE RESPONSE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; DOCKING INTERACTIONS; MUTATIONAL ANALYSIS; BINDING DOMAIN; YEAST; SPECIFICITY; PATHWAY; MECHANISMS	The scaffold protein Ste5 is required to properly direct signaling through the yeast mating pathway to the mitogen-activated protein kinase (MAPK), Fus3. Scaffolds are thought to function by tethering kinase and substrate in proximity. We find, however, that the previously identified Fus3-binding site on Ste5 is not required for signaling, suggesting an alternative mechanism controls Fus3's activation by the MAPKK Ste7. Reconstituting MAPK signaling in vitro, we find that Fus3 is an intrinsically poor substrate for Ste7, although the related filamentation MAPK, Kss1, is an excellent substrate. We identify and structurally characterize a domain in Ste5 that catalytically unlocks Fus3 for phosphorylation by Ste7. This domain selectively increases the k(cat) of Ste7 -> Fus3 phosphorylation but has no effect on Ste7 -> Kss1 phosphorylation. The dual requirement for both Ste7 and this Ste5 domain in Fus3 activation explains why Fus3 is selectively activated by the mating pathway and not by other pathways that also utilize Ste7.	[Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Remenyi, Attila] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Good, Matthew] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Eotvos Lorand University; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Remenyi, Attila/N-1345-2016; Good, Matthew C/GLS-0964-2022	Good, Matthew/0000-0002-6367-1034; Remenyi, Attila/0000-0002-8345-1311	Genentech; Achievement Rewards for College Scientists; Leukemia and Lymphoma Society; National Institutes of Health; Packard Foundation; Wellcome Trust; Marie Curie Reintegration Grant; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Achievement Rewards for College Scientists; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Reintegration Grant(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by fellowships from Genentech (M. C. G.) and Achievement Rewards for College Scientists (M. C. G.), and the Leukemia and Lymphoma Society (A. R.). It was also supported by the National Institutes of Health (W. A. L.) and the Packard Foundation (W. A. L.), The Wellcome Trust (A. R.) a Marie Curie Reintegration Grant (A. R.) and the Howard Hughes Medical Institute. Thanks to P. Egea for help with structure determination, and to G. Narlikar, A. Chau, N. Helman, and J. Zalatan for assistance and advice. Also thanks to J. Weissman, D. Morgan, E. McCullagh, and H. Ramage, and members of the Lim Lab for thoughtful discussions. W. A. L. would like to dedicate this paper to the memory of Jeremy R. Knowles and Frederic M. Richards, two of his teachers.	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 2002, CURR OPIN IMMUNOL, V14, P312, DOI 10.1016/S0952-7915(02)00347-3; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Schwartz MA, 2006, CURR GENET, V49, P351, DOI 10.1007/s00294-006-0061-6; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	31	139	143	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1085	1097		10.1016/j.cell.2009.01.049	http://dx.doi.org/10.1016/j.cell.2009.01.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303851	Bronze, Green Accepted			2022-12-24	WOS:000264403900014
J	Herzig, SJ; Howell, MD; Ngo, LH; Marcantonio, ER				Herzig, Shoshana J.; Howell, Michael D.; Ngo, Long H.; Marcantonio, Edward R.			Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STRESS-ULCER PROPHYLAXIS; CRITICALLY-ILL PATIENTS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; GASTRIC COLONIZATION; NOSOCOMIAL PNEUMONIA; ADMINISTRATIVE DATA; GENERAL-PRACTICE; CARE PATIENTS; OMEPRAZOLE	Context The use of acid-suppressive medication has been steadily increasing, particularly in the inpatient setting, despite lack of an accepted indication in the majority of these patients. Objective To examine the association between acid-suppressive medication and hospital-acquired pneumonia. Design, Setting, and Patients Prospective pharmacoepidemiologic cohort study. All patients who were admitted to a large, urban, academic medical center in Boston, Massachusetts, from January 2004 through December 2007; at least 18 years of age; and hospitalized for 3 or more days were eligible for inclusion. Admissions with time spent in the intensive care unit were excluded. Acid-suppressive medication use was defined as any order for a proton-pump inhibitor or histamine(2) receptor antagonist. Traditional and propensity-matched multivariable logistic regression were used to control for confounders. Main Outcome Measure Incidence of hospital-acquired pneumonia, defined via codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (JCD-9-CM), in patients exposed and unexposed to acid-suppressive medication. Results The final cohort comprised 63 878 admissions. Acid-suppressive medication was ordered in 52% of admissions and hospital-acquired pneumonia occurred in 2219 admissions (3.5%). The unadjusted incidence of hospital-acquired pneumonia was higher in the group exposed to acid-suppressive medication than in the unexposed group (4.9% vs 2.0%; odds ratio [OR], 2.6; 95% confidence interval [CI], 2.3-2.8). Using multivariable logistic regression, the adjusted OR of hospital-acquired pneumonia in the group exposed to acid-suppressive medication was 1.3 (95% CI, 1.1-1.4). The matched propensity-score analyses yielded identical results. The association was significant for proton-pump inhibitors (OR, 1.3; 95% CI, 1.1-1.4) but not for histamine2 receptor antagonists (OR, 1.2;95% CI, 0.98-1.4). Conclusions In this large, hospital-based pharmacoepidemiologic cohort, acid-suppressive medication use was associated with 30% increased odds of hospital-acquired pneumonia. In subset analyses, statistically significant risk was demonstrated only for proton-pump inhibitor use. JAMA. 2009;301(20):2120-2128 www.jama.com	[Herzig, Shoshana J.; Ngo, Long H.; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; [Herzig, Shoshana J.; Ngo, Long H.; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Primary Care, Boston, MA 02215 USA; [Howell, Michael D.] Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Herzig, Shoshana J.; Howell, Michael D.; Ngo, Long H.; Marcantonio, Edward R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Herzig, SJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave,DEC311, Boston, MA 02215 USA.	sherzig@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017; Howell, Michael/B-8065-2009	Marcantonio, Edward R/0000-0002-2911-4250; Howell, Michael/0000-0001-7003-6971	Health Resources and Services Administration of the Department of Health and Human Services [T32HP11001]	Health Resources and Services Administration of the Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Dr Herzig was funded by grant T32HP11001 from the Health Resources and Services Administration of the Department of Health and Human Services to support the Harvard Medical School Fellowship in General Medicine and Primary Care.	Adams K., 2003, PRIORITY AREAS NATL; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; APTE NM, 1992, CRIT CARE MED, V20, P590, DOI 10.1097/00003246-199205000-00008; Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Capodicasa E, 1999, IMMUNOPHARM IMMUNOT, V21, P357, DOI 10.3109/08923979909052768; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook Deborah J., 1996, JAMA (Journal of the American Medical Association), V275, P308, DOI 10.1001/jama.275.4.308; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; DONOWITZ LG, 1986, INFECT CONT HOSP EP, V7, P23, DOI 10.1017/S0195941700063748; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUMOULIN GC, 1982, LANCET, V1, P242; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; GARVEY BM, 1989, CRIT CARE MED, V17, P211, DOI 10.1097/00003246-198903000-00002; Grube RRA, 2007, AM J HEALTH-SYST PH, V64, P1396, DOI 10.2146/ajhp060393; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hartmann M, 1996, ALIMENT PHARM THERAP, V10, P359, DOI 10.1111/j.0953-0673.1996.00359.x; *HCUP, HCUP FACTS FIG 2006; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; Janicki T, 2007, J HOSP MED, V2, P86, DOI 10.1002/jhm.177; Kantorova I, 2004, HEPATO-GASTROENTEROL, V51, P757; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lowe DO, 2006, CLIN INFECT DIS, V43, P1272, DOI 10.1086/508453; Mallow Stephanie, 2004, Curr Surg, V61, P452, DOI 10.1016/j.cursur.2004.03.014; Messori A, 2000, BMJ-BRIT MED J, V321, P1103, DOI 10.1136/bmj.321.7269.1103; Mikawa K, 1999, ANESTH ANALG, V89, P218, DOI 10.1097/00000539-199907000-00040; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Parente F, 2003, ALIMENT PHARM THER, V17, P1503, DOI 10.1046/j.1365-2036.2003.01600.x; Parsons LS, P 26 ANN SAS US GROU, DOI www2. sas. com/ proceedings/ sugi26/ p214- 26. pdf.; Pham CQD, 2006, ANN PHARMACOTHER, V40, P1261, DOI 10.1345/aph.1G703; PRODHOM G, 1994, ANN INTERN MED, V120, P653, DOI 10.7326/0003-4819-120-8-199404150-00005; Qadeer MA, 2006, J HOSP MED, V1, P13, DOI 10.1002/jhm.10; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Scagliarini R, 2005, DIGEST DIS SCI, V50, P2307, DOI 10.1007/s10620-005-3052-4; Scaringi L, 1996, SCAND J IMMUNOL, V44, P204, DOI 10.1046/j.1365-3083.1996.d01-300.x; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	42	298	321	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 27	2009	301	20					2120	2128		10.1001/jama.2009.722	http://dx.doi.org/10.1001/jama.2009.722			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449KF	19470989	Bronze			2022-12-24	WOS:000266328800024
J	Okada, D; Ozawa, F; Inokuchi, K				Okada, Daisuke; Ozawa, Fumiko; Inokuchi, Kaoru			Input-Specific Spine Entry of Soma-Derived Vesl-1S Protein Conforms to Synaptic Tagging	SCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; LATE MAINTENANCE; PLASTICITY; LTP; STIMULATION; EXPRESSION	Late-phase synaptic plasticity depends on the synthesis of new proteins that must function only in the activated synapses. The synaptic tag hypothesis requires input-specific functioning of these proteins after undirected transport. Confirmation of this hypothesis requires specification of a biochemical tagging activity and an example protein that behaves as the hypothesis predicts. We found that in rat neurons, soma-derived Vesl-1S (Homer-1a) protein, a late-phase plasticity-related synaptic protein, prevailed in every dendrite and did not enter spines. N-methyl-D-aspartate receptor activation triggered input-specific spine entry of Vesl-1S proteins, which met many criteria for synaptic tagging. These results suggest that Vesl-1S supports the hypothesis and that the activity-dependent regulation of spine entry functions as a synaptic tag.	[Okada, Daisuke] Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo 1948511, Japan; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Japan Science & Technology Agency (JST)	Okada, D (corresponding author), Mitsubishi Kagaku Inst Life Sci MITILS, 11 Minamiooya, Tokyo 1948511, Japan.	kaoru@mitils.jp; dada@mitils.jp	Inokuchi, Kaoru/AAI-9693-2020	Inokuchi, Kaoru/0000-0002-5393-3133	Ministry of Education, Technology and Culture; MEXT of the Japanese Government; JST-CREST	Ministry of Education, Technology and Culture; MEXT of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank A. Miyawaki (RIKEN, Japan) for the gift of PAGFP. Supported partly by grants from the Ministry of Education, Technology and Culture (K.I.), the Special Coordinate Funds for Promoting Science and Technology from MEXT of the Japanese Government (K.I.), and JST-CREST (K.I.).	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; Ango F, 2000, J NEUROSCI, V20, P8710; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Inoue N, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-7; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Mackenzie PJ, 1998, J NEUROPHYSIOL, V80, P2089, DOI 10.1152/jn.1998.80.4.2089; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Niibori Y, 2007, NEUROSCI RES, V57, P399, DOI 10.1016/j.neures.2006.11.014; Okubo-Suzuki R, 2008, MOL CELL NEUROSCI, V38, P266, DOI 10.1016/j.mcn.2008.03.001; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	33	82	83	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					904	909		10.1126/science.1171498	http://dx.doi.org/10.1126/science.1171498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443779				2022-12-24	WOS:000266048800029
J	Schipper, K; Abma, TA; Hene, RJ; Widdershoven, GAM				Schipper, K.; Abma, Tineke A.; Hene, Ronald J.; Widdershoven, Guy A. M.			A Patient's Journey Polycystic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schipper, K.; Abma, Tineke A.; Widdershoven, Guy A. M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Hene, Ronald J.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Abma, TA (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, Postbox 7057, NL-1007 MB Amsterdam, Netherlands.	T.Abma@HES.unimaas.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2009	338								b1595	10.1136/bmj.b1595	http://dx.doi.org/10.1136/bmj.b1595			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IW	19433503				2022-12-24	WOS:000266116300001
J	Enerback, S				Enerbaeck, Sven			The Origins of Brown Adipose Tissue.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WHITE FAT		Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Enerback, S (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.							Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	8	123	137	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2009	360	19					2021	2023		10.1056/NEJMcibr0809610	http://dx.doi.org/10.1056/NEJMcibr0809610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	441QN	19420373				2022-12-24	WOS:000265784400015
J	Gregg, EW; Albright, AL				Gregg, Edward W.; Albright, Ann L.			The Public Health Response to Diabetes-Two Steps Forward, One Step Back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; US; PREVENTION; DISEASE; ADULTS; TRENDS		[Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1169; Burrows NR, 2008, ADV CHRONIC KIDNEY D, V15, P147, DOI 10.1053/j.ackd.2008.01.002; *CDCP, 2008, COUNT LEV EST DIAGN; *CDCP, 2009, DAT TRENDS DIAB SURV; Centers for Disease Control and Prevention, 2008, NAT DIAB SURV SYST; Colagiuri R, 2006, AM J PUBLIC HEALTH, V96, P1562, DOI 10.2105/AJPH.2005.067587; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; KRUGER H, 2007, HLTH IMPACT SMOKING; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Wang J, 2006, DIABETES CARE, V29, P2018, DOI 10.2337/dc06-0311; Wells H.F., 2008, EC INFORM B	15	24	25	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1596	1598		10.1001/jama.2009.519	http://dx.doi.org/10.1001/jama.2009.519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366782				2022-12-24	WOS:000265137900033
J	Whitmer, RA; Karter, AJ; Yaffe, K; Quesenberry, CP; Selby, JV				Whitmer, Rachel A.; Karter, Andrew J.; Yaffe, Kristine; Quesenberry, Charles P., Jr.; Selby, Joseph V.			Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; GLYCEMIC CONTROL; BLOOD-GLUCOSE; ET-AL; POPULATION; BRAIN	Context Although acute hypoglycemia may be associated with cognitive impairment in children with type 1 diabetes, no studies to date have evaluated whether hypoglycemia is a risk factor for dementia in older patients with type 2 diabetes. Objective To determine if hypoglycemic episodes severe enough to require hospitalization are associated with an increased risk of dementia in a population of older patients with type 2 diabetes followed up for 27 years. Design, Setting, and Patients A longitudinal cohort study from 1980-2007 of 16 667 patients with a mean age of 65 years and type 2 diabetes who are members of an integrated health care delivery system in northern California. Main Outcome Measure Hypoglycemic events from 1980-2002 were collected and reviewed using hospital discharge and emergency department diagnoses. Cohort members with no prior diagnoses of dementia, mild cognitive impairment, or general memory complaints as of January 1, 2003, were followed up for a dementia diagnosis through January 15, 2007. Dementia risk was examined using Cox proportional hazard regression models, adjusted for age, sex, race/ethnicity, education, body mass index, duration of diabetes, 7-year mean glycated hemoglobin, diabetes treatment, duration of insulin use, hyperlipidemia, hypertension, cardiovascular disease, stroke, transient cerebral ischemia, and end-stage renal disease. Results At least 1 episode of hypoglycemia was diagnosed in 1465 patients (8.8%) and dementia was diagnosed in 1822 patients (11%) during follow-up; 250 patients had both dementia and at least 1 episode of hypoglycemia (16.95%). Compared with patients with no hypoglycemia, patients with single or multiple episodes had a graded increase in risk with fully adjusted hazard ratios (HRs): for 1 episode (HR, 1.26; 95% confidence interval [CI], 1.10-1.49); 2 episodes (HR, 1.80; 95% CI, 1.37-2.36); and 3 or more episodes (HR, 1.94; 95% CI, 1.42-2.64). The attributable risk of dementia between individuals with and without a history of hypoglycemia was 2.39% per year (95% CI, 1.72%-3.01%). Results were not attenuated when medical utilization rates, length of health plan membership, or time since initial diabetes diagnosis were added to the model. When examining emergency department admissions for hypoglycemia for association with risk of dementia (535 episodes), results were similar (compared with patients with 0 episodes) with fully adjusted HRs: for 1 episode (HR, 1.42; 95% CI, 1.12-1.78) and for 2 or more episodes (HR, 2.36; 95% CI, 1.57-3.55). Conclusions Among older patients with type 2 diabetes, a history of severe hypoglycemic episodes was associated with a greater risk of dementia. Whether minor hypoglycemic episodes increase risk of dementia is unknown.	[Whitmer, Rachel A.; Karter, Andrew J.; Quesenberry, Charles P., Jr.; Selby, Joseph V.] Kaiser Permanente, Div Res, Sect Etiol & Prevent, Oakland, CA 94612 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol & Epidemiol, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whitmer, RA (corresponding author), Kaiser Permanente, Div Res, Sect Etiol & Prevent, 2000 Broadway, Oakland, CA 94612 USA.	raw@dor.kaiser.org			National Institutes of Health [DK066308, DK081796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK066308, R01DK081796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: Dr Whitmer receives funding from the National Institutes of Health grants DK066308 and DK081796.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Artola A, 2002, PROG BRAIN RES, V138, P305, DOI 10.1016/S0079-6123(02)38084-1; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chalmers J, 2007, J HYPERTENS, V25, pS23, DOI 10.1097/01.hjh.0000271506.69949.46; Cosway R, 2001, DIABETIC MED, V18, P803, DOI 10.1046/j.1464-5491.2001.00577.x; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Cryer PE, 2007, DIABETES CARE, V30, P190, DOI 10.2337/dc-06-1670; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; Deary IJ, 1996, BMJ-BRIT MED J, V313, P767; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, 2007, NEW ENGL J MED, V356, P1842; DRAELOS MT, 1995, AM J MED, V98, P135, DOI 10.1016/S0002-9343(99)80397-0; Ettner SL, 2009, HEALTH ECON, V18, P645, DOI 10.1002/hec.1394; Fanelli CG, 2004, DIABETES-METAB RES, V20, pS32, DOI 10.1002/dmrr.514; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gordon N P, 1991, Adv Health Econ Health Serv Res, V12, P19; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; JARJOUR IT, 1995, DIABETOLOGIA, V38, P1090, DOI 10.1007/s001250050396; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2004, DIABETES CARE, V27, P850, DOI 10.2337/diacare.27.3.850-a; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; KARTER AJ, 1997, DIABETES; Karter AJ, 1998, J REGISTRY MANAGEMEN, V25, P7; Karter AJ, 2008, AM J PUBLIC HEALTH, V98, P365, DOI 10.2105/AJPH.2005.083501; Karter Andrew J, 2006, Endocr Pract, V12 Suppl 1, P110; Karter AJ, 2006, DIABETES CARE, V29, P1757, DOI 10.2337/dc06-2073; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Klein JP, 2003, LANCET NEUROL, V2, P548, DOI 10.1016/S1474-4422(03)00503-9; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; McNay EC, 2005, NEUROBIOL AGING, V26, pS76, DOI 10.1016/j.neurobiolaging.2005.08.014; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236; Schmittdiel JA, 2008, J GEN INTERN MED, V23, P588, DOI 10.1007/s11606-008-0554-8; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; Selby JV, 1997, ANN INTERN MED, V127, P719, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00056; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; WREDLING R, 1990, DIABETOLOGIA, V33, P152, DOI 10.1007/BF00404042; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865	59	685	718	4	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1565	1572		10.1001/jama.2009.460	http://dx.doi.org/10.1001/jama.2009.460			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366776	Green Accepted, Bronze			2022-12-24	WOS:000265137900027
J	Carpenter, LM; Linsell, L; Brooks, C; Keegan, TJ; Langdon, T; Doyle, P; Maconochie, NES; Fletcher, T; Nieuwenhuijsen, MJ; Beral, V; Venables, KM				Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Doyle, P.; Maconochie, N. E. S.; Fletcher, T.; Nieuwenhuijsen, M. J.; Beral, V.; Venables, K. M.			Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MUSTARD GAS; EXPOSURES	Objective To determine cancer morbidity in members of the armed forces who took part in tests of chemical warfare agents from 1941 to 1989. Design Historical cohort study, with cohort members followed up to December 2004. Data source Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants All veterans included in the cohort study of mortality, excluding those known to have died or been lost to follow-up before 1 January 1971 when the UK cancer registration system commenced. 17 013 male members of the UK armed forces who took part in tests (Porton Down veterans) and a similar group of 16 520 who did not (non-Porton Down veterans). Main outcome measures Cancer morbidity in each group of veterans; rate ratios, with 95% confidence intervals, adjusted for age group and calendar period. Results 3457 cancers were reported in the Porton Down veterans compared with 3380 cancers in the non-Porton Down veterans. While overall cancer morbidity was the same in both groups (rate ratio 1.00, 95% confidence interval 0.95 to 1.05), Porton Down veterans had higher rates of ill defined malignant neoplasms (1.12, 1.02 to 1.22), in situ neoplasms (1.45, 1.06 to 2.00), and those of uncertain or unknown behaviour (1.32, 1.01 to 1.73). Conclusion Overall cancer morbidity in Porton Down veterans was no different from that in non-Porton Down veterans.	[Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Venables, K. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Doyle, P.; Maconochie, N. E. S.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of Oxford	Carpenter, LM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	lucy.carpenter@dphpc.ox.ac.uk; kate.venables@dphpc.ox.ac.uk	Fletcher, Tony/D-2394-2011; Nieuwenhuijsen, Mark J/C-3914-2017	Fletcher, Tony/0000-0003-3385-200X; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Keegan, Thomas/0000-0003-3691-953X; Brooks, Claire/0000-0002-3410-8971	MRC; Department of Public Health; Nuffield College, University of Oxford; Medical Research Council [G0200288] Funding Source: researchfish; MRC [G0200288] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The Universities of Oxford and London are independent of both the MRC and the MoD.	EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; Hills, 1993, STAT MODELS EPIDEMIO; International Agency for Research Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; Pechura C., 1993, VETERANS RISK HLTH E; VENABLES KM, 2009, BRIT MED J, pB613; WADA S, 1968, LANCET, V1, P1161	11	5	5	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2009	338								b655	10.1136/bmj.b655	http://dx.doi.org/10.1136/bmj.b655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318700	hybrid, Green Accepted, Green Published			2022-12-24	WOS:000264639500010
J	Garber, AM				Garber, Alan M.			An Uncertain Future for Cardiovascular Drug Development?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Natl Bur Econ Res, Hlth Care Program, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; National Bureau of Economic Research	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.		Garber, Alan M/F-1476-2010					Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; *PHARM RES MAN AM, 2009 REP MED DEV HEA; *US DRUG SAF SYST, 2007, FUT DRUG SAF PROM PR; Wald NJ, 2003, BRIT MED J, V327, P586; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WALD NJ, 2006, BMJ-BRIT MED J, V60, P823; Wang S.S., 2008, WALL STREET J   0930	7	18	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1169	1171		10.1056/NEJMp0808414	http://dx.doi.org/10.1056/NEJMp0808414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297568	Green Published, Green Submitted			2022-12-24	WOS:000264283400001
J	Steinhubl, SR; Bhatt, DL; Brennan, DM; Montalescot, G; Hankey, GJ; Eikelboom, JW; Berger, PB; Topol, EJ				Steinhubl, Steven R.; Bhatt, Deepak L.; Brennan, Danielle M.; Montalescot, Gilles; Hankey, Graeme J.; Eikelboom, John W.; Berger, Peter B.; Topol, Eric J.		CHARISMA Investigators	Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding	ANNALS OF INTERNAL MEDICINE			English	Article							PLATELET-FUNCTION; CORONARY; RISK; BIOSYNTHESIS; PROSTACYCLIN; EVENTS; ANGINA	Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversial. Objective: To assess the incidence of and risk factors for adverse clinical outcomes by investigator-determined aspirin dose in a primary prevention trial. Design: Post hoc observational analyses of data from a doubleblind, placebo-controlled, randomized trial. Setting: Outpatient. Patients: 15 595 patients with cardiovascular disease or multiple risk factors. Intervention: Clopidogrel, 75 mg/d, or placebo, with aspirin, 75 to 162 mg/d, as selected by the investigators. Measurements: Incidence of the composite outcome of myocardial infarction, stroke, or cardiovascular death (efficacy end point), and incidence of severe or life-threatening bleeding (safety end point), at a median of 28 months (interquartile range, 23 to 31 months) of follow-up. Results: Daily aspirin doses were categorized as less than 100 mg (75 or 81 mg) (n = 7180), 100 mg (n = 4961), and greater than 100 mg (150 or 162 mg) (n = 3454). The hazard of the primary efficacy end point was the same regardless of dose (adjusted hazard ratio, 0.95 [95% CI, 0.80 to 1.13] for 100 mg vs. less than 100 mg, and 1.0 [CI, 0.85 to 1.18] for greater than 100 mg vs. less than 100 mg). The hazard of the primary safety end point also did not depend on dose (adjusted hazard ratio, 0.85 [CI, 0.57 to 1.26] for 100 mg vs. less than 100 mg and 1.05 [CI, 0.74 to 1.48] for greater than 100 mg vs. less than 100 mg). In patients also receiving clopidogrel, daily aspirin doses greater than 100 mg seemed to be non- statistically significantly associated with reduced efficacy (adjusted hazard ratio, 1.16 [CI, 0.93 to 1.44]) and increased harm (adjusted hazard ratio, 1.30 [CI, 0.83 to 2.04]). Limitation: The analysis was post hoc, and aspirin use was not randomized or blinded. Conclusion: Daily aspirin doses of 100 mg or greater were associated with no clear benefit in patients taking aspirin only and possibly with harm in patients taking clopidogrel. Daily doses of 75 to 81 mg may optimize efficacy and safety for patients requiring aspirin for long-term prevention, especially for those receiving dual antiplatelet therapy.	[Steinhubl, Steven R.] Medicines Co, CH-8058 Zurich, Switzerland; Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; CHU Pitie Salpetriere, Inst Cardiol, Paris, France; Royal Perth Hosp, Perth, WA, Australia; McMaster Univ, Hamilton, ON, Canada; Scripps Clin, Scripps Translat Sci Inst, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Royal Perth Hospital; University of Western Australia; McMaster University; Scripps Research Institute	Steinhubl, SR (corresponding author), Medicines Co, CH-8058 Zurich, Switzerland.	steven.steinhubl@themedco.com	Walker, Philip J/F-3034-2010; Eikelboom, John/AAG-6117-2019; Hankey, Graeme J/H-4968-2014	Eikelboom, John/0000-0003-4126-1285; Hankey, Graeme J/0000-0002-6044-7328; Topol, Eric/0000-0002-1478-4729	Sanofi-Aventis; Bristol-Myers Squibb	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb)	Grant Support: The CHARISMA study was funded by Sanofi-Aventis and Bristol-Myers Squibb.	Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belton O, 2000, CIRCULATION, V102, P840; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cox D, 2006, STROKE, V37, P2153, DOI 10.1161/01.STR.0000231683.43347.ec; DiChiara J, 2007, DIABETES, V56, P3014, DOI 10.2337/db07-0707; Eikelboom JW, 2008, CIRCULATION, V118, P1705, DOI 10.1161/CIRCULATIONAHA.108.768283; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; GIBSON PC, 1949, LANCET, V257, P1172; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; LEE M, 1994, ANN INTERN MED, V120, P184, DOI 10.7326/0003-4819-120-3-199402010-00002; MONTALESCOT G, 1991, CIRCULATION, V84, P2054, DOI 10.1161/01.CIR.84.5.2054; Ng W, 2006, WORLD J GASTROENTERO, V12, P2923, DOI 10.3748/wjg.v12.i18.2923; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Rao SV, 2006, REV CARDIOVASC MED, V7, pS12; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; *US FDA, FIN RUL PROF LAB ASP; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827	28	124	131	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					379	W68		10.7326/0003-4819-150-6-200903170-00006	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293071				2022-12-24	WOS:000264468500003
J	Corl, AB; Berger, KH; Ophir-Shohat, G; Gesch, J; Simms, JA; Bartlett, SE; Heberlein, U				Corl, Ammon B.; Berger, Karen H.; Ophir-Shohat, Galit; Gesch, Julie; Simms, Jeffrey A.; Bartlett, Selena E.; Heberlein, Ulrike			Happyhour, a Ste20 Family Kinase, Implicates EGFR Signaling in Ethanol-Induced Behaviors	CELL			English	Article							TARGETED GENE-EXPRESSION; GROWTH-FACTOR RECEPTOR; GERMINAL CENTER KINASE; N-TERMINAL KINASE; PROTEIN-KINASE; DROSOPHILA-MELANOGASTER; ALCOHOL DEPENDENCE; BINDING PROTEIN; LOW-LEVEL; PATHWAY	The consequences of alcohol use disorders (AUDs) are devastating to individuals and society, yet few treatments are currently available. To identify genes regulating the behavioral effects of ethanol, we conducted a genetic screen in Drosophila and identified amutant, happyhour (hppy), dueto its increased-resistance to the sedative effects of ethanol. Hppy protein shows strong homology to mammalian Ste20 family kinases of the GCK-1 subfamily. Genetic and biochemical experiments revealed that the epidermal growth factor (EGF)-signaling pathway regulates ethanol sensitivity in Drosophila and that Hppy functions as an inhibitor of the pathway. Acute pharmacological inhibition of the EGF receptor (EGFR) in adult animals altered acute ethanol sensitivity in both flies and mice and reduced ethanol consumption in a preclinical rat model of alcoholism. Inhibitors of the EGFR or components of its signaling pathway are thus potential pharmacotherapies for AUDs.	[Corl, Ammon B.; Heberlein, Ulrike] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Ophir-Shohat, Galit; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Berger, Karen H.; Gesch, Julie; Simms, Jeffrey A.; Bartlett, Selena E.; Heberlein, Ulrike] Ernest Gallo Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Heberlein, U (corresponding author), Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA.	ulrike.heberlein@ucsf.edu	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958	NIH/NIAAA; Department of Defense; State of California for Medical Research; UCSF Neuroscience Training Grant; ARCS Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Defense(United States Department of Defense); State of California for Medical Research; UCSF Neuroscience Training Grant; ARCS Foundation; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We are grateful to Aylin Rodan for initiating this project, Linus Tsai and Ian King for outcrossing many of the lines used in this study, Amy Lasek for designing the primer/probe sets used for hppy QPCR, Melissa Sniffen for assistance with Drosophila CNS dissections, and all other members of the Heberlein lab for thoughtful discussions regarding this project. We thank Kevin Moses, Marek Mlodzik, Tim Tully, Mariann Bienz, Celeste Berg, Kunihiro Matsumoto, Barry Dickson, and the Bloomington Stock Center for providing fly lines. Scanning electron microscopy was performed at the Cornell Integrated Microscopy Center at Cornell University in Ithaca, NY. We gratefully acknowledge the gift of Tarceva from OSI Pharmaceuticals. We also thank Joan Holgate and Carsten Nielsen, in the preclinical development group, for assistance with the rodent experiments. This research was supported by grants from the NIH/NIAAA ( U. H.), the Department of Defense ( U. H. and S. E. B.), the State of California for Medical Research through UCSF ( U. H. and S. E. B.), and the UCSF Neuroscience Training Grant and the ARCS Foundation ( A. B. C.).	Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Arlinde C, 2004, PHARMACOGENOMICS J, V4, P208, DOI 10.1038/sj.tpj.6500243; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Ciardiello F, 2004, CURR OPIN ONCOL, V16, P130, DOI 10.1097/00001622-200403000-00008; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Dick DM, 2004, ALCOHOL CLIN EXP RES, V28, P4, DOI 10.1097/01.ALC.0000108645.54345.98; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lovinger DM, 1997, N-S ARCH PHARMACOL, V356, P267, DOI 10.1007/PL00005051; Ma CL, 2005, BIOCHEM PHARMACOL, V69, P1785, DOI 10.1016/j.bcp.2005.03.029; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Ranson M, 2004, J CLIN PHARM THER, V29, P95, DOI 10.1111/j.1365-2710.2004.00543.x; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REICH T, 1999, J NEUROSCI, V22, P9490; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; Schuckit MA, 2004, ALCOHOL CLIN EXP RES, V28, P1449, DOI 10.1097/01.ALC.0000141637.01925.F6; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Thiele TE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0006.2002; Thiele TE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0003.2000; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Urizar NL, 2007, J NEUROSCI, V27, P4541, DOI 10.1523/JNEUROSCI.0305-07.2007; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wolf FW, 2002, J NEUROSCI, V22, P11035	50	81	81	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					949	960		10.1016/j.cell.2009.03.020	http://dx.doi.org/10.1016/j.cell.2009.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19464045	Bronze			2022-12-24	WOS:000266454800024
J	Fan, HY; Liu, ZL; Shimada, M; Sterneck, E; Johnson, PF; Hedrick, SM; Richards, JS				Fan, Heng-Yu; Liu, Zhilin; Shimada, Masayuki; Sterneck, Esta; Johnson, Peter F.; Hedrick, Stephen M.; Richards, JoAnne S.			MAPK3/1 (ERK1/2) in Ovarian Granulosa Cells Are Essential for Female Fertility	SCIENCE			English	Article							C/EBP-BETA; CUMULUS EXPANSION; KNOCKOUT MICE; MOUSE; EXPRESSION; OVULATION; FOLLICLE; PHOSPHORYLATION; COMMUNICATION; ACTIVATION	A surge of luteinizing hormone (LH) from the pituitary gland triggers ovulation, oocyte maturation, and luteinization for successful reproduction in mammals. Because the signaling molecules RAS and ERK1/2 ( extracellular signal-regulated kinases 1 and 2) are activated by an LH surge in granulosa cells of preovulatory follicles, we disrupted Erk1/2 in mouse granulosa cells and provide in vivo evidence that these kinases are necessary for LH-induced oocyte resumption of meiosis, ovulation, and luteinization. In addition, biochemical analyses and selected disruption of the Cebpb gene in granulosa cells demonstrate that C/EBPb (CCAAT/Enhancer-binding protein-beta) is a critical downstream mediator of ERK1/2 activation. Thus, ERK1/2 and C/EBPb constitute an in vivo LH-regulated signaling pathway that controls ovulation- and luteinization-related events.	[Fan, Heng-Yu; Liu, Zhilin; Richards, JoAnne S.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Shimada, Masayuki] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Appl Anim Sci, Higashihiroshima 7398528, Japan; [Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21702 USA; [Johnson, Peter F.] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cell & Mol Biol, La Jolla, CA 92093 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	Baylor College of Medicine; Hiroshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; University of California System; University of California San Diego	Richards, JS (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	joanner@bcm.edu	Shimada, Masayuki/Q-3673-2016; Hedrick, Stephen M/E-9171-2010; Johnson, Peter/A-1940-2012	Shimada, Masayuki/0000-0002-6500-2088; Sterneck, Esta/0000-0001-7716-8766; Johnson, Peter/0000-0002-4145-4725; Hedrick, Stephen/0000-0002-6345-8751	NIH [NIH-HD16229, NIH-HD07495, NIH-HD07165]; Project II; Japan Society for the Promotion of Science [18688016]; Intramural Research Program of NIH; National Cancer Institute, Center for Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165, R01HD016229, U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, R37HD016229, R56HD016229] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010307, ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project II; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Pouyssegur and J. Shao for providing Erk1 mice and adenoviral vector of C/EBPSS, respectively. This work was supported by NIH grants NIH HD16229, NIH HD07495, Project II J.S.R., Grant in Aid for Scientific Research No. 18688016 from the Japan Society for the Promotion of Science M.S., Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research P.F.J. and E.S., and NIH Postdoctoral Training Grant NIH HD07165 H.Y.F. The Gene Expression Omnibus accession number for microarray data is GSE15135.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Maizels ET, 1998, ENDOCRINOLOGY, V139, P3353, DOI 10.1210/en.139.7.3353; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Sela-Abramovich S, 2005, ENDOCRINOLOGY, V146, P1236, DOI 10.1210/en.2004-1006; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221	18	431	452	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					938	941		10.1126/science.1171396	http://dx.doi.org/10.1126/science.1171396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443782	Green Accepted			2022-12-24	WOS:000266048800039
J	Goldman, SR; Ebright, RH; Nickels, BE				Goldman, Seth R.; Ebright, Richard H.; Nickels, Bryce E.			Direct Detection of Abortive RNA Transcripts in Vivo	SCIENCE			English	Article							LAC UV5 PROMOTER; POLYMERASE; ESCAPE; INITIATION; VITRO; REGION; SIGMA(70); MECHANISM; ELEMENTS; PROTEIN	During transcription initiation in vitro, prokaryotic and eukaryotic RNA polymerase ( RNAP) can engage in abortive initiation-the synthesis and release of short (2 to 15 nucleotides) RNA transcripts-before productive initiation. It has not been known whether abortive initiation occurs in vivo. Using hybridization with locked nucleic acid probes, we directly detected abortive transcripts in bacteria. In addition, we show that in vivo abortive initiation shows characteristics of in vitro abortive initiation: Abortive initiation increases upon stabilizing interactions between RNAP and either promoter DNA or sigma factor, and also upon deleting elongation factor GreA. Abortive transcripts may have functional roles in regulating gene expression in vivo.	[Goldman, Seth R.; Nickels, Bryce E.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Dept Chem, Piscataway, NJ 08854 USA; [Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick	Nickels, BE (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	bnickels@waksman.rutgers.edu	Ebright, Richard/O-3321-2019; Nickels, Bryce/AAF-2549-2020	Ebright, Richard/0000-0001-8915-7140; Nickels, Bryce/0000-0001-7449-8831	NIH [GM41376]; Howard Hughes Medical Institute; Pew Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R37GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hochschild, A. Revyakin, and J. Roberts for materials, and A. Gann, S. Garrity, A. Hochschild, L. Hsu, W. McAllister, E. McGlinn, and R. Sousa for discussion. Work was supported by NIH grant GM41376 and a Howard Hughes Medical Institute Investigatorship to R.H.E. and by a Pew Scholars Award to B.E.N.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Chan CL, 2001, J BIOL CHEM, V276, P38201; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Leibman M, 2007, EMBO J, V26, P1579, DOI 10.1038/sj.emboj.7601612; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v	18	81	84	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					927	928		10.1126/science.1169237	http://dx.doi.org/10.1126/science.1169237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19443781	Green Accepted			2022-12-24	WOS:000266048800035
J	Hawkes, N				Hawkes, Nigel			Observations Body Politic Fools rush in?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dancer SJ, 2008, J HOSP INFECT, V69, P315, DOI 10.1016/j.jhin.2008.05.002; 2008, JAMA-J AM MED ASSOC, V299, P1149	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 15	2009	338								b1533	10.1136/bmj.b1533	http://dx.doi.org/10.1136/bmj.b1533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369279				2022-12-24	WOS:000265296700005
J	Kosiborod, M; Inzucchi, SE; Goyal, A; Krumholz, HM; Masoudi, FA; Xiao, L; Spertus, JA				Kosiborod, Mikhail; Inzucchi, Silvio E.; Goyal, Abhinav; Krumholz, Harlan M.; Masoudi, Frederick A.; Xiao, Lan; Spertus, John A.			Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE INSULIN THERAPY; STRESS HYPERGLYCEMIA; BLOOD-GLUCOSE; ADVERSE OUTCOMES; NONDIABETIC PATIENTS; DIABETIC-PATIENTS; PLASMA-GLUCOSE; ASSOCIATION; ADMISSION; RISK	Context While glucose control is recommended by professional societies for patients with hyperglycemia hospitalized with acute myocardial infarction (AMI), enthusiasm for glucose lowering is tempered, in part, by concerns of inducing hypoglycemia. Yet, whether episodic hypoglycemia that occurs as a result of glucose-lowering therapy is harmful in patients with AMI is unknown. Objective To determine whether the mortality risk associated with hypoglycemic events is similar in patients who develop hypoglycemia spontaneously and those who develop it as a result of insulin therapy. Design, Setting, and Patients Retrospective cohort study using data from Health Facts, a contemporary database of patients hospitalized across the United States in 40 hospitals between January 1, 2000, and December 31, 2005. Of all the patients in the database, 7820 patients were hospitalized with AMI and were hyperglycemic on admission (glucose level >= 140 mg/dL). Patients were stratified based on whether they developed a hypoglycemic event (random glucose level <60 mg/dL) during subsequent hospitalization. Logistic regression models were used to evaluate the association between hypoglycemia and in-hospital mortality within subgroups of patients who were and were not treated with insulin therapy. Main Outcome Measure All-cause in-hospital mortality. Results Among patients treated or not treated with insulin, those with hypoglycemia were older and had more comorbidity. Hypoglycemia was associated with increased mortality in patients not treated with insulin (18.4% [25/136] mortality in patients with hypoglycemia vs 9.2% [425/4639] in those without hypoglycemia; P<.001), but not in those treated with insulin (10.4% [36/346] mortality in patients with hypoglycemia vs 10.2% [276/2699] in those without hypoglycemia; P=.92). After multivariable adjustment, there was a significant interaction between hypoglycemia and insulin therapy (P value for interaction=.01). Hypoglycemia was a predictor of higher mortality in patients who were not treated with insulin (odds ratio, 2.32 [95% confidence interval, 1.31-4.12] vs patients without hypoglycemia), but not in patients treated with insulin (odds ratio, 0.92 [95% confidence interval, 0.58-1.45] vs patients without hypoglycemia). Conclusions While hypoglycemia was associated with increased mortality in patients with AMI, this risk was confined to patients who developed hypoglycemia spontaneously. In contrast, iatrogenic hypoglycemia after insulin therapy was not associated with higher mortality risk.	[Kosiborod, Mikhail; Xiao, Lan; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Kosiborod, Mikhail; Spertus, John A.] Univ Missouri, Dept Med, Kansas City, MO USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Atlanta, GA USA; [Goyal, Abhinav] Emory Sch Med, Atlanta, GA USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Denver, CO USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Emory University; Rollins School Public Health; Emory University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kosiborod, M (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mkosiborod@cc-pc.com	Kosiborod, Mikhail/HDO-1541-2022; , Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021; Masoudi, Frederick/Q-7467-2019; Goyal, Abhinav/J-5086-2012; Inzucchi, Silvio/ABF-4121-2021	Kosiborod, Mikhail/0000-0002-3750-9789; Goyal, Abhinav/0000-0002-6286-2349; 	American Heart Association; Cerner Corporation	American Heart Association(American Heart Association); Cerner Corporation	Funding/Support: The research for this article was supported by the American Heart Association Career Development Award in Implementation Research awarded to Dr Kosiborod and by the Cerner Corporation.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; ANTMAN EM, ACC AHA GUIDELINES M; BELLODI G, 1989, AM J CARDIOL, V64, P885, DOI 10.1016/0002-9149(89)90836-9; Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Childs BP, 2005, DIABETES CARE, V28, P1245; Deedwania P, 2008, CIRCULATION, V117, P1610, DOI 10.1161/CIRCULATIONAHA.107.188629; Foo K, 2003, HEART, V89, P512, DOI 10.1136/heart.89.5.512; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Goyal A, 2006, EUR HEART J, V27, P1289, DOI 10.1093/eurheartj/ehi884; Hadjadj S, 2004, DIABETIC MED, V21, P305, DOI 10.1111/j.1464-5491.2004.01112.x; Ishihara M, 2003, AM HEART J, V146, P674, DOI 10.1016/S0002-8703(03)00167-4; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Kadri Z, 2006, HEART, V92, P910, DOI 10.1136/hrt.2005.073791; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; MADSEN JK, 1986, ACTA MED SCAND, V220, P329; Mak K. H., 1993, Annals Academy of Medicine Singapore, V22, P291; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meier JJ, 2005, DIABETES CARE, V28, P2551, DOI 10.2337/diacare.28.10.2551; MELLBIN LG, 2008, HEART           1124, DOI DOI 10.1136/HRT.2008.152835; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; OSULLIVAN JJ, 1991, DIABETES CARE, V14, P758, DOI 10.2337/diacare.14.8.758; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; OSWALD GA, 1984, LANCET, V1, P1264; OSWALD GA, 1987, DIABETIC MED, V4, P68, DOI 10.1111/j.1464-5491.1987.tb00833.x; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Sala J, 2002, J EPIDEMIOL COMMUN H, V56, P707, DOI 10.1136/jech.56.9.707; SEWDARSEN M, 1987, DIABETES RES CLIN EX, V6, P47; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Swinnen S, 2009, DIABETOLOGIA, V52, P38, DOI 10.1007/s00125-008-1147-0; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Wahab NN, 2002, J AM COLL CARDIOL, V40, P1748, DOI 10.1016/S0735-1097(02)02483-X; Wong VW, 2004, DIABETES RES CLIN PR, V64, P85, DOI 10.1016/j.diabres.2003.10.016; YUDKIN JS, 1987, BRIT MED J, V294, P773, DOI 10.1136/bmj.294.6574.773	42	233	241	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1556	1564		10.1001/jama.2009.496	http://dx.doi.org/10.1001/jama.2009.496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366775	Bronze			2022-12-24	WOS:000265137900026
J	Venables, KM; Brooks, C; Linsell, L; Keegan, TJ; Langdon, T; Fletcher, T; Nieuwenhuijsen, MJ; Maconochie, NES; Doyle, P; Beral, V; Carpenter, LM				Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Fletcher, T.; Nieuwenhuijsen, M. J.; Maconochie, N. E. S.; Doyle, P.; Beral, V.; Carpenter, L. M.			Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MUSTARD-GAS INJURY; LUNG-CANCER; WORLD-WAR-1 VETERANS; EXPOSURES; NEOPLASIA	Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants 18 276 male members of the UK armed forces who had spent one or more short periods (median 4 days between first and last test) at Porton Down and a comparison group of 17 600 non-Porton Down veterans followed to 31 December 2004. Main outcome measures Mortality rate ratio of Porton Down compared with non-Porton Down veterans and standardised mortality ratio of each veteran group compared with the general population. Both ratios adjusted for age group and calendar period. Results Porton Down veterans were similar to non-Porton Down veterans in year of enlistment (median 1951) but had longer military service (median 6.2 v 5.0 years). After a median follow-up of 43 years, 40% (7306) of Porton Down and 39% (6900) of non-Porton Down veterans had died. All cause mortality was slightly greater in Porton Down veterans (rate ratio 1.06, 95% confidence interval 1.03 to 1.10, P<0.001), more so for deaths outside the UK (1.26, 1.09 to 1.46). Of 12 cause specific groups examined, rate ratios in Porton Down veterans were increased for deaths attributed to infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign, and unspecified neoplasms (0.60, 0.37 to 0.99). There was no clear relation between type of chemical exposure and cause specific mortality. The mortality in both groups of veterans was lower than that in the general population (standardised mortality ratio 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84). Conclusions Mortality was slightly higher in Porton Down than non-Porton Down veterans. With lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down.	[Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Carpenter, L. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Maconochie, N. E. S.; Doyle, P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Venables, KM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	kate.venables@dphpc.ox.ac.uk; lucy.carpenter@dphpc.ox.ac.uk	Nieuwenhuijsen, Mark J/C-3914-2017; Fletcher, Tony/D-2394-2011	Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Fletcher, Tony/0000-0003-3385-200X; Keegan, Thomas/0000-0003-3691-953X; Brooks, Claire/0000-0002-3410-8971	MRC; Department of Public Health; Nuffield College, University of Oxford; MRC [G0200288] Funding Source: UKRI; Medical Research Council [G0200288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The universities of Oxford and London are independent of both the MRC and the MoD.	Allender S, 2006, OCCUP MED-OXFORD, V56, P329, DOI 10.1093/occmed/kql059; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; BEEBE GW, 1960, J NATL CANCER I, V25, P1231; Bullman T, 2000, ANN EPIDEMIOL, V10, P333, DOI 10.1016/S1047-2797(00)00060-0; CARPENTER LM, 2009, BMJ-BRIT MED J, pB655; Carter G. B., 2000, CHEM BIOL DEFENCE PO; Case RAM, 1955, BRIT J PREV SOC MED, V9, P62; Coleman K, 2005, HISTORY OF CHEMICAL WARFARE, P1, DOI 10.1057/9780230501836; Council N. R, 1985, POSSIBLE LONG TERM H, V3; DARBY SC, 1990, BRIT J IND MED, V47, P793; EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; HARRIS R, 1982, HIGHER FORM KILLING; Hills, 1993, STAT MODELS EPIDEMIO; Inskip H, 1997, OCCUP ENVIRON MED, V54, P209, DOI 10.1136/oem.54.3.209; International Agency for Research Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V1; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V2; NORMAN JE, 1975, JNCI-J NATL CANCER I, V54, P311, DOI 10.1093/jnci/54.2.311; Pechura C., 1993, VETERANS RISK HLTH E; WADA S, 1968, LANCET, V1, P1161	25	4	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2009	338								b613	10.1136/bmj.b613	http://dx.doi.org/10.1136/bmj.b613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318699	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-24	WOS:000264639500009
J	Takeuchi, JK; Bruneau, BG				Takeuchi, Jun K.; Bruneau, Benoit G.			Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors	NATURE			English	Article							CHROMATIN-REMODELING COMPLEX; ANTEROPOSTERIOR AXIS; STEM-CELLS; MESP1; DIFFERENTIATION; TRANSCRIPTION; GENE; EXPRESSION; INDUCTION; MYOCARDIN	Heart disease is the leading cause of mortality and morbidity in the western world. The heart has little regenerative capacity after damage, leading to much interest in understanding the factors required to produce new cardiac myocytes. Despite a robust understanding of the molecular networks regulating cardiac differentiation(1,2), no single transcription factor or combination of factors has been shown to activate the cardiac gene program de novo in mammalian cells or tissues. Here we define the minimal requirements for transdifferentiation of mouse mesoderm to cardiac myocytes. We show that two cardiac transcription factors, Gata4 and Tbx5, and a cardiac-specific subunit of BAF chromatin-remodelling complexes, Baf60c (also called Smarcd3), can direct ectopic differentiation of mouse mesoderm into beating cardiomyocytes, including the normally non-cardiogenic posterior mesoderm and the extraembryonic mesoderm of the amnion. Gata4 with Baf60c initiated ectopic cardiac gene expression. Addition of Tbx5 allowed differentiation into contracting cardiomyocytes and repression of non-cardiac mesodermal genes. Baf60c was essential for the ectopic cardiogenic activity of Gata4 and Tbx5, partly by permitting binding of Gata4 to cardiac genes, indicating a novel instructive role for BAF complexes in tissues-specific regulation. The combined function of these factors establishes a robust mechanism for controlling cellular differentiation, and may allow reprogramming of new cardiomyocytes for regenerative purposes.	[Takeuchi, Jun K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Takeuchi, Jun K.] Tokyo Inst Technol, Global Edge Inst, Div Cardiovasc Res, Midori Ku, Kanagawa 2268503, Japan; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Tokyo Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	takeuchi.j.ab@m.titech.ac.jp; bbruneau@gladstone.ucsf.edu		Bruneau, Benoit/0000-0002-0804-7597	Human Frontiers Science Program CDA; MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation; NHLBI [R01HL085860]; NIH/NCRR [C06 RR018928]; William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085860] Funding Source: NIH RePORTER	Human Frontiers Science Program CDA(Human Frontier Science Program); MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Koshiba-Takeuchi for assistance with immunohistochemistry, H. Ogawa for advice on chromatin immunoprecipitation, B. L. Black and D. Srivastava for discussions and expression constructs, G. R. Crabtree, M. Nemer, E. N. Olson and Y. Saga for expression constructs, and G. Howard and S. Ordway for editorial assistance. This work was supported by Human Frontiers Science Program CDA and short-term fellowships (J. K. T.), MEXT's program for young independent researchers ( J. K. T.), Mitsubishi Foundation (J. K. T.), the Takeda Science Foundation ( J. K. T.) and NHLBI (R01HL085860, B. G. B.). This work was also supported by an NIH/NCRR grant (C06 RR018928, J. David Gladstone Institutes) and by William H. Younger, Jr ( B. G. B.).	Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	30	389	417	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					708	U112		10.1038/nature08039	http://dx.doi.org/10.1038/nature08039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396158	Green Accepted			2022-12-24	WOS:000266608600045
J	Annas, GJ				Annas, George J.			Globalized Clinical Trials and Informed Consent	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ETHICS		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Kimmelman J, 2009, LANCET, V373, P13, DOI 10.1016/S0140-6736(08)61936-4; Stephens Joe, 2000, WASHINGTON POST 1217, pA1	4	47	48	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2009	360	20					2050	2053		10.1056/NEJMp0901474	http://dx.doi.org/10.1056/NEJMp0901474			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	444WN	19439740				2022-12-24	WOS:000266011200003
J	Weinstein, JA; Jiang, N; White, RA; Fisher, DS; Quake, SR				Weinstein, Joshua A.; Jiang, Ning; White, Richard A., III; Fisher, Daniel S.; Quake, Stephen R.			High-Throughput Sequencing of the Zebrafish Antibody Repertoire	SCIENCE			English	Article							IMMUNE RECEPTORS; PERSPECTIVES; DIVERSITY	Despite tremendous progress in understanding the nature of the immune system, the full diversity of an organism's antibody repertoire is unknown. We used high-throughput sequencing of the variable domain of the antibody heavy chain from 14 zebrafish to analyze VDJ usage and antibody sequence. Zebrafish were found to use between 50 and 86% of all possible VDJ combinations and shared a similar frequency distribution, with some correlation of VDJ patterns between individuals. Zebrafish antibodies retained a few thousand unique heavy chains that also exhibited a shared frequency distribution. We found evidence of convergence, in which different individuals made the same antibody. This approach provides insight into the breadth of the expressed antibody repertoire and immunological diversity at the level of an individual organism.	[Weinstein, Joshua A.; Fisher, Daniel S.; Quake, Stephen R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Jiang, Ning; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [White, Richard A., III; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fisher, Daniel S.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Fisher, Daniel S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	quake@stanford.edu	White, Richard Allen/H-5142-2019; Jiang, Ning/M-5448-2017; Fisher, Daniel S/A-4134-2011	Jiang, Ning/0000-0003-1103-5922; Weinstein, Joshua/0000-0002-0103-9738; White III, Richard Allen/0000-0002-6292-5936; Fisher, Daniel/0000-0002-5559-2491	NIH Directors Pioneer award; Arthritis Foundation Postdoctoral Fellowship; NSF graduate fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	NIH Directors Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; NSF graduate fellowship(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank W. Talbot for useful conversations and the generous loan of equipment and N. Neff for assistance with sequencing. IgM and IgZ sequence and quality-score files are available on the NIH short-read archive, with accession number SRA008134. This research was supported by the NIH Directors Pioneer award (S.R.Q.), the Arthritis Foundation Postdoctoral Fellowship (N.J.), and an NSF graduate fellowship (J.A.W.).	Boudinot P, 2008, MOL IMMUNOL, V45, P2437, DOI 10.1016/j.molimm.2007.12.018; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; GOLUB ES, 1987, CELL, V48, P723, DOI 10.1016/0092-8674(87)90066-3; Janeway C., 2004, IMMUNOBIOLOGY; KINDT TJ, 1984, ANTIBODY ENGIMA; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SINGH SP, 1978, Z ALLG MIKROBIOL, V18, P111, DOI 10.1002/jobm.3630180205; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1	14	314	352	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					807	810		10.1126/science.1170020	http://dx.doi.org/10.1126/science.1170020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423829	Green Accepted			2022-12-24	WOS:000265832400053
J	Coombes, R				Coombes, Rebecca			A/H1N1 influenza: questions and answers	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 7	2009	338								b1849	10.1136/bmj.b1849	http://dx.doi.org/10.1136/bmj.b1849			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	444GW	19423622				2022-12-24	WOS:000265969700005
J	Concato, J; Jain, D; Uchio, E; Risch, H; Li, WW; Wells, CK				Concato, John; Jain, Dhanpat; Uchio, Edward; Risch, Harvey; Li, William W.; Wells, Carolyn K.			Molecular Markers and Death From Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							ANDROGEN DEPRIVATION; RADIATION-THERAPY; GLEASON SCORE; CELL-CYCLE; IN-VITRO; BCL-2; EXPRESSION; MEN; P53; ANGIOGENESIS	Background: Current methods to assess the prognosis of prostate cancer at the time of diagnosis are limited. Objective: To determine whether molecular markers of cell cycle regulation (bcl-2 and p53) and angiogenesis (beta-3 integrin, vascular endothelial growth factor, and microvessel density) are associated with increased long-term risk for death among men with prostate cancer. Design: Observational cohort study from 1991 to 2006. Setting: The Veterans Affairs Healthcare System in New England. Patients: Among 64 545 veterans at least 50 years of age, 1313 patients who had incident prostate cancer from 1991 to 1995 were identified. Clinical data were available for 1270 men and complete for 1172 men. Measurements: Data were extracted from medical records, including patient age, race, and comorbid conditions, as well as tumor-related anatomical extent, histologic grade (Gleason score), prostate-specific antigen level, symptoms, and treatment. Immunohistochemical analyses of tissue obtained at diagnosis, which used antibodies against the selected markers, were also conducted. Proportional hazards analysis was used to evaluate the association of these factors with death from prostate cancer through 2006. Results: At diagnosis, the median age was 72 years, the median prostate-specific antigen level was 10.0 mu g/L, and most tumors were moderately differentiated. During an 11- to 16-year follow-up, 71.8% (842 of 1172) of men died, with 21.5% (181 of 842) of deaths attributable to prostate cancer. Among 1007 men with results for all pertinent markers and after adjustment for age and clinical characteristics, bcl-2 (adjusted hazard ratio [HR] for positive vs. negative staining, 1.61 [95% CI, 1.01 to 2.57]; P = 0.045), p53 (adjusted HR for positive vs. negative staining, 1.48 [CI, 1.06 to 2.08]; P = 0.022), and microvessel density ( adjusted HR for highest vs. lowest quartile, 3.20 [CI, 1.77 to 5.78]; P < 0.001) were associated with death from prostate cancer. Limitations: Results may be affected by residual confounding. Some patients were not included in complete case analyses because information was not available from clinical care records (7.5%) or tissue staining (12.6%). Conclusion: Immunohistochemical evidence of bcl-2, p53, or high microvessel density in prostate cancer biopsy specimens at diagnosis is associated with an increased long-term risk for death from prostate cancer. Primary Funding Source: Office of Research and Development, Veterans Health Administration.	Vet Affairs Connecticut Healthcare Syst, Vet Affairs Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; Yale Univ, Sch Med, New Haven, CT USA; Angiogenesis Fdn, Cambridge, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Concato, J (corresponding author), Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, Mail Code 151B,950 Campbell Ave, West Haven, CT 06516 USA.				Office of Research and Development; Veterans Health Administration; Clinical Science Research and Development Service; Merit Review Award Program	Office of Research and Development; Veterans Health Administration(US Department of Veterans Affairs); Clinical Science Research and Development Service; Merit Review Award Program	Office of Research and Development, Veterans Health Administration.; By the Clinical Science Research and Development Service, Merit Review Award Program, Office of Research and Development, Veterans Health Administration.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; BRAWER MK, 1992, J CELL BIOCHEM, P62; Bubendorf L, 1999, CANCER RES, V59, P803; BURKE HB, 1993, CANCER, V72, P3131, DOI 10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Che M, 2007, INT J RADIAT ONCOL, V69, P1117, DOI 10.1016/j.ijrobp.2007.04.070; COLOMBEL M, 1993, AM J PATHOL, V143, P390; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Concato J, 2001, CANCER, V91, P1607, DOI 10.1002/1097-0142(20010415)91:8+<1607::AID-CNCR1174>3.0.CO;2-J; Concato J, 2007, BJU INT, V100, P1259, DOI 10.1111/j.1464-410X.2007.07136.x; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Deutsch E, 2004, LANCET ONCOL, V5, P303, DOI 10.1016/S1470-2045(04)01468-8; Downing Sean R, 2003, Can J Urol, V10, P1924; Epstein JI, 2000, AM J SURG PATHOL, V24, P477, DOI 10.1097/00000478-200004000-00001; Ferrer FA, 1997, J UROLOGY, V157, P2329, DOI 10.1016/S0022-5347(01)64775-X; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Gelmann EP, 2008, NEW ENGL J MED, V358, P961, DOI 10.1056/NEJMe0708703; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; Holmboe ES, 2000, J GEN INTERN MED, V15, P694, DOI 10.1046/j.1525-1497.2000.90842.x; Izawa JI, 2001, CAN MED ASSOC J, V164, P662; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; KAMATH A, 2008, APPL IMMUNOHISTOCHEM; Kenny LM, 2007, BJU INT, V100, P244, DOI 10.1111/j.1464-410X.2007.07063.x; Khor LY, 2007, CLIN CANCER RES, V13, P3585, DOI 10.1158/1078-0432.CCR-06-2972; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; MELLON K, 1992, J UROLOGY, V147, P496, DOI 10.1016/S0022-5347(17)37287-7; Moul JW, 2001, UROL CLIN N AM, V28, P459, DOI 10.1016/S0094-0143(05)70155-5; Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; RAFFO AJ, 1995, CANCER RES, V55, P4438; Ross JS, 2003, AM J CLIN PATHOL, V120, P822, DOI 10.1309/6CQ7AXQ6WHHBXUWH; Rubin MA, 2002, AM J SURG PATHOL, V26, P312, DOI 10.1097/00000478-200203000-00004; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Schlomm T, 2007, WORLD J UROL, V25, P19, DOI 10.1007/s00345-007-0153-z; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Trikha M, 1996, CANCER RES, V56, P5071; VISAKORPI T, 1992, J NATL CANCER I, V84, P883, DOI 10.1093/jnci/84.11.883; WEIDNER N, 1993, AM J PATHOL, V143, P401; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	50	32	33	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2009	150	9					595	U6		10.7326/0003-4819-150-9-200905050-00005	http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	443IQ	19414838	Green Submitted			2022-12-24	WOS:000265903800003
J	Brewer, PG; Peltzer, ET				Brewer, Peter G.; Peltzer, Edward T.			Limits to Marine Life	SCIENCE			English	Editorial Material							OCEAN ACIDIFICATION; CONSEQUENCES		[Brewer, Peter G.; Peltzer, Edward T.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Brewer, PG (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	brpe@mbari.org		Brewer, Peter/0000-0002-5448-0199; Peltzer, Edward/0000-0003-2821-3553				Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; REDFIELD AC, 1963, SEA, V2; Rue EL, 1997, DEEP-SEA RES PT I, V44, P113, DOI 10.1016/S0967-0637(96)00088-X; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SABINE CL, 2005, ORNLCDIAC145 US DOE; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847	10	133	136	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					347	348		10.1126/science.1170756	http://dx.doi.org/10.1126/science.1170756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372421				2022-12-24	WOS:000265221600030
J	Pantilat, SZ				Pantilat, Steven Z.			Communicating With Seriously Ill Patients Better Words to Say	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; END; SKILLS		Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Pantilat, SZ (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, Box 0903,521 Parnassus Ave,Ste C-126, San Francisco, CA 94143 USA.	stevep@medicine.ucsf.edu						Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Block S D, 1998, J Palliat Med, V1, P347, DOI 10.1089/jpm.1998.1.347; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lienard A, 2006, ANN ONCOL, V17, P1450, DOI 10.1093/annonc/mdl142; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010; Selph RB, 2008, J GEN INTERN MED, V23, P1311, DOI 10.1007/s11606-008-0643-8; Stapleton RD, 2006, CRIT CARE MED, V34, P1679, DOI 10.1097/01.CCM.0000218409.58256.AA; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359	14	33	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1279	1281		10.1001/jama.2009.396	http://dx.doi.org/10.1001/jama.2009.396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318656				2022-12-24	WOS:000264492800029
J	Benitez, MA				Benitez, Mary Ann			Climate change could affect mosquito-borne diseases in Asia	LANCET			English	Editorial Material																			0	24	27	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1070	1070		10.1016/S0140-6736(09)60634-6	http://dx.doi.org/10.1016/S0140-6736(09)60634-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19338070				2022-12-24	WOS:000264773600013
J	Ohya, T; Miaczynska, M; Coskun, U; Lommer, B; Runge, A; Drechsel, D; Kalaidzidis, Y; Zerial, M				Ohya, Takeshi; Miaczynska, Marta; Coskun, Unal; Lommer, Barbara; Runge, Anja; Drechsel, David; Kalaidzidis, Yannis; Zerial, Marino			Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes	NATURE			English	Article							TRANSPORT-VESICLE; GDP/GTP EXCHANGE; EFFECTOR EEA1; ALPHA-SNAP; COMPLEX; PROTEINS; DOCKING; SPECIFICITY; DOMAIN; DISSOCIATION	Rab GTPases and SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) are evolutionarily conserved essential components of the eukaryotic intracellular transport system. Although pairing of cognate SNAREs is sufficient to fuse membranes in vitro, a complete reconstitution of the Rab-SNARE machinery has never been achieved. Here we report the reconstitution of the early endosomal canine Rab5 GTPase, its key regulators and effectors together with SNAREs into proteoliposomes using a set of 17 recombinant human proteins. These vesicles behave like minimal 'synthetic' endosomes, fusing with purified early endosomes or with each other in vitro. Membrane fusion measured by content-mixing and morphological assays requires the cooperativity between Rab5 effectors and cognate SNAREs which, together, form a more efficient 'core machinery' than SNAREs alone. In reconstituting a fusion mechanism dependent on both a Rab GTPase and SNAREs, our work shows that the two machineries act coordinately to increase the specificity and efficiency of the membrane tethering and fusion process.	[Ohya, Takeshi; Miaczynska, Marta; Coskun, Unal; Lommer, Barbara; Runge, Anja; Drechsel, David; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01309 Dresden, Germany.	zerial@mpi-cbg.de	Coskun, Ünal/F-4683-2011; Kalaidzidis, Yannis/H-3094-2016	Coskun, Ünal/0000-0003-4375-3144; Kalaidzidis, Yannis/0000-0002-6137-1193; Miaczynska, Marta/0000-0003-0031-5267	German Ministry for Education and Research [0313082J]; EU Integrated Project EndoTrack; DFG; Max Planck Society; The Nakatomi Foundation	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); EU Integrated Project EndoTrack; DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); The Nakatomi Foundation	We are grateful to K. Simons and B. Hoflack for discussions, to C. Stroupe and W. Wickner for sharing unpublished information, and to G. Marsne, I. Baines, W. Huttner, K. Simons, C. Stroupe and W. Wickner for critical reading of the manuscript. We acknowledge support by the systems biology network HepatoSys of the German Ministry for Education and Research ( BMBF, grant 0313082J), the EU Integrated Project EndoTrack, the DFG and the Max Planck Society ( including the Max Planck Partner Group grant to M. Z. and M. M.). T. O. was supported by The Nakatomi Foundation.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Liu TT, 2005, BIOPHYS J, V89, P2458, DOI 10.1529/biophysj.105.062539; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zimmerberg J, 2006, NAT CHEM BIOL, V2, P564, DOI 10.1038/nchembio1106-564; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	50	155	159	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1091	U77		10.1038/nature08107	http://dx.doi.org/10.1038/nature08107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19458617				2022-12-24	WOS:000267636700035
J	Bell, CM; Hatch, WV; Fischer, HD; Cernat, G; Paterson, JM; Gruneir, A; Gill, SS; Bronskill, SE; Anderson, GM; Rochon, PA				Bell, Chaim M.; Hatch, Wendy V.; Fischer, Hadas D.; Cernat, Geta; Paterson, J. Michael; Gruneir, Andrea; Gill, Sudeep S.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.			Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLOPPY-IRIS-SYNDROME; BENIGN PROSTATIC HYPERPLASIA; ALPHA(1)-ADRENERGIC RECEPTOR ANTAGONISTS; ACUTE ENDOPHTHALMITIS; CLINICAL-OUTCOMES; POPULATION; FLOMAX; POWER; RISK	Context Both benign prostatic hyperplasia (BPH) and cataract formation are common in older men. The alpha-adrenergic receptor blocker tamsulosin is frequently prescribed to treat BPH, and research suggests this drug may increase the intraoperative difficulty of cataract surgery. No studies have documented whether use of tamsulosin or other alpha-blocker drug therapies affect the risk of serious postoperative adverse events. Objective To assess the risk of adverse events following cataract surgery in older men prescribed tamsulosin or other alpha-blocking drugs used to treat BPH. Design, Setting, and Patients Nested case-control analysis of a population-based retrospective cohort study using linked health care databases from Ontario, Canada. We included all men aged 66 years or older who had cataract surgery between 2002 and 2007 (N=96 128). Main Outcome Measures A composite of procedures signifying retinal detachment, lost lens or lens fragment, or endophthalmitis occurring within 14 days after cataract surgery. The risk of these adverse events was compared between men treated with tamsulosin or other alpha-blockers and men with no exposure to these medications in the year prior to cataract surgery. We separately examined the association of drug exposure that was either recent ( within the 14 days before surgery) or previous (15-365 days before surgery). Results Overall, 3550 patients (3.7%) in the cohort had recent exposure to tamsulosin and 7426 patients (7.7%) had recent exposure to other alpha-blockers. Two hundred eighty-four patients (0.3%) had an adverse event. We randomly matched 280 of the cases to 1102 controls according to their age, surgeon, and year of surgery. Adverse events were significantly more common among patients with recent tamsulosin exposure (7.5% vs 2.7%; adjusted odds ratio [OR], 2.33; 95% confidence interval [CI], 1.22-4.43) but were not associated with recent exposure to other alpha-blockers (7.5% vs 8.0%; adjusted OR, 0.91; 95% CI, 0.54-1.54) or to previous exposure to either tamsulosin (<= 1.8% vs 1%; adjusted OR, 0.94; 95% CI, 0.27-3.34) or other alpha-blockers (2.9% vs 2.1%; adjusted OR, 1.08; 95% CI, 0.47-2.48). This corresponds to an estimated number needed to harm (NNH) of 255 (95% CI, 99-1666). Conclusions Exposure to tamsulosin within 14 days of cataract surgery was significantly associated with serious postoperative ophthalmic adverse events. There were no significant associations with exposure to other alpha-blocker medications used to treat BPH. JAMA. 2009;301(19):1991-1996 www.jama.com	[Bell, Chaim M.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.; Fischer, Hadas D.; Cernat, Geta; Paterson, J. Michael; Gruneir, Andrea; Gill, Sudeep S.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.] Inst Clin Evaluat Sci0, Toronto, ON, Canada; [Bell, Chaim M.; Rochon, Paula A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.; Bronskill, Susan E.; Anderson, Geoffrey M.; Rochon, Paula A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hatch, Wendy V.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Gruneir, Andrea; Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Gruneir, Andrea] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; [Paterson, J. Michael] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Gill, Sudeep S.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Baycrest; McMaster University; Queens University - Canada	Bell, CM (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	bellc@smh.toronto.on.ca	Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes [OTG-88591]; Interdisciplinary Capacity Enhancement [HOA-80075]; CIHR Institute of Gender and Health; CIHR Institute of Aging; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); Interdisciplinary Capacity Enhancement; CIHR Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by Team Grant OTG-88591 from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes and by an Interdisciplinary Capacity Enhancement Grant, HOA-80075, from the CIHR Institute of Gender and Health and the CIHR Institute of Aging. Dr Bell is supported by a New Investigator Award from the CIHR Institute of Aging. This study was conducted at the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).	Armitage JN, 2007, BRIT MED J, V335, P1199, DOI 10.1136/bmj.39377.617269.55; Bell CM, 2007, OPHTHALMOLOGY, V114, P405, DOI 10.1016/j.ophtha.2006.08.036; Bendel RE, 2006, J CATARACT REFR SURG, V32, P1603, DOI 10.1016/j.jcrs.2006.04.039; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Blouin MC, 2007, J CATARACT REFR SURG, V33, P1227, DOI 10.1016/j.jcrs.2007.03.032; *BOEHR ING, BOEHR ING ANN REP 20; *BOEHR ING, 2007, FLOM TAMS HYDR PACK; Cantrell MA, 2008, ANN PHARMACOTHER, V42, P558, DOI 10.1345/aph.1K679; Chadha V, 2007, BRIT J OPHTHALMOL, V91, P40, DOI 10.1136/bjo.2006.103036; Chang DF, 2007, OPHTHALMOLOGY, V114, P957, DOI 10.1016/j.ophtha.2007.01.011; Chang DF, 2005, J CATARACT REFR SURG, V31, P664, DOI 10.1016/j.jcrs.2005.02.027; Cheung CMG, 2007, AM J OPHTHALMOL, V143, P1070, DOI 10.1016/j.ajo.2007.02.044; Cheung CMG, 2006, J CATARACT REFR SURG, V32, P1336, DOI 10.1016/j.jcrs.2006.03.034; Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Gurbaxani A, 2007, EYE, V21, P331, DOI 10.1038/sj.eye.6702172; Habib MS, 2005, BRIT J OPHTHALMOL, V89, P1143, DOI 10.1136/bjo.2005.070235; Hatch WV, 2009, OPHTHALMOLOGY, V116, P425, DOI 10.1016/j.ophtha.2008.09.039; Lawrentschuk N, 2006, BJU INT, V97, P2, DOI 10.1111/j.1464-410X.2006.05960.x; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lundstrom M, 2002, ACTA OPHTHALMOL SCAN, V80, P248, DOI 10.1034/j.1600-0420.2002.800304.x; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Morlet N, 2003, BRIT J OPHTHALMOL, V87, P574, DOI 10.1136/bjo.87.5.574; Nguyen DQ, 2007, EYE, V21, P443, DOI 10.1038/sj.eye.6702616; Norregaard JC, 1999, OPHTHALMOLOGY, V106, P42, DOI 10.1016/S0161-6420(99)90004-0; Osher RH, 2006, J CATARACT REFR SURG, V32, P547, DOI 10.1016/j.jcrs.2006.01.008; Oshika T, 2007, AM J OPHTHALMOL, V143, P150, DOI 10.1016/j.ajo.2006.07.046; Parssinen O, 2006, INVEST OPHTH VIS SCI, V47, P3766, DOI 10.1167/iovs.06-0153; Riley AF, 2002, BRIT J OPHTHALMOL, V86, P185, DOI 10.1136/bjo.86.2.185; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schwinn DA, 2006, SURV OPHTHALMOL, V51, P501, DOI 10.1016/j.survophthal.2006.06.011; Srinivasan S, 2007, J CATARACT REFR SURG, V33, P1826, DOI 10.1016/j.jcrs.2007.06.033; Talamaz T, 2007, EUR J OPHTHALMOL, V17, P909; *THOMS, 2005, PHYS DESK REF; USCINOWICZ T, 2005, COMMUNICATION   1014; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; Williams A, 2006, ARCH OPHTHALMOL-CHIC, V124, P1308, DOI 10.1001/archopht.124.9.1308; Williams J. I., 1996, PATTERNS HLTH CARE O, P339; Wong TY, 2004, OPHTHALMOLOGY, V111, P699, DOI 10.1016/j.ophtha.2003.07.014	40	81	84	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 20	2009	301	19					1991	1996		10.1001/jama.2009.683	http://dx.doi.org/10.1001/jama.2009.683			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446YU	19454637				2022-12-24	WOS:000266159600023
J	Takken, FLW; Tameling, WIL				Takken, F. L. W.; Tameling, W. I. L.			To Nibble at Plant Resistance Proteins	SCIENCE			English	Editorial Material							NB-LRR PROTEIN; NUCLEOTIDE-BINDING; CASPASE-1 ACTIVATION; ATP HYDROLYSIS; APOPTOSOME; RECOGNITION; PERCEPTION; MUTATIONS; EXCHANGE; DOMAINS	To intercept invading microbes that threaten growth and reproduction, plants evolved a sophisticated innate immune system. Recognition of specialized pathogens is mediated by resistance proteins that function as molecular switches. Pathogen perception by these multidomain proteins seems to trigger a series of conformational changes dependent on nucleotide exchange. The activated resistance protein switches on host defenses, often culminating in the death of infected cells. Given their control over life and death, activity of these proteins requires tight regulation that involves intramolecular interactions between the various domains.	[Takken, F. L. W.] Univ Amsterdam, SILS, NL-1090 GE Amsterdam, Netherlands; [Tameling, W. I. L.] Wageningen Univ, Phytopathol Lab, NL-6700 EE Wageningen, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research	Takken, FLW (corresponding author), Univ Amsterdam, SILS, POB 94215, NL-1090 GE Amsterdam, Netherlands.	F.L.W.Takken@uva.nl; wladimir.tameling@wur.nl	Takken, Frank/C-8051-2012	Takken, Frank/0000-0003-2655-3108				Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gabriels SHEJ, 2007, PLANT J, V50, P14, DOI 10.1111/j.1365-313X.2007.03027.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Marquenet E, 2007, MOL CELL, V28, P187, DOI 10.1016/j.molcel.2007.08.014; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Rairdan G, 2007, MICROBES INFECT, V9, P677, DOI 10.1016/j.micinf.2007.01.019; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sprang S R, 2000, Sci STKE, V2000, ppe1; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003	27	110	123	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					744	746		10.1126/science.1171666	http://dx.doi.org/10.1126/science.1171666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423813				2022-12-24	WOS:000265832400032
J	Serneels, L; Van Biervliet, J; Craessaerts, K; Dejaegere, T; Horre, K; Van Houtvin, T; Esselmann, H; Paul, S; Schafer, MK; Berezovska, O; Hyman, BT; Sprangers, B; Sciot, R; Moons, L; Jucker, M; Yang, ZX; May, PC; Karran, E; Wiltfang, J; D'Hooge, R; De Strooper, B				Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; Esselmann, Hermann; Paul, Sabine; Schaefer, Martin K.; Berezovska, Oksana; Hyman, Bradley T.; Sprangers, Ben; Sciot, Raf; Moons, Lieve; Jucker, Mathias; Yang, Zhixiang; May, Patrick C.; Karran, Eric; Wiltfang, Jens; D'Hooge, Rudi; De Strooper, Bart			gamma-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MODERATE REDUCTION; TRANSGENIC MODEL; IN-VIVO; MICE; PRESENILIN-1; COMPLEXES; DEFICIENCY; EXPRESSION; CLEAVAGE	The gamma-secretase complex plays a role in Alzheimer's disease and cancer progression. The development of clinically useful inhibitors, however, is complicated by the role of the gamma-secretase complex in regulated intramembrane proteolysis of Notch and other essential proteins. Different gamma-secretase complexes containing different Presenilin or Aph1 protein subunits are present in various tissues. Here we show that these complexes have heterogeneous biochemical and physiological properties. Specific inactivation of the Aph1B gamma-secretase in a mouse Alzheimer's disease model led to improvements of Alzheimer's disease-relevant phenotypic features without any Notch-related side effects. The Aph1B complex contributes to total gamma-secretase activity in the human brain, and thus specific targeting of Aph1B-containing gamma-secretase complexes may help generate less toxic therapies for Alzheimer's disease.	[Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Duisburg Essen, Rhine State Hosp Essen, Dept Psychiat & Psychotherapy, D-45147 Essen, Germany; [Schaefer, Martin K.] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Neurosci, D-35032 Marburg, Germany; [Berezovska, Oksana; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Disorders, Charlestown, MA 02129 USA; [Sprangers, Ben] Katholieke Univ Leuven, Lab Expt Transplantat, B-3000 Louvain, Belgium; [Sciot, Raf] Katholieke Univ Leuven, Lab Morphol & Mol Pathol, B-3000 Louvain, Belgium; [Moons, Lieve] Katholieke Univ Leuven, Lab Neural Circuit Dev & Regenerat, Dept Biol, B-3000 Louvain, Belgium; [Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Yang, Zhixiang; May, Patrick C.] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; [Karran, Eric] Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England; [D'Hooge, Rudi] Katholieke Univ Leuven, Dept Psychol, Lab Biol Psychol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Erlangen Nuremberg; University of Duisburg Essen; Philipps University Marburg; Harvard University; Massachusetts General Hospital; KU Leuven; KU Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eli Lilly; Eli Lilly; KU Leuven	De Strooper, B (corresponding author), Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	bart.destrooper@med.kuleuven.be	Cruz e Silva, Odete/AAH-5595-2020; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019; Sprangers, Ben/T-6559-2017	De Strooper, Bart/0000-0001-5455-5819; Sprangers, Ben/0000-0003-1314-9675; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Serneels, Lutgarde/0000-0002-5463-4231; Wiltfang, Jens/0000-0003-1492-5330; sciot, raf/0000-0003-2244-5839; Horre, Katrien/0000-0002-6801-3137	Alzheimers Association; Fund for Scientific Research Flanders; KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; Flemish Government [Methusalem]; MEMOSAD of the European Union [F2-2007-200611]; NIH [P01AG015379, R01AG026593, AG026593, AG 13579]; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG026593] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Fund for Scientific Research Flanders(FWO); KULeuven (Geconcerteerde onderzoeksacties)(KU Leuven); Federal Office for Scientific Affairs, Belgium; Flemish Government(European Commission); MEMOSAD of the European Union; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Peeters for assistance in pathological evaluations, C. Mathieu for FACS analysis, L. Van Aerschot for assistance with behavioral testing, S. Terclavers and H. Schieb for technical assistance, and A. Thathiah for proofreading the manuscript. This work was supported by a Pioneer award from the Alzheimers Association; the Fund for Scientific Research Flanders (to R.D. and B.D.S.); KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; a Methusalem grant of the Flemish Government; MEMOSAD (F2-2007-200611) of the European Union; and NIH grants P01AG015379, R01AG026593, and AG026593 (to B.T.H.) and NIH AG 13579 (to B.T.H. and O.B.). B.D.S. is a paid consultant for Eli Lilly and Envivo Pharmaceuticals; B.T.H. is a paid consultant for Elan, Genentech, Pfizer, Takeda, Link, and Neurophage.	Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Choi SH, 2007, J NEUROSCI, V27, P13579, DOI 10.1523/JNEUROSCI.4821-07.2007; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Hollingworth P, 2006, J AM GERIATR SOC, V54, P1348, DOI 10.1111/j.1532-5415.2006.00854.x; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Kawai T, 2005, NEUROSCI LETT, V380, P17, DOI 10.1016/j.neulet.2005.01.005; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	24	195	210	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					639	642		10.1126/science.1171176	http://dx.doi.org/10.1126/science.1171176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299585	Green Accepted			2022-12-24	WOS:000265608800043
J	Schneider, S				Schneider, Stephen			The worst-case scenario	NATURE			English	Editorial Material							CLIMATE-CHANGE		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Schneider, S (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	shs@stanford.edu						Fischlin A., 2007, CONTRIBUTION WORKING, P211; Hansen J, 2007, ATMOS CHEM PHYS, V7, P2287, DOI 10.5194/acp-7-2287-2007; Kundzewiczs ZW, 2007, CLIMATE CHANGE 2007, P173, DOI DOI 10.1007/S11269-006-3091-4; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Schneider SH, 2008, PHILOS T R SOC A, V366, P3843, DOI 10.1098/rsta.2008.0145; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1	10	47	48	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1104	1105		10.1038/4581104a	http://dx.doi.org/10.1038/4581104a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441FL	19407776	Bronze			2022-12-24	WOS:000265754600019
J	Watanabe, Y; Farquhar, J; Ohmoto, H				Watanabe, Yumiko; Farquhar, James; Ohmoto, Hiroshi			Anomalous Fractionations of Sulfur Isotopes During Thermochemical Sulfate Reduction	SCIENCE			English	Article							RISE; SEDIMENTS; BACTERIAL; EVOLUTION; SULFITE	Anomalously fractionated sulfur isotopes in many sedimentary rocks older than 2.4 billion years have been widely believed to be the products of ultraviolet photolysis of volcanic sulfur dioxide in an anoxic atmosphere. Our laboratory experiments have revealed that reduced-sulfur species produced by reactions between powders of amino acids and sulfate at 150 to 200 C possess anomalously fractionated sulfur isotopes: Delta S-33 = +0.1 to +2.1 per mil and Delta S-36 = -1.1 to +1.1 per mil. These results suggest that reactions between organic matter in sediments and sulfate-rich hydrothermal solutions may have produced anomalous sulfur isotope signatures in some sedimentary rocks. If so, the sulfur isotope record of sedimentary rocks may be linked to the biological and thermal evolution of Earth in ways different than previously thought.	[Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA; [Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Farquhar, James] Univ Maryland, Dept Geol, Coll Med, College Pk, MD 20742 USA; [Farquhar, James] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, Coll Med, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Watanabe, Y (corresponding author), Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA.	yumiko@geosc.psu.edu			NASA Astrobiology Institute [CA#NNA04CC06A, CA#NNG04GK00G]; NASA Exobiology Program; NSF [EAR-0229556]	NASA Astrobiology Institute; NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We are grateful to H. Naraoka for the suggestion to use amino acids in SO42 reduction and for discussions. We thank D. Walizer, H. Hamasaki, A. Klarke, B. Wing, A. L. Masterson, and S.-T. Kim for technical assistance; A. C. Lasaga, T. Otake, S. R. Poulson, and I. Johnson for discussions and review of an earlier manuscript; and three anonymous reviewers for useful comments. This study was supported by grants to H.O. from the NASA Astrobiology Institute (CA#NNA04CC06A), NASA Exobiology Program (CA#NNG04GK00G), and NSF (EAR-0229556).	Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Buchachenko AL, 2000, PURE APPL CHEM, V72, P2243, DOI 10.1351/pac200072122243; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Goldhaber MB, 1995, ACS SYM SER, V612, P412; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Johnston DT, 2005, AM J SCI, V305, P645, DOI 10.2475/ajs.305.6-8.645; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Lasaga AC, 2008, EARTH PLANET SC LETT, V268, P225, DOI 10.1016/j.epsl.2008.01.016; Libes S.M., 1992, INTRO MARINE BIOGEOC; Machel HG, 2001, SEDIMENT GEOL, V140, P143, DOI 10.1016/S0037-0738(00)00176-7; Madigan M.T., 2000, BROCK BIOL MICROORGA, V9th ed., P29; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ohmoto H, 2006, GEOL SOC AM MEM, V198, P291, DOI 10.1130/2006.1198(17); Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Sasaki A., 1979, CHISHITSU CHOSAJO GE, V30, P241; SKYRING GW, 1982, PRECAMBRIAN RES, V17, P41, DOI 10.1016/0301-9268(82)90153-X; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; Watanabe K, 1997, GEOCHIM COSMOCHIM AC, V61, P3441	30	115	118	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					370	373		10.1126/science.1169289	http://dx.doi.org/10.1126/science.1169289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372427				2022-12-24	WOS:000265221600037
J	Kiatpongsan, S; Sipp, D				Kiatpongsan, Sorapop; Sipp, Douglas			Monitoring and Regulating Offshore Stem Cell Clinics	SCIENCE			English	Editorial Material									[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Kiatpongsan, Sorapop] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Vincent Obstet & Gynecol Serv,Vincent Ctr Reprod, Boston, MA 02114 USA; [Kiatpongsan, Sorapop] Harvard Univ, John F Kennedy Sch Govt, Sci Technol & Publ Policy Program, Sci Technol & Globalizat Project,Belfer Ctr Sci &, Cambridge, MA 02138 USA; [Sipp, Douglas] Kyoto Univ, Ctr iPS Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	RIKEN; Chulalongkorn University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Kyoto University	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017; Kiatpongsan, Sorapop/ABG-7845-2021	Sipp, Doug/0000-0002-5979-0938; 				Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Arom Kitipan V, 2008, Asian Cardiovasc Thorac Ann, V16, P143; BOSELEY S, 2006, GUARDIAN        0501; DU J, 2005, STEM CELL MISSION CH; EBBIN M, 2007, BERMUDA SUN     0914; EINHORN B, 2005, BUSINESS WEEK   0110, P34; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; *INT SOC STEM CELL, 2008, GUID CLIN TRANSL STE; *JUV DIAB RES FDN, PART CLIN TRIAL; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; ONO D, 2007, KABC TV NEWS; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; PRENTICE D, 2004, MONITORING STEM CELL; PRICE S, 2007, NATION NEWS BAR 1126; SIPP D, 2007, STEM CELL REPORT, V2, P62; STEELE J, 2007, VESCELL ADULT S 1219; *US FTC, FREQ ASK ADV QUEST G; Zarembo A., 2005, LOS ANGELES TIM 0220; 2008, ROYAL GAZETTE   0818; 2008, BANGKOK POST    0622	21	76	77	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1564	1565		10.1126/science.1168451	http://dx.doi.org/10.1126/science.1168451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299604				2022-12-24	WOS:000264342300022
J	Squyres, SW; Knoll, AH; Arvidson, RE; Ashley, JW; Bell, JF; Calvin, WM; Christensen, PR; Clark, BC; Cohen, BA; de Souza, PA; Edgar, L; Farrand, WH; Fleischer, I; Gellert, R; Golombek, MP; Grant, J; Grotzinger, J; Hayes, A; Herkenhoff, KE; Johnson, JR; Jolliff, B; Klingelhofer, G; Knudson, A; Li, R; Mccoy, TJ; McLennan, SM; Ming, DW; Mittlefehldt, DW; Morris, RV; Rice, JW; Schroder, C; Sullivan, RJ; Yen, A; Yingst, RA				Squyres, S. W.; Knoll, A. H.; Arvidson, R. E.; Ashley, J. W.; Bell, J. F., III; Calvin, W. M.; Christensen, P. R.; Clark, B. C.; Cohen, B. A.; de Souza, P. A., Jr.; Edgar, L.; Farrand, W. H.; Fleischer, I.; Gellert, R.; Golombek, M. P.; Grant, J.; Grotzinger, J.; Hayes, A.; Herkenhoff, K. E.; Johnson, J. R.; Jolliff, B.; Klingelhoefer, G.; Knudson, A.; Li, R.; McCoy, T. J.; McLennan, S. M.; Ming, D. W.; Mittlefehldt, D. W.; Morris, R. V.; Rice, J. W., Jr.; Schroeder, C.; Sullivan, R. J.; Yen, A.; Yingst, R. A.			Exploration of Victoria Crater by the Mars Rover Opportunity	SCIENCE			English	Article							MERIDIANI-PLANUM; BURNS FORMATION	The Mars rover Opportunity has explored Victoria crater, a similar to 750-meter eroded impact crater formed in sulfate-rich sedimentary rocks. Impact-related stratigraphy is preserved in the crater walls, and meteoritic debris is present near the crater rim. The size of hematite-rich concretions decreases up-section, documenting variation in the intensity of groundwater processes. Layering in the crater walls preserves evidence of ancient wind-blown dunes. Compositional variations with depth mimic those similar to 6 kilometers to the north and demonstrate that water-induced alteration at Meridiani Planum was regional in scope.	[Squyres, S. W.; Bell, J. F., III; Sullivan, R. J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Knoll, A. H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Arvidson, R. E.; Jolliff, B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; [Ashley, J. W.; Christensen, P. R.; Knudson, A.; Rice, J. W., Jr.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Calvin, W. M.] Univ Nevada, Reno, NV 89557 USA; [Clark, B. C.] Lockheed Martin Corp, Littleton, CO 80127 USA; [Cohen, B. A.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [de Souza, P. A., Jr.] CSIRO, Tasmanian Informat & Commun Technol Ctr, Hobart, Tas 7000, Australia; [Edgar, L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Farrand, W. H.] Space Sci Inst, Boulder, CO 80301 USA; [Fleischer, I.; Klingelhoefer, G.; Schroeder, C.] Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, Mainz, Germany; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Golombek, M. P.; Yen, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Grant, J.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Herkenhoff, K. E.; Johnson, J. R.] US Geol Survey, Flagstaff, AZ 86001 USA; [Li, R.] Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; [McCoy, T. J.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D. W.; Mittlefehldt, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Yingst, R. A.] Univ Wisconsin, Green Bay, WI 54311 USA	Cornell University; Harvard University; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; Nevada System of Higher Education (NSHE); University of Nevada Reno; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; Johannes Gutenberg University of Mainz; University of Guelph; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Wisconsin System	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Space Sci Bldg, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Schröder, Christian/B-3870-2009; de Souza, Paulo A/B-8961-2008; Hayes, Alexander G/P-2024-2014; de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Sullivan, Robert/AAR-8193-2020; Johnson, Jeffrey R/F-3972-2015; COHEN, BARBARA/AAV-8199-2021	Schröder, Christian/0000-0002-7935-6039; de Souza, Paulo A/0000-0002-0091-8925; Hayes, Alexander G/0000-0001-6397-2630; de Souza, Paulo/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Grant, John/0000-0001-8276-1281; Cohen, Barbara/0000-0001-5896-5903; McCoy, Timothy/0000-0002-4573-3553	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was carried out for the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Amundson R, 2008, GEOCHIM COSMOCHIM AC, V72, P3845, DOI 10.1016/j.gca.2008.04.038; Bell JF, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002444; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bland PA, 2000, ICARUS, V144, P21, DOI 10.1006/icar.1999.6253; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Calvin WM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003048; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Farrand WH, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002773; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003155; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Herkenhoff KE, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003100; KIMURA M, 1991, P NIPR S ANT MET, V4, P263; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Knoll AH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002949; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Schroeder C, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002990; Squyres SW, 2006, SCIENCE, V313, P1403, DOI 10.1126/science.1130890; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Weitz CM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002541	23	118	119	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1058	1061		10.1126/science.1170355	http://dx.doi.org/10.1126/science.1170355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461001	Green Submitted			2022-12-24	WOS:000266246700038
J	Oldroyd, GED; Harrison, MJ; Paszkowski, U				Oldroyd, Giles E. D.; Harrison, Maria J.; Paszkowski, Uta			Reprogramming Plant Cells for Endosymbiosis	SCIENCE			English	Editorial Material							SYMBIOSIS SIGNALING PATHWAY; ARBUSCULAR MYCORRHIZA; MEDICAGO-TRUNCATULA; ROOT ENDOSYMBIOSES; GENE-EXPRESSION; COMMON; PROTEINS; RHIZOBIA; LEGUMES; SYSTEMS	The establishment of arbuscular mycorrhizal (AM) symbioses, formed by most flowering plants in association with glomeromycotan fungi, and the root-nodule (RN) symbiosis, formed by legume plants and rhizobial bacteria, requires an ongoing molecular dialogue that underpins the reprogramming of root cells for compatibility. In both endosymbioses, there are distinct phases to the interaction, including a presymbiotic anticipation phase and, subsequently, an intraradical accommodation of the microsymbiont. Maintenance of the endosymbiosis then depends on reciprocal nutrient exchange with the microsymbiont-obtaining plant photosynthates in exchange for mineral nutrients: enhanced phosphate and nitrogen uptake from AM fungi and fixed nitrogen from rhizobia. Despite the taxonomically distinct groups of symbionts, commonalities are observed in the signaling components and the modulation of host cell responses in both AM and RN symbioses, reflecting common mechanisms for plant cell reprogramming during endosymbiosis.	[Harrison, Maria J.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Oldroyd, Giles E. D.] John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; [Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Cornell University; Boyce Thompson Institute for Plant Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Lausanne	Harrison, MJ (corresponding author), Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	mjh78@cornell.edu	Oldroyd, Giles/ABD-8143-2021; Oldroyd, Giles/ABA-7501-2020	Oldroyd, Giles/0000-0002-5245-6355; Harrison, Maria J/0000-0001-8716-1875	Biotechnology and Biological Sciences Research Council [BB/E003850/1, BBS/E/J/00000603] Funding Source: Medline; BBSRC [BB/E003850/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Banba M, 2008, PLANT CELL PHYSIOL, V49, P1659, DOI 10.1093/pcp/pcn153; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Besserer A, 2008, PLANT PHYSIOL, V148, P402, DOI 10.1104/pp.108.121400; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; *GEDO BIOT BIOL SC, BBE0038501 GEDO BIOT; Genre A, 2009, PLANT PHYSIOL, V149, P1424, DOI 10.1104/pp.108.132225; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Kambara K, 2009, MOL MICROBIOL, V71, P92, DOI 10.1111/j.1365-2958.2008.06507.x; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Krehenbrink M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-55; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; *MJH NSF, 0343975 MJH NSF; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; *UP SWISS NAT SCI, PP00A110874 UP SWISS; *USDA, 20083530119039 USDA; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105	21	117	126	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					753	754		10.1126/science.1171644	http://dx.doi.org/10.1126/science.1171644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423817				2022-12-24	WOS:000265832400036
J	Jungers, WL; Harcourt-Smith, WEH; Wunderlich, RE; Tocheri, MW; Larson, SG; Sutikna, T; Due, RA; Morwood, MJ				Jungers, W. L.; Harcourt-Smith, W. E. H.; Wunderlich, R. E.; Tocheri, M. W.; Larson, S. G.; Sutikna, T.; Due, Rhokus Awe; Morwood, M. J.			The foot of Homo floresiensis	NATURE			English	Article							PRESSURE DISTRIBUTION; LATE PLEISTOCENE; HADAR HOMINIDS; EVOLUTION; LOCOMOTION; BIPEDALISM; INDONESIA; DMANISI; FOSSILS; GAIT	Homo floresiensis is an endemic hominin species that occupied Liang Bua, a limestone cave on Flores in eastern Indonesia, during the Late Pleistocene epoch(1,2). The skeleton of the type specimen (LB1) of H. floresiensis includes a relatively complete left foot and parts of the right foot(3). These feet provide insights into the evolution of bipedalism and, together with the rest of the skeleton, have implications for hominin dispersal events into Asia. Here we show that LB1's foot is exceptionally long relative to the femur and tibia, proportions never before documented in hominins but seen in some African apes. Although the metatarsal robusticity sequence is human-like and the hallux is fully adducted, other intrinsic proportions and pedal features are more ape-like. The postcranial anatomy of H. floresiensis is that of a biped(1-3), but the unique lower-limb proportions and surprising combination of derived and primitive pedal morphologies suggest kinematic and biomechanical differences from modern human gait. Therefore, LB1 offers the most complete glimpse of a bipedal hominin foot that lacks the full suite of derived features characteristic of modern humans and whose mosaic design may be primitive for the genus Homo. These new findings raise the possibility that the ancestor of H. floresiensis was not Homo erectus but instead some other, more primitive, hominin whose dispersal into southeast Asia is still undocumented.	[Jungers, W. L.; Larson, S. G.] SUNY Stony Brook, Med Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [Harcourt-Smith, W. E. H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Wunderlich, R. E.] James Madison Univ, Dept Biol Sci, Harrisonburg, VA 22807 USA; [Tocheri, M. W.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Humans Origins Program, Washington, DC 20013 USA; [Sutikna, T.; Due, Rhokus Awe] Natl Res & Dev Ctr Archaeol, Jakarta 12001, Indonesia; [Morwood, M. J.] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH); James Madison University; Smithsonian Institution; Smithsonian National Museum of Natural History; National Research & Development Centre for Archaeology - Indonesia; University of Wollongong	Jungers, WL (corresponding author), SUNY Stony Brook, Med Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.	william.jungers@stonybrook.edu	Tocheri, Matthew/C-5288-2013; Larson, Susan/AAL-1935-2021; Tocheri, Matthew/H-8851-2019; Sutikna, Thomas/C-4709-2018	Tocheri, Matthew/0000-0001-7600-8998; Sutikna, Thomas/0000-0002-9742-4226	Australian Research Council; National Geographic Society; Wenner-Gren Foundation for Anthropological Research; Wellcome Trust and the Leakey Foundation	Australian Research Council(Australian Research Council); National Geographic Society(National Geographic Society); Wenner-Gren Foundation for Anthropological Research; Wellcome Trust and the Leakey Foundation(Wellcome Trust)	This work was supported by grants from the Australian Research Council, the National Geographic Society, the Wenner-Gren Foundation for Anthropological Research, the Wellcome Trust and the Leakey Foundation. We also thank our colleagues Jatmiko, E. Wahyu Saptomo and T. Djubiantono for their encouragement and assistance in the excavations.	ARCHIBALD JD, 1972, AM J PHYS ANTHROPOL, V37, P93, DOI 10.1002/ajpa.1330370112; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Gebol DL, 2006, AM J PHYS ANTHROPOL, V129, P499, DOI 10.1002/ajpa.20320; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; LEWIS OJ, 1989, FUNCTIONAL MORPHOLOG, P328; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; RHOADS JG, 1977, AM J PHYS ANTHROPOL, V46, P29, DOI 10.1002/ajpa.1330460106; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; RODGERS MM, 1989, MED SCI SPORT EXER, V21, P23, DOI 10.1249/00005768-198902000-00005; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; SUSMAN RL, 1988, AM J PHYS ANTHROPOL, V77, P7, DOI 10.1002/ajpa.1330770103; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Wallace IJ, 2008, AM J PHYS ANTHROPOL, V136, P375, DOI 10.1002/ajpa.20827; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; WINTER DA, 1992, PHYS THER, V72, P45, DOI 10.1093/ptj/72.1.45; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	30	122	125	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 7	2009	459	7243					81	84		10.1038/nature07989	http://dx.doi.org/10.1038/nature07989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441WN	19424155				2022-12-24	WOS:000265801300033
J	Zimetbaum, PJ				Zimetbaum, Peter J.			Dronedarone for Atrial Fibrillation - An Odyssey	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RHYTHM		[Zimetbaum, Peter J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zimetbaum, Peter J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zimetbaum, PJ (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	5	49	58	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1811	1813		10.1056/NEJMp0902248	http://dx.doi.org/10.1056/NEJMp0902248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403901				2022-12-24	WOS:000265560300003
J	Isalan, M; Morrison, M				Isalan, Mark; Morrison, Matthew			This title is false	NATURE			English	Editorial Material									[Isalan, Mark] Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain; [Morrison, Matthew] Univ Westminster, London W1R 8AL, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); University of Westminster	Isalan, M (corresponding author), Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain.	isalan@crg.es		Isalan, Mark/0000-0002-4652-0365					0	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					969	969		10.1038/458969a	http://dx.doi.org/10.1038/458969a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396124	Bronze			2022-12-24	WOS:000265412900018
J	Patel, JC; Hueffer, K; Lam, TT; Galan, JE				Patel, Jayesh C.; Hueffer, Karsten; Lam, Tukiet T.; Galan, Jorge E.			Diversification of a Salmonella Virulence Protein Function by Ubiquitin-Dependent Differential Localization	CELL			English	Article							III SECRETION SYSTEMS; HOST-CELL; RECEPTOR ENDOCYTOSIS; NUCLEAR RESPONSES; GROWTH-FACTOR; RHO GTPASES; TYPHIMURIUM; DEGRADATION; INVASION; EFFECTORS	Many bacterial pathogens and symbionts utilize type III secretion systems to deliver bacterial effector proteins into host cells. These effector proteins have the capacity to modulate a large variety of cellular functions in a highly regulated manner. Here, we report that the phosphoinositide phosphatase SopB, a Salmonella Typhimurium type III secreted effector protein, diversifies its function by localizing to different cellular compartments in a ubiquitin-dependent manner. We show that SopB utilizes the same enzymatic activity to modulate actin-mediated bacterial internalization and Akt activation at the plasma membrane and vesicular trafficking and intracellular bacterial replication at the phagosome. Thus, by exploiting the host cellular machinery, Salmonella Typhimurium has evolved the capacity to broaden the functional repertoire of a virulence factor to maximize its ability to modulate cellular functions.	[Patel, Jayesh C.; Hueffer, Karsten; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Lam, Tukiet T.] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06511 USA	Yale University; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Hueffer, Karsten/0000-0001-7154-9066	Damon Runyon Cancer Research Foundation; Public Health Research [AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055472] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Public Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Walther Mothes for providing reagents, Christopher Case and Catarina Nogueira for caspase-1-deficient bone-marrow-derived macrophages, and members of the J.E.G. laboratory for critical review of this manuscript. K. H. was supported by a fellowship from the Damon Runyon Cancer Research Foundation. This work was supported by Public Health Research Grant AI055472 to J.E.G.	Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Drecktrah D, 2005, CELL MICROBIOL, V7, P105, DOI 10.1111/j.1462-5822.2004.00436.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galyov E. E., 1997, MOL MICROBIOL, V25, P1903; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hong KH, 1998, J BACTERIOL, V180, P1793, DOI 10.1128/JB.180.7.1793-1802.1998; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Patel JC, 2008, METHOD ENZYMOL, V439, P145, DOI 10.1016/S0076-6879(07)00411-9; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	42	120	125	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					283	294		10.1016/j.cell.2009.01.056	http://dx.doi.org/10.1016/j.cell.2009.01.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379694	Bronze, Green Accepted			2022-12-24	WOS:000265456800021
J	Halford, J; Hunt, L; Millington, G				Halford, Julie; Hunt, Laura; Millington, George			A Patient's Journey Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halford, Julie] Hampshire Clin, Old Basing RG24 7AL, England; [Millington, George] Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Halford, J (corresponding author), Hampshire Clin, Old Basing RG24 7AL, England.	info@hyperhidrosisuk.org							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1166	10.1136/bmj.b1166	http://dx.doi.org/10.1136/bmj.b1166			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351672				2022-12-24	WOS:000265102800002
J	Trifonov, V; Khiabanian, H; Rabadan, R				Trifonov, Vladimir; Khiabanian, Hossein; Rabadan, Raul			Geographic Dependence, Surveillance, and Origins of the 2009 Influenza A (H1N1) Virus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMANS		[Trifonov, Vladimir; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, New York, NY 10032 USA	Columbia University	Trifonov, V (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, 630 W 168th St, New York, NY 10032 USA.		Simonsen, Lone/K-4531-2014; Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019	Simonsen, Lone/0000-0003-1535-8526; Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255				Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FRASER C, 2009, SCIENCE         0514; GARTEN RJ, 2009, SCIENCE         0522; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Trifonov V, 2009, EURO SURVEILL, V14	5	201	218	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					115	119		10.1056/NEJMp0904572	http://dx.doi.org/10.1056/NEJMp0904572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19474418				2022-12-24	WOS:000267748900003
J	Gielen, M; Retchless, BS; Mony, L; Johnson, JW; Paoletti, P				Gielen, Marc; Retchless, Beth Siegler; Mony, Laetitia; Johnson, Jon W.; Paoletti, Pierre			Mechanism of differential control of NMDA receptor activity by NR2 subunits	NATURE			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; ZINC INHIBITION; LIGAND-BINDING; MOLECULAR DETERMINANTS; CHANNEL; DOMAIN; AFFINITY; ACTIVATION; PROTON	N-methyl-D-aspartate ( NMDA) receptors (NMDARs) are a major class of excitatory neurotransmitter receptors in the central nervous system. They form glutamate-gated ion channels that are highly permeable to calcium and mediate activity-dependent synaptic plasticity(1). NMDAR dysfunction is implicated in multiple brain disorders, including stroke, chronic pain and schizophrenia(2). NMDARs exist as multiple subtypes with distinct pharmacological and biophysical properties that are largely determined by the type of NR2 subunit (NR2A to NR2D) incorporated in the heteromeric NR1/NR2 complex(1,3,4). A fundamental difference between NMDAR subtypes is their channel maximal open probability (Po), which spans a 50-fold range from about 0.5 for NR2A-containing receptors to about 0.01 for receptors containing NR2C and NR2D; NR2B-containing receptors have an intermediate value (about 0.1)(5-9). These differences in Po confer unique charge transfer capacities and signalling properties on each receptor subtype(4,6,10,11). The molecular basis for this profound difference in activity between NMDAR subtypes is unknown. Here we show that the subunit-specific gating of NMDARs is controlled by the region formed by the NR2 amino-terminal domain (NTD), an extracellular clamshell-like domain previously shown to bind allosteric inhibitors(12-15), and the short linker connecting the NTD to the agonist-binding domain (ABD). The subtype specificity of NMDAR Po largely reflects differences in the spontaneous (ligand-independent) equilibrium between open-cleft and closed-cleft conformations of the NR2-NTD. This NTD-driven gating control also affects pharmacological properties by setting the sensitivity to the endogenous inhibitors zinc and protons. Our results provide a proof of concept for a drug-based bidirectional control of NMDAR activity by using molecules acting either as NR2-NTD 'closers' or 'openers' promoting receptor inhibition or potentiation, respectively.	[Gielen, Marc; Mony, Laetitia; Paoletti, Pierre] CNRS, Ecole Normale Super, Neurobiol Lab, F-75005 Paris, France; [Retchless, Beth Siegler; Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Paoletti, P (corresponding author), CNRS, Ecole Normale Super, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Mony, Laetitia/F-3790-2017; Gielen, Marc/AAA-8760-2020; Mony, Laetitia/AAZ-9340-2020; Paoletti, Pierre/L-7358-2013	Mony, Laetitia/0000-0001-7753-6231; Paoletti, Pierre/0000-0002-3681-4845; Gielen, Marc/0000-0003-0941-4325	Ministere de la Recherche; Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM); NIH [R01 MH045817]; Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale pour la Recherche (ANR); GlaxoSmith Kline; Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045817, F31MH079755] Funding Source: NIH RePORTER	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); GlaxoSmith Kline(GlaxoSmithKline); Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Barbour, P.-J. Corringer, J. Neyton and D. Stroebel for comments on the manuscript, and S. Carvalho, M. Casado and M. Gendrel for experimental help. This work was supported by the Ministere de la Recherche (M. G., L. M.), the Universite Pierre et Marie Curie (UPMC) and the Fondation pour la Recherche Medicale (FRM) ( M. G.), NIH grant R01 MH045817 ( J. W. J.), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale pour la Recherche (ANR), GlaxoSmith Kline and an Equipe FRM grant (P. P.).	Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Colquhoun David, 1995, P483; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mony L, 2009, MOL PHARMACOL, V75, P60, DOI 10.1124/mol.108.050971; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	38	236	247	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					703	U107		10.1038/nature07993	http://dx.doi.org/10.1038/nature07993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19404260	Green Submitted, Green Accepted			2022-12-24	WOS:000266608600044
J	Adler, AI; Shaw, EJ; Stokes, T; Ruiz, F				Adler, Amanda I.; Shaw, Elizabeth J.; Stokes, Tim; Ruiz, Francis		Guideline Dev Grp	Guidelines Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adler, Amanda I.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Shaw, Elizabeth J.; Stokes, Tim] Natl Inst Hlth & Clin Excellence, Manchester M1 4BD, Lancs, England; [Ruiz, Francis] Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England	University of Cambridge; National Institute for Health & Care Excellence; National Institute for Health & Care Excellence	Adler, AI (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England.	aia31@medschl.cam.ac.uk	Stokes, Tim/M-9420-2018	Stokes, Tim/0000-0002-1127-1952				National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG BL; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; *NIH CLIN EXC, 2007, GUID SHORT CLIN GUID	3	32	35	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2009	338								b1668	10.1136/bmj.b1668	http://dx.doi.org/10.1136/bmj.b1668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448NU	19465464				2022-12-24	WOS:000266270100002
J	Ohlrogge, J; Allen, D; Berguson, B; DellaPenna, D; Shachar-Hill, Y; Stymne, S				Ohlrogge, John; Allen, Doug; Berguson, Bill; DellaPenna, Dean; Shachar-Hill, Yair; Stymne, Sten			Driving on Biomass	SCIENCE			English	Editorial Material							BIOFUELS		[Ohlrogge, John; Allen, Doug; Shachar-Hill, Yair] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ohlrogge, John; Allen, Doug; Shachar-Hill, Yair] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Berguson, Bill] Univ Minnesota, Nat Resources Res Inst, Forestry Program, Duluth, MN 55811 USA; [DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding & Biotechnol, Alnarp, Sweden	Michigan State University; Michigan State University; United States Department of Energy (DOE); University of Minnesota System; University of Minnesota Duluth; Michigan State University; Swedish University of Agricultural Sciences	Ohlrogge, J (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	ohlrogge@msu.edu	Allen, Doug K/M-2836-2013; Shachar-Hill, Yair/B-6165-2013	Allen, Doug K/0000-0001-8599-8946; Shachar-Hill, Yair/0000-0001-8793-5084				Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; *DOE, DIES VEH; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Franco A, 2005, INT J THERM SCI, V44, P163, DOI 10.1016/j.ijthermalsci.2004.07.005; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Koplow D., 2007, BIOFUELS WHAT COST G; *NAT RES DEF COUNC, 2007, ENV ASS PLUG IN HYBR, V1; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Towler GP, 2004, ENVIRON PROG, V23, P334, DOI 10.1002/ep.10052; COMP VEHICLE ENERGY	11	124	129	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1019	1020		10.1126/science.1171740	http://dx.doi.org/10.1126/science.1171740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19460990				2022-12-24	WOS:000266246700023
J	Bockarie, MJ; Molyneux, DH				Bockarie, Moses J.; Molyneux, David H.			Tropical Diseases The end of lymphatic filariasis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL PROGRAM; MALARIA		[Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Bockarie, MJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	moses.bockarie@liv.ac.uk	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021					[Anonymous], 2004, Wkly Epidemiol Rec, V79, P417; BRENGUES J., 1969, Cahiers ORSTOM, Serie Entomologie Medicale et Parasiiologie, V7, P279; Durrheim DN, 2004, TROP MED INT HEALTH, V9, P843, DOI 10.1111/j.1365-3156.2004.01287.x; Gyapong JO, 2005, EXPERT OPIN PHARMACO, V6, P179, DOI 10.1517/14656566.6.2.179; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Kere NK, 1996, MED VET ENTOMOL, V10, P145, DOI 10.1111/j.1365-2915.1996.tb00720.x; Molyneux DH, 2009, LANCET, V373, P529, DOI 10.1016/S0140-6736(09)60181-1; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; 1870, BRIT MED J, V2, P559, DOI DOI 10.1136/BMJ.2.516.555	13	29	30	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2009	338								b1686	10.1136/bmj.b1686	http://dx.doi.org/10.1136/bmj.b1686			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IZ	19439451	Green Accepted			2022-12-24	WOS:000266116600003
J	Ionescu-Ittu, R; Marelli, AJ; Mackie, AS; Pilote, L				Ionescu-Ittu, Raluca; Marelli, Ariane J.; Mackie, Andrew S.; Pilote, Louise			Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; MULTIVITAMIN SUPPLEMENTATION; 1ST-TRIMESTER EXPOSURE; PERICONCEPTIONAL USE; PRENATAL-DIAGNOSIS; FOOD FORTIFICATION; FOLATE INTAKE; RISK-FACTORS; MALFORMATIONS	Objective To investigate whether the 1998 government policy for mandatory fortification of flour and pasta products with folate was followed by a reduction in the prevalence of severe congenital heart defects. Design Time trend analysis. Setting Province of Quebec, Canada. Participants Infants born in 1990-2005 identified with severe congenital heart defects (tetralogy of Fallot, endocardial cushion defects, univentricular hearts, truncus arteriosus, or transposition complexes) in Quebec administrative databases. Methods Data analysed in two time periods (before and after fortification). Birth prevalence measured annually as infants (live and stillbirths) with severe congenital heart defects per 1000 births in Quebec. Changes in the birth prevalence from the period before to the period after fortification were estimated with Poisson regression. Results Among the 1 324 440 births in Quebec in 19902005 there were 2083 infants born with severe congenital heart defects, corresponding to an average birth prevalence of 1.57/1000 births. Time trend analysis showed no change in the birth prevalence of severe birth defects in the nine years before fortification (rate ratio 1.01, 95% confidence interval 0.99 to 1.03), while in the seven years after fortification there was a significant 6% decrease per year (0.94, 0.90 to 0.97). Conclusions Public health measures to increase folic acid intake were followed by a decrease in the birth prevalence of severe congenital heart defects. These findings support the hypothesis that folic acid has a preventive effect on heart defects.	[Ionescu-Ittu, Raluca] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Marelli, Ariane J.] McGill Univ, Ctr Hlth, McGill Adult Unit Congenital Heart Dis Excellence, Montreal, PQ, Canada; [Mackie, Andrew S.] Univ Alberta, Stollery Childrens Hosp, Div Cardiol, Edmonton, AB, Canada; [Pilote, Louise] McGill Univ, Ctr Hlth, Div Gen Internal Med, Montreal, PQ, Canada	McGill University; McGill University; Stollery Children's Hospital; University of Alberta; McGill University	Pilote, L (corresponding author), Royal Victoria Hosp, V Bldg,687 Pine Ave W,Room V2-17, Montreal, PQ H3A 1A1, Canada.	louise.pilote@mcgill.ca		Pilote, Louise/0000-0002-6159-0628; Mackie, Andrew/0000-0001-6126-1130	Heart and Stroke Foundation of Canada; Fonds de Recherche en Sante du Quebec (FRSQ)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	AJM was funded by the Heart and Stroke Foundation of Canada. ASM is funded by the Fonds de Recherche en Sante du Quebec (FRSQ). LP is a senior investigator funded by the FRSQ and James McGill professor of Medicine. The study was funded in part by the Heart and Stroke foundation of Canada and by the FRSQ.	ACUNA J, 1999, PREVENTION NEURAL TU; ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Bakker MK, 2007, BIRTH DEFECTS RES A, V79, P652, DOI 10.1002/bdra.20388; BECERRA JE, 1990, PEDIATRICS, V85, P1; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; BLACKBURN S, 2007, MATERNAL FETAL NEONA; Blomberg M, 2000, ACTA PAEDIATR, V89, P1238, DOI 10.1080/080352500750027637; Boneva RS, 2001, CIRCULATION, V103, P2376; Bottega NA, 2008, CIRCULATION, V118, pS929; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Botto LD, 2004, AM J MED GENET C, V125C, P12, DOI 10.1002/ajmg.c.30004; Botto LD, 2003, AM J MED GENET A, V121A, P95, DOI 10.1002/ajmg.a.20132; *BUR FOOD REG INT, 1998, CANADA GAZETTE 2, V132, P3029; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; *CAN S, 2007, CAN S CANSIM TABL 05; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Czeizel AE, 2001, REPROD TOXICOL, V15, P637, DOI 10.1016/S0890-6238(01)00178-2; Czeizel AE, 1998, LANCET, V352, P1225, DOI 10.1016/S0140-6736(05)60567-3; de Jong-van den Berg LTW, 2005, AM J OBSTET GYNECOL, V192, P121, DOI 10.1016/j.ajog.2004.05.085; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; DUCHESNE L, 2006, SITUATION DEMOGRAPHI, P69; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Girard C., 2007, BILAN DEMOGRAPHIQUE; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Health Canada, 2002, CONG AN CAN PER HLTH; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Huhta JC, 2006, CURR OPIN PEDIATR, V18, P484, DOI 10.1097/01.mop.0000245347.45336.d7; Huhta JC, 2005, FETAL PEDIATR PATHOL, V24, P71, DOI 10.1080/15227950591008240; *I SATT QUEB, 2007, NAISS SEL DUR GROSS; *I STAT QUEB, 2001, PORTR SOC QUEB DONN; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; LIU S, EVALUATION FOOD FORT; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Mills JL, 2004, BIRTH DEFECTS RES A, V70, P844, DOI 10.1002/bdra.20075; *MIN PUBL WORKS GO, 2002, CONG AN CAN PER HLTH, P15; MONGEAU L, 2005, EXCES POIDS POPULATI; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; Peller AJ, 2004, OBSTET GYNECOL, V104, P957, DOI 10.1097/01.AOG.0000142718.53380.8f; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Ramos E, 2007, BJOG-INT J OBSTET GY, V114, P1055, DOI 10.1111/j.1471-0528.2007.01387.x; Ray JG, 2004, NUTR REV, V62, pS35, DOI 10.1111/j.1753-4887.2004.tb00072.x; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; RIEDER MJ, 1994, CLIN PERINATOL, V21, P483, DOI 10.1016/S0095-5108(18)30328-2; Scanlon KS, 1998, EPIDEMIOLOGY, V9, P95, DOI 10.1097/00001648-199801000-00019; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Talner NS, 1998, PEDIATRICS, V102, P258; Tam LE, 2005, J OBSTET GYNAECOL CA, V27, P232, DOI 10.1016/S1701-2163(16)30515-1; Tang LS, 2004, BIRTH DEFECTS RES A, V70, P449, DOI 10.1002/bdra.20043; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; Wacholder S, 1995, Stat Methods Med Res, V4, P293, DOI 10.1177/096228029500400403; WALLER DK, 1994, AM J OBSTET GYNECOL, V170, P541, DOI 10.1016/S0002-9378(94)70224-1; Watkins ML, 2001, EPIDEMIOLOGY, V12, P439, DOI 10.1097/00001648-200107000-00014; Wen SW, 2000, TERATOLOGY, V61, P342, DOI 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; 1993, J SOGC S, P41; 1996, FED REG, V61, P8781	63	142	150	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2009	338								b1673	10.1136/bmj.b1673	http://dx.doi.org/10.1136/bmj.b1673			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	446IX	19436079	Green Published			2022-12-24	WOS:000266116400003
J	McConnell, J				McConnell, John			Influenza begs many questions	LANCET			English	Editorial Material									The Lancet, Infect Dis, London NW1 7BY, England		McConnell, J (corresponding author), The Lancet, Infect Dis, London NW1 7BY, England.			McConnell, John/0000-0002-9928-6568					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1590	1590		10.1016/S0140-6736(09)60880-1	http://dx.doi.org/10.1016/S0140-6736(09)60880-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19427944				2022-12-24	WOS:000266066300011
J	Randau, L; Stanley, BJ; Kohlway, A; Mechta, S; Xiong, Y; Soll, D				Randau, Lennart; Stanley, Bradford J.; Kohlway, Andrew; Mechta, Sarah; Xiong, Yong; Soll, Dieter			A Cytidine Deaminase Edits C to U in Transfer RNAs in Archaea	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ADENOSINE-DEAMINASE; FUNCTIONAL IMPLICATIONS; METHANOPYRUS-KANDLERI; ESCHERICHIA-COLI; GENETIC ELEMENTS; DOMAIN; 4-THIOURIDINE; APOBEC3G; INOSINE	All canonical transfer RNAs (tRNAs) have a uridine at position 8, involved in maintaining tRNA tertiary structure. However, the hyperthermophilic archaeon Methanopyrus kandleri harbors 30 (out of 34) tRNA genes with cytidine at position 8. Here, we demonstrate C-to-U editing at this location in the tRNA's tertiary core, and present the crystal structure of a tRNA-specific cytidine deaminase, CDAT8, which has the cytidine deaminase domain linked to a tRNA-binding THUMP domain. CDAT8 is specific for C deamination at position 8, requires only the acceptor stem hairpin for activity, and belongs to a unique family within the "cytidine deaminase-like" superfamily. The presence of this C-to-U editing enzyme guarantees the proper folding and functionality of all M. kandleri tRNAs.	[Randau, Lennart; Stanley, Bradford J.; Kohlway, Andrew; Mechta, Sarah; Xiong, Yong; Soll, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soll, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University	Randau, L (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	lennart.randau@yale.edu; yong.xiong@yale.edu; dieter.soll@yale.edu		Randau, Lennart/0000-0002-2780-2076	NIH [GM22854, AI078831]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078831, R33AI078831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Yuan, P. ODonoghue, and R. L. Sherrer for help and encouragement; K. O. Stetter for a gift of M. kandleri cells; and the staff at the Advanced Photon Source (beamline 24-ID), the National Synchrotron Light Source (beamlines X25 and X6A), and the Center for Structural Biology at Yale University. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (code 3G8Q). Supported by NIH grants GM22854 (D.S.) and AI078831 (Y.X.).	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P215, DOI 10.1016/S0968-0004(01)01826-6; Borner GV, 1996, EMBO J, V15, P5949, DOI 10.1002/j.1460-2075.1996.tb00981.x; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; GROSJEAN H, 1995, NUCLEIC ACIDS RES, V23, P4312, DOI 10.1093/nar/23.21.4312; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jones CN, 2008, J BIOL CHEM, V283, P34445, DOI 10.1074/jbc.M806992200; Lauhon CT, 2004, J BIOL CHEM, V279, P23022, DOI 10.1074/jbc.M401757200; Maas S, 1999, P NATL ACAD SCI USA, V96, P8895, DOI 10.1073/pnas.96.16.8895; MARSCHALEK R, 1989, SCIENCE, V244, P1493, DOI 10.1126/science.2567533; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; PALMER JR, 1992, BIOCHIM BIOPHYS ACTA, V1132, P315, DOI 10.1016/0167-4781(92)90168-Y; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; She QX, 2002, RES MICROBIOL, V153, P325, DOI 10.1016/S0923-2508(02)01331-1; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Steinhauser S, 1999, J MOL EVOL, V48, P303, DOI 10.1007/PL00006473; STERNER T, 1995, RNA, V1, P841; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Waterman DG, 2006, J MOL BIOL, V356, P97, DOI 10.1016/j.jmb.2005.11.013; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362	23	51	53	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					657	659		10.1126/science.1170123	http://dx.doi.org/10.1126/science.1170123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407206	Green Accepted			2022-12-24	WOS:000265608800049
J	Sathyapalan, T; Atkin, SL				Sathyapalan, T.; Atkin, Stephen L.			Rational testing Investigating hirsutism	BRITISH MEDICAL JOURNAL			English	Editorial Material							POLYCYSTIC-OVARY-SYNDROME; CONGENITAL ADRENAL-HYPERPLASIA; INSULIN-RESISTANCE; DIAGNOSTIC-VALUE; PREVALENCE; WOMEN; HYPERANDROGENISM; CRITERIA		[Atkin, Stephen L.] Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England; [Sathyapalan, T.] Hull Royal Infirm, Michael White Diabet Ctr, Kingston Upon Hull HU3 2RW, England	University of Hull; University of York - UK; University of Hull	Atkin, SL (corresponding author), Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England.	Stephen.Atkin@hyms.ac.uk	Sathyapalan, Thozhukat/J-5212-2012; atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	Sathyapalan, Thozhukat/0000-0003-3544-2231; atkin, stephen/0000-0002-5887-7257; 				Azziz R., 2006, ANDROGEN EXCESS DISO, V2nd; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Chang WY, 2005, FERTIL STERIL, V83, P1717, DOI 10.1016/j.fertnstert.2005.01.096; Escobar-Morreale HF, 2008, J CLIN ENDOCR METAB, V93, P527, DOI 10.1210/jc.2007-2053; Escobar-Morreale HF, 2001, EUR J ENDOCRINOL, V145, P619, DOI 10.1530/eje.0.1450619; Hahn S, 2007, CLIN CHEM LAB MED, V45, P202, DOI 10.1515/CCLM.2007.031; Hopkinson ZEC, 1998, BRIT MED J, V317, P329, DOI 10.1136/bmj.317.7154.329; MENGDEN T, 1992, CLIN INVESTIGATOR, V70, P545; [Rotterdam ESHRE ASRM-Sponsored PCOS consensus workshop group], 2004, HUM REPROD, V19, P41; Sowers M, 2003, J CLIN ENDOCR METAB, V88, P4904, DOI 10.1210/jc.2003-030350; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245	13	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2009	338								b912	10.1136/bmj.b912	http://dx.doi.org/10.1136/bmj.b912			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JV	19401328				2022-12-24	WOS:000265697500009
J	Viel, KR; Ameri, A; Abshire, TC; Iyer, RV; Watts, RG; Lutcher, C; Channell, C; Cole, SA; Fernstrom, KM; Nakaya, S; Kasper, CK; Thompson, AR; Almasy, L; Howard, TE				Viel, Kevin R.; Ameri, Afshin; Abshire, Thomas C.; Iyer, Rathi V.; Watts, Raymond G.; Lutcher, Charles; Channell, Cynthia; Cole, Shelley A.; Fernstrom, Karl M.; Nakaya, Shelley; Kasper, Carol K.; Thompson, Arthur R.; Almasy, Laura; Howard, Tom E.			Inhibitors of Factor VIII in Black Patients with Hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	48th Annual Meeting of the American-Society-of-Hematology	DEC 09-12, 2006	Orlando, FL	Amer Soc Hematol			PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; GENETIC ASSOCIATION; AFRICAN-AMERICANS; F8 GENE; MUTATIONS; RISK; INVERSION; IDENTIFICATION; POLYMORPHISMS	BACKGROUND Black patients with hemophilia A (factor VIII deficiency) are twice as likely as white patients to produce inhibitors against factor VIII proteins given as replacement therapy. There are six wild-type factor VIII proteins, designated H1 through H6, but only two (H1 and H2) match the recombinant factor VIII products used clinically. H1 and H2 are found in all racial groups and are the only factor VIII proteins found in the white population to date. H3, H4, and H5 have been found only in blacks. We hypothesized that mismatched factor VIII transfusions contribute to the high incidence of inhibitors among black patients. METHODS We sequenced the factor VIII gene (F8) in black patients with hemophilia A to identify causative mutations and the background haplotypes on which they reside. Results from previous Bethesda assays and information on the baseline severity of hemophilia, age at enrollment, and biologic relationships among study patients were obtained from review of the patients' medical charts. We used multivariable logistic regression to control for these potential confounders while testing for associations between F8 haplotype and the development of inhibitors. RESULTS Of the 78 black patients with hemophilia enrolled, 24% had an H3 or H4 background haplotype. The prevalence of inhibitors was higher among patients with either of these haplotypes than among patients with haplotype H1 or H2 (odds ratio, 3.6; 95% confidence interval, 1.1 to 12.3; P = 0.04), despite a similar spectrum of hemophilic mutations and degree of severity of illness in these two subgroups. CONCLUSIONS These preliminary results suggest that mismatched factor VIII replacement therapy may be a risk factor for the development of anti-factor VIII alloantibodies.	[Viel, Kevin R.; Cole, Shelley A.; Almasy, Laura] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Ameri, Afshin; Lutcher, Charles] Med Coll Georgia, Augusta, GA 30912 USA; [Abshire, Thomas C.; Channell, Cynthia; Fernstrom, Karl M.] Emory Univ, Atlanta, GA 30322 USA; [Iyer, Rathi V.] Univ Mississippi, Med Ctr, Jackson, MS USA; [Watts, Raymond G.] Univ Alabama Birmingham, Birmingham, AL USA; [Nakaya, Shelley; Thompson, Arthur R.] Univ Washington, Seattle, WA 98195 USA; [Kasper, Carol K.; Howard, Tom E.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Kasper, Carol K.] Orthoped Hosp, Los Angeles, CA USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Howard, Tom E.] Greater Los Angeles Vet Affairs Hosp, Los Angeles, CA USA	Texas Biomedical Research Institute; University System of Georgia; Augusta University; Emory University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Howard, TE (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol & Lab Med, 11301 Wilshire Blvd,Bldg 500,Rm 12S4, Los Angeles, CA 90073 USA.	tom.howard@va.gov	Almasy, Laura/V-3156-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072533, R01HL070751, K08HL071130] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-72533, R01 HL070751, HL-71130, R01 HL072533-05, HL-70751, R01 HL070751-07, R01 HL072533, HL-07109, K08 HL071130, K08 HL071130-06] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADDIEGO JE, 1994, BLOOD, V84, pA239; Aledort LM, 1998, HAEMOPHILIA, V4, P68; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2001, HAEMOPHILIA, V7, P267, DOI 10.1046/j.1365-2516.2001.00510.x; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Bagnall RD, 2006, J THROMB HAEMOST, V4, P591, DOI 10.1111/j.1538-7836.2006.01840.x; Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Benjamin RJ, 2008, TRANSFUSION, V48, P295, DOI 10.1111/j.1537-2995.2007.01523.x; BRAY GL, 1994, BLOOD, V83, P2428; Castaman G, 2007, HAEMOPHILIA, V13, P311, DOI 10.1111/j.1365-2516.2007.01459.x; David D, 2006, HAEMATOLOGICA, V91, P840; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Garratty G, 2004, TRANSFUSION, V44, P703, DOI 10.1111/j.1537-2995.2004.03338.x; Gill F M, 1984, Prog Clin Biol Res, V150, P19; Gitschier J, 2004, J THROMB HAEMOST, V2, P383, DOI 10.1111/j.1538-7933.2004.00614.x; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Glynn SA, 2006, TRANSFUSION, V46, P980, DOI 10.1111/j.1537-2995.2006.00831.x; Goodeve A, 2003, BLOOD COAGUL FIBRIN, V14, pS17, DOI 10.1097/00001721-200306001-00005; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Howard T, 2004, BLOOD, V104, p113A, DOI 10.1182/blood.V104.11.384.384; Howard TE, 2005, BLOOD, V106, p896A; Howard TE, 2006, BLOOD, V108, p230A; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Kempton CL, 2006, J THROMB HAEMOST, V4, P2576, DOI 10.1111/j.1538-7836.2006.02233.x; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Lollar P, 2004, J THROMB HAEMOST, V2, P1082, DOI 10.1111/j.1538-7836.2004.00802.x; Lorenzo JI, 2001, BRIT J HAEMATOL, V113, P600, DOI 10.1046/j.1365-2141.2001.02828.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Ma GC, 2008, HAEMOPHILIA, V14, P787, DOI 10.1111/j.1365-2516.2008.01687.x; Mansvelt EPG, 1998, THROMB HAEMOSTASIS, V80, P561; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; Oldenburg J, 2004, SEMIN HEMATOL, V41, P82, DOI 10.1053/j.seminhematol.2003.11.016; Oldenburg J, 1997, BEITR INFUS, V34, P224; Redden DT, 2006, BEHAV GENET, V36, P678, DOI 10.1007/s10519-006-9060-0; Repesse Y, 2007, J THROMB HAEMOST, V5, P1469, DOI 10.1111/j.1538-7836.2007.02591.x; Rossetti LC, 2005, CLIN CHEM, V51, P1154, DOI 10.1373/clinchem.2004.046490; Rothschild C, 1998, THROMB HAEMOSTASIS, V80, P779; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Schroder J, 2006, J THROMB HAEMOST, V4, P1141, DOI 10.1111/j.1538-7836.2006.01884.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Tsai HJ, 2006, HUM GENET, V118, P626, DOI 10.1007/s00439-005-0080-2; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Viel KR, 2007, BLOOD, V109, P3713, DOI 10.1182/blood-2006-06-026104; Wang B, 2004, TRANSFUSION, V44, P1243, DOI 10.1111/j.1537-2995.2004.04034.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	53	147	157	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1618	1627		10.1056/NEJMoa075760	http://dx.doi.org/10.1056/NEJMoa075760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	433BH	19369668	Green Accepted			2022-12-24	WOS:000265178000006
J	Kahn, SE				Kahn, Steven E.			Glucose Control in Type 2 Diabetes Still Worthwhile and Worth Pursuing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; HYPOGLYCEMIA		[Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst 151, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@u.washington.edu		Kahn, Steven/0000-0001-7307-9002				Bottini P, 1997, DIABETES, V46, P814, DOI 10.2337/diabetes.46.5.814; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949	15	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1590	1592		10.1001/jama.2009.511	http://dx.doi.org/10.1001/jama.2009.511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366780				2022-12-24	WOS:000265137900031
J	Hansen, DM; Galetti, M				Hansen, Dennis M.; Galetti, Mauro			The Forgotten Megafauna	SCIENCE			English	Editorial Material							SEED DISPERSAL; ANACHRONISMS; EXTINCTIONS; FRUITS		[Hansen, Dennis M.; Galetti, Mauro] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Galetti, Mauro] UNESP Sao Paulo State Univ, Dept Ecol, BR-13506900 Sao Paulo, Brazil	Stanford University; Universidade Estadual Paulista	Hansen, DM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	dmhansen@stanford.edu	Galetti, Mauro/M-8751-2013; Galetti, Mauro/C-5275-2008; Hansen, Dennis M/A-3307-2008	Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Hansen, Dennis M/0000-0002-9584-2766				Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; HALLWACHS W, 1986, FRUGIVORES SEED DISP, P285, DOI DOI 10.1007/978-94-009-4812-9_25; Hansen DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002111; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Martin P. S., 1995, QUATERNARY EXTINCTIO; Meehan HJ, 2002, J BIOGEOGR, V29, P695, DOI 10.1046/j.1365-2699.2002.00718.x; Owen-Smith N., 1988, MEGAHERBIVORES INFLU; Wallace AR., 1876, GEOGRAPHICAL DISTRIB; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x	13	145	148	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					42	43		10.1126/science.1172393	http://dx.doi.org/10.1126/science.1172393			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342573				2022-12-24	WOS:000264802100021
J	Adhiyaman, V; Adhiyaman, S				Adhiyaman, Vedamurthy; Adhiyaman, Sonja			10-Minute Consultation Transient ischaemic attack	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adhiyaman, Vedamurthy] Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales; [Adhiyaman, Sonja] Laurels Surg, Flint CH6 5AF, England		Adhiyaman, V (corresponding author), Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales.	adhiyamanv@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2009	338								a2343	10.1136/bmj.a2343	http://dx.doi.org/10.1136/bmj.a2343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307272				2022-12-24	WOS:000264639400001
J	Hara, K; Shiga, A; Fukutake, T; Nozaki, H; Miyashita, A; Yokoseki, A; Kawata, H; Koyama, A; Arima, K; Takahashi, T; Ikeda, M; Shiota, H; Tamura, M; Shimoe, Y; Hirayama, M; Arisato, T; Yanagawa, S; Tanaka, A; Nakano, I; Ikeda, S; Yoshida, Y; Yamamoto, T; Ikeuchi, T; Kuwano, R; Nishizawa, M; Tsuji, S; Onodera, O				Hara, Kenju; Shiga, Atsushi; Fukutake, Toshio; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Kawata, Hirotoshi; Koyama, Akihide; Arima, Kunimasa; Takahashi, Toshiaki; Ikeda, Mari; Shiota, Hiroshi; Tamura, Masato; Shimoe, Yutaka; Hirayama, Mikio; Arisato, Takayo; Yanagawa, Sohei; Tanaka, Akira; Nakano, Imaharu; Ikeda, Shu-ichi; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Tsuji, Shoji; Onodera, Osamu			Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; AUTOSOMAL RECESSIVE ARTERIOPATHY; BONE MORPHOGENETIC PROTEINS; SERINE-PROTEASE HTRA1; GROWTH-FACTOR; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; SUBCORTICAL INFARCTS; BETA; EXPRESSION	BACKGROUND The genetic cause of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), which is characterized by ischemic, non-hypertensive, cerebral small-vessel disease with associated alopecia and spondylosis, is unclear. METHODS In five families with CARASIL, we carried out linkage analysis, fine mapping of the region implicated in the disease, and sequence analysis of a candidate gene. We also conducted functional analysis of wild-type and mutant gene products and measured the signaling by members of the transforming growth factor beta (TGF-beta) family and gene and protein expression in the small arteries in the cerebrum of two patients with CARASIL. RESULTS We found linkage of the disease to the 2.4-Mb region on chromosome 10q, which contains the HtrA serine protease 1 (HTRA1) gene. HTRA1 is a serine protease that represses signaling by TGF-beta family members. Sequence analysis revealed two nonsense mutations and two missense mutations in HTRA1. The missense mutations and one of the nonsense mutations resulted in protein products that had comparatively low levels of protease activity and did not repress signaling by the TGF-beta family. The other nonsense mutation resulted in the loss of HTRA1 protein by nonsense-mediated decay of messenger RNA. Immunohistochemical analysis of the cerebral small arteries in affected persons showed increased expression of the extra domain-A region of fibronectin and versican in the thickened tunica intima and of TGF-beta 1 in the tunica media. CONCLUSIONS CARASIL is associated with mutations in the HTRA1 gene. Our findings indicate a link between repressed inhibition of signaling by the TGF-beta family and ischemic cerebral small-vessel disease, alopecia, and spondylosis.	[Hara, Kenju; Shiga, Atsushi; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Koyama, Akihide; Takahashi, Toshiaki; Ikeda, Mari; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Onodera, Osamu] Niigata Univ, Niigata, Japan; [Fukutake, Toshio] Kameda Med Ctr, Kamogawa City, Chiba, Japan; [Kawata, Hirotoshi; Tanaka, Akira; Nakano, Imaharu] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Arima, Kunimasa] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Shiota, Hiroshi] Nihon Univ, Sch Med, Tokyo, Japan; [Tamura, Masato] Nagaoka Nishi Hosp, Nagaoka, Niigata, Japan; [Shimoe, Yutaka] Kashima Rosai Hosp, Kashima, Japan; [Hirayama, Mikio] Kasugai Municipal Hosp, Kasugai, Aichi, Japan; [Arisato, Takayo] Minamikyushu Natl Hosp, Kagoshima, Japan; [Yanagawa, Sohei] Iida Municipal Hosp, Iida, Japan; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan; [Tsuji, Shoji] Univ Tokyo, Tokyo, Japan	Niigata University; Jichi Medical University; National Center for Neurology & Psychiatry - Japan; Nihon University; Shinshu University; University of Tokyo	Onodera, O (corresponding author), Brain Res Inst, Niigata 9518585, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Dichgans, Martin/0000-0002-0654-387X	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science, and Niigata University	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, and Niigata University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported in part by grants from the Advanced Brain Science Project and Applied Genomics, the Center for Integrated Brain Medical Science, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Science, and Niigata University.	Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; FUKUTAKE T, 1995, EUR NEUROL, V35, P69, DOI 10.1159/000117096; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gilicze A, 2007, MOL IMMUNOL, V44, P2961, DOI 10.1016/j.molimm.2007.01.004; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; MAEDA S, 1976, Folia Psychiatrica et Neurologica Japonica, V30, P165; O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okeda R, 2004, NEUROPATHOLOGY, V24, P21, DOI 10.1111/j.1440-1789.2003.00534.x; Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885, DOI 10.1093/jnen/62.9.885; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Tanoi Y, 2000, ACTA NEUROPATHOL, V100, P347, DOI 10.1007/s004010000203; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Yanagawa S, 2002, NEUROLOGY, V58, P817, DOI 10.1212/WNL.58.5.817; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	39	307	331	2	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1729	1739		10.1056/NEJMoa0801560	http://dx.doi.org/10.1056/NEJMoa0801560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387015	Bronze			2022-12-24	WOS:000265377800007
J	Cornelis, MC; Qi, L; Zhang, CL; Kraft, P; Manson, J; Cai, TX; Hunter, DJ; Hu, FB				Cornelis, Marilyn C.; Qi, Lu; Zhang, Cuilin; Kraft, Peter; Manson, JoAnn; Cai, Tianxi; Hunter, David J.; Hu, Frank B.			Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U. S. Men and Women of European Ancestry	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; NURSES HEALTH; LIFE-STYLE; FAT MASS; MELLITUS; LOCI; REPRODUCIBILITY; DISCRIMINATION; REPLICATION	Background: Genome-wide association studies have identified novel type 2 diabetes loci, each of which has a modest impact on risk. Objective: To examine the joint effects of several type 2 diabetes risk variants and their combination with conventional risk factors on type 2 diabetes risk in 2 prospective cohorts. Design: Nested case-control study. Setting: United States. Participants: 2809 patients with type 2 diabetes and 3501 healthy control participants of European ancestry from the Health Professionals Follow-up Study and Nurses' Health Study. Measurements: A genetic risk score (GRS) was calculated on the basis of 10 polymorphisms in 9 loci. Results: After adjustment for age and body mass index (BMI), the odds ratio for type 2 diabetes with each point of GRS, corresponding to 1 risk allele, was 1.19 ( 95% CI, 1.14 to 1.24) and 1.16 (CI, 1.12 to 1.20) for men and women, respectively. Persons with a BMI of 30 kg/m(2) or greater and a GRS in the highest quintile had an odds ratio of 14.06 (CI, 8.90 to 22.18) compared with persons with a BMI less than 25 kg/m(2) and a GRS in the lowest quintile after adjustment for age and sex. Persons with a positive family history of diabetes and a GRS in the highest quintile had an odds ratio of 9.20 (CI, 5.50 to 15.40) compared with persons without a family history of diabetes and with a GRS in the lowest quintile. The addition of the GRS to a model of conventional risk factors improved discrimination by 1% ( P < 0.001). Limitation: The study focused only on persons of European ancestry; whether GRS is associated with type 2 diabetes in other ethnic groups remains unknown. Conclusion: Although its discriminatory value is currently limited, a GRS that combines information from multiple genetic variants might be useful for identifying subgroups with a particularly high risk for type 2 diabetes.	[Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Rockville, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Bldg 2,665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013	Zhang, Cuilin/0000-0002-8014-2708	National Institutes of Health [DK58845, CA87969]; Canadian Institutes of Health Research Fellowship; American Heart Association Scientist Development; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association Scientist Development(American Heart Association); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health (grants DK58845 and CA87969). Dr. Cornelis is a recipient of a Canadian Institutes of Health Research Fellowship. Dr. Qi is a recipient of the American Heart Association Scientist Development Award. Dr. Zhang is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ludovico O, 2007, OBESITY, V15, P1076, DOI 10.1038/oby.2007.617; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Petersen M, 2003, DIABETES CARE, V26, P917; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi L, 2006, HUM MOL GENET, V15, P1914, DOI 10.1093/hmg/ddl113; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; RISCH N, 1990, AM J HUM GENET, V46, P222; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 2012, NUTR EPIDEMIOLOGY; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	179	189	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					541	W98		10.7326/0003-4819-150-8-200904210-00008	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380854	Green Accepted			2022-12-24	WOS:000265457000004
J	Fletcher, CM; Coyne, MJ; Villa, OF; Chatzidaki-Livanis, M; Comstock, LE				Fletcher, C. Mark; Coyne, Michael J.; Villa, Otto F.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.			A General O-Glycosylation System Important to the Physiology of a Major Human Intestinal Symbiont	CELL			English	Article							HOST-MICROBIAL INTERACTIONS; PROTEIN GLYCOSYLATION; DNA INVERSIONS; DIVERSITY; SURFACE; BIOSYNTHESIS; LIPOPROTEIN; EXPRESSION; BACTERIA; GLYCOPROTEINS	The Bacteroides are a numerically dominant genus of the human intestinal microbiota. These organisms harbor a rare bacterial pathway for incorporation of exogenous fucose into capsular polysaccharides and glycoproteins. The infrequency of glycoprotein synthesis by bacteria prompted a more detailed analysis of this process. Here, we demonstrate that Bacteroides fragilis has a general O-glycosylation system. The proteins targeted for glycosylation include those predicted to be involved in protein folding, protein-protein interactions, peptide degradation as well as surface lipoproteins. Protein glycosylation is central to the physiology of B. fragilis and is necessary for the organism to competitively colonize the mammalian intestine. We provide evidence that general O-glycosylation systems are conserved among intestinal Bacteroides species and likely contribute to the predominance of Bacteroides in the human intestine.	[Fletcher, C. Mark; Coyne, Michael J.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Villa, Otto F.] Mt Sinai Sch Med, Dept Med, Pulm Crit Care & Sleep Div, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			NCRR [RR018502]; NIH/NIAID [AI067711]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067711] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Azadi and S. Park of the Complex Carbohydrate Research Center (CCRC) for glycan release and Z. Waldon of Children's Hospital Boston for MS. This work was supported in part by NCRR grant RR018502 to the CCRC and mostly by NIH/NIAID grant AI067711.	Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Comstock LE, 2000, INFECT IMMUN, V68, P6182, DOI 10.1128/IAI.68.11.6182-6188.2000; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MELDGAARD M, 1994, MICROBIOL-UK, V140, P159, DOI 10.1099/13500872-140-1-159; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; NOLTMANN EA, 1966, METHOD ENZYMOL, V9, P557; Nsofor MN, 2006, BBA-GEN SUBJECTS, V1760, P1160, DOI 10.1016/j.bbagen.2006.03.004; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Reilly TJ, 1999, J BACTERIOL, V181, P6797, DOI 10.1128/JB.181.21.6797-6805.1999; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SALYERS AA, 1980, J BACTERIOL, V143, P781, DOI 10.1128/JB.143.2.781-788.1980; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Schaffer C, 2001, PROTEOMICS, V1, P248; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; Sijbrandi R, 2008, MICROBES INFECT, V10, P514, DOI 10.1016/j.micinf.2008.01.015; SMITH CJ, 1992, PLASMID, V27, P141, DOI 10.1016/0147-619X(92)90014-2; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990; TOKUDA H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pN1; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	57	126	134	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					321	331		10.1016/j.cell.2009.02.041	http://dx.doi.org/10.1016/j.cell.2009.02.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379697	Green Accepted, Bronze			2022-12-24	WOS:000265456800024
J	Kramer, JM				Kramer, Judith M.			Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists - The Influence of Values	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA	Duke University	Kramer, JM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA.							[Anonymous], [No title captured]; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	3	84	86	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1592	1595		10.1056/NEJMp0810561	http://dx.doi.org/10.1056/NEJMp0810561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369665				2022-12-24	WOS:000265178000003
J	Maron, BJ; Roberts, WC; Arad, M; Haas, TS; Spirito, P; Wright, GB; Almquist, AK; Baffa, JM; Saul, JP; Ho, CY; Seidman, J; Seidman, CE				Maron, Barry J.; Roberts, William C.; Arad, Michael; Haas, Tammy S.; Spirito, Paolo; Wright, Gregory B.; Almquist, Adrian K.; Baffa, Jeanne M.; Saul, J. Philip; Ho, Carolyn Y.; Seidman, Jonathan; Seidman, Christine E.			Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOSIN HEAVY-CHAIN; HYPERTROPHIC CARDIOMYOPATHY; DANON DISEASE; TROPONIN-T; PREVALENCE; MUTATIONS; GENE	Context Mutations in X-linked lysosome-associated membrane protein gene (LAMP2; Danon disease) produce a cardiomyopathy in young patients that clinically mimics severe hypertrophic cardiomyopathy (HCM) due to sarcomere protein mutations. However, the natural history and phenotypic expression of this newly recognized disease is incompletely resolved and its identification may have important clinical implications. Objectives To determine the clinical consequences, outcome, and phenotypic expression of LAMP2 cardiomyopathy associated with diagnostic and management strategies. Design, Setting, and Patients Clinical course and outcome were assessed prospectively in 7 young patients (6 boys) with defined LAMP2 mutations from the time of diagnosis (age 7-17 years; median, 14 years) to October 2008. Phenotypic expression of this disease was assessed both clinically and at autopsy. Main Outcome Measures Progressive heart failure, cardiac death, and transplant. Results Over a mean (SD) follow-up of 8.6 (2.6) years, and by age 14 to 24 years, the study patients developed left ventricular systolic dysfunction (mean [SD] ejection fraction, 25% [7%]) and cavity enlargement, as well as particularly adverse clinical consequences, including progressive refractory heart failure and death (n= 4), sudden death (n= 1), aborted cardiac arrest (n= 1), or heart transplantation (n= 1). Left ventricular hypertrophy was particularly marked (maximum thickness, 29-65 mm; mean [SD], 44 [15] mm), including 2 patients with massive ventricular septal thickness of 60 mm and 65 mm at ages 23 and 14 years, respectively. In 6 patients, a ventricular pre-excitation pattern at study entry was associated with markedly increased voltages of R-wave or S-wave (15-145 mm; mean [SD], 69 [39] mm), and deeply inverted T-waves. Autopsy findings included a combination of histopathologic features that were consistent with a lysosomal storage disease (ie, clusters of vacuolated myocytes) but also typical of HCM due to sarcomere protein mutations (ie, myocyte disarray, small vessel disease, myocardial scarring). Conclusions LAMP2 cardiomyopathy is a profound disease process characterized by progressive clinical deterioration leading rapidly to cardiac death in young patients (<25 years). These observations underscore the importance of timely molecular diagnosis for predicting prognosis and early consideration of heart transplantation.	[Maron, Barry J.; Haas, Tammy S.; Almquist, Adrian K.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Roberts, William C.] Baylor Cardiovasc Res Inst, Dallas, TX USA; [Arad, Michael] Chaim Sheba Med Ctr, Inst Heart, Tal Hashomer, Israel; [Arad, Michael] Chaim Sheba Med Ctr, Heart Failure Serv, Tal Hashomer, Israel; [Spirito, Paolo] Osped Osped Galliera, Div Cardiol, Genoa, Italy; [Wright, Gregory B.] Childrens Heart Clin, Minneapolis, MN USA; [Baffa, Jeanne M.] Alfred I Dupont Hosp Children, Nemours Cardiac Ctr, Wilmington, DE USA; [Saul, J. Philip] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Ho, Carolyn Y.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Seidman, Jonathan; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Minneapolis Heart Institute Foundation; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ente Ospedaliero Ospedali Galliera; Nemours Alfred I. duPont Hospital for Children; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org		Ho, Carolyn/0000-0002-7334-7924	Howard Hughes Medical Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This study was supported in part by grants from the Howard Hughes Medical Institute and National Institutes of Health.	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Bertini E, 2005, NEUROPEDIATRICS, V36, P309, DOI 10.1055/s-2005-872844; Charron P, 2004, HEART, V90, P842, DOI 10.1136/hrt.2003.029504; Echaniz-Laguna A, 2006, MUSCLE NERVE, V33, P393, DOI 10.1002/mus.20471; Fanin M, 2006, AM J PATHOL, V168, P1309, DOI 10.2353/ajpath.2006.050646; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; ROBERTS CS, 1989, PROGR CARDIOLOGY, V2, P3; ROBERTS WC, 1985, AM J CARDIOL, V55, P485, DOI 10.1016/0002-9149(85)90399-6; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Taylor MRG, 2007, J HUM GENET, V52, P830, DOI 10.1007/s10038-007-0184-8; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Yang Z, 2005, CIRCULATION, V112, P1612, DOI 10.1161/CIRCULATIONAHA.105.546481	22	223	240	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1253	1259		10.1001/jama.2009.371	http://dx.doi.org/10.1001/jama.2009.371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318653	Green Accepted, Bronze			2022-12-24	WOS:000264492800025
J	Lipsitch, M; Riley, S; Cauchemez, S; Ghani, AC; Ferguson, NM				Lipsitch, Marc; Riley, Steven; Cauchemez, Simon; Ghani, Azra C.; Ferguson, Neil M.			Managing and Reducing Uncertainty in an Emerging Influenza Pandemic.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Riley, Steven] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Cauchemez, Simon; Ghani, Azra C.; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Ctr Outbreak Anal & Modeling, MRC, London, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong; Imperial College London	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Riley, Steven/0000-0001-7904-4804; Ghani, Azra/0000-0002-0007-4910; Lipsitch, Marc/0000-0003-1504-9213	NIGMS NIH HHS [U54 GM088558, U54 GM088558-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Medical Research Council [G0600719B] Funding Source: researchfish	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Neustadt Richard E., 1983, EPIDEMIC NEVER WAS P; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; 2009, MMWR MORB MORTAL WKL, V58, P453	5	147	152	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2009	361	2					112	115		10.1056/NEJMp0904380	http://dx.doi.org/10.1056/NEJMp0904380			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	467OS	19474417	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000267748900002
J	Yi, JS; Du, M; Zajac, AJ				Yi, John S.; Du, Ming; Zajac, Allan J.			A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOTOXIC T-LYMPHOCYTES; CD8-T-CELL MEMORY; CD4-T-CELL HELP; CELL RESPONSES; MICE; PERSISTENCE; CD4(+); IL-21; EXPANSION	Understanding the factors that regulate the induction, quality, and longevity of antiviral T cell responses is essential for devising rational strategies to prevent or combat infections. In this study, we show that interleukin-21 (IL-21), likely produced by CD4(+) T cells, directly influences the generation of polyfunctional CD8(+) T cells and that the number of CD4(+) T cells that produce IL-21 differs markedly between acute and chronic infections. IL-21 regulates the development of CD8(+) T cell exhaustion and the ability to contain chronic lymphocytic choriomeningitis virus infection. Thus, IL-21 serves as a critical helper factor that shapes the functional quality of antiviral CD8(+) T cells and is required for viral control.	[Yi, John S.; Du, Ming; Zajac, Allan J.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zajac, AJ (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.	azajac@uab.edu	Yi, John/I-1784-2019	Yi, John/0000-0001-7777-2437	NIH [AI049360, AI067993, T32 AI007051]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R56AI049360, R01AI067993, R01AI049360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Harrington, P. Goepfert, B. Hahn, G. Shaw, and the members of the Zajac laboratory for discussions and assistance. This work was supported by grants AI049360 and AI067993 (to A.J.Z.) and T32 AI007051 (to J.S.Y.) from the NIH.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Bourgeois C, 2002, EUR J IMMUNOL, V32, P2199, DOI 10.1002/1521-4141(200208)32:8<2199::AID-IMMU2199>3.0.CO;2-L; Brandt K, 2007, CYTOKINE GROWTH F R, V18, P223, DOI 10.1016/j.cytogfr.2007.04.003; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; BUCHMEIER MJ, 1999, PERSISTENT VIRAL INF, P575; Dodds MG, 2009, CANCER IMMUNOL IMMUN, V58, P843, DOI 10.1007/s00262-008-0600-8; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	29	397	414	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1572	1576		10.1126/science.1175194	http://dx.doi.org/10.1126/science.1175194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19443735	Green Published, Green Accepted			2022-12-24	WOS:000267130600047
J	Townsend, JA; Wright, DA; Winfrey, RJ; Fu, FL; Maeder, ML; Joung, JK; Voytas, DF				Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli; Maeder, Morgan L.; Joung, J. Keith; Voytas, Daniel F.			High-frequency modification of plant genes using engineered zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; RESISTANCE; TOXICITY	An efficient method for making directed DNA sequence modifications to plant genes (gene targeting) is at present lacking, thereby frustrating efforts to dissect plant gene function and engineer crop plants that better meet the world's burgeoning need for food, fibre and fuel. Zinc-finger nucleases (ZFNs)-enzymes engineered to create DNA double-strand breaks at specific loci-are potent stimulators of gene targeting(1,2); for example, they can be used to precisely modify engineered reporter genes in plants(3,4). Here we demonstrate high-frequency ZFN-stimulated gene targeting at endogenous plant genes, namely the tobacco acetolactate synthase genes (ALS SuRA and SuRB), for which specific mutations are known to confer resistance to imidazolinone and sulphonylurea herbicides(5). Herbicide-resistance mutations were introduced into SuR loci by ZFN-mediated gene targeting at frequencies exceeding 2% of transformed cells for mutations as far as 1.3 kilobases from the ZFN cleavage site. More than 40% of recombinant plants had modifications in multiple SuR alleles. The observed high frequency of gene targeting indicates that it is now possible to efficiently make targeted sequence changes in endogenous plant genes.	[Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Voytas, DF (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu		Voytas, Daniel/0000-0002-4944-1224	National Science Foundation; National Institutes of Health; Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Eichtinger for help in making ZFA reagents. This work was supported by grants to D. F. V. from the National Science Foundation and to J. K. J. from the National Institutes of Health and the Massachusetts General Hospital Department of Pathology.	Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; LEE KY, 1988, EMBO J, V7, P1241, DOI 10.1002/j.1460-2075.1988.tb02937.x; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259	18	457	587	3	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					442	U161		10.1038/nature07845	http://dx.doi.org/10.1038/nature07845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404258	Green Accepted			2022-12-24	WOS:000266243700049
J	Sullivan, NL; Marquis, KA; Rudner, DZ				Sullivan, Nora L.; Marquis, Kathleen A.; Rudner, David Z.			Recruitment of SMC by ParB-parS Organizes the Origin Region and Promotes Efficient Chromosome Segregation	CELL			English	Article							BACILLUS-SUBTILIS CHROMOSOME; ESCHERICHIA-COLI CHROMOSOME; ASYMMETRIC CELL-DIVISION; PROTEIN SPO0J PARB; REPLICATION INITIATION; SUBCELLULAR-LOCALIZATION; CAULOBACTER-CRESCENTUS; PARTITIONING PROTEINS; ACTIVE SEGREGATION; DNA-REPLICATION	Organization and segregation of replicated chromosomes are essential processes during cell division in all organisms. Similar to eukaryotes, bacteria possess centromere-like DNA sequences (parS) that cluster at the origin of replication and the structural maintenance of chromosomes (SMC) complexes for faithful chromosome segregation. In Bacillus subtilis, parS sites are bound by the partitioning protein Spo0J (ParB), and we show here that Spo0J recruits the SMC complex to the origin. We demonstrate that the SMC complex colocalizes with Spo0J at the origin and that insertion of parS sites near the replication terminus targets SMC to this position leading to defects in chromosome organization and segregation. Consistent with these findings, the subcellular localization of the SMC complex is disrupted in the absence of Spo0J or the parS sites. We propose a model in which recruitment of SMC to the origin by Spo0J-parS organizes the origin region and promotes efficient chromosome segregation.	[Sullivan, Nora L.; Marquis, Kathleen A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rudner, DZ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	rudner@hms.harvard.edu			National Institute of Health [GM073831-01A1]; Hellman Family Faculty Fund; Damon Runyon Cancer Research Foundation [DRS-44-05]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, R01GM086466] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hellman Family Faculty Fund; Damon Runyon Cancer Research Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N. L. S. and K. A. M. contributed equally to this work. We thank members of the Rudner laboratory past and present, Briana Burton, Rich Losick, Alan Grossman, Adam Brier, Cathy Lee, Matt Waldor, Barbara Meyer, Johannes Walter, and Nancy Kleckner for valuable discussions. We thank Alan Grossman for generously providing numerous strains, plasmids, and antibodies. We thank Bill Burkholder and Dan Kearns for strains and plasmids and Rebecca Roush for preliminary SMC depletion experiments. Support for this work comes in part from the National Institute of Health Grant GM073831-01A1 and the Hellman Family Faculty Fund. D. Z. R. was supported by the Damon Runyon Cancer Research Foundation (DRS-44-05). N. L. S. was supported by a fellowship from NSF.	Autret S, 2001, MOL MICROBIOL, V41, P743, DOI 10.1046/j.1365-2958.2001.02551.x; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Doan T, 2007, MOL MICROBIOL, V64, P500, DOI 10.1111/j.1365-2958.2007.05677.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jensen RB, 2003, J BACTERIOL, V185, P3068, DOI 10.1128/JB.185.10.3068-3075.2003; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Niki H, 2000, GENE DEV, V14, P212; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	50	207	207	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					697	707		10.1016/j.cell.2009.04.044	http://dx.doi.org/10.1016/j.cell.2009.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450517	Bronze, Green Accepted			2022-12-24	WOS:000266114100018
J	Bednarek, P; Osbourn, A				Bednarek, Pawel; Osbourn, Anne			Plant-Microbe Interactions: Chemical Diversity in Plant Defense	SCIENCE			English	Editorial Material							ARBUSCULAR MYCORRHIZAL FUNGI; DISEASE RESISTANCE; GENE-CLUSTER; ARABIDOPSIS; METABOLISM; TOMATINASE; TOMATO; BIOSYNTHESIS; PHYTOALEXINS; ANTIBIOTICS	The chemical diversity within the plant kingdom is likely to be a consequence of niche colonization and adaptive evolution. Plant-derived natural products have important functions in defense. They also have broader ecological roles and may in addition participate in plant growth and development. Recent data suggest that some antimicrobial phytochemicals may not serve simply as chemical barriers but could also have functions in defense-related signaling processes. It is important, therefore, that we should not to be too reductionist in our thinking when endeavoring to understand the forces and mechanisms that drive chemical diversification in plants.	[Bednarek, Pawel] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-5000 Cologne, Germany; [Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich, Norfolk, England	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bednarek, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-5000 Cologne, Germany.	bednarek@mpiz-koeln.mpg.de; anne.osbourn@bbsrc.ac.uk	Bednarek, Pawel/D-2561-2009	Bednarek, Pawel/0000-0002-3064-7775	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bouarab K, 2002, NATURE, V418, P889, DOI 10.1038/nature00950; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2006, NEW PHYTOL, V172, P193, DOI 10.1111/j.1469-8137.2006.01863.x; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Geu-Flores F, 2009, PLANTA, V229, P261, DOI 10.1007/s00425-008-0825-y; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hadwiger LA, 2008, PHYTOPATHOLOGY, V98, P372, DOI 10.1094/PHYTO-98-4-0372; Ito S, 2004, FEBS LETT, V571, P31, DOI 10.1016/j.febslet.2004.06.053; Kant MR, 2007, CURR OPIN GENET DEV, V17, P519, DOI 10.1016/j.gde.2007.09.002; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Pareja-Jaime Y, 2008, MOL PLANT MICROBE IN, V21, P728, DOI 10.1094/MPMI-21-6-0728; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; QI X, Patent No. 2581099; QI X, Patent No. 11248986; QI X, Patent No. 06044508; QI X, 2004, Patent No. 1240312; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Simons V, 2006, ANTIMICROB AGENTS CH, V50, P2732, DOI 10.1128/AAC.00289-06; SNYDER BA, 1990, SCIENCE, V248, P1637, DOI 10.1126/science.248.4963.1637; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; 2000, Patent No. 0146391; 783739; 2007, Patent No. 7186884; 2392435; 18709752; 2008, Patent No. 259077; 11940638; 2009, Patent No. 2009041932	46	235	259	6	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					746	748		10.1126/science.1171661	http://dx.doi.org/10.1126/science.1171661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423814				2022-12-24	WOS:000265832400033
J	Goldstein, DB				Goldstein, David B.			Common Genetic Variation and Human Traits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ASSOCIATION		Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA	Duke University	Goldstein, DB (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA.		Goldstein, David/AAY-8125-2020					Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	5	678	707	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1696	1698		10.1056/NEJMp0806284	http://dx.doi.org/10.1056/NEJMp0806284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369660				2022-12-24	WOS:000265377800002
J	Smirnov, DA; Morley, M; Shin, E; Spielman, RS; Cheung, VG				Smirnov, Denis A.; Morley, Michael; Shin, Eunice; Spielman, Richard S.; Cheung, Vivian G.			Genetic analysis of radiation-induced changes in human gene expression	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CELLS; LINKAGE; DISSECTION; APOPTOSIS; TRAITS; GROWTH	Humans are exposed to radiation through the environment and in medical settings. To deal with radiation-induced damage, cells mount complex responses that rely on changes in gene expression. These gene expression responses differ greatly between individuals(1) and contribute to individual differences in response to radiation(2). Here we identify regulators that influence expression levels of radiation-responsive genes. We treated radiation-induced changes in gene expression as quantitative phenotypes(3,4), and conducted genetic linkage and association studies to map their regulators. For more than 1,200 of these phenotypes there was significant evidence of linkage to specific chromosomal regions. Nearly all of the regulators act in trans to influence the expression of their target genes; there are very few cis-acting regulators. Some of the transacting regulators are transcription factors, but others are genes that were not known to have a regulatory function in radiation response. These results have implications for our basic and clinical understanding of how human cells respond to radiation.	[Smirnov, Denis A.; Cheung, Vivian G.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Morley, Michael; Shin, Eunice; Cheung, Vivian G.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Spielman, Richard S.; Cheung, Vivian G.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	National Center for Research Resources; National Institutes of Health; University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. George and W. Ewens for advice and discussion, A. Bruzel, S. Solomon, T. Weber and K. Halasa for technical help, and C. McGarry for manuscript preparation. Some analyses for this paper were performed by using the program package S. A. G. E., which is supported by a grant from the National Center for Research Resources. This work is supported by grants from the National Institutes of Health (to V. G. C. and R. S. S.), by seed grants from the University of Pennsylvania Center for Excellence in Environmental Toxicology (to V. G. C.), by the W. W. Smith Endowed Chair (to V. G. C.) and the Howard Hughes Medical Institute (to V. G. C.).	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Correa CR, 2004, AM J HUM GENET, V75, P885, DOI 10.1086/425221; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers Jason W, 2006, J RNAi Gene Silencing, V2, P181; Pan DN, 2006, CANCER LETT, V235, P26, DOI 10.1016/j.canlet.2005.03.045; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sato N, 2000, EXP CELL RES, V255, P321, DOI 10.1006/excr.1999.4797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	30	155	158	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					587	U120		10.1038/nature07940	http://dx.doi.org/10.1038/nature07940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19349959	Green Accepted			2022-12-24	WOS:000266370500043
J	Lee, YJ; Yi, H; Kim, WJ; Kang, K; Yun, DS; Strano, MS; Ceder, G; Belcher, AM				Lee, Yun Jung; Yi, Hyunjung; Kim, Woo-Jae; Kang, Kisuk; Yun, Dong Soo; Strano, Michael S.; Ceder, Gerbrand; Belcher, Angela M.			Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes	SCIENCE			English	Article							CARBON NANOTUBE; ELECTRODE PERFORMANCE; HIGH-CAPACITY; PEPTIDES; CATHODE; FEPO4	Development of materials that deliver more energy at high rates is important for high-power applications, including portable electronic devices and hybrid electric vehicles. For lithium-ion (Li+) batteries, reducing material dimensions can boost Li+ ion and electron transfer in nanostructured electrodes. By manipulating two genes, we equipped viruses with peptide groups having affinity for single-walled carbon nanotubes (SWNTs) on one end and peptides capable of nucleating amorphous iron phosphate (a-FePO4) fused to the viral major coat protein. The virus clone with the greatest affinity toward SWNTs enabled power performance of a-FePO4 comparable to that of crystalline lithium iron phosphate (c-LiFePO4) and showed excellent capacity retention upon cycling at 1C. This environmentally benign low-temperature biological scaffold could facilitate fabrication of electrodes from materials previously excluded because of extremely low electronic conductivity.	[Lee, Yun Jung; Yi, Hyunjung; Yun, Dong Soo; Ceder, Gerbrand; Belcher, Angela M.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kim, Woo-Jae; Strano, Michael S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Taejon 305701, South Korea; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Inst Ecoenergy, Taejon 305701, South Korea; [Belcher, Angela M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	belcher@mit.edu	Yi, Hyunjung/C-8672-2012; Kang, Kisuk/B-5776-2011; Ceder, Gerbrand/Y-2544-2019; Kim, Woo-Jae/F-8036-2013	Yi, Hyunjung/0000-0001-8812-497X; Kim, Woo-Jae/0000-0001-8761-6809; Kang, Kisuk/0000-0002-8696-1886	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program; Korean Government [KRF-2005-214-D00260]; Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology [R01-2008-000-10913-0]; Energy Resource Technology Development program by the Ministry of Knowledge Economy [2008-E-EL11-P-08-3-010]; Office of Naval Research; EPSRC [EP/C01197X/2, EP/C01197X/1] Funding Source: UKRI	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program(National Science Foundation (NSF)); Korean Government(Korean Government); Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology; Energy Resource Technology Development program by the Ministry of Knowledge Economy; Office of Naval Research(Office of Naval Research); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB) and U.S. NSF through the Materials Research Science and Engineering Centers program. H.Y. is grateful for Korean Government Overseas Scholarship. W.-J.K. is grateful for support from the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-214-D00260). K.K is grateful for funding support from Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology (No. R01-2008-000-10913-0) and Energy Resource Technology Development program by the Ministry of Knowledge Economy (No. 2008-E-EL11-P-08-3-010). M.S.S. is grateful for funding from the NSF and the Office of Naval Research Young Investigator Grant.	Ahn S, 1998, ELECTROCHEM SOLID ST, V1, P111; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; Croce F, 2002, ELECTROCHEM SOLID ST, V5, pA47, DOI 10.1149/1.1449302; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Hu YS, 2007, ADV MATER, V19, P1963, DOI 10.1002/adma.200700697; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Kavan L, 2007, CHEM MATER, V19, P4716, DOI 10.1021/cm071107p; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Kim DH, 2006, ELECTROCHEM SOLID ST, V9, pA439, DOI 10.1149/1.2218308; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Nam KT, 2008, P NATL ACAD SCI USA, V105, P17227, DOI 10.1073/pnas.0711620105; Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n; Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536; Prosini PP, 2002, J ELECTROCHEM SOC, V149, pA297, DOI 10.1149/1.1435359; Sakamoto JS, 2002, J ELECTROCHEM SOC, V149, pA26, DOI 10.1149/1.1425791; Shi ZC, 2008, ELECTROCHIM ACTA, V53, P2665, DOI 10.1016/j.electacta.2007.06.079; Tarascon JM, 2004, DALTON T, P2988, DOI 10.1039/b408442j; Wang Q, 2007, J AM CHEM SOC, V129, P3163, DOI 10.1021/ja066260j; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	24	622	650	10	670	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1051	1055		10.1126/science.1171541	http://dx.doi.org/10.1126/science.1171541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19342549				2022-12-24	WOS:000266246700036
J	Kriaucionis, S; Heintz, N				Kriaucionis, Skirmantas; Heintz, Nathaniel			The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain	SCIENCE			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; OXIDATIVE DAMAGE; 5-METHYLCYTOSINE	Despite the importance of epigenetic regulation in neurological disorders, little is known about neuronal chromatin. Cerebellar Purkinje neurons have large and euchromatic nuclei, whereas granule cell nuclei are small and have a more typical heterochromatin distribution. While comparing the abundance of 5-methylcytosine in Purkinje and granule cell nuclei, we detected the presence of an unusual DNA nucleotide. Using thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry, we identified the nucleotide as 5-hydroxymethyl-2'-deoxycytidine (hmdC). hmdC constitutes 0.6% of total nucleotides in Purkinje cells, 0.2% in granule cells, and is not present in cancer cell lines. hmdC is a constituent of nuclear DNA that is highly abundant in the brain, suggesting a role in epigenetic control of neuronal function.	[Kriaucionis, Skirmantas; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015; jia, xu/A-8386-2016	Kriaucionis, Skirmantas/0000-0002-2273-5994; 	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative	We thank B. Gauthier for technical assistance; S. Mazel, C. Bare, and X. Fan for flow cytometry advice and nuclei sorts; and H. Deng and J. Fernandez for acquirement of MS data and help with HPLC. We are grateful to members of the Heintz laboratory for discussions and support. This work was supported by the Howard Hughes Medical Institute and the Simons Foundation Autism Research Initiative.	Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; Cadet J, 2006, NAT CHEM BIOL, V2, P348, DOI 10.1038/nchembio0706-348; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; GOMMERSAMPT JH, 1995, FASEB J, V9, P1034, DOI 10.1096/fasebj.9.11.7649402; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KOTHARI RM, 1976, J MOL EVOL, V7, P325, DOI 10.1007/BF01743628; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	14	1926	2015	2	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					929	930		10.1126/science.1169786	http://dx.doi.org/10.1126/science.1169786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372393	Green Accepted			2022-12-24	WOS:000266048800036
J	Foltz, DR; Jansen, LET; Bailey, AO; Yates, JR; Bassett, EA; Wood, S; Black, BE; Cleveland, DW				Foltz, Daniel R.; Jansen, Lars E. T.; Bailey, Aaron O.; Yates, John R., III; Bassett, Emily A.; Wood, Stacey; Black, Ben E.; Cleveland, Don W.			Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP	CELL			English	Article							INNER KINETOCHORE PLATE; DNA-REPLICATION INVITRO; HISTONE VARIANT H3.3; ALPHA-SATELLITE DNA; SACCHAROMYCES-CEREVISIAE; CHROMATIN REQUIRES; MITOTIC CHECKPOINT; CANCER-CELLS; IN-VITRO; PROTEIN	The centromere is responsible for accurate chromosome segregation. Mammalian centromeres are specified epigenetically, with all active centromeres containing centromere-specific chromatin in which CENP-A replaces histone H3 within the nucleosome. The proteins responsible for assembly of human CENP-A into centromeric nucleosomes during the G1 phase of the cell cycle are shown here to be distinct from the chromatin assembly factors previously shown to load other histone H3 variants. Here we demonstrate that prenucleosomal CENP-A is complexed with histone H4, nucleophosmin 1, and HJURP. Recruitment of new ENP-Aintonucleosomes at replicated centromeres is dependent on HJURP. Recognition by HJURP is mediated through the centromere targeting domain (CATD) of CENP-A, a region that we demonstrated previously to induce a unique conformational rigidity to both the subnucleosomal CENP-A heterotetramer and the corresponding assembled nucleosome. We propose HJURP to be a cell-cycle-regulated CENP-A-specific histone chaperone required for centromeric chromatin assembly.	[Foltz, Daniel R.; Jansen, Lars E. T.; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Foltz, Daniel R.; Jansen, Lars E. T.; Cleveland, Don W.] Univ Calif San Diego, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Bailey, Aaron O.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA; [Bassett, Emily A.; Wood, Stacey; Black, Ben E.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Pennsylvania	Foltz, DR (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	dfoltz@virginia.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Bailey, Aaron/ABB-8522-2021	Bailey, Aaron/0000-0001-8063-3032; Wood, Stacey/0000-0001-5805-6670; Cleveland, Don/0000-0002-1934-3682; Jansen, Lars/0000-0002-2158-0345	National Institutes of Health; Leukemia and Lymphoma Society; Burroughs Welcome Fund; Philip Morris USA Inc; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM082989, R01GM074150, F32GM067401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Burroughs Welcome Fund(Burroughs Wellcome Fund); Philip Morris USA Inc; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Iain Cheeseman, Andrew Holland, Karen Oegema, Arshad Desai, and members of the Cleveland Lab for helpful discussion and reagents. This work was supported by grants from the National Institutes of Health to B. E.B. and D.W.C.D.R.F. was supported by a Special Fellowship from the Leukemia and Lymphoma Society. B.E.B. was supported by a Career Award in the Biomedical Sciences from the Burroughs Welcome Fund. L.E.T.J. was supported by a postdoctoral fellowship from Philip Morris USA Inc. Salary support for D.W.C. is provided by the Ludwig Institute for Cancer Research.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Chang JH, 1998, BIOCHEM J, V329, P539; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luhn P, 2007, PROTEINS, V67, P479, DOI 10.1002/prot.21288; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; MANUELIDIS L, 1978, NATURE, V276, P92, DOI 10.1038/276092a0; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; WILLARD HF, 1985, AM J HUM GENET, V37, P524; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	59	471	479	3	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 1	2009	137	3					472	484		10.1016/j.cell.2009.02.039	http://dx.doi.org/10.1016/j.cell.2009.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410544	Green Accepted, Bronze			2022-12-24	WOS:000265677200017
J	Frost, A; Unger, VM; De Camilli, P				Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro			The BAR Domain Superfamily: Membrane-Molding Macromolecules	CELL			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; AMPHIPHYSIN-2 BIN1; STRUCTURAL BASIS; FISSION YEAST; PROTEINS; CURVATURE; FAMILY; INVAGINATION	Membrane-shaping proteins of the BAR domain superfamily are determinants of organelle biogenesis, membrane trafficking, cell division, and cell migration. An upsurge of research now reveals new principles of BAR domain-mediated membrane remodeling, enhancing our understanding of membrane curvature-mediated information processing.	[Frost, Adam; Unger, Vinzenz M.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06510 USA; [Frost, Adam; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Unger, VM (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	vinzenz.unger@yale.edu; pietro.decamilli@yale.edu		Frost, Adam/0000-0003-2231-2577	Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [P30 DA018343, R21 DA024101] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101, P30DA018343] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KANBE T, 1989, J CELL SCI, V94, P647; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kusumi N, 2007, CELL STRUCT FUNCT, V32, P101, DOI 10.1247/csf.07024; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; ROBERTSGALBRAIT.RH, 2008, POMBE CDC15 HOMOLOGY; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	45	414	421	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					191	196		10.1016/j.cell.2009.04.010	http://dx.doi.org/10.1016/j.cell.2009.04.010			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379681	Green Accepted, Bronze			2022-12-24	WOS:000265456800006
J	Kudla, G; Murray, AW; Tollervey, D; Plotkin, JB				Kudla, Grzegorz; Murray, Andrew W.; Tollervey, David; Plotkin, Joshua B.			Coding-Sequence Determinants of Gene Expression in Escherichia coli	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; RNA SECONDARY STRUCTURE; MESSENGER-RNA; TRANSLATION INITIATION; PROTEIN EXPRESSION; BIAS; DOWNSTREAM; MUTATIONS; STABILITY; SELECTION	Synonymous mutations do not alter the encoded protein, but they can influence gene expression. To investigate how, we engineered a synthetic library of 154 genes that varied randomly at synonymous sites, but all encoded the same green fluorescent protein (GFP). When expressed in Escherichia coli, GFP protein levels varied 250-fold across the library. GFP messenger RNA (mRNA) levels, mRNA degradation patterns, and bacterial growth rates also varied, but codon bias did not correlate with gene expression. Rather, the stability of mRNA folding near the ribosomal binding site explained more than half the variation in protein levels. In our analysis, mRNA folding and associated rates of translation initiation play a predominant role in shaping expression levels of individual genes, whereas codon bias influences global translation efficiency and cellular fitness.	[Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA; [Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tollervey, David] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Pennsylvania; University of Pennsylvania; Harvard University; University of Edinburgh; University of Edinburgh	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Tollervey, David/AAR-6662-2020; Plotkin, Joshua B/E-6947-2013	Tollervey, David/0000-0003-2894-2772; Kudla, Grzegorz/0000-0002-7924-2744	Burroughs Wellcome Fund; James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Foundation for Polish Science; European Molecular Biology Organization; Wellcome Trust/BBSRC [BB/DO19621/1]; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust/BBSRC(Wellcome TrustUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Helwak, J. Lucks, P. Sharp, L. Hurst, and members of the Plotkin and Tollervey laboratories for conceptual input; and A. Heath (Sigma), A. Aitken, J. Skerker, T. Shimizu, I. Iost, and J. Han for reagents, protocols, and equipment. Support provided by the Burroughs Wellcome Fund, James S. McDonnell Foundation, Penn Genome Frontiers Institute, and Defense Advanced Research Projects Agency "FunBio Program" HR0011-05-1-0057 (J.B.P.); Foundation for Polish Science and European Molecular Biology Organization (G.K.); Wellcome Trust/BBSRC grant BB/DO19621/1 (D.T.).	AKASHI H, 1994, GENETICS, V136, P927; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; ROSENBERG AH, 1993, J BACTERIOL, V175, P716, DOI 10.1128/JB.175.3.716-722.1993; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	28	968	1001	10	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					255	258		10.1126/science.1170160	http://dx.doi.org/10.1126/science.1170160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359587	Green Accepted			2022-12-24	WOS:000265024400047
J	Zoncu, R; Perera, RM; Balkin, DM; Pirruccello, M; Toomre, D; De Camilli, P				Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro			A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes	CELL			English	Article							CLATHRIN-COATED PITS; ENDOCYTIC PATHWAY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INDEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; BAR-PH; RECEPTOR; PROTEIN; MEMBRANE; RAB5	The recent identification of several novel endocytic compartments has challenged our current understanding of the topological and functional organization of the endocytic pathway. Using quantitative single vesicle imaging and acute manipulation of phosphoinositides we show that APPL endosomes, which participate in growth factor receptor trafficking and signaling, represent an early endocytic intermediate common to a subset of clathrin derived endocytic vesicles and macropinosomes. Most APPL endosomes are precursors of classical PI3P positive endosomes, and PI3P plays a critical role in promoting this conversion. Depletion of PI3P causes a striking reversion of Rab5 positive endosomes to the APPL stage, and results in enhanced growth factor signaling. These findings reveal a surprising plasticity of the early endocytic pathway. Importantly, PI3P functions as a switch to dynamically regulate maturation and signaling of APPL endosomes.	[Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Toomre, D (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	derek.toomre@yale.edu; pietro.decamilli@yale.edu		Pirruccello-Straub, Michelle/0000-0002-7996-857X	NIH [CA46128, DK45735, NS36251, DA018343]; New Innovator award [1DP20D002980-01]; MSTP TG [5T32GM07205]; Mathers Charitable Foundation; Keck Foundation; Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Innovator award; MSTP TG; Mathers Charitable Foundation; Keck Foundation(W.M. Keck Foundation); Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. P. Di Fiore and S. Ferguson for critical reading of the manuscript; Ariad Pharmaceuticals for generously providing us with the rapalogue AP021967; J, Keen, B. Larijani, N. Fili, S. Corvera, and S. Grinstein for valuable reagents; A. Karpikov for help with the TIRF calibration; D. Sabatini and J. Settleman for support. This work was supported by grants from the NIH (CA46128, DK45735, NS36251, and DA018343 to P. D. C., New Innovator award 1DP20D002980-01 to D. T., and MSTP TG 5T32GM07205 to D. M. B.), the G. Harold and Leila Y. Mathers Charitable Foundation, the Keck Foundation and the Kavli Foundation to P. D. C., and the Yale Cancer Center ASC-IRG grant to D. T.	Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Haglund Kaisa, 2007, Critical Reviews in Oncogenesis, V13, P39; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	51	255	262	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1110	1121		10.1016/j.cell.2009.01.032	http://dx.doi.org/10.1016/j.cell.2009.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303853	Green Accepted, Bronze			2022-12-24	WOS:000264403900016
J	Brangwynne, CP; Eckmann, CR; Courson, DS; Rybarska, A; Hoege, C; Gharakhani, J; Julicher, F; Hyman, AA				Brangwynne, Clifford P.; Eckmann, Christian R.; Courson, David S.; Rybarska, Agata; Hoege, Carsten; Gharakhani, Joebin; Juelicher, Frank; Hyman, Anthony A.			Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; CELL; PROTEINS; EMBRYOS; SEGREGATION; DEGRADATION; ASYMMETRY; POLARITY; LESSONS	In sexually reproducing organisms, embryos specify germ cells, which ultimately generate sperm and eggs. In Caenorhabditis elegans, the first germ cell is established when RNA and protein-rich P granules localize to the posterior of the one-cell embryo. Localization of P granules and their physical nature remain poorly understood. Here we show that P granules exhibit liquid-like behaviors, including fusion, dripping, and wetting, which we used to estimate their viscosity and surface tension. As with other liquids, P granules rapidly dissolved and condensed. Localization occurred by a biased increase in P granule condensation at the posterior. This process reflects a classic phase transition, in which polarity proteins vary the condensation point across the cell. Such phase transitions may represent a fundamental physicochemical mechanism for structuring the cytoplasm.	[Brangwynne, Clifford P.; Eckmann, Christian R.; Rybarska, Agata; Hoege, Carsten; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Brangwynne, Clifford P.; Gharakhani, Joebin; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Brangwynne, Clifford P.; Courson, David S.; Gharakhani, Joebin; Juelicher, Frank; Hyman, Anthony A.] Marine Biol Lab, Woods Hole, MA 02543 USA	Max Planck Society; Max Planck Society; Marine Biological Laboratory - Woods Hole	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Julicher, Frank/B-1828-2009; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Julicher, Frank/0000-0003-4731-9185; 	Helen Hay Whitney Foundation fellowship	Helen Hay Whitney Foundation fellowship	We thank T. Mitchison for advice and discussion, together with students of the MBL Physiology Course 2008; and S. Grill, N. Goehring, and members of the Hyman and Eckmann Laboratories for helpful comments. We thank S. Hell, R. Medda, and B. Harke for assistance with stimulated emission depletion microscopy. Some strains used in this study were obtained from the Caenorhabditis Genetics Center. C.P.B. is supported by a fellowship from the Helen Hay Whitney Foundation.	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 1983, PHASE TRANSITIONS CR; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; DAOUD M, 1999, SOFT MATTER PHYS; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hird SN, 1996, DEVELOPMENT, V122, P1303; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Spike CA, 2003, CURR BIOL, V13, pR837, DOI 10.1016/j.cub.2003.10.016; Strasser MJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-58; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060	21	1413	1429	60	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1729	1732		10.1126/science.1172046	http://dx.doi.org/10.1126/science.1172046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19460965				2022-12-24	WOS:000267338200046
J	Calcraft, PJ; Ruas, M; Pan, Z; Cheng, XT; Arredouani, A; Hao, XM; Tang, JS; Rietdorf, K; Teboul, L; Chuang, KT; Lin, PH; Xiao, R; Wang, CB; Zhu, YM; Lin, YK; Wyatt, CN; Parrington, J; Ma, JJ; Evans, AM; Galione, A; Zhu, MX				Calcraft, Peter J.; Ruas, Margarida; Pan, Zui; Cheng, Xiaotong; Arredouani, Abdelilah; Hao, Xuemei; Tang, Jisen; Rietdorf, Katja; Teboul, Lydia; Chuang, Kai-Ting; Lin, Peihui; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Wyatt, Christopher N.; Parrington, John; Ma, Jianjie; Evans, A. Mark; Galione, Antony; Zhu, Michael X.			NAADP mobilizes calcium from acidic organelles through two-pore channels	NATURE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PANCREATIC BETA-CELLS; CA2+ RELEASE; INOSITOL TRISPHOSPHATE; RYANODINE RECEPTORS; STORES; HEART; MECHANISM; MESSENGER	Ca2+ mobilization from intracellular stores represents an important cell signalling process(1) that is regulated, in mammalian cells, by inositol-1,4,5-trisphosphate (InsP(3)), cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate (NAADP). InsP(3) and cyclic ADP ribose cause the release of Ca2+ from sarcoplasmic/endoplasmic reticulum stores by the activation of InsP(3) and ryanodine receptors (InsP(3)Rs and RyRs). In contrast, the nature of the intracellular stores targeted by NAADP and the molecular identity of the NAADP receptors remain controversial(1,2), although evidence indicates that NAADP mobilizes Ca2+ from lysosome-related acidic compartments(3,4). Here we show that two-pore channels (TPCs) comprise a family of NAADP receptors, with human TPC1 (also known as TPCN1) and chicken TPC3 (TPCN3) being expressed on endosomal membranes, and human TPC2 (TPCN2) on lysosomal membranes when expressed in HEK293 cells. Membranes enriched with TPC2 show high affinity NAADP binding, and TPC2 underpins NAADP-induced Ca2+ release from lysosome-related stores that is subsequently amplified by Ca2+-induced Ca2+ release by InsP3Rs. Responses to NAADP were abolished by disrupting the lysosomal proton gradient and by ablating TPC2 expression, but were only attenuated by depleting endoplasmic reticulum Ca2+ stores or by blocking InsP3Rs. Thus, TPCs form NAADP receptors that release Ca2+ from acidic organelles, which can trigger further Ca2+ signals via sarcoplasmic/endoplasmic reticulum. TPCs therefore provide new insights into the regulation and organization of Ca2+ signals in animal cells, and will advance our understanding of the physiological role of NAADP.	[Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Calcraft, Peter J.; Wyatt, Christopher N.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Ruas, Margarida; Cheng, Xiaotong; Arredouani, Abdelilah; Rietdorf, Katja; Chuang, Kai-Ting; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Pan, Zui; Lin, Peihui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Hao, Xuemei] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Edinburgh; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Peking University; MRC Harwell	Zhu, MX (corresponding author), Ohio State Univ, Dept Neurosci, 1060 Carmack Rd, Columbus, OH 43210 USA.	zhu.55@osu.ed	Xiao, Rui/G-1193-2011; Lin, Pei-Hui/I-3011-2015; Galione, Antony/E-5884-2011; arredouani, abdelilah/Q-9650-2019; Teboul, Lydia/P-2428-2019	Lin, Pei-Hui/0000-0002-3894-5099; Teboul, Lydia/0000-0002-2789-8637; Galione, Antony/0000-0002-4132-7646; Ruas, Margarida/0000-0002-4872-7618; Pan, Zui/0000-0003-4105-901X; arredouani, abdelilah/0000-0002-5060-916X; Xiao, Rui/0000-0001-5541-6685	UK Wellcome Trust [070772]; British Heart Foundation; US National Institutes of Health; American Heart Association; British Heart Foundation [FS/05/050]; US National Institutes of Health [P30-NS045758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042183, P30NS045758, R21NS056942] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1502/1] Funding Source: researchfish; MRC [MC_UP_1502/1] Funding Source: UKRI	UK Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Wellcome Trust and the British Heart Foundation to A. G., J. P. and A. M. E., the US National Institutes of Health to M. X. Z. and J. M., and the American Heart Association to M. X. Z. A. G. was a Wellcome Senior Research Fellow in basic Biomedical Science. The work of A. M. E. was funded by a Wellcome Trust Project Grant (CNW, reference number 070772) and a British Heart Foundation Studentship (PJC, reference number FS/05/050). Part of the work of M. X. Z. was made possible by US National Institutes of Health grant P30-NS045758. We thank T. Kong and W. Li for the HepG2 cell line, O. Ogunbayo for technical assistance, and F. Platt, A. Morgan and M. Viapiano for help with the manuscript.	Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mojzisova A, 2001, PFLUG ARCH EUR J PHY, V441, P674, DOI 10.1007/s004240000465; Morgan A. J., 2006, METHODS CALCIUM SIGN, P267; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	30	554	571	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					596	U130		10.1038/nature08030	http://dx.doi.org/10.1038/nature08030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387438	Green Accepted			2022-12-24	WOS:000266370500045
J	Ho, MC; Menetret, JF; Tsuruta, H; Allen, KN				Ho, Meng-Chiao; Menetret, Jean-Francois; Tsuruta, Hiro; Allen, Karen N.			The origin of the electrostatic perturbation in acetoacetate decarboxylase	NATURE			English	Article							ACTIVE-SITE; ENZYMATIC DECARBOXYLATION; MECHANISM; SOFTWARE; LYSINE; RESOLUTION; SYSTEM; PK(A); MODEL	Acetoacetate decarboxylase (AADase) has long been cited as the prototypical example of the marked shifts in the pK(a) values of ionizable groups that can occur in an enzyme active site. In 1966, it was hypothesized that in AADase the origin of the large pK(a) perturbation (-4.5 log units) observed in the nucleophilic Lys 115 results from the proximity of Lys 116, marking the first proposal of microenvironment effects in enzymology. The electrostatic perturbation hypothesis has been demonstrated in a number of enzymes, but never for the enzyme that inspired its conception, owing to the lack of a three-dimensional structure. Here we present the X-ray crystal structures of AADase and of the enamine adduct with the substrate analogue 2,4-pentanedione. Surprisingly, the shift of the pK(a) of Lys 115 is not due to the proximity of Lys 116, the side chain of which is oriented away from the active site. Instead, Lys 116 participates in the structural anchoring of Lys 115 in a long, hydrophobic funnel provided by the novel fold of the enzyme. Thus, AADase perturbs the pK(a) of the nucleophile by means of a desolvation effect by placement of the side chain into the protein core while enforcing the proximity of polar residues, which facilitate decarboxylation through electrostatic and steric effects.	[Ho, Meng-Chiao; Menetret, Jean-Francois; Allen, Karen N.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Tsuruta, Hiro] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	Boston University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Allen, KN (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	drkallen@bu.edu	Allen, Karen N./J-7045-2019; Ho, Meng-Chiao/H-2448-2015	Allen, Karen N./0000-0001-7296-0551; Ho, Meng-Chiao/0000-0002-5424-4524	National Science Foundation; Offices of Biological and Environmental Research (BER); Basic Energy Sciences (BES) of the US Department of Energy (DOE); National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)	National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research (BER); Basic Energy Sciences (BES) of the US Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A. Murzin for provisional classification of the AADase fold and C. Akey for valuable advice on the execution and interpretation of the electron microscopy work. We also thank H. Robinson and A. Soares for help with data collection. This work was supported by a grant to K. N. A. from the National Science Foundation. Data for this study were measured at Beamlines X12B, X25 and X29A of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research (BER) and of Basic Energy Sciences (BES) of the US Department of Energy (DOE), and from the National Center for Research Resources (NCRR) of the National Institutes of Health (NIH). Small-angle X-ray scattering analyses were carried out at the Stanford Synchrotron Radiation Lightsource, funded by DOE, BES. The SSRL Structural Molecular Biology Program is supported by DOE, BER, and by NIH, NCRR. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CROSBY J, 1970, J AM CHEM SOC, V92, P2891, DOI 10.1021/ja00712a048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIDOVICH I, 1968, J BIOL CHEM, V243, P1043; FRIDOVICH I, 1962, J AM CHEM SOC, V84, P3208, DOI 10.1021/ja00875a050; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GarciaMoreno B, 1997, BIOPHYS CHEM, V64, P211, DOI 10.1016/S0301-4622(96)02238-7; Gerlt JA, 2007, NATURE, V447, P543, DOI 10.1038/447543a; HAMILTON GA, 1959, J AM CHEM SOC, V81, P6332, DOI 10.1021/ja01532a058; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; KOKESH FC, 1971, J AM CHEM SOC, V93, P7270, DOI 10.1021/ja00755a025; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURSEN RA, 1966, J AM CHEM SOC, V88, P3426, DOI 10.1021/ja00966a044; Lee JK, 1997, SCIENCE, V276, P942, DOI 10.1126/science.276.5314.942; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; O'Leary M. H., 1992, MECH CATALYSIS, P239; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RASHIN AA, 1985, J PHYS CHEM-US, V89, P5588, DOI 10.1021/j100272a006; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; STITES WE, 1991, J MOL BIOL, V221, P7, DOI 10.1016/0022-2836(91)90795-8; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1997, PROTEINS, V27, P110; TAGAKI W, 1968, BIOCHEMISTRY-US, V7, P891, DOI 10.1021/bi00843a001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tjioe E, 2007, J APPL CRYSTALLOGR, V40, P782, DOI 10.1107/S002188980702420X; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; WARREN S, 1966, BIOCHEMISTRY-US, V5, P817, DOI 10.1021/bi00867a002; WESTHEIMER FH, 1995, TETRAHEDRON, V51, P3, DOI 10.1016/0040-4020(94)00865-R; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988	39	78	81	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					393	U107		10.1038/nature07938	http://dx.doi.org/10.1038/nature07938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458715				2022-12-24	WOS:000266243700038
J	Powner, MW; Gerland, B; Sutherland, JD				Powner, Matthew W.; Gerland, Beatrice; Sutherland, John D.			Synthesis of activated pyrimidine ribonucleotides in prebiotically plausible conditions	NATURE			English	Article							NUCLEOSIDES; RNA; PHOSPHORYLATION; PHOSPHORUS; CHEMISTRY; PHOSPHATE; EVOLUTION; MINERALS; CYTIDINE; ORIGIN	At some stage in the origin of life, an informational polymer must have arisen by purely chemical means. According to one version of the 'RNA world' hypothesis(1-3) this polymer was RNA, but attempts to provide experimental support for this have failed(4,5). In particular, although there has been some success demonstrating that 'activated' ribonucleotides can polymerize to form RNA(6,7), it is far from obvious how such ribonucleotides could have formed from their constituent parts ( ribose and nucleobases). Ribose is difficult to form selectively(8,9), and the addition of nucleobases to ribose is inefficient in the case of purines(10) and does not occur at all in the case of the canonical pyrimidines(11). Here we show that activated pyrimidine ribonucleotides can be formed in a short sequence that bypasses free ribose and the nucleobases, and instead proceeds through arabinose amino-oxazoline and anhydronucleoside intermediates. The starting materials for the synthesis-cyanamide, cyanoacetylene, glycolaldehyde, glyceraldehyde and inorganic phosphate-are plausible prebiotic feedstock molecules(12-15), and the conditions of the synthesis are consistent with potential early-Earth geochemical models. Although inorganic phosphate is only incorporated into the nucleotides at a late stage of the sequence, its presence from the start is essential as it controls three reactions in the earlier stages by acting as a general acid/base catalyst, a nucleophilic catalyst, a pH buffer and a chemical buffer. For prebiotic reaction sequences, our results highlight the importance of working with mixed chemical systems in which reactants for a particular reaction step can also control other steps.	[Powner, Matthew W.; Gerland, Beatrice; Sutherland, John D.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester	Sutherland, JD (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	john.sutherland@manchester.ac.uk		Powner, Matthew/0000-0002-6368-3190	UK Engineering and Physical Sciences Research Council; EPSRC [EP/D05592X/1, EP/E032753/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E032753/1, EP/D05592X/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been funded by the UK Engineering and Physical Sciences Research Council through the provision of a postdoctoral fellowship ( B. G.) and a PhD studentship ( M. W. P.). We thank J. Raftery and M. Helliwell for X-ray crystallography.	Anastasi C, 2007, CHEM BIODIVERS, V4, P721, DOI 10.1002/cbdv.200790060; Anastasi C, 2006, ANGEW CHEM INT EDIT, V45, P6176, DOI 10.1002/anie.200601267; Bryant DE, 2006, CHEM COMMUN, P2344, DOI 10.1039/b602651f; COCKERILL AF, 1976, SYNTHESIS-STUTTGART, P591; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; ESCHENMOSER A, 1992, CHEM SOC REV, V21, P1, DOI 10.1039/cs9922100001; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; FERRIS JP, 1970, J AM CHEM SOC, V92, P6598, DOI 10.1021/ja00725a036; FULLER WD, 1972, J MOL BIOL, V67, P25, DOI 10.1016/0022-2836(72)90383-X; Joyce GF, 2006, COLD SPRING HARB MON, V43, P23; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kofoed J, 2005, ORG BIOMOL CHEM, V3, P1850, DOI 10.1039/b501512j; LOHRMANN R, 1968, SCIENCE, V161, P64, DOI 10.1126/science.161.3836.64; LOHRMANN R, 1971, SCIENCE, V171, P490, DOI 10.1126/science.171.3970.490; MILLER N, 1968, P NATL ACAD SCI USA, V59, P34, DOI 10.1073/pnas.59.1.34; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pasek MA, 2005, ASTROBIOLOGY, V5, P515, DOI 10.1089/ast.2005.5.515; Powner MW, 2007, CHEMBIOCHEM, V8, P1170, DOI 10.1002/cbic.200700098; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; ROBERTSON MP, 1995, NATURE, V375, P772, DOI 10.1038/375772a0; SANCHEZ R A, 1970, Journal of Molecular Biology, V47, P531, DOI 10.1016/0022-2836(70)90320-7; SANCHEZ RA, 1966, SCIENCE, V154, P784, DOI 10.1126/science.154.3750.784; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SHANNAHOFF DH, 1973, J ORG CHEM, V38, P593, DOI 10.1021/jo00943a040; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; TAPIERO CM, 1971, NATURE, V231, P42, DOI 10.1038/231042a0; Thaddeus P, 2006, PHILOS T R SOC B, V361, P1681, DOI 10.1098/rstb.2006.1897; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; Woese C, 1967, GENETIC CODE, P179	30	789	811	15	408	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					239	242		10.1038/nature08013	http://dx.doi.org/10.1038/nature08013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	445FR	19444213				2022-12-24	WOS:000266036100038
J	Dunleavy, EM; Roche, D; Tagami, H; Lacoste, N; Ray-Gallet, D; Nakamura, Y; Daigo, Y; Nakatani, Y; Almouzni-Pettinotti, G				Dunleavy, Elaine M.; Roche, Daniele; Tagami, Hideaki; Lacoste, Nicolas; Ray-Gallet, Dominique; Nakamura, Yusuke; Daigo, Yataro; Nakatani, Yoshihiro; Almouzni-Pettinotti, Genevieve			HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres	CELL			English	Article							HISTONE H3 VARIANT; FISSION YEAST SCM3; BUDDING YEAST; CHROMATIN; PROTEIN; KINETOCHORE; COMPLEX; NUCLEOSOME; CHAPERONE; DNA	The histone H3 variant CenH3, called CENP-A in humans, is central in centromeric chromatin to ensure proper chromosome segregation. In the absence of an underlying DNA sequence, it is still unclear how CENP-A deposition at centromeres is determined. Here, we purified non-nucleosomal CENP-A complexes to identify direct CENP-A partners involved in such a mechanism and identified HJURP. HJURP was not detected in H3.1- or H3.3-containing complexes, indicating its specificity for CENP- A. HJURP centromeric localization is cell cycle regulated, and its transient appearance at the centromere coincides precisely with the proposed time window for new CENP- A deposition. Furthermore, HJURP downregulation leads to a major reduction in CENP-A at centromeres and impairs deposition of newly synthesized CENP-A, causing mitotic defects. We conclude that HJURP is a key factor for CENP-A deposition and maintenance at centromeres.	[Dunleavy, Elaine M.; Roche, Daniele; Lacoste, Nicolas; Ray-Gallet, Dominique; Almouzni-Pettinotti, Genevieve] Inst Curie, CNRS, Lab Nucl Dynam & Genome Plast, UMR218, F-75248 Paris 05, France; [Tagami, Hideaki; Nakatani, Yoshihiro] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Aichi 4678501, Japan; [Nakamura, Yusuke; Daigo, Yataro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1130033, Japan	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Nagoya City University; University of Tokyo	Almouzni-Pettinotti, G (corresponding author), Inst Curie, CNRS, Lab Nucl Dynam & Genome Plast, UMR218, 26 Rue Ulm, F-75248 Paris 05, France.	genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021; Ray-Gallet, Dominique/A-9224-2019	Almouzni, Genevieve/0000-0001-5570-0723; Daigo, Yataro/0000-0002-0915-3025	ANR [NT05-4_42267, PCV06_142302]; Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue); PIC Programs; European Commission Network of Excellence Epigenome [LSHG-CT-2004-503433]; Canceropole IdF "Breast cancer and Epigenetics'' [ACI-2007]	ANR(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue)(Institut National du Cancer (INCA) France); PIC Programs; European Commission Network of Excellence Epigenome(European CommissionEuropean Commission Joint Research Centre); Canceropole IdF "Breast cancer and Epigenetics''	We thank W. Earnshaw for CENP-C antibodies, Y. Tang for prediction on HJURP sequence, C. Baldeyron and P. LeBaccon for microscopy, D. Filipescu for GST-HJURP protein, J.P. Quivy and A. Cook for critical reading. This work and E. M. D. were supported by ANR "CenRNA'' NT05-4_42267 and ANR "FaRC'' PCV06_142302, la Ligue Nationale contre le Cancer (Equipe labellise'e la Ligue), PIC Programs ("Retinoblastome and "Replication, Instabilite chromosomique et cancer''), the European Commission Network of Excellence Epigenome (LSHG-CT-2004-503433), ACI-2007-Canceropole IdF "Breast cancer and Epigenetics.''	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; BLOWER MD, 2002, NAT REV MOL CELL BIO, V3, P575; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Ekwall K, 2007, ANNU REV GENET, V41, P63, DOI 10.1146/annurev.genet.41.110306.130127; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; SHELBY RD, 2000, GENE DEV, V22, P1313; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	64	453	462	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					485	497		10.1016/j.cell.2009.02.040	http://dx.doi.org/10.1016/j.cell.2009.02.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410545	Bronze			2022-12-24	WOS:000265677200018
J	Miyauchi, K; Kim, Y; Latinovic, O; Morozov, V; Melikyan, GB				Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.			HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; MEMBRANE-FUSION; T-CELLS; ENVELOPE GLYCOPROTEIN; PLASMA-MEMBRANE; VIRION FUSION; TYPE-1 ENTRY; INFECTION; CD4	Enveloped viruses that rely on a low pH-dependent step for entry initiate infection by fusing with acidic endosomes, whereas the entry sites for pH-independent viruses, such as HIV-1, have not been defined. These viruses have long been assumed to fuse directly with the plasma membrane. Here we used population-based measurements of the viral content delivery into the cytosol and time-resolved imaging of single viruses to demonstrate that complete IV-1 fusion occurred in endosomes. In contrast, viral fusion with the plasma membrane did not progress beyond the lipid mixing step. HIV-1 underwent receptor-mediated internalization long before endosomal fusion, thus minimizing the surface exposure of conserved viral epitopes during fusion and reducing the efficacy of inhibitors targeting these epitopes. We also show that, strikingly, endosomal fusion is sensitive to a dynamin inhibitor, dynasore. These findings imply that HIV-1 infects cells via endocytosis and envelope glycoprotein- and dynamin-dependent fusion with intracellular compartments.	[Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke; Kim, Yuri; Latinovic, Olga; Morozov, Vladimir; Melikyan, Gregory B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Melikyan, GB (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	gmelikian@ihv.umaryland.edu	Serei, Virian D/B-4616-2015	Vladimir, Morozov/0000-0001-6587-572X; Morozov, Vladimir/0000-0001-7013-7115	NIH AIDS Research and Reference Reagent Program [R01 GM054787, AI053668]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	NIH AIDS Research and Reference Reagent Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Dr. T. Kirchhausen for dynasore and to Drs. C. Aiken, M. Alizon, J. Binley, J. Cunningham, M. Kielian, G. Lewis, M. Lu, W. Mothes, J. Strizki, L. Wang, and J. Young, as well as the NIH AIDS Research and Reference Reagent Program for reagents, expression vectors, and cell lines. We thank Dr. M. Reitz for his help in designing the MA-GFP-CA construct and Drs. L. Chernomordik and R. Dutch for stimulating discussions. This work was supported by NIH R01 GM054787 and AI053668 grants to G.B.M. Y.K. was partially supported by the SDG from the American Heart Association.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Marsh M, 1997, J CELL SCI, V110, P95; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; PAUZA CD, 1988, J CELL BIOL, V107, P959, DOI 10.1083/jcb.107.3.959; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	47	496	508	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					433	444		10.1016/j.cell.2009.02.046	http://dx.doi.org/10.1016/j.cell.2009.02.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410541	Green Accepted, Bronze			2022-12-24	WOS:000265677200014
J	Ohinata, Y; Ohta, H; Shigeta, M; Yamanaka, K; Wakayama, T; Saitou, M				Ohinata, Yasuhide; Ohta, Hiroshi; Shigeta, Mayo; Yamanaka, Kaori; Wakayama, Teruhiko; Saitou, Mitinori			A Signaling Principle for the Specification of the Germ Cell Lineage in Mice	CELL			English	Article							ANTERIOR VISCERAL ENDODERM; EARLY MOUSE EMBRYO; EXTRAEMBRYONIC ECTODERM; AXIS FORMATION; GENERATION; REQUIREMENT; DYNAMICS; PROLIFERATION; GASTRULATION; ANTAGONISTS	Specification of the germ cell lineage is vital to development and heredity. In mice, the germ cell fate is induced in pluripotent epiblast cells by signaling molecules, yet the underlying mechanism remains unknown. Here we demonstrate that germ cell fate in the epiblast is a direct consequence of Bmp4 signaling from the extraembryonic ectoderm (ExE), which is antagonized by the anterior visceral endoderm (AVE). Strikingly, Bmp8b from the ExE restricts AVE development, thereby contributing to Bmp4 signaling. Furthermore, Wnt3 in the epiblast ensures its responsiveness to Bmp4. Serum-free, defined cultures revealed that, in response to Bmp4, competent epiblast cells uniformly expressed key transcriptional regulators Blimp1 and Prdm14 and acquired germ-cell properties, including genome-wide epigenetic reprogramming, in an orderly fashion. Notably, the induced cells contributed to both spermatogenesis and fertility of offspring. By identifying a signaling principle in germ cell specification, our study establishes a robust strategy for reconstituting the mammalian germ cell lineage in vitro.	[Ohinata, Yasuhide; Shigeta, Mayo; Yamanaka, Kaori; Saitou, Mitinori] RIKEN, Kobe Inst, Ctr Dev Biol, Chuo Ku,Lab Mammalian Germ Cell Biol, Kobe, Hyogo 6500047, Japan; [Ohta, Hiroshi; Wakayama, Teruhiko] RIKEN, Kobe Inst, Ctr Dev Biol, Chuo Ku,Lab Genom Reprogramming, Kobe, Hyogo 6500047, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; RIKEN; Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@cdb.riken.jp	Ohta, Hiroshi/C-3375-2009		MEXT of Japan; JST.	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST.(Japan Science & Technology Agency (JST))	We thank B. Hogan and K. Lawson, K. Hayashi, R. Behringer, M. Nomura and En Li, and M. Yamamoto and H. Hamada, for the mutant mice for Bmp4, Smad1, Wnt3, Smad2, and FoxH1, respectively, and M. Okabe for the acro/act-EGFP transgenic strain. We also thank S. Aizawa and P. Q. Thomas for Cer1 and Hex probes, respectively. We are grateful to the Animal Resources and Genetic Engineering Units for their support in deriving and maintaining the mice, and to the Genome Resource and Analysis Unit for their support in DNA sequencing. We thank D. Sipp for his help in manuscript preparation. Y.O. is a fellow in the Special Postdoctoral Researchers Program of RIKEN. This study was supported in part by a Grant-in-Aid from the MEXT of Japan, and by a PRESTO project grant from the JST.	Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; Nagy A., 2003, MANIPULATING MOUSE E; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, J PHYS CHEM A, V112, P11306, DOI 10.1021/jp805593m; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173	39	351	372	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					571	584		10.1016/j.cell.2009.03.014	http://dx.doi.org/10.1016/j.cell.2009.03.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410550	Bronze			2022-12-24	WOS:000265677200025
J	Choi, CM; Vilain, S; Langen, M; Van Kelst, S; De Geest, N; Yan, J; Verstreken, P; Hassan, BA				Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.			Conditional Mutagenesis in Drosophila	SCIENCE			English	Article							GENE		[Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Dev Genet, B-3000 Louvain, Belgium; [Langen, Marion; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Cognit Neurosci, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Hassan, BA (corresponding author), VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	Bassem.Hassan@med.kuleuven.be	Vilain, Sven/AHA-7944-2022; Hassan, Bassem A/D-5221-2012; Verstreken, Patrik/AAC-7591-2022	Hassan, Bassem A/0000-0001-9533-4908; Verstreken, Patrik/0000-0002-5073-5393; Langen, Marion/0000-0001-6109-6593	VIB; Impuls; CREA; GOA; K. U. Leuven [G.0542.08N, G.0543.08N]; FWO [G.0542.08N, G.0543.08N]; Marie Curie [MEXT-CT-2006-042267]; Flemish government	VIB; Impuls; CREA; GOA; K. U. Leuven(KU Leuven); FWO(FWO); Marie Curie(European Commission); Flemish government(European Commission)	We thank A. Jarman, H. Bellen, M. Calos, J. Bischof, K. Basler, J. Bateman, T. Wu, A. Roebroeck, as well as the Developmental Studies Hybridoma Bank (DSHB) and the Bloomington Stock Center, for sharing flies and reagents. We thank X. Quan, S. Aerts, J. Kasprowicz, and S. Kuenen for useful discussion and technical assistance. This work was supported by VIB (B.A.H., P.V.), and Impuls, CREA, and GOA (Geconcerteerd Onderzoeks Acties) grants from K. U. Leuven and FWO (Fonds Wetenschaplijke Onderzoek) grants G.0542.08N and G.0543.08N to B.A.H. as well as Research fund K. U. Leuven, and a Marie Curie Excellence grant (MEXT-CT-2006-042267) to P.V. S.V. was partially supported by a K.U. Leuven Methusalem grant from the Flemish government. pSTAR GenBank accession number is FJ710212.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Rooke JE, 2000, METH MOL B, V137, P15; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426	6	41	41	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					54	54		10.1126/science.1168275	http://dx.doi.org/10.1126/science.1168275			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342580				2022-12-24	WOS:000264802100028
J	Alberti, S; Halfmann, R; King, O; Kapila, A; Lindquist, S				Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan			A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRIONS; HET-S; ENVIRONMENTAL-STRESS; GENETIC-VARIATION; AMYLOID FIBRILS; SUP35 PROTEIN; PSI+ PRION; RICH PRION; IN-VITRO	Prions are proteins that convert between structurally and functionally distinct states, one or more of which is transmissible. In yeast, this ability allows them to act as non-Mendelian elements of phenotypic inheritance. To further our understanding of prion biology, we conducted a bioinformatic proteome-wide survey for prionogenic proteins in S. cerevisiae, followed by experimental investigations of 100 prion candidates. We found an unexpected amino acid bias in aggregation-prone candidates and discovered that 19 of these could also form prions. At least one of these prion proteins, Mot3, produces a bona fide prion in its natural context that increases population-level phenotypic heterogeneity. The self-perpetuating states of these proteins present a vast source of heritable phenotypic variation that increases the adaptability of yeast populations to diverse environments.	[Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Halfmann, Randal; Kapila, Atul; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [King, Oliver] Boston Biomed Res Inst, Watertown, MA 02472 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston Biomedical Research Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Alberti, Simon/0000-0003-4017-6505; Halfmann, Randal/0000-0002-6592-1471	G. Harold and Leila Y. Mathers Foundation; NIH [GM025874]; HHMI; Deutsche Forschungsgemeinschaft (DFG); NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the G. Harold and Leila Y. Mathers Foundation, NIH grant GM025874, and HHMI. S.A. was supported by a fellowship of the Deutsche Forschungsgemeinschaft (DFG). R.H. was supported by a fellowship of the NSF. We are grateful to Ndubuisi Azubuine and Tsering Nanchung for constant supply of plates and media. We thank Sherwin Chan and Gerald Fink for contributing the URA3-HIS5 plasmid. We thank Jijun Dong for assisting with TEM, and members of the Lindquist lab for critical reading of the manuscript.	Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grishin AV, 1998, GENETICS, V149, P879; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King OD, 2007, THEOR POPUL BIOL, V72, P560, DOI 10.1016/j.tpb.2007.08.006; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mrsa V, 1999, J BACTERIOL, V181, P3076, DOI 10.1128/JB.181.10.3076-3086.1999; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Saupe SJ, 2000, CURR OPIN MICROBIOL, V3, P608, DOI 10.1016/S1369-5274(00)00148-X; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Tuite M, 2008, BIOCHEM SOC T, V36, P1083, DOI 10.1042/BST0361083; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	77	701	715	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					146	158		10.1016/j.cell.2009.02.044	http://dx.doi.org/10.1016/j.cell.2009.02.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345193	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000264813300021
J	Gros, J; Feistel, K; Viebahn, C; Blum, M; Tabin, CJ				Gros, Jerome; Feistel, Kerstin; Viebahn, Christoph; Blum, Martin; Tabin, Clifford J.			Cell Movements at Hensen's Node Establish Left/Right Asymmetric Gene Expression in the Chick	SCIENCE			English	Article							EMBRYO; CILIA	In vertebrates, the readily apparent left/right (L/R) anatomical asymmetries of the internal organs can be traced to molecular events initiated at or near the time of gastrulation. However, the earliest steps of this process do not seem to be universally conserved. In particular, how this axis is first defined in chicks has remained problematic. Here we show that asymmetric cell rearrangements take place within chick embryos, creating a leftward movement of cells around the node. It is the relative displacement of cells expressing sonic hedgehog (Shh) and fibroblast growth factor 8 (Fgf8) that is responsible for establishing their asymmetric expression patterns. The creation of asymmetric expression domains as a passive effect of cell movements represents an alternative strategy for breaking L/R symmetry in gene activity.	[Gros, Jerome; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Feistel, Kerstin; Blum, Martin] Univ Hohenheim, Inst Zool, D-70953 Stuttgart, Germany; [Viebahn, Christoph] Univ Gottingen, Dept Anat & Embryol, D-37079 Gottingen, Germany	Harvard University; Harvard Medical School; University Hohenheim; University of Gottingen	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Feistel, Kerstin/0000-0003-3397-8972; Gros, Jerome/0000-0002-2264-2851	Human Frontier Science Program fellowship; Ph.D. fellowship from the Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft (DFG) [VI 151-8-1]; NIH [R01-HD045499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045499] Funding Source: NIH RePORTER	Human Frontier Science Program fellowship(Human Frontier Science Program); Ph.D. fellowship from the Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Levin for helpful suggestions for addressing the role of ion channels, R. ORahilly for providing information regarding human embryos, D. Rath and P. Schwarts for provision of pig embros and assistance with electron microscopy; and C. Cui, C. Little, and B. Rongish for discussing data before publication. This work was supported by a Human Frontier Science Program fellowship to J.G., a Ph.D. fellowship from the Boehringer Ingelheim Fonds to K.F., a grant from the Deutsche Forschungsgemeinschaft (DFG) to M.B., a grant from the DFG (VI 151-8-1) to C.V., and grant R01-HD045499 from NIH to C.J.T.	Cui C, 2009, ANAT REC, V292, P557, DOI 10.1002/ar.20872; Dathe V, 2002, ANAT EMBRYOL, V205, P343, DOI 10.1007/s00429-002-0269-2; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; HERTWIG O, 1910, LEHRBUCH ENGWICKLUNG; Kirby ML, 2003, DEV BIOL, V253, P175, DOI 10.1016/S0012-1606(02)00024-6; Kolliker A, 1879, ENTWICKLUNGSGESCHICH; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; O'Rahilly R. R, 2006, EMBRYONIC HUMAN BRAI; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Wei L, 2001, DEVELOPMENT, V128, P2953; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464	15	126	128	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					941	944		10.1126/science.1172478	http://dx.doi.org/10.1126/science.1172478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359542	Green Accepted			2022-12-24	WOS:000266048800040
J	Smith, KF; Behrens, M; Schloegel, LM; Marano, N; Burgiel, S; Daszak, P				Smith, Katherine F.; Behrens, Michael; Schloegel, Lisa M.; Marano, Nina; Burgiel, Stas; Daszak, Peter			Reducing the Risks of the Wildlife Trade	SCIENCE			English	Editorial Material							MONKEYPOX		[Smith, Katherine F.] Brown Univ, Providence, RI 02912 USA; [Smith, Katherine F.; Schloegel, Lisa M.; Daszak, Peter] Wildlife Trust, New York, NY 10001 USA; [Behrens, Michael] Pacific Lutheran Univ, Tacoma, WA 98447 USA; [Schloegel, Lisa M.] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England; [Marano, Nina] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Burgiel, Stas] Global Invas Species Programme, Alexandria, VA 22301 USA	Brown University; Pacific Lutheran University; Kingston University; Centers for Disease Control & Prevention - USA	Smith, KF (corresponding author), Brown Univ, Providence, RI 02912 USA.	katherine_smith@brown.edu; daszak@wildlifetrust.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695				Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Defenders of Wildlife, 2007, BROK SCREENS REG LIV; DEPOORTER M, 2008, IN DEPTH REV ONGOING; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Fowler AJ, 2007, FRONT ECOL ENVIRON, V5, P353, DOI 10.1890/1540-9295(2007)5[353:FOTLAT]2.0.CO;2; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; SCHLOEGEL LM, BIOL CONSER IN PRESS; Vitousek PM, 1996, AM SCI, V84, P468; 2003, FED REG, V68, P36566	15	171	179	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					594	595		10.1126/science.1174460	http://dx.doi.org/10.1126/science.1174460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439DW	19407185				2022-12-24	WOS:000265608800025
J	Singh, R; Kaushik, S; Wang, YJ; Xiang, YQ; Novak, I; Komatsu, M; Tanaka, K; Cuervo, AM; Czaja, MJ				Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Komatsu, Masaaki; Tanaka, Keiji; Cuervo, Ana Maria; Czaja, Mark J.			Autophagy regulates lipid metabolism	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TRIACYLGLYCEROL; LIPOLYSIS; DISEASE; STRESS; CYP2E1; ROLES; LIVER	The intracellular storage and utilization of lipids are critical to maintain cellular energy homeostasis. During nutrient deprivation, cellular lipids stored as triglycerides in lipid droplets are hydrolysed into fatty acids for energy. A second cellular response to starvation is the induction of autophagy, which delivers intracellular proteins and organelles sequestered in double-membrane vesicles (autophagosomes) to lysosomes for degradation and use as an energy source. Lipolysis and autophagy share similarities in regulation and function but are not known to be interrelated. Here we show a previously unknown function for autophagy in regulating intracellular lipid stores (macrolipophagy). Lipid droplets and autophagic components associated during nutrient deprivation, and inhibition of autophagy in cultured hepatocytes and mouse liver increased triglyceride storage in lipid droplets. This study identifies a critical function for autophagy in lipid metabolism that could have important implications for human diseases with lipid over-accumulation such as those that comprise the metabolic syndrome.	[Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Novak, Inna] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Tokyo Metropolitan Institute of Medical Science	Czaja, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	amcuervo@aecom.yu.edu; czaja@aecom.yu.edu	Komatsu, Masaaki/B-8321-2011; Kaushik, Susmita/GVS-3186-2022; Novak, Inna/ABF-9575-2020	Komatsu, Masaaki/0000-0001-7672-7722; Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087776, R01DK061498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, P01AG031782] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Silver for his discussions, N. Mizushima for providing the Atg5<SUP>-/-</SUP> mouse embryonic fibroblasts, R. Stockert for the protein disulphide isomerase antibody and the personnel at the Analytical Imaging Facility for their technical assistance. This work was supported by National Institutes of Health grants from the National Institute of Diabetes and Digestive and Kidney Diseases and National Institute on Aging, a Glenn Award and an American Liver Foundation Postdoctoral Research Fellowship Award (R.S.).	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	35	2527	2643	24	536	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1131	U64		10.1038/nature07976	http://dx.doi.org/10.1038/nature07976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339967	Green Accepted, Green Submitted			2022-12-24	WOS:000265754600039
J	Gradinaru, V; Mogri, M; Thompson, KR; Henderson, JM; Deisseroth, K				Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Henderson, Jaimie M.; Deisseroth, Karl			Optical Deconstruction of Parkinsonian Neural Circuitry	SCIENCE			English	Article							DEEP-BRAIN-STIMULATION; MOTOR CORTEX STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; TREATMENT-RESISTANT DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; BASAL GANGLIA; MOVEMENT-DISORDERS; IN-VIVO; TRANSGENIC MICE; DISEASE	Deep brain stimulation (DBS) is a therapeutic option for intractable neurological and psychiatric disorders, including Parkinson's disease and major depression. Because of the heterogeneity of brain tissues where electrodes are placed, it has been challenging to elucidate the relevant target cell types or underlying mechanisms of DBS. We used optogenetics and solid-state optics to systematically drive or inhibit an array of distinct circuit elements in freely moving parkinsonian rodents and found that therapeutic effects within the subthalamic nucleus can be accounted for by direct selective stimulation of afferent axons projecting to this region. In addition to providing insight into DBS mechanisms, these results demonstrate an optical approach for dissection of disease circuitry and define the technological toolbox needed for systematic deconstruction of disease circuits by selectively controlling individual components.	[Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gradinaru, Viviana] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu		Henderson, Jaimie/0000-0002-3276-2267	Kinetics Foundation; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF; National Institute of Mental Health; National Institute on Drug Abuse; NIH Pioneer Award; SGF; SIGF; Bio-X; NARSAD; John Blume Foundation; Davis Phinney Foundation	Kinetics Foundation; William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SGF; SIGF; Bio-X; NARSAD(NARSAD); John Blume Foundation; Davis Phinney Foundation	K.D. is supported by the Kinetics Foundation, the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, and the Wallace Coulter Foundation, as well as by California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, NSF, National Institute of Mental Health, National Institute on Drug Abuse, and the NIH Pioneer Award. V.G. is supported by SGF and SIGF (Stanford Graduate Fellowships). M.M is supported by Bio-X and SGF Fellowships. K.R.T. is supported by NARSAD. J.M.H is supported by the Coulter Foundation, the John Blume Foundation and the Davis Phinney Foundation. We especially thank A. M. Aravanis for mentoring and advice on animal surgery and in vivo recordings, F. Zhang and H. C. Tsai for assistance with Cre-dependent opsin targeting, L. Meltzer for useful discussion, advice and help on immunohistochemistry, G. Feng and G. Augustine for collaboration on generation of the Thy-1 mice (available at the Jackson Laboratory), and V. Sohal for help with power spectra analysis. We also thank the entire Deisseroth lab for useful discussions. The materials and methods described herein are freely distributed and supported by the authors (www.stanford.edu/group/dlab).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arle JE, 2008, J NEUROSURG, V109, P133, DOI 10.3171/JNS/2008/109/7/0133; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Canavero S, 2000, MOVEMENT DISORD, V15, P169, DOI 10.1002/1531-8257(200001)15:1<169::AID-MDS1030>3.0.CO;2-W; Cilia R, 2007, MOVEMENT DISORD, V22, P111, DOI 10.1002/mds.21207; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2002, MOVEMENT DISORD, V17, pS63, DOI 10.1002/mds.10143; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gross RE, 2008, CLIN NEUROPHYSIOL, V119, P1947, DOI 10.1016/j.clinph.2008.06.003; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Liu Y, 2008, NEUROSCI BIOBEHAV R, V32, P343, DOI 10.1016/j.neubiorev.2006.10.007; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Matsuya T, 2007, J PHARMACOL SCI, V103, P329, DOI 10.1254/jphs.SCZ070058; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; McNeely HE, 2008, J NERV MENT DIS, V196, P405, DOI 10.1097/NMD.0b013e3181710927; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pagni C A, 2003, J Neurosurg Sci, V47, P189; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rezai AR, 2008, NEUROSURGERY, V62, P809, DOI [10.1227/01.NEU.0000297003.12598.89, 10.1227/01.neu.0000316285.52865.53]; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; RIVKEES SA, 1995, BRAIN RES, V677, P193, DOI 10.1016/0006-8993(95)00062-U; Shen KZ, 2003, NEUROSCIENCE, V116, P99, DOI 10.1016/S0306-4522(02)00656-5; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; Strafella AP, 2007, MOVEMENT DISORD, V22, P2113, DOI 10.1002/mds.21691; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang L., UNPUB; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	58	1084	1140	7	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					354	359		10.1126/science.1167093	http://dx.doi.org/10.1126/science.1167093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19299587	Green Accepted			2022-12-24	WOS:000265221600033
J	Rahighi, S; Ikeda, F; Kawasaki, M; Akutsu, M; Suzuki, N; Kato, R; Kensche, T; Uejima, T; Bloor, S; Komander, D; Randow, F; Wakatsuki, S; Dikic, I				Rahighi, Simin; Ikeda, Fumiyo; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Kensche, Tobias; Uejima, Tamami; Bloor, Stuart; Komander, David; Randow, Felix; Wakatsuki, Soichi; Dikic, Ivan			Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappa B Activation	CELL			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; BINDING DOMAINS; IKK-GAMMA; COMPLEX; IMMUNODEFICIENCY; TURNOVER; REQUIRES; REVEALS	Activation of nuclear factor-kappa B (NF-kappa B), a key mediator of inducible transcription in immunity, requires binding of NF-kappa B essential modulator (NEMO) to ubiquitinated substrates. Here, we report that the UBAN (ubiquitin binding in ABIN and NEMO) motif of NEMO selectively binds linear (head-to-tail) ubiquitin chains. Crystal structures of the UBAN motif revealed a parallel coiled-coil dimer that formed a heterotetrameric complex with two linear diubiquitin molecules. The UBAN dimer contacted all four ubiquitin moieties, and the integrity of each binding site was required for efficient NF-kappa B activation. Binding occurred via a surface on the proximal ubiquitin moiety and the canonical Ile44 surface on the distal one, thereby providing specificity for linear chain recognition. Residues of NEMO involved in binding linear ubiquitin chains are required for NF-kappa B activation by TNF-alpha and other agonists, providing an explanation for the detrimental effect of NEMO mutations in patients suffering from X-linked ectodermal dysplasia and immunodeficiency.	[Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Uejima, Tamami; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Kato, Ryuichi; Wakatsuki, Soichi] Grad Univ Adv Studies, Kanagawa 2400193, Japan; [Ikeda, Fumiyo; Kensche, Tobias; Dikic, Ivan] Univ Frankfurt, Inst Biochem & Cluster Excellence Frankfurt 2, Sch Med, D-60590 Frankfurt, Main, Germany; [Ikeda, Fumiyo; Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Akutsu, Masato; Bloor, Stuart; Komander, David; Randow, Felix] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Dikic, Ivan] Univ Split, Dept Immunol, Sch Med, Split 21000, Croatia	High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Goethe University Frankfurt; MRC Laboratory Molecular Biology; University of Split	Wakatsuki, S (corresponding author), High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan.	soichi.wakatsuki@kek.jp; ivan.dikic@biochem2.de	akutsu, masato/L-4095-2016; Ikeda, Fumiyo/AAD-3770-2020; Suzuki, Nobuhiro/M-7238-2015; Uejima, Tamami/C-4128-2017; Dikic, Ivan/O-4650-2015	akutsu, masato/0000-0002-9839-3345; Ikeda, Fumiyo/0000-0003-0407-2768; Suzuki, Nobuhiro/0000-0001-8420-5852; Dikic, Ivan/0000-0001-8156-9511; Kato, Ryuichi/0000-0003-2087-2896; Wakatsuki, Soichi/0000-0001-5896-7968	Deutsche Forschungsgemeinschaft [EXC115]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MRC [MC_U105192732, MC_U105170648] Funding Source: UKRI; Medical Research Council [MC_U105170648, MC_U105192732] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Marc Schmidt-Supprian for the NEMO-KOMEFs used in this study. We are thankful to Kazuhiro Iwai for sharing results prior to publication of the manuscripts. We thank Caroline Grabbe, Daniela Hoeller, and the members of our labs for discussions, constructive comments, and critical reading of the manuscript. I. F. is a postdoctoral fellow of the Japan Society for the Promotion of Science. This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I. D., and partly by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to M. K. and Target Protein Research Program of the MEXT to S. W.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	35	545	565	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1098	1109		10.1016/j.cell.2009.03.007	http://dx.doi.org/10.1016/j.cell.2009.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303852	Bronze			2022-12-24	WOS:000264403900015
J	Funakoshi, M; Tomko, RJ; Kobayashi, H; Hochstrasser, M				Funakoshi, Minoru; Tomko, Robert J., Jr.; Kobayashi, Hideki; Hochstrasser, Mark			Multiple Assembly Chaperones Govern Biogenesis of the Proteasome Regulatory Particle Base	CELL			English	Article							26 S-PROTEASOME; 20S PROTEASOME; PROTEIN-DEGRADATION; ATPASE SUBUNITS; YEAST; COMPLEX; IDENTIFICATION; RECOGNITION; DESTRUCTION; ACTIVATION	The central protease of eukaryotes, the 26S proteasome, has a 20S proteolytic core particle (CP) and an attached 19S regulatory particle ( RP). The RP is further subdivided into lid and base subcomplexes. Little is known about RP assembly. Here, we show that four conserved assembly factors govern biogenesis of the yeast RP base. Nas2 forms a complex with the Rpt4 and Rpt5 ATPases and enhances 26S proteasome formation in vivo and in vitro. Other RP subcomplexes contain Hsm3, which is related to mammalian proteasome subunit S5b. Hsm3 also contributes to base assembly. Larger Hsm3-containing complexes include two additional proteins, Nas6 and Rpn14, which function as assembly chaperones as well. Specific deletion combinations affecting these four factors cause severe perturbations to RP assembly. Our results demonstrate that proteasomal RP biogenesis requires multiple, functionally overlapping chaperones and suggest a model in which subunits form specific subcomplexes that then assemble into the base.	[Funakoshi, Minoru; Tomko, Robert J., Jr.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama 7008530, Japan	Yale University; Okayama University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Tomko Jr., Robert/0000-0003-2515-1078; Hochstrasser, Mark/0000-0002-1131-5484	Japan Society for the Promotion of Science Postdoctoral Fellowship; National Institutes of Health [GM046904, GM083050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083050, R37GM046904, R01GM046904] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Enenkel, D. Finley, T. Kodadek, W. Tansey, and D. H. Wolf for antibodies and A. Kusmierczyk and M. Kunjappu for comments on the manuscript. M. F. was supported in part by a Japan Society for the Promotion of Science Postdoctoral Fellowship. This work was supported initially by National Institutes of Health grant GM046904 and more recently by GM083050 to M. H.	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Fedorova IV, 2000, GENETICS, V154, P495; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; GUTHRIE C, 2002, GUIDE YEAST GENETICS, V350; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Heinemeyer W, 2004, CELL MOL LIFE SCI, V61, P1562, DOI 10.1007/s00018-004-4130-z; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1996, J BIOL CHEM, V271, P32810, DOI 10.1074/jbc.271.51.32810; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Whitby FG, 2007, STRUCTURE, V15, P137, DOI 10.1016/j.str.2007.01.009	41	127	136	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					887	899		10.1016/j.cell.2009.04.061	http://dx.doi.org/10.1016/j.cell.2009.04.061			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446322	Green Accepted, Bronze			2022-12-24	WOS:000266454800019
J	Tirosh, I; Reikhav, S; Levy, AA; Barkai, N				Tirosh, Itay; Reikhav, Sharon; Levy, Avraham A.; Barkai, Naama			A Yeast Hybrid Provides Insight into the Evolution of Gene Expression Regulation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; DROSOPHILA; PATTERNS; CIS	During evolution, novel phenotypes emerge through changes in gene expression, but the genetic basis is poorly understood. We compared the allele-specific expression of two yeast species and their hybrid, which allowed us to distinguish changes in regulatory sequences of the gene itself (cis) from changes in upstream regulatory factors (trans). Expression divergence between species was generally due to changes in cis. Divergence in trans reflected a differential response to the environment and explained the tendency of certain genes to diverge rapidly. Hybrid-specific expression, deviating from the parental range, occurred through novel cis-trans interactions or, more often, through modified trans regulation associated with environmental sensing. These results provide insights on the regulatory changes in cis and trans during the divergence of species and upon hybridization.	[Reikhav, Sharon; Levy, Avraham A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Tirosh, Itay; Reikhav, Sharon; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Levy, AA (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	avi.levy@weizmann.ac.il; naama.barkai@weizmann.ac.il			Helen and Martin Kimmel Award for Innovative Investigations; Kahn Fund for Systems Biology at the Weizmann Institute of Science; Israeli Ministry of Science; Bi-national Science Foundation; European Research Council	Helen and Martin Kimmel Award for Innovative Investigations; Kahn Fund for Systems Biology at the Weizmann Institute of Science; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Bi-national Science Foundation(US-Israel Binational Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank J. Berman, Y. Eshed, N. Sigal, A. Sheperberg, and members of our groups for discussions and comments. This work was supported by the Helen and Martin Kimmel Award for Innovative Investigations and grants from the Kahn Fund for Systems Biology at the Weizmann Institute of Science, the Israeli Ministry of Science, the Bi-national Science Foundation, and the European Research Council (Ideas) (to N.B). A.A.L. holds the Gilbert de Botton chair of Plant Science. Microarray data has been deposited at the Gene Expression Omnibus with accession number GSE14708 [NCBI GEO] .	Brown KM, 2008, MOL ECOL, V17, P2985, DOI 10.1111/j.1365-294X.2008.03765.x; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Wang DY, 2007, GENOME RES, V17, P1161, DOI 10.1101/gr.6328907; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	18	275	276	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					659	662		10.1126/science.1169766	http://dx.doi.org/10.1126/science.1169766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407207				2022-12-24	WOS:000265608800050
J	Soucy, TA; Smith, PG; Milhollen, MA; Berger, AJ; Gavin, JM; Adhikari, S; Brownell, JE; Burke, KE; Cardin, DP; Critchley, S; Cullis, CA; Doucette, A; Garnsey, JJ; Gaulin, JL; Gershman, RE; Lublinsky, AR; McDonald, A; Mizutani, H; Narayanan, U; Olhava, EJ; Peluso, S; Rezaei, M; Sintchak, MD; Talreja, T; Thomas, MP; Traore, T; Vyskocil, S; Weatherhead, GS; Yu, J; Zhang, J; Dick, LR; Claiborne, CF; Rolfe, M; Bolen, JB; Langston, SP				Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.			An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer	NATURE			English	Article							NEDD8 CONJUGATION PATHWAY; KAPPA-B-ALPHA; UBIQUITIN LIGASE; DNA-DAMAGE; G(2)/M CHECKPOINT; ACTIVATING ENZYME; CELL-CYCLE; DEGRADATION; CDT1; COMPLEX	The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.	[Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Soucy, TA (corresponding author), Millennium Pharmaceut Inc, 40 Landsdowne St, Cambridge, MA 02139 USA.	teresa.soucy@mpi.com	Dick, Lawrence/ABA-8831-2021; Zhang, Julie/GQH-2525-2022	Dick, Larry/0000-0002-6880-0405				Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; BLOCH A, 1971, BIOCHEMISTRY-US, V10, P4394, DOI 10.1021/bi00800a007; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1982, J BIOL CHEM, V257, P329; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wilkinson KD, 2005, P NATL ACAD SCI USA, V102, P15280, DOI 10.1073/pnas.0504842102; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	46	1326	1381	8	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 9	2009	458	7239					732	U67		10.1038/nature07884	http://dx.doi.org/10.1038/nature07884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	433GZ	19360080				2022-12-24	WOS:000265193600033
J	Carreira, A; Hilario, J; Amitani, I; Baskin, RJ; Shivji, MKK; Venkitaraman, AR; Kowalczykowski, SC				Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Shivji, Mahmud K. K.; Venkitaraman, Ashok R.; Kowalczykowski, Stephen C.			The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51	CELL			English	Article							HOMOLOGY-DIRECTED REPAIR; REPLICATION PROTEIN-A; FILAMENT FORMATION; STRAND EXCHANGE; RECOMBINATION; PROMOTES; COMPLEX; CANCER; STABILIZATION; MEDIATOR	The breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair. BRCA2 delivers RAD51 to double-stranded DNA (dsDNA) breaks through interaction with eight conserved, similar to 35 amino acid motifs, the BRC repeats. Here we show that the solitary BRC4 promotes assembly of RAD51 onto single-stranded DNA (ssDNA), but not dsDNA, to stimulate DNA strand exchange. BRC4 acts by blocking ATP hydrolysis and thereby maintaining the active ATP-bound form of the RAD51-ssDNA filament. Single-molecule visualization shows that BRC4 does not disassemble RAD51-dsDNA filaments but rather blocks nucleation of RAD51 onto dsDNA. Furthermore, this behavior is manifested by a domain of BRCA2 comprising all eight BRC repeats. These results establish that the BRC repeats modulate RAD51-DNA interaction in two opposing but functionally reinforcing ways: targeting active RAD51 to ssDNA and prohibiting RAD51 nucleation onto dsDNA. Thus, BRCA2 recruits RAD51 to DNA breaks and, we propose, the BRC repeats regulate DNA-binding selectivity.	[Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Shivji, Mahmud K. K.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 0XZ, England	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Carreira, Aura/0000-0001-5489-4343	NIH [GM-62653, GM-64745]; Ministerio de Educacion y Ciencia (Spain); Susan G. Komen postdoctoral fellowship [PDF0707927]; U. K. Medical Research Council; MRC [G9900064, G0700651, G0600332, MC_U105359877] Funding Source: UKRI; Medical Research Council [G0700651, G9900064, G0600332, MC_U105359877] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R01GM064745, R37GM062653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Ryan Jensen for providing us with the full-length BRCA2 construct and to all the members of the Kowalczykowski lab (Jason Bell, Petr Cejka, Anthony Forget, Ryan Jensen, Taeho Kim, Edgar Valencia-Morales, Amitabh Nimonkar, Jody Plank, Katsumi Morimatsu, Behzad Rad, Jason Wong, Rebecca Wright, and Liang Yang) for insightful comments on the manuscript. This work was supported by NIH grants (GM-62653 and GM-64745) to S. C. K., a postdoctoral fellowship from Ministerio de Educacion y Ciencia (Spain) to A. C., a Susan G. Komen postdoctoral fellowship (PDF0707927) to J. H., and funds from the U. K. Medical Research Council to M. K. K. S. and A. R. V. We thank Owen Davies and Luca Pellegrini for BRCA2BRC1-8 purification.	Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Kim HK, 2002, GENES CELLS, V7, P1125, DOI 10.1046/j.1365-2443.2002.00588.x; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nomme J, 2008, GENES CELLS, V13, P471, DOI 10.1111/j.1365-2443.2008.01180.x; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	34	169	178	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1032	1043		10.1016/j.cell.2009.02.019	http://dx.doi.org/10.1016/j.cell.2009.02.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303847	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000264403900010
J	Volkow, ND; Fowler, JS; Logan, J; Alexoff, D; Zhu, W; Telang, F; Wang, GJ; Jayne, M; Hooker, JM; Wong, C; Hubbard, B; Carter, P; Warner, D; King, P; Shea, C; Xu, YW; Muench, L; Apelskog-Torres, K				Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Alexoff, David; Zhu, Wei; Telang, Frank; Wang, Gene-Jack; Jayne, Millard; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Muench, Lisa; Apelskog-Torres, Karen			Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED WAKEFULNESS; DOUBLE-BLIND; ORAL METHYLPHENIDATE; C-11 RACLOPRIDE; BLOOD-FLOW; BINDING; DRUG; PET; AMPHETAMINE; INCREASES	Context Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer. Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent preclinical studies suggest otherwise. Objective To measure the acute effects of modafinil at doses used therapeutically (200 mg and 400 mg given orally) on extracellular dopamine and on dopamine transporters in the male human brain. Design, Setting, and Participants Positron emission tomography with [C-11] raclopride (D-2/D-3 radioligand sensitive to changes in endogenous dopamine) and [C-11] cocaine (dopamine transporter radioligand) was used to measure the effects of modafinil on extracellular dopamine and on dopamine transporters in 10 healthy male participants. The study took place over an 8-month period (2007-2008) at Brookhaven National Laboratory. Main Outcome Measures Primary outcomes were changes in dopamine D-2/D-3 receptor and dopamine transporter availability (measured by changes in binding potential) after modafinil when compared with after placebo. Results Modafinil decreased mean (SD) [C-11] raclopride binding potential in caudate (6.1% [6.5%]; 95% confidence interval [CI], 1.5% to 10.8%; P = .02), putamen (6.7% [4.9%]; 95% CI, 3.2% to 10.3%; P = .002), and nucleus accumbens (19.4% [20%]; 95% CI, 5% to 35%; P = .02), reflecting increases in extracellular dopamine. Modafinil also decreased [C-11] cocaine binding potential in caudate (53.8% [13.8%]; 95% CI, 43.9% to 63.6%; P < .001), putamen (47.2% [11.4%]; 95% CI, 39.1% to 55.4%; P < .001), and nucleus accumbens (39.3% [10%]; 95% CI, 30% to 49%; P = .001), reflecting occupancy of dopamine transporters. Conclusions In this pilot study, modafinil blocked dopamine transporters and increased dopamine in the human brain ( including the nucleus accumbens). Because drugs that increase dopamine in the nucleus accumbens have the potential for abuse, and considering the increasing use of modafinil, these results highlight the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Jayne, Millard; Muench, Lisa] NIAAA, Bethesda, MD USA; [Fowler, Joanna S.; Logan, Jean; Alexoff, David; Wang, Gene-Jack; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Apelskog-Torres, Karen] Brookhaven Natl Lab, Upton, NY 11973 USA; [Fowler, Joanna S.; Wang, Gene-Jack] Mt Sinai Sch Med, New York, NY USA; [Fowler, Joanna S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Hooker, Jacob M/P-5716-2018	Hooker, Jacob M/0000-0002-9394-7708; Logan, Jean/0000-0002-6993-9994	Brookhaven National Laboratory [DE-AC02-98CH10886]; Office of Biological and Environmental Research; National Institutes of Health [K05DA020001]; National Institute on Alcohol Abuse; Alcoholism Intramural research program [F32EB997320]; National Institute of Biomedical Imaging and Bioengineering; General Research Clinical Centers [MO1RR10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001] Funding Source: NIH RePORTER	Brookhaven National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); General Research Clinical Centers; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out at Brookhaven National Laboratory under contract DE-AC02-98CH10886 with the US Department of Energy with infrastructure support from its Office of Biological and Environmental Research. Support was also provided by grant K05DA020001 (J.S.F.) from the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism Intramural research program, grant F32EB997320 (J.M.H.) from the National Institute of Biomedical Imaging and Bioengineering, and grant MO1RR10710 from the General Research Clinical Centers. A Goldhaber distinguished fellowship provided support for Dr Hooker.	ALEXOFF DL, 1995, NUCL MED BIOL, V22, P893, DOI 10.1016/0969-8051(95)00042-V; [Anonymous], 2007, NATURE, V450, P320, DOI 10.1038/450320a; Biederman J, 2006, J CLIN PSYCHIAT, V67, P727, DOI 10.4088/JCP.v67n0506; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; EHRIN E, 1987, J LABELLED COMPD RAD, V24, P931, DOI 10.1002/jlcr.2580240808; Ferraro L, 1997, BIOL PSYCHIAT, V42, P1181, DOI 10.1016/S0006-3223(97)00353-3; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Gjedde A, 2005, INT REV NEUROBIOL, V63, P1, DOI 10.1016/S0074-7742(05)63001-2; Gold LH, 1996, PSYCHOPHARMACOLOGY, V126, P286, DOI 10.1007/BF02247379; Greenhill LL, 2006, PEDIATR ANN, V35, P552, DOI 10.3928/0090-4481-20060801-07; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Kruszewski SP, 2006, AM J PSYCHIAT, V163, P549, DOI 10.1176/appi.ajp.163.3.549; Kruszewski SP, 2007, J CLIN PSYCHIAT, V68, P970, DOI 10.4088/JCP.v68n0624b; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995, DOI 10.1038/jcbfm.1994.132; MACNAIR DM, 1971, EDITS MANUAL PROFILE; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Myrick Hugh, 2004, Ann Clin Psychiatry, V16, P101, DOI 10.1080/10401230490453743; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; SAS Institute Inc, SAS STAT 9 2 US GUID; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Stoops WW, 2005, PSYCHOPHARMACOLOGY, V182, P186, DOI 10.1007/s00213-005-0044-1; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; 2006, 2006 PHYS DESK REFER, P1002	38	372	377	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1148	1154		10.1001/jama.2009.351	http://dx.doi.org/10.1001/jama.2009.351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293415	Green Published, Green Accepted			2022-12-24	WOS:000264244200020
J	Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; Fisher, AG; Merkenschlager, M				Hadjur, Suzana; Williams, Luke M.; Ryan, Natalie K.; Cobb, Bradley S.; Sexton, Tom; Fraser, Peter; Fisher, Amanda G.; Merkenschlager, Matthias			Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus	NATURE			English	Article							CCCTC-BINDING FACTOR; GENE-EXPRESSION; CELL DIFFERENTIATION; INTERFERON-GAMMA; CONTROL REGION; CTCF; TRANSCRIPTION; CHROMATIN; CONFORMATION; GENOME	Cohesin-mediated sister chromatid cohesion is essential for chromosome segregation and post-replicative DNA repair(1,2). In addition, evidence from model organisms(3-6) and from human genetics(7) suggests that cohesin is involved in the control of gene expression(8,9). This non-canonical role has recently been rationalized by the findings that mammalian cohesin complexes are recruited to a subset of DNase I hypersensitive sites and to conserved noncoding sequences by the DNA-binding protein CTCF10-13. CTCF functions at insulators (which control interactions between enhancers and promoters) and at boundary elements (which demarcate regions of distinct chromatin structure)(14), and cohesin contributes to its enhancer-blocking activity(10,11). The underlying mechanisms remain unknown, and the full spectrum of cohesin functions remains to be determined. Here we show that cohesin forms the topological and mechanistic basis for cell-type-specific long-range chromosomal interactions in cis at the developmentally regulated cytokine locus IFNG. Hence, the ability of cohesin to constrain chromosome topology is used not only for the purpose of sister chromatid cohesion(1,2), but also to dynamically define the spatial conformation of specific loci. This new aspect of cohesin function is probably important for normal development(3-6) and disease(7).	[Hadjur, Suzana; Williams, Luke M.; Ryan, Natalie K.; Cobb, Bradley S.; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Sexton, Tom; Fraser, Peter] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England	Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Merkenschlager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk	Fraser, Peter/B-7549-2009; Ryan, Natalie K/H-1539-2011	Merkenschlager, Matthias/0000-0003-2889-3288; Sexton, Thomas/0000-0002-7824-1846; Fraser, Peter/0000-0002-0041-1227	Medical Research Council, UK; BBSRC [BBS/E/B/0000C151] Funding Source: UKRI; MRC [MC_U120027516, G117/530] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C151] Funding Source: researchfish; Medical Research Council [G117/530, MC_U120027516] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Messi, F. Sallusto and L. Bruno for help and advice with human T cells, L. Aragon for discussions, M. Leleu and M. Spivakov for help with informatics, D. Dormann for help with image analysis and E. Ng, E. O'Connor and P. Hexley for cell sorting. Supported by the Medical Research Council, UK.	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Gause M, 2008, BIOESSAYS, V30, P715, DOI 10.1002/bies.20787; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	30	396	404	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2009	460	7253					410	U130		10.1038/nature08079	http://dx.doi.org/10.1038/nature08079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470MO	19458616	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000267979000042
J	Nakagawa, T; Lomb, DJ; Haigis, MC; Guarente, L				Nakagawa, Takashi; Lomb, David J.; Haigis, Marcia C.; Guarente, Leonard			SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle	CELL			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; RAT-LIVER MITOCHONDRIA; CALORIE RESTRICTION; LIFE-SPAN; LYSINE ACETYLATION; CELL-SURVIVAL; SACCHAROMYCES-CEREVISIAE; GLUTAMATE-DEHYDROGENASE; CAENORHABDITIS-ELEGANS; DEPENDENT DEACETYLASE	Sirtuins are NAD-dependent protein deacetylases that connect metabolism and aging. In mammals, there are seven sirtuins (SIRT1-7), three of which are associated with mitochondria. Here, we show that SIRT5 localizes in the mitochondrial matrix and interacts with carbamoyl phosphate synthetase 1 (CPS1), an enzyme, catalyzing the initial step of the urea cycle for ammonia detoxification and disposal. SIRT5 deacetylates CPS1 and upregulates its activity. During fasting, NAD in liver mitochondria increases, thereby triggering SIRT5 deacetylation of CPS1 and adaptation to the increase in amino acid catabolism. Indeed, SIRT5 KO mice fail to upregulate CPS1 activity and show elevated blood ammonia during fasting. Similar effects occur during long-term calorie restriction or a high protein diet. These findings demonstrate SIRT5 plays a pivotal role in ammonia detoxification and disposal by activating CPS1.	[Nakagawa, Takashi; Guarente, Leonard] MIT, Paul F Glenn Lab Sci Aging, Cambridge, MA 02139 USA; [Nakagawa, Takashi; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lomb, David J.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lomb, David J.; Haigis, Marcia C.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Guarente, L (corresponding author), MIT, Paul F Glenn Lab Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605	Human Frontier Science Program; National Institutes of Health (NIH); Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING [R01AG011119, R01AG015339] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Eric Bell, Huan-chung Chang, Sergiy Libert, and Gizem Donmez for reading the manuscript and Shin-ichiro Imai for valuable comments. We also thank Fred Alt, David Lombard and Raul Mostovslavsky for sharing the SIRT5 KO mice, Danica Chen for SIRT3 KO mice, Jun-ichi Miyazaki for the gift of pCAG plasmid and Su-Ju Lin for technical comments on NAD/NADH measurement. This work was supported by a grant from Human Frontier Science Program to T. N. and grants from the National Institutes of Health (NIH) and the Paul F. Glenn Foundation to L.G. L.G. is a consultant for Sirtris Pharmaceuticals.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; EXTON JH, 1972, J BIOL CHEM, V247, P4996; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Nuzum CT, 1976, UREA CYCLE, P325; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; SCHIMKE RT, 1962, J BIOL CHEM, V237, P1921; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stanley CA, 2004, MOL GENET METAB, V81, pS45, DOI 10.1016/j.ymgme.2003.10.013; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wraith JE, 2001, ARCH DIS CHILD, V84, P84, DOI 10.1136/adc.84.1.84; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yefimenko I, 2005, J MOL BIOL, V349, P127, DOI 10.1016/j.jmb.2005.03.078; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	58	557	586	5	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					560	570		10.1016/j.cell.2009.02.026	http://dx.doi.org/10.1016/j.cell.2009.02.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410549	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000265677200024
J	Badis, G; Berger, MF; Philippakis, AA; Talukder, S; Gehrke, AR; Jaeger, SA; Chan, ET; Metzler, G; Vedenko, A; Chen, XY; Kuznetsov, H; Wang, CF; Coburn, D; Newburger, DE; Morris, Q; Hughes, TR; Bulyk, ML				Badis, Gwenael; Berger, Michael F.; Philippakis, Anthony A.; Talukder, Shaheynoor; Gehrke, Andrew R.; Jaeger, Savina A.; Chan, Esther T.; Metzler, Genita; Vedenko, Anastasia; Chen, Xiaoyu; Kuznetsov, Hanna; Wang, Chi-Fong; Coburn, David; Newburger, Daniel E.; Morris, Quaid; Hughes, Timothy R.; Bulyk, Martha L.			Diversity and Complexity in DNA Recognition by Transcription Factors	SCIENCE			English	Article							BINDING SPECIFICITIES; GENE-REGULATION; PROTEIN; SEQUENCE; REPRESSOR; IDENTIFICATION; MICROARRAYS; EXPRESSION; DOMAIN; SITES	Sequence preferences of DNA binding proteins are a primary mechanism by which cells interpret the genome. Despite the central importance of these proteins in physiology, development, and evolution, comprehensive DNA binding specificities have been determined experimentally for only a few proteins. Here, we used microarrays containing all 10-base pair sequences to examine the binding specificities of 104 distinct mouse DNA binding proteins representing 22 structural classes. Our results reveal a complex landscape of binding, with virtually every protein analyzed possessing unique preferences. Roughly half of the proteins each recognized multiple distinctly different sequence motifs, challenging our molecular understanding of how proteins interact with their DNA binding sites. This complexity in DNA recognition may be important in gene regulation and in the evolution of transcriptional regulatory networks.	[Badis, Gwenael; Talukder, Shaheynoor; Chen, Xiaoyu; Coburn, David; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Berger, Michael F.; Philippakis, Anthony A.; Gehrke, Andrew R.; Jaeger, Savina A.; Newburger, Daniel E.; Bulyk, Martha L.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Berger, Michael F.; Philippakis, Anthony A.; Bulyk, Martha L.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Talukder, Shaheynoor; Chan, Esther T.; Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Metzler, Genita; Kuznetsov, Hanna] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vedenko, Anastasia] Wellesley Coll, Dept Biol, Wellesley, MA 02481 USA; [Wang, Chi-Fong] MIT, Dept Phys, Cambridge, MA 02139 USA; [Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Morris, Quaid; Hughes, Timothy R.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of Toronto; Massachusetts Institute of Technology (MIT); Wellesley College; Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto; Harvard University; Brigham & Women's Hospital	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	t.hughes@utoronto.ca; mlbulyk@receptor.med.harvard.edu	Morris, Quaid/ABE-8343-2020; Badis-Breard, Gwenael/AAE-3783-2019	Badis-Breard, Gwenael/0000-0003-2078-3076; Chan, Esther/0000-0002-2406-2623; Morris, Quaid/0000-0002-2760-6999	Canadian Institutes of Health Research [MOP-77721]; Genome Canada through the Ontario Genomics Institute; Ontario Research Fund; Canadian Institute for Advanced Research; NSF; Canadian Foundation for Innovation; NIH/National Human Genome Research Institute [R01 HG003985]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NSF(National Science Foundation (NSF)); Canadian Foundation for Innovation(Canada Foundation for Innovation); NIH/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by funding from the Canadian Institutes of Health Research (MOP-77721 and postdoctoral fellowship to G.B.); Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund, and the Canadian Institute for Advanced Research (to T.R.H.); NSF (to M.F.B.); the Canadian Foundation for Innovation and Ontario Research Fund (to Q.M.); and grant R01 HG003985 from NIH/National Human Genome Research Institute (to M.L.B.). We thank L. Pena-Castillo, A. Cheung, M. Chan, S. Bhinder, F. Breard, P. Qureshi, S. Mnaimneh, M. Kekis, F. Khalid, J. Holroyd, D. Terterov, and K. Robasky for technical assistance and S. Gisselbrecht, K. Struhl, and S. Sunyaev for critical reading of the manuscript. PBM data are available at http://the_brain.bwh.harvard.edu/pbms/webworks/ and also via the publicly available UniPROBE database (31).	BARASH Y, 2003, P 7 ANN INT C COMP C; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bosher JM, 1996, ONCOGENE, V13, P1701; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lee MLT, 2002, BIOMETRICS, V58, P981, DOI 10.1111/j.0006-341X.2002.00981.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	33	689	700	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2009	324	5935					1720	1723		10.1126/science.1162327	http://dx.doi.org/10.1126/science.1162327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462GE	19443739	Green Accepted			2022-12-24	WOS:000267338200043
J	Yun, MH; Hiom, K				Yun, Maximina H.; Hiom, Kevin			CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; END RESECTION; MAMMALIAN-CELLS; DAMAGE; BRCA1; CTIP; DOMAINS; PROTEIN; GENE; LINE	The repair of DNA double-strand breaks (DSBs) is tightly regulated during the cell cycle. In G1 phase, the absence of a sister chromatid means that repair of DSBs occurs through non-homologous end-joining or microhomology-mediated end-joining (MMEJ)(1). These pathways often involve loss of DNA sequences at the break site and are therefore error-prone. In late S and G2 phases, even though DNA end-joining pathways remain functional(2), there is an increase in repair of DSBs by homologous recombination, which is mostly error-free(3,4). Consequently, the relative contribution of these different pathways to DSB repair in the cell cycle has a large influence on the maintenance of genetic integrity. It has remained unknown how DSBs are directed for repair by different, potentially competing, repair pathways. Here we identify a role for CtIP (also known as RBBP8) in this process in the avian B-cell line DT40. We establish that CtIP is required not only for repair of DSBs by homologous recombination in S/G2 phase but also for MMEJ in G1. The function of CtIP in homologous recombination, but not MMEJ, is dependent on the phosphorylation of serine residue 327 and recruitment of BRCA1. Cells expressing CtIP protein that cannot be phosphorylated at serine 327 are specifically defective in homologous recombination and have a decreased level of single-stranded DNA after DNA damage, whereas MMEJ remains unaffected. Our data support a model in which phosphorylation of serine 327 of CtIP as cells enter S phase and the recruitment of BRCA1 functions as a molecular switch to shift the balance of DSB repair from error-prone DNA end-joining to error-free homologous recombination.	[Yun, Maximina H.; Hiom, Kevin] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hiom, K (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	hiom@mrc-lmb.cam.ac.uk		Yun, Maximina/0000-0001-9019-2453	Medical Research Council [MC_U105184300, U.1051.03.005(78826)] Funding Source: Medline; MRC [MC_U105184300] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	21	378	386	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					460	U184		10.1038/nature07955	http://dx.doi.org/10.1038/nature07955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19357644	Green Accepted			2022-12-24	WOS:000266243700053
J	Sato, T; Vries, RG; Snippert, HJ; van de Wetering, M; Barker, N; Stange, DE; van Es, JH; Abo, A; Kujala, P; Peters, PJ; Clevers, H				Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Abo, Arie; Kujala, Pekka; Peters, Peter J.; Clevers, Hans			Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche	NATURE			English	Article							SMALL-INTESTINE; EPITHELIAL-CELLS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INHIBITION; CULTURES; GROWTH; COLON; MICE	The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently demonstrated the presence of about six cycling Lgr(5+) stem cells at the bottoms of small-intestinal crypts(1). Here we describe the establishment of long-term culture conditions under which single crypts undergo multiple crypt fission events, while simultanously generating villus-like epithelial domains in which all differentiated cell types are present. Single sorted Lgr(5+) stem cells can also initiate these crypt-villus organoids. Tracing experiments indicate that the Lgr(5+) stem-cell hierarchy is maintained in organoids. We conclude that intestinal crypt-villus units are self-organizing structures, which can be built from a single stem cell in the absence of a non-epithelial cellular niche.	[Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Abo, Arie] Nuvelo Inc, San Carlos, CA 94070 USA; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Sato, Toshiro/J-3522-2014; Stange, Daniel E/O-1837-2015; van+Es, Johan/ABD-5411-2021	Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137; Stange, Daniel E/0000-0003-4246-2230; 				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; EVANS GS, 1992, J CELL SCI, V101, P219; FUKAMACHI H, 1992, J CELL SCI, V103, P511; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kedinger M, 1998, ANN NY ACAD SCI, V859, P1, DOI 10.1111/j.1749-6632.1998.tb11107.x; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sasaki T, 2002, EXP CELL RES, V275, P185, DOI 10.1006/excr.2002.5499; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	30	3823	3997	54	590	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					262	U147		10.1038/nature07935	http://dx.doi.org/10.1038/nature07935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19329995				2022-12-24	WOS:000266036100043
J	Saini, P; Eyler, DE; Green, R; Dever, TE				Saini, Preeti; Eyler, Daniel E.; Green, Rachel; Dever, Thomas E.			Hypusine-containing protein eIF5A promotes translation elongation	NATURE			English	Article							SYNTHESIS INITIATION-FACTORS; YEAST; PURIFICATION; MECHANISM; BINDING; CELLS; GENE	Translation elongation factors facilitate protein synthesis by the ribosome. Previous studies identified two universally conserved translation elongation factors, EF-Tu in bacteria (known as eEF1A in eukaryotes) and EF-G (eEF2), which deliver aminoacyl-tRNAs to the ribosome and promote ribosomal translocation, respectively(1). The factor eIF5A (encoded by HYP2 and ANB1 in Saccharomyces cerevisiae), the sole protein in eukaryotes and archaea to contain the unusual amino acid hypusine (N-epsilon-(4-amino-2-hydroxybutyl)lysine)(2), was originally identified based on its ability to stimulate the yield (endpoint) of methionylpuromycin synthesis-a model assay for first peptide bond synthesis thought to report on certain aspects of translation initiation(3,4). Hypusine is required for eIF5A to associate with ribosomes(5,6) and to stimulate methionyl-puromycin synthesis(7). Because eIF5A did not stimulate earlier steps of translation initiation(8), and depletion of eIF5A in yeast only modestly impaired protein synthesis(9), it was proposed that eIF5A function was limited to stimulating synthesis of the first peptide bond or that eIF5A functioned on only a subset of cellular messenger RNAs. However, the precise cellular role of eIF5A is unknown, and the protein has also been linked to mRNA decay, including the nonsense-mediated mRNA decay pathway(10,11), and to nucleocytoplasmic transport(12,13). Here we use molecular genetic and biochemical studies to show that eIF5A promotes translation elongation. Depletion or inactivation of eIF5A in the yeast S. cerevisiae resulted in the accumulation of polysomes and an increase in ribosomal transit times. Addition of recombinant eIF5A from yeast, but not a derivative lacking hypusine, enhanced the rate of tripeptide synthesis in vitro. Moreover, inactivation of eIF5A mimicked the effects of the eEF2 inhibitor sordarin, indicating that eIF5A might function together with eEF2 to promote ribosomal translocation. Because eIF5A is a structural homologue of the bacterial protein EF-P-14,P-15, we propose that eIF5A/EF-P is a universally conserved translation elongation factor.	[Saini, Preeti; Dever, Thomas E.] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Eyler, Daniel E.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Johns Hopkins University	Dever, TE (corresponding author), NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@nih.gov	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678	HHMI; NIH; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Acknowledgements We thank T. G. Kinzy for providing anti-yeast eEF1A, eEF2 and eEF3 antisera, as well as constructs for the purification of eEF2 and eEF3; J. Lorsch for providing constructs for purification of yeast initiation factors; J. Dinmann for frameshifting reporter vectors, and A. Hinnebusch, T. G. Kinzy, A. Jivotovskaya, D. Shelton, C. Grant, J. Lorsch and members of the Dever and Hinnebusch laboratories for comments and discussion. Salary support provided by HHMI (R. G.) and NIH (D. E. E.). This work was supported in part by the Intramural Research Program of the NIH, NICHD (to T. E. D.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Anand M, 2003, J BIOL CHEM, V278, P6985, DOI 10.1074/jbc.M209224200; BENNE R, 1978, J BIOL CHEM, V253, P3078; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Harger JW, 2001, VIROLOGY, V286, P216, DOI 10.1006/viro.2001.0997; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; KANG HA, 1994, J BIOL CHEM, V269, P3934; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; PARK MH, 1991, J BIOL CHEM, V266, P7988; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Schrader R, 2006, J BIOL CHEM, V281, P35336, DOI 10.1074/jbc.M601460200; SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; SMIRNOV VN, 1976, FEBS LETT, V66, P12, DOI 10.1016/0014-5793(76)80573-X; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195; Zhang SA, 1997, RNA, V3, P234; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	35	294	308	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					118	U129		10.1038/nature08034	http://dx.doi.org/10.1038/nature08034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424157	Green Accepted			2022-12-24	WOS:000265801300041
J	Aller, SG; Yu, J; Ward, A; Weng, Y; Chittaboina, S; Zhuo, RP; Harrell, PM; Trinh, YT; Zhang, QH; Urbatsch, IL; Chang, G				Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey			Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding	SCIENCE			English	Article							ABC TRANSPORTER; MULTIDRUG-RESISTANCE; CASSETTE TRANSPORTER; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; PURIFICATION; CONFORMATION; RECOGNITION; MECHANISMS; MICROSCOPY	P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chemically unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers. Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors. The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of similar to 6000 angstroms cubed with a 30 angstrom separation of the two nucleotide-binding domains. Two additional P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and aromatic interactions. Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry. The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.	[Aller, Stephen G.; Yu, Jodie; Weng, Yue; Chittaboina, Srinivas; Zhang, Qinghai; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ward, Andrew] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA; [Weng, Yue] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China	Scripps Research Institute; Scripps Research Institute; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Wuhan University	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB105, La Jolla, CA 92037 USA.	gchang@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Weng, Yue/0000-0001-9126-3321; Aller, Stephen/0000-0003-0379-5534	Army [W81XWH-05-1-0316]; NIH [GM61905, GM078914, GM073197]; Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078914, R01GM061905, P50GM073197] Funding Source: NIH RePORTER	Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees, I. Wilson, R. H. Spencer, M. B. Stowell, A. Senior, A. Frost, V. M. Unger, C. D. Stout, and P. Wright. Y. Weng was supported by a scholarship from P. R. China. We thank Stanford Synchrotron Radiation Lightsource, Advanced Light Source, and Advanced Photon Source. This work was supported by grants from the Army (W81XWH-05-1-0316), NIH (GM61905, GM078914, and GM073197), the Beckman Foundation, the Skaggs Chemical Biology Foundation, Jasper L. and Jack Denton Wilson Foundation, the Southwest Cancer and Treatment Center, and the Norton B. Gilula Fellowship. Coordinates and structure factors deposited to the Protein DataBank (PDB accession codes 3G5U, 3G60, and 3G61).	*AM CANC SOC HOM, 2007, GLOB CANC FACTS FIG; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	32	1506	1566	7	453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1718	1722		10.1126/science.1168750	http://dx.doi.org/10.1126/science.1168750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325113	Green Accepted			2022-12-24	WOS:000264559800037
J	Boothroyd, CE; Dreesen, O; Leonova, T; Ly, KI; Figueiredo, LM; Cross, GAM; Papavasiliou, FN				Boothroyd, Catharine E.; Dreesen, Oliver; Leonova, Tatyana; Ly, K. Ina; Figueiredo, Luisa M.; Cross, George A. M.; Papavasiliou, F. Nina			A yeast-endonuclease-generated DNA break induces antigenic switching in Trypanosoma brucei	NATURE			English	Article							VSG EXPRESSION SITE; AFRICAN TRYPANOSOMES; SURFACE-ANTIGENS; GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; SEQUENCES; COPIES; END	Trypanosoma brucei is the causative agent of African sleeping sickness in humans and one of the causes of nagana in cattle. This protozoan parasite evades the host immune system by antigenic variation, a periodic switching of its variant surface glycoprotein (VSG) coat. VSG switching is spontaneous and occurs at a rate of about 10(-2)-10(-3) per population doubling in recent isolates from nature, but at a markedly reduced rate (10(-5)-10(-6)) in laboratory-adapted strains(1-3). VSG switching is thought to occur predominantly through gene conversion, a form of homologous recombination initiated by a DNA lesion that is used by other pathogens (for example, Candida albicans, Borrelia sp. and Neisseria gonorrhoeae) to generate surface protein diversity, and by B lymphocytes of the vertebrate immune system to generate antibody diversity. Very little is known about the molecular mechanism of VSG switching in T. brucei. Here we demonstrate that the introduction of a DNA double-stranded break (DSB) adjacent to the similar to 70-base-pair ( bp) repeats upstream of the transcribed VSG gene increases switching in vitro similar to 250-fold, producing switched clones with a frequency and features similar to those generated early in an infection. We were also able to detect spontaneous DSBs within the 70-bp repeats upstream of the actively transcribed VSG gene, indicating that a DSB is a natural intermediate of VSG gene conversion and that VSG switching is the result of the resolution of this DSB by break-induced replication.	[Boothroyd, Catharine E.; Leonova, Tatyana; Ly, K. Ina; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA; [Dreesen, Oliver; Figueiredo, Luisa M.; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA.	papavas@rockefeller.edu	Cross, George A M/B-7444-2011; Figueiredo, Luisa Miranda/C-3908-2018; Dreesen, Oliver/AAJ-2132-2020	Cross, George A M/0000-0003-1374-6955; Figueiredo, Luisa Miranda/0000-0002-5752-6586; 	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01AI021729]; C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation; Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI085973] Funding Source: NIH RePORTER	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the C. H. Revson Foundation ( to C. E. B.), the German National Academic Foundation ( to K. I. L.), the Otto Ritter Foundation ( to K. I. L.), the W. M. Keck Foundation ( to F. N. P.), the Irma T. Hirschl Foundation ( to F. N. P.) and by grant number R01AI021729 from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health ( to G. A. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH.	Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; DELANGE T, 1985, EMBO J, V4, P3299, DOI 10.1002/j.1460-2075.1985.tb04080.x; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, EUKARYOT CELL, V5, P2114, DOI 10.1128/EC.00059-06; Dreesen O, 2006, MOL CELL BIOL, V26, P4911, DOI 10.1128/MCB.00212-06; Glover L, 2008, NUCLEIC ACIDS RES, V36, P2608, DOI 10.1093/nar/gkn104; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HOEIJMAKERS JHJ, 1980, NATURE, V284, P78, DOI 10.1038/284078a0; Horn D, 1997, MOL BIOCHEM PARASIT, V84, P189, DOI 10.1016/S0166-6851(96)02794-6; Horn D, 2004, CURR MOL MED, V4, P563, DOI 10.2174/1566524043360078; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	30	107	108	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					278	U168		10.1038/nature07982	http://dx.doi.org/10.1038/nature07982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19369939	Green Accepted			2022-12-24	WOS:000266036100047
J	Sessions, OM; Barrows, NJ; Souza-Neto, JA; Robinson, TJ; Hershey, CL; Rodgers, MA; Ramirez, JL; Dimopoulos, G; Yang, PL; Pearson, JL; Garcia-Blanco, MA				Sessions, October M.; Barrows, Nicholas J.; Souza-Neto, Jayme A.; Robinson, Timothy J.; Hershey, Christine L.; Rodgers, Mary A.; Ramirez, Jose L.; Dimopoulos, George; Yang, Priscilla L.; Pearson, James L.; Garcia-Blanco, Mariano A.			Discovery of insect and human dengue virus host factors	NATURE			English	Article							WEST-NILE-VIRUS; ALPHA-GLUCOSIDASE INHIBITORS; JAPANESE ENCEPHALITIS-VIRUS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; ENDOCYTIC PATHWAY; BAFILOMYCIN A1; INFECTED-CELLS; AEDES-AEGYPTI	Dengue fever is the most frequent arthropod-borne viral disease of humans, with almost half of the world's population at risk of infection(1). The high prevalence, lack of an effective vaccine, and absence of specific treatment conspire to make dengue fever a global public health threat(1,2). Given their compact genomes, dengue viruses (DENV-1-4) and other flaviviruses probably require an extensive number of host factors; however, only a limited number of human, and an even smaller number of insect host factors, have been identified(3-10). Here we identify insect host factors required for DENV-2 propagation, by carrying out a genome-wide RNA interference screen in Drosophila melanogaster cells using a well-established 22,632 double-stranded RNA library. This screen identified 116 candidate dengue virus host factors (DVHFs). Although some were previously associated with flaviviruses (for example, V-ATPases and alpha-glucosidases)(3-5,7,9,10), most of the DVHFs were newly implicated in dengue virus propagation. The dipteran DVHFs had 82 readily recognizable human homologues and, using a targeted short-interfering-RNA screen, we showed that 42 of these are human DVHFs. This indicates notable conservation of required factors between dipteran and human hosts. This work suggests new approaches to control infection in the insect vector and the mammalian host.	[Sessions, October M.; Robinson, Timothy J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Sessions, October M.; Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Duke RNAi Facil, Durham, NC 27710 USA; [Barrows, Nicholas J.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Program Mol Canc Biol, Durham, NC 27710 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Hershey, Christine L.; Rodgers, Mary A.; Yang, Priscilla L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Programin Emerging Infect Dis, Singapore 169547, Singapore	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; National University of Singapore	Pearson, JL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	pears016@mc.duke.edu; garci001@mc.duke.edu	Souza-Neto, Jayme A/E-7841-2010	Souza-Neto, Jayme A/0000-0001-9281-894X; Ramirez, Jose Luis/0000-0001-9607-1097; Rodgers, Mary/0000-0001-8815-8651; Dimopoulos, George/0000-0001-6755-8111	National Institutes of Health (NIH) [RO1 GM067761, R21-AI64925, 5U54-AI057157-05S, 1RO1AI076442, 1R01AI061576-01, 1SA0RR024572-1]; American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center [5P30-CA14236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064925, R01AI076442, R01AI061576, T32AI007417, R21AI090188, U54AI057157, U54AI057159, R01AI078997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063845] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. de Silva, C. Lambeth, E. Wagner, F. Scholle, P. Florez de Sessions, J. Umbach, S. Braderick, B. Cullen, J. Nevins, M. Marengo, M. Gromeier, R. Wharton, D. Gubler, E. E. Ooi and S. Vasudevan, and members of the Triangle Flavivirology Group for reagents, time and insights. M. A. G.-B. thanks the late R. Shope for his inspiration and mentorship. We thank the Drosophila RNAi Screening Center (Harvard Medical School), which is funded by National Institutes of Health (NIH) grant RO1 GM067761, for expert assistance. We give special thanks to B. Mathey-Prevot for his support, advice and expertise, and for pointing out the important overlap of our screen with others previously published. We acknowledge funding from the NIH (R21-AI64925 and 5U54-AI057157-05S to M. A. G.-B., 1RO1AI076442 to P. L. Y., and 1R01AI061576-01 to G. D.); the American Society of Microbiology (to J. L. R.); and Johns Hopkins Malaria Research Institute (to J. A. S.-N.). M. A. R. is a Karnovsky Fellow. P. L. Y. acknowledges an award from the Giovanni Armenise-Harvard Foundation. We also acknowledge funding from the North Carolina Biotechnology Center, NIH (1SA0RR024572-1 to M. A. G.-B.), Duke Center for RNA Biology, Duke University School of Medicine, Institute of Genome Sciences and Policy, and Duke Comprehensive Cancer Center (5P30-CA14236) in support of the RNAi facility.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Andoh T, 1998, J NEUROVIROL, V4, P627, DOI 10.3109/13550289809114229; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chapel C, 2006, J GEN VIROL, V87, P861, DOI 10.1099/vir.0.81503-0; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Nawa M, 1998, ARCH VIROL, V143, P1555, DOI 10.1007/s007050050398; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	30	288	295	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1047	1050		10.1038/nature07967	http://dx.doi.org/10.1038/nature07967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396146	Green Submitted, Green Accepted			2022-12-24	WOS:000265412900047
J	King, RD; Rowland, J; Oliver, SG; Young, M; Aubrey, W; Byrne, E; Liakata, M; Markham, M; Pir, P; Soldatova, LN; Sparkes, A; Whelan, KE; Clare, A				King, Ross D.; Rowland, Jem; Oliver, Stephen G.; Young, Michael; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Pir, Pinar; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda			The Automation of Science	SCIENCE			English	Article							ONTOLOGY; GROWTH	The basis of science is the hypothetico-deductive method and the recording of experiments in sufficient detail to enable reproducibility. We report the development of Robot Scientist "Adam," which advances the automation of both. Adam has autonomously generated functional genomics hypotheses about the yeast Saccharomyces cerevisiae and experimentally tested these hypotheses by using laboratory automation. We have confirmed Adam's conclusions through manual experiments. To describe Adam's research, we have developed an ontology and logical language. The resulting formalization involves over 10,000 different research units in a nested treelike structure, 10 levels deep, that relates the 6.6 million biomass measurements to their logical description. This formalization describes how a machine contributed to scientific knowledge.	[King, Ross D.; Rowland, Jem; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Oliver, Stephen G.; Pir, Pinar] Univ Cambridge, Dept Biochem, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales	Aberystwyth University; University of Cambridge; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	King, RD (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales.	rdk@aber.ac.uk	Pir, Pinar/AAA-5103-2022; Oliver, Stephen/AAQ-5992-2021; Aubrey, Wayne/AAE-7321-2021; Soldatova, Larisa/AAE-4656-2020	Oliver, Stephen/0000-0003-3410-6439; Pir, Pinar/0000-0002-0078-4904; Soldatova, Larisa/0000-0001-6489-3029; Clare, Amanda/0000-0001-8315-3659; King, Ross/0000-0001-7208-4387; Liakata, Maria/0000-0001-5765-0416	Biotechnology and Biological Sciences Research Council; SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council; Royal Academy of Engineering; RC-UK Fellowship; BBSRC [BB/F008228/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Academy of Engineering(Royal Academy of Engineering - UK); RC-UK Fellowship(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Biotechnology and Biological Sciences Research Council to R.D.K., S.G.O., and M.Y.; by a SRIF 2 award to R.D.K.; by fellowships from the Royal Commission for the Great Exhibition of 1851, the Engineering and Physical Sciences Research Council, and the Royal Academy of Engineering to A.C.; and by a RC-UK Fellowship to L.N.S. We thank D. Struttman for help with yeast and M. Benway for help with Adam.	[Anonymous], 2006, NATURE, V440, P383, DOI 10.1038/440383a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; BUCHANAN BG, 1969, MACH INTELL, V5, P209; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; HEY T, 2003, GRID COMPUTING MAKIN, V36, P809; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horrocks I., 2003, J WEB SEMANT, V1, P7, DOI DOI 10.1016/J.WEBSEM.2003.07.001; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; KING RD, 2008, ROBOT SCI PROJECT; Langley P., 1987, SCI DISCOVERY COMPUT; Soldatova LN, 2006, BIOINFORMATICS, V22, pE464, DOI 10.1093/bioinformatics/btl207; Soldatova LN, 2006, J R SOC INTERFACE, V3, P795, DOI 10.1098/rsif.2006.0134; TOULMIN S, 2003, ENCY BRITANNICA DELU; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Ullman J., 1988, PRINCIPLES DATABASE, V1; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; YOUNG M, 1973, J EXP BOT, V24, P1172, DOI 10.1093/jxb/24.6.1172; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; ZYTKOW JM, 1990, PROCEEDINGS : EIGHTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P889	21	303	311	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					85	89		10.1126/science.1165620	http://dx.doi.org/10.1126/science.1165620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342587	Green Published			2022-12-24	WOS:000264802100037
J	Aliev, AE; Oh, JY; Kozlov, ME; Kuznetsov, AA; Fang, SL; Fonseca, AF; Ovalle, R; Lima, MD; Haque, MH; Gartstein, YN; Zhang, M; Zakhidov, AA; Baughman, RH				Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.			Giant-Stroke, Superelastic Carbon Nanotube Aerogel Muscles	SCIENCE			English	Article							ACTUATORS; ELASTOMERS; NANOCOMPOSITES; SHEETS; MEMORY	Improved electrically powered artificial muscles are needed for generating force, moving objects, and accomplishing work. Carbon nanotube aerogel sheets are the sole component of new artificial muscles that provide giant elongations and elongation rates of 220% and (3.7 x 10(4))% per second, respectively, at operating temperatures from 80 to 1900 kelvin. These solid-state-fabricated sheets are enthalpic rubbers having gaslike density and specific strength in one direction higher than those of steel plate. Actuation decreases nanotube aerogel density and can be permanently frozen for such device applications as transparent electrodes. Poisson's ratios reach 15, a factor of 30 higher than for conventional rubbers. These giant Poisson's ratios explain the observed opposite sign of width and length actuation and result in rare properties: negative linear compressibility and stretch densification.	[Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Lima, Marcio/G-4634-2012; Fonseca, Alexandre F./K-5477-2019; Baughman, Ray/A-8628-2018; Aliev, Ali/R-3034-2019; Fonseca, Alexandre/H-3105-2011	Baughman, Ray/0000-0001-5845-5137; Fonseca, Alexandre/0000-0001-8413-9744; Zakhidov, Anvar/0000-0003-3983-2229; Aliev, Ali/0000-0003-0034-9707	Air Force Office of Scientific Research [FA9550-05-C-0088]; NSF [DMI-0609115]; Office of Naval Research [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank T. Mirfakhrai, J. D. W. Madden, and V. M. Agranovich for their contributions. Supported by Air Force Office of Scientific Research grant FA9550-05-C-0088, NSF grant DMI-0609115, Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation Grant AT-0029, Honda Corporation, Lintec Corporation, and the Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A provisional patent for nanofiber actuators and strain amplifiers has been filed by the authors (Patent Office Provisional Filing No. 61089275).	Ahir SV, 2005, NAT MATER, V4, P491, DOI 10.1038/nmat1391; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Baughman RH, 2003, NATURE, V425, P667, DOI 10.1038/425667a; Courty S, 2003, EUROPHYS LETT, V64, P654, DOI 10.1209/epl/i2003-00277-9; Deshpande VV, 2006, NANO LETT, V6, P1092, DOI 10.1021/nl052513f; Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3; Gupta S, 2004, J APPL PHYS, V95, P2038, DOI 10.1063/1.1641518; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Sapmaz S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235414; Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8; Vohrer U, 2004, CARBON, V42, P1159, DOI 10.1016/j.carbon.2003.12.044; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	19	422	440	33	666	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1575	1578		10.1126/science.1168312	http://dx.doi.org/10.1126/science.1168312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299612				2022-12-24	WOS:000264342300030
J	Hofius, D; Schultz-Larsen, T; Joensen, J; Tsitsigiannis, DI; Petersen, NHT; Mattsson, O; Jorgensen, LB; Jones, JDG; Mundy, J; Petersen, M				Hofius, Daniel; Schultz-Larsen, Torsten; Joensen, Jan; Tsitsigiannis, Dimitrios I.; Petersen, Nikolaj H. T.; Mattsson, Ole; Jorgensen, Lise Bolt; Jones, Jonathan D. G.; Mundy, John; Petersen, Morten			Autophagic Components Contribute to Hypersensitive Cell Death in Arabidopsis	CELL			English	Article							PLANT INNATE IMMUNITY; PSEUDOMONAS-SYRINGAE; RESISTANCE; GENES; DEFENSE; ATG8; MACROAUTOPHAGY; APOPTOSIS; RESPONSES; THALIANA	Autophagy has been implicated as a prosurvival mechanism to restrict programmed cell death (PCD) associated with the pathogen-triggered hypersensitive response (HR) during plant innate immunity. This model is based on the observation that HR lesions spread in plants with reduced autophagy gene expression. Here, we examined receptor-mediated HR PCD responses in autophagy-deficient Arabidopsis knockout mutants (atg), and show that infection-induced lesions are contained in atg mutants. We also provide evidence that HR cell death initiated via Toll/Interleukin-1 (TIR)-type immune receptors through the defense regulator EDS1 is suppressed in atg mutants. Furthermore, we demonstrate that PCD triggered by coiled-coil (CC)-type immune receptors via NDR1 is either autophagy-independent or engages autophagic components with cathepsins and other unidentified cell death mediators. Thus, autophagic cell death contributes to HR PCD and can function in parallel with other prodeath pathways.	[Hofius, Daniel; Schultz-Larsen, Torsten; Joensen, Jan; Petersen, Nikolaj H. T.; Mattsson, Ole; Jorgensen, Lise Bolt; Mundy, John; Petersen, Morten] Univ Copenhagen, Copenhagen Bioctr, Dept Biol, DK-2200 Copenhagen, Denmark; [Tsitsigiannis, Dimitrios I.; Jones, Jonathan D. G.] John Innes Ctr, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Petersen, M (corresponding author), Univ Copenhagen, Copenhagen Bioctr, Dept Biol, DK-2200 Copenhagen, Denmark.	shutko@bio.ku.dk	Tsitsigiannis, Dimitrios/F-1009-2017; mundy, john/A-2361-2013; Jones, Jonathan DG/J-5129-2012; Schultz-Larsen, Torsten/F-6845-2014; Petersen, Morten/J-5023-2014	Tsitsigiannis, Dimitrios/0000-0003-2006-6106; mundy, john/0000-0001-7490-4588; Jones, Jonathan DG/0000-0002-4953-261X; Schultz-Larsen, Torsten/0000-0001-6759-0074; Petersen, Morten/0000-0002-3035-5991	Danish Cancer Society [DP03048]; Research Council [274-06-0460, 272-06-0049]; European Union [LSHG-CT-2004-511983]; Danish Agricultural Research Council [23-02-0101, 23-04-0143]	Danish Cancer Society(Danish Cancer Society); Research Council; European Union(European Commission); Danish Agricultural Research Council	We thank Suksawad Vongvisuttikun, Henriette Larsen, and Lis Munk Frederiksen for technical assistance. We also thank Yoshinori Ohsumi (National Institute for Basic Biology, Okazaki, Japan) and Kohki Yoshimoto (RIKEN Plant Science Center, Yokohama, Japan) for carefully reading versions of this manuscript and providing binary plasmids carrying GFP-ATG8s as well as seeds of atg9 and atg4a/b. We are grateful to R. Vierstra (University of Wisconsin, Madison, WI) for providing seeds of atg7 and atg5. Finally, we thank J. Chang (Oregon State University, Corvallis, OR) for providing modified Pf0-1 strains. This work was funded by grants to J. M. from the Danish Cancer Society (DP03048) and Research Council (274-06-0460, 272-06-0049), and the European Union (LSHG-CT-2004-511983) as well as to M. P. (23-02-0101) and D. H. (23-04-0143) from the Danish Agricultural Research Council.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; BOZZOLA JJ, 1999, ELECT MICROSCOPY PRI, V2; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harrison-Lowe NJ, 2008, AUTOPHAGY, V4, P339, DOI 10.4161/auto.5629; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Seay M, 2006, CELL MICROBIOL, V8, P899, DOI 10.1111/j.1462-5822.2006.00715.x; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Woltering EJ, 2004, TRENDS PLANT SCI, V9, P469, DOI 10.1016/j.tplants.2004.08.001; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	46	271	290	11	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					773	783		10.1016/j.cell.2009.02.036	http://dx.doi.org/10.1016/j.cell.2009.02.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450522	Bronze			2022-12-24	WOS:000266114100024
J	Mehra, A; Shi, M; Baker, CL; Colot, HV; Loros, JJ; Dunlap, JC				Mehra, Arun; Shi, Mi; Baker, Christopher L.; Colot, Hildur V.; Loros, Jennifer J.; Dunlap, Jay C.			A Role for Casein Kinase 2 in the Mechanism Underlying Circadian Temperature Compensation	CELL			English	Article							PERIOD LENGTH; FREQUENCY DETERMINES; NEUROSPORA CLOCK; PROTEIN; PHOSPHORYLATION; DROSOPHILA; RHYTHMS; GENE; TIME; CK2	Temperature compensation of circadian clocks is an unsolved problem with relevance to the general phenomenon of biological compensation. We identify casein kinase 2 (CK2) as a key regulator of temperature compensation of the Neurospora clock by determining that two long-standing clock mutants, chrono and period-3, displaying distinctive alterations in compensation encode the beta 1 and alpha subunits of CK2, respectively. Reducing the dose of these subunits, particularly beta 1, significantly alters temperature compensation without altering the enzyme's Q(10). By contrast, other kinases and phosphatases implicated in clock function do not play appreciable roles in temperature compensation. CK2 exerts its effects on the clock by directly phosphorylating FREQUENCY (FRQ), and this phosphorylation is compromised in CK2 hypomorphs. Finally, mutation of certain putative CK2 phosphosites on FRQ, shown to be phosphorylated in vivo, predictably alters temperature compensation profiles effectively phenocopying CK2 mutants.	[Mehra, Arun; Shi, Mi; Baker, Christopher L.; Colot, Hildur V.; Loros, Jennifer J.; Dunlap, Jay C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Loros, Jennifer J.; Dunlap, Jay C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Dunlap, JC (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	jay.c.dunlap@dartmouth.edu	Shi, Mi/A-5884-2012; Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Shi, Mi/0000-0002-3044-912X; Dunlap, Jay/0000-0003-1577-0457	Canadian Institutes of Health Research Postdoctoral Fellowship; National Institutes of Health [R01 GM34985, P01 GM68087, R01 GM083336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087, R01GM083336] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L. Larrondo kindly provided strains 1061-1 and 1066-6. We thank C. Hammell for technical assistance with GST-FRQ purification, P. Ruoff for helpful discussions, and R. Lambreghts and H. Benchabane for critical reading of the manuscript. This work was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship to A. M. and by grants from the National Institutes of Health to J.C.D. (R01 GM34985 and P01 GM68087) and to J. J. L. and J. C. D. (R01 GM083336).	Akman OE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.28; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 2005, MOL CELL BIOCHEM, V274, P141, DOI 10.1007/s11010-005-2943-1; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; BARRETT RK, 1995, J NEUROSCI, V15, P5681; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 2005, METHOD ENZYMOL, V393, P3, DOI 10.1016/S0076-6879(05)93001-2; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; GARDNER GF, 1981, PLANT PHYSIOL, V68, P1244, DOI 10.1104/pp.68.6.1244; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; HASTINGS JW, 1957, P NATL ACAD SCI USA, V43, P804, DOI 10.1073/pnas.43.9.804; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hong CI, 1997, CHRONOBIOL INT, V14, P521, DOI 10.3109/07420529709001473; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; Kalmus H., 1935, Biologia Generalis Wien, V11, P93; KALMUS HANS, 1934, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P405; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; Kurosawa G, 2005, J THEOR BIOL, V233, P453, DOI 10.1016/j.jtbi.2004.10.012; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; LAKINTHOMAS PI, 1991, J BIOL RHYTHM, V6, P281, DOI 10.1177/074873049100600401; Lambreghts R, 2009, GENETICS, V181, P767, DOI 10.1534/genetics.108.089292; Larrondo LF, 2009, EUKARYOT CELL, V8, P800, DOI 10.1128/EC.00072-09; Leloup JC, 1997, CHRONOBIOL INT, V14, P511, DOI 10.3109/07420529709001472; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Mizoguchi T, 2006, INT REV CYTOL, V250, P47, DOI 10.1016/S0074-7696(06)50002-6; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; NJUS D, 1977, J COMP PHYSIOL, V117, P335, DOI 10.1007/BF00691559; Nowrousian M, 2003, GENETICS, V164, P923; Pagano MA, 2005, MOL CELL BIOCHEM, V274, P23, DOI 10.1007/s11010-005-3116-y; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Price JL, 1997, CHRONOBIOL INT, V14, P455, DOI 10.3109/07420529709001468; Rothenfluh A, 2000, GENETICS, V156, P665; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 1997, CHRONOBIOL INT, V14, P499, DOI 10.3109/07420529709001471; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Takeuchi T, 2007, J THEOR BIOL, V246, P195, DOI 10.1016/j.jtbi.2006.12.028; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Tosini G, 1998, NEUROREPORT, V9, P1001, DOI 10.1097/00001756-199804200-00009; Wahl O., 1932, Zeitschrift fuer Vergleichende Physiologie Berlin, V16, P529; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003	70	82	84	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					749	760		10.1016/j.cell.2009.03.019	http://dx.doi.org/10.1016/j.cell.2009.03.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450520	Green Accepted, Bronze			2022-12-24	WOS:000266114100022
J	Penuelas, J; Rutishauser, T; Filella, I				Penuelas, Josep; Rutishauser, This; Filella, Iolanda			Phenology Feedbacks on Climate Change	SCIENCE			English	Editorial Material							HEAT-WAVE		[Penuelas, Josep; Rutishauser, This; Filella, Iolanda] Univ Autonoma Barcelona, Global Ecol Unit, Ctr Ecol Res & Forestry Applicat CREAF CEAB CSIC, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Penuelas, J (corresponding author), Univ Autonoma Barcelona, Global Ecol Unit, Ctr Ecol Res & Forestry Applicat CREAF CEAB CSIC, E-08193 Barcelona, Spain.	josep.penuelas@uab.cat; this@creaf.uab.cat; i.filella@creaf.uab.cat	Penuelas, Josep/D-9704-2011; Filella, Iolanda/A-2860-2015	Penuelas, Josep/0000-0002-7215-0150; Filella, Iolanda/0000-0001-6262-5733				[Anonymous], 2007, PHYS SCI BAS CONTR W; Bonan G.B., 2008, ECOLOGICAL CLIMATOLO, DOI [10.1017/CBO9781107339200, DOI 10.1017/CBO9781107339200]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Fitzjarrald DR, 2001, J CLIMATE, V14, P598, DOI 10.1175/1520-0442(2001)014<0598:CCOLPI>2.0.CO;2; Garbulsky MF, 2008, GLOBAL CHANGE BIOL, V14, P2860, DOI 10.1111/j.1365-2486.2008.01684.x; Jiang XY, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010756; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Penuelas J, 2003, TRENDS PLANT SCI, V8, P105, DOI 10.1016/S1360-1385(03)00008-6; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Schwartz MD, 1996, J CLIMATE, V9, P803, DOI 10.1175/1520-0442(1996)009<0803:ETSDID>2.0.CO;2; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; Stockli R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000781; Zaitchik BF, 2006, INT J CLIMATOL, V26, P743, DOI 10.1002/joc.1280	17	540	574	29	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					887	888		10.1126/science.1173004	http://dx.doi.org/10.1126/science.1173004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443770				2022-12-24	WOS:000266048800020
J	Airan, RD; Thompson, KR; Fenno, LE; Bernstein, H; Deisseroth, K				Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl			Temporally precise in vivo control of intracellular signalling	NATURE			English	Article							ACTIVATION; NUCLEUS; PHOTOSTIMULATION; ADDICTION; RECEPTORS; REVEALS	In the study of complex mammalian behaviours, technological limitations have prevented spatiotemporally precise control over intracellular signalling processes. Here we report the development of a versatile family of genetically encoded optical tools ('optoXRs') that leverage common structure -function relationships(1) among G-protein-coupled receptors (GPCRs) to recruit and control, with high spatiotemporal precision, receptor-initiated biochemical signalling pathways. In particular, we have developed and characterized two optoXRs that selectively recruit distinct, targeted signalling pathways in response to light. The two optoXRs exerted opposing effects on spike firing in nucleus accumbens in vivo, and precisely timed optoXR photostimulation in nucleus accumbens by itself sufficed to drive conditioned place preference in freely moving mice. The optoXR approach allows testing of hypotheses regarding the causal impact of biochemical signalling in behaving mammals, in a targetable and temporally precise manner.	[Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAF-9638-2019; Fenno, Lief/AAK-2924-2020	Bernstein, Hannah/0000-0002-6512-1378; Airan, Raag/0000-0001-5259-5606	NIH/NIMH National Research Service Award; Stanford Medical Scientist Training Program; NARSAD Young Investigator Award; CIRM; McKnight; Coulter; Klingenstein; Keck; NSF; NIDA; NIH Pioneer Award; Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	NIH/NIMH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanford Medical Scientist Training Program; NARSAD Young Investigator Award(NARSAD); CIRM(California Institute for Regenerative Medicine); McKnight; Coulter; Klingenstein(Klingenstein Philanthropies); Keck; NSF(National Science Foundation (NSF)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	We thank B. Kobilka, B. Knutson, M. P. Bokoch, T. Sudhof, R. Malenka and the Deisseroth Laboratory for comments and discussion. We appreciate the gifts of pCNGA2-C460W/E583M from J. W. Karpen, pcDNA3.1-beta<INF>2</INF>AR from B. Kobilka and pDT-alpha<INF>1</INF>AR from C. Hague. We thank T. Jardetzky for use of a Biotek Synergy4 plate reader. R. D. A. is supported by a NIH/NIMH National Research Service Award and the Stanford Medical Scientist Training Program. K. R. T. is supported by a NARSAD Young Investigator Award. K. D. is supported by CIRM, McKnight, Coulter, Klingenstein, Keck, NSF, NIMH, NIDA, the NIH Pioneer Award, the Albert Yu and Mary Bechmann Foundation and the Kinetics Foundation.	Airan RD, 2007, CURR OPIN NEUROBIOL, V17, P587, DOI 10.1016/j.conb.2007.11.003; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P359, DOI 10.1016/j.tips.2007.06.010; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Oliveira L, 1999, PROTEIN ENG, V12, P1087, DOI 10.1093/protein/12.12.1087; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Potts JT, 2005, NEUROSCIENCE, V132, P1123, DOI 10.1016/j.neuroscience.2004.12.018; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; WHITE FJ, 1986, J NEUROSCI, V6, P274; WILSON CJ, 2003, SYNAPTIC ORG BRAIN, P361; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	30	483	537	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1025	1029		10.1038/nature07926	http://dx.doi.org/10.1038/nature07926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295515				2022-12-24	WOS:000265412900042
J	Cantone, I; Marucci, L; Iorio, F; Ricci, MA; Belcastro, V; Bansal, M; Santini, S; di Bernardo, M; di Bernardo, D; Cosma, MP				Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego; Cosma, Maria Pia			A Yeast Synthetic Network for In Vivo Assessment of Reverse-Engineering and Modeling Approaches	CELL			English	Article							ASH1 MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; REGULATORY NETWORKS; CELL-CYCLE; EXPRESSION PROFILES; ORDERED RECRUITMENT; ESCHERICHIA-COLI; GENE NETWORKS; BUDDING YEAST	Systems biology approaches are extensively used to model and reverse engineer gene regulatory networks from experimental data. Conversely, synthetic biology allows "de novo'' construction of a regulatory network to seed new functions in the cell. At present, the usefulness and predictive ability of modeling and reverse engineering cannot be assessed and compared rigorously. We built in the yeast Saccharomyces cerevisiae a synthetic network, IRMA, for in vivo "benchmarking'' of reverse-engineering and modeling approaches. The network is composed of five genes regulating each other through a variety of regulatory interactions; it is negligibly affected by endogenous genes, and it is responsive to small molecules. We measured time series and steady-state expression data after multiple perturbations. These data were used to assess state-of-the-art modeling and reverse-engineering techniques. A semiquantitative model was able to capture and predict the behavior of the network. Reverse engineering based on differential equations and Bayesian networks correctly inferred regulatory interactions from the experimental data.	[Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; di Bernardo, Diego; Cosma, Maria Pia] TIGEM, I-80131 Naples, Italy; [Marucci, Lucia; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego] Univ Naples Federico 2, Dept Syst & Comp Engn, I-80125 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II	di Bernardo, D (corresponding author), TIGEM, I-80131 Naples, Italy.	dibernardo@tigem.it; cosma@tigem.it	di Bernardo, Mario/AAL-9311-2021; di Bernardo, Mario/I-2805-2012; di Bernardo, Diego/I-9440-2012; Marucci, Lucia/P-1582-2016; Cantone, Irene/AAB-1071-2020; Iorio, Francesco/H-3282-2019; Cosma, Maria Pia/E-8731-2015; di Bernardo, Diego/AAF-5881-2021; Iorio, Francesco/H-3284-2019	di Bernardo, Mario/0000-0002-2171-4745; di Bernardo, Diego/0000-0002-1911-7407; Marucci, Lucia/0000-0002-7553-6358; Cantone, Irene/0000-0002-8156-7126; Cosma, Maria Pia/0000-0003-4207-5097; di Bernardo, Diego/0000-0002-1911-7407; Iorio, Francesco/0000-0001-7063-8913; Belcastro, Vincenzo/0000-0003-3749-0018	EC; "Fondazione Telethon" Institutional; SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET	EC(European CommissionEuropean Commission Joint Research Centre); "Fondazione Telethon" Institutional(Fondazione Telethon); SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by EC Framework 6 (COBIOS) and by a "Fondazione Telethon" Institutional grant to TIGEM; I.C. and M.B. were supported by SEMM (European School of Molecular Medicine). F.I. is part of the University of Salerno Ph.D. program. M.A.R. is part of University of Naples "Federico II" undergraduate program. V.B. is part of the Open University Ph.D. program and supported by Italian MIUR-FIRB ITALBIONET to D.d.B. We thank Graciana Diez-Roux, Andrea Ballabio, and Joerg Stelling for helping with the manuscript; Kim Nasmyth for providing the K2072 yeast strain; Mark Johnston for providing the YM4271 strain; and Susan Lindquist for providing Gateway vectors.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALON U, 2006, DESIGN PRINCIPLES BI, V10; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ferreiro JA, 2004, NUCLEIC ACIDS RES, V32, P1617, DOI 10.1093/nar/gkh324; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonsalvez GB, 2003, RNA, V9, P1383, DOI 10.1261/rna.5120803; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jona G, 2000, BBA-GENE STRUCT EXPR, V1491, P37, DOI 10.1016/S0167-4781(00)00016-6; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; KURAS L, 1995, FEBS LETT, V367, P15, DOI 10.1016/0014-5793(95)00528-H; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu Jingdong, 1993, Methods (Orlando), V5, P125, DOI 10.1006/meth.1993.1017; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; MELLOR J, 1990, EMBO J, V9, P4017, DOI 10.1002/j.1460-2075.1990.tb07623.x; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1987, CELL, V48, P579, DOI 10.1016/0092-8674(87)90236-4; OCONNELL KF, 1995, MOL CELL BIOL, V15, P1879; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Szallasi Z, 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	44	278	286	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					172	181		10.1016/j.cell.2009.01.055	http://dx.doi.org/10.1016/j.cell.2009.01.055			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19327819	Bronze			2022-12-24	WOS:000264813300023
J	Bibbins-Domingo, K; Pletcher, MJ; Lin, F; Vittinghoff, E; Gardin, JM; Arynchyn, A; Lewis, CE; Williams, OD; Hulley, SB				Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Gardin, Julius M.; Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale; Hulley, Stephen B.			Racial Differences in Incident Heart Failure among Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; DENSITY-LIPOPROTEIN CHOLESTEROL; HIGH BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; LIFETIME RISK; RENAL-DISEASE; WORKING GROUP; HYPERTENSION; BLACK; HYPERTROPHY	Background The antecedents and epidemiology of heart failure in young adults are poorly understood. Methods We prospectively assessed the incidence of heart failure over a 20-year period among 5115 blacks and whites of both sexes who were 18 to 30 years of age at baseline. Using Cox models, we examined predictors of hospitalization or death from heart failure. Results Over the course of 20 years, heart failure developed in 27 participants (mean [+/- SD] age at onset, 39 +/- 6 years), all but 1 of whom were black. The cumulative incidence of heart failure before the age of 50 years was 1.1% (95% confidence interval [CI], 0.6 to 1.7) in black women, 0.9% (95% CI, 0.5 to 1.4) in black men, 0.08% (95% CI, 0.0 to 0.5) in white women, and 0% (95% CI, 0 to 0.4) in white men (P = 0.001 for the comparison of black participants and white participants). Among blacks, independent predictors at 18 to 30 years of age of heart failure occurring 15 years, on average, later included higher diastolic blood pressure (hazard ratio per 10.0 mm Hg, 2.1; 95% CI, 1.4 to 3.1), higher body-mass index (the weight in kilograms divided by the square of the height in meters) (hazard ratio per 5.7 units, 1.4; 95% CI, 1.0 to 1.9), lower high-density lipoprotein cholesterol (hazard ratio per 13.3 mg per deciliter [0.34 mmol per liter], 0.6; 95% CI, 0.4 to 1.0), and kidney disease (hazard ratio, 19.8; 95% CI, 4.5 to 87.2). Three quarters of those in whom heart failure subsequently developed had hypertension by the time they were 40 years of age. Depressed systolic function, as assessed on a study echocardiogram when the participants were 23 to 35 years of age, was independently associated with the development of heart failure 10 years, on average, later (hazard ratio for abnormal systolic function, 36.9; 95% CI, 6.9 to 198.3; hazard ratio for borderline systolic function, 3.5; 95% CI, 1.2 to 10.2). Myocardial infarction, drug use, and alcohol use were not associated with the risk of heart failure. Conclusions Incident heart failure before 50 years of age is substantially more common among blacks than among whites. Hypertension, obesity, and systolic dysfunction that are present before a person is 35 years of age are important antecedents that may be targets for the prevention of heart failure. (ClinicalTrials.govnumber, NCT00005130.)	[Bibbins-Domingo, Kirsten; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, UCSF Ctr Vulnerable Populat, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Gardin, Julius M.] Hackensack Univ, Med Ctr, Dept Med, Hackensack, NJ USA; [Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Hackensack University Medical Center; University of Alabama System; University of Alabama Birmingham	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.				National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204]; Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK078124]; University of California, San Francisco; Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045134, N01HC005187, N01HC095095, N01HC048048, N01HC048050, N01HC048049, N01HC048047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R01HL048048, R01HL081257, R29HL048048, R01HL048049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078124] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Francisco(University of California System); Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Heart, Lung, and Blood Institute (a diversity supplement to CARDIA contract N01-HC-95095), the Robert Wood Johnson Amos Faculty Development Program, and the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK078124), and a University of California, San Francisco, Hellman Family Faculty Award (all to Dr. Bibbins-Domingo). The CARDIA study is supported by contracts from the National Heart, Lung, and Blood Institute (N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, and N01-HC-45204).	Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Bakris GL, 2003, ARCH INTERN MED, V163, P1555, DOI 10.1001/archinte.163.13.1555; Bibbins-Domingo K, 2006, ARCH INTERN MED, V166, P1396, DOI 10.1001/archinte.166.13.1396; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Cohn JN, 2002, J CARD FAIL, V8, P56, DOI 10.1054/jcaf.2002.32950; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Goldberg LR, 2006, CIRCULATION, V113, P2851, DOI 10.1161/CIRCULATIONAHA.105.600437; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Horio T, 2003, AM J HYPERTENS, V16, P938, DOI 10.1016/S0895-7061(03)01015-X; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; KALOGEROPOULOS A, ARCH INTERN IN PRESS; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; LAUER MS, 1991, J AM COLL CARDIOL, V18, P1287, DOI 10.1016/0735-1097(91)90549-O; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Liu K, 1996, CIRCULATION, V93, P60, DOI 10.1161/01.CIR.93.1.60; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; *NAT I ALC AB ALC, WHAT IS SAF LEV DRIN; Nunez E, 2005, HYPERTENSION, V45, P58, DOI 10.1161/01.HYP.0000149951.70491.4c; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Stehman-Breen CO, 2003, J AM SOC NEPHROL, V14, P2352, DOI 10.1097/01.ASN.0000083392.11042.14; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; Victor RG, 2008, ARCH INTERN MED, V168, P1285, DOI 10.1001/archinte.168.12.1285; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Yancy CW, 2005, AM J CARDIOL, V96, p3I, DOI 10.1016/j.amjcard.2005.07.028; 2005, MMWR MORB MORTAL WKL, V54, P7	46	379	380	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1179	1190		10.1056/NEJMoa0807265	http://dx.doi.org/10.1056/NEJMoa0807265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297571	Green Accepted, Bronze			2022-12-24	WOS:000264283400004
J	Lee, SJR; Escobedo-Lozoya, Y; Szatmari, EM; Yasuda, R				Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei			Activation of CaMKII in single dendritic spines during long-term potentiation	NATURE			English	Article							PROTEIN-KINASE-II; YELLOW FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; CA2+ CHANNELS; SYNAPTIC PLASTICITY; LTP; INDUCTION; NEURONS; RAS; PHOSPHORYLATION	Calcium/calmodulin-dependent kinase II (CaMKII) plays a central part in long-term potentiation (LTP), which underlies some forms of learning and memory. Here we monitored the spatiotemporal dynamics of CaMKII activation in individual dendritic spines during LTP using two-photon fluorescence lifetime imaging microscopy, in combination with two-photon glutamate uncaging. Induction of LTP and associated spine enlargement in single spines triggered transient (similar to 1 min) CaMKII activation restricted to the stimulated spines. CaMKII in spines was specifically activated by NMDA receptors and L-type voltage-sensitive calcium channels, presumably by nanodomain Ca2+ near the channels, in response to glutamate uncaging and depolarization, respectively. The high degree of compartmentalization and channel specificity of CaMKII signalling allow stimuli-specific spatiotemporal patterns of CaMKII signalling and may be important for synapse-specificity of synaptic plasticity.	[Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Burroughs Wellcome Fund; Dana Foundation; Alfred P. Sloan Foundation; Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association; National Institute of Mental Health [R01MH08004]; National Science Foundation [0642000]; Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association(Alzheimer's Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. Murakoshi for purified mEGFP and technical advice, Y. Hayashi for complementary DNAs and shRNA, A. Wang for cultured slices, T. Zimmerman and D. Kloetzer for laboratory management, and M. Ehlers, C. Harvey, J. Lisman, M. Patterson, S. Raghavachari, K. Svoboda, R. Weinberg and H. Zhong for comments on the manuscript. This study was funded by Burroughs Wellcome Fund, Dana Foundation, Alfred P. Sloan Foundation, Autism Speaks, National Alliance of Autism Research, Whitehall Foundation, Alzheimer's Association, National Institute of Mental Health (R01MH08004), National Science Foundation (0642000), Duke University Undergraduate Research Support Grants (S.- J. R. L.), Howard Hughes Neuroscience Forum Fellowship (S.- J. R. L.), and Ruth K. Broad Biomedical Research Foundation (E.M.S.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Conti R, 2002, HIPPOCAMPUS, V12, P667, DOI 10.1002/hipo.10096; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCALLISTER AK, 2000, SCI STKE, pPL1; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ohno M, 2002, CURR BIOL, V12, P654, DOI 10.1016/S0960-9822(02)00767-4; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	45	457	464	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					299	U58		10.1038/nature07842	http://dx.doi.org/10.1038/nature07842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295602	Green Accepted			2022-12-24	WOS:000264285600033
J	Gubernator, NG; Zhang, H; Staal, RGW; Mosharov, EV; Pereira, DB; Yue, M; Balsanek, V; Vadola, PA; Mukherjee, B; Edwards, RH; Sulzer, D; Sames, D				Gubernator, Niko G.; Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Balsanek, Vojtech; Vadola, Paul A.; Mukherjee, Bipasha; Edwards, Robert H.; Sulzer, David; Sames, Dalibor			Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals	SCIENCE			English	Article							VESICULAR MONOAMINE TRANSPORTER; NEURONS; AMPHETAMINES; TRANSMITTER; PROBABILITY; GRANULES; NICOTINE; SYNAPSE	The nervous system transmits signals between neurons via neurotransmitter release during synaptic vesicle fusion. In order to observe neurotransmitter uptake and release from individual presynaptic terminals directly, we designed fluorescent false neurotransmitters as substrates for the synaptic vesicle monoamine transporter. Using these probes to image dopamine release in the striatum, we made several observations pertinent to synaptic plasticity. We found that the fraction of synaptic vesicles releasing neurotransmitter per stimulus was dependent on the stimulus frequency. A kinetically distinct "reserve" synaptic vesicle population was not observed under these experimental conditions. A frequency-dependent heterogeneity of presynaptic terminals was revealed that was dependent in part on D2 dopamine receptors, indicating a mechanism for frequency-dependent coding of presynaptic selection.	[Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Zhang, Hui; Staal, Roland G. W.; Mosharov, Eugene V.; Pereira, Daniela B.; Yue, Minerva; Sulzer, David] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Gubernator, Niko G.; Balsanek, Vojtech; Vadola, Paul A.; Sames, Dalibor] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Mukherjee, Bipasha; Edwards, Robert H.] Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; [Mukherjee, Bipasha; Edwards, Robert H.] Univ Calif San Francisco, Dept Physiol, Sch Med, San Francisco, CA 94143 USA; [Sulzer, David] New York Psychiat Inst, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.	ds43@columbia.edu; sames@chem.columbia.edu	Pereira, Daniela/AAZ-5285-2021	B. Pereira, Daniela/0000-0003-4872-5505; Staal, Roland/0000-0002-2857-2241	The G. Harold and Leila Y. Mathers Charitable Foundation; Columbia Universitys Research Initiatives in Science and Engineering; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Picower and Parkinsons Disease Foundations; National Alliance for Research on Schizophrenia and Depression; Michael J. Fox Foundation; National Parkinson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007418] Funding Source: NIH RePORTER	The G. Harold and Leila Y. Mathers Charitable Foundation; Columbia Universitys Research Initiatives in Science and Engineering; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Picower and Parkinsons Disease Foundations; National Alliance for Research on Schizophrenia and Depression(NARSAD); Michael J. Fox Foundation; National Parkinson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Burke for 6-OHDA injections and advice, M. Sonders for discussion, M. Siu for imaging analysis programming, and J. Schmoranzer for technical support with the TIRFM setup. Columbia University has applied for a patent on fluorescent false neurotransmitters. D. Sames thanks The G. Harold and Leila Y. Mathers Charitable Foundation and Columbia Universitys Research Initiatives in Science and Engineering. D. Sulzer thanks the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Picower and Parkinsons Disease Foundations. H.Z. thanks the National Alliance for Research on Schizophrenia and Depression. R.H.E. thanks the Michael J. Fox Foundation, the National Parkinson Foundation, NIDA, and NIMH.	Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Chen G, 2005, J AM CHEM SOC, V127, P4544, DOI 10.1021/ja0428457; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; KOPIN IJ, 1968, ANNU REV PHARMACOLOG, V8, P377, DOI 10.1146/annurev.pa.08.040168.002113; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oo TF, 2002, EXP NEUROL, V175, P1, DOI 10.1006/exnr.2002.7881; Partilla JS, 2006, J PHARMACOL EXP THER, V319, P237, DOI 10.1124/jpet.106.103622; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SULZER D, 1990, NEURON, V5, P797, DOI 10.1016/0896-6273(90)90339-H; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	23	147	154	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1441	1444		10.1126/science.1172278	http://dx.doi.org/10.1126/science.1172278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19423778	Green Accepted			2022-12-24	WOS:000266878700045
J	Cash, SS; Halgren, E; Dehghani, N; Rossetti, AO; Thesen, T; Wang, C; Devinsky, O; Kuzniecky, R; Doyle, W; Madsen, JR; Bromfield, E; Eross, L; Halasz, P; Karmos, G; Csercsa, R; Wittner, L; Ulbert, I				Cash, Sydney S.; Halgren, Eric; Dehghani, Nima; Rossetti, Andrea O.; Thesen, Thomas; Wang, ChunMao; Devinsky, Orrin; Kuzniecky, Ruben; Doyle, Werner; Madsen, Joseph R.; Bromfield, Edward; Eross, Lorand; Halasz, Peter; Karmos, George; Csercsa, Richard; Wittner, Lucia; Ulbert, Istvan			The Human K-Complex Represents an Isolated Cortical Down-State	SCIENCE			English	Article							SLOW-WAVE SLEEP; NEOCORTICAL NEURONS; NETWORK MECHANISMS; OSCILLATION; MODEL; HZ	The electroencephalogram (EEG) is a mainstay of clinical neurology and is tightly correlated with brain function, but the specific currents generating human EEG elements remain poorly specified because of a lack of microphysiological recordings. The largest event in healthy human EEGs is the K-complex (KC), which occurs in slow-wave sleep. Here, we show that KCs are generated in widespread cortical areas by outward dendritic currents in the middle and upper cortical layers, accompanied by decreased broadband EEG power and decreased neuronal firing, which demonstrate a steep decline in network activity. Thus, KCs are isolated "down-states," a fundamental cortico-thalamic processing mode already characterized in animals. This correspondence is compatible with proposed contributions of the KC to sleep preservation and memory consolidation.	[Cash, Sydney S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Epilepsy Div, Boston, MA 02114 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Halgren, Eric; Dehghani, Nima] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Thesen, Thomas; Wang, ChunMao; Devinsky, Orrin; Kuzniecky, Ruben; Doyle, Werner] NYU, Sch Med, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Madsen, Joseph R.] Childrens Hosp, Boston, MA 02115 USA; [Rossetti, Andrea O.; Bromfield, Edward] Brigham & Womens Hosp, Boston, MA 02115 USA; [Eross, Lorand; Wittner, Lucia; Ulbert, Istvan] Natl Inst Neurosurg, H-1145 Budapest, Hungary; [Halasz, Peter] Epilepsy Ctr, Natl Inst Psychiat & Neurol, H-1145 Budapest, Hungary; [Karmos, George; Csercsa, Richard; Wittner, Lucia; Ulbert, Istvan] Hungarian Acad Sci, Inst Psychol, H-1394 Budapest, Hungary; [Halasz, Peter; Karmos, George; Ulbert, Istvan] Peter Pazmany Catholic Univ, Dept Informat Technol, H-1083 Budapest, Hungary	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Cash, SS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol,Epilepsy Div, Boston, MA 02114 USA.	scash@partners.org	Rossetti, Andrea O./A-6712-2008; Ulbert, Istvan/F-2213-2010; Wittner, Lucia/C-9386-2013	Rossetti, Andrea O./0000-0002-7878-172X; Wittner, Lucia/0000-0001-6800-0953; Dehghani, Nima/0000-0003-2032-8903; Eross, Lorand/0000-0002-5796-5546; Devinsky, Orrin/0000-0003-0044-4632	National Institute of Neurogical Disorders and Stroke (NIH) [NS18741, NS44623]; Neuroprobes [IST-027017, OTKA49122, ETT135/2006]; Janos Szentagothai Knowledge Center [RET 05/2004]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044623, R01NS018741] Funding Source: NIH RePORTER	National Institute of Neurogical Disorders and Stroke (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroprobes; Janos Szentagothai Knowledge Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Neurogical Disorders and Stroke (NIH) grants NS18741 and NS44623 to E.H. and Neuroprobes IST-027017, OTKA49122, ETT135/2006, Janos Szentagothai Knowledge Center RET 05/2004 grants to I.U. We thank L. Papp for technical support; and L. Grand, A. Magony, B. Dombovari, and D. Fabo for support in data analysis and recording. The authors dedicate this work to the memory of Edward Bromfield, who passed away on 10 May 2009.	Amzica F, 1998, NEUROSCIENCE, V82, P671; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Buzsaki G., 2006, RHYTHMS BRAIN; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; LOOMIS AL, 1938, J NEUROPHYSIOL S, V13, P231; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; *NAT I NEUR DIS ST, NS18741 NIH NAT I NE; Numminen J, 1996, ELECTROEN CLIN NEURO, V99, P544; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Ulbert I, 2001, J NEUROSCI METH, V106, P69, DOI 10.1016/S0165-0270(01)00330-2; Velasco M, 2002, CLIN NEUROPHYSIOL, V113, P25, DOI 10.1016/S1388-2457(01)00707-6; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wennberg RA, 2003, CLIN NEUROPHYSIOL, V114, P1403, DOI 10.1016/S1388-2457(03)00152-4	27	234	237	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 22	2009	324	5930					1084	1087		10.1126/science.1169626	http://dx.doi.org/10.1126/science.1169626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461004	Green Accepted			2022-12-24	WOS:000266246700045
J	Shukla, VK; Doyon, Y; Miller, JC; DeKelver, RC; Moehle, EA; Worden, SE; Mitchell, JC; Arnold, NL; Gopalan, S; Meng, XD; Choi, VM; Rock, JM; Wu, YY; Katibah, GE; Zhifang, G; McCaskill, D; Simpson, MA; Blakeslee, B; Greenwalt, SA; Butler, HJ; Hinkley, SJ; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD				Shukla, Vipula K.; Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.			Precise genome modification in the crop species Zea mays using zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MEDIATED TRANSFORMATION; GENE; EXPRESSION; MAIZE; CLEAVAGE; SEQUENCE; CELLS; MUTAGENESIS; DISRUPTION	Agricultural biotechnology is limited by the inefficiencies of conventional random mutagenesis and transgenesis. Because targeted genome modification in plants has been intractable(1), plant trait engineering remains a laborious, time-consuming and unpredictable undertaking. Here we report a broadly applicable, versatile solution to this problem: the use of designed zinc-finger nucleases (ZFNs) that induce a double-stranded break at their target locus(2). We describe the use of ZFNs to modify endogenous loci in plants of the crop species Zea mays. We show that simultaneous expression of ZFNs and delivery of a simple heterologous donor molecule leads to precise targeted addition of an herbicide-tolerance gene at the intended locus in a significant number of isolated events. ZFN-modified maize plants faithfully transmit these genetic changes to the next generation. Insertional disruption of one target locus, IPK1, results in both herbicide tolerance and the expected alteration of the inositol phosphate profile in developing seeds. ZFNs can be used in any plant species amenable to DNA delivery; our results therefore establish a new strategy for plant genetic manipulation in basic science and agricultural applications.	[Shukla, Vipula K.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.] Dow AgroSci, Indianapolis, IN 46268 USA; [Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Point Richmond Tech Ctr, Richmond, CA 94804 USA	Dow Chemical Company	Shukla, VK (corresponding author), Dow AgroSci, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	vkshukla@dow.com		Rock, Jeremy/0000-0002-9310-951X; Gregory, Philip/0000-0001-9249-2468; Doyon, Yannick/0000-0002-3889-9563				Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; BUSCHER BAP, 1995, J CHROMATOGR A, V712, P235, DOI 10.1016/0021-9673(95)00202-X; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Iida S, 2005, PLANT MOL BIOL, V59, P205, DOI 10.1007/s11103-005-2162-x; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MADDALONI M, 1989, NUCLEIC ACIDS RES, V17, P7532, DOI 10.1093/nar/17.18.7532; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petolino JF, 2000, PLANT CELL REP, V19, P781, DOI 10.1007/s002999900180; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Sun YJ, 2007, PLANT PHYSIOL, V144, P1278, DOI 10.1104/pp.107.095455; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; WOHLLEBEN W, 1988, GENE, V70, P25, DOI 10.1016/0378-1119(88)90101-1; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x	44	565	686	3	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					437	U156		10.1038/nature07992	http://dx.doi.org/10.1038/nature07992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404259				2022-12-24	WOS:000266243700048
J	Gruber, S; Errington, J				Gruber, Stephan; Errington, Jeff			Recruitment of Condensin to Replication Origin Regions by ParB/SpoOJ Promotes Chromosome Segregation in B. subtilis	CELL			English	Article							BACILLUS-SUBTILIS; SMC PROTEIN; ESCHERICHIA-COLI; DNA-BINDING; CAULOBACTER-CRESCENTUS; STRUCTURAL MAINTENANCE; SPO0J; BACTERIAL; PARB; INITIATION	Proper segregation of DNA replication products is essential in all cells. In Bacillus subtilis, two protein complexes have been implicated in this process: the ParAB homologs, Soj and SpoOJ, and the bacterial Smc/ScpAB complex, also called condensin. Here we demonstrate that Smc is highly enriched in the region around the origin of replication, specifically near parS sites to which SpoOJ binds and at highly transcribed genes. Furthermore, we find that efficient recruitment of Smc to a large region around the origin of replication depends on the presence of SpoOJ. We show that SpoOJ performs two independent functions: regulation of initiation of DNA replication via Soj and promotion of chromosome segregation by Smc recruitment. Our results demonstrate a direct functional interaction between two widely conserved systems involved in chromosome replication and segregation.	[Gruber, Stephan; Errington, Jeff] Univ Newcastle, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Errington, J (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeff.errington@ncl.ac.uk	Gruber, Stephan/G-5686-2012; Errington, Jeff/G-1832-2011; Gruber, Stephan/AFC-4848-2022	Errington, Jeff/0000-0002-6977-9388; Gruber, Stephan/0000-0002-0150-0395	BBSRC; European Molecular Biology Organization (EMBO); International Human Frontier Science Program Organization (HFSPO)	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program)	We are grateful to Alan Grossman for kindly providing the alpha-Smc antibody. We thank Mark Leaver, Heath Murray, Jan-Willem Veening, and Ling Juan Wu for plasmids, strains, and reagents and for critical reading of the manuscript. This work was supported by a BBSRC grant to J. E. S. G. was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and the International Human Frontier Science Program Organization (HFSPO).	Autret S, 2001, MOL MICROBIOL, V41, P743, DOI 10.1046/j.1365-2958.2001.02551.x; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; SANSEAU P, 1990, ANAL BIOCHEM, V189, P142, DOI 10.1016/0003-2697(90)90060-M; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Soppa J, 2001, GENE, V278, P253, DOI 10.1016/S0378-1119(01)00733-8; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656	34	221	221	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					685	696		10.1016/j.cell.2009.02.035	http://dx.doi.org/10.1016/j.cell.2009.02.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450516	Bronze			2022-12-24	WOS:000266114100017
J	Hare, TA; Camerer, CF; Rangel, A				Hare, Todd A.; Camerer, Colin F.; Rangel, Antonio			Self-Control in Decision-Making Involves Modulation of the vmPFC Valuation System	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; LIMITED-RESOURCE; WORKING-MEMORY; REWARD; DELAY; CONFLICT; PERFORMANCE	Every day, individuals make dozens of choices between an alternative with higher overall value and a more tempting but ultimately inferior option. Optimal decision-making requires self-control. We propose two hypotheses about the neurobiology of self-control: (i) Goal-directed decisions have their basis in a common value signal encoded in ventromedial prefrontal cortex (vmPFC), and (ii) exercising self-control involves the modulation of this value signal by dorsolateral prefrontal cortex (DLPFC). We used functional magnetic resonance imaging to monitor brain activity while dieters engaged in real decisions about food consumption. Activity in vmPFC was correlated with goal values regardless of the amount of self-control. It incorporated both taste and health in self-controllers but only taste in non-self-controllers. Activity in DLPFC increased when subjects exercised self-control and correlated with activity in vmPFC.	[Hare, Todd A.; Camerer, Colin F.; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology	Hare, TA (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	thare@hss.caltech.edu	Hare, Todd A/E-7091-2017; Hare, Todd/AAE-8574-2019	Hare, Todd A/0000-0002-0260-2772; Hare, Todd/0000-0002-0260-2772	Moore Foundation; Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity	Moore Foundation(Gordon and Betty Moore Foundation); Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity	This work was funded by the Moore Foundation and the Economic Research Service of the U.S. Department of Agriculture on Behavioral Health Economics Research on Dietary Choice and Obesity.	Ainslie G, 2003, J EXP ANAL BEHAV, V79, P37, DOI 10.1901/jeab.2003.79-37; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Campbell-Meiklejohn DK, 2008, BIOL PSYCHIAT, V63, P293, DOI 10.1016/j.biopsych.2007.05.014; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Monterosso J, 2007, DRUG ALCOHOL DEPEN, V90, pS100, DOI 10.1016/j.drugalcdep.2006.09.004; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Vohs KD, 2008, J PERS SOC PSYCHOL, V94, P883, DOI 10.1037/0022-3514.94.5.883; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 2005, EXP BRAIN RES, V166, P263, DOI 10.1007/s00221-005-2358-y	28	1235	1270	11	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					646	648		10.1126/science.1168450	http://dx.doi.org/10.1126/science.1168450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439DW	19407204	Green Accepted			2022-12-24	WOS:000265608800045
J	Akopyants, NS; Kimblin, N; Secundino, N; Patrick, R; Peters, N; Lawyer, P; Dobson, DE; Beverley, SM; Sacks, DL				Akopyants, Natalia S.; Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Dobson, Deborah E.; Beverley, Stephen M.; Sacks, David L.			Demonstration of Genetic Exchange During Cyclical Development of Leishmania in the Sand Fly Vector	SCIENCE			English	Article							TRYPANOSOMA-BRUCEI; GENOMIC ORGANIZATION; DONOVANI COMPLEX; MAJOR FRIEDLIN; RECOMBINATION; TRANSMISSION; EXPRESSION; VIRULENCE; MARKER; CROSS	Genetic exchange has not been shown to be a mechanism underlying the extensive diversity of Leishmania parasites. We report here evidence that the invertebrate stages of Leishmania are capable of having a sexual cycle consistent with a meiotic process like that described for African trypanosomes. Hybrid progeny were generated that bore full genomic complements from both parents, but kinetoplast DNA maxicircles from one parent. Mating occurred only in the sand fly vector, and hybrids were transmitted to the mammalian host by sand fly bite. Genetic exchange likely contributes to phenotypic diversity in natural populations, and analysis of hybrid progeny will be useful for positional cloning of the genes controlling traits such as virulence, tissue tropism, and drug resistance.	[Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Sacks, David L.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Akopyants, Natalia S.; Dobson, Deborah E.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Sacks, DL (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	dsacks@nih.gov	Secundino, Nagila/AAM-4553-2020; Peters, Nathan/AAW-8289-2020	Peters, Nathan/0000-0002-2548-9581; Beverley, Stephen/0000-0001-5319-0811	Intramural Research Program of the NIH; National Institute of Allergy and Infectious Diseases (NIAID) [A1029646, A1020941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646, ZIAAI000256] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID), and in part by NIAID grant support (S.M.B., D.E.D., and N.S.A. A1029646 and A1020941). We thank K. Owens for inventorying and shipping parasite strains; K. Beacht for mouse infection studies; and M. Grigg, L. Miller, and A. Sher for critical review of the manuscript. Maxicircle sequences have been submitted to GenBank and had been assigned accession numbers FJ349262 to FJ349263 (12S rRNA) and FJ349264 to FJ349265 (Divergent region).	Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Dobson DE, 2006, MOL BIOCHEM PARASIT, V146, P231, DOI 10.1016/j.molbiopara.2005.12.012; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Martinez-Calvillo S, 2001, MOL BIOCHEM PARASIT, V116, P147, DOI 10.1016/S0166-6851(01)00310-3; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; MOODY ME, 1993, GENETICS, V134, P649; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ravel C, 1998, PARASITOL TODAY, V14, P301, DOI 10.1016/S0169-4758(98)01275-7; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Rose MD, 1996, ANNU REV CELL DEV BI, V12, P663, DOI 10.1146/annurev.cellbio.12.1.663; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; Tibayrenc M., 1993, Archives de l'Institut Pasteur de Tunis, V70, P375; TURNER CMR, 1995, EXP PARASITOL, V80, P234, DOI 10.1006/expr.1995.1029	26	224	226	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					265	268		10.1126/science.1169464	http://dx.doi.org/10.1126/science.1169464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359589	Green Accepted			2022-12-24	WOS:000265024400050
J	Warren, WS; Jenista, E; Branca, RT; Chen, X				Warren, Warren S.; Jenista, Elizabeth; Branca, Rosa Tamara; Chen, Xin			Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates	SCIENCE			English	Article							MAGNETIC-RESONANCE SPECTRA; POLARIZATION; NMR	The sensitivity limitations for magnetic resonance imaging of organic molecules have recently been addressed by hyperpolarization methods, which prepare excess nuclear spin polarization. This approach can increase sensitivity by orders of magnitude, but the enhanced signal relaxes away in tens of seconds, even in favorable cases. Here we show theoretically that singlet states between strongly coupled spins in molecules can be used to store and retrieve population in very-long-lived disconnected eigenstates, as long as the coupling between the spins substantially exceeds both the couplings to other spins and the resonance frequency difference between them. Experimentally, 2,3-carbon-13-labeled diacetyl has a disconnected eigenstate that can store population for minutes and is read out by hydration to make the two spins inequivalent.	[Warren, Warren S.] Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA	Duke University; Duke University	Warren, WS (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	warren.warren@duke.edu		Branca, Rosa Tamara/0000-0002-6871-1824	NIH [EB02122]; North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH under grant EB02122 and by the North Carolina Biotechnology Center. We thank D. Bhattacharyya for his help in determining optimal conditions to hyperpolarize diacetyl; M. Jenista for help with calculations; T. Ribiero for his assistance in running NMR spectra; L. Bouchard for discussions of singlet character in strongly coupled systems; and S. Craig, E. Toone, D. Coltart, and M. S. Warren for particularly useful discussions on the chemistry of these compounds. A provisional patent has been submitted on this work by W.S.W. and Duke University.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; ABRAHAM RJ, 1961, CAN J CHEM, V39, P216, DOI 10.1139/v61-025; Ahuja P, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2778429; ANET FA, 1961, CAN J CHEM, V39, P2262, DOI 10.1139/v61-300; BECKER ED, 2000, HIGH RESOLUTION NMR, P171; Bell R., 1966, ADV PHYS ORG CHEM, V4, P1, DOI DOI 10.1016/S0065-3160(08)60351-2; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; Carravetta M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153003; Day IJ, 2007, MAGN RESON CHEM, V45, P1018, DOI 10.1002/mrc.2090; DELCAMPO G, 1992, ANALYST, V117, P1343, DOI 10.1039/an9921701343; Gabellieri C, 2008, J AM CHEM SOC, V130, P4598, DOI 10.1021/ja8001293; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Hall DA, 1997, SCIENCE, V276, P930, DOI 10.1126/science.276.5314.930; HOECKER W. H., 1942, Journal of Dairy Science, V25, P175, DOI 10.3168/jds.S0022-0302(42)95279-2; Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0; Kiselyov AS, 2006, CHEM BIOL DRUG DES, V68, P308, DOI 10.1111/j.1747-0285.2006.00456.x; Kurhanewicz J, 2008, J NUCL MED, V49, P341, DOI 10.2967/jnumed.107.045112; MacFall JR, 1996, RADIOLOGY, V200, P553, DOI 10.1148/radiology.200.2.8685356; McCarney ER, 2007, P NATL ACAD SCI USA, V104, P1754, DOI 10.1073/pnas.0610540104; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MUSHER JI, 1962, TETRAHEDRON, V18, P791, DOI 10.1016/S0040-4020(01)92729-2; Natterer J, 1997, PROG NUCL MAG RES SP, V31, P293, DOI 10.1016/S0079-6565(97)00007-1; POPLE JA, 1957, CAN J CHEM, V35, P1060, DOI 10.1139/v57-143; SAUPE A, 1965, Z NATURFORSCH PT A, VA 20, P572; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC	28	169	171	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1711	1714		10.1126/science.1167693	http://dx.doi.org/10.1126/science.1167693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325112	Green Accepted, Green Submitted			2022-12-24	WOS:000264559800035
J	Cardin, JA; Carlen, M; Meletis, K; Knoblich, U; Zhang, F; Deisseroth, K; Tsai, LH; Moore, CI				Cardin, Jessica A.; Carlen, Marie; Meletis, Konstantinos; Knoblich, Ulf; Zhang, Feng; Deisseroth, Karl; Tsai, Li-Huei; Moore, Christopher I.			Driving fast-spiking cells induces gamma rhythm and controls sensory responses	NATURE			English	Article							NEURONAL SYNCHRONIZATION; ELECTRICAL SYNAPSES; CORTICAL NETWORKS; FAST OSCILLATIONS; CORTEX; INTERNEURONS; BRAIN; SCHIZOPHRENIA; GENERATION; ATTENTION	Cortical gamma oscillations (20-80 Hz) predict increases in focused attention, and failure in gamma regulation is a hallmark of neurological and psychiatric disease. Current theory predicts that gamma oscillations are generated by synchronous activity of fast-spiking inhibitory interneurons, with the resulting rhythmic inhibition producing neural ensemble synchrony by generating a narrow window for effective excitation. We causally tested these hypotheses in barrel cortex in vivo by targeting optogenetic manipulation selectively to fast-spiking interneurons. Here we show that light-driven activation of fast-spiking interneurons at varied frequencies (8-200 Hz) selectively amplifies gamma oscillations. In contrast, pyramidal neuron activation amplifies only lower frequency oscillations, a cell-type-specific double dissociation. We found that the timing of a sensory input relative to a gamma cycle determined the amplitude and precision of evoked responses. Our data directly support the fast-spiking-gamma hypothesis and provide the first causal evidence that distinct network activity states can be induced in vivo by cell-type-specific activation.	[Cardin, Jessica A.; Knoblich, Ulf; Moore, Christopher I.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cardin, Jessica A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Howard Hughes Medical Institute	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	deissero@stanford.edu; lhtsai@mit.edu; cim@mit.edu	Macrae, Rhiannon/AAX-1536-2020; Moore, Christopher/C-5588-2009; Meletis, Konstantinos/ABE-6777-2020; Carlen, Marie Carlen/C-9112-2014; Knoblich, Ulf/A-1762-2010	Carlen, Marie Carlen/0000-0003-1658-1631; Knoblich, Ulf/0000-0002-0756-5587; Meletis, Konstantinos/0000-0001-5665-4781; Moore, Christopher/0000-0003-4534-1602	NIH/NEI; Knut och Alice Wallenberg Foundation; NARSAD Young Investigator Award; NIH NRSA; Tom F. Petersen; NIH; NSF; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NARSAD Young Investigator Award(NARSAD); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom F. Petersen; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S. Arber for the PV-Cre mice, S. Tonegawa for the CW2 mice, and A. Bradshaw, C. Ruehlmann and S. Su for technical assistance. We thank members of the Boyden laboratory and J. Bernstein for help in setting up optical techniques. We thank members of the Tsai and Moore laboratories, D. Vierling-Claassen and M. J. Higley for discussions and comments on the paper. This study was supported by grants from Tom F. Petersen, the NIH and the NSF to C. I. M. and by the Simons Foundation Autism Research Initiative to L.-H. T. K. D. is supported by the NIH Pioneer Program. L.-H. T. is an investigator of the Howard Hughes Medical Institute. J. A. C. is supported by a K99 from the NIH/NEI, M. C. and K. M. by postdoctoral fellowships from the Knut och Alice Wallenberg Foundation, M. C. by a NARSAD Young Investigator Award, and F. Z. by an NIH NRSA.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Berger H, 1969, ELECTROENCEPHALOGR S, P37; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Cauli B, 1997, J NEUROSCI, V17, P3894; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hubbard JI., 1969, ELECTROPHYSIOLOGICAL; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; REN JQ, 1992, EXP BRAIN RES, V92, P1; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	33	1678	1735	8	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					663	U63		10.1038/nature08002	http://dx.doi.org/10.1038/nature08002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396156	Green Accepted			2022-12-24	WOS:000266608600035
J	Dean, S; Marchetti, R; Kirk, K; Matthews, KR				Dean, Samuel; Marchetti, Rosa; Kirk, Kiaran; Matthews, Keith R.			A surface transporter family conveys the trypanosome differentiation signal	NATURE			English	Article							BLOOD-STREAM; LIFE-CYCLE; AFRICAN TRYPANOSOMES; PROCYCLIC FORMS; BRUCEI; TRANSFORMATION; MALARIA; ACID; TEMPERATURE; PROGRESSION	Microbial pathogens use environmental cues to trigger the developmental events needed to infect mammalian hosts or transmit to disease vectors. The parasites causing African sleeping sickness respond to citrate or cis-aconitate (CCA) to initiate life-cycle development when transmitted to their tsetse fly vector. This requires hypersensitization of the parasites to CCA by exposure to low temperature, conditions encountered after tsetse fly feeding at dusk or dawn. Here we identify a carboxylate-transporter family, PAD (proteins associated with differentiation), required for perception of this differentiation signal. Consistent with predictions for the response of trypanosomes to CCA, PAD proteins are expressed on the surface of the transmission-competent 'stumpy-form' parasites in the bloodstream, and at least one member is thermoregulated, showing elevated expression and surface access at low temperature. Moreover, RNA-interference-mediated ablation of PAD expression diminishes CCA-induced differentiation and eliminates CCA hypersensitivity under cold-shock conditions. As well as being molecular transducers of the differentiation signal in these parasites, PAD proteins provide the first example of a surface marker able to discriminate the transmission stage of trypanosomes in their mammalian host.	[Dean, Samuel; Matthews, Keith R.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Marchetti, Rosa; Kirk, Kiaran] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia	University of Edinburgh; Australian National University	Matthews, KR (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keith.matthews@ed.ac.uk	Kirk, Kiaran/C-8299-2009	Kirk, Kiaran/0000-0002-5613-2622; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184; Dean, Samuel/0000-0002-4792-2198	Wellcome Trust; BBSRC studentship; Wellcome Trust Programme; Centre for Immunity, Infection and Evolution; BBSRC REI; Biotechnology and Biological Sciences Research Council [BB/E012442/1] Funding Source: researchfish; BBSRC [BB/E012442/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Programme(Wellcome Trust); Centre for Immunity, Infection and Evolution; BBSRC REI(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Ullu for the gift of genomic macroarrays, M. Engstler and M. Boshart for the gift of the AnTat1.1 90: 13 line, and A. Schneider for pALC14. We thank D. Hall, P. Davies and D. Levin for technical assistance, P. MacGregor for statistical analysis and A. Paterou and D. Murray for Image analysis. This work was supported by a Wellcome Trust project grant and programme grant to K. R. M. S. D. was supported by a BBSRC studentship, a Wellcome Trust Programme Grant to K. R. M. and by a Journal of Cell Science Travelling fellowship for a visit to the laboratory of K. K. Support was also provided through a Wellcome Trust strategic award for the Centre for Immunity, Infection and Evolution and a BBSRC REI award for confocal facilities.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BASS KE, 1991, MOL BIOCHEM PARASIT, V44, P261, DOI 10.1016/0166-6851(91)90012-U; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bruce D, 1912, P R SOC LOND B-CONTA, V85, P423, DOI 10.1098/rspb.1912.0068; CZICHOS J, 1986, EXP PARASITOL, V62, P283, DOI 10.1016/0014-4894(86)90033-0; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Fang J, 2002, NATURE, V418, P742, DOI 10.1038/418742a; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; HUNT M, 1994, PARASITOL RES, V80, P600, DOI 10.1007/BF00933009; JACOBS SL, 1964, J NUCL MED, V5, P297; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; MATTHEWS KR, 1994, J CELL BIOL, V125, P1147, DOI 10.1083/jcb.125.5.1147; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Robertson M, 1912, P R SOC LOND B-CONTA, V85, P241, DOI 10.1098/rspb.1912.0048; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; SHAPIRO SZ, 1984, ACTA TROP, V41, P313; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Tasker M, 2000, MOL BIOL CELL, V11, P1905, DOI 10.1091/mbc.11.5.1905; TURNER CMR, 1988, PARASITOL RES, V74, P507, DOI 10.1007/BF00531626; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vassella E, 1997, J CELL SCI, V110, P2661; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	32	154	154	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					213	U93		10.1038/nature07997	http://dx.doi.org/10.1038/nature07997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444208	Green Accepted			2022-12-24	WOS:000266036100032
J	Hardy, J; Singleton, A				Hardy, John; Singleton, Andrew			CURRENT CONCEPTS Genomewide Association Studies and Human Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; GENE-EXPRESSION; PARKINSONS-DISEASE; WIDE ASSOCIATION; RISK; LOCUS; DROSOPHILA-PINK1; SUSCEPTIBILITY; CHOLESTEROL		[Hardy, John] UCL, Inst Neurol, London WC1N 3BG, England; [Singleton, Andrew] Neurogenet Lab, Bethesda, MD USA	University of London; University College London	Hardy, J (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	jhardy@ion.ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423	National Institute on Aging of the National Institutes of Health [1-Z01-AG000949-02]; Medical Research Council; MRC [G0701075] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000949, ZIAAG000932, Z01AG000949] Funding Source: NIH RePORTER; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	Supported in part by the Intramural Research Program of the National Institute on Aging of the National Institutes of Health ( project number, 1-Z01-AG000949-02) and by the Medical Research Council.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brenner S, 2000, NAT BIOTECHNOL, V18, P1021; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hardy J, 2000, NEUROBIOL DIS, V7, P65, DOI 10.1006/nbdi.2000.0291; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melquist S, 2007, AM J HUM GENET, V80, P769, DOI 10.1086/513320; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; *NIH RODAM MED RES, GEN TISS EXPR GTEX P; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; 1000 GENOMES DEEP CA	46	532	564	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1759	1768		10.1056/NEJMra0808700	http://dx.doi.org/10.1056/NEJMra0808700			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369657	Green Accepted			2022-12-24	WOS:000265377800010
J	Flames, N; Hobert, O				Flames, Nuria; Hobert, Oliver			Gene regulatory logic of dopamine neuron differentiation	NATURE			English	Article							OLFACTORY-BULB INTERNEURONS; C-ELEGANS; TRANSCRIPTIONAL CODES; EXPRESSION; BRAIN; ARCHITECTURE; INSIGHTS; IDENTITY; ER81; AXON	Dopamine signalling regulates a variety of complex behaviours, and defects in dopamine neuron function or survival result in severe human pathologies, such as Parkinson's disease(1). The common denominator of all dopamine neurons is the expression of dopamine pathway genes, which code for a set of phylogenetically conserved proteins involved in dopamine synthesis and transport. Gene regulatory mechanisms that result in the direct activation of dopamine pathway genes and thereby ultimately determine the identity of dopamine neurons are poorly understood in all systems studied so far(2). Here we show that a simple cis-regulatory element, the dopamine (DA) motif, controls the expression of all dopamine pathway genes in all dopaminergic cell types in Caenorhabditis elegans. The DA motif is activated by the ETS transcription factor AST-1. Loss of ast-1 results in the failure of all distinct dopaminergic neuronal subtypes to terminally differentiate. Ectopic expression of ast-1 is sufficient to activate the dopamine pathway in some cellular contexts. Vertebrate dopamine pathway genes also contain phylogenetically conserved DA motifs that can be activated by the mouse ETS transcription factor Etv1 (also known as ER81), and a specific class of dopamine neurons fails to differentiate in mice lacking Etv1. Moreover, ectopic Etv1 expression induces dopaminergic fate marker expression in neuronal primary cultures. Mouse Etv1 can also functionally substitute for ast-1 in C. elegans. Our studies reveal a simple and apparently conserved regulatory logic of dopamine neuron terminal differentiation and may provide new entry points into the diagnosis or therapy of conditions in which dopamine neurons are defective.	[Flames, Nuria; Hobert, Oliver] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Flames, N (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, 630 W 168th St, New York, NY 10032 USA.	nf2171@columbia.edu; or38@columbia.edu	Flames, Nuria/L-2290-2017	Flames, Nuria/0000-0003-0961-0609; Hobert, Oliver/0000-0002-7634-2854	National Institutes of Health [R01NS039996-05, R01NS050266-03]; Howard Hughes Medical Institute; EMBO; Marie Curie Outgoing International fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Outgoing International fellowship(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for injection assistance, M. Doitsidou and J. Chen for providing the ot417 allele, E. Savner for initiating some of the promoter analysis, A. Kruyer for technical help, the CGC for strains, the C. elegans Gene Knockout Consortia, led by S. Mitani at Tokyo Women's Medical University School of Medicine and by D. Moerman at the University of British Columbia, for knockout alleles, H. Hutter, N. Tavernarakis and T. Jessell for strains and reagents, several members of Columbia University community for sharing their equipment, Hobert laboratory members, especially M. Doitsidou, for discussion, and A. Abeliovich, R. J. Johnston and I. Greenwald for comments on the manuscript. This work was funded by the National Institutes of Health (R01NS039996-05; R01NS050266-03), the Howard Hughes Medical Institute and a EMBO long term fellowship and Marie Curie Outgoing International fellowship to N. F.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Allen ZJ, 2007, J MOL HISTOL, V38, P517, DOI 10.1007/s10735-007-9115-4; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duggan A, 1998, DEVELOPMENT, V125, P4107; Etchberger JF, 2008, NAT METHODS, V5, P3, DOI 10.1038/nmeth0108-3; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Saino-Saito S, 2007, J COMP NEUROL, V502, P485, DOI 10.1002/cne.21293; Schmid C, 2006, DEV BIOL, V293, P403, DOI 10.1016/j.ydbio.2006.02.042; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Voglis G, 2008, EMBO J, V27, P3288, DOI 10.1038/emboj.2008.252; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004	25	163	180	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					885	U7		10.1038/nature07929	http://dx.doi.org/10.1038/nature07929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19287374	Green Accepted			2022-12-24	WOS:000265182500042
J	Schmidt, M; Lipson, H				Schmidt, Michael; Lipson, Hod			Distilling Free-Form Natural Laws from Experimental Data	SCIENCE			English	Article							PRINCIPLES; DISCOVERY; SCIENCE	For centuries, scientists have attempted to identify and document analytical laws that underlie physical phenomena in nature. Despite the prevalence of computing power, the process of finding natural laws and their corresponding equations has resisted automation. A key challenge to finding analytic relations automatically is defining algorithmically what makes a correlation in observed data important and insightful. We propose a principle for the identification of nontriviality. We demonstrated this approach by automatically searching motion-tracking data captured from various physical systems, ranging from simple harmonic oscillators to chaotic double-pendula. Without any prior knowledge about physics, kinematics, or geometry, the algorithm discovered Hamiltonians, Lagrangians, and other laws of geometric and momentum conservation. The discovery rate accelerated as laws found for simpler systems were used to bootstrap explanations for more complex systems, gradually uncovering the "alphabet" used to describe those systems.	[Lipson, Hod] Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University	Lipson, H (corresponding author), Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu	Giagounidis, Aristoteles/S-7097-2019; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Integrative Graduate Education and Research Traineeship program; U.S. NSF graduate research fellowship; NSF Creative-IT [0757478]; CAREER [0547376]	Integrative Graduate Education and Research Traineeship program(National Science Foundation (NSF)); U.S. NSF graduate research fellowship; NSF Creative-IT; CAREER(National Science Foundation (NSF))	This research was supported in part by Integrative Graduate Education and Research Traineeship program in nonlinear systems, a U.S. NSF graduate research fellowship, and NSF Creative-IT grant 0757478 and CAREER grant 0547376. We thank M. Kurman for editorial consultation and substantive editing of the manuscript.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Clery D, 2005, SCIENCE, V308, P809, DOI 10.1126/science.308.5723.809; CYRIL F, 2007, 2007 IEEE C EV COMP, P23; De Jong E. D., 2003, Genetic Programming and Evolvable Machines, V4, P211, DOI 10.1023/A:1025122906870; Duffy J, 2002, STUD FUZZ SOFT COMP, V100, P61; ELENA B, 2005, 7 INT S SYMB NUM ALG, P321; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; GREGORY P, 2003, EV ART 6 INT C, V2936, P267; Hanc J, 2004, AM J PHYS, V72, P428, DOI 10.1119/1.1591764; Jackel P, 1998, P ROY SOC A-MATH PHY, V454, P3257, DOI 10.1098/rspa.1998.0300; Jones RM, 2005, COMPUT INTELL-US, V21, P480, DOI 10.1111/j.1467-8640.2005.00283.x; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Koza JR, 1992, GENETIC PROGRAMMING; LANGLEY P, 1981, COGNITIVE SCI, V5, P31, DOI 10.1016/S0364-0213(81)80025-0; Liang Y, 2008, NONLINEAR DYNAM, V52, P181, DOI 10.1007/s11071-007-9270-x; Marquet PA, 2002, NATURE, V418, P723, DOI 10.1038/418723c; MOR M, 2007, P 21 ASME BIENN C ME, P1; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Noether E, 1918, MATHEMATISCH PHYSIKA, P235, DOI DOI 10.1080/00411457108231446; SHINBROT T, 1992, AM J PHYS, V60, P491, DOI 10.1119/1.16860; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szalay A, 2006, NATURE, V440, P413, DOI 10.1038/440413a; Valdes-Perez RE, 1999, COMMUN ACM, V42, P37, DOI 10.1145/319382.319389	24	1187	1212	33	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					81	85		10.1126/science.1165893	http://dx.doi.org/10.1126/science.1165893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342586				2022-12-24	WOS:000264802100036
J	Jencks, SF; Williams, MV; Coleman, EA				Jencks, Stephen F.; Williams, Mark V.; Coleman, Eric A.			Rehospitalizations among Patients in the Medicare Fee-for-Service Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Meeting on Reducing Hospital Readmissions	JAN 25, 2008	Washington, DC	Commwlth Fund, Acad Hlth			HEART-FAILURE; HOSPITAL READMISSIONS; RANDOMIZED-TRIAL; CARE	Background Reducing rates of rehospitalization has attracted attention from policymakers as a way to improve quality of care and reduce costs. However, we have limited information on the frequency and patterns of rehospitalization in the United States to aid in planning the necessary changes. Methods We analyzed Medicare claims data from 2003-2004 to describe the patterns of rehospitalization and the relation of rehospitalization to demographic characteristics of the patients and to characteristics of the hospitals. Results Almost one fifth (19.6%) of the 11,855,702 Medicare beneficiaries who had been discharged from a hospital were rehospitalized within 30 days, and 34.0% were rehospitalized within 90 days; 67.1% of patients who had been discharged with medical conditions and 51.5% of those who had been discharged after surgical procedures were rehospitalized or died within the first year after discharge. In the case of 50.2% of the patients who were rehospitalized within 30 days after a medical discharge to the community, there was no bill for a visit to a physician's office between the time of discharge and rehospitalization. Among patients who were rehospitalized within 30 days after a surgical discharge, 70.5% were rehospitalized for a medical condition. We estimate that about 10% of rehospitalizations were likely to have been planned. The average stay of rehospitalized patients was 0.6 day longer than that of patients in the same diagnosis-related group whose most recent hospitalization had been at least 6 months previously. We estimate that the cost to Medicare of unplanned rehospitalizations in 2004 was $17.4 billion. Conclusions Rehospitalizations among Medicare beneficiaries are prevalent and costly.	[Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA; [Coleman, Eric A.] Univ Colorado, Div Hlth Care Policy & Res, Care Transit Program, Denver, CO 80202 USA	Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Denver			Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Williams, Mark V/0000-0001-6107-0457				A Path to Bundled Payment Around a Rehospitalization, 2005, REP C REF DEL SYST, P83; Adeyemo D, 2007, ANN ROY COLL SURG, V89, P363, DOI 10.1308/003588407X183409; ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; [Anonymous], 2007, MED MED STAT SUPPL; BARR M, 2006, ADV MED HOME PATIENT; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Centers for Medicare Medicaid Services, 2008, FED REGISTER, V73, P23673; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Connolly Ceci, 2009, WASHINGTON POST 0130, pA1; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Gohler A, 2006, J CARD FAIL, V12, P554, DOI 10.1016/j.cardfail.2006.03.003; *IOW FDN MED CAR, 2008, CHRON COND DAT WAR C; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; National Quality Forum, 2007, CAND HOSP CAR ADD PR; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; *SAS I, SAS WIND VERS 8 2	22	3598	3649	3	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1418	1428		10.1056/NEJMsa0803563	http://dx.doi.org/10.1056/NEJMsa0803563			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	427AL	19339721				2022-12-24	WOS:000264751800007
J	Yang, XF; Figueiredo, LM; Espinal, A; Okubo, E; Li, B				Yang, Xiaofeng; Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo			RAP1 Is Essential for Silencing Telomeric Variant Surface Glycoprotein Genes in Trypanosoma brucei	CELL			English	Article							DNA-BINDING DOMAIN; CELL-CYCLE ARREST; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; EXPRESSION SITES; FISSION YEAST; HISTONE H3; PROTEIN; KU	Trypanosoma brucei expresses variant surface glycoprotein (VSG) genes in a strictly monoallelic fashion in its mammalian hosts, but it is unclear how this important virulence mechanism is enforced. Telomere position effect, an epigenetic phenomenon, has been proposed to play a critical role in VSG regulation, yet no telomeric protein has been identified whose disruption led to VSG derepression. We now identify tbRAP1 as an intrinsic component of the T. brucei telomere complex and a major regulator for silencing VSG expression sites (ESs). Knockdown of tbRAP1 led to derepression of all VSGs in silent ESs, but not VSGs located elsewhere, and resulted in stronger derepression of genes located within 10 kb from telomeres than genes located further upstream. This graduated silencing pattern suggests that telomere integrity plays a key role in tbRAP1-dependent silencing and VSG regulation.	[Yang, Xiaofeng; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA; [Yang, Xiaofeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710061, Shaanxi Prov, Peoples R China; [Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	University System of Ohio; Cleveland State University; Xi'an Jiaotong University; Rockefeller University	Li, B (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA.	b.li37@csuohio.edu	Figueiredo, Luisa Miranda/C-3908-2018	Figueiredo, Luisa Miranda/0000-0002-5752-6586	National Institute of Health [AI050614, AI21729, AI066095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050614, R01AI066095, R01AI021729, R37AI021729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Piet Borst for the VSG9 antibody and Keith Gull for the RNA Pol I and tubulin antibodies. We greatly appreciate Titia de Lange and George A.M. Cross for insightful discussions, and we thank Margaret J. Irwin, Audrey Lynn, and members of the Li and Cross labs for comments on the manuscript, critical discussions, and technical support. DeltaVision Microscopy was carried out at the RU Bio-Imaging Resource Center with guidance from Alison North and in BGES Department at CSU. FACS analysis was done at the Flow Cytometry Resource Center at RU and the Flow Cytometry Core at CCF. This work was supported by National Institute of Health grants to G.A.M. Cross (AI050614 and AI21729) and to B.L. (AI066095).	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2005, NUCLEIC ACIDS RES, V33, P4536, DOI 10.1093/nar/gki769; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Evans SK, 1998, CHROMOSOMA, V107, P352, DOI 10.1007/s004120050318; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Glover L, 2006, EMBO REP, V7, P93, DOI 10.1038/sj.embor.7400575; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; GOMMERSAMPT J, 1991, NUCLEIC ACIDS RES, V19, P1745, DOI 10.1093/nar/19.8.1745; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Janzen CJ, 2004, NUCLEIC ACIDS RES, V32, P6575, DOI 10.1093/nar/gkh991; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landeira D, 2007, J CELL BIOL, V176, P133, DOI 10.1083/jcb.200607174; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Navarro M, 1996, MOL CELL BIOL, V16, P3615; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Park MJ, 2002, MOL CELLS, V13, P327; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pedram M, 2006, MOL CELL BIOL, V26, P1865, DOI 10.1128/MCB.26.5.1865-1878.2006; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Teixeira MT, 2005, CHROMOSOME RES, V13, P535, DOI 10.1007/s10577-005-0999-0; VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	68	125	125	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					99	109		10.1016/j.cell.2009.01.037	http://dx.doi.org/10.1016/j.cell.2009.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345190	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000264813300017
J	Elsaesser, H; Sauer, K; Brooks, DG				Elsaesser, Heidi; Sauer, Karsten; Brooks, David G.			IL-21 Is Required to Control Chronic Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ACUTE HEPATITIS-C; T-CELL RESPONSES; IMMUNE EVASION; PERSISTENCE; CD8; INTERLEUKIN-21; EXHAUSTION; CLEARANCE; RECEPTOR	CD4(+) and CD8(+) T cell functions are rapidly aborted during chronic infection, preventing viral clearance. CD4(+) T cell help is required throughout chronic infection so as to sustain CD8(+) T cell responses; however, the necessary factor(s) provided by CD4(+) T cells are currently unknown. Using a mouse model of chronic viral infection, we demonstrated that interleukin-21 (IL-21) is an essential component of CD4(+) T cell help. In the absence of IL-21 signaling, despite elevated CD4(+) T cell responses, CD8(+) T cell responses are severely impaired. CD8(+) T cells directly require IL-21 to avoid deletion, maintain immunity, and resolve persistent infection. Thus, IL-21 specifically sustains CD8(+) T cell effector activity and provides a mechanism of CD4(+) T cell help during chronic viral infection.	[Elsaesser, Heidi; Brooks, David G.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Elsaesser, Heidi; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Scripps Research Institute	Brooks, DG (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	dbrooks@em.ucla.edu		Brooks, David/0000-0001-7763-8764	M. Oldstone [AI09484]; UCLA Center for AIDS Research; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NIH [AI077012, AI082975, AI070845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082975, R01AI085043, R21AI077012, R01AI070845] Funding Source: NIH RePORTER	M. Oldstone; UCLA Center for AIDS Research; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Oldstone for his generous support (AI09484). Our work was supported by the UCLA Center for AIDS Research, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, and NIH grants AI077012, AI082975 (to D.G.B.), and AI070845 (to K.S.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Holm C, 2006, CYTOKINE, V33, P41, DOI 10.1016/j.cyto.2005.11.014; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Smyk-Pearson S, 2008, J VIROL, V82, P1827, DOI 10.1128/JVI.01581-07; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	21	411	425	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1569	1572		10.1126/science.1174182	http://dx.doi.org/10.1126/science.1174182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19423777	Green Accepted			2022-12-24	WOS:000267130600046
J	Wellen, KE; Hatzivassiliou, G; Sachdeva, UM; Bui, TV; Cross, JR; Thompson, CB				Wellen, Kathryn E.; Hatzivassiliou, Georgia; Sachdeva, Uma M.; Bui, Thi V.; Cross, Justin R.; Thompson, Craig B.			ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation	SCIENCE			English	Article							TRANSCRIPTION; H4; DEACETYLATION; ACETYLTRANSFERASE; SYNTHETASE; ACTIVATION; EXPRESSION; COMPLEXES; DYNAMICS; SIRTUINS	Histone acetylation in single-cell eukaryotes relies on acetyl coenzyme A (acetyl-CoA) synthetase enzymes that use acetate to produce acetyl-CoA. Metazoans, however, use glucose as their main carbon source and have exposure only to low concentrations of extracellular acetate. We have shown that histone acetylation in mammalian cells is dependent on adenosine triphosphate (ATP)-citrate lyase (ACL), the enzyme that converts glucose-derived citrate into acetyl-CoA. We found that ACL is required for increases in histone acetylation in response to growth factor stimulation and during differentiation, and that glucose availability can affect histone acetylation in an ACL-dependent manner. Together, these findings suggest that ACL activity is required to link growth factor-induced increases in nutrient metabolism to the regulation of histone acetylation and gene expression.	[Wellen, Kathryn E.; Hatzivassiliou, Georgia; Sachdeva, Uma M.; Bui, Thi V.; Cross, Justin R.; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu		Cross, Justin/0000-0002-6356-057X	NIH [T32-HL07439-27]; National Cancer Institute; Damon Runyon Cancer Research Foundation [DRG-1955-07]; NATIONAL CANCER INSTITUTE [R01CA092660, R01CA105463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Thompson laboratory for helpful comments and discussion and A. Stout for assistance with the deconvolution microscopy. Supported by grants to C.B.T. from NIH and the National Cancer Institute. K.E.W. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation, DRG-1955-07. U.M.S. is supported in part by a training grant from NIH, T32-HL07439-27.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Johnsson A, 2006, EUKARYOT CELL, V5, P1337, DOI 10.1128/EC.00101-06; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KNOSP O, 1991, MOL CELL BIOCHEM, V101, P51; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	31	1373	1408	11	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1076	1080		10.1126/science.1164097	http://dx.doi.org/10.1126/science.1164097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19461003	Green Accepted			2022-12-24	WOS:000266246700043
J	Douglas, SM; Dietz, H; Liedl, T; Hogberg, B; Graf, F; Shih, WM				Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.			Self-assembly of DNA into nanoscale three-dimensional shapes	NATURE			English	Article							DOUBLE-CROSSOVER MOLECULES; CONDUCTIVE NANOWIRES; NANOSTRUCTURES; OCTAHEDRON; NANOTUBES; COMPLEXES; LATTICES; DESIGN	Molecular self-assembly offers a 'bottom-up' route to fabrication with subnanometre precision of complex structures from simple components(1). DNA has proved to be a versatile building block(2-5) for programmable construction of such objects, including two-dimensional crystals(6), nanotubes(7-11), and three-dimensional wire-frame nanopolyhedra(12-17). Templated self-assembly of DNA(18) into custom two-dimensional shapes on the megadalton scale has been demonstrated previously with a multiple-kilobase 'scaffold strand' that is folded into a flat array of antiparallel helices by interactions with hundreds of oligonucleotide 'staple strands'(19,20). Here we extend this method to building custom three-dimensional shapes formed as pleated layers of helices constrained to a honeycomb lattice. We demonstrate the design and assembly of nanostructures approximating six shapes-monolith, square nut, railed bridge, genie bottle, stacked cross, slotted cross-with precisely controlled dimensions ranging from 10 to 100 nm. We also show hierarchical assembly of structures such as homomultimeric linear tracks and heterotrimeric wireframe icosahedra. Proper assembly requires week-long folding times and calibrated monovalent and divalent cation concentrations. We anticipate that our strategy for self-assembling custom three-dimensional shapes will provide a general route to the manufacture of sophisticated devices bearing features on the nanometre scale.	[Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Douglas, Shawn M.; Dietz, Hendrik; Liedl, Tim; Hoegberg, Bjoern; Graf, Franziska; Shih, William M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Douglas, Shawn M.; Graf, Franziska; Shih, William M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Shih, WM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	william_shih@dfci.harvard.edu	CHEN, Jin-dong/F-3610-2011; Douglas, Shawn/GVU-2004-2022; Liedl, Tim/O-7539-2014	Douglas, Shawn/0000-0001-5398-9041; Liedl, Tim/0000-0002-0040-0173; Dietz, Hendrik/0000-0003-1270-3662; Hogberg, Bjorn/0000-0003-2715-7887	Claudia Adams Barr Program Investigator grant; Wyss Institute for Biologically Inspired Engineering; NIH [1DP2OD004641-01]; Humboldt Fellowship; Deutscher Akademischer Austauschdienst (DAAD); Swedish Science Council (Vetenskapsra det); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	Claudia Adams Barr Program Investigator grant; Wyss Institute for Biologically Inspired Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Humboldt Fellowship(Alexander von Humboldt Foundation); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Swedish Science Council (Vetenskapsra det)(Swedish Research Council); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Su for assistance in cloning M13-based scaffold sequences and G. Hess for pilot studies on the railed-bridge design. This work was supported by a Claudia Adams Barr Program Investigator grant, a Wyss Institute for Biologically Inspired Engineering at Harvard grant, and an NIH New Investigator grant (1DP2OD004641-01) to W. M. S., a Humboldt Fellowship to H. D., Deutscher Akademischer Austauschdienst (DAAD) Fellowship to T. L., and Swedish Science Council (Vetenskapsra det) Fellowship to B. H.	Budker V, 2006, BIOPOLYMERS, V83, P646, DOI 10.1002/bip.20602; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; DIEKMANN S, 1987, NUCLEIC ACIDS RES, V15, P5765, DOI 10.1093/nar/15.14.5765; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; DOUGLAS SM, NUCL ACIDS IN PRESS; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Harris JR, 1996, MICROSC MICROANAL, V2, P43, DOI [10.1017/S1431927696210438, DOI 10.1017/S1431927696210438]; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hibino K, 2006, CHEM PHYS LETT, V426, P405, DOI 10.1016/j.cplett.2006.05.120; Jungmann R, 2008, J AM CHEM SOC, V130, P10062, DOI 10.1021/ja8030196; Li XJ, 1996, J AM CHEM SOC, V118, P6131, DOI 10.1021/ja960162o; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	29	1726	1820	28	945	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					414	418		10.1038/nature08016	http://dx.doi.org/10.1038/nature08016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19458720	Green Submitted, Green Accepted			2022-12-24	WOS:000266243700043
J	Meijsing, SH; Pufall, MA; So, AY; Bates, DL; Chen, L; Yamamoto, KR				Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Bates, Darren L.; Chen, Lin; Yamamoto, Keith R.			DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity	SCIENCE			English	Article							RESPONSE ELEMENTS; NUCLEAR RECEPTOR; GENE; EXPRESSION; REPRESSION; MOTIF	Genes are not simply turned on or off, but instead their expression is fine-tuned to meet the needs of a cell. How genes are modulated so precisely is not well understood. The glucocorticoid receptor (GR) regulates target genes by associating with specific DNA binding sites, the sequences of which differ between genes. Traditionally, these binding sites have been viewed only as docking sites. Using structural, biochemical, and cell-based assays, we show that GR binding sequences, differing by as little as a single base pair, differentially affect GR conformation and regulatory activity. We therefore propose that DNA is a sequence-specific allosteric ligand of GR that tailors the activity of the receptor toward specific target genes.	[Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94107 USA; [Bates, Darren L.; Chen, Lin] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	yamamoto@cmp.ucsf.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Pufall, Miles/0000-0002-7022-6916	NIH [GM08537]; NATIONAL CANCER INSTITUTE [R01CA020535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, T32GM008537, R01GM077320] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.C. Bolton, A. Kroch, J. J. Miranda, and A. Frankel for reviewing the manuscript. Work by M.A.P. was performed under NIH grant GM08537 and by M.A.P. and S.H.M. as fellows of the Leukemia and Lymphoma Society. We received research support from NIH grants (to K.R.Y., D.L.B., and L.C.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3FYL, 3G6P, 3G6Q, 3G6R, 3G6T, 3G6U, 3G8U, 3G97, 3G8X, 3G99, 3G9I, 3G9J, 3G9M, 3G9O, and 3G9P. K.R.Y. is a paid consultant with Merck and Company.	GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; KASAI Y, 1990, FEBS LETT, V274, P99, DOI 10.1016/0014-5793(90)81339-P; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Meyer T, 1997, DNA CELL BIOL, V16, P919, DOI 10.1089/dna.1997.16.919; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101	23	502	517	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					407	410		10.1126/science.1164265	http://dx.doi.org/10.1126/science.1164265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372434	Green Accepted			2022-12-24	WOS:000265221600048
J	Cypess, AM; Lehman, S; Williams, G; Tal, I; Rodman, D; Goldfine, AB; Kuo, FC; Palmer, EL; Tseng, Y; Doria, A; Kolodny, GM; Kahn, CR				Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald			Identification and Importance of Brown Adipose Tissue in Adult Humans.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DIET-INDUCED THERMOGENESIS; F-18-FDG PET/CT; FDG-UPTAKE; USA-FAT; OBESITY; TEMPERATURE; PATIENT; MUSCLE; SCANS	Background: Obesity results from an imbalance between energy intake and expenditure. In rodents and newborn humans, brown adipose tissue helps regulate energy expenditure by thermogenesis mediated by the expression of uncoupling protein 1 (UCP1), but brown adipose tissue has been considered to have no physiologic relevance in adult humans. Methods: We analyzed 3640 consecutive (sup 18)F-fluorodeoxyglucose ((sup 18)F-FDG) positron-emission tomographic and computed tomographic (PET-CT) scans performed for various diagnostic reasons in 1972 patients for the presence of substantial depots of putative brown adipose tissue. Such depots were defined as collections of tissue that were more than 4 mm in diameter, had the density of adipose tissue according to CT, and had maximal standardized uptake values of (sup 18)F-FDG of at least 2.0 g per milliliter, indicating high metabolic activity. Clinical indexes were recorded and compared with those of date-matched controls. Immunostaining for UCP1 was performed on biopsy specimens from the neck and supraclavicular regions in patients undergoing surgery. Results: Substantial depots of brown adipose tissue were identified by PET-CT in a region extending from the anterior neck to the thorax. Tissue from this region had UCP1-immunopositive, multilocular adipocytes indicating brown adipose tissue. Positive scans were seen in 76 of 1013 women (7.5%) and 30 of 959 men (3.1%), corresponding to a female:male ratio greater than 2:1 (P<0.001). Women also had a greater mass of brown adipose tissue and higher (sup 18)F-FDG uptake activity. The probability of the detection of brown adipose tissue was inversely correlated with years of age (P<0.001), outdoor temperature at the time of the scan (P=0.02), beta-blocker use (P<0.001), and among older patients, body-mass index (P=0.007). Conclusions: Defined regions of functionally active brown adipose tissue are present in adult humans, are more frequent in women than in men, and may be quantified noninvasively with the use of (sup 18)F-FDG PET-CT. Most important, the amount of brown adipose tissue is inversely correlated with body-mass index, especially in older people, suggesting a potential role of brown adipose tissue in adult human metabolism. N Engl J Med 2009;360:1509-17.	[Kahn, C. Ronald] Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, Boston, MA 02215 USA; [Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Kolodny, Gerald M.] Beth Israel Deaconess Med Ctr, Div Nucl Med, Boston, MA 02215 USA; [Kuo, Frank C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Palmer, Edwin L.] Massachusetts Gen Hosp, Div Nucl Med, Boston, MA 02114 USA; [Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Doria, Alessandro/H-9157-2018; Kahn, Ronald/AAY-2435-2021; Tseng, Yu-Hua/AAE-6471-2021	Doria, Alessandro/0000-0002-3830-4304; Kahn, Ronald/0000-0002-7583-9228; Tseng, Yu-Hua/0000-0003-2053-9559; mcmurry, andy/0000-0001-5604-0704	National Institutes of Health [DK070722, P30 DK46200, DK33201, DK55545, DK046200-16]; Eli Lilly Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056690, R01DK055545, R21DK070722, T32DK007260, R01DK033201, P30DK040561, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Foundation(Eli Lilly); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Clinical Investigator Training Program, Beth Israel Deaconess Medical Center-Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer and Merck; grants from the National Institutes of Health (DK070722 and P30 DK46200 [to Dr. Tseng], DK33201 and DK55545 [to Dr. Kahn], and DK046200-16 [to Dr. Cypess]); and the Eli Lilly Foundation.	Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; ASTRUP A, 1984, CLIN SCI, V66, P179, DOI 10.1042/cs0660179; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Barbaras L, 2007, AM J ROENTGENOL, V188, pW565, DOI 10.2214/AJR.06.1058; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; Dobert N, 2004, Q J NUCL MED MOL IM, V48, P33; ENGLISH JT, 1973, RADIOLOGY, V107, P279, DOI 10.1148/107.2.279; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fukuchi K, 2004, EXP CLIN ENDOCR DIAB, V112, P601, DOI 10.1055/s-2004-830407; Garcia CA, 2004, MOL IMAGING BIOL, V6, P368, DOI 10.1016/j.mibio.2004.08.003; GARRUTI G, 1992, INT J OBESITY, V16, P383; Gelfand MJ, 2005, PEDIATR RADIOL, V35, P984, DOI 10.1007/s00247-005-1505-8; Gesta S, 2008, CELL, V135, P366, DOI 10.1016/j.cell.2008.09.048; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HEATON JM, 1972, J ANAT, V112, P35; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Hossain P, 2007, NEW ENGL J MED, V356, P973; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Parodi K, 2007, INT J RADIAT ONCOL, V68, P920, DOI 10.1016/j.ijrobp.2007.01.063; Parysow O, 2007, CLIN NUCL MED, V32, P351, DOI 10.1097/01.rlu.0000259570.69163.04; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROSS R, 1991, J APPL PHYSIOL, V70, P2164, DOI 10.1152/jappl.1991.70.5.2164; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Rousseau C, 2006, EUR J NUCL MED MOL I, V33, P785, DOI 10.1007/s00259-006-0066-x; Sharma AM, 2001, HYPERTENSION, V37, P250, DOI 10.1161/01.HYP.37.2.250; Tatsumi M, 2004, J NUCL MED, V45, P1189; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Williams G, 2008, AM J ROENTGENOL, V190, P1406, DOI 10.2214/AJR.07.3205; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Yeung HWD, 2003, J NUCL MED, V44, P1789	41	2963	3103	12	367	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1509	1517		10.1056/NEJMoa0810780	http://dx.doi.org/10.1056/NEJMoa0810780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357406	Green Accepted			2022-12-24	WOS:000264976800007
J	Cho, DH; Nakamura, T; Fang, JG; Cieplak, P; Godzik, A; Gu, Z; Lipton, SA				Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Cieplak, Piotr; Godzik, Adam; Gu, Zezong; Lipton, Stuart A.			S-Nitrosylation of Drp1 Mediates beta-Amyloid-Related Mitochondrial Fission and Neuronal Injury	SCIENCE			English	Article							NITRIC-OXIDE; ALZHEIMERS-DISEASE; DYNAMIN; PROTEIN; NEURODEGENERATION; APOPTOSIS	Mitochondria continuously undergo two opposing processes, fission and fusion. The disruption of this dynamic equilibrium may herald cell injury or death and may contribute to developmental and neurodegenerative disorders. Nitric oxide functions as a signaling molecule, but in excess it mediates neuronal injury, in part via mitochondrial fission or fragmentation. However, the underlying mechanism for nitric oxide-induced pathological fission remains unclear. We found that nitric oxide produced in response to beta-amyloid protein, thought to be a key mediator of Alzheimer's disease, triggered mitochondrial fission, synaptic loss, and neuronal damage, in part via S-nitrosylation of dynamin-related protein 1 (forming SNO-Drp1). Preventing nitrosylation of Drp1 by cysteine mutation abrogated these neurotoxic events. SNO-Drp1 is increased in brains of human Alzheimer's disease patients and may thus contribute to the pathogenesis of neurodegeneration.	[Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Gu, Zezong; Lipton, Stuart A.] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Cieplak, Piotr; Godzik, Adam] Burnham Inst Med Res, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Fang, Jianguo/K-8058-2016; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Lipton, Stuart/0000-0002-3490-1259	Japan Society for the Promotion of Science; NIH [P01 HD29587, R01 EY05477, P01 ES016738, P30 NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Newmeyer, J. Zaremba, J. Russo, E. Masliah, H. Xu, and Y. Zhang for help or reagents. Supported by the Japan Society for the Promotion of Science (T.N.) and NIH grants P01 HD29587, R01 EY05477, P01 ES016738, and P30 NS057096 (S.A.L.).	Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	21	795	830	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					102	105		10.1126/science.1171091	http://dx.doi.org/10.1126/science.1171091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342591	Green Accepted			2022-12-24	WOS:000264802100042
J	Maeda, S; Nakagawa, S; Suga, M; Yamashita, E; Oshima, A; Fujiyoshi, Y; Tsukihara, T				Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Oshima, Atsunori; Fujiyoshi, Yoshinori; Tsukihara, Tomitake			Structure of the connexin 26 gap junction channel at 3.5 angstrom resolution	NATURE			English	Article							AMINO-ACID-RESIDUES; EXTRACELLULAR LOOP; GATING POLARITY; 3-DIMENSIONAL STRUCTURE; CHARGE SELECTIVITY; DIFFRACTION DATA; PORE; MODEL; IDENTIFICATION; TERMINUS	Gap junctions consist of arrays of intercellular channels between adjacent cells that permit the exchange of ions and small molecules. Here we report the crystal structure of the gap junction channel formed by human connexin 26 (Cx26, also known as GJB2) at 3.5 angstrom resolution, and discuss structural determinants of solute transport through the channel. The density map showed the two membrane-spanning hemichannels and the arrangement of the four transmembrane helices of the six protomers forming each hemichannel. The hemichannels feature a positively charged cytoplasmic entrance, a funnel, a negatively charged transmembrane pathway, and an extracellular cavity. The pore is narrowed at the funnel, which is formed by the six amino-terminal helices lining the wall of the channel, which thus determines the molecular size restriction at the channel entrance. The structure of the Cx26 gap junction channel also has implications for the gating of the channel by the transjunctional voltage.	[Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, OLABB, Inst Prot Res, Osaka 5650874, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Akoh, Hyogo 6781297, Japan	Osaka University; Kyoto University; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, OLABB, Inst Prot Res, 6-2-3 Furuedai, Osaka 5650874, Japan.	tsuki@protein.osaka-u.ac.jp	Oshima, Atsunori/F-8346-2010; Yamashita, Eiki/V-6758-2019; Fujiyoshi, Yoshinori/E-5989-2012; Suga, Michi/C-2870-2015	Yamashita, Eiki/0000-0002-4278-0039; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Maeda, Shoji/0000-0002-7762-9793; Oshima, Atsunori/0000-0003-1174-1368	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10687101, 16087206, 18207006, A-041]; Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Specially Promoted Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Specially Promoted Research	We thank T. Tomizaki for help in the diffraction data collection on X06SA at the Swiss Light Source. This work was supported by Grants-in-Aid for Scientific Research ( 10687101, 16087206 and 18207006) and the GCOE program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to T. T.), the Japan Biological Informatics Consortium ( to T. T.), the Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency ( to T. T.), and Grants-in-Aid for Specially Promoted Research ( to Y. F.) and the New Energy and Industrial Technology Development Organization ( to Y. F.). We thank T. Walz for critical reading of this manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano W., 2006, PYMOL MOL GRAPHICS S; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Dodson E, 1996, ACTA CRYSTALLOGR D, V52, P228, DOI 10.1107/S0907444995010638; EBIHARA L, 1995, BIOPHYS J, V68, P1796, DOI 10.1016/S0006-3495(95)80356-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 2004, BIOPHYS J, V87, P912, DOI 10.1529/biophysj.103.038448; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2008, CELL COMMUN ADHES, V15, P85, DOI 10.1080/15419060802013588; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SHERIDAN RP, 1982, P NATL ACAD SCI-BIOL, V79, P4545, DOI 10.1073/pnas.79.15.4545; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	58	519	530	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					597	U61		10.1038/nature07869	http://dx.doi.org/10.1038/nature07869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340074				2022-12-24	WOS:000264796200033
J	Martin, SG; Berthelot-Grosjean, M				Martin, Sophie G.; Berthelot-Grosjean, Martine			Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle	NATURE			English	Article							NIM1/CDR1 MITOTIC INDUCER; DUAL-SPECIFICITY KINASE; FISSION YEAST; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; NEGATIVE REGULATION; DIVISION PLANE; GROWTH; WEE1; PHOSPHORYLATION	Cells normally grow to a certain size before they enter mitosis and divide. Entry into mitosis depends on the activity of Cdk1, which is inhibited by the Wee1 kinase and activated by the Cdc25 phosphatase(1). However, how cells sense their size for mitotic commitment remains unknown. Here we show that an intracellular gradient of the dual-specificity tyrosine-phosphorylation regulated kinase (DYRK) Pom1, which emanates from the ends of rod-shaped Schizosaccharomyces pombe cells, serves to measure cell length and control mitotic entry. Pom1 provides positional information both for polarized growth and to inhibit cell division at cell ends(2-5). We discovered that Pom1 is also a dose-dependent G2-M inhibitor. Genetic analyses indicate that Pom1 negatively regulates Cdr1 and Cdr2, two previously described Wee1 inhibitors of the SAD kinase family(6-10). This inhibition may be direct, because in vivo and in vitro evidence suggest that Pom1 phosphorylates Cdr2. Whereas Cdr1 and Cdr2 localize to a medial cortical region, Pom1 forms concentration gradients from cell tips that overlap with Cdr1 and Cdr2 in short cells, but not in long cells. Disturbing these Pom1 gradients leads to Cdr2 phosphorylation and imposes a G2 delay. In short cells, Pom1 prevents precocious M-phase entry, suggesting that the higher medial Pom1 levels inhibit Cdr2 and promote a G2 delay. Thus, gradients of Pom1 from cell ends provide a measure of cell length to regulate M-phase entry.	[Martin, Sophie G.; Berthelot-Grosjean, Martine] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Martin, SG (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Sophie.Martin@unil.ch	Martin, Sophie/AAE-3198-2019	Martin, Sophie/0000-0002-5317-2557; Berthelot-Grosjean, Martine/0000-0002-7168-2622	Swiss National Science Foundation Professorship [PP00A-114936]; Human Frontiers Science Program Career Development Award [CDA0016/2008]	Swiss National Science Foundation Professorship(Swiss National Science Foundation (SNSF)); Human Frontiers Science Program Career Development Award(Human Frontier Science Program)	We wish to thank J. Bahler, F. Chang, P. Cruz, K. Gull, I. Hagan, P. Russell, K. Shiozaki and V. Simanis for strains and reagents. We thank R. Benton, F. Chang, C. Fankhauser, N. Hernandez and F. Bendezu for critical reading of the manuscript. We also wish to thank J. Moseley and P. Nurse for open discussion before publication. Research in the laboratory of S. G. M. is supported by a Swiss National Science Foundation Professorship grant (PP00A-114936) and a Human Frontiers Science Program Career Development Award (CDA0016/2008).	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Souza GM, 1998, DEVELOPMENT, V125, P2291; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0; Wu L, 1997, EMBO J, V16, P1342, DOI 10.1093/emboj/16.6.1342	32	227	229	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 11	2009	459	7248					852	U7		10.1038/nature08054	http://dx.doi.org/10.1038/nature08054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474792				2022-12-24	WOS:000267084500041
J	Park, SY; Fung, P; Nishimura, N; Jensen, DR; Fujii, H; Zhao, Y; Lumba, S; Santiago, J; Rodrigues, A; Chow, TFF; Alfred, SE; Bonetta, D; Finkelstein, R; Provart, NJ; Desveaux, D; Rodriguez, PL; McCourt, P; Zhu, JK; Schroeder, JI; Volkman, BF; Cutler, SR				Park, Sang-Youl; Fung, Pauline; Nishimura, Noriyuki; Jensen, Davin R.; Fujii, Hiroaki; Zhao, Yang; Lumba, Shelley; Santiago, Julia; Rodrigues, Americo; Chow, Tsz-Fung F.; Alfred, Simon E.; Bonetta, Dario; Finkelstein, Ruth; Provart, Nicholas J.; Desveaux, Darrell; Rodriguez, Pedro L.; McCourt, Peter; Zhu, Jian-Kang; Schroeder, Julian I.; Volkman, Brian F.; Cutler, Sean R.			Abscisic Acid Inhibits Type 2C Protein Phosphatases via the PYR/PYL Family of START Proteins	SCIENCE			English	Article							NEGATIVE REGULATOR; SEED-GERMINATION; GENE-EXPRESSION; LIGAND-BINDING; ARABIDOPSIS; RECEPTORS; HORMONE; REVEAL; FOLD; ABI1	Type 2C protein phosphatases (PP2Cs) are vitally involved in abscisic acid (ABA) signaling. Here, we show that a synthetic growth inhibitor called pyrabactin functions as a selective ABA agonist. Pyrabactin acts through PYRABACTIN RESISTANCE 1 (PYR1), the founding member of a family of START proteins called PYR/PYLs, which are necessary for both pyrabactin and ABA signaling in vivo. We show that ABA binds to PYR1, which in turn binds to and inhibits PP2Cs. We conclude that PYR/PYLs are ABA receptors functioning at the apex of a negative regulatory pathway that controls ABA signaling by inhibiting PP2Cs. Our results illustrate the power of the chemical genetic approach for sidestepping genetic redundancy.	[Park, Sang-Youl; Fujii, Hiroaki; Zhu, Jian-Kang; Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fung, Pauline; Zhao, Yang; Lumba, Shelley; Chow, Tsz-Fung F.; Alfred, Simon E.; Provart, Nicholas J.; Desveaux, Darrell; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Provart, Nicholas J.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Nishimura, Noriyuki; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Santiago, Julia; Rodrigues, Americo; Rodriguez, Pedro L.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON L1H 7K4, Canada; [Finkelstein, Ruth] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Jensen, Davin R.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Inst Genome Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of Toronto; University of Toronto; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Ontario Tech University; University of California System; University of California Santa Barbara; Medical College of Wisconsin; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Cutler, SR (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	sean.cutler@ucr.edu	Cutler, Sean R/D-6617-2011; Zhu, Jian-Kang/F-7658-2011; Rodrigues, Americo/F-9573-2010; Nishimura, Noriyuki/E-3580-2010; Finkelstein, Ruth/Y-3274-2019; Rodriguez, Pedro L./K-4605-2014; Volkman, Brian F./ABE-7306-2020; Volkman, Brian F./ABE-7312-2020	Zhu, Jian-Kang/0000-0001-5134-731X; Rodrigues, Americo/0000-0002-5293-5583; Nishimura, Noriyuki/0000-0003-2946-3124; Rodriguez, Pedro L./0000-0002-5886-9425; Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Cutler, Sean/0000-0002-8593-0885; Santiago, Julia/0000-0002-5765-6495; Fujii, Hiroaki/0000-0002-0013-5891	CRC; NSERC; NSF [IOS0820508, MCB0417118]; NIH [R01GM060396, 01GM59138, U54GM074901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396, R01GM059138, U54GM074901] Funding Source: NIH RePORTER	CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Raikhel, J. Bailey-Serres, and C. Larive for comments; K. Nito and T. Demura for materials. Supported by CRC (S.R.C., P.M., D.D.); NSERC (S.R.C., D.D., N.J.P.); NSF awards IOS0820508 (S.R.C.) and MCB0417118 (J.I.S.); NIH awards R01GM060396 (J.I.S.), 01GM59138 (J.-K.Z.), and U54GM074901 (B.V.). S.R.C. thanks J.R. Coleman for early support. Patent application "Control of plant stress tolerance, water use efficiency and gene expression using novel ABA recpetor proteins and synthetic agonists" inventors: S.R. Cutler, S.Y. Park, N. Nishimura, J.I. Schroeder, and A. Defries. Author contributions are as follows. Microarrays: P.F. and N.J.P.; pyr1 mutants: P.F. ; mutant analyses: P.F. and T.F.C.; yeast two-hybrid assays, biochemistry, and Pyr/Pyl genetics: S.Y.P.; pyr1 complementation and allele sequencing: Y.Z.; in planta pull-downs: N.N. and J.I.S.; PYL12-AHG3 and SnRK2-PP2C asinteractions: R.F.; HSQC experiments: D.J. and B.V.; SnRK2 assays: H.F. and J.-K.Z.; GFP-PYR1 localization: S.E.A.: PP2C assays: S.Y.P., J.S., A.R., and P.R.; EMS seed: D.B.; ABA orfeome: S.L., D.D., and P.M.; project conception, positional cloning, phone calls, and writing: S.R.C.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; LYTLE B, PROTEINS IN PRESS, DOI DOI 10.1002/PROT.22396; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 1999, ANNU REV PLANT PHYS, V50, P219, DOI 10.1146/annurev.arplant.50.1.219; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; SONDHEIM.E, 1971, SCIENCE, V174, P829, DOI 10.1126/science.174.4011.829; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	34	1805	1982	35	698	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1068	1071		10.1126/science.1173041	http://dx.doi.org/10.1126/science.1173041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407142	Green Accepted			2022-12-24	WOS:000266246700041
J	Tishkoff, SA; Reed, FA; Friedlaender, FR; Ehret, C; Ranciaro, A; Froment, A; Hirbo, JB; Awomoyi, AA; Bodo, JM; Doumbo, O; Ibrahim, M; Juma, AT; Kotze, MJ; Lema, G; Moore, JH; Mortensen, H; Nyambo, TB; Omar, SA; Powell, K; Pretorius, GS; Smith, MW; Thera, MA; Wambebe, C; Weber, JL; Williams, SM				Tishkoff, Sarah A.; Reed, Floyd A.; Friedlaender, Francoise R.; Ehret, Christopher; Ranciaro, Alessia; Froment, Alain; Hirbo, Jibril B.; Awomoyi, Agnes A.; Bodo, Jean-Marie; Doumbo, Ogobara; Ibrahim, Muntaser; Juma, Abdalla T.; Kotze, Maritha J.; Lema, Godfrey; Moore, Jason H.; Mortensen, Holly; Nyambo, Thomas B.; Omar, Sabah A.; Powell, Kweli; Pretorius, Gideon S.; Smith, Michael W.; Thera, Mahamadou A.; Wambebe, Charles; Weber, James L.; Williams, Scott M.			The Genetic Structure and History of Africans and African Americans	SCIENCE			English	Article							PYGMY HUNTER-GATHERERS; Y-CHROMOSOME; HUMAN-POPULATIONS; MTDNA VARIATION; DIVERSITY; ORIGINS; POLYMORPHISMS; PROPORTIONS; EVOLUTION; ANCESTRY	Africa is the source of all modern humans, but characterization of genetic variation and of relationships among populations across the continent has been enigmatic. We studied 121 African populations, four African American populations, and 60 non-African populations for patterns of variation at 1327 nuclear microsatellite and insertion/deletion markers. We identified 14 ancestral population clusters in Africa that correlate with self-described ethnicity and shared cultural and/or linguistic properties. We observed high levels of mixed ancestry in most populations, reflecting historical migration events across the continent. Our data also provide evidence for shared ancestry among geographically diverse hunter-gatherer populations (Khoesan speakers and Pygmies). The ancestry of African Americans is predominantly from Niger-Kordofanian (similar to 71%), European (similar to 13%), and other African (similar to 8%) populations, although admixture levels varied considerably among individuals. This study helps tease apart the complex evolutionary history of Africans and African Americans, aiding both anthropological and genetic epidemiologic studies.	[Tishkoff, Sarah A.; Reed, Floyd A.; Ranciaro, Alessia; Hirbo, Jibril B.; Awomoyi, Agnes A.; Mortensen, Holly; Powell, Kweli] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ehret, Christopher] Univ Calif Los Angeles, Dept Hist, Los Angeles, CA 90095 USA; [Ranciaro, Alessia] Univ Ferrara, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy; [Froment, Alain] Musee Homme Paris, IRD MNHN, UMR 208, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Doumbo, Ogobara; Thera, Mahamadou A.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Ibrahim, Muntaser; Juma, Abdalla T.] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum 1513, Sudan; [Kotze, Maritha J.] Univ Stellenbosch, Fac Hlth Sci, Dept Pathol, ZA-7505 Tygerberg, South Africa; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi 5484000200, Kenya; [Pretorius, Gideon S.] Univ Stellenbosch, Fac Hlth Sci, Div Human Genet, ZA-7505 Tygerberg, South Africa; [Smith, Michael W.] NCI, Lab Genom Div, Frederick, MD 21702 USA; [Wambebe, Charles] Int Biomed Res Africa, Abuja, Nigeria; [Weber, James L.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	University System of Maryland; University of Maryland College Park; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Los Angeles; University of Ferrara; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Bamako; University of Khartoum; Stellenbosch University; Muhimbili University of Health & Allied Sciences; Dartmouth College; Dartmouth College; Kenya Medical Research Institute; Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tishkoff@mail.med.upenn.edu	Moore, Jason H./AAV-9645-2021; Kotze, Maritha J/GMX-0989-2022; Smith, Michael/B-5341-2012; Williams, Scott/Q-4812-2019; Williams, Scott/B-9491-2012	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Thera, Mahamadou A/0000-0002-2679-035X; Reed, Floyd/0000-0003-4703-530X; Hirbo, Jibril/0000-0002-8932-7311; Kotze, Martha/0000-0002-6050-2876	L. S. B. Leakey and Wenner Gren Foundation; NSF [BCS-0196183, BSC-0552486, BCS-0827436]; NIH [R01GM076637, 1R01GM083606-01, F32HG03801, R01 HL65234]; NHLBI Mammalian Genotyping Service; National Cancer Institute [N01-CO-12400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG003801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637, R01GM083606] Funding Source: NIH RePORTER	L. S. B. Leakey and Wenner Gren Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the thousands of people who donated DNA samples used in this study. We thank D. Bygott, S. J. Deo, D. Guracha, J. Hanby, D. Kariuki, P. Lufungulo, A. Mabulla, A. A. Mohamed, W. Ntandu, L. A. Nyindodo, C. Plowe, and A. Tibwitta for assisting with sample collection; K. Panchapakesan and L. Pfeiffer for assistance in sample preparation; S. Dobrin for assistance with genotyping; J. Giles, J. Bartlett, N. Kodaman, and J. Jarvis for assistance with analyses; and N. Rosenberg, J. Pritchard, A. Brooks, J. S. Friedlaender, J. Jarvis, C. Lambert, B. Payseur, N. Patterson, and J. Plotkin for helpful suggestions and discussions. Conducted in part using the ACCRE computing facility at Vanderbilt University, Nashville, TN. Supported by L. S. B. Leakey and Wenner Gren Foundation grants, NSF grants BCS-0196183, BSC-0552486, and BCS-0827436, NIH grants R01GM076637 and 1R01GM083606-01, and David and Lucile Packard and Burroughs Wellcome Foundation Career Awards (S.A.T.); NIH grant F32HG03801 (F.A.R.); and NIH grant R01 HL65234 (S.M.W. and J.H.M.). Genotyping was supported by the NHLBI Mammalian Genotyping Service. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. The project included in this manuscript has been funded in part with federal funds from the National Cancer Institute under contract N01-CO-12400. Original genotype data are available at http://research.marshfieldclinic.org/genetics/genotypingData_Statistics/humanDiversityPanel.asp. Data used for analyses in the current manuscript are available at www.med.upenn.edu/tishkoff/Supplemental/files.html and at http://chgr.mc.vanderbilt.edu/page/supplementary-data.	Ambrose SH, 1982, ARCHAEOLOGICAL LINGU, P104; [Anonymous], TRANSATLANTIC SLAVE; Batini C, 2007, MOL PHYLOGENET EVOL, V43, P635, DOI 10.1016/j.ympev.2006.09.014; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bereir RE, 2007, EUR J HUM GENET, V15, P1183, DOI 10.1038/sj.ejhg.5201892; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Coia V, 2004, AM J HUM BIOL, V16, P57, DOI 10.1002/ajhb.10236; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Destro-Bisol G, 2004, AM NAT, V163, P212, DOI 10.1086/381405; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Ehret C., 1983, CULTURE HIST SO SUDA, P19; EHRET C, 2006, W AFRICAN LINGUISTIC, P56; EHRET C, 1974, ETHIOPIANS E AFRICAN; EHRET C, 1980, HIST RECONSTRUCTION; EHRET C, 1986, SUGIA, V7, P105; Ehret C, 2008, SOUTH AFR HUMANIT, V20, P7; Ehret Christopher, 1998, AFRICAN CLASSICAL AG; Elderkin ED, 1982, SPRACHE GESCH AFRIKA, V4, P67; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2007, SCIENCE, V316, P50, DOI 10.1126/science.316.5821.50; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Klieman Kairn, 2003, PYGMIES WERE OUR COM; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIM L, 1992, THESIS BROWN U; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; LOMAX A, 1968, FOLK SONG STYLE CULT, P16; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; NEWMAN JL, 1997, PEOPLING AFRICA; Nurse GT., 1985, PEOPLES SO AFRICA TH; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; ROSENBERG NA, 2002, PLOS GENET, V298, P2381; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; SANDS B, 1998, LANGUAGE IDENTITY CO, V15, P266; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	63	987	1015	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1035	1044		10.1126/science.1172257	http://dx.doi.org/10.1126/science.1172257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407144	Green Accepted			2022-12-24	WOS:000266246700033
J	Hayden, BY; Pearson, JM; Platt, ML				Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.			Fictive Reward Signals in the Anterior Cingulate Cortex	SCIENCE			English	Article							SEQUENTIAL INVESTMENT TASK; DECISION-MAKING; COUNTERFACTUAL THINKING; ORBITOFRONTAL CORTEX; INCENTIVE SALIENCE; VALUATION; UNCERTAINTY; REGRET; CHOICE	The neural mechanisms supporting the ability to recognize and respond to fictive outcomes, outcomes of actions that one has not taken, remain obscure. We hypothesized that neurons in the anterior cingulate cortex (ACC), which monitors the consequences of actions and mediates subsequent changes in behavior, would respond to fictive reward information. We recorded responses of single neurons during performance of a choice task that provided information about the reward values of options that were not chosen. We found that ACC neurons signal fictive reward information and use a coding scheme similar to that used to signal experienced outcomes. Thus, individual ACC neurons process both experienced and fictive rewards.	[Hayden, Benjamin Y.; Pearson, John M.; Platt, Michael L.] Duke Univ, Sch Med, Ctr Neuroecon Studies, Ctr Cognit Neurosci,Dept Neurobiol, Durham, NC 27701 USA; [Platt, Michael L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27701 USA	Duke University; Duke University	Hayden, BY (corresponding author), Duke Univ, Sch Med, Ctr Neuroecon Studies, Ctr Cognit Neurosci,Dept Neurobiol, Durham, NC 27701 USA.	hayden@neuro.duke.edu	Hayden, Benjamin/J-7994-2013	Hayden, Benjamin/0000-0002-7678-4281; Pearson, John/0000-0002-9876-7837	National Institute on Drug Abuse postdoctoral fellowship [023338]; National Eye Institute [013496]; Duke Institute for Brain Studies; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA023338, K99DA027718] Funding Source: NIH RePORTER	National Institute on Drug Abuse postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke Institute for Brain Studies; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a postdoctoral fellowship to B.Y.H. National Institute on Drug Abuse (023338) a R01 to M.L.P., (National Eye Institute 013496), and the Duke Institute for Brain Studies (M.L.P.). We thank K. Watson for help in training the animals and S. Heilbronner for useful discussions on the tasks. The authors declare no conflicts of interest.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lee D, 2005, COGNITIVE BRAIN RES, V25, P416, DOI 10.1016/j.cogbrainres.2005.07.003; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Reid R. L, 1986, J GAMBLING BEHAV, V2, P32, DOI [DOI 10.1007/BF01019932, 10.1007/BF01019932]; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136; Ursu S, 2005, COGNITIVE BRAIN RES, V23, P51, DOI 10.1016/j.cogbrainres.2005.01.004	27	153	158	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					948	950		10.1126/science.1168488	http://dx.doi.org/10.1126/science.1168488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443783	Green Accepted			2022-12-24	WOS:000266048800042
J	Shu, XK; Royant, A; Lin, MZ; Aguilera, TA; Lev-Ram, V; Steinbach, PA; Tsien, RY				Shu, Xiaokun; Royant, Antoine; Lin, Michael Z.; Aguilera, Todd A.; Lev-Ram, Varda; Steinbach, Paul A.; Tsien, Roger Y.			Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome	SCIENCE			English	Article							BACTERIOPHYTOCHROME; BILIVERDIN	Visibly fluorescent proteins (FPs) from jellyfish and corals have revolutionized many areas of molecular and cell biology, but the use of FPs in intact animals, such as mice, has been handicapped by poor penetration of excitation light. We now show that a bacteriophytochrome from Deinococcus radiodurans, incorporating biliverdin as the chromophore, can be engineered into monomeric, infrared-fluorescent proteins (IFPs), with excitation and emission maxima of 684 and 708 nm, respectively; extinction coefficient >90,000 M-1 cm(-1); and quantum yield of 0.07. IFPs express well in mammalian cells and mice and spontaneously incorporate biliverdin, which is ubiquitous as the initial intermediate in heme catabolism but has negligible fluorescence by itself. Because their wavelengths penetrate tissue well, IFPs are suitable for whole-body imaging. The IFPs developed here provide a scaffold for further engineering.	[Shu, Xiaokun; Steinbach, Paul A.; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Shu, Xiaokun; Lin, Michael Z.; Aguilera, Todd A.; Lev-Ram, Varda; Steinbach, Paul A.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Royant, Antoine] Inst Biol Struct 41, F-38027 Grenoble 1, France; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rtsien@ucsd.edu	Royant, Antoine/G-3684-2012	Royant, Antoine/0000-0002-1919-8649; Lin, Michael/0000-0002-0492-1961; shu, Xiaokun/0000-0001-9248-7095; Aguilera, Todd/0000-0002-3734-3758	NIGMS [R01 GM086197]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. C. Lagarias and S. Field for donation of cDNAs encoding HO-1 and AKT1s PH domain, respectively; J. M. Saathoff and G. Tran for help with plasmid purification; M. Timmers for help with tissue culture; S. Adams for help with light scattering measurements; L. Gross for mass spectrometry; and Q. Xiong for flow cytometry. This work was supported by NIGMS grant R01 GM086197 and the Howard Hughes Medical Institute.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; HARRIS JW, 1970, RED CELL; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105	23	529	557	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					804	807		10.1126/science.1168683	http://dx.doi.org/10.1126/science.1168683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423828	Green Accepted			2022-12-24	WOS:000265832400052
J	Ramsey, KM; Yoshino, J; Brace, CS; Abrassart, D; Kobayashi, Y; Marcheva, B; Hong, HK; Chong, JL; Buhr, ED; Lee, C; Takahashi, JS; Imai, SI; Bass, J				Ramsey, Kathryn Moynihan; Yoshino, Jun; Brace, Cynthia S.; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Lee, Choogon; Takahashi, Joseph S.; Imai, Shin-ichiro; Bass, Joseph			Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD(+) Biosynthesis	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; GLUCOSE-HOMEOSTASIS; CALORIE RESTRICTION; LIFE-SPAN; SIRT1; TRANSCRIPTION; EXTENSION; COMPONENT; BINDING; CELLS	The circadian clock is encoded by a transcription-translation feedback loop that synchronizes behavior and metabolism with the light-dark cycle. Here we report that both the rate-limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, nicotinamide phosphoribosyltransferase (NAMPT), and levels of NAD(+) display circadian oscillations that are regulated by the core clock machinery in mice. Inhibition of NAMPT promotes oscillation of the clock gene Per2 by releasing CLOCK: BMAL1 from suppression by SIRT1. In turn, the circadian transcription factor CLOCK binds to and up-regulates Nampt, thus completing a feedback loop involving NAMPT/NAD(+) and SIRT1/CLOCK:BMAL1.	[Yoshino, Jun; Brace, Cynthia S.; Imai, Shin-ichiro] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] NorthShore Univ Hlth Syst Res Inst, Evanston, IL 60201 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] Evanston Hosp Corp, Dept Med, Evanston, IL 60201 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; NorthShore University Health System; NorthShore University Health System; State University System of Florida; Florida State University; Howard Hughes Medical Institute; Northwestern University	Imai, SI (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	imaishin@wustl.edu; j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625; Yoshino, Jun/0000-0001-9833-4356	National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK007169]; National Institute on Aging [AG02150]; Ellison Medical Foundation; Longer Life Foundation; NIH [PO1 AG011412]; Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation; National Institute of Mental Health [P50 MH074924]; Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412, R01AG024150] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Longer Life Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals(Bristol-Myers Squibb); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S.-H. Yoo and members of the Bass, Imai, and Takahashi laboratories for discussions. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007169) to K.M.R.; the National Institute on Aging (AG02150), the Ellison Medical Foundation, and the Longer Life Foundation to S.I.; NIH (PO1 AG011412), the Chicago Biomedical Consortium Searle Funds, and the Juvenile Diabetes Research Foundation to J.B.; and a grant from the National Institute of Mental Health (P50 MH074924) to J.S.T. J.Y. is supported by the Japan Research Foundation for Clinical Pharmacology and Keio University Medical Science Fund, J.S.T. is an Investigator in the Howard Hughes Medical Institute and a cofounder of ReSet Therapeutics, and J.S.T. and J.B. are members of its scientific advisory board. J.B. is also an adviser and receives support from Amylin Pharmaceuticals. S.I. holds a patent related to the work reported in this paper, specifically NAMPT and NMN.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	25	785	832	10	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					651	654		10.1126/science.1171641	http://dx.doi.org/10.1126/science.1171641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299583	Green Accepted			2022-12-24	WOS:000265608800047
J	Katz, DJ; Edwards, TM; Reinke, V; Kelly, WG				Katz, David J.; Edwards, T. Matthew; Reinke, Valerie; Kelly, William G.			A C. elegans LSD1 Demethylase Contributes to Germline Immortality by Reprogramming Epigenetic Memory	CELL			English	Article							CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MAMMALIAN DEVELOPMENT; CELL DEVELOPMENT; POLE CELLS; CHROMATIN; COMPLEX; LINEAGE; NANOS	Epigenetic information undergoes extensive reprogramming in the germline between generations. This reprogramming may be essential to establish a developmental ground state in the zygote. We show that mutants in spr-5, the Caenorhabditis elegans ortholog of the H3K4me2 demethylase LSD1/KDM1, exhibit progressive sterility over many generations. This sterility correlates with the misregulation of spermatogenesis-expressed genes and transgenerational accumulation of the histone modification dimethylation of histone H3 on lysine 4 (H3K4me2). This suggests that H3K4me2 can serve as a stable epigenetic memory, and that erasure of H3K4me2 by LSD/KDM1 in the germline prevents the inappropriate transmission of this epigenetic memory from one generation to the next. Thus, our results provide direct mechanistic insights into the processes that are required for epigenetic reprogramming between generations.	[Katz, David J.; Edwards, T. Matthew; Kelly, William G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Emory University; Yale University	Kelly, WG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	bkelly@biology.emory.edu	Katz, David J/H-4555-2017	Katz, David J/0000-0002-3040-1142	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Baumeister for providing strains; A. Printz for help with data presentation; C. Bean, B. Lakowski, G. Reuter, T. Schedl, Y. Shi, and J. Waddle for helpful discussions on the work; T. Caspary, J. Lucchesi, and S. Tilghman for critical comments on the manuscript; and all of our laboratory members for assistance throughout. This work was supported by grants from the National Institutes of Health to D. J. K. and W. G. K.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Katz DJ, 2005, MOL CELL BIOL, V25, P3855, DOI 10.1128/MCB.25.10.3855-3863.2005; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nishikawa S, 2007, NAT BIOTECHNOL, V25, P877, DOI 10.1038/nbt0807-877; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Poux S, 2002, DEVELOPMENT, V129, P2483; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SZABAD J, 1988, MOL GEN GENET, V211, P56, DOI 10.1007/BF00338393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P489, DOI 10.1007/BF00375889; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3	44	228	246	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					308	320		10.1016/j.cell.2009.02.015	http://dx.doi.org/10.1016/j.cell.2009.02.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379696	Green Accepted, Bronze			2022-12-24	WOS:000265456800023
J	Kloxin, AM; Kasko, AM; Salinas, CN; Anseth, KS				Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.			Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties	SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; BEHAVIOR; TISSUE; DEGRADATION; MIGRATION; GROWTH; BIOMATERIALS; NETWORKS; POLYMERS	We report a strategy to create photodegradable poly(ethylene glycol)-based hydrogels through rapid polymerization of cytocompatible macromers for remote manipulation of gel properties in situ. Postgelation control of the gel properties was demonstrated to introduce temporal changes, creation of arbitrarily shaped features, and on-demand pendant functionality release. Channels photodegraded within a hydrogel containing encapsulated cells allow cell migration. Temporal variation of the biochemical gel composition was used to influence chondrogenic differentiation of encapsulated stem cells. Photodegradable gels that allow real-time manipulation of material properties or chemistry provide dynamic environments with the scope to answer fundamental questions about material regulation of live cell function and may affect an array of applications from design of drug delivery vehicles to tissue engineering systems.	[Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Kasko, Andrea M.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Anseth, KS (corresponding author), Univ Colorado, Dept Chem & Biol Engn, 424 UCB ECCH 111, Boulder, CO 80309 USA.	Kristi.Anseth@colorado.edu			Howard Hughes Medical Institute; NIH [DE12998, DE16523]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012998] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank C. Bowman, T. Scott, and C. Kloxin for comments on early versions of this manuscript and valuable discussions; A. Aimetti for peptide synthesis training; J. McCall and S. Anderson for cell culture assistance; M. Schwartz for cell migration discussions; C. Bowman and his laboratory for use of and assistance with the rheometer and profilometer; C. Kloxin for assistance with image analysis; C. DeForest, Carl Zeiss, Inc., and the Howard Hughes Medical Institute Janelia Farms campus for assistance with and use of the Zeiss 710 two-photon confocal LSM; and the Howard Hughes Medical Institute and the NIH (grants DE12998 and DE16523) for research support. A.K. thanks the NASA Graduate Student Researchers Program fellowship and the Department of Education Graduate Assistance in Areas of National Need fellowship for support. A patent related to this work has been submitted (U.S. Patent Application No. 11/374,471).	Alvarez M, 2008, ADV MATER, V20, P4563, DOI 10.1002/adma.200800746; [Anonymous], 1991, INTRO POLYM; Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; BRYANT SJ, 2005, SCAFFOLDING TISSUE E, P69; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647; Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; KHAN SA, 1992, RHEOL ACTA, V31, P151, DOI 10.1007/BF00373237; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o; Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Rice MA, 2006, BIOMACROMOLECULES, V7, P1968, DOI 10.1021/bm060086+; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004; Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tavella S, 1997, J CELL SCI, V110, P2261; Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m; Zhao YR, 2004, J AM CHEM SOC, V126, P4653, DOI 10.1021/ja036958m	34	1290	1341	37	1036	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					59	63		10.1126/science.1169494	http://dx.doi.org/10.1126/science.1169494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	427TN	19342581	Green Accepted			2022-12-24	WOS:000264802100030
J	Rhee, HJ; June, YG; Lee, JS; Lee, KK; Ha, JH; Kim, ZH; Jeon, SJ; Cho, MH				Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Ha, Jeong-Hyon; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng			Femtosecond characterization of vibrational optical activity of chiral molecules	NATURE			English	Article							CIRCULAR-DICHROISM; SPECTROSCOPY; POLYPEPTIDES	Optical activity(1-3) is the result of chiral molecules interacting differently with left versus right circularly polarized light. Because of this intrinsic link to molecular structure, the determination of optical activity through circular dichroism (CD) spectroscopy has long served as a routine method for obtaining structural information about chemical and biological systems in condensed phases(4-6). A recent development is time-resolved CD spectroscopy, which can in principle map the structural changes associated with biomolecular function(7) and thus lead to mechanistic insights into fundamental biological processes. But implementing time-resolved CD measurements is experimentally challenging because CD is a notoriously weak effect (a factor of 10(-4)-10(-6) smaller than absorption). In fact, this problem has so far prevented time-resolved vibrational CD experiments. Here we show that vibrational CD spectroscopy with femtosecond time resolution can be realized when using heterodyned spectral interferometry to detect(8-10) the phase and amplitude of the infrared optical activity free-induction-decay field in time (much like in a pulsed NMR experiment). We show that we can detect extremely weak signals in the presence of large achiral background contributions, by simultaneously measuring with a femtosecond laser pulse the vibrational CD and optical rotatory dispersion spectra of dissolved chiral limonene molecules. We have so far only targeted molecules in equilibrium, but it would be straightforward to extend the method for the observation of ultrafast structural changes such as those occurring during protein folding or asymmetric chemical reactions. That is, we should now be in a position to produce 'molecular motion pictures'(11) of fundamental molecular processes from a chiral perspective.	[Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng] Korea Univ, Dept Chem, Seoul 136701, South Korea; [Rhee, Hanju; Lee, Jang-Soo; Lee, Kyung-Koo; Cho, Minhaeng] Korea Univ, Ctr Multidimens Spect, Seoul 136701, South Korea; [Ha, Jeong-Hyon; Jeon, Seung-Joon; Cho, Minhaeng] Korea Basic Sci Inst, Multidimens Spect Lab, Seoul 136713, South Korea	Korea University; Korea University; Korea Basic Science Institute (KBSI)	Cho, MH (corresponding author), Korea Univ, Dept Chem, Seoul 136701, South Korea.	mcho@korea.ac.kr	Cho, Minhaeng/C-9983-2011; Kim, Zee Hwan/A-9273-2010	Cho, Minhaeng/0000-0003-1618-1056; Lee, Jangsoo/0000-0002-0255-1629	Creative Research Initiatives of MEST/KOSEF; Frontier Research Laboratory Program of KBSI	Creative Research Initiatives of MEST/KOSEF(Korea Science and Engineering Foundation); Frontier Research Laboratory Program of KBSI	This work was supported by Creative Research Initiatives (CMDS) of MEST/KOSEF ( M. C.) and the Frontier Research Laboratory Program of KBSI (S.--J.J)	BRIDGES TJ, 1965, APPL OPTICS, V4, P1121, DOI 10.1364/AO.4.001121; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Chin DH, 2002, P NATL ACAD SCI USA, V99, P15416, DOI 10.1073/pnas.232591399; CHIRGADZE YN, 1971, BIOPOLYMERS, V10, P809, DOI 10.1002/bip.360100505; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Cho M, 2006, NATURE, V444, P431, DOI 10.1038/444431a; Choi JH, 2004, J CHEM PHYS, V120, P4383, DOI 10.1063/1.1644100; Choi JH, 2008, PHYS CHEM CHEM PHYS, V10, P3839, DOI 10.1039/b719263k; Choi JH, 2006, BIOPOLYMERS, V83, P519, DOI 10.1002/bip.20583; Clarke DT, 1999, P NATL ACAD SCI USA, V96, P7232, DOI 10.1073/pnas.96.13.7232; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Gallagher SM, 1998, J OPT SOC AM B, V15, P2338, DOI 10.1364/JOSAB.15.002338; GILLARD RD, 1990, NATURE, V347, P594; Goldbeck RA, 1997, ANNU REV PHYS CHEM, V48, P453, DOI 10.1146/annurev.physchem.48.1.453; Guo CN, 2006, VIB SPECTROSC, V42, P254, DOI 10.1016/j.vibspec.2006.05.013; KEIDERLING TA, 1986, NATURE, V322, P851, DOI 10.1038/322851a0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; LEWIS JW, 1985, J PHYS CHEM-US, V89, P289, DOI 10.1021/j100248a023; Nakanishi K., 2000, CIRCULAR DICHROISM P; Niezborala C, 2006, J OPT SOC AM B, V23, P2418, DOI 10.1364/JOSAB.23.002418; Rhee H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968130; Rosenfeld L, 1929, Z PHYS, V52, P161, DOI 10.1007/BF01342393; SCHRADER VB, 1972, ANGEW CHEM, V84, P218; Silva RAGD, 2000, P NATL ACAD SCI USA, V97, P8318, DOI 10.1073/pnas.140161997; TINOCO I, 1987, ANNU REV BIOPHYS BIO, V16, P319, DOI 10.1146/annurev.bb.16.060187.001535; Walecki WJ, 1997, OPT LETT, V22, P81, DOI 10.1364/OL.22.000081; XIE XL, 1990, J AM CHEM SOC, V112, P7802, DOI 10.1021/ja00177a054; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998	29	139	140	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					310	313		10.1038/nature07846	http://dx.doi.org/10.1038/nature07846			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295604				2022-12-24	WOS:000264285600035
J	Gibbs, RA; Taylor, JF; Van Tassell, CP; Barendse, W; Eversoie, KA; Gill, CA; Green, RD; Hamernik, DL; Kappes, SM; Lien, S; Matukumalli, LK; McEwan, JC; Nazareth, LV; Schnabel, RD; Taylor, JF; Weinstock, GM; Wheeler, DA; Ajmone-Marsan, P; Barendse, W; Boettcher, PJ; Caetano, AR; Garcia, JF; Hanotte, O; Mariani, P; Skow, LC; Williams, JL; Caetano, AR; Diallo, B; Green, RD; Hailemariam, L; Hanotte, O; Martinez, ML; Morris, CA; Silva, LOC; Spelman, RJ; Taylor, JF; Mulatu, W; Zhao, KY; Abbey, CA; Agaba, M; Araujo, FR; Bunch, RJ; Burton, J; Gill, CA; Gorni, C; Olivier, H; Harrison, BE; Luff, B; Machado, MA; Mariani, P; Morris, CA; Mwakaya, J; Plastow, G; Sim, W; Skow, LC; Smith, T; Sonstegard, TS; Spelman, RJ; Taylor, JF; Thomas, MB; Valentini, A; Williams, P; Womack, J; Wooliams, JA; Liu, Y; Qin, X; Worley, KC; Gao, C; Gill, CA; Jiang, HY; Liu, Y; Moore, SS; Nazareth, LV; Ren, YR; Song, XZ; Bustamante, CD; Hernandez, RD; Muzny, DM; Nazareth, LV; Patil, S; Lucas, AS; Fu, Q; Kent, MP; Moore, SS; Vega, R; Abbey, CA; Gao, C; Gill, CA; Green, RD; Matukumalli, LK; Matukumalli, A; McWilliam, S; Schnabel, RD; Sclep, G; Ajmone-Marsan, P; Bryc, K; Bustamante, CD; Choi, J; Gao, H; Grefenstette, JJ; Murdoch, B; Stella, A; Villa-Angulo, R; Wright, M; Aerts, J; Jann, O; Negrini, R; Sonstegard, TS; Williams, JL; Taylor, JF; Villa-Angulo, R; Goddard, ME; Hayes, BJ; Barendse, W; Bradley, DG; Boettcher, PJ; Bustamante, CD; da Silva, MB; Lau, LPL; Liu, GE; Lynn, DJ; Panzitta, F; Sclep, G; Wright, M; Dodds, KG				Gibbs, Richard A.; Taylor, Jeremy F.; Van Tassell, Curtis P.; Barendse, William; Eversoie, Kallye A.; Gill, Clare A.; Green, Ronnie D.; Hamernik, Debora L.; Kappes, Steven M.; Lien, Sigbjorn; Matukumalli, Lakshmi K.; McEwan, John C.; Nazareth, Lynne V.; Schnabel, Robert D.; Taylor, Jeremy F.; Weinstock, George M.; Wheeler, David A.; Ajmone-Marsan, Paolo; Barendse, William; Boettcher, Paul J.; Caetano, Alexandre R.; Garcia, Jose Fernando; Hanotte, Olivier; Mariani, Paola; Skow, Loren C.; Williams, John L.; Caetano, Alexandre R.; Diallo, Boubacar; Green, Ronnie D.; Hailemariam, Lemecha; Hanotte, Olivier; Martinez, Mario L.; Morris, Chris A.; Silva, Luiz O. C.; Spelman, Richard J.; Taylor, Jeremy F.; Mulatu, Woudyalew; Zhao, Keyan; Abbey, Colette A.; Agaba, Morris; Araujo, Flabio R.; Bunch, Rowan J.; Burton, James; Gill, Clare A.; Gorni, Chiara; Olivier, Hanotte; Harrison, Blair E.; Luff, Bill; Machado, Marco A.; Mariani, Paola; Morris, Chris A.; Mwakaya, Joel; Plastow, Graham; Sim, Warren; Skow, Loren C.; Smith, Timothy; Sonstegard, Tad S.; Spelman, Richard J.; Taylor, Jeremy F.; Thomas, Merle B.; Valentini, Alessio; Williams, Paul; Womack, James; Wooliams, John A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Gao, Chuan; Gill, Clare A.; Jiang, Huaiyang; Liu, Yue; Moore, Stephen S.; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Bustamante, Carlos D.; Hernandez, Ryan D.; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Kent, Matthew P.; Moore, Stephen S.; Vega, Richard; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Green, Ronnie D.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; McWilliam, Sean; Schnabel, Robert D.; Sclep, Gert; Ajmone-Marsan, Paolo; Bryc, Katarzyna; Bustamante, Carlos D.; Choi, Jungwoo; Gao, Hong; Grefenstette, John J.; Murdoch, Brenda; Stella, Alessandra; Villa-Angulo, Rafael; Wright, Mark; Aerts, Jan; Jann, Oliver; Negrini, Riccardo; Sonstegard, Tad S.; Williams, John L.; Taylor, Jeremy F.; Villa-Angulo, Rafael; Goddard, Mike E.; Hayes, Ben J.; Barendse, William; Bradley, Daniel G.; Boettcher, Paul J.; Bustamante, Carlos D.; da Silva, Marcos Barbosa; Lau, Lilian P. L.; Liu, George E.; Lynn, David J.; Panzitta, Francesca; Sclep, Gert; Wright, Mark; Dodds, Ken G.			Genome-Wide Survey of SNP Variation Uncovers the Genetic Structure of Cattle Breeds	SCIENCE			English	Article							MISSENSE MUTATION; MILK-YIELD; IDENTIFICATION; SELECTION; ORIGIN; SCANS; QTL	The imprints of domestication and breed development on the genomes of livestock likely differ from those of companion animals. A deep draft sequence assembly of shotgun reads from a single Hereford female and comparative sequences sampled from six additional breeds were used to develop probes to interrogate 37,470 single-nucleotide polymorphisms (SNPs) in 497 cattle from 19 geographically and biologically diverse breeds. These data show that cattle have undergone a rapid recent decrease in effective population size from a very large ancestral population, possibly due to bottlenecks associated with domestication, selection, and breed formation. Domestication and artificial selection appear to have left detectable signatures of selection within the cattle genome, yet the current levels of diversity within breeds are at least as great as exists within humans.	[Van Tassell, Curtis P.; Matukumalli, Lakshmi K.; Sonstegard, Tad S.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; Sonstegard, Tad S.; da Silva, Marcos Barbosa; Liu, George E.] ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.; Taylor, Jeremy F.; Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; Williams, Paul; McWilliam, Sean; Barendse, William] CSIRO, Livestock Ind, St Lucia, Qld 4067, Australia; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; McWilliam, Sean; Barendse, William] Univ New England, CRC, Beef Genet Technol, Armidale, NSW 2351, Australia; [Eversoie, Kallye A.] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Gill, Clare A.; Abbey, Colette A.; Gill, Clare A.; Gao, Chuan; Gill, Clare A.; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Choi, Jungwoo] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Green, Ronnie D.; Kappes, Steven M.; Green, Ronnie D.; Olivier, Hanotte; Green, Ronnie D.] ARS, USDA, Natl Program Staff, Beltsville, MD 20705 USA; [Hamernik, Debora L.] USDA Cooperat State Res Educ & Extens Serv, Washington, DC 20250 USA; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Ctr Integrat Genet, N-1432 As, Norway; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Matukumalli, Lakshmi K.; Matukumalli, Lakshmi K.; Grefenstette, John J.; Villa-Angulo, Rafael; Villa-Angulo, Rafael] George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA; [McEwan, John C.; Dodds, Ken G.] AgResearch, Anim Genom, Invermay 9053, Mosgiel, New Zealand; [Ajmone-Marsan, Paolo; Ajmone-Marsan, Paolo; Negrini, Riccardo] Univ Cattolica Sacro Cuore, Ist Zootecn, I-29100 Piacenza, Italy; [Boettcher, Paul J.; Garcia, Jose Fernando; Boettcher, Paul J.] IAEA, Joint United Nations FAO, Div Nucl Tech Food & Agr, A-1400 Vienna, Austria; [Caetano, Alexandre R.; Caetano, Alexandre R.] Embrapa Genet Resources & Biotechnol Ctr, BR-70770900 Brasilia, DF, Brazil; [Garcia, Jose Fernando] UNESP, Dept Anim Prod & Hlth, IAEA, Collaborat Ctr Anim Genom & Bioinformat, BR-16050680 Aracatuba, SP, Brazil; [Hanotte, Olivier; Hanotte, Olivier; Agaba, Morris] Int Livestock Res Inst, Nairobi 00100, Kenya; [Skow, Loren C.; Skow, Loren C.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biol Sci, College Stn, TX 77843 USA; [Williams, John L.; Wooliams, John A.; Aerts, Jan; Jann, Oliver; Williams, John L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin E25 9PS, Midlothian, Scotland; [Diallo, Boubacar] Direct Natl Elevage, Conakry, Guinea; [Hailemariam, Lemecha] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Martinez, Mario L.; Machado, Marco A.; da Silva, Marcos Barbosa] Embrapa Dairy Cattle Ctr, BR-36038330 Juiz De Fora, MG, Brazil; [Morris, Chris A.; Morris, Chris A.] AgResearch, Anim Genom, Hamilton 3240, New Zealand; [Silva, Luiz O. C.; Araujo, Flabio R.] Embrapa Beef Cattle Ctr, BR-79002970 Campo Grande, MS, Brazil; [Spelman, Richard J.; Spelman, Richard J.] LIC, Res & Dev, Hamilton 3240, New Zealand; [Mulatu, Woudyalew] Int Livestock Res Inst, Addis Ababa, Ethiopia; [Zhao, Keyan; Bustamante, Carlos D.; Hernandez, Ryan D.; Bryc, Katarzyna; Bustamante, Carlos D.; Gao, Hong; Wright, Mark; Bustamante, Carlos D.; Wright, Mark] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Burton, James] Univ Edinburgh Summerhall, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Plastow, Graham; Moore, Stephen S.; Moore, Stephen S.; Murdoch, Brenda] Univ Alberta, AgFor Ctr 410, Edmonton, AB T6G 2P5, Canada; [Smith, Timothy] ARS, USDA, US Meat Anim Res Ctr, Mol Genet Res Unit, Clay Ctr, NE 68933 USA; [Valentini, Alessio] Univ Tuscia, Dipartimento Prod Anim, I-01100 Viterbo, Italy; [Womack, James] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Aerts, Jan] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Goddard, Mike E.] Univ Melbourne, Fac Land & Food Resources, Parkville, Vic 3010, Australia; [Bradley, Daniel G.; Lau, Lilian P. L.; Lynn, David J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Lynn, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Missouri System; University of Missouri Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New England; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Norwegian University of Life Sciences; Norwegian University of Life Sciences; George Mason University; AgResearch - New Zealand; Catholic University of the Sacred Heart; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; CGIAR; International Livestock Research Institute (ILRI); Texas A&M University System; Texas A&M University College Station; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Ethiopian Institute of Agricultural Research (EIAR); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); AgResearch - New Zealand; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; International Livestock Research Institute (ILRI); Cornell University; University of Edinburgh; University of Alberta; United States Department of Agriculture (USDA); Tuscia University; Texas A&M University System; Texas A&M University College Station; Wellcome Trust Sanger Institute; University of Melbourne; Trinity College Dublin; Simon Fraser University	Van Tassell, CP (corresponding author), ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA.	agibbs@bcm.tmc.edu; taylorjerr@missouri.edu; curt.vantassell@ars.usda.gov	Stella, Alessandra/AAY-7322-2020; Weinstock, George M/C-6314-2013; Wheeler, David A/M-9740-2018; Gao, Chuan/A-8808-2015; Caetano, Alexandre Rodrigues/B-5227-2017; Eversole, Kellye/AAN-6141-2020; Aerts, Jan/AAQ-6949-2020; valentini, alessio/L-3970-2013; Bradley, Daniel G/A-3240-2012; Van Tassell, Curtis P./O-4247-2019; McWilliam, Sean M/H-8978-2013; McEwan, John/A-1143-2008; Villa-Angulo, Rafael/I-5937-2015; Hayes, Ben J/L-3308-2016; Gill, Clare/R-3677-2019; stella, Alessandra/ABB-1952-2021; stella, Alessandra/AAG-6401-2021; Hanotte, Olivier/B-4669-2013; Barendse, William J/D-8608-2011; Liu, George/K-3371-2019; Moore, Stephen S/F-5285-2013; AJMONE MARSAN, Paolo/M-2466-2018	Weinstock, George M/0000-0002-2997-4592; Wheeler, David A/0000-0002-9056-6299; Gao, Chuan/0000-0002-1399-8450; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; Eversole, Kellye/0000-0002-8784-4913; Aerts, Jan/0000-0002-6416-2717; valentini, alessio/0000-0003-4733-7519; Van Tassell, Curtis P./0000-0002-8416-2087; McWilliam, Sean M/0000-0002-3148-0428; McEwan, John/0000-0003-4801-6207; Villa-Angulo, Rafael/0000-0002-7698-6617; Hayes, Ben J/0000-0002-5606-3970; Gill, Clare/0000-0003-2640-1825; stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Barendse, William J/0000-0002-5464-0658; Liu, George/0000-0003-0192-6705; Schnabel, Robert/0000-0001-5018-7641; Zhao, Keyan/0000-0002-8800-2304; Bustamante, Carlos D./0000-0002-4187-7920; Goddard, Michael/0000-0001-9917-7946; NEGRINI, Riccardo/0000-0002-8735-0286; Wright, Mark/0000-0001-8036-1161; Hanotte, Olivier/0000-0002-2877-4767; Worley, Kim/0000-0002-0282-1000; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Williams, John/0000-0001-5188-7957; Skow, Loren/0000-0001-8998-359X; Bradley, Daniel G/0000-0001-7335-7092; Plastow, Graham/0000-0002-3774-3110; Moore, Stephen/0000-0002-9758-166X; Dodds, Ken/0000-0002-9347-6379; Lynn, David/0000-0003-4664-1404; mariani, paola/0000-0002-5604-4550	National Human Genome Research Institute of the National Institutes of Health; U.S. Department of Agricultures Agricultural Research Service (USDA-ARS); Cooperative State Research, Education and Extension Service (USDA CSREES); Research Council of Norway; American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna; International Livestock Research Institute-Kenya; Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation; Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); BBSRC [BBS/E/R/00001618, BBS/E/D/05191130, BBS/E/R/00001610] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/R/00000673, BBS/E/D/05191130, BBS/E/R/00001610, BBS/E/R/00001618, BBS/B/05710] Funding Source: researchfish	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agricultures Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cooperative State Research, Education and Extension Service (USDA CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Research Council of Norway(Research Council of Norway); American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna(International Atomic Energy Agency); International Livestock Research Institute-Kenya(CGIAR); Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation(Livestock Improvement Corporation); Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Bovine Hapmap Consortium funded by the National Human Genome Research Institute of the National Institutes of Health, U.S. Department of Agricultures Agricultural Research Service (USDA-ARS) and Cooperative State Research, Education and Extension Service (USDA CSREES), the Research Council of Norway, as well as: American Angus Association, American Hereford Association, American Jersey Cattle Association, AgResearch (New Zealand), Beef CRC and Meat and Livestock Australia for the Australian Brahman Breeders Association, Beefmaster Breeders United, The Brazilian Agricultural Research Corporation (Embrapa), Brown Swiss Association, Commonwealth Scientific and Industrial Research Organization, Dairy InSight, GENO Breeding and Artificial Insemination Association-Norway, Herd Book/France Limousin Selection, Holstein Association USA, International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna, International Livestock Research Institute-Kenya, Italian Piedmontese Breeders-Parco Tecnologico Padano, Italian Romagnola Society-Universita Cattolica del Sacro Cuore, Livestock Improvement Corporation, Meat and Wool New Zealand. North American Limousin Foundation, Red Angus Association of America, Roslin Institute for UK Guernsey, and Sygen (now Genus). See SOM for additional acknowledgements. The genome sequence (AAFC03000000) and SNPs (SOM) are available from NCBI.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barendse W, 2004, AUST J EXP AGR, V44, P669, DOI 10.1071/EA02156; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Kappes SM, 2000, J ANIM SCI, V78, P3053; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schreiber A, 1999, J HERED, V90, P165, DOI 10.1093/jhered/90.1.165; SVED J A, 1971, Theoretical Population Biology, V2, P125; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	22	599	637	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					528	532		10.1126/science.1167936	http://dx.doi.org/10.1126/science.1167936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390050	Green Accepted, Green Published			2022-12-24	WOS:000265411200051
J	Tonelli, M; Klarenbach, S; Rose, C; Wiebe, N; Gill, J				Tonelli, Marcello; Klarenbach, Scott; Rose, Caren; Wiebe, Natasha; Gill, John			Access to Kidney Transplantation Among Remote- and Rural-Dwelling Patients With Kidney Failure in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC REVASCULARIZATION SERVICES; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; URBAN AREAS; INDICATORS; HOSPITALS; RESIDENCE; LOCATION; SCOTLAND; CANADA	Context US residents with end-stage renal disease ( ESRD) may live far away from the closest transplant center, which could compromise their access to kidney transplantation. Objective To assess access to kidney transplantation as a function of distance from the closest transplant center or as a function of rural rather than urban residence. Design, Setting, and Participants Observational study of 699 751 adult patients with kidney failure who had initiated renal replacement in the United States between 1995 and 2007 and were thus placed on a prospective mandatory registry list. Main Outcome Measures Time to placement on the kidney transplant waiting list and time to kidney transplantation, both measured at the start of renal replacement. Results During a median follow-up of 2.0 years (range, 0.0-12.5 years), 122 785 (17.5%) patients received a kidney transplant. Median distance to the closest transplant center was 15 miles. Participants were classified into distance categories by miles from a transplant center with 0 to 15 miles serving as the referent category. Compared with the referent category, the adjusted hazard ratios of deceased or living donor transplantation within each category follows: 16 to 50 miles, 1.03 (95% CI, 1.02-1.05); 51 to 100 miles, 1.11 (95% CI, 1.09-1.12); 101 to 136 miles, 1.14 (95% CI, 1.11-1.17); 137 to 231 miles, 1.16 (95% CI, 1.13-1.20); 232 to 310 miles, 1.20 (95% CI, 1.12-1.28); and more than 310 miles, 1.16 (95% CI, 1.09-1.23). When residence location was classified using rural-urban commuter areas, 79.6% of patients lived in urban; 10.3%, micropolitan; and 10.0%, rural areas. Compared with those living in metropolitan areas, the adjusted hazard ratios of deceased or living donor transplantation among patients residing in micropolitan communities was 1.13 (95% CI, 1.11-1.15) and 1.15 (95% CI, 1.13-1.18) for rural areas. Results were similar for both deceased donor and living donor transplantation and were consistent in multiple sensitivity analyses. Conclusion Remote or rural residence was not associated with increased time to kidney transplantation among people treated for ESRD in the United States.	[Tonelli, Marcello; Klarenbach, Scott; Wiebe, Natasha] Univ Alberta, Dept Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Div Crit Care Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello; Klarenbach, Scott] Inst Hlth Econ, Edmonton, AB, Canada; [Rose, Caren; Gill, John] St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada; [Gill, John] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA	University of Alberta; University of Alberta; University of Alberta; St. Paul's Hospital; University of Saskatchewan; Tufts Medical Center	Tonelli, M (corresponding author), Univ Alberta, Dept Med, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2B7, Canada.	mtonelli-admin@med.ualberta.ca	Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187	Alberta Heritage Foundation for Medical Research; Alberta Health and Wellness and the University of Alberta; Canadian Institutes of Health Research; Michael Smith Foundation for Medical Research	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Health and Wellness and the University of Alberta(University of Alberta); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Medical Research(Michael Smith Foundation for Health Research)	Funding/Support: Drs Tonelli and Klarenbach were supported by Population Health Investigator Awards from the Alberta Heritage Foundation for Medical Research and by a joint initiative between Alberta Health and Wellness and the University of Alberta. Dr Tonelli was also supported by a New Investigator Award from the Canadian Institutes of Health Research. Dr Gill was supported by the Michael Smith Foundation for Medical Research.	Alexander GC, 2001, AM J KIDNEY DIS, V37, P321, DOI 10.1053/ajkd.2001.21297; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P408, DOI 10.1136/jech.49.4.408; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Brabyn L., 2004, CARTOGRAPHICA, V39, P41, DOI [10.3138/TH62-2668-3273-3344, DOI 10.3138/TH62-2668-3273-3344]; Brabyn Lars, 2002, Int J Health Geogr, V1, P3, DOI 10.1186/1476-072X-1-3; Ellison MD, 2003, TRANSPLANTATION, V76, P1389, DOI 10.1097/01.TP.0000090332.30050.BA; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Gregory PM, 2000, MED CARE, V38, P45, DOI 10.1097/00005650-200001000-00006; Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Kasiske BL, 2008, AM J TRANSPLANT, V8, P647, DOI 10.1111/j.1600-6143.2007.02130.x; KASISKE BL, 1995, J AM SOC NEPHROL, V6, P1; Larson RC, 1981, URBAN OPERATIONS RES; LEESE GP, 1993, BRIT MED J, V306, P187, DOI 10.1136/bmj.306.6871.187; Leira EC, 2008, ARCH NEUROL-CHICAGO, V65, P887, DOI 10.1001/archneur.65.7.887; Levin KA, 2006, AM J PUBLIC HEALTH, V96, P145, DOI 10.2105/AJPH.2004.051193; Loubeau P R, 2001, Prog Transplant, V11, P291; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; Neylan JF, 1999, J AM SOC NEPHROL, V10, P2237; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Pong RW, 2002, CAN J PUBLIC HEALTH, V93, pS52, DOI 10.1007/BF03405119; Seidel JE, 2004, CAN J CARDIOL, V20, P517; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Tonelli M, 2006, CAN MED ASSOC J, V175, P478, DOI 10.1503/cmaj.051356; Turnbull J, 2008, BRIT J GEN PRACT, V58, P471, DOI 10.3399/bjgp08X319431; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	28	68	68	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1681	1690		10.1001/jama.2009.545	http://dx.doi.org/10.1001/jama.2009.545			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383959				2022-12-24	WOS:000265350700024
J	Zhao, SM; Lin, Y; Xu, W; Jiang, WQ; Zha, ZY; Wang, P; Yu, W; Li, ZQ; Gong, LL; Peng, YJ; Ding, JP; Lei, QY; Guan, KL; Xiong, Y				Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Li, Zhiqiang; Gong, Lingling; Peng, Yingjie; Ding, Jianping; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue			Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 alpha	SCIENCE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; MECHANISM; TUMORS	Heterozygous mutations in the gene encoding isocitrate dehydrogenase-1 (IDH1) occur in certain human brain tumors, but their mechanistic role in tumor development is unknown. We have shown that tumor-derived IDH1 mutations impair the enzyme's affinity for its substrate and dominantly inhibit wild-type IDH1 activity through the formation of catalytically inactive heterodimers. Forced expression of mutant IDH1 in cultured cells reduces formation of the enzyme product, alpha-ketoglutarate (alpha-KG), and increases the levels of hypoxia-inducible factor subunit HIF-1 alpha, a transcription factor that facilitates tumor growth when oxygen is low and whose stability is regulated by alpha-KG. The rise in HIF-1 alpha levels was reversible by an alpha-KG derivative. HIF-1 alpha levels were higher in human gliomas harboring an IDH1 mutation than in tumors without a mutation. Thus, IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.	[Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Wang, Pu; Yu, Wei; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lei, Qunying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Li, Zhiqiang] Wuhan Univ, Dept Neurosurg, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Gong, Lingling] Wuhan Univ, Dept Pathol, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Peng, Yingjie; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Guan, KL (corresponding author), Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, 130 Dong An Rd, Shanghai 200032, Peoples R China.	kuguan@ucsd.edu; yxiong@email.unc.edu	YU, WEI/C-3822-2012; Guan, Kun-Liang/ADK-7088-2022; Peng, Yingjie/B-1280-2013; Lei, Qun-Ying/J-1390-2017; YU, WEI/G-6710-2013	Lei, Qun-Ying/0000-0002-8547-8518; Zhiqiang, LI/0000-0002-4148-780X; YU, WEI/0000-0001-9898-4607; ding, jian ping/0000-0001-7029-7346	Chinese Ministry of Education; State Key Development Programs of China [2009CB918401, 2006CB806700]; National 863 Program of China [2006AA02A308]; China NSF [30600112, 30871255]; Shanghai Key Basic Research Projects [06JC14086, 07PJ14011, 08JC1400900]; NIH; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER	Chinese Ministry of Education(Ministry of Education, China); State Key Development Programs of China; National 863 Program of China(National High Technology Research and Development Program of China); China NSF(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Fudan Molecular and Cell Biology Laboratory for valuable input; Y. Liu, X. Liu, and H. Zhu for assistance with histology; Z. Bao, L. Yang, Q. Shi, and G. Zhao for clinical samples; and S. Jackson for reading the manuscript. This work is supported by the 985 program from the Chinese Ministry of Education, State Key Development Programs of China (2009CB918401, 2006CB806700), National 863 Program of China (2006AA02A308), China NSF grants (30600112 and 30871255) and Shanghai Key Basic Research Projects (06JC14086, 07PJ14011, and 08JC1400900), and NIH grants (to K.-L.G. and Y.X.). Y. Xiong, K.-L. Guan, and S. Zhao are applying for a patent related to the work on permeable alpha-ketogluterate.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; INGEBRETSEN OC, 1976, BIOCHIM BIOPHYS ACTA, V452, P302, DOI 10.1016/0005-2744(76)90180-7; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	12	869	966	4	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					261	265		10.1126/science.1170944	http://dx.doi.org/10.1126/science.1170944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359588	Green Accepted			2022-12-24	WOS:000265024400049
J	Matsuura, K; Vargo, EL; Kawatsu, K; Labadie, PE; Nakano, H; Yashiro, T; Tsuji, K				Matsuura, Kenji; Vargo, Edward L.; Kawatsu, Kazutaka; Labadie, Paul E.; Nakano, Hiroko; Yashiro, Toshihisa; Tsuji, Kazuki			Queen Succession Through Asexual Reproduction in Termites	SCIENCE			English	Article							CLONAL REPRODUCTION; COLONY FOUNDATION; RHINOTERMITIDAE; PARTHENOGENESIS; ISOPTERA; ANT		[Matsuura, Kenji; Nakano, Hiroko; Yashiro, Toshihisa] Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Kawatsu, Kazutaka] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Okinawa 9000213, Japan	Okayama University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kyoto University; University of the Ryukyus	Matsuura, K (corresponding author), Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan.	kenjijpn@cc.okayama-u.ac.jp	Yashiro, Toshihisa/J-3120-2015; Vargo, Edward/D-1097-2010; Tsuji, Kazuki/D-6607-2014; Kawtasu, Kazutaka/B-1066-2010; Matsuura, Kenji/H-8364-2019	Yashiro, Toshihisa/0000-0002-9582-4605; Vargo, Edward/0000-0002-8712-1248; Tsuji, Kazuki/0000-0002-2027-8582; Kawtasu, Kazutaka/0000-0003-4447-4761; Matsuura, Kenji/0000-0002-9099-6694	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Biosciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences	We are grateful to K. Shimizu, E. Hasegawa, S. Dobata, and N. E. Pierce for discussion and to W. Booth, D. R. Tarpy, K. Ross, L. Keller, and C. Schal for comments on the manuscript. Funded by the Japan Society for the Promotion of Science (K.M., K.T.) and the Program for Promotion of Basic Research Activities for Innovative Biosciences (K.M.).	Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Matsuura K, 2001, POPUL ECOL, V43, P119, DOI 10.1007/PL00012022; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Shellman-Reeve JS, 1999, P ROY SOC B-BIOL SCI, V266, P137, DOI 10.1098/rspb.1999.0613; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833	7	108	115	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1687	1687		10.1126/science.1169702	http://dx.doi.org/10.1126/science.1169702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325106				2022-12-24	WOS:000264559800028
J	Moseley, JB; Mayeux, A; Paoletti, A; Nurse, P				Moseley, James B.; Mayeux, Adeline; Paoletti, Anne; Nurse, Paul			A spatial gradient coordinates cell size and mitotic entry in fission yeast	NATURE			English	Article							PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; CONTRACTILE RING; GENETIC-CONTROL; DIVISION PLANE; CYTOKINESIS; MITOSIS; MID1P; INDUCER; GROWTH	Many eukaryotic cell types undergo size-dependent cell cycle transitions controlled by the ubiquitous cyclin-dependent kinase Cdk1 (refs 1-4). The proteins that control Cdk1 activity are well described but their links with mechanisms monitoring cell size remain elusive. In the fission yeast Schizosaccharomyces pombe, cells enter mitosis and divide at a defined and reproducible size owing to the regulated activity of Cdk1 (refs 2, 3). Here we show that the cell polarity protein kinase Pom1, which localizes to cell ends(5), regulates a signalling network that contributes to the control of mitotic entry. This network is located at cortical nodes in the middle of interphase cells, and these nodes contain the Cdk1 inhibitor Wee1, the Wee1-inhibitory kinases Cdr1 (also known as Nim1) and Cdr2, and the anillin-like protein Mid1. Cdr2 establishes the hierarchical localization of other proteins in the nodes, and receives negative regulatory signals from Pom1. Pom1 forms a polar gradient extending from the cell ends towards the cell middle and acts as a dose-dependent inhibitor of mitotic entry, working through the Cdr2 pathway. As cells elongate, Pom1 levels decrease at the cell middle, leading to mitotic entry. We propose that the Pom1 polar gradient and the medial cortical nodes generate information about cell size and coordinate this with mitotic entry by regulating Cdk1 through Pom1, Cdr2, Cdr1 and Wee1.	[Moseley, James B.; Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA; [Mayeux, Adeline; Paoletti, Anne] CNRS, UMR144, F-75248 Paris 05, France; [Mayeux, Adeline; Paoletti, Anne] Ctr Rech, Inst Curie, F-75248 Paris 05, France	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Moseley, JB (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	jmoseley@rockefeller.edu	PAOLETTI, Anne/CAF-4643-2022	PAOLETTI, Anne/0000-0002-9004-559X	American Cancer Society [PF-07-129-01-MBC]; ANR [BLAN06-3_135468]; ARC [4934]; FRM [INE20071110973]; Breast Cancer Research Foundation; Rockefeller University	American Cancer Society(American Cancer Society); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Breast Cancer Research Foundation; Rockefeller University	We thank members of the Nurse laboratory for discussions and critical reading of the manuscript, A. Puszynska for technical assistance, The Rockefeller University Bio-Imaging Resource Center for assistance with microscopy, The Rockefeller University Proteomics Resource Center for mass spectrometry, K. Gould, J.-Q. Wu, T. Pollard, J. Bahler, F. Chang and K. Sawin for yeast strains, plasmids and antibodies, and S. Martin for sharing unpublished data and for discussions. J. B. M. was supported by a postdoctoral fellowship from the American Cancer Society (PF-07-129-01-MBC); A. P. by funding from ANR (BLAN06-3_135468), ARC (no. 4934) and FRM (INE20071110973); and P. N. by the Breast Cancer Research Foundation and The Rockefeller University.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	29	273	281	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					857	U8		10.1038/nature08074	http://dx.doi.org/10.1038/nature08074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19474789				2022-12-24	WOS:000267084500042
J	Mueller, M; Grauschopf, U; Maier, T; Glockshuber, R; Ban, N				Mueller, Marcus; Grauschopf, Ulla; Maier, Timm; Glockshuber, Rudi; Ban, Nenad			The structure of a cytolytic alpha-helical toxin pore reveals its assembly mechanism	NATURE			English	Article							HEMOLYSIN-E HLYE; ESCHERICHIA-COLI; MOLECULAR ANALYSIS; CRYSTAL-STRUCTURE; BACTERIAL TOXIN; CLYA; PROTEIN; SHEA; SOFTWARE; REFINEMENT	Pore-forming toxins (PFTs) are a class of potent virulence factors that convert from a soluble form to a membrane-integrated pore(1). They exhibit their toxic effect either by destruction of the membrane permeability barrier or by delivery of toxic components through the pores. Among the group of bacterial PFTs are some of the most dangerous toxins, such as diphtheria and anthrax toxin. Examples of eukaryotic PFTs are perforin and the membrane-attack complex, proteins of the immune system(2). PFTs can be subdivided into two classes, alpha-PFTs and beta-PFTs, depending on the suspected mode of membrane integration, either by alpha-helical or beta-sheet elements(3). The only high-resolution structure of a transmembrane PFT pore is available for a beta-PFT-alpha-haemolysin from Staphylococcus aureus 4. Cytolysin A (ClyA, also known as HlyE), an alpha-PFT, is a cytolytic alpha-helical toxin responsible for the haemolytic phenotype of several Escherichia coli and Salmonella enterica strains(5-8). ClyA is cytotoxic towards cultured mammalian cells, induces apoptosis of macrophages and promotes tissue pervasion(9-11). Electron microscopic reconstructions demonstrated that the soluble monomer of ClyA(12) must undergo large conformational changes to form the transmembrane pore(13,14). Here we report the 3.3 angstrom crystal structure of the 400 kDa dodecameric transmembrane pore formed by ClyA. The tertiary structure of ClyA protomers in the pore is substantially different from that in the soluble monomer. The conversion involves more than half of all residues. It results in large rearrangements, up to 140 angstrom, of parts of the monomer, reorganization of the hydrophobic core, and transitions of beta-sheets and loop regions to alpha-helices. The large extent of interdependent conformational changes indicates a sequential mechanism for membrane insertion and pore formation.	[Mueller, Marcus; Grauschopf, Ulla; Maier, Timm; Glockshuber, Rudi; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR); Structural Biology program of the SNSF	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Structural Biology program of the SNSF	We thank B. Blattmann for help with initial screening, N. Eifler and A. Engel for providing electron microscopy maps, D. Boehringer for sample characterization, and H. Fah-Rechsteiner for technical assistance. We also acknowledge the staff of X06SA at the Swiss Light Source for developing an excellent beamline and support with data collection, T. C. Terwilliger for his support using RESOLVE, and M. Leibundgut and D. Boehringer for critically reading the manuscript. This work was supported by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkins A, 2000, J BIOL CHEM, V275, P41150, DOI 10.1074/jbc.M005420200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano WL., 2020, PYMOL MOL GRAPHICS S; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Evans W, 1997, CHEM BRIT, V33, P22; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; Hunt S, 2008, MICROBIOL-SGM, V154, P633, DOI 10.1099/mic.0.2007/011700-0; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawate T, 2003, PROTEIN SCI, V12, P997, DOI 10.1110/ps.0231203; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Ludwig A, 2004, J BACTERIOL, V186, P5311, DOI 10.1128/JB.186.16.5311-5320.2004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Tzokov SB, 2006, J BIOL CHEM, V281, P23042, DOI 10.1074/jbc.M602421200; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wyborn NR, 2004, MICROBIOL-SGM, V150, P1495, DOI 10.1099/mic.0.26877-0	47	247	257	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					726	U135		10.1038/nature08026	http://dx.doi.org/10.1038/nature08026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19421192				2022-12-24	WOS:000266608600049
J	Jin, ZY; Li, Y; Pitti, R; Lawrence, D; Pham, VC; Lill, JR; Ashkenazi, A				Jin, Zhaoyu; Li, Yun; Pitti, Robert; Lawrence, David; Pham, Victoria C.; Lill, Jennie R.; Ashkenazi, Avi			Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED CELL-DEATH; UBIQUITIN LIGASES; ACTIVATION; RECEPTOR; PROTEIN; DEGRADATION; AUTOPHAGY; PATHWAYS	Cell-surface death receptors such as DR4 and DR5 trigger apoptosis through a death-inducing signaling complex (DISC) that recruits the apical protease caspase-8. Apoptosis commitment requires efficient activation and autocatalytic release of caspase-8 into the cytoplasm to engage executioner caspases. While DISC recruitment initiates caspase-8 stimulation, full activation of the protease depends on further molecular aggregation events that are not fully understood. Here, we show that death receptor ligation induces polyubiquitination of caspase-8, through a previously unknown interaction of the DISC with a cullin3 (CUL3)-based E3 ligase. CUL3-mediated caspase-8 polyubiquitination required the RING box protein RBX1, whereas the deubiquitinase A20 reversed this modification. The ubiquitin-binding protein p62/sequestosome-1 promoted aggregation of CUL3-modified caspase-8 within p62-dependent foci, leading to full activation and processing of the enzyme and driving commitment to cell death. These results identify a mechanism that positively controls apoptosis signaling by polyubiquitination and aggregation of a key initiator caspase.	[Jin, Zhaoyu; Li, Yun; Pitti, Robert; Lawrence, David; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Pham, Victoria C.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Austin CD, 2006, P NATL ACAD SCI USA, V103, P10283, DOI 10.1073/pnas.0604044103; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Israel A, 2006, TRENDS IMMUNOL, V27, P395, DOI 10.1016/j.it.2006.07.003; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KIM I, 2006, SCI STKE, V330, pPE18; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zornig M, 2001, BBA-REV CANCER, V1551, pF1, DOI 10.1016/S0304-419X(01)00031-2	46	473	492	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					721	735		10.1016/j.cell.2009.03.015	http://dx.doi.org/10.1016/j.cell.2009.03.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19427028	Bronze			2022-12-24	WOS:000266114100020
J	Li, LJ; Gattass, RR; Gershgoren, E; Hwang, H; Fourkas, JT				Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Hwang, Hana; Fourkas, John T.			Achieving lambda/20 Resolution by One-Color Initiation and Deactivation of Polymerization	SCIENCE			English	Article							2-PHOTON; LITHOGRAPHY; MICROSCOPY; NANOSCOPY	In conventional photolithography, diffraction limits the resolution to about one-quarter of the wavelength of the light used. We introduce an approach to photolithography in which multiphoton absorption of pulsed 800-nanometer (nm) light is used to initiate cross-linking in a polymer photoresist and one-photon absorption of continuous-wave 800-nm light is used simultaneously to deactivate the photopolymerization. By employing spatial phase-shaping of the deactivation beam, we demonstrate the fabrication of features with scalable resolution along the beam axis, down to a 40-nm minimum feature size. We anticipate application of this technique for the fabrication of diverse two- and three-dimensional structures with a feature size that is a small fraction of the wavelength of the light employed.	[Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Fourkas, John T.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Hwang, Hana] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Maryland NanoCtr, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fourkas, JT (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	fourkas@umd.edu	Hwang, Hana/B-3999-2011; li, linjie/C-7845-2009; Fourkas, John T/B-3500-2009	Fourkas, John T/0000-0002-4522-9584	UMD-NSF-MRSEC [DMR 05-20471]	UMD-NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We appreciate the support of the Maryland NanoCenter and its Nanoscale Imaging, Spectroscopy, and Properties Laboratory (NISPLab). NISPLab is supported in part by NSF as a Materials Research Science and Engineering Center (MRSEC) Shared Experimental Facility. This work was supported in part by the UMD-NSF-MRSEC under grant DMR 05-20471. We are grateful to E. Williams for the use of her AFM and to J. Goldhar, Y. Leng, and V. Yun for fabricating the phase mask used in this work. The University of Maryland has filed a provision patent based on the work presented in this paper.	BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Colley CS, 2002, J AM CHEM SOC, V124, P14952, DOI 10.1021/ja026099m; Farrer RA, 2005, NANO LETT, V5, P1139, DOI 10.1021/nl050687r; Harke B, 2008, NANO LETT, V8, P1309, DOI 10.1021/nl073164n; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hirschfelder J. O., 1954, MOL THEORY GASES LIQ; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995; Rumi M, 2008, ADV POLYM SCI, V213, P1, DOI 10.1007/12_2008_133; Sun HB, 2003, APPL PHYS LETT, V83, P819, DOI 10.1063/1.1598293; Sun HB, 2002, APPL PHYS LETT, V80, P3673, DOI 10.1063/1.1478128; Tan DF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2535504; Thompson SE, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71539-5; Xing JF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717532; Yang D, 2005, MRS BULL, V30, P976, DOI 10.1557/mrs2005.251	19	384	406	12	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					910	913		10.1126/science.1168996	http://dx.doi.org/10.1126/science.1168996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359543				2022-12-24	WOS:000266048800030
J	Semmelhack, JL; Wang, JW				Semmelhack, Julia L.; Wang, Jing W.			Select Drosophila glomeruli mediate innate olfactory attraction and aversion	NATURE			English	Article							ANTENNAL LOBE; BEHAVIORAL-RESPONSES; FLY BRAIN; NEURONS; RECEPTORS; MAP; MELANOGASTER; REPRESENTATION; INFORMATION; CHANNELS	Fruitflies show robust attraction to food odours, which usually excite several glomeruli. To understand how the representation of such odours leads to behaviour, we used genetic tools to dissect the contribution of each activated glomerulus. Apple cider vinegar triggers robust innate attraction at a relatively low concentration, which activates six glomeruli. By silencing individual glomeruli, here we show that the absence of activity in two glomeruli, DM1 and VA2, markedly reduces attraction. Conversely, when each of these two glomeruli was selectively activated, flies showed as robust an attraction to vinegar as wild-type flies. Notably, a higher concentration of vinegar excites an additional glomerulus and is less attractive to flies. We show that activation of the extra glomerulus is necessary and sufficient to mediate the behavioural switch. Together, these results indicate that individual glomeruli, rather than the entire pattern of active glomeruli, mediate innate behavioural output.	[Semmelhack, Julia L.; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Semmelhack, Julie/0000-0002-8154-264X	Whitehall Foundation; National Institute of Deafness and other Communication Disorders [R01DC009597]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank D. Anderson, R. Axel, C. Zuker and M. Gallio for comments on the manuscript. We thank M. Hilker for help with the design of the four- field olfactometer. We thank C. Root for generating the data presented in Supplementary Fig. 4. We thank L. Vosshall, B. Dickson and T. Lee for providing fly stocks. This work was partially supported by a research grant from the Whitehall Foundation to J. W. W. and a grant from the National Institute of Deafness and other Communication Disorders to J. W. W. (R01DC009597). J. W. W. is a Beckman Young Investigator, a Hellman Faculty scholar, and a Searle scholar.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; AURAND LW, 1966, J FOOD SCI, V31, P172, DOI 10.1111/j.1365-2621.1966.tb00474.x; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; LAING DG, 1978, CHEM SENS FLAV, V3, P149, DOI 10.1093/chemse/3.2.149; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	47	219	221	2	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					218	U100		10.1038/nature07983	http://dx.doi.org/10.1038/nature07983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19396157	Green Accepted			2022-12-24	WOS:000266036100033
J	Macosko, EZ; Pokala, N; Feinberg, EH; Chalasani, SH; Butcher, RA; Clardy, J; Bargmann, CI				Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Butcher, Rebecca A.; Clardy, Jon; Bargmann, Cornelia I.			A hub-and-spoke circuit drives pheromone attraction and social behaviour in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; NATURAL VARIATION; CHEMOSENSORY NEURONS; CHEMICAL REPELLENTS; NEUROPEPTIDE-Y; GENE; CHEMOTAXIS; INHIBITION; MODULATION; EXPRESSION	Innate social behaviours emerge from neuronal circuits that interpret sensory information on the basis of an individual's own genotype, sex and experience. The regulated aggregation behaviour of the nematode Caenorhabditis elegans, a simple animal with only 302 neurons, is an attractive system to analyse these circuits. Wild social strains of C. elegans aggregate in the presence of specific sensory cues, but solitary strains do not(1-4). Here we identify the RMG inter/motor neuron as the hub of a regulated circuit that controls aggregation and related behaviours. RMG is the central site of action of the neuropeptide receptor gene npr-1, which distinguishes solitary strains (high npr-1 activity) from wild social strains (low npr-1 activity); high RMG activity is essential for all aspects of social behaviour. Anatomical gap junctions connect RMG to several classes of sensory neurons known to promote aggregation, and to ASK sensory neurons, which are implicated in male attraction to hermaphrodite pheromones(5). We find that ASK neurons respond directly to pheromones, and that high RMG activity enhances ASK responses in social strains, causing hermaphrodite attraction to pheromones at concentrations that repel solitary hermaphrodites. The coordination of social behaviours by RMG suggests an anatomical hub-and-spoke model for sensory integration in aggregation, and points to functions for related circuit motifs in the C. elegans wiring diagram.	[Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, 1230 York Ave, New York, NY 10065 USA.	cori@rockefeller.edu	Macosko, Evan/X-4664-2019; Pokala, Navin/AAH-5719-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute; Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health [GM07739, CA24487, GM077943]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, F32GM077943] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Looger for GCaMP2.2b, M. Nonet for cleavage-resistant synaptobrevin, and J. Ragains for synthesizing ascarosides. This work was funded by the Howard Hughes Medical Institute, the Harold and Leila Y Mathers Charitable Foundation, the Jensam Foundation, and National Institute of Health grants GM07739 (E.Z.M. and E. H. F.), CA24487 ( J. C.) and GM077943 ( R. A. B.). C. I. B. is an Investigator of the Howard Hughes Medical Institute.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; HART AC, 2006, WORMBOOK BEHAV; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hodgkin J, 1997, GENETICS, V146, P149; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	309	313	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1171	U110		10.1038/nature07886	http://dx.doi.org/10.1038/nature07886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19349961	Green Accepted, Green Submitted			2022-12-24	WOS:000265754600048
J	Deneault, E; Cellot, S; Faubert, A; Laverdure, JP; Frechette, M; Chagraoui, J; Mayotte, N; Sauvageau, M; Ting, SB; Sauvageau, G				Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy			A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity	CELL			English	Article							IN-VITRO; SELF-RENEWAL; EXPANSION; OVEREXPRESSION; VIVO; HOXB4; GENE; HSC	Despite tremendous progress made toward the identification of the molecular circuitry that governs cell fate in embryonic stem cells, genes controlling this process in the adult hematopoietic stem cell have proven to be more difficult to unmask. We now report the results of a novel gain-of-function screening approach, which identified a series of 18 nuclear factors that affect hematopoietic stem cell activity. Overexpression of ten of these factors resulted in an increased repopulating activity compared to unmanipulated cells. Interestingly, at least four of the 18 factors, Fos, Tcfec, Hmgb1, and Sfpi1, show non-cell-autonomous functions. The utilization of this screening method together with the creation of a database enriched for potential determinants of hematopoietic stem cell self-renewal will serve as a resource to uncover regulatory networks in these cells.	[Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy] Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada; [Sauvageau, Guy] Hop Maison Neuve Rosemont, Div Hematol & Leukemia Cell Bank Quebec BCLQ, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca	Sauvageau, Martin/A-8967-2013	Sauvageau, Martin/0000-0001-9487-5016; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institute of Health Research (CIHR) [154290, 2006-2011]; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The authors thank J. Krosl, R. Bisaillon and B. T. Wilhelm for technical help, C. Charbonneau from IRIC imagery platform, D. Gagne from IRIC flow cytometry platform, and P. Chagnon and R. Lambert from IRIC genomic platform for their expertise with quantitative RT-PCR. We also want to acknowledge C. Perreault, M. Therrien, K. J. Hope, and R. K. Humphries for discussions and critical comments about the manuscript. This work was supported by the Canadian Institute of Health Research (CIHR) Team Grant in Hematopoietic Stem Cell Self-Renewal: From Genes to Bedside (Grant number 154290, 2006-2011). G. S. holds a Canada Research Chair on molecular genetics of stem cells; E. D. and S. C. are recipients of a CIHR studentship and Clinician Scientist award, respectively; J. C. holds an American Society of Hematology fellowship; M. S. holds a National Canadian Institute of Cancer studentship; and S. B. T. is the recipient of National Health Medical Research Council and a Royal Australian College of Physicians fellowships. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche en Sante du Quebec (FRSQ).	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Uchida N, 2004, BLOOD, V103, P4487, DOI 10.1182/blood-2003-11-3989	23	100	102	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					369	379		10.1016/j.cell.2009.03.026	http://dx.doi.org/10.1016/j.cell.2009.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379700	Green Accepted, Bronze			2022-12-24	WOS:000265456800028
J	Olive, KP; Jacobetz, MA; Davidson, CJ; Gopinathan, A; McIntyre, D; Honess, D; Madhu, B; Goldgraben, MA; Caldwell, ME; Allard, D; Frese, KK; DeNicola, G; Feig, C; Combs, C; Winter, SP; Ireland-Zecchini, H; Reichelt, S; Howat, WJ; Chang, A; Dhara, M; Wang, LF; Ruckert, F; Grutzmann, R; Pilarsky, C; Izeradjene, K; Hingorani, SR; Huang, P; Davies, SE; Plunkett, W; Egorin, M; Hruban, RH; Whitebread, N; McGovern, K; Adams, J; Iacobuzio-Donahue, C; Griffiths, J; Tuveson, DA				Olive, Kenneth P.; Jacobetz, Michael A.; Davidson, Christian J.; Gopinathan, Aarthi; McIntyre, Dominick; Honess, Davina; Madhu, Basetti; Goldgraben, Mae A.; Caldwell, Meredith E.; Allard, David; Frese, Kristopher K.; DeNicola, Gina; Feig, Christine; Combs, Chelsea; Winter, Stephen P.; Ireland-Zecchini, Heather; Reichelt, Stefanie; Howat, William J.; Chang, Alex; Dhara, Mousumi; Wang, Lifu; Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian; Izeradjene, Kamel; Hingorani, Sunil R.; Huang, Pearl; Davies, Susan E.; Plunkett, William; Egorin, Merrill; Hruban, Ralph H.; Whitebread, Nigel; McGovern, Karen; Adams, Julian; Iacobuzio-Donahue, Christine; Griffiths, John; Tuveson, David A.			Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer	SCIENCE			English	Article							DUCTAL ADENOCARCINOMA; SONIC HEDGEHOG; GEMCITABINE; GROWTH; METASTASIS; DIAGNOSIS; SURVIVAL; THERAPY; TUMORS; TRIAL	Pancreatic ductal adenocarcinoma (PDA) is among the most lethal human cancers in part because it is insensitive to many chemotherapeutic drugs. Studying a mouse model of PDA that is refractory to the clinically used drug gemcitabine, we found that the tumors in this model were poorly perfused and poorly vascularized, properties that are shared with human PDA. We tested whether the delivery and efficacy of gemcitabine in the mice could be improved by coadministration of IPI-926, a drug that depletes tumor-associated stromal tissue by inhibition of the Hedgehog cellular signaling pathway. The combination therapy produced a transient increase in intratumoral vascular density and intratumoral concentration of gemcitabine, leading to transient stabilization of disease. Thus, inefficient drug delivery may be an important contributor to chemoresistance in pancreatic cancer.	[Olive, Kenneth P.; Jacobetz, Michael A.; Gopinathan, Aarthi; McIntyre, Dominick; Honess, Davina; Madhu, Basetti; Goldgraben, Mae A.; Caldwell, Meredith E.; Allard, David; Frese, Kristopher K.; DeNicola, Gina; Feig, Christine; Winter, Stephen P.; Ireland-Zecchini, Heather; Reichelt, Stefanie; Howat, William J.; Griffiths, John; Tuveson, David A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 ORE, England; [Davidson, Christian J.; Gopinathan, Aarthi; DeNicola, Gina; Combs, Chelsea; Wang, Lifu] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Sidney Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA; [Chang, Alex; Dhara, Mousumi; Hruban, Ralph H.; Iacobuzio-Donahue, Christine] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Wang, Lifu] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gastroenterol, Sch Med, Shanghai 200025, Peoples R China; [Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian] Univ Hosp Dresden, Dept Surg, D-01307 Dresden, Germany; [Izeradjene, Kamel; Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Clin Res & Publ Hlth Sci Div, Seattle, WA 98109 USA; [Izeradjene, Kamel; Hingorani, Sunil R.] Univ Washington, Seattle, WA 98109 USA; [Huang, Pearl] Merck & Co Inc, Oncol Franchise, N Wales, PA 19454 USA; [Davies, Susan E.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Plunkett, William] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Egorin, Merrill] Univ Pittsburgh, Med Ctr, Div Hematol & Oncol, Pittsburgh, PA 15213 USA; [Whitebread, Nigel; McGovern, Karen; Adams, Julian] Infin Pharmaceut, Cambridge, MA 01239 USA	Cancer Research UK; CRUK Cambridge Institute; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Shanghai Jiao Tong University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Merck & Company; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tuveson, DA (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 ORE, England.	david.tuveson@cancer.org.uk	Iacobuzio-Donahue, Christine/ABF-1295-2020; Griffiths, John R/F-2853-2010; McIntyre, Dominick/F-2998-2010; Madhu, Basetti/AAW-9665-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; McIntyre, Dominick/0000-0002-0269-6545; Madhu, Basetti/0000-0001-5844-856X; Feig, Christine/0000-0003-1385-7049; Hingorani, Sunil/0000-0002-3869-8729; DeNicola, Gina/0000-0001-6611-6696; Olive, Kenneth/0000-0002-3392-8994; Reichelt, Stefanie/0000-0003-4151-0712; Pilarsky, Christian/0000-0002-7968-3283; Goldgraben, Mae/0000-0002-1111-2804	Lustgarten Foundation; University of Cambridge; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; National Institute for Health Research Cambridge Biomedical Research Centre; NIH [CA101973, CA111292, CA084291, CA105490, K08 CA106610, CA15704, CA114028, F32CA123939-02, F32CA123887-01]; Mead Foundation; University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative; NATIONAL CANCER INSTITUTE [K08CA106610, F32CA123939, F32CA123887, K08CA114028, R01CA101973, U01CA105490, U01CA084291, P30CA015704] Funding Source: NIH RePORTER	Lustgarten Foundation; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mead Foundation; University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the animal care staffs of the Cambridge Research Institute (CRI), University of Pennsylvania Translational Research Labs, FHCRC, and University Hospital Dresden as well as the histology and genomics cores at CRI, and P. Calses for technical assistance. We also thank B. Bean of Transnetyx Inc. for developing high-throughput genotyping assays for the KPC mice. This research was supported by the Lustgarten Foundation, the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the National Institute for Health Research Cambridge Biomedical Research Centre, and NIH (grants CA101973, CA111292, CA084291, and CA105490 to D.A.T.; K08 CA106610 to C.I.-D.; and CA15704 and CA114028 to S.R.H.). S.R.H. was supported by a grant from the Mead Foundation. Preliminary studies were supported by a grant from the University of Pennsylvania GlaxoSmithKline Alternative Drug Discovery Initiative. K.P.O. and K.K.F. were supported by NIH under Ruth L. Kirschstein National Research Service Awards F32CA123939-02 (K.P.O.) and F32CA123887-01 (K.K.F.). In addition to being an officer of Infinity Pharmaceuticals, J.A. is a member of the Senior Advisory Boards of Constellation Pharma and Auspex Pharma. Cancer Research Technology, which is associated with Cancer Research UK, has filed a U.S. provisional patent application related to this work.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bruns CJ, 2002, INT J CANCER, V102, P101, DOI 10.1002/ijc.10681; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cook N, 2008, METHOD ENZYMOL, V439, P73, DOI 10.1016/S0076-6879(07)00406-5; Duan JX, 2008, J MED CHEM, V51, P2412, DOI 10.1021/jm701028q; EGORIN MJ, 1974, CANCER RES, V34, P2243; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018; SCHULTZ RM, 1993, ONCOL RES, V5, P223; Shimamura T, 2007, CANCER RES, V67, P9903, DOI 10.1158/0008-5472.CAN-06-4558; Sofuni A, 2005, J GASTROENTEROL, V40, P518, DOI 10.1007/s00535-005-1578-z; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	27	2285	2352	15	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2009	324	5933					1457	1461		10.1126/science.1171362	http://dx.doi.org/10.1126/science.1171362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456VD	19460966	Green Accepted			2022-12-24	WOS:000266878700050
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Two types of dopamine neuron distinctly convey positive and negative motivational signals	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE; NUCLEUS-ACCUMBENS; LATERAL HABENULA; AVERSIVE STIMULI; DISCHARGE RATE; REWARD; STRIATUM; PRIMATE	Midbrain dopamine neurons are activated by reward or sensory stimuli predicting reward(1-4). These excitatory responses increase as the reward value increases(5). This response property has led to a hypothesis that dopamine neurons encode value-related signals and are inhibited by aversive events. Here we show that this is true only for a subset of dopamine neurons. We recorded the activity of dopamine neurons in monkeys (Macaca mulatta) during a Pavlovian procedure with appetitive and aversive outcomes (liquid rewards and airpuffs directed at the face, respectively). We found that some dopamine neurons were excited by reward-predicting stimuli and inhibited by airpuff-predicting stimuli, as the value hypothesis predicts. However, a greater number of dopamine neurons were excited by both of these stimuli, inconsistent with the hypothesis. Some dopamine neurons were also excited by both rewards and airpuffs themselves, especially when they were unpredictable. Neurons excited by the airpuff-predicting stimuli were located more dorsolaterally in the substantia nigra pars compacta, whereas neurons inhibited by the stimuli were located more ventromedially, some in the ventral tegmental area. A similar anatomical difference was observed for their responses to actual airpuffs. These findings suggest that different groups of dopamine neurons convey motivational signals in distinct manners.	[Matsumoto, Masayuki; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Matsumoto, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	matsumotom@nei.nih.gov			Intramural Research Program at the National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Hong, E. Bromberg-Martin, M. Yasuda, S. Yamamoto and Y. Tachibana for discussion, M. K. Smith for his histological expertise, J. W. McClurkin, A. M. Nichols, T. W. Ruffner, A. V. Hays and L. P. Jensen for technical assistance, and G. Tansey, D. Parker and B. Nagy for animal care. This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute.	CARLI M, 1985, NATURE, V313, P679, DOI 10.1038/313679a0; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Davies RM, 2006, J NEUROPHYSIOL, V96, P906, DOI 10.1152/jn.01030.2005; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KITAMA T, 1991, NEUROSCI RES, V12, P287, DOI 10.1016/0168-0102(91)90118-I; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P625, DOI 10.1016/0306-4522(94)90182-1; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360	29	871	878	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					837	U4		10.1038/nature08028	http://dx.doi.org/10.1038/nature08028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19448610	Green Accepted			2022-12-24	WOS:000267084500038
J	Feher, O; Wang, HB; Saar, S; Mitra, PP; Tchernichovski, O				Feher, Olga; Wang, Haibin; Saar, Sigal; Mitra, Partha P.; Tchernichovski, Ofer			De novo establishment of wild-type song culture in the zebra finch	NATURE			English	Article							WHITE-CROWNED SPARROW; TAENIOPYGIA-GUTTATA; CONSPECIFIC SONG; UNTUTORED SONG; BIRD SONG; EVOLUTION; BEHAVIOR; SELECTIVITY; LANGUAGE; RULES	Culture is typically viewed as consisting of traits inherited epigenetically, through social learning. However, cultural diversity has species-typical constraints(1), presumably of genetic origin. A celebrated, if contentious, example is whether a universal grammar constrains syntactic diversity in human languages(2). Oscine songbirds exhibit song learning and provide biologically tractable models of culture: members of a species show individual variation in song(3) and geographically separated groups have local song dialects(4,5). Different species exhibit distinct song cultures(6,7), suggestive of genetic constraints(8,9). Without such constraints, innovations and copying errors should cause unbounded variation over multiple generations or geographical distance, contrary to observations(9). Here we report an experiment designed to determine whether wild-type song culture might emerge over multiple generations in an isolated colony founded by isolates, and, if so, how this might happen and what type of social environment is required(10). Zebra finch isolates, unexposed to singing males during development, produce song with characteristics that differ from the wild-type song found in laboratory(11) or natural colonies. In tutoring lineages starting from isolate founders, we quantified alterations in song across tutoring generations in two social environments: tutor-pupil pairs in sound-isolated chambers and an isolated semi-natural colony. In both settings, juveniles imitated the isolate tutors but changed certain characteristics of the songs. These alterations accumulated over learning generations. Consequently, songs evolved towards the wild-type in three to four generations. Thus, species-typical song culture can appear de novo. Our study has parallels with language change and evolution(12-14). In analogy to models in quantitative genetics(15,16), we model song culture as a multigenerational phenotype partly encoded genetically in an isolate founding population, influenced by environmental variables and taking multiple generations to emerge.	[Feher, Olga; Saar, Sigal; Tchernichovski, Ofer] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Wang, Haibin; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	City University of New York (CUNY) System; City College of New York (CUNY); Cold Spring Harbor Laboratory	Feher, O (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	olcifeher@gmail.com	Tchernichovski, Ofer/AAC-5678-2019	Tchernichovski, Ofer/0000-0001-6788-614X; Mitra, Partha/0000-0001-8818-6804	US National Institutes of Health (NIH); NIH Research Centers in Minority Institutions; Crick-Clay Professorship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crick-Clay Professorship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Wallman and H. Williams for critical reading of the manuscript and consultation and F. Nottebohm, C. Harding and N. Leader for recordings of WT songs. The study was supported by US National Institutes of Health (NIH) grants to O. T. and P. P. M., by a NIH Research Centers in Minority Institutions grant to City College, City University of New York, and by the Crick-Clay Professorship to P. P. M.	Adret P, 2004, ANN NY ACAD SCI, V1016, P303, DOI 10.1196/annals.1298.005; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; BOAKE CRB, 1994, QUANTITATIVE GENETIC, P94; BOHNER J, 1983, ANIM BEHAV, V31, P231, DOI 10.1016/S0003-3472(83)80193-6; Boyd R., 1985, CULTURE EVOLUTIONARY; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; Cheverud JM, 2003, P NATL ACAD SCI USA, V100, P4357, DOI 10.1073/pnas.0931311100; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; DICKERSON GE, 1947, IOWA AGR EXPT STATIO, V354, P489; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gardner TJ, 2005, SCIENCE, V308, P1046, DOI 10.1126/science.1108214; Jones AE, 1996, J COMP PSYCHOL, V110, P354; KEGL J, 2002, LANG ACQUIS, P207; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1985, ANIM BEHAV, V33, P57, DOI 10.1016/S0003-3472(85)80120-2; Mundinger PC, 1995, ANIM BEHAV, V50, P1491, DOI 10.1016/0003-3472(95)80006-9; NELSON DA, 1994, P NATL ACAD SCI USA, V91, P10498, DOI 10.1073/pnas.91.22.10498; Niyogi P, 2006, CURR STUD LINGUIST, V43, P1; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Olofsson H, 2008, BEHAV ECOL, V19, P594, DOI 10.1093/beheco/arn002; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Saar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001461; Soha JA, 2000, ANIM BEHAV, V60, P297, DOI 10.1006/anbe.2000.1499; Soha JA, 2001, ETHOLOGY, V107, P813, DOI 10.1046/j.1439-0310.2001.00713.x; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; VOLMAN SF, 1995, J COMP PSYCHOL, V109, P211, DOI 10.1037/0735-7036.109.3.211; West M.J., 1985, P245; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; WILLIAMS H, 1993, ANIM BEHAV, V45, P695, DOI 10.1006/anbe.1993.1084	32	204	207	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					564	U94		10.1038/nature07994	http://dx.doi.org/10.1038/nature07994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449ZS	19412161	Green Accepted, Green Submitted			2022-12-24	WOS:000266370500038
J	Li, X; Cassidy, JJ; Reinke, CA; Fischboeck, S; Carthew, RW				Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.			A MicroRNA Imparts Robustness against Environmental Fluctuation during Development	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR; SIGNAL INTEGRATION; NETWORK MOTIFS; TARGET GENES; NOTCH; CANALIZATION; EXPRESSION; FEEDBACK; RECEPTOR; DIFFERENTIATION	The microRNA miR-7 is perfectly conserved from annelids to humans, and yet some of the genes that it regulates in Drosophila are not regulated in mammals. We have explored the role of lineage restricted targets, using Drosophila, in order to better understand the evolutionary significance of microRNA-target relationships. From studies of two well characterized developmental regulatory networks, we find that miR-7 functions in several interlocking feedback and feedforward loops, and propose that its role in these networks is to buffer them against perturbation. To directly demonstrate this function for miR-7, we subjected the networks to temperature fluctuation and found that miR-7 is essential for the maintenance of regulatory stability under conditions of environmental flux. We suggest that some conserved microRNAs like miR-7 may enter into novel genetic relationships to buffer developmental programs against variation and impart robustness to diverse regulatory networks.	[Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569	Chicago Biomedical Consortium; Chicago Community Trust; NIH [GM077581]; Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Chicago Community Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bellen, S. Bray, C. Delidakis, S. Cohen, T. Hayashi, G. Mardon, and the Bloomington stock center for fly strains; N. Baker, H. Bellen, T. Hayashi, Z.C. Lai, and the Developmental Studies Hybridoma Bank for antibodies; T. Hayashi for sharing unpublished data; R. Gejman for advice and help with all stages of the informatic analysis; Carthew lab members and C. Labonne for discussions; the Biology Imaging Facility at Northwestern University for imaging. This work was supported by the by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust, the NIH (GM077581), the Northwestern Vision Training Grant (C.A.R.), the CMDB Training Grant (J.J.C.), and the Malkin Scholars program.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; RENDEL J. M., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P36; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.1111/j.1558-5646.1959.tb03033.x; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0	60	349	364	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					273	282		10.1016/j.cell.2009.01.058	http://dx.doi.org/10.1016/j.cell.2009.01.058			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379693	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000265456800020
J	Worden, AZ; Lee, JH; Mock, T; Rouze, P; Simmons, MP; Aerts, AL; Allen, AE; Cuvelier, ML; Derelle, E; Everett, MV; Foulon, E; Grimwood, J; Gundlach, H; Henrissat, B; Napoli, C; McDonald, SM; Parker, MS; Rombauts, S; Salamov, A; Von Dassow, P; Badger, JH; Coutinho, PM; Demir, E; Dubchak, I; Gentemann, C; Eikrem, W; Gready, JE; John, U; Lanier, W; Lindquist, EA; Lucas, S; Mayer, KFX; Moreau, H; Not, F; Otillar, R; Panaud, O; Pangilinan, J; Paulsen, I; Piegu, B; Poliakov, A; Robbens, S; Schmutz, J; Toulza, E; Wyss, T; Zelensky, A; Zhou, K; Armbrust, EV; Bhattacharya, D; Goodenough, UW; Van de Peer, Y; Grigoriev, IV				Worden, Alexandra Z.; Lee, Jae-Hyeok; Mock, Thomas; Rouze, Pierre; Simmons, Melinda P.; Aerts, Andrea L.; Allen, Andrew E.; Cuvelier, Marie L.; Derelle, Evelyne; Everett, Meredith V.; Foulon, Elodie; Grimwood, Jane; Gundlach, Heidrun; Henrissat, Bernard; Napoli, Carolyn; McDonald, Sarah M.; Parker, Micaela S.; Rombauts, Stephane; Salamov, Aasf; Von Dassow, Peter; Badger, Jonathan H.; Coutinho, Pedro M.; Demir, Elif; Dubchak, Inna; Gentemann, Chelle; Eikrem, Wenche; Gready, Jill E.; John, Uwe; Lanier, William; Lindquist, Erika A.; Lucas, Susan; Mayer, Klaus F. X.; Moreau, Herve; Not, Fabrice; Otillar, Robert; Panaud, Olivier; Pangilinan, Jasmyn; Paulsen, Ian; Piegu, Benoit; Poliakov, Aaron; Robbens, Steven; Schmutz, Jeremy; Toulza, Eve; Wyss, Tania; Zelensky, Alexander; Zhou, Kemin; Armbrust, E. Virginia; Bhattacharya, Debashish; Goodenough, Ursula W.; Van de Peer, Yves; Grigoriev, Igor V.			Green Evolution and Dynamic Adaptations Revealed by Genomes of the Marine Picoeukaryotes Micromonas	SCIENCE			English	Article							GENE-EXPRESSION; LAND PLANTS; ALGAE; CHLAMYDOMONAS; ENDOSYMBIOSIS; RIBOSWITCHES; PERSPECTIVE; METABOLISM; PROVIDES; ORIGIN	Picoeukaryotes are a taxonomically diverse group of organisms less than 2 micrometers in diameter. Photosynthetic marine picoeukaryotes in the genus Micromonas thrive in ecosystems ranging from tropical to polar and could serve as sentinel organisms for biogeochemical fluxes of modern oceans during climate change. These broadly distributed primary producers belong to an anciently diverged sister clade to land plants. Although Micromonas isolates have high 18S ribosomal RNA gene identity, we found that genomes from two isolates shared only 90% of their predicted genes. Their independent evolutionary paths were emphasized by distinct riboswitch arrangements as well as the discovery of intronic repeat elements in one isolate, and in metagenomic data, but not in other genomes. Divergence appears to have been facilitated by selection and acquisition processes that actively shape the repertoire of genes that are mutually exclusive between the two isolates differently than the core genes. Analyses of the Micromonas genomes offer valuable insights into ecological differentiation and the dynamic nature of early plant evolution.	[Worden, Alexandra Z.; Simmons, Melinda P.; Cuvelier, Marie L.; McDonald, Sarah M.; Demir, Elif] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Lee, Jae-Hyeok; Goodenough, Ursula W.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Mock, Thomas; Parker, Micaela S.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Aerts, Andrea L.; Grimwood, Jane; Salamov, Aasf; Dubchak, Inna; Lindquist, Erika A.; Lucas, Susan; Otillar, Robert; Pangilinan, Jasmyn; Poliakov, Aaron; Schmutz, Jeremy; Zhou, Kemin; Grigoriev, Igor V.] US DOE, JGI, Walnut Creek, CA 94598 USA; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Cuvelier, Marie L.; Everett, Meredith V.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Derelle, Evelyne] Univ Paris 06, CNRS, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Foulon, Elodie; Von Dassow, Peter; Not, Fabrice] Univ Paris 06, CNRS, Stn Biol Roscoff, Roscoff, France; [Grimwood, Jane; Mayer, Klaus F. X.; Schmutz, Jeremy] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Coutinho, Pedro M.] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [Napoli, Carolyn] Univ Arizona, Inst Biol, Tucson, AZ 85719 USA; [Gentemann, Chelle] Remote Sensing Syst, Santa Rosa, CA 95401 USA; [Eikrem, Wenche] Univ Oslo, N-0316 Oslo, Norway; [Gready, Jill E.] Australian Natl Univ, Coll Med Biol & Environm, Div Mol Biosci, Canberra, ACT 2601, Australia; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lanier, William; Bhattacharya, Debashish] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Panaud, Olivier; Piegu, Benoit] Univ Perpignan, Lab Genome & Dev Plantes, F-66860 Perpignan, France; [Paulsen, Ian] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia; [Toulza, Eve] Univ Montpellier 2, F-34095 Montpellier 05, France; [Wyss, Tania] Univ Miami, Dept Biol, Miami, FL 33149 USA; [Zelensky, Alexander] Erasmus MC, Dept Genet, NL-3015 CE Rotterdam, Netherlands	Monterey Bay Aquarium Research Institute; Washington University (WUSTL); University of Washington; University of Washington Seattle; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; United States Department of Energy (DOE); Joint Genome Institute - JGI; J. Craig Venter Institute; University of Miami; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Arizona; University of Oslo; Australian National University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Iowa; Universite Perpignan Via Domitia; Macquarie University; Universite de Montpellier; University of Miami; Erasmus University Rotterdam; Erasmus MC	Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	azworden@mbari.org	Van de Peer, Yves/D-4388-2009; Mayer, Klaus FX/M-7941-2015; Zelensky, Alex/S-3162-2019; Paulsen, Ian T/K-3832-2012; Worden, Alexandra Z./AAD-6567-2019; Henrissat, Bernard/J-2475-2012; von Dassow, Peter/A-5399-2012; john, uwe/S-3009-2016; Schmutz, Jeremy/N-3173-2013; Rombauts, Stephane/P-2420-2019; Van de Peer, Yves/AAE-7666-2019; Rombauts, Stephane M/D-7640-2014; Toulza, Eve/A-9919-2012; Allen, Andrew E/C-4896-2012; Zelensky, Alex/G-1201-2012; Zelensky, Alexander/Y-7734-2018; Grimwood, Jane/ABD-5737-2021; Mock, Thomas/A-3127-2008	Van de Peer, Yves/0000-0003-4327-3730; Mayer, Klaus FX/0000-0001-6484-1077; Zelensky, Alex/0000-0002-2664-271X; Paulsen, Ian T/0000-0001-9015-9418; Henrissat, Bernard/0000-0002-3434-8588; john, uwe/0000-0002-1297-4086; Schmutz, Jeremy/0000-0001-8062-9172; Rombauts, Stephane/0000-0002-3985-4981; Van de Peer, Yves/0000-0003-4327-3730; Rombauts, Stephane M/0000-0002-3985-4981; Toulza, Eve/0000-0003-2049-2279; Allen, Andrew E/0000-0001-5911-6081; Zelensky, Alex/0000-0002-2664-271X; Zelensky, Alexander/0000-0003-3387-7346; Mock, Thomas/0000-0001-9604-0362; Derelle, Evelyne/0000-0002-1499-4240; von Dassow, Peter/0000-0002-1858-1953; Worden, Alexandra/0000-0002-9888-9324; Parker, Micaela/0000-0003-1007-4612; Gundlach, Heidrun/0000-0002-6757-0943; Grigoriev, Igor/0000-0002-3136-8903; Gentemann, Chelle/0000-0002-2250-3106	DOE Biological and Environmental Research Program [DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, DEFC02-99ER62873]; NSF Molecular and Cellular Biosciences (MCB) [0326829, 0429359]; Gordon and Betty Moore Foundation; Lucille and David Packard Foundation	DOE Biological and Environmental Research Program; NSF Molecular and Cellular Biosciences (MCB); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Lucille and David Packard Foundation	We thank the Culture Collection for Marine Phytoplankton and Roscoff Culture Collection for providing isolates, in particular F. LeGall, A. Houdan, and D. Vaulot. We also thank R. Gausling, C. Perle, Q. Ren, D. Root, L. Stal, J. Van Wye, T. Weissman, R.M. Welsh, and U. Wollenzien. F. Partensky, N. Simon, P. Deschamps, and S. Ball facilitated chloroplast and starch (29) annotations; C. Rancurel and B. Cantarel assisted with carbohydrate-active enzymes (with CNRS funding). We are grateful to S. Giovannoni for thoughtful criticism of the manuscript and overall enthusiasm. Genome sequencing was performed under the DOE Biological and Environmental Research Program contracts DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, and DEFC02-99ER62873. U.W.G. and J.-H.L. were funded by NSF Molecular and Cellular Biosciences (MCB) grant 0326829. Funding carrying the project from inception to completion was provided by a Young Investigator in Marine Microbiology award to A.Z.W. from the Gordon and Betty Moore Foundation with additional funds from NSF MCB grant 0429359 and the Lucille and David Packard Foundation. A.Z.W. coordinated the project and annotation; A.Z.W. and U.W.G. wrote the manuscript with input and sections from J.-H.L., T.M., P.R., and M.P.S. (joint second authors are listed in alphabetical order), and Y.V.P. and D.B. performed intellectually based editing to which S. Rombauts and M.S.P. contributed; I.V.G. coordinated the sequencing and analysis at JGI. A.L.A., A.E.A., M.L.C., E. Derelle, M.V.E., E.F., J.G., H.G., B.H., C.N., S.M.M., M.S.P., S. Rombauts, A.S., and P.V.D. also made substantial contributions (listed in alphabetical order). J.H.B. and A.E.A. constructed the phylogenomic analysis tool. A.Z.W., E.V.A., K.F.X.M., U.W.G., and Y.V.P. supervised analyses; A.Z.W. conceived the study with input from D.B., H.M., and E.V.A. All others contributed as members of the Micromonas genome consortium or JGI sequencing and are listed in alphabetical order. RCC299 and CCMP1545 assemblies and annotations are available at www.jgi.doe.gov/MicromonasRCC299 and www.jgi.doe.gov/MicromonasCCMP1545, respectively. Genome assemblies together with predicted gene models and annotations were deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank under the project accession numbers ACCO00000000 and ACCP00000000 for RCC299 and CCMP1545, respectively.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; DellaPenna D, 2008, SCIENCE, V320, P479, DOI 10.1126/science.1153715; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lynch M, 2007, ORIGINS GENOME ARCHI; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Worden AZ, 2006, AQUAT MICROB ECOL, V43, P165, DOI 10.3354/ame043165	28	472	776	6	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					268	272		10.1126/science.1167222	http://dx.doi.org/10.1126/science.1167222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359590	Green Submitted			2022-12-24	WOS:000265024400051
J	Hagedorn, M; Rohde, KH; Russell, DG; Soldati, T				Hagedorn, Monica; Rohde, Kyle H.; Russell, David G.; Soldati, Thierry			Infection by Tubercular Mycobacteria Is Spread by Nonlytic Ejection from Their Amoeba Hosts	SCIENCE			English	Article							MARINUM; MACROPHAGES; VISUALIZATION; SECRETION; GRANULOMA; VIRULENCE	To generate efficient vaccines and cures for Mycobacterium tuberculosis, we need a far better understanding of its modes of infection, persistence, and spreading. Host cell entry and the establishment of a replication niche are well understood, but little is known about how tubercular mycobacteria exit host cells and disseminate the infection. Using the social amoeba Dictyostelium as a genetically tractable host for pathogenic mycobacteria, we discovered that M. tuberculosis and M. marinum, but not M. avium, are ejected from the cell through an actin-based structure, the ejectosome. This conserved nonlytic spreading mechanism requires a cytoskeleton regulator from the host and an intact mycobacterial ESX-1 secretion system. This insight offers new directions for research into the spreading of tubercular mycobacteria infections in mammalian cells.	[Hagedorn, Monica; Soldati, Thierry] Univ Geneva, Fac Sci, Dept Biochim, CH-1211 Geneva 4, Switzerland; [Rohde, Kyle H.; Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Geneva; Cornell University	Soldati, T (corresponding author), Univ Geneva, Fac Sci, Dept Biochim, Sci 2,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	thierry.soldati@unige.ch	Russell, David G/N-5280-2019; Russell, David G/D-4533-2009; SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931	Swiss National Science Foundation; Swiss 3R Foundation; U.S. NIH [AI 067027, HL 055936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067027] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss 3R Foundation; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge L. Ramakrishnan and C. Cosma for providing strains of M. marinum, various GFP expression vectors, and advice; G. Griffiths for GFP-expressing M. avium; B. C. VanderVen for providing GFP-expressing M. tuberculosis; F. Rivero and M. Maniak for providing Dictyostelium mutant strains; C. Bauer of the National Center of Competence in Research imaging platform for his help with microscopy; P. Walther and E. Schmid for their expert help with the SEM; and D. Soldati for critical reading of the manuscript. The work was supported by the Swiss National Science Foundation in the form of a grant to T.S. and an individual short-term fellowship to M.H. The T.S. group participates in the NEMO (nonmammalian experimental models for the study of bacterial infections) network supported by the Swiss 3R Foundation. D.G.R. and K.H.R. are supported by grants AI 067027 and HL 055936 from the U.S. NIH.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Byrd TF, 1998, INFECT IMMUN, V66, P5132, DOI 10.1128/IAI.66.11.5132-5139.1998; Carlsson F, 2006, J CELL PHYSIOL, V209, P288, DOI 10.1002/jcp.20721; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1111/j.1574-6968.2002.tb11258.x; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Somesh BP, 2006, TRAFFIC, V7, P1194, DOI 10.1111/j.1600-0854.2006.00455.x; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	27	157	159	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1729	1733		10.1126/science.1169381	http://dx.doi.org/10.1126/science.1169381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325115	Green Published, Green Accepted			2022-12-24	WOS:000264559800040
J	Toledo-Arana, A; Dussurget, O; Nikitas, G; Sesto, N; Guet-Revillet, H; Balestrino, D; Loh, E; Gripenland, J; Tiensuu, T; Vaitkevicius, K; Barthelemy, M; Vergassola, M; Nahori, MA; Soubigou, G; Regnault, B; Coppee, JY; Lecuit, M; Johansson, J; Cossart, P				Toledo-Arana, Alejandro; Dussurget, Olivier; Nikitas, Georgios; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Barthelemy, Mathieu; Vergassola, Massimo; Nahori, Marie-Anne; Soubigou, Guillaume; Regnault, Beatrice; Coppee, Jean-Yves; Lecuit, Marc; Johansson, Joergen; Cossart, Pascale			The Listeria transcriptional landscape from saprophytism to virulence	NATURE			English	Article							SMALL NONCODING RNAS; MONOCYTOGENES VIRULENCE; IDENTIFICATION; GENOME; EXPRESSION; GENE; INFECTION; MODEL; RIBOSWITCHES; TARGETS	The bacterium Listeria monocytogenes is ubiquitous in the environment and can lead to severe food-borne infections. It has recently emerged as a multifaceted model in pathogenesis. However, how this bacterium switches from a saprophyte to a pathogen is largely unknown. Here, using tiling arrays and RNAs from wild-type and mutant bacteria grown in vitro, ex vivo and in vivo, we have analysed the transcription of its entire genome. We provide the complete Listeria operon map and have uncovered far more diverse types of RNAs than expected: in addition to 50 small RNAs (<500 nucleotides), at least two of which are involved in virulence in mice, we have identified antisense RNAs covering several open-reading frames and long overlapping 59 and 39 untranslated regions. We discovered that riboswitches can act as terminators for upstream genes. When Listeria reaches the host intestinal lumen, an extensive transcriptional reshaping occurs with a SigB-mediated activation of virulence genes. In contrast, in the blood, PrfA controls transcription of virulence genes. Remarkably, several non-coding RNAs absent in the non-pathogenic species Listeria innocua exhibit the same expression patterns as the virulence genes. Together, our data unravel successive and coordinated global transcriptional changes during infection and point to previously unknown regulatory mechanisms in bacteria.	[Toledo-Arana, Alejandro; Dussurget, Olivier; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Toledo-Arana, Alejandro; Dussurget, Olivier; Nikitas, Georgios; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Lecuit, Marc; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Toledo-Arana, Alejandro; Dussurget, Olivier; Sesto, Nina; Guet-Revillet, Helene; Balestrino, Damien; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Nikitas, Georgios; Lecuit, Marc] Inst Pasteur, Microorganismes & Barrieres Hote G5, F-75015 Paris, France; [Nikitas, Georgios; Lecuit, Marc] INSERM, U604, F-75015 Paris, France; [Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Johansson, Joergen] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Loh, Edmund; Gripenland, Jonas; Tiensuu, Teresa; Vaitkevicius, Karolis; Johansson, Joergen] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Barthelemy, Mathieu; Soubigou, Guillaume; Regnault, Beatrice; Coppee, Jean-Yves] Inst Pasteur, F-75015 Paris, France; [Vergassola, Massimo] Inst Pasteur, UP Genet Sil, F-75015 Paris, France; [Vergassola, Massimo] CNRS, URA2171, F-75015 Paris, France; [Lecuit, Marc] Univ Paris 05, Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Umea University; Umea University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pascale.cossart@pasteur.fr	Vaitkevicius, Karolis/R-9714-2016; Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019; Toledo-Arana, Alejandro/F-9624-2011	Vaitkevicius, Karolis/0000-0001-9309-3653; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; Toledo-Arana, Alejandro/0000-0001-8148-6281; Loh, Edmund/0000-0001-7050-566X; Vergassola, Massimo/0000-0002-7212-8244; gripenland, jonas/0000-0002-9445-8586; BALESTRINO, Damien/0000-0001-5378-0379; REGNAULT, Beatrice/0000-0002-3914-1914; Marie-Anne, Nahori/0000-0002-4066-4528; Johansson, Jorgen/0000-0002-0904-497X; Dussurget, Olivier/0000-0001-9924-0837	Swedish Research Council [K2008-58X-15144-05-3, 621-2006-4450]; EU [Nu 018618, 2005-018618]; Institut Pasteur [GPH 9]; Inserm; INRA; ANR [ANR-05-MIIM-026-01]; ERC [233348]; Howard Hughes Medical Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We are grateful to E. Charpentier and the members of her group for providing the RACE protocol. We thank L. Frangeul for helping with L. monocytogenes annotation files. J. J. is supported by the Swedish Research Council grants K2008-58X-15144-05-3 and 621-2006-4450 and EU (BacRNA 2005 Contract Nu 018618). Work in the laboratory of P. C. received financial support from Institut Pasteur (GPH 9), Inserm, INRA, EU (BacRNA 2005-018618), ANR (ANR-05-MIIM-026-01) and ERC (Advanced Grant 233348). A. T.-A. was an EMBO long-term fellow. P. C. is an international research scholar of the Howard Hughes Medical Institute.	Barry T, 1999, FEMS MICROBIOL LETT, V173, P47, DOI 10.1111/j.1574-6968.1999.tb13483.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chakraborty T, 2000, INT J MED MICROBIOL, V290, P167; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Glaser P, 2001, SCIENCE, V294, P849; Gregory BD, 2008, PLANT J, V53, P636, DOI 10.1111/j.1365-313X.2007.03320.x; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Hain T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-20; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; Loh E, 2006, TRENDS MICROBIOL, V14, P294, DOI 10.1016/j.tim.2006.05.001; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Raengpradub S, 2008, APPL ENVIRON MICROB, V74, P158, DOI 10.1128/AEM.00951-07; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Winkler WC, 2005, CURR OPIN CHEM BIOL, V9, P594, DOI 10.1016/j.cbpa.2005.09.016; Yazaki J, 2007, CURR OPIN PLANT BIOL, V10, P534, DOI 10.1016/j.pbi.2007.07.006	37	661	683	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					950	956		10.1038/nature08080	http://dx.doi.org/10.1038/nature08080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19448609				2022-12-24	WOS:000267063500035
J	Steltzer, H; Post, E				Steltzer, Heidi; Post, Eric			Seasons and Life Cycles	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; PHENOLOGICAL RESPONSE; VEGETATION INDEX; LEAF PHENOLOGY; PLANT-GROWTH; METAANALYSIS; LATITUDES; GRASSLAND; ECOSYSTEM; IMPACTS		[Steltzer, Heidi] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Post, Eric] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Post, Eric] Aarhus Univ, Natl Environm Res Inst, Dept Arctic Environm, DK-4000 Roskilde, Denmark	Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Aarhus University	Steltzer, H (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	steltzer@nrel.colostate.edu; esp10@psu.edu						Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Delbart N, 2008, GLOBAL CHANGE BIOL, V14, P603, DOI 10.1111/j.1365-2486.2007.01505.x; DOUGHTY CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI DOI 10.1029/2007JG000590; Gazal R, 2008, GLOBAL CHANGE BIOL, V14, P1568, DOI 10.1111/j.1365-2486.2008.01602.x; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Jarrad FC, 2008, AUST J BOT, V56, P617, DOI 10.1071/BT08018; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; Petrie PR, 2008, AUST J GRAPE WINE R, V14, P33, DOI 10.1111/j.1755-0238.2008.00005.x; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Wittich KP, 2008, INT J BIOMETEOROL, V52, P167, DOI 10.1007/s00484-007-0108-5; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	24	96	110	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					886	887		10.1126/science.1171542	http://dx.doi.org/10.1126/science.1171542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445KD	19443769				2022-12-24	WOS:000266048800019
J	Adamo, L; Naveiras, O; Wenzel, PL; McKinney-Freeman, S; Mack, PJ; Gracia-Sancho, J; Suchy-Dicey, A; Yoshimoto, M; Lensch, MW; Yoder, MC; Garcia-Cardena, G; Daley, GQ				Adamo, Luigi; Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Mack, Peter J.; Gracia-Sancho, Jorge; Suchy-Dicey, Astrid; Yoshimoto, Momoko; Lensch, M. William; Yoder, Mervin C.; Garcia-Cardena, Guillermo; Daley, George Q.			Biomechanical forces promote embryonic haematopoiesis	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; STEM-CELLS; MOUSE EMBRYO; DEFINITIVE HEMATOPOIESIS; IN-VITRO; YOLK-SAC; EXPRESSION DEFINES; ENDOTHELIAL-CELLS; PROGENITOR CELLS; FLOW	Biomechanical forces are emerging as critical regulators of embryogenesis, particularly in the developing cardiovascular system(1,2). After initiation of the heartbeat in vertebrates, cells lining the ventral aspect of the dorsal aorta, the placental vessels, and the umbilical and vitelline arteries initiate expression of the transcription factor Runx1 (refs 3-5), a master regulator of haematopoiesis, and give rise to haematopoietic cells(4). It remains unknown whether the biomechanical forces imposed on the vascular wall at this developmental stage act as a determinant of haematopoietic potential(6). Here, using mouse embryonic stem cells differentiated in vitro, we show that fluid shear stress increases the expression of Runx1 in CD41(+)c-Kit(+) haematopoietic progenitor cells(7), concomitantly augmenting their haematopoietic colony-forming potential. Moreover, we find that shear stress increases haematopoietic colony-forming potential and expression of haematopoietic markers in the para-aortic splanchnopleura/aorta-gonads-mesonephros of mouse embryos and that abrogation of nitric oxide, a mediator of shear-stress-induced signalling(8), compromises haematopoietic potential in vitro and in vivo. Collectively, these data reveal a critical role for biomechanical forces in haematopoietic development.	[Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Adamo, Luigi; Mack, Peter J.; Gracia-Sancho, Jorge; Suchy-Dicey, Astrid; Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Naveiras, Olaia; Wenzel, Pamela L.; McKinney-Freeman, Shannon; Lensch, M. William; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Yoshimoto, Momoko; Yoder, Mervin C.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	guillermo_garcia-cardena@hms.harvard.edu; george.daley@childrens.harvard.edu	Wenzel, Pamela/A-2992-2010; McKinney-Freeman, Shannon/N-8161-2018; Garcia-Cardena, Guillermo/Q-6649-2019; Yoshimoto, Momoko/AFP-3523-2022; Yoshimoto, Momoko/N-4238-2014; Gracia-Sancho, Jordi/C-8920-2014; Suchy-Dicey, Astrid/AAM-6640-2021; Wenzel, Pamela/AAJ-1944-2021	McKinney-Freeman, Shannon/0000-0001-8061-2557; Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Gracia-Sancho, Jordi/0000-0001-7736-4089; Suchy-Dicey, Astrid/0000-0002-5608-7817; Wenzel, Pamela/0000-0002-4530-015X; Yoder, Mervin/0000-0003-4354-7631; Naveiras, Olaia/0000-0003-3434-0022	Giovanni Armenise- Harvard Foundation; Barrie de la Maza Foundation; National Institutes of Health; NIH Director's Pioneer Award of the NIH Roadmap for Medical Research; Burroughs Wellcome Fund Clinical Scientist Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080759] Funding Source: NIH RePORTER	Giovanni Armenise- Harvard Foundation; Barrie de la Maza Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award of the NIH Roadmap for Medical Research; Burroughs Wellcome Fund Clinical Scientist Award(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Losyev for assistance with flow cytometry, S. Schmitt for critical help in optimizing AGM culture conditions, C. Lengerke and Y. Mukouyama for critical discussions. L. A. was partially funded by the Giovanni Armenise- Harvard Foundation. O. N. was partially funded by the Barrie de la Maza Foundation. G. G.-C. was supported by grants from the National Institutes of Health and G. Q. D was supported by grants from the National Institutes of Health ( NIH), and the NIH Director's Pioneer Award of the NIH Roadmap for Medical Research. G. Q. D. is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and is an Investigator of the Howard Hughes Medical Institute.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Blackman BR, 2002, J BIOMECH ENG-T ASME, V124, P397, DOI 10.1115/1.1486468; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Garin G, 2006, ENDOTHELIUM-J ENDOTH, V13, P375, DOI 10.1080/10623320601061599; HAAR JL, 1971, ANAT REC, V170, P199, DOI 10.1002/ar.1091700206; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Ji RP, 2003, CIRC RES, V92, P133, DOI 10.1161/01.RES.0000056532.18710.C0; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lensch MW, 2004, CURR TOP DEV BIOL, V60, P127; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; NOSEK TM, 2000, ESSENTIALS HUMAN PHY; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Phoon CKL, 2002, AM J PHYSIOL-HEART C, V283, pH908, DOI 10.1152/ajpheart.00869.2001; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Tavian M, 2005, ANN NY ACAD SCI, V1044, P41, DOI 10.1196/annals.1349.006; Tiboni GM, 2007, BIRTH DEFECTS RES B, V80, P28, DOI 10.1002/bdrb.20100; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	33	374	385	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1131	U120		10.1038/nature08073	http://dx.doi.org/10.1038/nature08073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19440194	Green Accepted, Green Published			2022-12-24	WOS:000267636700044
J	Roelofs, J; Park, S; Haas, W; Tian, G; McAllister, FE; Huo, Y; Lee, BH; Zhang, F; Shi, YG; Gygi, SP; Finley, D				Roelofs, Jeroen; Park, Soyeon; Haas, Wilhelm; Tian, Geng; McAllister, Fiona E.; Huo, Ying; Lee, Byung-Hoon; Zhang, Fan; Shi, Yigong; Gygi, Steven P.; Finley, Daniel			Chaperone-mediated pathway of proteasome regulatory particle assembly	NATURE			English	Article							YEAST 26S PROTEASOME; 20S PROTEASOMES; S PROTEASOME; COMPLEX; PROTEINS; SUBUNITS; ATPASE; TRANSCRIPTION; ONCOPROTEIN; SUBSTRATE	The proteasome is a protease that controls diverse processes in eukaryotic cells. Its regulatory particle (RP) initiates the degradation of ubiquitin-protein conjugates by unfolding the substrate and translocating it into the proteasome core particle (CP) to be degraded(1). The RP has 19 subunits, and their pathway of assembly is not understood. Here we show that in the yeast Saccharomyces cerevisiae three proteins are found associated with RP but not with the RP-CP holoenzyme: Nas6, Rpn14 and Hsm3. Mutations in the corresponding genes confer proteasome loss-of-function phenotypes, despite their virtual absence from the holoenzyme. These effects result from deficient RP assembly. Thus, Nas6, Rpn14 and Hsm3 are RP chaperones. The RP contains six ATPases-the Rpt proteins-and each RP chaperone binds to the carboxy-terminal domain of a specific Rpt. We show in an accompanying study(2) that RP assembly is templated through the Rpt C termini, apparently by their insertion into binding pockets in the CP. Thus, RP chaperones may regulate proteasome assembly by directly restricting the accessibility of Rpt C termini to the CP. In addition, competition between the RP chaperones and the CP for Rpt engagement may explain the release of RP chaperones as proteasomes mature.	[Roelofs, Jeroen; Park, Soyeon; Haas, Wilhelm; Tian, Geng; McAllister, Fiona E.; Huo, Ying; Lee, Byung-Hoon; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Fan; Shi, Yigong] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Harvard University; Harvard Medical School; Princeton University	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Tian, Geng/G-7374-2011; Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Shi, Yigong/0000-0003-2030-168X; Lee, Byung-Hoon/0000-0002-7101-0471	NIH [GM043601, GM67945]; NIH NRSA [5F32GM75737-2]; EMBO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R01GM067945, F32GM075737, R37GM043601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mann for Rpt1 (also known as Cim5) and Rpt6 (Cim3) antibodies, K. Kubota for preparing HeLa lysates and especially L. Huang for the human Rpn112HTBH-expressing cell line. We also thank J. Hanna, M. Schmidt and members of the Finley laboratory, in particular S. Elsasser, for critically reading the manuscript. This work was supported by the NIH (GM043601 to D. F. and GM67945 to S. P. G.), a NIH NRSA postdoctoral fellowship (5F32GM75737-2 to S. P.) and an EMBO long-term fellowship (to J. R.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; ZHANG F, MOL CELL IN PRESS	29	133	145	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2009	459	7248					861	865		10.1038/nature08063	http://dx.doi.org/10.1038/nature08063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459EV	19412159	Green Accepted			2022-12-24	WOS:000267084500043
J	Gross, O; Poeck, H; Bscheider, M; Dostert, C; Hannesschlager, N; Endres, S; Hartmann, G; Tardivel, A; Schweighoffer, E; Tybulewicz, V; Mocsai, A; Tschopp, J; Ruland, J				Gross, Olaf; Poeck, Hendrik; Bscheider, Michael; Dostert, Catherine; Hannesschlaeger, Nicole; Endres, Stefan; Hartmann, Gunther; Tardivel, Aubry; Schweighoffer, Edina; Tybulewicz, Victor; Mocsai, Attila; Tschopp, Juerg; Ruland, Juergen			Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence	NATURE			English	Article							NALP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; ACTIVATION; RECEPTOR; IL-1-BETA; INHIBITOR; DEFICIENT; CRYSTALS; IMMUNITY	Fungal infections represent a serious threat, particularly in immunocompromised patients(1). Interleukin-1 beta (IL-1 beta) is a key pro-inflammatory factor in innate antifungal immunity(2). The mechanism by which the mammalian immune system regulates IL-1 beta production after fungal recognition is unclear. Two signals are generally required for IL-1 beta production: an NF-kappa B-dependent signal that induces the synthesis of pro-IL-1 beta (p35), and a second signal that triggers proteolytic pro-IL-1 beta processing to produce bioactive IL-1 beta (p17) via Caspase-1-containing multiprotein complexes called inflammasomes(3). Here we demonstrate that the tyrosine kinase Syk, operating downstream of several immunoreceptor tyrosine-based activation motif (ITAM)-coupled fungal pattern recognition receptors, controls both pro-IL-1 beta synthesis and inflammasome activation after cell stimulation with Candida albicans. Whereas Syk signalling for pro-IL-1 beta synthesis selectively uses the Card9 pathway, inflammasome activation by the fungus involves reactive oxygen species production and potassium efflux. Genetic deletion or pharmalogical inhibition of Syk selectively abrogated inflammasome activation by C. albicans but not by inflammasome activators such as Salmonella typhimurium or the bacterial toxin nigericin. Nlrp3 (also known as NALP3) was identified as the critical NOD-like receptor family member that transduces the fungal recognition signal to the inflammasome adaptor Asc (Pycard) for Caspase-1 (Casp1) activation and pro-IL-1 beta processing. Consistent with an essential role for Nlrp3 inflammasomes in antifungal immunity, we show that Nlrp3-deficient mice are hypersusceptible to Candida albicans infection. Thus, our results demonstrate the molecular basis for IL-1 beta production after fungal infection and identify a crucial function for the Nlrp3 inflammasome in mammalian host defence in vivo.	[Gross, Olaf; Poeck, Hendrik; Hannesschlaeger, Nicole; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; [Gross, Olaf; Dostert, Catherine; Tardivel, Aubry; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Bscheider, Michael; Endres, Stefan] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80539 Munich, Germany; [Hartmann, Gunther] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Schweighoffer, Edina; Tybulewicz, Victor] Natl Inst Med Res, London NW7 1AA, England; [Mocsai, Attila] Semmelweis Univ, Sch Med, Budapest, Hungary	Technical University of Munich; University of Lausanne; University of Munich; University of Bonn; MRC National Institute for Medical Research; Semmelweis University	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Ismaninger Str 22, D-81675 Munich, Germany.	jruland@lrz.tum.de	Gross, Olaf/E-4570-2010; Dostert, Catherine/AAJ-5473-2020; Ruland, Jürgen/Q-6680-2018; Mocsai, Attila/B-2792-2008; Hartmann, Gunther/P-7492-2017	Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Hartmann, Gunther/0000-0003-1021-2018; Tybulewicz, Victor/0000-0003-2439-0798; Mocsai, Attila/0000-0002-0512-1157	Marie Curie RTN ApopTrain Fellowship; Swiss National Science Foundation; Deutsche Krebshilfe; Sonderforschungsbereich; Deutsche Forschungsgemeinschaft; MRC [MC_U117527252] Funding Source: UKRI; Medical Research Council [MC_U117527252] Funding Source: researchfish	Marie Curie RTN ApopTrain Fellowship(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Peschel for helpful conversations, K. Schroder for critically reading the manuscript, RIGEL Inc. for providing the Syk inhibitor R406, P. Vandenabeele for the anti-Caspase-1 antibody and V. Dixit for Nlrc4 2/2 mice. O. G. is supported by a Marie Curie RTN ApopTrain Fellowship. This work was supported by Swiss National Science Foundation National Center of Competence in Research molecular oncology and Mugen grants to J. T., an EMBO long-term fellowship to C. D. and a Max-Eder-Program grant from Deutsche Krebshilfe and Sonderforschungsbereich grants from Deutsche Forschungsgemeinschaft to J. R.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mencacci A, 2000, INFECT IMMUN, V68, P5126, DOI 10.1128/IAI.68.9.5126-5131.2000; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pine PR, 2007, CLIN IMMUNOL, V124, P244, DOI 10.1016/j.clim.2007.03.543; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	29	663	695	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					433	U149		10.1038/nature07965	http://dx.doi.org/10.1038/nature07965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339971				2022-12-24	WOS:000266243700047
J	Hartley, PD; Madhani, HD				Hartley, Paul D.; Madhani, Hiten D.			Mechanisms that Specify Promoter Nucleosome Location and Identity	CELL			English	Article							BINDING-SITES; HISTONE H2A.Z; CHROMATIN; YEAST; VARIANT; RSC; OCCUPANCY; SEQUENCE; PROTEIN; REGION	The chromatin architecture of eukaryotic gene promoters is generally characterized by a nucleosome-free region (NFR) flanked by at least one H2A.Z variant nucleosome. Computational predictions of nucleosome positions based on thermodynamic properties of DNA-histone interactions have met with limited success. Here we show that the action of the essential RSC remodeling complex in S. cerevisiae helps explain the discrepancy between theory and experiment. In RSC-depleted cells, NFRs shrink such that the average positions of flanking nucleosomes move toward predicted sites. Nucleosome positioning at distinct subsets of promoters additionally requires the essential Myb family proteins Abf1 and Reb1, whose binding sites are enriched in NFRs. In contrast, H2A.Z deposition is dispensable for nucleosome positioning. By regulating H2A.Z deposition using a steroid-inducible protein splicing strategy, we show that NFR establishment is necessary for H2A.Z deposition. These studies suggest an ordered pathway for the assembly of promoter chromatin architecture.	[Hartley, Paul D.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,MC2200, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	National Institutes of Health Kirschstein [1F31GM083619, 5R01GM071801]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083619, R01GM071801] Funding Source: NIH RePORTER	National Institutes of Health Kirschstein(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank past and present members of our laboratory for discussions and advice over the course of this research. We thank Leslie Chu and Joachim Li for the pMET3 degron construct. We are especially grateful to Allen Buskirk and David Liu for providing the 4-hydroxytamoxifen-regulated intein construct. This work was supported by a National Institutes of Health Kirschstein predoctoral fellowship (1F31GM083619) to P. D. H. and NIH grant 5R01GM071801 to H. D. M. H. D. M. is a scholar of the Leukemia and Lymphoma Society.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beinoraviciute-Kellner R, 2005, FEBS LETT, V579, P4535, DOI 10.1016/j.febslet.2005.07.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; DEWINDE JH, 1993, YEAST, V9, P847, DOI 10.1002/yea.320090805; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; HARBISON CT, 2004, NAT GENET, V38, P1210; JAKOBOVITS EB, 1980, NATURE, V285, P263, DOI 10.1038/285263a0; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; SARAGOSTI S, 1980, CELL, V20, P65, DOI 10.1016/0092-8674(80)90235-4; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal MR, 2008, STAT APPL GENET MOL, V7; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	45	285	288	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					445	458		10.1016/j.cell.2009.02.043	http://dx.doi.org/10.1016/j.cell.2009.02.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410542	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000265677200015
J	Donlea, JM; Ramanan, N; Shaw, PJ				Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.			Use-Dependent Plasticity in Clock Neurons Regulates Sleep Need in Drosophila	SCIENCE			English	Article							PDF CELLS; GENE; DEPRIVATION; MEMORY; SRF; CONSOLIDATION; MELANOGASTER; MUTANTS; CIRCUIT; AROUSAL	Sleep is important for memory consolidation and is responsive to waking experience. Clock circuitry is uniquely positioned to coordinate interactions between processes underlying memory and sleep need. Flies increase sleep both after exposure to an enriched social environment and after protocols that induce long-term memory. We found that flies mutant for rutabaga, period, and blistered were deficient for experience-dependent increases in sleep. Rescue of each of these genes within the ventral lateral neurons (LN(V)s) restores increased sleep after social enrichment. Social experiences that induce increased sleep were associated with an increase in the number of synaptic terminals in the LNV projections into the medulla. The number of synaptic terminals was reduced during sleep and this decline was prevented by sleep deprivation.	[Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63130 USA.	shawp@pcg.wustl.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018		NIH [R01-NS051305-01A1, T32-GM008151]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305, F31NS063514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Thimgan, W. Vanderheyden, P. Gray, and P. Taghert for comments. This study was funded by NIH grants R01-NS051305-01A1 and T32-GM008151.	AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; Decker S, 2007, P NATL ACAD SCI USA, V104, P15905, DOI 10.1073/pnas.0702082104; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GAUTHIERROUVIERE C, 1993, EXP CELL RES, V209, P208, DOI 10.1006/excr.1993.1303; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Montagne J, 1996, DEVELOPMENT, V122, P2589; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roch F, 1998, DEVELOPMENT, V125, P1823; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	24	172	173	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					105	108		10.1126/science.1166657	http://dx.doi.org/10.1126/science.1166657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342592	Green Accepted			2022-12-24	WOS:000264802100043
J	Saijo, K; Winner, B; Carson, CT; Collier, JG; Boyer, L; Rosenfeld, MG; Gage, FH; Glass, CK				Saijo, Kaoru; Winner, Beate; Carson, Christian T.; Collier, Jana G.; Boyer, Leah; Rosenfeld, Michael G.; Gage, Fred H.; Glass, Christopher K.			A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death	CELL			English	Article							ORPHAN NUCLEAR RECEPTOR; PARKINSONS-DISEASE; GENE-EXPRESSION; ALPHA-SYNUCLEIN; ACTIVATION; NEURODEGENERATION; CELLS; NURR1; HETERODIMERIZATION; PHOSPHORYLATION	Nurr1, an orphan nuclear receptor, plays an essential role in the generation and maintenance of dopaminergic neurons in the brain. Rare mutations in Nurr1 are associated with familial Parkinson's disease, but the underlying basis for this relationship has not been established. Here, we demonstrate that Nurr1 unexpectedly functions to inhibit expression of pro-inflammatory neurotoxic mediators in both microglia and astrocytes. Reduced Nurr1 expression results in exaggerated inflammatory responses in microglia that are further amplified by astrocytes, leading to the production of factors that cause death of tyrosine hydroxylase-expressing neurons. Nurr1 exerts anti-inflammatory effects by docking to NF-kappa B-p65 on target inflammatory gene promoters in a signal-dependent manner. Subsequently, Nurr1 recruits the CoREST corepressor complex, resulting in clearance of NF-kappa B-p65 and transcriptional repression. These studies suggest that Nurr1 protects against loss of dopaminergic neurons in Parkinson's disease in part by limiting the production of neurotoxic mediators by microglia and astrocytes.	[Saijo, Kaoru; Collier, Jana G.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Boyer, Leah] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Winner, Beate; Carson, Christian T.; Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Saijo, K (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ksaijo@ucsd.edu; ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021; Winner, Beate/O-8213-2019; Winner, Beate/K-3730-2012	Glass, Christopher/0000-0003-4344-3592; Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Boyer, Leah/0000-0002-0546-4344	NIH [CA52599, DK39949, NS34934, DK1877]; Fondation Leducq; CIRM, ISPEN/Biomeasure; Picower Foundation; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694, R01HL088129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R01DK039949, R01DK091183, R37DK039949, K11DK001877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); CIRM, ISPEN/Biomeasure(California Institute for Regenerative Medicine); Picower Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Christian Schmedt, Amy Sullivan, and Mary Lynn Gage for critical reading of the manuscript. We thank Katerina Akassoglou for BV2 cells; Alexander Mata de Urquiza for the NBRE-luciferase construct; Inder Verma for the lentivirus vector; Amir Gamliel for the Myc-SUMO1, 2, and 3 constructs; Roberto Jappelli and Roland Riek for the lentivirus encoding A30P alpha-Synuclein; Richard Mulligan and Jeng-Shin Lee for pHAGE vector. We thank Chris Benner for statistical analysis; Eunice Meija, Robert Aigner, and Rosa Luna for technical assistance; and Lynn Bautista for help with preparing figures. KS, JGC, and CKG are supported by grants from the NIH (CA52599) and Fondation Leducq. F.H.G., B.W., L.B., and C.C. are supported by grants from CIRM, ISPEN/Biomeasure and the Picower Foundation. B.W. is a Feodor-Lynen fellow of the Alexander von Humboldt Foundation. MGR is supported by grants from NIH (DK39949, NS34934, and DK1877) and is an investigator of Howard Hughes Medical Institute.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Atkinson TJ, 2008, INT REV IMMUNOL, V27, P255, DOI 10.1080/08830180801959072; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hartmann A, 2003, EXP NEUROL, V184, P561, DOI 10.1016/j.expneurol.2003.08.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Nordzell M, 2004, BIOCHEM BIOPH RES CO, V313, P205, DOI 10.1016/j.bbrc.2003.11.079; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; THERY C, 1992, J NEUROCHEM, V59, P1183, DOI 10.1111/j.1471-4159.1992.tb08366.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yasuda J, 2004, CANCER SCI, V95, P52, DOI 10.1111/j.1349-7006.2004.tb03170.x; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	660	687	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					47	59		10.1016/j.cell.2009.01.038	http://dx.doi.org/10.1016/j.cell.2009.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345186	Green Accepted, Bronze			2022-12-24	WOS:000264813300013
J	Makris, NC; Ratilal, P; Jagannathan, S; Gong, Z; Andrews, M; Bertsatos, I; Godo, OR; Nero, RW; Jech, JM				Makris, Nicholas C.; Ratilal, Purnima; Jagannathan, Srinivasan; Gong, Zheng; Andrews, Mark; Bertsatos, Ioannis; Godo, Olav Rune; Nero, Redwood W.; Jech, J. Michael			Critical Population Density Triggers Rapid Formation of Vast Oceanic Fish Shoals	SCIENCE			English	Article							HERRING CLUPEA-HARENGUS; FISHERIES ACOUSTICS; BEHAVIOR; SCHOOLS; DYNAMICS; COMPLEX; GULF	Similarities in the behavior of diverse animal species that form large groups have motivated attempts to establish general principles governing animal group behavior. It has been difficult, however, to make quantitative measurements of the temporal and spatial behavior of extensive animal groups in the wild, such as bird flocks, fish shoals, and locust swarms. By quantifying the formation processes of vast oceanic fish shoals during spawning, we show that (i) a rapid transition from disordered to highly synchronized behavior occurs as population density reaches a critical value; (ii) organized group migration occurs after this transition; and (iii) small sets of leaders significantly influence the actions of much larger groups. Each of these findings confirms general theoretical predictions believed to apply in nature irrespective of animal species.	[Makris, Nicholas C.; Jagannathan, Srinivasan; Bertsatos, Ioannis] MIT, Cambridge, MA 02139 USA; [Ratilal, Purnima; Gong, Zheng; Andrews, Mark] Northeastern Univ, Boston, MA 02115 USA; [Godo, Olav Rune] Inst Marine Res, N-5817 Bergen, Norway; [Nero, Redwood W.] SE Fisheries Sci Ctr, Pascagoula, MS 39568 USA; [Jech, J. Michael] NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA	Makris, NC (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	makris@mit.edu	Gong, Zheng/K-5808-2012	Godo, Olav Rune/0000-0001-8826-8068	National Oceanographic Partnership Program; Office of Naval Research; Alfred P. Sloan Foundation	National Oceanographic Partnership Program; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was supported by the National Oceanographic Partnership Program, the Office of Naval Research, and the Alfred P. Sloan Foundation and is a contribution to the Census of Marine Life. We would like to thank the science parties, officers, and crew of the research vessels Oceanus, Endeavor, Delaware II, and Hugh Sharp	Blaxter J.H.S., 1982, Advances in Marine Biology, V20, P1, DOI 10.1016/S0065-2881(08)60140-6; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Godo OR, 2004, ICES J MAR SCI, V61, P1093, DOI 10.1016/j.icesjms.2004.06.009; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Hoare DJ, 2000, OIKOS, V89, P546, DOI 10.1034/j.1600-0706.2000.890314.x; Huse I, 1996, ICES J MAR SCI, V53, P863, DOI 10.1006/jmsc.1996.9999; Jech JM, 2006, CAN J FISH AQUAT SCI, V63, P2225, DOI 10.1139/F06-126; Link JS, 2001, J FISH BIOL, V59, P783, DOI 10.1111/j.1095-8649.2001.tb00149.x; Mackinson S, 1999, J FISH BIOL, V55, P972, DOI 10.1111/j.1095-8649.1999.tb00733.x; MacLennan D.N., 1992, SPRINGER SCI BUS MED; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; MILINSKI M, 1993, PREDATION RISK FEEDI, P285; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz W.J., 2006, J NW ATLANTIC FISHER, V36, P127; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; PITCHER TJ, 2001, ENCY OCEAN SCI, P978; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; RAY C, 1999, PETERSON FIELD GUIDE; RAYLEIGH JWS, 1976, THEORY SOUND, V2, P1; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Skaret G, 2003, AQUAT LIVING RESOUR, V16, P299, DOI 10.1016/S0990-7440(03)00006-8; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; TORESEN R, 1991, ICES J MAR SCI, V48, P15, DOI 10.1093/icesjms/48.1.15; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019; ZINKENVICH VN, 1967, ICNAF RES B, V4, P101	33	140	145	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1734	1737		10.1126/science.1169441	http://dx.doi.org/10.1126/science.1169441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325116				2022-12-24	WOS:000264559800041
J	Whitlock, G; Lewington, S; Sherliker, P; Clarke, R; Emberson, J; Halsey, J; Qizilbash, N; Collins, R; Peto, R; Lewington, S; MacMahon, S; Peto, R; Aromaa, A; Baigent, C; Carstensen, J; Chen, Z; Clarke, R; Collins, R; Duffy, S; Kromhout, D; Neaton, J; Qizilbash, N; Rodgers, A; Tominaga, S; Tornberg, S; Tunstall-Pedoe, H; Whitlock, G; Chambless, L; De Backer, G; De Bacquer, D; Kornitzer, M; Whincup, P; Wannamethee, SG; Morris, R; Wald, N; Morris, J; Law, M; Knuiman, M; Bartholomew, H; Smith, GD; Sweetnam, P; Elwood, P; Yarnell, J; Kronmal, R; Kromhout, D; Sutherland, S; Keil, J; Jensen, G; Schnohr, P; Hames, C; Tyroler, A; Aromaa, A; Knekt, P; Reunanen, A; Tuomilehto, J; Jousilahti, P; VArtiainen, E; Puska, P; Kuznetsova, T; Richart, T; Staessen, J; Thijs, L; Jorgensen, T; Thomsen, T; Sharp, D; Curb, JD; Qizilbash, N; Iso, H; Sato, S; Kitamura, A; Naito, Y; Benetos, A; Guize, L; Goldbourt, U; Tomita, M; Nishimoto, Y; Murayama, T; Criqui, M; Davis, C; Hart, C; Smith, GD; Hole, D; Gillis, C; Jacobs, D; Blackburn, H; Luepker, R; Neaton, J; Eberly, L; Cox, C; Levy, D; D'Agostino, R; Silbershatz, H; Tverdal, A; Selmer, R; Meade, T; Garrow, K; Cooper, J; Speizer, F; Stampfer, M; Menotti, A; Spagnolo, A; Tsuji, I; Imai, Y; Ohkubo, T; Hisamichi, S; Haheim, L; Holme, I; Hjermann, I; Leren, P; Ducimetiere, P; Empana, J; Jamrozik, K; Broadhurst, R; Assmann, G; Schulte, H; Bengtsson, C; Bjorkelund, C; Lissner, L; Sorlie, P; Garcia-Palmieri, M; Barrett-Conner, E; Criqui, M; Langer, R; Hart, C; Smith, GD; Hole, D; Nakachi, K; Imai, K; Fang, X; Li, S; Buzina, R; Nissinen, A; Aravanis, C; Dontas, A; Kafatos, A; Menotti, A; Adachi, H; Toshima, H; Imaizumi, T; Kromhout, D; Nedeljkovic, S; Ostojic, M; Chen, Z; Tunstall-Pedoe, H; Nakayama, T; Yoshiike, N; Yokoyama, T; Date, C; Tanaka, H; Keller, J; Bonaa, K; Arnesen, E; Tunstall-Pedoe, H; Rimm, E; Gaziano, M; Buring, JE; Hennekens, C; Tornberg, S; Carstensen, J; Shipley, M; Leon, D; Marmot, M; Clarke, R; Collins, R; Emberson, J; Halsey, J; Lewington, S; Palmer, A; Parish, S; Peto, R; Sherliker, P; Whitlock, G				Whitlock, Gary; Lewington, Sarah; Sherliker, Paul; Clarke, Robert; Emberson, Jonathan; Halsey, Jim; Qizilbash, Nawab; Collins, Rory; Peto, Richard; Lewington, S.; MacMahon, S.; Peto, R.; Aromaa, A.; Baigent, C.; Carstensen, J.; Chen, Z.; Clarke, R.; Collins, R.; Duffy, S.; Kromhout, D.; Neaton, J.; Qizilbash, N.; Rodgers, A.; Tominaga, S.; Toernberg, S.; Tunstall-Pedoe, H.; Whitlock, G.; Chambless, L.; De Backer, G.; De Bacquer, D.; Kornitzer, M.; Whincup, P.; Wannamethee, S. G.; Morris, R.; Wald, N.; Morris, J.; Law, M.; Knuiman, M.; Bartholomew, H.; Smith, G. Davey; Sweetnam, P.; Elwood, P.; Yarnell, J.; Kronmal, R.; Kromhout, D.; Sutherland, S.; Keil, J.; Jensen, G.; Schnohr, P.; Hames, C.; Tyroler, A.; Aromaa, A.; Knekt, P.; Reunanen, A.; Tuomilehto, J.; Jousilahti, P.; VArtiainen, E.; Puska, P.; Kuznetsova, T.; Richart, T.; Staessen, J.; Thijs, L.; Jorgensen, T.; Thomsen, T.; Sharp, D.; Curb, J. D.; Qizilbash, N.; Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.; Benetos, A.; Guize, L.; Goldbourt, U.; Tomita, M.; Nishimoto, Y.; Murayama, T.; Criqui, M.; Davis, C.; Hart, C.; Smith, G. Davey; Hole, D.; Gillis, C.; Jacobs, D.; Blackburn, H.; Luepker, R.; Neaton, J.; Eberly, L.; Cox, C.; Levy, D.; D'Agostino, R.; Silbershatz, H.; Tverdal, A.; Selmer, R.; Meade, T.; Garrow, K.; Cooper, J.; Speizer, F.; Stampfer, M.; Menotti, A.; Spagnolo, A.; Tsuji, I.; Imai, Y.; Ohkubo, T.; Hisamichi, S.; Haheim, L.; Holme, I.; Hjermann, I.; Leren, P.; Ducimetiere, P.; Empana, J.; Jamrozik, K.; Broadhurst, R.; Assmann, G.; Schulte, H.; Bengtsson, C.; Bjoerkelund, C.; Lissner, L.; Sorlie, P.; Garcia-Palmieri, M.; Barrett-Conner, E.; Criqui, M.; Langer, R.; Hart, C.; Smith, G. Davey; Hole, D.; Nakachi, K.; Imai, K.; Fang, X.; Li, S.; Buzina, R.; Nissinen, A.; Aravanis, C.; Dontas, A.; Kafatos, A.; Menotti, A.; Adachi, H.; Toshima, H.; Imaizumi, T.; Kromhout, D.; Nedeljkovic, S.; Ostojic, M.; CHen, Z.; Tunstall-Pedoe, H.; Nakayama, T.; Yoshiike, N.; Yokoyama, T.; Date, C.; Tanaka, H.; Keller, J.; Bonaa, K.; Arnesen, E.; Tunstall-Pedoe, H.; Rimm, E.; Gaziano, M.; Buring, J. E.; Hennekens, C.; Tornberg, S.; Carstensen, J.; Shipley, M.; Leon, D.; Marmot, M.; Clarke, R.; Collins, R.; Emberson, J.; Halsey, J.; Lewington, S.; Palmer, A.; Parish, S.; Peto, R.; Sherliker, P.; Whitlock, G.		PSC Collaborator ARIC	Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; ABDOMINAL ADIPOSITY; BLOOD-PRESSURE; RISK; OBESITY; OVERWEIGHT; STROKE; CANCER; ASSOCIATION; SMOKING	Background The main associations of body-mass index (BMI) with overall and-cause-specific mortality can best be assessed by long-term prospective follow-up of large numbers of people. The Prospective Studies Collaboration aimed to investigate these associations by sharing data from many studies. Methods Collaborative analyses were undertaken of baseline BMI versus mortality in 57 prospective studies with 894576 participants, mostly in western Europe and North America (61% [n=541452] male, mean recruitment age 46 [SD 11] years, median recruitment year 1,979 [IQR 1975-85], mean BMI 25 [SD 4] kg/m(2)). The analyses were adjusted for age, sex, smoking status, and study. To limit reverse causality, the first 5 years of follow up were excluded, leaving 66 552 deaths of known cause during a mean of 8 (SD 6) further years of follow-up (mean age at death 67 [SD 10] years): 30 416 vascular; 2070 diabetic, renal or hepatic; 22 592 neoplastic; 3770 respiratory; 7704 other. Findings In both sexes, mortality was lowest at about 22.5-25 kg/m(2). Above this range, positive associations were recorded for several specific causes and inverse associations for none, the absolute excess risks for higher BMI and smoking were roughly additive, and each 5 kg/m2 higher BMI was on average associated with about 30% higher overall mortality (hazard ratio per 5 kg/m(2) [HR] 1.29 [95% CI 1.27-1.32]): 40% for vascular mortality (HR 1.41 [1.37-1.45]); 60-120% for diabetic, renal, and hepatic mortality (HRs 2.16 [1.89-2.46], 1.59 [1.27-1.99], and 1.82 [1.59-2.09], respectively); 10% for neoplastic mortality (HR 1.10 [1.06-1.15]); and 20% for respiratory and for all other mortality (HRs 1.20 [1.07-1.34] and 1.20 [1.16-1.25], respectively). Below the range 22.5-25 kg/m(2), BMI was associated inversely with overall mortality, mainly because of strong inverse associations with respiratory disease and lung cancer. These inverse associations were much stronger for smokers than for non-smokers, despite cigarette consumption per smoker varying little with BMI. Interpretation Although other anthropometric measures (eg, waist circumference, waist-to-hip ratio) could well add extra information to BMI, and BMI to them, BMI is in itself a strong predictor of overall mortality both above and below the apparent optimum of about 22.5-25 kg/m(2). The progressive excess mortality above this range is due mainly to vascular disease and is probably largely causal. At 30 35 kg/m(2), median survival is reduced by 2-4 years; at 40-45 kg/m(2), it is reduced by 8-10 years (which is comparable with the effects of smoking). The definite excess mortality below 22.5 kg/m(2) is due mainly to smoking-related diseases, and is not fully explained. Funding UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, US National Institute on Aging, and Clinical Trial Service Unit (Oxford, UK).	[Whitlock, Gary] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Jensen, G.; Schnohr, P.] Copenhagen City Heart Study, Copenhagen, Denmark; [Sharp, D.; Curb, J. D.] Honolulu Heart Program, Honolulu, HI USA; [Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.] Ikawa Noichi & Kyowa, Kyowa, Hokkaido, Japan; [Benetos, A.; Guize, L.] Ctr Invest Prevent & Clin IPC, Paris, France; [Levy, D.; D'Agostino, R.; Silbershatz, H.] NHLBI Framingham Heart Study, Framingham, MA USA; [Menotti, A.; Spagnolo, A.] Occupat Grp, Rome, Italy; [Ducimetiere, P.; Empana, J.] Paris Prospect Study, Paris, France; [Bengtsson, C.; Bjoerkelund, C.; Lissner, L.] Prospect Study Women, Gothenburg, Sweden; [Nakachi, K.; Imai, K.] Saitama Cohort Study, Saitama, Japan	University of Oxford; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Whitlock, G (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	psc@ctsu.ox.ac.uk	Davey Smith, George/A-7407-2013; Morris, Joan/AAT-9211-2020; Staessen, Jan A/A-1065-2011; NAKAYAMA, Takeo/HCH-0537-2022; Jørgensen, Torben/Z-1335-2018; Kromhout, Daan/A-8566-2014; Empana, Jean-Philippe/AAF-6923-2021; Leon, David A/G-2195-2010; Lennon, Lucy/ABB-9433-2020; Wald, Nicholas/AAY-2814-2021; Marmot, M G/Y-3920-2019; Wald, Nicholas/AAY-8924-2021; De Bacquer, Dirk/HGU-3191-2022; De Backer, Guy/AAI-4607-2021; Knuiman, Matthew W/I-5549-2013; Kuznetsova, Tatiana/ABI-5662-2020	Davey Smith, George/0000-0002-1407-8314; Morris, Joan/0000-0002-7164-612X; Staessen, Jan A/0000-0002-3026-1637; Empana, Jean-Philippe/0000-0002-1469-7772; Leon, David A/0000-0001-9747-1762; Lennon, Lucy/0000-0002-1738-1351; Marmot, M G/0000-0002-2431-6419; Kuznetsova, Tatiana/0000-0003-4293-4576; Emberson, Jonathan/0000-0001-7792-9422; Thijs, Lutgarde/0000-0002-8108-2356; Eberly, Lynn/0000-0003-4763-330X; De Bacquer, Dirk/0000-0002-3202-7238; Lewington, Sarah/0000-0002-4496-4771; Whincup, Peter/0000-0002-5589-4107; Morris, Richard/0000-0001-7240-4563; MacMahon, Stephen/0000-0003-2064-7699; Jacobs, David/0000-0002-7232-0543; Rodgers, Anthony/0000-0003-1282-1896; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nakayama, Takeo/0000-0002-7918-6252; Jorgensen, Torben/0000-0001-9453-2830; Carstensen, John/0000-0003-2256-8089; Tverdal, Aage/0000-0002-2909-5678	UK Medical Research Council; British Heart Foundation; Cancer Research UK; EU BIOMED; NIA [P01 AG17625-01]; CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600705, MC_U137686857] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G0100222, G0600705, G8802774, MC_U137686857, G19/35] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); EU BIOMED; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Prospective Studies Collaboration has been supported by the UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, NIA grant P01 AG17625-01, and CTSU overheads. Merck (F Walker) helped support the 1996 meeting of collaborators. Gary Whitlock was supported by a Girdlers' Health Research Council of New Zealand Fellowship, Sarah Lewington had a British Heart Foundation Fellowship to coordinate the project. Sarah Parish supplied unpublished analyses of BMI and cotinine (webappendix).	[Anonymous], 2 WHO GLOB INFOBASE; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Gaemers IC, 2006, CURR OPIN LIPIDOL, V17, P268, DOI 10.1097/01.mol.0000226118.43178.98; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; MICOZZI MS, 1990, AM J PHYS ANTHROPOL, V81, P375, DOI 10.1002/ajpa.1330810307; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PETO R, 2006, DEATHS SMOKING; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Turnbull F, 2003, LANCET, V362, P1527; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou M, 2008, STROKE, V39, P753, DOI 10.1161/STROKEAHA.107.495374; 2004, HLTH SURVEY ENGLAND	38	2935	3054	6	308	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1083	1096		10.1016/S0140-6736(09)60318-4	http://dx.doi.org/10.1016/S0140-6736(09)60318-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19299006	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000264773600029
J	Wang, DO; Kim, SM; Zhao, YL; Hwang, H; Miura, SK; Sossin, WS; Martin, KC				Wang, Dan Ohtan; Kim, Sang Mok; Zhao, Yali; Hwang, Hongik; Miura, Satoru K.; Sossin, Wayne S.; Martin, Kelsey C.			Synapse- and Stimulus-Specific Local Translation During Long-Term Neuronal Plasticity	SCIENCE			English	Article							APLYSIA SENSORY NEURONS; PROTEIN-SYNTHESIS; MESSENGER-RNAS; HIPPOCAMPAL-NEURONS; MEMORY STORAGE; FACILITATION; EXPRESSION; LOCALIZATION; IDENTIFICATION; POLYRIBOSOMES	Long-term memory and synaptic plasticity require changes in gene expression and yet can occur in a synapse-specific manner. Messenger RNA localization and regulated translation at synapses are thus critical for establishing synapse specificity. Using live-cell microscopy of photoconvertible fluorescent protein translational reporters, we directly visualized local translation at synapses during long-term facilitation of Aplysia sensory-motor synapses. Translation of the reporter required multiple applications of serotonin, was spatially restricted to stimulated synapses, was transcript-and stimulus-specific, and occurred during long-term facilitation but not during long-term depression of sensory-motor synapses. Translational regulation only occurred in the presence of a chemical synapse and required calcium signaling in the postsynaptic motor neuron. Thus, highly regulated local translation occurs at synapses during long-term plasticity and requires trans-synaptic signals.	[Wang, Dan Ohtan; Kim, Sang Mok; Zhao, Yali; Hwang, Hongik; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Kim, Sang Mok] Univ Calif Los Angeles, Interdepartmental Program Neurosci, Los Angeles, CA 90095 USA; [Miura, Satoru K.; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; McGill University	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, BSRB 390B,615 Charles E Young Dr S, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu	Wang, Dan Ohtan/AAF-5704-2019; Wang, Dan Ohtan/E-1953-2011; Miura, Satoru/GZH-1685-2022	Wang, Dan Ohtan/0000-0002-3126-8558; Miura, Satoru/0000-0002-6698-9435	NIH [NS045324]; Canadian Institute of Health Research [MT-15121]; Nakajima Foundation fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Nakajima Foundation fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Braslow and K. Cadenas for assistance with image analysis; R. Grambo for assistance with figures; D. Black, C. Heusner, E. Meer, and L. Zipursky for critical reading of the manuscript; and G. Weinmaster and Martin laboratory members for helpful discussions. This work was supported by NIH grant NS045324, a W. M. Keck Foundation Young Scholar Award and Eleanor Leslie Term Chair from the UCLA Brain Research Institute (to K.C.M.), Canadian Institute of Health Research grant MT-15121 (to W.S.S.), and a fellowship from the Nakajima Foundation (to S.K.M.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alberini CM, 1999, J EXP BIOL, V202, P2887; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; Cai DC, 2008, CURR BIOL, V18, P920, DOI 10.1016/j.cub.2008.05.038; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hu JY, 2006, J NEUROSCI, V26, P1026, DOI 10.1523/JNEUROSCI.4258-05.2006; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Liu K, 2003, J NEUROBIOL, V56, P275, DOI 10.1002/neu.10242; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Moccia R, 2003, J NEUROSCI, V23, P9409; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Santarelli L, 1996, J NEUROBIOL, V31, P297, DOI 10.1002/(SICI)1097-4695(199611)31:3<297::AID-NEU3>3.3.CO;2-P; STEWARD O, 1982, J NEUROSCI, V2, P284; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Suzuki T, 2007, NEUROSCI RES, V57, P61, DOI 10.1016/j.neures.2006.09.009; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	32	150	154	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1536	1540		10.1126/science.1173205	http://dx.doi.org/10.1126/science.1173205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19443737	Green Accepted			2022-12-24	WOS:000267130600036
J	Butler, G; Rasmussen, MD; Lin, MF; Santos, MAS; Sakthikumar, S; Munro, CA; Rheinbay, E; Grabherr, M; Forche, A; Reedy, JL; Agrafioti, I; Arnaud, MB; Bates, S; Brown, AJP; Brunke, S; Costanzo, MC; Fitzpatrick, DA; de Groot, PWJ; Harris, D; Hoyer, LL; Hube, B; Klis, FM; Kodira, C; Lennard, N; Logue, ME; Martin, R; Neiman, AM; Nikolaou, E; Quail, MA; Quinn, J; Santos, MC; Schmitzberger, FF; Sherlock, G; Shah, P; Silverstein, KAT; Skrzypek, MS; Soll, D; Staggs, R; Stansfield, I; Stumpf, MPH; Sudbery, PE; Srikantha, T; Zeng, QD; Berman, J; Berriman, M; Heitman, J; Gow, NAR; Lorenz, MC; Birren, BW; Kellis, M; Cuomo, CA				Butler, Geraldine; Rasmussen, Matthew D.; Lin, Michael F.; Santos, Manuel A. S.; Sakthikumar, Sharadha; Munro, Carol A.; Rheinbay, Esther; Grabherr, Manfred; Forche, Anja; Reedy, Jennifer L.; Agrafioti, Ino; Arnaud, Martha B.; Bates, Steven; Brown, Alistair J. P.; Brunke, Sascha; Costanzo, Maria C.; Fitzpatrick, David A.; de Groot, Piet W. J.; Harris, David; Hoyer, Lois L.; Hube, Bernhard; Klis, Frans M.; Kodira, Chinnappa; Lennard, Nicola; Logue, Mary E.; Martin, Ronny; Neiman, Aaron M.; Nikolaou, Elissavet; Quail, Michael A.; Quinn, Janet; Santos, Maria C.; Schmitzberger, Florian F.; Sherlock, Gavin; Shah, Prachi; Silverstein, Kevin A. T.; Skrzypek, Marek S.; Soll, David; Staggs, Rodney; Stansfield, Ian; Stumpf, Michael P. H.; Sudbery, Peter E.; Srikantha, Thyagarajan; Zeng, Qiandong; Berman, Judith; Berriman, Matthew; Heitman, Joseph; Gow, Neil A. R.; Lorenz, Michael C.; Birren, Bruce W.; Kellis, Manolis; Cuomo, Christina A.			Evolution of pathogenicity and sexual reproduction in eight Candida genomes	NATURE			English	Article							ALBICANS GENOME; MATING-TYPE; SEQUENCE; YEASTS; VIRULENCE; LODDEROMYCES; PARAPSILOSIS; MEIOSIS; FAMILY; CODON	Candida species are the most common cause of opportunistic fungal infection worldwide. Here we report the genome sequences of six Candida species and compare these and related pathogens and non-pathogens. There are significant expansions of cell wall, secreted and transporter gene families in pathogenic species, suggesting adaptations associated with virulence. Large genomic tracts are homozygous in three diploid species, possibly resulting from recent recombination events. Surprisingly, key components of the mating and meiosis pathways are missing from several species. These include major differences at the mating-type loci (MTL); Lodderomyces elongisporus lacks MTL, and components of the alpha 1/alpha 2 cell identity determinant were lost in other species, raising questions about how mating and cell types are controlled. Analysis of the CUG leucine-to-serine genetic-code change reveals that 99% of ancestral CUG codons were erased and new ones arose elsewhere. Lastly, we revise the Candida albicans gene catalogue, identifying many new genes.	[Lin, Michael F.; Sakthikumar, Sharadha; Grabherr, Manfred; Kodira, Chinnappa; Zeng, Qiandong; Birren, Bruce W.; Kellis, Manolis; Cuomo, Christina A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Butler, Geraldine; Fitzpatrick, David A.; Logue, Mary E.] Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Rasmussen, Matthew D.; Lin, Michael F.; Rheinbay, Esther; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Santos, Manuel A. S.; Santos, Maria C.] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Santos, Manuel A. S.; Santos, Maria C.] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal; [Munro, Carol A.; Brown, Alistair J. P.; Nikolaou, Elissavet; Stansfield, Ian; Gow, Neil A. R.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Rheinbay, Esther] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Forche, Anja; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Reedy, Jennifer L.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Agrafioti, Ino; Stumpf, Michael P. H.] Univ London Imperial Coll Sci Technol & Med, Ctr Bioinformat, London SW7 2AY, England; [Arnaud, Martha B.; Costanzo, Maria C.; Schmitzberger, Florian F.; Sherlock, Gavin; Shah, Prachi; Skrzypek, Marek S.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bates, Steven] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England; [Brunke, Sascha; Hube, Bernhard; Martin, Ronny] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, D-07745 Jena, Germany; [de Groot, Piet W. J.; Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1090 GB Amsterdam, Netherlands; [Harris, David; Lennard, Nicola; Quail, Michael A.; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Hoyer, Lois L.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Quinn, Janet] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Silverstein, Kevin A. T.; Staggs, Rodney] Univ Minnesota, Mason Canc Ctr, Biostat & Bioinformat Grp, Minneapolis, MN 55455 USA; [Soll, David; Srikantha, Thyagarajan] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Sudbery, Peter E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Lorenz, Michael C.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University College Dublin; Massachusetts Institute of Technology (MIT); Universidade de Aveiro; Universidade de Aveiro; University of Aberdeen; Boston University; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Imperial College London; Stanford University; University of Exeter; Hans Knoll Institute (HKI); University of Amsterdam; Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Newcastle University - UK; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Sheffield; University of Texas System; University of Texas Health Science Center Houston	Cuomo, CA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	geraldine.butler@ucd.ie; manoli@mit.edu; cuomo@broad.mit.edu	Santos, Manuel/E-6704-2010; Santos, Conceição/ABE-6172-2020; Berman, Judith/ABA-8528-2021; Heitman, Joseph/ABC-6006-2021; Klis, Frans M/B-9085-2008; Munro, Carol A/A-5175-2011; santos, conceição/GQQ-7378-2022; Kellis, Manolis/ABE-7385-2020; Quail, michael/ABE-6131-2020; dos Santos, Maria/B-7426-2012; Cuomo, Christina/L-2222-2019; Brunke, Sascha/G-1486-2012; Berman, Judith/AAS-5115-2021; Zeng, Qiandong/AAF-3305-2019; Brown, Alistair J.P./B-6627-2014; De Groot, Piet/L-7737-2014; Berriman, Matthew/A-7618-2011; GOW, Neil/AAS-5323-2021; Sherlock, Gavin J/E-9110-2012; Quinn, Janet/AAR-9957-2021; Hoyer, Lois/G-2004-2015	Santos, Manuel/0000-0002-0437-1146; Santos, Conceição/0000-0003-4129-6381; Berman, Judith/0000-0002-8577-0084; Klis, Frans M/0000-0003-0079-9492; Kellis, Manolis/0000-0001-7113-9630; Cuomo, Christina/0000-0002-5778-960X; Brunke, Sascha/0000-0001-7740-4570; De Groot, Piet/0000-0002-3112-6947; Berriman, Matthew/0000-0002-9581-0377; GOW, Neil/0000-0002-2776-5850; Agrafioti, Ino/0000-0002-6374-2322; Neiman, Aaron/0000-0002-6600-6996; Bates, Steven/0000-0003-0489-5705; Hoyer, Lois/0000-0002-0827-4984; Nikolaou, Elissavet/0000-0003-4797-4710; Brown, Alistair JP/0000-0003-1406-4251; Hube, Bernhard/0000-0002-6028-0425; Munro, Carol/0000-0003-0761-1755; Sherlock, Gavin/0000-0002-1692-4983; Grabherr, Manfred/0000-0001-8792-6508; Lorenz, Michael/0000-0002-7881-8027; Quinn, Janet/0000-0002-8732-7676; Fitzpatrick, David/0000-0001-7345-6998; Butler, Geraldine/0000-0002-1770-5301	US National Human Genome Research Institute (NHGRI); Fungal Genome Initiative at the Broad Institute; Wellcome Trust; NHGRI; National Institute of Allergy and Infectious Disease; US National Institutes of Health (NIH); Department of Health and Human Services; Science Foundation Ireland; NIH; US National Science Foundation; Sloan Foundation; Biotechnology and Biological Sciences Research Council [BB/F00513X/1, BB/F013566/1, BB/F007892/1] Funding Source: researchfish; Medical Research Council [G0400284] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075096, R01AI050113] Funding Source: NIH RePORTER; BBSRC [BB/F013566/1, BB/F00513X/1, BB/F007892/1] Funding Source: UKRI; MRC [G0400284] Funding Source: UKRI	US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Fungal Genome Initiative at the Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the US National Human Genome Research Institute (NHGRI) for support under the Fungal Genome Initiative at the Broad Institute. We thank C. Kurtzman for providing the sequenced strains of L. elongisporus, C. guilliermondii and C. lusitaniae, M. Koehrsen for Broad Institute website support, D. Park for informatics support and K. Wolfe and A. Regev for comments on the manuscript. We acknowledge the contributions of the Broad Institute Sequencing Platform and A. Barron, L. Clark, C. Corton, D. Ormond, D. Saunders, K. Seeger and R. Squares from the Wellcome Trust Sanger Institute for the C. parapsilosis sequencing and assembly. N. A. R. G., A. J. P. B., M. B. and co-workers were supported by the Wellcome Trust; M. G., S. S., Q. Z., C. K., B. W. B. and C. A. C. were supported by NHGRI and the National Institute of Allergy and Infectious Disease, US National Institutes of Health (NIH), Department of Health and Human Services; G. B. and co-workers were supported by Science Foundation Ireland; J. B., A. F., J. H., A. M. N. and co- workers were supported by the NIH; and M. K., M. D. R. and M. F. L. by the NIH, the US National Science Foundation and the Sloan Foundation.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bates S, 2007, INFECT IMMUN, V75, P2922, DOI 10.1128/IAI.00102-07; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Chau AS, 2005, ANTIMICROB AGENTS CH, V49, P3646, DOI 10.1128/AAC.49.9.3646-3651.2005; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Daniels KJ, 2006, EMBO J, V25, P2240, DOI 10.1038/sj.emboj.7601099; de los Santos T, 2003, GENETICS, V164, P81; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Forche A, 2004, EUKARYOT CELL, V3, P705, DOI 10.1128/EC.3.3.705-714.2004; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Legrand M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040001; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lockhart SR, 2002, GENETICS, V162, P737; Logue ME, 2005, EUKARYOT CELL, V4, P1009, DOI 10.1128/EC.4.6.1009-1017.2005; Massey SE, 2003, GENOME RES, V13, P544, DOI 10.1101/gr.811003; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; SLUTSKY B, 1985, SCIENCE, V230, P666, DOI 10.1126/science.3901258; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; VANDERWA.JP, 1966, ANTON VAN LEE J M S, V32, P1; VANDERWALT JP, 1977, A VAN LEEUW J MICROB, V43, P205, DOI 10.1007/BF00395675; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhang J, 1997, DIAGN MICR INFEC DIS, V27, P63, DOI 10.1016/S0732-8893(97)00002-3; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	40	727	1448	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					657	662		10.1038/nature08064	http://dx.doi.org/10.1038/nature08064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19465905	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000266608600034
J	Lopez-Aviles, S; Kapuy, O; Novak, B; Uhlmann, F				Lopez-Aviles, Sandra; Kapuy, Orsolya; Novak, Bela; Uhlmann, Frank			Irreversibility of mitotic exit is the consequence of systems-level feedback	NATURE			English	Article							ANAPHASE PROMOTING COMPLEX; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PHOSPHATASE CDC14; PROTEIN-KINASE; PHOSPHORYLATION; APC; PROTEOLYSIS; INHIBITOR	The eukaryotic cell cycle comprises an ordered series of events, orchestrated by the activity of cyclin-dependent kinases (Cdks), leading from chromosome replication during S phase to their segregation in mitosis. The unidirectionality of cell-cycle transitions is fundamental for the successful completion of this cycle. It is thought that irrevocable proteolytic degradation of key cell-cycle regulators makes cell-cycle transitions irreversible, thereby enforcing directionality(1-3). Here we have experimentally examined the contribution of cyclin proteolysis to the irreversibility of mitotic exit, the transition from high mitotic Cdk activity back to low activity in G1. We show that forced cyclin destruction in mitotic budding yeast cells efficiently drives mitotic exit events. However, these remain reversible after termination of cyclin proteolysis, with recovery of the mitotic state and cyclin levels. Mitotic exit becomes irreversible only after longer periods of cyclin degradation, owing to activation of a double-negative feedback loop involving the Cdk inhibitor Sic1 (refs 4, 5). Quantitative modelling suggests that feedback is required to maintain low Cdk activity and to prevent cyclin resynthesis. Our findings demonstrate that the unidirectionality of mitotic exit is not the consequence of proteolysis but of systems-level feedback required to maintain the cell cycle in a new stable state.	[Lopez-Aviles, Sandra; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [Kapuy, Orsolya; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Kapuy, Orsolya] Budapest Univ Technol & Econ, H-1521 Budapest, Hungary	Cancer Research UK; University of Oxford; Budapest University of Technology & Economics	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Novak, Bela/D-5365-2009	Novak, Bela/0000-0002-6961-1366; Uhlmann, Frank/0000-0002-3527-6619; Lopez-Aviles, Sandra/0000-0002-0498-1331	European Commission Marie Curie Individual Fellowship; BBSRC; EC FP7	European Commission Marie Curie Individual Fellowship(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP7(European Commission)	We thank C. Bouchoux, J. Kilmartin, E. Schwob and W. Zachariae for antibodies and constructs, and members of our laboratory for discussion and critical reading of the manuscript. This work was supported by a European Commission Marie Curie Individual Fellowship to S. L.-A., and the BBSRC and EC FP7 (O. K.).	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	75	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					592	595		10.1038/nature07984	http://dx.doi.org/10.1038/nature07984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387440	Green Accepted			2022-12-24	WOS:000266370500044
J	Klin, A; Lin, DJ; Gorrindo, P; Ramsay, G; Jones, W				Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren			Two-year-olds with autism orient to non-social contingencies rather than biological motion	NATURE			English	Article							PERCEPTION; FACE; AREA; RECOGNITION; FIXATION; DEFICITS; INFANTS	Typically developing human infants preferentially attend to biological motion within the first days of life(1). This ability is highly conserved across species(2,3) and is believed to be critical for filial attachment and for detection of predators(4). The neural underpinnings of biological motion perception are overlapping with brain regions involved in perception of basic social signals such as facial expression and gaze direction(5), and preferential attention to biological motion is seen as a precursor to the capacity for attributing intentions to others(6). However, in a serendipitous observation(7), we recently found that an infant with autism failed to recognize point-light displays of biological motion, but was instead highly sensitive to the presence of a non-social, physical contingency that occurred within the stimuli by chance. This observation raised the possibility that perception of biological motion may be altered in children with autism from a very early age, with cascading consequences for both social development and the lifelong impairments in social interaction that are a hallmark of autism spectrum disorders(8). Here we show that two-year-olds with autism fail to orient towards point-light displays of biological motion, and their viewing behaviour when watching these point-light displays can be explained instead as a response to non-social, physical contingencies-physical contingencies that are disregarded by control children. This observation has far-reaching implications for understanding the altered neurodevelopmental trajectory of brain specialization in autism(9).	[Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA; [Ramsay, Gordon] Haskins Labs Inc, New Haven, CT 06511 USA; [Jones, Warren] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Haskins Laboratories; Yale University	Klin, A (corresponding author), Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA.	ami.klin@yale.edu; warren.jones@yale.edu		Gorrindo, Phillip/0000-0002-0296-8790	National Institutes of Mental Health [U54-MH66494]; Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066494] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Mental Health (U54-MH66494), by Autism Speaks (piloting of methods), and by the Simons Foundation ( current methodological developments). We wish to thank the families of the children included in this study for their time and participation. We would also like to thank F. Shic for conceptual discussions and thoughts on methods. We would like to thank L. Dickholtz, A. Kord, L. Else and M. Campisi for their assistance in creating the biological motion stimuli. We also wish to thank K. Carr, A. Blank, A. Bhatt, S. Shultz and K. Knoch for their help in this research project, and our colleagues K. Chawarska, R. Paul and F. Volkmar for conceptual discussions and for their contributions to the clinical characterization of the samples.	Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; BLAKE R, 1993, PSYCHOL SCI, V4, P54, DOI 10.1111/j.1467-9280.1993.tb00557.x; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; BREDIN H, 2006, IET INT C VIS INF EN, P255; Chawarska K., 2008, AUTISM SPECTRUM DISO; CHEN PY, 2002, CORRELATION PARAMETR, P20; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Hershey J, 2000, ADV NEUR IN, V12, P813; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson MH, 2006, CURR BIOL, V16, pR376, DOI 10.1016/j.cub.2006.04.008; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jordan H, 2002, PSYCHOL SCI, V13, P162, DOI 10.1111/1467-9280.00429; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; LEIGH RJ, 1999, NEUROLOGY EYE MOVEME, P94; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Omori E, 1996, INT J COMPARAT PSYCH, V9, P92; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Rabiner L. R., 1978, DIGITAL PROCESSING S; Regolin L, 2000, ANIM COGN, V3, P53, DOI 10.1007/s100710050050; Reid VM, 2006, NEUROSCI LETT, V395, P211, DOI 10.1016/j.neulet.2005.10.080; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Tchorz J, 2002, SPEECH COMMUN, V38, P1, DOI 10.1016/S0167-6393(01)00040-1; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; VONCOLLANI E, 2001, BINOMIAL DISTRIBUTIO, P182	36	521	539	5	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					257	U142		10.1038/nature07868	http://dx.doi.org/10.1038/nature07868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19329996	Green Accepted			2022-12-24	WOS:000266036100042
J	Lee, HC; Chang, SS; Choudhary, S; Aalto, AP; Maiti, M; Bamford, DH; Liu, Y				Lee, Heng-Chi; Chang, Shwu-Shin; Choudhary, Swati; Aalto, Antti P.; Maiti, Mekhala; Bamford, Dennis H.; Liu, Yi			qiRNA is a new type of small interfering RNA induced by DNA damage	NATURE			English	Article							NEUROSPORA-CRASSA; PROTEIN; TRANSCRIPTION; SIRNA; METHYLATION; SENSITIVITY; HISTIDINE; INTERACTS; MUTANTS; PATHWAY	RNA interference pathways use small RNAs to mediate gene silencing in eukaryotes. In addition to small interfering RNAs (siRNAs) and microRNAs, several types of endogenously produced small RNAs have important roles in gene regulation, germ cell maintenance and transposon silencing(1-4). The production of some of these RNAs requires the synthesis of aberrant RNAs (aRNAs) or pre-siRNAs, which are specifically recognized by RNA-dependent RNA polymerases to make double-stranded RNA. The mechanism for aRNA synthesis and recognition is largely unknown. Here we show that DNA damage induces the expression of the Argonaute protein QDE-2 and a new class of small RNAs in the filamentous fungus Neurospora crassa. This class of small RNAs, known as qiRNAs because of their interaction with QDE-2, are about 20-21 nucleotides long (several nucleotides shorter than Neurospora siRNAs), with a strong preference for uridine at the 59 end, and originate mostly from the ribosomal DNA locus. The production of qiRNAs requires the RNA-dependent RNA polymerase QDE-1, the Werner and Bloom RecQ DNA helicase homologue QDE-3 and dicers. qiRNA biogenesis also requires DNA-damage-induced aRNAs as precursors, a process that is dependent on both QDE-1 and QDE-3. Notably, our results suggest that QDE-1 is the DNA-dependent RNA polymerase that produces aRNAs. Furthermore, the Neurospora RNA interference mutants show increased sensitivity to DNA damage, suggesting a role for qiRNAs in the DNA-damage response by inhibiting protein translation.	[Lee, Heng-Chi; Chang, Shwu-Shin; Choudhary, Swati; Maiti, Mekhala; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Aalto, Antti P.; Bamford, Dennis H.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Aalto, Antti P.; Bamford, Dennis H.] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Helsinki; University of Helsinki	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	yi.liu@UTSouthwestern.edu		Bamford, Dennis/0000-0002-6438-8118; Lee, Heng-Chi/0000-0001-8154-906X	Welch Foundation; National Institutes of Health (NIH); Academy of Finland Finnish Centre of Excellence [1213467, 1213992]; Helsinki Graduate School in Biotechnology and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084283, R01GM068496] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland Finnish Centre of Excellence(Academy of Finland); Helsinki Graduate School in Biotechnology and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Wang and H. Yuan for technical assistance, and C. Tang for critical comments on the manuscript. We thank Q. Liu and X. Liu for assistance in small RNA cloning, and E. Selker for providing an rDNA plasmid. The work was supported by funds from the Welch Foundation and the National Institutes of Health (NIH) to Y. L. and the Academy of Finland Finnish Centre of Excellence Programme 2006-2011 ( 1213467, 1213992) to D. H. B. A. P. A. is a fellow of the Helsinki Graduate School in Biotechnology and Molecular Biology.	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Calabrese JM, 2006, RNA, V12, P2092, DOI 10.1261/rna.224606; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CHARY P, 1994, GENETICS, V137, P723; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; HOWARD CA, 1988, CURR GENET, V13, P391, DOI 10.1007/BF00365660; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Makeyev EV, 2000, EMBO J, V19, P124, DOI 10.1093/emboj/19.1.124; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; SRIVASTAVA VK, 1988, MUTAT RES, V200, P45, DOI 10.1016/0027-5107(88)90070-X; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105	31	200	220	0	34	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					274	U163		10.1038/nature08041	http://dx.doi.org/10.1038/nature08041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19444217	Green Accepted			2022-12-24	WOS:000266036100046
J	Guan, JS; Haggarty, SJ; Giacometti, E; Dannenberg, JH; Joseph, N; Gao, J; Nieland, TJF; Zhou, Y; Wang, XY; Mazitschek, R; Bradner, JE; DePinho, RA; Jaenisch, R; Tsai, LH				Guan, Ji-Song; Haggarty, Stephen J.; Giacometti, Emanuela; Dannenberg, Jan-Hermen; Joseph, Nadine; Gao, Jun; Nieland, Thomas J. F.; Zhou, Ying; Wang, Xinyu; Mazitschek, Ralph; Bradner, James E.; DePinho, Ronald A.; Jaenisch, Rudolf; Tsai, Li-Huei			HDAC2 negatively regulates memory formation and synaptic plasticity	NATURE			English	Article							HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; MOUSE MODEL; HUNTINGTONS-DISEASE; CHROMATIN; ACETYLATION; MICE; MODULATION; RECEPTORS; MECHANISM	Chromatin modifications, especially histone-tail acetylation, have been implicated in memory formation. Increased histone-tail acetylation induced by inhibitors of histone deacetylases (HDACis) facilitates learning and memory in wild-type mice as well as in mouse models of neurodegeneration. Harnessing the therapeutic potential of HDACis requires knowledge of the specific HDAC family member(s) linked to cognitive enhancement. Here we show that neuron-specific overexpression of HDAC2, but not that of HDAC1, decreased dendritic spine density, synapse number, synaptic plasticity and memory formation. Conversely, Hdac2 deficiency resulted in increased synapse number and memory facilitation, similar to chronic treatment with HDACis in mice. Notably, reduced synapse number and learning impairment of HDAC2-overexpressing mice were ameliorated by chronic treatment with HDACis. Correspondingly, treatment with HDACis failed to further facilitate memory formation in Hdac2-deficient mice. Furthermore, analysis of promoter occupancy revealed an association of HDAC2 with the promoters of genes implicated in synaptic plasticity and memory formation. Taken together, our results suggest that HDAC2 functions in modulating synaptic plasticity and long-lasting changes of neural circuits, which in turn negatively regulates learning and memory. These observations encourage the development and testing of HDAC2-selective inhibitors for human diseases associated with memory impairment.	[Guan, Ji-Song; Joseph, Nadine; Gao, Jun; Zhou, Ying; Wang, Xinyu; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Guan, Ji-Song; Joseph, Nadine; Gao, Jun; Zhou, Ying; Wang, Xinyu; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Guan, Ji-Song; Haggarty, Stephen J.; Joseph, Nadine; Nieland, Thomas J. F.; Mazitschek, Ralph; Bradner, James E.; Tsai, Li-Huei] Harvard Univ, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Guan, Ji-Song; Haggarty, Stephen J.; Joseph, Nadine; Nieland, Thomas J. F.; Mazitschek, Ralph; Bradner, James E.; Tsai, Li-Huei] MIT, Cambridge, MA 02142 USA; [Haggarty, Stephen J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Cambridge, MA 02142 USA; [Giacometti, Emanuela; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Giacometti, Emanuela; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dannenberg, Jan-Hermen; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Mazitschek, Ralph] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Haggarty, Stephen J/M-9495-2016; Mazitschek, Ralph/E-3741-2013	Haggarty, Stephen J/0000-0002-7872-168X; Mazitschek, Ralph/0000-0002-1105-689X; DePinho, Ronald/0000-0002-5625-577X; Guan, Ji-Song/0000-0001-5219-0289	National Institute of Neurological Disorders and Stroke [2 ROI NS051874]; Stanley Center for Psychiatric Research; National Alliance for Research on Schizophrenia and Depression Foundation; Damon-Runyon Cancer Research Foundation; Dutch Cancer Society; NIH [5-RO1-CA087869, 5-R37-CA084198, 5-RO1-HD0445022]; Robert A. and Renee E. Belfer Institute for Applied Cancer Science; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanley Center for Psychiatric Research; National Alliance for Research on Schizophrenia and Depression Foundation(NARSAD); Damon-Runyon Cancer Research Foundation; Dutch Cancer Society(KWF Kankerbestrijding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Institute for Applied Cancer Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Scolnick, D. Fass, P. Sklar, T. Petryshen, B. A. Samuels, A. Fischer, C. Frank, D. Kim, S. Su and Y. Hayashi for advice and critical reading of the manuscript; T. Petryshen, A. Graybiel, J. Crittenden and M. C. Lewis for providing the T-maze behaviour model; R. Neve for providing tdTomato HSV. Funding was provided by a grant from the National Institute of Neurological Disorders and Stroke (2 ROI NS051874) to L.-H. T., by a research fund from the Stanley Center for Psychiatric Research to L.-H. T. and S. J. H., by the National Alliance for Research on Schizophrenia and Depression Foundation to S. J. H.; by a fellowship from the Damon-Runyon Cancer Research Foundation and The Dutch Cancer Society (KWF) to J. H. D. R. J. is supported by NIH grants (5-RO1-CA087869, 5-R37-CA084198, 5-RO1-HD0445022); R. A. D. is supported by the Robert A. and Renee E. Belfer Institute for Applied Cancer Science. L.-H. T. is an investigator of the Howard Hughes Medical Institute.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; BRESLOW R, 1993, Patent No. 1993007148; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Radulovic J, 1999, J NEUROSCI, V19, P5016; RAMONMOLINIER E, 1970, CONT RES METHODS NEU; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047	35	1173	1242	3	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					55	U58		10.1038/nature07925	http://dx.doi.org/10.1038/nature07925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424149	Green Accepted, Green Submitted			2022-12-24	WOS:000265801300027
J	Li, CJ; Vagin, VV; Lee, SH; Xu, J; Ma, SM; Xi, HL; Seitz, H; Horwich, MD; Syrzycka, M; Honda, BM; Kittler, ELW; Zapp, ML; Klattenhoff, C; Schulz, N; Theurkauf, WE; Weng, ZP; Zamore, PD				Li, Chengjian; Vagin, Vasily V.; Lee, Soohyun; Xu, Jia; Ma, Shengmei; Xi, Hualin; Seitz, Herve; Horwich, Michael D.; Syrzycka, Monika; Honda, Barry M.; Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.; Weng, Zhiping; Zamore, Phillip D.			Collapse of Germline piRNAs in the Absence of Argonaute3 Reveals Somatic piRNAs in Flies	CELL			English	Article							EMBRYONIC AXIS SPECIFICATION; SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; FLAMENCO GENE; PIWI; PATHWAY; AUBERGINE; PROTEIN; GYPSY; ENCODES	Piwi-interacting RNAs (piRNAs) silence transposons in animal germ cells. piRNAs are thought to derive from long transcripts spanning transposon-rich genomic loci and to direct an autoamplification loop in which an antisense piRNA, bound to Aubergine or Piwi protein, triggers production of a sense piRNA bound to the PIWI protein Argonaute3 (Ago3). In turn, the new piRNA is envisioned to produce a second antisense piRNA. Here, we describe strong loss-of-function mutations in ago3, allowing a direct genetic test of this model. We find that Ago3 acts to amplify piRNA pools and to enforce on them an antisense bias, increasing the number of piRNAs that can act to silence transposons. We also detect a second, Ago3-independent piRNA pathway centered on Piwi. Transposons targeted by this second pathway often reside in the flamenco locus, which is expressed in somatic ovarian follicle cells, suggesting a role for piRNAs beyond the germline.	[Lee, Soohyun; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01605 USA; [Lee, Soohyun; Xi, Hualin] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xi, Hualin] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA 02139 USA; [Syrzycka, Monika; Honda, Barry M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Pfizer; Simon Fraser University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Seitz, Hervé/AAE-6487-2019; Xu, Jia/F-7750-2012	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Lee, Soohyun/0000-0002-3594-6213; Xu, Jia/0000-0003-3921-018X	National Institutes of Health [GM62862, GM65236]; Natural Sciences and Engineering Research Council of Canada [GM050898, HD049116]; Canadian Institutes of Health Research; Pfizer, Inc; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050898, R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer, Inc(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mikiko and Haruhiko Siomi and Greg Hannon for antibodies, Erica Selva for flies expressing nanos-Gal4 from a transgene on the second chromosome, Paul Lasko for GFP-Vasa flies, Bradley Till for assistance with tilling primer design, Alicia Boucher for assistance with fly husbandry, Gwen Farley for technical assistance, and members of the Zamore and Weng laboratories for advice, suggestions, and critical comments on the text. This work was supported in part by grants from the National Institutes of Health to P.D.Z. (GM62862 and GM65236) and W.E.T. (GM050898 and HD049116) and from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research to B.M.H. H.X. was supported in part by Pfizer, Inc.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; BALAKIREVA MD, 1992, NUCLEIC ACIDS RES, V20, P3731, DOI 10.1093/nar/20.14.3731; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Fuller Margaret T., 1993, P71; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; MALONE CD, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.03.040; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; PALUMBO G, 1994, GENETICS, V138, P1181; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; PIMPINELLI S, 1985, GENETICS, V109, P701; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmidt A, 1999, GENETICS, V151, P749; SCHUPBACH T, 1991, GENETICS, V129, P1119; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	54	390	402	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					509	521		10.1016/j.cell.2009.04.027	http://dx.doi.org/10.1016/j.cell.2009.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395009	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000265677200020
J	Bowman, DMJS; Balch, JK; Artaxo, P; Bond, WJ; Carlson, JM; Cochrane, MA; D'Antonio, CM; DeFries, RS; Doyle, JC; Harrison, SP; Johnston, FH; Keeley, JE; Krawchuk, MA; Kull, CA; Marston, JB; Moritz, MA; Prentice, IC; Roos, CI; Scott, AC; Swetnam, TW; van der Werf, GR; Pyne, SJ				Bowman, David M. J. S.; Balch, Jennifer K.; Artaxo, Paulo; Bond, William J.; Carlson, Jean M.; Cochrane, Mark A.; D'Antonio, Carla M.; DeFries, Ruth S.; Doyle, John C.; Harrison, Sandy P.; Johnston, Fay H.; Keeley, Jon E.; Krawchuk, Meg A.; Kull, Christian A.; Marston, J. Brad; Moritz, Max A.; Prentice, I. Colin; Roos, Christopher I.; Scott, Andrew C.; Swetnam, Thomas W.; van der Werf, Guido R.; Pyne, Stephen J.			Fire in the Earth System	SCIENCE			English	Review							FOREST-FIRES; CLIMATE; EXPANSION; HISTORY; ECOSYSTEMS; EVOLUTION; SYNCHRONY; EMISSIONS; ECOLOGY; CYCLE	Fire is a worldwide phenomenon that appears in the geological record soon after the appearance of terrestrial plants. Fire influences global ecosystem patterns and processes, including vegetation distribution and structure, the carbon cycle, and climate. Although humans and fire have always coexisted, our capacity to manage fire remains imperfect and may become more difficult in the future as climate change alters fire regimes. This risk is difficult to assess, however, because fires are still poorly represented in global models. Here, we discuss some of the most important issues involved in developing a better understanding of the role of fire in the Earth system.	[Balch, Jennifer K.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Johnston, Fay H.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia; [Balch, Jennifer K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Balch, Jennifer K.] Woods Hole Res Ctr, Woods Hole, MA 02543 USA; [Artaxo, Paulo] Univ Sao Paulo, Inst Fis, BR-05508900 Sao Paulo, Brazil; [Bond, William J.] Univ Cape Town, Dept Bot, ZA-7925 Cape Town, South Africa; [Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Cochrane, Mark A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Environm Studies Program, Santa Barbara, CA 93106 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [DeFries, Ruth S.] Columbia Univ, New York, NY 10027 USA; [Doyle, John C.] CALTECH, Dept Control & Dynam Syst, Pasadena, CA 91125 USA; [Harrison, Sandy P.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Keeley, Jon E.] US Geol Survey, Western Ecol Res Ctr, Sequoia Kings Canyon Field Stn, Three Rivers, CA 93271 USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Krawchuk, Meg A.; Moritz, Max A.] Univ Calif Berkeley, Ecosyst Sci Div, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kull, Christian A.] Monash Univ, Sch Geog & Environm Sci, Melbourne, Vic 3800, Australia; [Marston, J. Brad] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Prentice, I. Colin] Univ Bristol, QUEST, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Roos, Christopher I.] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Scott, Andrew C.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Swetnam, Thomas W.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [van der Werf, Guido R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hydrol & Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands; [Pyne, Stephen J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	National Center for Ecological Analysis & Synthesis; University of Tasmania; Menzies Institute for Medical Research; Yale University; Woods Hole Research Center; Universidade de Sao Paulo; University of Cape Town; University of California System; University of California Santa Barbara; South Dakota State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Columbia University; California Institute of Technology; University of Bristol; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Monash University; Brown University; University of Bristol; University System of Ohio; Ohio State University; University of London; Royal Holloway University London; University of Arizona; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Balch, JK (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	balch@nceas.ucsb.edu	Scott, Andrew C/C-6661-2008; Roos, Christopher/F-3379-2011; van der Werf, Guido/M-8260-2016; Artaxo, Paulo/E-8874-2010; Swetnam, Thomas/A-6052-2008; Marston, Brad/B-3144-2012; Bowman, David M.J.S./A-2930-2011; Bond, William/AAY-7631-2020; Cochrane, Mark A/A-1735-2018; Nahas, Alberth/C-8379-2013; Kull, Christian A/C-5806-2015	Scott, Andrew C/0000-0002-1998-3508; van der Werf, Guido/0000-0001-9042-8630; Artaxo, Paulo/0000-0001-7754-3036; Swetnam, Thomas/0000-0001-7268-2184; Bowman, David M.J.S./0000-0001-8075-124X; Cochrane, Mark A/0000-0002-4573-568X; Harrison, Sandy/0000-0001-5687-1903; Roos, Christopher/0000-0001-8754-7655; Kull, Christian/0000-0002-7516-7898; Johnston, Fay Helena/0000-0002-5150-8678; Bond, William/0000-0002-3441-2084	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF [PHY05-51164, DEB-0553768]; University of California, Santa Barbara; State of California; Instituto do Milenio Program; U.S. Geological Survey; Natural Environment Research Council [NE/E007600/1, quest010001, NE/E006183/1] Funding Source: researchfish; NERC [quest010001, NE/E006183/1, NE/E007600/1] Funding Source: UKRI	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Instituto do Milenio Program; U.S. Geological Survey(United States Geological Survey); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Curran, M. Einhorn, D. Gross, S. Hampton, D. Nepstad, and R. Whittaker for encouraging this synthesis, and G. Williamson for assistance with Fig. 2. This work was conducted as part of the Pyrogeography and Climate Change Working Group supported by the Kavli Institute for Theoretical Physics (KITP) and the National Center for Ecological Analysis and Synthesis (NCEAS), funded by NSF grants PHY05-51164 and DEB-0553768, respectively; the University of California, Santa Barbara; and the State of California. Additional support was provided by NCEAS (to J.K.B., the Postdoctoral Associate in the Group); CNPq/MCT Instituto do Milenio Program (to P.A.); and the U.S. Geological Survey (to J.E.K.). Contributions: D.M.J.S.B. conceived of the original idea; J.K.B. and D.M.J.S.B. co-organized the KITP/NCEAS workshop and assumed editorial responsibility; all authors participated in the workshop and/or contributed to manuscript writing; G.R.W., P.A., and I.C.P. developed the radiative forcing figure; C.A.K., C.I.R., and A.C.S. designed the timeline diagram.	Alencar A, 2006, EARTH INTERACT, V10; Allen CD, 2002, ECOL APPL, V12, P1418; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; ARINO O, 1999, EARTH OBS Q, V64, P1; Arora VK, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000042; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Cochrane M. A, 2002, SPREAD LIK WILDF TRO; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Forsyth Greg G., 2008, Koedoe, V50, P3; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; IPCC, 2007, CLIM CHANG 2007 PHYS; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Kitzberger T, 2001, GLOBAL ECOL BIOGEOGR, V10, P315, DOI 10.1046/j.1466-822X.2001.00234.x; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Langenfelds RL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001466; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Lenton TM, 2001, GLOBAL CHANGE BIOL, V7, P613, DOI 10.1046/j.1354-1013.2001.00429.x; Lohman DJ, 2007, SCIENCE, V316, P376, DOI 10.1126/science.1140278; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; MARSTON JB, 1991, NATURE, V349, P573, DOI 10.1038/349573b0; McGlone MS, 1999, J QUATERNARY SCI, V14, P239, DOI 10.1002/(SICI)1099-1417(199905)14:3<239::AID-JQS438>3.0.CO;2-9; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Platek SM, 2002, MED HYPOTHESES, V58, P1, DOI 10.1054/mehy.2001.1385; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Pyne Stephen, 2001, FIRE BRIEF HIST; Pyne SJ, 2007, INT J WILDLAND FIRE, V16, P271, DOI 10.1071/WF06041; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; SCHWEITHELM J, 1999, INDONESIAS FIRE HAZE; Schwilk DW, 2002, OIKOS, V99, P431, DOI 10.1034/j.1600-0706.2002.11730.x; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tansey K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031567; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	48	1794	1865	57	1001	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					481	484		10.1126/science.1163886	http://dx.doi.org/10.1126/science.1163886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390038				2022-12-24	WOS:000265411200037
J	Elsik, CG; Tellam, RL; Worley, KC; Gibbs, RA; Abatepaulo, ARR; Abbey, CA; Adelson, DL; Aerts, J; Ahola, V; Alexander, L; Alioto, T; Almeida, IG; Amadio, AF; Anatriello, E; Antonarakis, SE; Anzola, JM; Astashyn, A; Bahadue, SM; Baldwin, CL; Barris, W; Baxter, R; Bell, SN; Bennett, AK; Bennett, GL; Biase, FH; Boldt, CR; Bradley, DG; Brinkman, FSL; Brinkmeyer-Langford, CL; Brown, WC; Brownstein, MJ; Buhay, C; Caetano, AR; Camara, F; Carroll, JA; Carvalho, WA; Casey, T; Cervelatti, EP; Chack, J; Chacko, E; Chandrabose, MM; Chapin, JE; Chapple, CE; Chen, HC; Chen, L; Cheng, Y; Cheng, Z; Childers, CP; Chitko-McKown, CG; Chiu, R; Choi, JW; Chrast, J; Colley, AJ; Connelley, T; Cree, A; Curry, S; Dalrymple, B; Diep Dao, M; Davis, C; de Oliveira, CJF; de Miranda Santos, IKF; de Campos, TA; Deobald, H; Devinoy, E; Dickens, CM; Ding, Y; Dinh, HH; De Donato, M; Donohue, KE; Donthu, R; Dovc, P; Dugan-Rocha, S; Durbin, KJ; Eberlein, A; Edgar, RC; Egan, A; Eggen, A; Eichler, EE; Elhaik, E; Ellis, SA; Elnitski, L; Ermolaeva, O; Eyras, E; Fitzsimmons, CJ; Fowler, GR; Franzin, AM; Fritz, K; Gabisi, RA; Garcia, GR; Garcia, JF; Genini, S; Gerlach, D; German, JB; Gilbert, JGR; Gill, CA; Gladney, CJ; Glass, EJ; Goodell, J; Grant, JR; Graur, D; Greaser, ML; Green, JA; Green, RD; Guan, L; Guigo, R; Hadsell, DL; Hagen, DE; Hakimov, HA; Halgren, R; Hamernik, DL; Hamilton, C; Harhay, GP; Harrow, JL; Hart, EA; Hastings, N; Havlak, P; Henrichsen, CN; Hernandez, J; Hernandez, M; Herzig, CTA; Hiendleder, SG; Hines, S; Hitchens, ME; Hlavina, W; Hobbs, M; Holder, M; Holt, RA; Hu, ZL; Hume, J; Iivanainen, A; Ingham, A; Iso-Touru, T; Jamis, C; Jann, O; Jensen, K; Jhangiani, SN; Jiang, HY; Johnson, AJ; Jones, SJM; Joshi, V; Junier, T; Kapetis, D; Kappes, SM; Kapustin, Y; Keele, JW; Kent, MP; Kerr, T; Khalil, SS; Khatib, H; Kiryutin, B; Kitts, P; Kokocinski, F; Kolbehdari, D; Kovar, CL; Kriventseva, EV; Kumar, CG; Kumar, D; Lahmers, KK; Landrum, M; Larkin, DM; Lau, LPL; Leach, R; Lee, JCM; Lee, S; Lemay, DG; Lewin, HA; Lewis, LR; Li, CX; Lien, S; Liu, GE; Liu, YS; Liu, Y; Logan, KM; Lopez, J; Lozado, RJ; Lutzow, YS; Lynn, DJ; MacNeil, MD; Maglott, D; Malinverni, R; Maqbool, NJ; Marques, E; Marra, MA; Martin, WF; Martins, NF; Maruyama, SR; Matukumalli, LK; Mazza, R; McEwan, JC; McKay, SD; McLean, KL; McWilliam, S; Medrano, JF; Memili, E; Moen, C; Molenaar, AL; Moore, SS; Moore, R; More, DD; Moreno, BT; Morgan, MB; Muntean, CT; Muzny, DM; Nandakumar, HP; Nazareth, LV; Nguyen, NB; Nicholas, FW; Nogueira, MFG; Okwuonu, GO; Olsaker, I; Pant, SD; Panzitta, F; Pastor, RCP; Patel, BM; Payne, GM; Plass, M; Poli, MA; Poslusny, N; Pruitt, K; Pu, LL; Qin, X; Rachagani, S; Raison, JM; Ranganathan, S; Ratnakumar, A; Razpet, A; Reecy, J; Reese, JT; Ren, Y; Reymond, A; Riggs, PK; Rijnkels, M; Rincon, G; Roberts, A; Rodriguez-Osorio, N; Rodriguez-Zas, SL; Romero, NE; Rosenwald, A; Ruiz, SJ; Sabo, A; Salih, H; Sando, L; Santibanez, J; Sapojnikov, V; Schein, JE; Schmutz, SM; Schnabel, RD; Schook, L; Searle, SM; Seo, SW; Shen, YF; Shen, LB; Sherman, L; Skow, LC; Smith, T; Snelling, WM; Sodergren, E; Solovyev, V; Song, H; Song, JZ; Sonstegard, TS; Southey, BR; Souvorov, A; Spurlock, D; Steffen, D; Stone, RT; Stothard, P; Sugimoto, Y; Sweedler, JV; Takasuga, A; Tammen, I; Taniguchi, M; Taylor, JF; Telugu, BPVL; Ucla, C; Urbanski, JM; Utsunomiya, YT; Van, CP; Vattathil, S; Verschoor, CP; Waardenberg, AJ; Walker, A; Wang, ZQ; Ward, R; Warren, JT; Waterman, RC; Weikard, R; Weinstock, GM; Welsh, TH; Wheeler, DA; Wheeler, TT; White, SN; Whitside, MD; Wilczek-Boney, K; Williams, JL; Williams, RL; Wilming, LG; Womack, J; Wright, RA; Wunderlich, KR; Wyss, C; Yang, MQ; Yang, JQ; Zdobnov, EM; Zhang, JK; Zhao, FQ; Zhu, B				Elsik, Christine G.; Tellam, Ross L.; Worley, Kim C.; Gibbs, Richard A.; Abatepaulo, Antonio R. R.; Abbey, Colette A.; Adelson, David L.; Aerts, Jan; Ahola, Virpi; Alexander, Lee; Alioto, Tyler; Almeida, Iassudara G.; Amadio, Ariel F.; Anatriello, Elen; Antonarakis, Stylianos E.; Anzola, Juan M.; Astashyn, Alex; Bahadue, Suria M.; Baldwin, Cynthia L.; Barris, Wes; Baxter, Rebecca; Bell, Stephanie Nicole; Bennett, Anna K.; Bennett, Gary L.; Biase, Fernando H.; Boldt, Clayton R.; Bradley, Daniel G.; Brinkman, Fiona S. L.; Brinkmeyer-Langford, Candice L.; Brown, Wendy C.; Brownstein, Michael J.; Buhay, Christian; Caetano, Alexandre R.; Camara, Francisco; Carroll, Jeffrey A.; Carvalho, Wanessa A.; Casey, Theresa; Cervelatti, Elaine P.; Chack, Joseph; Chacko, Elsa; Chandrabose, Mimi M.; Chapin, Jennifer E.; Chapple, Charles E.; Chen, Hsiu-Chuan; Chen, Lin; Cheng, Ye; Cheng, Ze; Childers, Christopher P.; Chitko-McKown, Carol G.; Chiu, Readman; Choi, Jungwoo; Chrast, Jacqueline; Colley, Adam J.; Connelley, Tomothy; Cree, Andy; Curry, Stacey; Dalrymple, Brian; Diep Dao, Marvin; Davis, Clay; de Oliveira, Carlo J. F.; de Miranda Santos, Isabel K. F.; de Campos, Tatiana A.; Deobald, Heather; Devinoy, Eve; Dickins, C. Michael; Yan, Ding; Dinh, Huyen H.; De Donato, Marcos; Donohue, Kaitlin E.; Donthu, Ravikiran; Dovc, Peter; Dugan-Rocha, Shannon; Durbin, K. James; Eberlein, Annett; Edgar, Robert C.; Egan, Amy; Eggen, Andre; Eichler, Evan E.; Elhaik, Eran; Ellis, Shirley A.; Elnitski, Laura; Ermolaeva, Olga; Eyras, Eduardo; Fitzsimmons, Carolyn J.; Fowler, Gerald R.; Franzin, Alessandra M.; Fritz, Krista; Gabisi, Ramatu Ayiesha; Garcia, Gustavo R.; Garcia, Jose Fernando; Genini, Sem; Gerlach, Daniel; German, J. Bruce; Gilbert, James G. R.; Gill, Clare A.; Gladney, Cody J.; Glass, Elizabeth J.; Goodell, Jason; Grant, Jason R.; Graur, Dan; Greaser, Marion L.; Green, Jonathan A.; Green, Ronnie D.; Guan, Leluo; Guigo, Roderic; Hadsell, Darryl L.; Hagen, Darren E.; Hakimov, Hatam A.; Halgren, Rob; Hamernik, Debora L.; Hamilton, Cerissa; Harhay, Gregory P.; Harrow, Jennifer L.; Hart, Elizabeth A.; Hastings, Nicola; Havlak, Paul; Henrichsen, Charlotte N.; Hernandez, Judith; Hernandez, Marta; Herzig, Carolyn T. A.; Hiendleder, Stefan G.; Hines, Sandra; Hitchens, Matthew Edward; Hlavina, Wratko; Hobbs, Matthew; Holder, Michael; Holt, Robert A.; Hu, Zhi-Liang; Hume, Jennifer; Iivanainen, Antti; Ingham, Aaron; Iso-Touru, Terhi; Jamis, Catherine; Jann, Oliver; Jensen, Kirsty; Jhangiani, Shalini N.; Jiang, Huaiyang; Johnson, Angela Jolivet; Jones, Steven J. M.; Joshi, Vandita; Junier, Thomas; Kapetis, Dimos; Kappes, Steve M.; Kapustin, Yuri; Keele, John W.; Kent, Matthew P.; Kerr, Tovah; Khalil, Sari S.; Khatib, Hasan; Kiryutin, Boris; Kitts, Paul; Kokocinski, Felix; Kolbehdari, Davood; Kovar, Christie L.; Kriventseva, Evgenia V.; Kumar, Charu G.; Kumar, Dinesh; Lahmers, Kevin K.; Landrum, Melissa; Larkin, Denis M.; Lau, Lilian P. L.; Leach, Richard; Lee, Justin C. M.; Lee, Sandra; Lemay, Danielle G.; Lewin, Harris A.; Lewis, Lora R.; Li, Changxi; Lien, Sigbjorn; Liu, George E.; Liu, Yih-shin; Liu, Yue; Logan, Krystin M.; Lopez, John; Lozado, Ryan J.; Lutzow, Ylva Strandberg; Lynn, David J.; MacNeil, Michael D.; Maglott, Donna; Malinverni, Roberto; Maqbool, Nauman J.; Marques, Elisa; Marra, Marco A.; Martin, William F.; Martins, Natalia F.; Maruyama, Sandra R.; Matukumalli, Lakshmi K.; Mazza, Raffaele; McEwan, John C.; McKay, Stephanie D.; McLean, Kim L.; McWilliam, Sean; Medrano, Juan F.; Memili, Erdogan; Moen, Charles; Molenaar, Adrian J.; Moore, Stephen S.; Moore, Richard; More, Daniela D.; Moreno, Barbara T.; Morgan, Margaret B.; Muntean, Carl T.; Muzny, Donna M.; Nandakumar, Hari P.; Nazareth, Lynne V.; Nguyen, Ngoc Bich; Nicholas, Frank W.; Nogueira, Marcelo F. G.; Okwuonu, Geoffrey O.; Olsaker, Ingrid; Pant, Sameer D.; Panzitta, Francesca; Pastor, Rosemeire C. P.; Patel, Bella Mayurkumar; Payne, Gemma M.; Plass, Mireya; Poli, Mario A.; Poslusny, Nathan; Pruitt, Kim; Pu, Ling-Ling; Qin, Xiang; Rachagani, Satyanarayana; Raison, Joy M.; Ranganathan, Shoba; Ratnakumar, Abhirami; Razpet, Andrej; Reecy, James; Reese, Justin T.; Ren, Yanru; Reymond, Alexandre; Riggs, Penny K.; Rijnkels, Monique; Rincon, Gonzalo; Roberts, Andy; Rodriguez-Osorio, Nelida; Rodriguez-Zas, Sandra L.; Romero, Natasha E.; Rosenwald, Anne; Ruiz, San Juana; Sabo, Aniko; Salih, Hanni; Sando, Lillian; Santibanez, Jireh; Sapojnikov, Victor; Schein, Jacqueline E.; Schmutz, Sheila M.; Schnabel, Robert D.; Schook, Lawrence; Searle, Stephen M.; Seo, Seongwon; Shen, Yufeng; Shen, Libing; Sherman, Laura; Skow, Loren C.; Smith, Timothy; Snelling, Warren M.; Sodergren, Erica; Solovyev, Victor; Song, Henry; Song, Jiuzhou; Sonstegard, Tad S.; Southey, Bruce R.; Souvorov, Alexandre; Spurlock, Diane; Steffen, David; Stone, Roger T.; Stothard, Paul; Sugimoto, Yoshikazu; Sweedler, Jonathan V.; Takasuga, Akiko; Tammen, Imke; Taniguchi, Masaaki; Taylor, Jeremy F.; Telugu, Bhanu Prakash V. L.; Ucla, Catherine; Urbanski, Jennifer M.; Utsunomiya, Yuri T.; Van, Curtis P.; Vattathil, Selina; Verschoor, Chris P.; Waardenberg, Ashley J.; Walker, Angela; Wang, Zhiquan; Ward, Robert; Warren, James T.; Waterman, Richard C.; Weikard, Rosemarie; Weinstock, George M.; Welsh, Thomas H., Jr.; Wheeler, David A.; Wheeler, Thomas T.; White, Stephen N.; Whiteside, Matthew D.; Wilczek-Boney, Katarzyna; Williams, John L.; Williams, Rex Lee, Jr.; Wilming, Laurens G.; Womack, James; Wright, Rita A.; Wunderlich, Kris R.; Wyss, Carine; Yang, Mary Q.; Yang, Jianqi; Zdobnov, Evgeny M.; Zhang, Jingkun; Zhao, Feng-Qi; Zhu, Bin		Bovine Genome Sequencing & Analysi	The Genome Sequence of Taurine Cattle: A Window to Ruminant Biology and Evolution	SCIENCE			English	Article							NEONATAL FC-RECEPTOR; GENE-EXPRESSION; BOVINE; ORGANIZATION; INTERFERON; FAMILY; ROLES; MAP	To understand the biology and evolution of ruminants, the cattle genome was sequenced to about sevenfold coverage. The cattle genome contains a minimum of 22,000 genes, with a core set of 14,345 orthologs shared among seven mammalian species of which 1217 are absent or undetected in noneutherian (marsupial or monotreme) genomes. Cattle-specific evolutionary breakpoint regions in chromosomes have a higher density of segmental duplications, enrichment of repetitive elements, and species-specific variations in genes associated with lactation and immune responsiveness. Genes involved in metabolism are generally highly conserved, although five metabolic genes are deleted or extensively diverged from their human orthologs. The cattle genome sequence thus provides a resource for understanding mammalian evolution and accelerating livestock genetic improvement for milk and meat production.	[Elsik, Christine G.] Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA; [Tellam, Ross L.] CSIRO Livestock Ind, St Lucia, Qld 4067, Australia; [Worley, Kim C.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; Univ Adelaide, Sch Mol Biomed & Sci, Sch Agr Food & Wine, Adelaide, SA 5005, Australia; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA 98195 USA; Natl Human Genome Res Inst, Natl Inst Hlth, Rockville, MD 20878 USA; Univ Pompeu Fabra, Ctr Genomic Regulation, Grp Recerca Informatica Biomed, Inst Municipal Invest Med, E-08003 Barcelona, Spain; USDA, Cooperative State Res Educ & Extension Serv, Washington, DC 20250 USA; USDA Agr Res Serv, Natl Program Staff, Beltsville, MD 20705 USA; Univ Illinois Urban Champaign, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois Urban Champaign, Inst Genomic Biol, Urbana, IL 61801 USA; Simon Fraser Univ, Dept Mol Biol Biochem, Burnaby, BC V5A 1S6, Canada; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Univ Lausanne, Ctr Integrative Genomics, CH-1015 Lausanne, Switzerland; Baylor Coll Med, Dept Pediat Nutr, USDA Agr Res Serv, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Texas A&M Univ, Dept Vet Integrative Biosci, College Stn, TX 77843 USA; Univ Geneva Med Sch, Dept Genetic Med & Dev, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformatics, CH-1211 Geneva, Switzerland; Imperial Coll, S Kensington Campus, Div Mol Biosci, London SW7 2AZ, England; Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotech Information, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst Hinxton, Informatics Dept, Cambridge CB10 1HH, England; Univ London, Royal Holloway Egham, Dept Comp Sci, Surrey TW20 0EX, England; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Johns Hopkins Univ Sch Med, McKusick Nathans Inst Genetic Med, Baltimore, MD 21205 USA; 45 Monterey Dr, Tiburon, CA 94920 USA; AgResearch, Anim Genomics, Mosgiel 9053, New Zealand; Univ Adelaide N Terrace, eRes SA, Adelaide, SA 5005, Australia; Univ Geneva Med Sch, Dept Struct Biol Bioinformatics, CH-1211 Geneva, Switzerland; Catalan Inst Res & Adv Studies, E-08010 Barcelona, Spain; Univ Pompeu Fabra, Comp Genomics, E-08003 Barcelona, Spain; Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; USDA Agr Res Serv, Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; Bovine Functional Genomics Lab, USDA Agr Res Serv, BARC E, Beltsville, MD 20705 USA; George Mason Univ, Dept Bioinformatics & Computational Biol, Manassas, VA 20110 USA; Univ Maryland, Dept Bioengineering, College Pk, MD 20742 USA; Trinity Coll Dublin, Smurfit Inst Genetics, Dublin 2, Ireland; Univ Missouri, Dept Vet Pathobiology, Columbia, MO 65211 USA; Daily Sci & Tech Section, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; Nestle Res Ctr, CH-1000 Lausanne, Switzerland; Univ Calif Davis, Dept Food Sci & Tech, Davis, CA 95616 USA; Bioinformatics Mathematics Stat, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Chungnam Natl Univ, Div Anim Sci & Resource, Daejeon 305764, South Korea; Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Studies, Midlothian EH25 9PS, Scotland; Washington State Univ, Dept Vet Microbiol & Pathology, Pullman, WA 99164 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Sci, Div Infect & Immunity, Midlothian EH25 9RG, Scotland; Inst Anim Hlth, Immunol Div, Compton RG20 7NN, England; Univ Helsinki, Dept Basic Vet Sci, FIN-00014 Helsinki, Finland; Wellcome Trust Sanger Inst, Genome Dynamics & Evolution, Cambridge CB10 1SA, England; Embrapa Recursos Geneticos Biotech, BR-70770900 Brasilia, DF, Brazil; UNESP Sao Paulo State Univ, Anim Prod & Hlth Dept, BR-16050680 Aracatuba, SP, Brazil; Texas AgriLife Res, College Stn, TX 77843 USA; Univ Adelaide, Sch Agr Food & Wine & Res Ctr Reprod Hlth, JS Davies Epigenetics & Genetics Grp, Roseworthy, SA 5371, Australia; Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; Polo Univ, Parco Tecnol Padano, Via Einstein, I-26900 Lodi, Italy; USDA Agr Res Serv, Fort Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA; NIH, Natl Inst Mental Hlth, Lab Genetics, Bethesda, MD 20892 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; Natl Inst Agrobiol Sci, Div of Anim Sci, Tsukuba, Ibaraki 3058602, Japan; Baylor Coll Med, Bioinfo Res Ctr, Houston, TX 77030 USA; Univ California Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; Columbia Univ, Dept Comp Sci & Ctr Comp Biol & Bioinfo, New York, NY 10032 USA; INRA, Anim Genetics & Integrative Biol, Bovine Genetics & Genomics, F-78350 Jouy En Josas, France; Pfizer Anim Hlth, Pfizer Anim Genetics, New York, NY 10017 USA; Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia; Norwegian Univ Life Sci, Ctr Integrative Genetics, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Shirakawa Inst Anim Genetics, Nishigo, Fukushima 9618061, Japan; Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; MTT Agrifood Res Finland, Biotech & Food Res, FIN-31600 Jokioinen, Finland; INTA, EEA Rafaela, RA-3080 Rafaela, Argentina; USDA Agr Res Serv, Livestock Issues Res Unit, Lubbock, TX 79403 USA; Macquarie Univ, Dept Chem & Biomol Sci, ARC Ctr Excellence Bioinfo, Sydney, NSW 2109, Australia; Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; Univ Oriente, Inst Invest Biomed & Ciencias Aplicadas, Cumana 6101, Sucre, Venezuela; Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 5A8, Canada; INRA UR1196, Genomique Phys Lactation, F-78352 Jouy En Josas, France; Univ Ljubljana, Dept Anim Sci, SI-1230 Domzale, Slovenia; Res Inst Biol Farm Anim FBN, Res Unit Mol Biol, D-18196 Dummerstorf, Germany; Univ Wisconsin Madison, Dept Anim Sci, Madison, WI 53706 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; EMBL Heidelberg, Cell Biol & Biophys, Heidelberg, Germany; ITACyL, Lab Mol Biol, E-47071 Valladolid, Spain; Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; Monsanto Co, Ankeny, IA 50021 USA; Natl Bur Anim Genetic Res, Genes & Genetic Res Mol Anal Lab, Karnal 132001, Haryana, India; Agr & Agri-Food Canada, Lacombe Res Ctr, Lacombe, AB T4L 1W1, Canada; Univ Guelph, Biomed Sci, Guelph, ON N1G 2W6, Canada; Univ Cattolica Sacro Cuore, Zootechnics Inst, I-29100 Piacenza, Italy; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; UNESP Sao Paulo State Univ, Dept Ciencias Biol, Fac Ciencias Letras, BR-19806900 Assis, SP, Brazil; Norwegian Sch Vet Sci, Dept Basic Sci & Aquatic Med, N-0033 Oslo, Norway; INTA, Inst Genetica Ewald Favret, RA-B1712WAA Buenos Aires, Argentina; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; Univ Antioquia, Grp CENTAURO, Medellin, Colombia; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, QLD 4111, Australia; Utah State Univ, Nutr & Food Sci, Logan, UT 84322 USA; USDA Agr Res Serv, Anim Dis Res Unit, Pullman, WA 99164 USA; Univ Iowa, Dept Pharm 2 344 BSB, Iowa City, IA 52242 USA; Univ Vermont, Dept Anim Sci 211 Terrill, Burlington, VT 05405 USA	Georgetown University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Baylor College of Medicine; Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; University of Adelaide; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Simon Fraser University; University of Sydney; University of Lausanne; Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Wellcome Trust Sanger Institute; University of London; Royal Holloway University London; University of Houston System; University of Houston; Johns Hopkins University; AgResearch - New Zealand; University of Adelaide; University of Geneva; ICREA; Pompeu Fabra University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); George Mason University; University System of Maryland; University of Maryland College Park; Trinity College Dublin; University of Missouri System; University of Missouri Columbia; AgResearch - New Zealand; Michigan State University; Nestle SA; University of California System; University of California Davis; AgResearch - New Zealand; Chungnam National University; University of Alberta; University of Massachusetts System; University of Massachusetts Amherst; University of Edinburgh; Washington State University; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Helsinki; Wellcome Trust Sanger Institute; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Adelaide; Mississippi State University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); British Columbia Cancer Agency; National Institute of Agrobiological Sciences - Japan; Baylor College of Medicine; University of California System; University of California Santa Cruz; University of Houston System; University of Houston; Columbia University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Pfizer; University of Sydney; Norwegian University of Life Sciences; University of Missouri System; University of Missouri Columbia; Uppsala University; Universidade de Sao Paulo; Natural Resources Institute Finland (Luke); Instituto Nacional de Tecnologia Agropecuaria (INTA); United States Department of Agriculture (USDA); Macquarie University; University of Guelph; University of Saskatchewan; INRAE; University of Ljubljana; Forschungsinstitut fur Nutztierbiologie (FBN); University of Wisconsin System; University of Wisconsin Madison; University of Guelph; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; Monsanto; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Agriculture & Agri Food Canada; University of Guelph; Catholic University of the Sacred Heart; University of California System; University of California Davis; Universidade Estadual Paulista; Norwegian University of Life Sciences; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Singapore; Universidad de Antioquia; University of Illinois System; University of Illinois Urbana-Champaign; Griffith University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); University of Iowa; University of Vermont	Elsik, CG (corresponding author), Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA.	ce75@georgetown.edu; ross.tellam@csiro.au; kworley@bcm.edu	MacNeil, Michael D/A-6772-2009; Riggs, Penny/AAE-8398-2020; Jones, Steven J/C-3621-2009; TANIGUCHI, Masaaki/I-2564-2019; Khaleel, Sari/ABH-2168-2021; Garcia, Gustavo/E-5182-2013; Dalrymple, Brian P/F-8721-2010; de Miranda Santos, Isabel KF/B-7597-2012; Waardenberg, Ashley/D-2595-2012; McEwan, John/A-1143-2008; Gasull, Martina/J-4076-2019; Casey, Theresa Marie/F-1171-2015; Malinverni, Roberto/K-2559-2017; Larkin, Denis/AAB-2249-2022; Zdobnov, Evgeny/AAB-2745-2022; Rodriguez-Osorio, Nelida/AAT-1650-2020; Memili, Erdogan/AAY-8726-2020; Eduardo, Eyras/L-1053-2014; Tellam, Ross/T-2423-2019; Tellam, Ross/H-2798-2013; Antonarakis, Stylianos E/N-8866-2014; Pant, Sameer Dinkar/D-1448-2017; Nicholas, Frank/AGY-8318-2022; Glass, Elizabeth J/L-4612-2016; Ferreira, Francisco Câmara/G-9841-2015; Riggs, Penny K/A-8192-2008; Brinkman, Fiona/N-3195-2013; Adelson, David L/E-5506-2011; Aerts, Jan/AAQ-6949-2020; Tammen, Imke/AFF-7998-2022; Caetano, Alexandre Rodrigues/B-5227-2017; Maruyama, Sandra R/G-1171-2012; Anatriello, Elen/N-1429-2015; Junier, Thomas/A-6748-2011; Nicholas, Frank William/AAE-5566-2022; Seo, Seongwon/E-9687-2013; Holt, Robert A/C-3303-2009; Elnitski, Laura/AAD-3595-2021; Biase, Fernando/AAB-5132-2020; Hor, Charlotte/AAB-4850-2020; Harhay, Gregory/AAC-5411-2022; Bradley, Daniel G/A-3240-2012; Hernandez, Marta/I-3276-2016; Sweedler, Jonathan V/A-9405-2009; Franzin, Alessandra/D-4545-2013; Solovyev, Victor/C-4614-2013; BIASE, FERNANDO/A-3994-2010; Ingham, Aaron/C-1166-2008; Ward, Robert E/E-1250-2011; Moore, Stephen S/F-5285-2013; Guigo, Roderic/D-1303-2010; Plass, Mireya/B-4240-2010; Bennett, Gary L/C-1124-2012; Kutalik, Zoltan/HHZ-5697-2022; Nguyen, Ngoc/HHZ-0886-2022; Alioto, Tyler/K-7267-2015; de Miranda Santos, Isabel K. F./D-5261-2016; Van Tassell, Curtis P./O-4247-2019; Utsunomiya, Yuri Tani T/K-5214-2013; Larkin, Denis/AAB-1633-2022; Hor, Charlotte/H-5908-2015; Nogueira, Marcelo Fábio Gouveia/D-9801-2012; McWilliam, Sean M/H-8978-2013; Marra, Marco A/B-5987-2008; Song, Jiuzhou/AAD-6440-2020; Keele, John W/A-5846-2009; Liu, George/K-3371-2019; Alioto, Tyler/AAF-6342-2020; Wheeler, David A/M-9740-2018; Greaser, Marion L/C-6147-2012; Eyras, Eduardo/A-1560-2010; Schein, Jacquie E/G-3674-2015; Eyras, Eduardo/ABG-7144-2020; De Donato, Marcos/I-5307-2012; Hadsell, Darryl/GPF-9037-2022; Weinstock, George M/C-6314-2013; Driemeier, David/H-3461-2012; Elsik, Christine G/C-4120-2017; LEWIN, HARRIS/HGC-6543-2022; martins, natalia florencio/AAE-7875-2019; Kumar, Charu/A-1582-2013; KUMAR, DINESH/GRJ-5448-2022; Zdobnov, Evgeny M/K-1133-2012; Khatib, Hasan/AAA-2693-2021; Zhu, Bin/E-4911-2010; Malinverni, Roberto/ABF-9644-2021; Elhaik, Eran/H-6838-2019; Lahmers, Kevin/E-8272-2017; Gill, Clare/R-3677-2019; plass, mireya/AAB-7483-2019	Riggs, Penny/0000-0003-3296-320X; Jones, Steven J/0000-0003-3394-2208; TANIGUCHI, Masaaki/0000-0001-8194-3577; Khaleel, Sari/0000-0002-0886-0860; Dalrymple, Brian P/0000-0003-3891-5233; McEwan, John/0000-0003-4801-6207; Casey, Theresa Marie/0000-0002-8835-3550; Malinverni, Roberto/0000-0002-0113-3417; Zdobnov, Evgeny/0000-0002-5178-1498; Rodriguez-Osorio, Nelida/0000-0002-2235-979X; Memili, Erdogan/0000-0002-8335-5645; Eduardo, Eyras/0000-0003-0793-6218; Tellam, Ross/0000-0003-2353-1640; Antonarakis, Stylianos E/0000-0001-8907-5823; Pant, Sameer Dinkar/0000-0002-0672-4478; Nicholas, Frank/0000-0002-9178-3965; Glass, Elizabeth J/0000-0002-6183-0185; Ferreira, Francisco Câmara/0000-0002-1971-5466; Riggs, Penny K/0000-0003-3296-320X; Brinkman, Fiona/0000-0002-0584-4099; Adelson, David L/0000-0003-2404-5636; Aerts, Jan/0000-0002-6416-2717; Tammen, Imke/0000-0002-5520-6597; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; Nicholas, Frank William/0000-0002-9178-3965; Holt, Robert A/0000-0002-7259-1247; Hor, Charlotte/0000-0002-5361-2372; Harhay, Gregory/0000-0002-0129-6822; Hernandez, Marta/0000-0001-6914-9987; Sweedler, Jonathan V/0000-0003-3107-9922; Solovyev, Victor/0000-0001-8885-493X; Ingham, Aaron/0000-0001-8006-9443; Ward, Robert E/0000-0002-6981-4040; Guigo, Roderic/0000-0002-5738-4477; Plass, Mireya/0000-0002-9891-2723; Bennett, Gary L/0000-0001-7649-018X; Kutalik, Zoltan/0000-0001-8285-7523; Alioto, Tyler/0000-0002-2960-5420; Van Tassell, Curtis P./0000-0002-8416-2087; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Larkin, Denis/0000-0001-7859-6201; Hor, Charlotte/0000-0002-5361-2372; Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; McWilliam, Sean M/0000-0002-3148-0428; Marra, Marco A/0000-0001-7146-7175; Liu, George/0000-0003-0192-6705; Alioto, Tyler/0000-0002-2960-5420; Wheeler, David A/0000-0002-9056-6299; Greaser, Marion L/0000-0002-6583-9566; Eyras, Eduardo/0000-0003-0793-6218; De Donato, Marcos/0000-0001-8860-6020; Weinstock, George M/0000-0002-2997-4592; Driemeier, David/0000-0003-3766-0654; Elsik, Christine G/0000-0002-4248-7713; LEWIN, HARRIS/0000-0002-1043-7287; KUMAR, DINESH/0000-0002-9641-6662; Malinverni, Roberto/0000-0002-0113-3417; Elhaik, Eran/0000-0003-4795-1084; Gill, Clare/0000-0003-2640-1825; plass, mireya/0000-0002-9891-2723; Molenaar, Adrian J./0000-0001-7347-0714; Jensen, Kirsty/0000-0002-0005-6931; White, Stephen N./0000-0001-9255-6054; Williams, John/0000-0001-5188-7957; martins, natalia florencio/0000-0002-8816-4258; Reymond, Alexandre/0000-0003-1030-8327; Childers, Chris/0000-0002-1253-5550; Seo, Seongwon/0000-0002-4131-0545; Lemay, Danielle/0000-0003-3318-0485; Lahmers, Kevin/0000-0002-5290-3426; Elnitski, Laura/0000-0003-1065-019X; Schnabel, Robert/0000-0001-5018-7641; Ranganathan, Shoba/0000-0002-8290-813X; Ternus, Krista/0000-0003-1138-5308; Lynn, David/0000-0003-4664-1404; Iso-Touru, Terhi/0000-0001-8258-9047; Pruitt, Kim/0000-0001-7950-1374; Waardenberg, Ashley/0000-0002-9382-7490; Bradley, Daniel G/0000-0001-7335-7092; Southey, Bruce/0000-0002-8959-7709; /0000-0001-6807-1452; carvalho, wanessa/0000-0002-1346-5240; Green, Jonathan/0000-0003-4968-8187; Roberts, Andrew/0000-0001-8720-322X; Kinney Ferreira de Miranda Santos, Isabel/0000-0002-0438-4430; Schook, Lawrence/0000-0002-6580-8364; Gerlach, Daniel/0000-0001-9338-3765; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Childers, Anna/0000-0002-0747-8539; Hobbs, Matthew/0000-0002-6879-1369; Rincon, Gonzalo/0000-0002-6149-9103; Kokocinski, Felix/0000-0002-8472-9207; Anzola, Juan/0000-0003-2677-6731; Maqbool, Nauman/0000-0002-9404-3647; Wilming, Laurens/0000-0002-4154-7358; Amadio, Ariel Fernando/0000-0002-1147-4485; McKay, Stephanie/0000-0003-1434-3111; Moore, Stephen/0000-0002-9758-166X; Skow, Loren/0000-0001-8998-359X; Hagen, Darren/0000-0001-8295-020X; Carroll, Jeffery/0000-0002-0202-4888; Worley, Kim/0000-0002-0282-1000; Harrow, Jennifer/0000-0003-0338-3070; Reecy, James/0000-0003-4602-0990; Gilbert, James/0000-0001-8079-3159	National Human Genome Research Institute [U54 HG003273]; U.S. Department of Agriculture's Agricultural Research Service [59-0790-3-196]; Cooperative State Research, Education, and Extension Service National Research Initiative [2004-35216-14163]; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway; Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; ICREA Funding Source: Custom; BBSRC [BB/D524040/2] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, ZIAHG200323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/13446, BB/D524040/2, BBS/B/13438] Funding Source: researchfish	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agriculture's Agricultural Research Service; Cooperative State Research, Education, and Extension Service National Research Initiative; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway(Research Council of Norway); Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; ICREA(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the National Human Genome Research Institute (NHGRI U54 HG003273); the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS agreement no. 59-0790-3-196) and Cooperative State Research, Education, and Extension Service National Research Initiative (grant no. 2004-35216-14163); the state of Texas; Genome Canada through Genome British Columbia; the Alberta Science and Research Authority; the Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd., Dairy Insight, Inc., and AgResearch Ltd., all of New Zealand; the Research Council of Norway; the Kleberg Foundation; and the National, Texas, and South Dakota Beef Check-off Funds. The master accession for this WGS sequencing project is AAFC03000000. The individual WGS sequences are AAFC03000001 to AAFC03131728, and the scaffold records are CM000177 to CM000206 (chromosomes) and DS490632 to DS495890 (unplaced scaffolds).	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Clawson ML, 2004, MAMM GENOME, V15, P227, DOI 10.1007/s00335-003-2320-x; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; IRWIN DM, 1995, J MOL EVOL, V41, P299, DOI 10.1007/BF01215177; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kordis D, 1999, GENE, V238, P171, DOI 10.1016/S0378-1119(99)00260-7; Larson JH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-227; Larson JH, 2006, PHYSIOL GENOMICS, V25, P405, DOI 10.1152/physiolgenomics.00307.2005; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; Mayer B, 2005, J DAIRY RES, V72, P107, DOI 10.1017/S0022029905001135; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NEWBY TJ, 1982, VET IMMUNOL IMMUNOP, V3, P67, DOI 10.1016/0165-2427(82)90032-0; Nilsen H, 2008, ANIM GENET, V39, P97, DOI 10.1111/j.1365-2052.2007.01686.x; Prasad A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-310; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Roberts RM, 2008, SEMIN CELL DEV BIOL, V19, P170, DOI 10.1016/j.semcdb.2007.10.007; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHMIDHAUSER C, 1992, MOL BIOL CELL, V3, P699, DOI 10.1091/mbc.3.6.699; Scocchi M, 1997, FEBS LETT, V417, P311, DOI 10.1016/S0014-5793(97)01310-0; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; WILLHAM RL, 1986, J ANIM SCI, V62, P1742, DOI 10.2527/jas1986.6261742x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	28	854	1042	7	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					522	528		10.1126/science.1169588	http://dx.doi.org/10.1126/science.1169588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390049	Green Accepted			2022-12-24	WOS:000265411200050
J	Boller, T; He, SY				Boller, Thomas; He, Sheng Yang			Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens	SCIENCE			English	Editorial Material							ARABIDOPSIS; KINASE; BAK1; PERCEPTION; COMPLEX; FLG22	For many years, research on a suite of plant defense responses that begin when plants are exposed to general microbial elicitors was underappreciated, for a good reason: There has been no critical experimental demonstration of their importance in mediating plant resistance during pathogen infection. Today, these microbial elicitors are named pathogen-or microbe-associated molecular patterns (PAMPs or MAMPs) and the plant responses are known as PAMP-triggered immunity (PTI). Recent studies provide an elegant explanation for the difficulty of demonstrating the role of PTI in plant disease resistance. It turns out that the important contribution of PTI to disease resistance is masked by pathogen virulence effectors that have evolved to suppress it.	[Boller, Thomas] Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; [He, Sheng Yang] Michigan State Univ, Dept Plant Biol, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	University of Basel; Michigan State University	Boller, T (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	thomas.boller@unibas.ch; hes@msu.edu	poinssot, benoit/B-2569-2009; Boller, Thomas/G-3500-2012	poinssot, benoit/0000-0001-5890-4318; Boller, Thomas/0000-0001-6768-7503; He, Sheng Yang/0000-0003-1308-498X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060761, R01AI060761, R01 AI060761-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; *SWISS NAT SCI FDN, 31003A105852TB SWISS; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	23	644	712	15	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					742	744		10.1126/science.1171647	http://dx.doi.org/10.1126/science.1171647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423812	Green Accepted			2022-12-24	WOS:000265832400031
J	Yu, JY; Hu, KJ; Smuga-Otto, K; Tian, SL; Stewart, R; Slukvin, II; Thomson, JA				Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.			Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STABLE REPLICATION; INDUCTION; FIBROBLASTS; GENERATION; PLASMIDS; REPLICON	Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.	[Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Slukvin, Igor I.; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JY (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	jyyu2008@gmail.com; thomson@primate.wisc.edu	wang, baocheng/B-7805-2008; Hu, Kejin/AAQ-8862-2021	wang, baocheng/0000-0002-8236-8014; Hu, Kejin/0000-0003-3111-4054	Charlotte Geyer Foundation; NIH [P51 RR000167, P01 GM081629]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Charlotte Geyer Foundation and NIH (grants P51 RR000167 and P01 GM081629). We thank A. Griep, P. Powers, B. Sugden, M. Probasco, A. Elwell, C. Glennon, V. Ruotti, and D. J. Faupel for assistance and advice. The authors declare competing financial interests: J.A.T. is a founder, stock owner, consultant, and board member of Cellular Dynamics International (CDI). He also serves as a scientific adviser to and has financial interests in Tactics II Stem Cell Ventures. I.I.S. is a founder, stock owner, and consultant for CDI. The authors are filing a patent based on the results reported in this paper. Combination 6 and 19 episomal vectors are deposited in Addgene (Cambridge, MA), and vector-free human iPS cell subclones are deposited in the WiCell International Stem Cell (WISC) Bank (Madison, WI). Microarray data are deposited in the Gene Expression Omnibus (GEO) database (accession number GSE15148 [NCBI GEO] ).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	1612	1883	6	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					797	801		10.1126/science.1172482	http://dx.doi.org/10.1126/science.1172482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19325077	Green Accepted			2022-12-24	WOS:000265832400050
J	Andersen, ES; Dong, M; Nielsen, MM; Jahn, K; Subramani, R; Mamdouh, W; Golas, MM; Sander, B; Stark, H; Oliveira, CLP; Pedersen, JS; Birkedal, V; Besenbacher, F; Gothelf, KV; Kjems, J				Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Golas, Monika M.; Sander, Bjoern; Stark, Holger; Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Birkedal, Victoria; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen			Self-assembly of a nanoscale DNA box with a controllable lid	NATURE			English	Article							SMALL-ANGLE SCATTERING; NANOSTRUCTURES; JUNCTIONS; ALIGNMENT	The unique structural motifs and self-recognition properties of DNA can be exploited to generate self-assembling DNA nanostructures of specific shapes using a 'bottom-up' approach(1). Several assembly strategies have been developed for building complex three-dimensional (3D) DNA nanostructures(2-8). Recently, the DNA 'origami' method was used to build two-dimensional addressable DNA structures of arbitrary shape(9) that can be used as platforms to arrange nanomaterials with high precision and specificity(9-13). A long-term goal of this field has been to construct fully addressable 3D DNA nanostructures(14,15). Here we extend the DNA origami method into three dimensions by creating an addressable DNA box 42 x 36 x 36 nm(3) in size that can be opened in the presence of externally supplied DNA 'keys'. We thoroughly characterize the structure of this DNA box using cryogenic transmission electron microscopy, small-angle X-ray scattering and atomic force microscopy, and use fluorescence resonance energy transfer to optically monitor the opening of the lid. Controlled access to the interior compartment of this DNA nanocontainer could yield several interesting applications, for example as a logic sensor for multiple-sequence signals or for the controlled release of nanocargos.	[Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen] Aarhus Univ, Danish Natl Res Fdn, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark; [Andersen, Ebbe S.; Dong, Mingdong; Nielsen, Morten M.; Jahn, Kasper; Subramani, Ramesh; Mamdouh, Wael; Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Birkedal, Victoria; Besenbacher, Flemming; Gothelf, Kurt V.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Andersen, Ebbe S.; Nielsen, Morten M.; Jahn, Kasper; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Dong, Mingdong; Subramani, Ramesh; Mamdouh, Wael; Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark; [Golas, Monika M.] Aarhus Univ, Water & Salt Res Ctr, Inst Anat, DK-8000 Aarhus, Denmark; [Sander, Bjoern] Aarhus Univ, Stereol & EM Res Lab, DK-8000 Aarhus, Denmark; [Oliveira, Cristiano L. P.; Pedersen, Jan Skov; Gothelf, Kurt V.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Golas, Monika M.; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Stark, Holger] Univ Gottingen, Gottingen Ctr Mol Biol, D-37077 Gottingen, Germany	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Max Planck Society; University of Gottingen	Gothelf, KV (corresponding author), Aarhus Univ, Danish Natl Res Fdn, Ctr DNA Nanotechnol, DK-8000 Aarhus, Denmark.	kvg@chem.au.dk; jk@mb.au.dk	Subramani, Ramesh/A-9583-2010; Dong, Mingdong/AAC-3023-2020; Pedersen, Jan Skov/A-8346-2008; Birkedal, Victoria/C-8899-2015; Dong, Mingdong/B-3341-2010; Besenbacher, Flemming/A-9623-2010; dong, mingdong/AAK-9315-2020; Sander, Bjoern/AAO-9021-2021; Andersen, Ebbe S/O-3936-2014; Complexos, INCT Fluidos/H-9172-2013; Subramani, Ramesh/AAF-1337-2020; Oliveira, Cristiano L P/B-4403-2008; Kjems, Jorgen/I-3490-2016	Dong, Mingdong/0000-0002-2025-2171; Pedersen, Jan Skov/0000-0002-7768-0206; Birkedal, Victoria/0000-0002-1360-8870; Dong, Mingdong/0000-0002-2025-2171; Sander, Bjoern/0000-0001-8495-2321; Andersen, Ebbe S/0000-0002-6236-8164; Subramani, Ramesh/0000-0002-2153-5595; Oliveira, Cristiano L P/0000-0002-3426-6507; Kjems, Jorgen/0000-0003-4128-9317; Mamdouh, Wael/0000-0003-0642-1992; Nielsen, Morten/0000-0002-8972-7577; Holger, Stark/0000-0002-6161-1118	Danish National Research Foundation; Federal Ministry of Education and Research, Germany [0311899]; European Union	Danish National Research Foundation(Danmarks Grundforskningsfond); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	We thank R. Rosendahl Hansen and J. Kristensen for technical assistance. This work was supported by grants from the Danish National Research Foundation to the Centre for DNA Nanotechnology and the Danish Research Agency through support to the Interdisciplinary Nanoscience Center, by the Federal Ministry of Education and Research, Germany (0311899), and by the Sixth Framework Program of the European Union through the Integrated Project '3D Repertoire' (H. S.).	Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; PEDERSEN JS, 1990, J APPL CRYSTALLOGR, V23, P321, DOI 10.1107/S0021889890003946; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI 10.1016/j.jsb,2005.04.004; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Simmel FC, 2008, ANGEW CHEM INT EDIT, V47, P5884, DOI 10.1002/anie.200801982; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williams BAR, 2007, ANGEW CHEM INT EDIT, V46, P3051, DOI 10.1002/anie.200603919; Yang H, 2008, ANGEW CHEM INT EDIT, V47, P2443, DOI 10.1002/anie.200703741; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	1141	1189	32	1094	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					73	U75		10.1038/nature07971	http://dx.doi.org/10.1038/nature07971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19424153	Green Published			2022-12-24	WOS:000265801300031
J	Harmon, LJ; Matthews, B; Des Roches, S; Chase, JM; Shurin, JB; Schluter, D				Harmon, Luke J.; Matthews, Blake; Des Roches, Simone; Chase, Jonathan M.; Shurin, Jonathan B.; Schluter, Dolph			Evolutionary diversification in stickleback affects ecosystem functioning	NATURE			English	Article							DISSOLVED ORGANIC-MATTER; RAPID EVOLUTION; SYMPATRIC STICKLEBACKS; BIODIVERSITY; PREY; SPECIATION; PREDATORS; DIVERSITY; SELECTION; DYNAMICS	Explaining the ecological causes of evolutionary diversification is a major focus of biology, but surprisingly little has been said about the effects of evolutionary diversification on ecosystems(1-3). The number of species in an ecosystem and their traits are key predictors of many ecosystem-level processes, such as rates of productivity, biomass sequestration and decomposition(4,5). Here we demonstrate short-term ecosystem-level effects of adaptive radiation in the threespine stickleback (Gasterosteus aculeatus) over the past 10,000 years. These fish have undergone recent parallel diversification in several lakes in coastal British Columbia, resulting in the formation of two specialized species (benthic and limnetic) from a generalist ancestor(6). Using a mesocosm experiment, we demonstrate that this diversification has strong effects on ecosystems, affecting prey community structure, total primary production, and the nature of dissolved organic materials that regulate the spectral properties of light transmission in the system. However, these ecosystem effects do not simply increase in their relative strength with increasing specialization and species richness; instead, they reflect the complex and indirect consequences of ecosystem engineering by sticklebacks. It is well known that ecological factors influence adaptive radiation(7,8). We demonstrate that adaptive radiation, even over short timescales, can have profound effects on ecosystems.	[Harmon, Luke J.; Des Roches, Simone] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Matthews, Blake] EAWAG, CH-6047 Kastanienbaum, Switzerland; [Chase, Jonathan M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Idaho; University of Idaho; University of British Columbia; University of British Columbia; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Washington University (WUSTL)	Harmon, LJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	lukeh@uidaho.edu	Harmon, Luke/A-8225-2012; B, A/AHB-5155-2022; Matthews, Blake/B-5608-2009; Des Roches, Simone/A-4814-2011	Matthews, Blake/0000-0001-9089-704X; Des Roches, Simone/0000-0002-5360-8197; Shurin, Jonathan/0000-0001-7870-1972; Harmon, Luke/0000-0002-4985-5750; Schluter, Dolph/0000-0003-1683-7836				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Bell T, 2003, OECOLOGIA, V134, P578, DOI 10.1007/s00442-002-1135-x; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Ghan D, 1998, CAN J FISH AQUAT SCI, V55, P1350, DOI 10.1139/cjfas-55-6-1350; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grant P. R., 2008, WHY SPECIES MULTIPLY; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOSOS JB, 2009, PORTRAIT ADAPTIVE RA; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Obernosterer I, 2004, LIMNOL OCEANOGR, V49, P117, DOI 10.4319/lo.2004.49.1.0117; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pienitz R, 2000, NATURE, V404, P484, DOI 10.1038/35006616; Retamal L, 2007, ESTUAR COAST SHELF S, V72, P261, DOI 10.1016/j.ecss.2006.10.022; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Stibor H, 2004, ECOL LETT, V7, P321, DOI 10.1111/j.1461-0248.2004.00580.x; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	30	264	266	4	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1167	1170		10.1038/nature07974	http://dx.doi.org/10.1038/nature07974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339968				2022-12-24	WOS:000265754600047
J	Hothorn, M; Neumann, H; Lenherr, ED; Wehner, M; Rybin, V; Hassa, PO; Uttenweiler, A; Reinhardt, M; Schmidt, A; Seiler, J; Ladurner, AG; Herrmann, C; Scheffzek, K; Mayer, A				Hothorn, Michael; Neumann, Heinz; Lenherr, Esther D.; Wehner, Mark; Rybin, Vladimir; Hassa, Paul O.; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Seiler, Jeanette; Ladurner, Andreas G.; Herrmann, Christian; Scheffzek, Klaus; Mayer, Andreas			Catalytic Core of a Membrane-Associated Eukaryotic Polyphosphate Polymerase	SCIENCE			English	Article							INORGANIC POLYPHOSPHATE; MYCORRHIZAL SYMBIOSIS; VTC PROTEINS; V-ATPASE; POLY-P; YEAST; METABOLISM; PHOSPHATE; TRIPHOSPHATASE; INSIGHTS	Polyphosphate (polyP) occurs ubiquitously in cells, but its functions are poorly understood and its synthesis has only been characterized in bacteria. Using x-ray crystallography, we identified a eukaryotic polyphosphate polymerase within the membrane-integral vacuolar transporter chaperone (VTC) complex. A 2.6 angstrom crystal structure of the catalytic domain grown in the presence of adenosine triphosphate (ATP) reveals polyP winding through a tunnel-shaped pocket. Nucleotide-and phosphate-bound structures suggest that the enzyme functions by metal-assisted cleavage of the ATP gamma-phosphate, which is then in-line transferred to an acceptor phosphate to form polyP chains. Mutational analysis of the transmembrane domain indicates that VTC may integrate cytoplasmic polymer synthesis with polyP membrane translocation. Identification of the polyP-synthesizing enzyme opens the way to determine the functions of polyP in lower eukaryotes.	[Hothorn, Michael; Lenherr, Esther D.; Rybin, Vladimir; Hassa, Paul O.; Seiler, Jeanette; Ladurner, Andreas G.; Scheffzek, Klaus] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Hothorn, Michael] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Neumann, Heinz; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; [Wehner, Mark; Herrmann, Christian] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Mayer, Andreas] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	European Molecular Biology Laboratory (EMBL); Salk Institute; University of Lausanne; Ruhr University Bochum; Baylor College of Medicine	Scheffzek, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	scheffzek@embl.de	Neumann, Heinz/F-7875-2014; Hothorn, Michael/C-6807-2011; Neumann, Heinz/ABC-7323-2021; Mayer, Andreas/AAE-4315-2020	Neumann, Heinz/0000-0001-9657-1913; Mayer, Andreas/0000-0001-6131-313X; Ladurner, Andreas/0000-0003-3835-232X; Hothorn, Michael/0000-0002-3597-5698	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship; Boehringer Ingelheim Fonds; German Science Foundation; Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation; National Science Foundation [IOS-0649389]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); German Science Foundation(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	With the exception of the AppNHp-Mn2+ and PPi complexes (determined at the Salk Institute), all crystallographic work was carried out at the European Molecular Biology Laboratory. We thank J. Noel, T. Gibson, and T. A. Steitz for discussion and J. Chory for generous support. This work was funded by the Peter and Traudl Engelhorn Foundation (Penzberg, Germany) and a European Molecular Biology Organization long-term fellowship (M.H), the Boehringer Ingelheim Fonds (A.U.), the German Science Foundation and the Landesstiftung Baden-Wurttemberg (K.S.), the Swiss National Science Foundation (A.M, P.O.H), and the National Science Foundation (IOS-0649389 to J. Chory). We thank the staff at the European Synchrotron Radiation Facility, Grenoble, France, at the Deutsches Elektronen Synchrotron, Hamburg, Germany, and at the Advanced Light Source, Berkeley, for technical support; and C. Muller and S. Cusack for sharing beam time. Coordinates and structure factors for Vtc2p183-553 (PDB-ID 3g3o), Vtc4p*-polyP (3g3q), Vtc4p*-AppNHp-Mn2+ (3g3r), Vtc4p*-Pi (3g3t), and Vtc4p*- PPi (3g3u) have been deposited with the Protein DataBank (www.rcsb.org).	AHN KH, 1990, J BIOL CHEM, V265, P11734; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Murray JM, 2000, GENETICS, V154, P155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Werner TP, 2007, FUNGAL GENET BIOL, V44, P845, DOI 10.1016/j.fgb.2007.01.008; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102	22	193	199	5	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					513	516		10.1126/science.1168120	http://dx.doi.org/10.1126/science.1168120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390046				2022-12-24	WOS:000265411200047
J	Caggiano, V; Fogassi, L; Rizzolatti, G; Thier, P; Casile, A				Caggiano, Vittorio; Fogassi, Leonardo; Rizzolatti, Giacomo; Thier, Peter; Casile, Antonino			Mirror Neurons Differentially Encode the Peripersonal and Extrapersonal Space of Monkeys	SCIENCE			English	Article							PREMOTOR CORTEX; BODY SCHEMA; AREA-6	Actions performed by others may have different relevance for the observer, and thus lead to different behavioral responses, depending on the regions of space in which they are executed. We found that in rhesus monkeys, the premotor cortex neurons activated by both the execution and the observation of motor acts (mirror neurons) are differentially modulated by the location in space of the observed motor acts relative to the monkey, with about half of them preferring either the monkey's peripersonal or extrapersonal space. A portion of these spatially selective mirror neurons encode space according to a metric representation, whereas other neurons encode space in operational terms, changing their properties according to the possibility that the monkey will interact with the object. These results suggest that a set of mirror neurons encodes the observed motor acts not only for action understanding, but also to analyze such acts in terms of features that are relevant to generating appropriate behaviors.	[Caggiano, Vittorio; Thier, Peter; Casile, Antonino] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; [Fogassi, Leonardo] Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Ist Italiano Tecnol, I-43100 Parma, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Casile, A (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany.	antonino.casile@uni-tuebingen.de	Caggiano, Vittorio/E-5623-2012; FOGASSI, Leonardo/K-3541-2018	Caggiano, Vittorio/0000-0002-2186-1550; FOGASSI, Leonardo/0000-0003-3348-039X; Thier, Peter/0000-0001-5909-4222	Deutsche Forschungsgemeinschaft [SFB550-C10]; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hermann and Lilly Schilling Foundation	We thank P. Dicke for many decisive technical contributions, two anonymous reviewers for helpful comments, and M. Giese for stimulating discussions. Supported by Deutsche Forschungsgemeinschaft grant SFB550-C10 and by the Hermann and Lilly Schilling Foundation.	Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Iriki A, 1996, NEUROREPORT, V7, P2325; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1983, BRAIN, V106, P655, DOI 10.1093/brain/106.3.655; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0	10	190	195	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					403	406		10.1126/science.1166818	http://dx.doi.org/10.1126/science.1166818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372433				2022-12-24	WOS:000265221600047
J	Solovei, I; Kreysing, M; Lanctot, C; Kosem, S; Peichl, L; Cremer, T; Guck, J; Joffe, B				Solovei, Irina; Kreysing, Moritz; Lanctot, Christian; Koesem, Sueleyman; Peichl, Leo; Cremer, Thomas; Guck, Jochen; Joffe, Boris			Nuclear Architecture of Rod Photoreceptor Cells Adapts to Vision in Mammalian Evolution	CELL			English	Article							CHROMOSOME TERRITORIES; GENE-EXPRESSION; MOUSE RETINA; INACTIVE-X; ORGANIZATION; GENOME; LOCUS; TRANSCRIPTION; REPRESSION; LAMINA	We show that the nuclear architecture of rod photoreceptor cells differs fundamentally in nocturnal and diurnal mammals. The rods of diurnal retinas possess the conventional architecture found in nearly all eukaryotic cells, with most heterochromatin situated at the nuclear periphery and euchromatin residing toward the nuclear interior. The rods of nocturnal retinas have a unique inverted pattern, where heterochromatin localizes in the nuclear center, whereas euchromatin, as well as nascent transcripts and splicing machinery, line the nuclear border. The inverted pattern forms by remodeling of the conventional one during terminal differentiation of rods. The inverted rod nuclei act as collecting lenses, and computer simulations indicate that columns of such nuclei channel light efficiently toward the light-sensing rod outer segments. Comparison of the two patterns suggests that the conventional architecture prevails in eukaryotic nuclei because it results in more flexible chromosome arrangements, facilitating positional regulation of nuclear functions.	[Kreysing, Moritz; Guck, Jochen] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [Solovei, Irina; Lanctot, Christian; Koesem, Sueleyman; Cremer, Thomas; Joffe, Boris] Univ Munich, Div Anthropol & Human Genet, Bioctr, D-82152 Planegg Martinsried, Germany; [Peichl, Leo] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; [Cremer, Thomas] CiPSM, D-81377 Munich, Germany	University of Cambridge; University of Munich; Max Planck Society	Guck, J (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	jg473@cam.ac.uk; boris.joffe@lrz.uni-muenchen.de	Kreysing, Moritz/B-3751-2017; Guck, Jochen/B-4412-2014; Cremer, Thomas/D-7979-2011; Solovei, Irina/K-1191-2014	Kreysing, Moritz/0000-0001-7432-3871; Guck, Jochen/0000-0002-1453-6119; Cremer, Thomas/0000-0002-1830-9589; Cremer, Thomas/0000-0001-7135-7216; Lanctot, Christian/0000-0003-3211-3061; Peichl, Leo/0000-0002-8141-0911; Solovei, Irina/0000-0002-6813-7279	Deutsche Forschungsgemeinschaft [Cr59/ 20]; Bundesministerium fur Bildung und Forschung NGFN II-EP [0213377A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung NGFN II-EP	We thank A. H. F. M. Peters (FMI for Biomedical Research, Basel) for antibodies against H3K9me3 and H4K20me3, M. Hess (University of Munich) for initial help with mouse retina, S. Heynck (MPI for Brain Research, Frankfurt) for perfect sectioning, all colleagues who kindly supplied us mammal retina material (see Table S2), S. Haverkamp (MPI for Brain Research) for a TEM image of mouse rod perykarion, B. Amos (MRC LMB, Cambridge, UK) for help with the Jamin-Lebedev microscope, and M. Gerard (Abattoir Haverhill) for the provision of pig eyes. We are grateful to D. Sheer (Queen Mary's School of Medicine and Dentistry, London), A. Reichenbach (University of Leipzig), W. Stephan (University of Munich), and T. D. Lamb (Australian National University, Canberra) for reading of the manuscript and/or critical comments. The study was supported by Deutsche Forschungsgemeinschaft grant Cr59/ 20 and Bundesministerium fur Bildung und Forschung NGFN II-EP grant 0213377A to T. C., fellowships from the Instituts de recherche en sante du Canada and the Humboldt Stiftung to C. L., and Engineering and Physical Sciences Research Council and Cambridge European Trust scholarships to M. K.	Acosta ML, 2008, J COMP NEUROL, V506, P506, DOI 10.1002/cne.21561; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cremer Marion, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4723; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Farjadpour A, 2006, OPT LETT, V31, P2972, DOI 10.1364/OL.31.002972; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Knabe W, 1997, VISION RES, V37, P267, DOI 10.1016/S0042-6989(96)00199-X; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Postberg J, 2005, J CELL SCI, V118, P3973, DOI 10.1242/jcs.02497; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; Ronneberger O, 2008, CHROMOSOME RES, V16, P523, DOI 10.1007/s10577-008-1236-4; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; SOLOVEI I, 2007, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PR0T4729; Sterling P, 2003, VISUAL NEUROSCIENCES, V1, P234; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMS RW, 2003, VISUAL NEUROSCIENCES, P65; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	44	513	533	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					356	368		10.1016/j.cell.2009.01.052	http://dx.doi.org/10.1016/j.cell.2009.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379699	Bronze			2022-12-24	WOS:000265456800027
J	Gilestro, GF; Tononi, G; Cirelli, C				Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara			Widespread Changes in Synaptic Markers as a Function of Sleep and Wakefulness in Drosophila	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; DEPENDENT PLASTICITY; PROTEIN; POTENTIATION; WAKING; NEED; DLG	Sleep is universal, strictly regulated, and necessary for cognition. Why this is so remains a mystery, although recent work suggests that sleep, memory, and plasticity are linked. However, little is known about how wakefulness and sleep affect synapses. Using Western blots and confocal microscopy in Drosophila, we found that protein levels of key components of central synapses were high after waking and low after sleep. These changes were related to behavioral state rather than time of day and occurred in all major areas of the Drosophila brain. The decrease of synaptic markers during sleep was progressive, and sleep was necessary for their decline. Thus, sleep may be involved in maintaining synaptic homeostasis altered by waking activities.	[Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu; ccirelli@wisc.edu	Tononi, Giulio/B-8387-2009; Gilestro, Giorgio/A-8721-2010	Gilestro, Giorgio/0000-0001-7512-8541	National Institute of General Medical Sciences [R01 GM075315]; NIH Director's Pioneer award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Director's Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Authors' contributions: G.F.G. performed the experiments; G.F.G., G.T., and C.C. designed the experiments; G.T. and C.C. conceived and coordinated the project. All authors wrote the manuscript and read and approved the final version. We thank D. Paasch, D. Denucci, and M. Uy for technical assistance with fly work; M. Pfister-Genskow for help with Western blot analysis; L. Rodenkirch and the UW Keck Laboratory for Biological Imaging for assistance in confocal microscopy; and D. Bushey for discussion and comments on the manuscript. Supported by National Institute of General Medical Sciences grant R01 GM075315 (C.C.) and an NIH Director's Pioneer award (G.T.).	Albornoz V, 2008, GENE EXPR PATTERNS, V8, P443, DOI 10.1016/j.gep.2008.04.001; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Kazama H, 2007, NEUROSCIENCE, V145, P1007, DOI 10.1016/j.neuroscience.2006.12.066; Klagges BRE, 1996, J NEUROSCI, V16, P3154; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	28	232	235	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					109	112		10.1126/science.1166673	http://dx.doi.org/10.1126/science.1166673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342593	Green Accepted			2022-12-24	WOS:000264802100044
J	Garten, RJ; Davis, CT; Russell, CA; Shu, B; Lindstrom, S; Balish, A; Sessions, WM; Xu, XY; Skepner, E; Deyde, V; Okomo-Adhiambo, M; Gubareva, L; Barnes, J; Smith, CB; Emery, SL; Hillman, MJ; Rivailler, P; Smagala, J; de Graaf, M; Burke, DF; Fouchier, RAM; Pappas, C; Alpuche-Aranda, CM; Lopez-Gatell, H; Olivera, H; Lopez, I; Myers, CA; Faix, D; Blair, PJ; Yu, C; Keene, KM; Dotson, PD; Boxrud, D; Sambol, AR; Abid, SH; George, KS; Bannerman, T; Moore, AL; Stringer, DJ; Blevins, P; Demmler-Harrison, GJ; Ginsberg, M; Kriner, P; Waterman, S; Smole, S; Guevara, HF; Belongia, EA; Clark, PA; Beatrice, ST; Donis, R; Katz, J; Finelli, L; Bridges, CB; Shaw, M; Jernigan, DB; Uyeki, TM; Smith, DJ; Klimov, AI; Cox, NJ				Garten, Rebecca J.; Davis, C. Todd; Russell, Colin A.; Shu, Bo; Lindstrom, Stephen; Balish, Amanda; Sessions, Wendy M.; Xu, Xiyan; Skepner, Eugene; Deyde, Varough; Okomo-Adhiambo, Margaret; Gubareva, Larisa; Barnes, John; Smith, Catherine B.; Emery, Shannon L.; Hillman, Michael J.; Rivailler, Pierre; Smagala, James; de Graaf, Miranda; Burke, David F.; Fouchier, Ron A. M.; Pappas, Claudia; Alpuche-Aranda, Celia M.; Lopez-Gatell, Hugo; Olivera, Hiram; Lopez, Irma; Myers, Christopher A.; Faix, Dennis; Blair, Patrick J.; Yu, Cindy; Keene, Kimberly M.; Dotson, P. David, Jr.; Boxrud, David; Sambol, Anthony R.; Abid, Syed H.; George, Kirsten St.; Bannerman, Tammy; Moore, Amanda L.; Stringer, David J.; Blevins, Patricia; Demmler-Harrison, Gail J.; Ginsberg, Michele; Kriner, Paula; Waterman, Steve; Smole, Sandra; Guevara, Hugo F.; Belongia, Edward A.; Clark, Patricia A.; Beatrice, Sara T.; Donis, Ruben; Katz, Jacqueline; Finelli, Lyn; Bridges, Carolyn B.; Shaw, Michael; Jernigan, Daniel B.; Uyeki, Timothy M.; Smith, Derek J.; Klimov, Alexander I.; Cox, Nancy J.			Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans	SCIENCE			English	Article							A VIRUS; PHYLOGENETIC ANALYSIS; UNITED-STATES; NORTH-AMERICA; EVOLUTION; PIGS; PATHOGENICITY; TRANSMISSION; EMERGENCE; INFECTION	Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages has continued to circulate in humans. The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period. Its low genetic diversity suggests that the introduction into humans was a single event or multiple events of similar viruses. Molecular markers predictive of adaptation to humans are not currently present in 2009 A(H1N1) viruses, suggesting that previously unrecognized molecular determinants could be responsible for the transmission among humans. Antigenically the viruses are homogeneous and similar to North American swine A(H1N1) viruses but distinct from seasonal human A(H1N1).	[Russell, Colin A.; Skepner, Eugene; de Graaf, Miranda; Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Garten, Rebecca J.; Davis, C. Todd; Shu, Bo; Lindstrom, Stephen; Balish, Amanda; Sessions, Wendy M.; Xu, Xiyan; Skepner, Eugene; Deyde, Varough; Okomo-Adhiambo, Margaret; Gubareva, Larisa; Barnes, John; Smith, Catherine B.; Emery, Shannon L.; Hillman, Michael J.; Rivailler, Pierre; Smagala, James; Pappas, Claudia; Guevara, Hugo F.; Belongia, Edward A.; Clark, Patricia A.; Beatrice, Sara T.; Donis, Ruben; Katz, Jacqueline; Finelli, Lyn; Bridges, Carolyn B.; Shaw, Michael; Jernigan, Daniel B.; Uyeki, Timothy M.; Klimov, Alexander I.; Cox, Nancy J.] Ctr Dis Control & Prevent CDC, WHO, Collaborating Ctr Influenza, Atlanta, GA 30333 USA; [Russell, Colin A.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [de Graaf, Miranda; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands; [Alpuche-Aranda, Celia M.; Lopez-Gatell, Hugo; Olivera, Hiram; Lopez, Irma] InDRE Prolongac Carpio, Mexico City 11340, DF, Mexico; [Myers, Christopher A.; Faix, Dennis; Blair, Patrick J.] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [Yu, Cindy] Arizona State Publ Hlth Lab, Phoenix, AZ 85007 USA; [Keene, Kimberly M.] Colorado Dept Publ Hlth & Environm, Denver, CO 80230 USA; [Dotson, P. David, Jr.] Indiana State Dept Hlth Labs, Indianapolis, IN 46202 USA; [Boxrud, David] Minnesota Dept Hlth, Publ Hlth Lab, St Paul, MN 55164 USA; [Sambol, Anthony R.] Nebraska Publ Hlth Lab, Omaha, NE 68198 USA; [Abid, Syed H.] Westchester Cty Dept Labs & Res Publ Hlth Labs, Valhalla, NY 10595 USA; [George, Kirsten St.] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA; [Bannerman, Tammy] Ohio Dept Hlth Lab, Reynoldsburg, OH USA; [Moore, Amanda L.] S Carolina Dept Hlth & Environm Control, Columbia, SC 29223 USA; [Stringer, David J.] Dallas Cty Hlth & Human Serv, Dallas, TX 75207 USA; [Blevins, Patricia] San Antonio Metro Hlth Dist, Brooks City Base, TX 78235 USA; [Demmler-Harrison, Gail J.] Texas Childrens Hosp, Diagnost Virol Lab, Houston, TX 77030 USA; [Ginsberg, Michele] San Diego Publ Hlth Lab, San Diego, CA 92186 USA; [Kriner, Paula] Imperial Cty Publ Hlth Dept, El Centro, CA 92243 USA; [Waterman, Steve] CDC, Border Infect Dis Surveillance Project, Atlanta, GA 30333 USA; [Smole, Sandra] Massachusetts Dept Publ Hlth, William A Hinton State Lab Inst, Jamaica Plain, MA 02130 USA; [Guevara, Hugo F.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA; [Belongia, Edward A.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Clark, Patricia A.] Michigan Dept Community Hlth, Lansing, MI 48906 USA; [Beatrice, Sara T.] NYU, Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY 10016 USA	University of Cambridge; Centers for Disease Control & Prevention - USA; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); Wadsworth Center; Baylor College of Medicine; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health; California Department of Public Health; Marshfield Clinic; MDHHS - Michigan Department of Health & Human Services; New York University	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk; njc1@cdc.gov	de Graaf, Miranda/AFM-6878-2022; Bannerman, Tammy/E-2694-2011; Burke, David F/C-2091-2013; Russell, Colin/ABE-7106-2020; Fouchier, Ron A/A-1911-2014; Finelli, Lyn/AAK-2360-2020; Smith, Derek/Z-3075-2019; de Graaf, Miranda/K-1262-2018	de Graaf, Miranda/0000-0002-7831-0098; Burke, David F/0000-0001-8830-3951; Fouchier, Ron A/0000-0001-8095-2869; Smith, Derek/0000-0002-2393-1890; de Graaf, Miranda/0000-0002-7831-0098; Russell, Colin/0000-0002-2113-162X; Okomo-Adhiambo, Margaret/0000-0003-0415-8916; Belongia, Edward/0000-0001-7478-0415; Barnes, John/0000-0002-5874-4411	National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; International Federation of Pharmaceutical Manufacturers and Associations [RG51953]; Research Fellowship from Clare College, Cambridge; NIH [DP1-OD000490-01]; European Union [223498 EMPERIE]; Human Frontier Science Program [RG P0050/2008]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Federation of Pharmaceutical Manufacturers and Associations; Research Fellowship from Clare College, Cambridge; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontier Science Program(Human Frontier Science Program); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the many individuals at the local, state, and national levels for their enormous contributions to the surveillance of the 2009 A(H1N1) virus; the entire CDC Influenza Division staff and emergency staff; the maintainers of the GISAID EpiFluDB and NCBI GenBank/IVR, and the members of the WHO Global Influenza Surveillance Network. The findings and conclusions of this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. R.A.M.F. was supported by National Institute of Allergy and Infectious Diseases under NIH contract HHSN266200700010C. E.S. was supported in part by the International Federation of Pharmaceutical Manufacturers and Associations through grant RG51953. C.A.R. was supported in part by a Research Fellowship from Clare College, Cambridge. D.J.S., C.A.R., E.S., and D.F.B. were supported by an NIH Directors Pioneer Award, part of the NIH roadmap for medical research, through grant DP1-OD000490-01, an FP7 grant, 223498 EMPERIE, from the European Union, and program grant RG P0050/2008 from the Human Frontier Science Program. GenBank accession numbers are listed in the Supporting Online Material	[Anonymous], MMWR MORB MORTAL WKL; *CDC, H1N1 FLU SWIN FLU; Chen Yixiang, 2008, Weishengwu Xuebao, V48, P466; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Gregory V, 2001, J GEN VIROL, V82, P1397, DOI 10.1099/0022-1317-82-6-1397; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KENDAL AP, 1977, J INFECT DIS, V136, pS381, DOI 10.1093/infdis/136.Supplement_3.S381; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Lee CS, 2008, VIRUS GENES, V37, P168, DOI 10.1007/s11262-008-0251-z; Maldonado J, 2006, VET J, V172, P377, DOI 10.1016/j.tvjl.2005.04.014; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SHEERAR MG, 1989, J GEN VIROL, V70, P3297, DOI 10.1099/0022-1317-70-12-3297; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Song DS, 2007, VIRUS RES, V125, P98, DOI 10.1016/j.virusres.2006.11.008; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Swofford D. L., 2003, PAUP; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Vincent AL, 2006, VET MICROBIOL, V118, P212, DOI 10.1016/j.vetmic.2006.07.017; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, INFL H1N1; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999; 2009, MMWR MORB MORTAL WKL, V58, P453; 2009, MMWR MORB MORTAL WKL, V58, P433	38	1824	1980	15	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 10	2009	325	5937					197	201		10.1126/science.1176225	http://dx.doi.org/10.1126/science.1176225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	468FK	19465683	Green Accepted			2022-12-24	WOS:000267802000046
J	Monecke, T; Guttler, T; Neumann, P; Dickmanns, A; Gorlich, D; Ficner, R				Monecke, Thomas; Guettler, Thomas; Neumann, Piotr; Dickmanns, Achim; Goerlich, Dirk; Ficner, Ralf			Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP	SCIENCE			English	Article							IMPORTIN-BETA; RIBOSOMAL-SUBUNITS; TRANSPORT; CYTOPLASM; BINDING; DOMAIN; ALPHA; IDENTIFICATION; RECOGNITION; PROTEINS	CRM1 mediates nuclear export of numerous unrelated cargoes, which may carry a short leucine-rich nuclear export signal or export signatures that include folded domains. How CRM1 recognizes such a variety of cargoes has been unknown up to this point. Here we present the crystal structure of the SPN1.CRM1.RanGTP export complex at 2.5 angstrom resolution (where SPN1 is snurportin1 and RanGTP is guanosine 5' triphosphate-bound Ran). SPN1 is a nuclear import adapter for cytoplasmically assembled, m(3)G-capped spliceosomal U snRNPs (small nuclear ribonucleoproteins). The structure shows how CRM1 can specifically return the cargo-free form of SPN1 to the cytoplasm. The extensive contact area includes five hydrophobic residues at the SPN1 amino terminus that dock into a hydrophobic cleft of CRM1, as well as numerous hydrophilic contacts of CRM1 to m3G cap-binding domain and carboxyl-terminal residues of SPN1. The structure suggests that RanGTP promotes cargo-binding to CRM1 solely through long-range conformational changes in the exportin.	[Guettler, Thomas; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany; [Monecke, Thomas; Neumann, Piotr; Dickmanns, Achim; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, GZMB, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Güttler, Thomas/O-4851-2016; Görlich, Dirk/B-8296-2017	Güttler, Thomas/0000-0002-1456-7310; Görlich, Dirk/0000-0002-4343-5210	Deutsche Forschungsgemeinschaft [SFB523]; Max-Planck-Gesellschaft; Alfried Krupp-Foundation; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society); Alfried Krupp-Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank the staff of synchrotron beamlines at BESSY (Berlin), the European Molecular Biology Laboratory/Deutsches Elektronen-Synchrotron (Hamburg), and the European Synchotron Radiation Facility (Grenoble) for assistance during data collection; D. Deichsel for excellent technical help; and S. Frey and S. Guttler for comments on the manuscript. We received funding from the Deutsche Forschungsgemeinschaft (grant SFB523 to R.F. and T.M.), the Max-Planck-Gesellschaft (to D.G. and T.G.), the Alfried Krupp-Foundation (to D.G. and T.G.), and the Boehringer Ingelheim Fonds (to T.G.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession code 3GJX.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Moy TI, 2002, J CELL SCI, V115, P2985; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065	33	164	176	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1087	1091		10.1126/science.1173388	http://dx.doi.org/10.1126/science.1173388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389996				2022-12-24	WOS:000266246700046
J	Hubner, W; McNerney, GP; Chen, P; Dale, BM; Gordon, RE; Chuang, FYS; Li, XD; Asmuth, DM; Huser, T; Chen, BK				Huebner, Wolfgang; McNerney, Gregory P.; Chen, Ping; Dale, Benjamin M.; Gordon, Ronald E.; Chuang, Frank Y. S.; Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas; Chen, Benjamin K.			Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CYTOPLASMIC TAIL; LYMPHOCYTES; FUSION; SPREAD; ENTRY; CYTOSKELETON; REPLICATION; ENDOCYTOSIS; INFECTION	The spread of HIV between immune cells is greatly enhanced by cell-cell adhesions called virological synapses, although the underlying mechanisms have been unclear. With use of an infectious, fluorescent clone of HIV, we tracked the movement of Gag in live CD4 T cells and captured the direct translocation of HIV across the virological synapse. Quantitative, high-speed three-dimensional (3D) video microscopy revealed the rapid formation of micrometer-sized "buttons" containing oligomerized viral Gag protein. Electron microscopy showed that these buttons were packed with budding viral crescents. Viral transfer events were observed to form virus-laden internal compartments within target cells. Continuous time-lapse monitoring showed preferential infection through synapses. Thus, HIV dissemination may be enhanced by virological synapse-mediated cell adhesion coupled to viral endocytosis.	[Huebner, Wolfgang; Chen, Ping; Dale, Benjamin M.; Chen, Benjamin K.] Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA; [Gordon, Ronald E.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [McNerney, Gregory P.; Chuang, Frank Y. S.; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Science Foundation (NSF); University of California System; University of California Davis; University of California System; University of California Davis	Chen, BK (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA.	ben.chen@mssm.edu	Huser, Thomas/K-7291-2019; Hubner, Wolfgang/O-7907-2016	Huser, Thomas/0000-0003-2348-7416; Chen, Benjamin K/0000-0002-5404-1997; Asmuth, David/0000-0003-0916-7950; Hubner, Wolfgang/0000-0002-1128-6468	NIH [AI074420-02]; Burroughs Wellcome Fund Investigator Award; Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility [NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, NIH-S10RR09145-01]; NSF Center for Biophotonics Science and Technology [PHY012099]; UCD Health System Research Award; UCD Clinical and Translational Science Center [NIH-NCRR ULRR024146]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator Award(Burroughs Wellcome Fund); Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility; NSF Center for Biophotonics Science and Technology; UCD Health System Research Award; UCD Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. H. Cheng, V. Simon, M. Klotman, R. Iyengar, and A. Del Portillo for critiques and discussions; R. Huq for microscopy support; S. Izadmehr for image analysis; M. Grisotto and V. Sahi for cell sorting; H. Bell for electron microscopy support; and S. Lira for imaging support. Work was supported by NIH grant AI074420-02, Burroughs Wellcome Fund Investigator Award, and Hirschl Weill Caulier Career Scientist Award to B.K.C. Imaging was supported by Mount Sinai School of Medicine Microscopy Shared Resource Facility grants NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, and NIH-S10RR09145-01; by the NSF Center for Biophotonics Science and Technology (cooperative agreement PHY012099); a UCD Health System Research Award to T.H.; and the UCD Clinical and Translational Science Center grant NIH-NCRR ULRR024146 (T.H. and D.M.A.).	Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005	26	359	363	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1743	1747		10.1126/science.1167525	http://dx.doi.org/10.1126/science.1167525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325119	Green Accepted			2022-12-24	WOS:000264559800044
J	Glessner, JT; Wang, K; Cai, GQ; Korvatska, O; Kim, CE; Wood, S; Zhang, HT; Estes, A; Brune, CW; Bradfield, JP; Imielinski, M; Frackelton, EC; Reichert, J; Crawford, EL; Munson, J; Sleiman, PMA; Chiavacci, R; Annaiah, K; Thomas, K; Hou, CP; Glaberson, W; Flory, J; Otieno, F; Garris, M; Soorya, L; Klei, L; Piven, J; Meyer, KJ; Anagnostou, E; Sakurai, T; Game, RM; Rudd, DS; Zurawiecki, D; McDougle, CJ; Davis, LK; Miller, J; Posey, DJ; Michaels, S; Kolevzon, A; Silverman, JM; Bernier, R; Levy, SE; Schultz, RT; Dawson, G; Owley, T; McMahon, WM; Wassink, TH; Sweeney, JA; Nurnberger, JI; Coon, H; Sutcliffe, JS; Minshew, NJ; Grant, SFA; Bucan, M; Cook, EH; Buxbaum, JD; Devlin, B; Schellenberg, GD; Hakonarson, H				Glessner, Joseph T.; Wang, Kai; Cai, Guiqing; Korvatska, Olena; Kim, Cecilia E.; Wood, Shawn; Zhang, Haitao; Estes, Annette; Brune, Camille W.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Reichert, Jennifer; Crawford, Emily L.; Munson, Jeffrey; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Soorya, Latha; Klei, Lambertus; Piven, Joseph; Meyer, Kacie J.; Anagnostou, Evdokia; Sakurai, Takeshi; Game, Rachel M.; Rudd, Danielle S.; Zurawiecki, Danielle; McDougle, Christopher J.; Davis, Lea K.; Miller, Judith; Posey, David J.; Michaels, Shana; Kolevzon, Alexander; Silverman, Jeremy M.; Bernier, Raphael; Levy, Susan E.; Schultz, Robert T.; Dawson, Geraldine; Owley, Thomas; McMahon, William M.; Wassink, Thomas H.; Sweeney, John A.; Nurnberger, John I., Jr.; Coon, Hilary; Sutcliffe, James S.; Minshew, Nancy J.; Grant, Struan F. A.; Bucan, Maja; Cook, Edwin H., Jr.; Buxbaum, Joseph D.; Devlin, Bernie; Schellenberg, Gerard D.; Hakonarson, Hakon			Autism genome-wide copy number variation reveals ubiquitin and neuronal genes	NATURE			English	Article							SPECTRUM DISORDER; SUSCEPTIBILITY GENE; MUTATIONS; ASSOCIATION; NEUROLIGINS; MIGRATION; LINKAGE	Autism spectrum disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins(1-4). Previous studies focusing on candidate genes or genomic regions have identified several copy number variations (CNVs) that are associated with an increased risk of ASDs(5-9). Here we present the results from a whole-genome CNV study on a cohort of 859 ASD cases and 1,409 healthy children of European ancestry who were genotyped with similar to 550,000 single nucleotide polymorphism markers, in an attempt to comprehensively identify CNVs conferring susceptibility to ASDs. Positive findings were evaluated in an independent cohort of 1,336 ASD cases and 1,110 controls of European ancestry. Besides previously reported ASD candidate genes, such as NRXN1 (ref. 10) and CNTN4 (refs 11, 12), several new susceptibility genes encoding neuronal cell-adhesion molecules, including NLGN1 and ASTN2, were enriched with CNVs in ASD cases compared to controls (P = 9.5 x 10(-3)). Furthermore, CNVs within or surrounding genes involved in the ubiquitin pathways, including UBE3A, PARK2, RFWD2 and FBXO40, were affected by CNVs not observed in controls (P = 3.3 x 10(-3)). We also identified duplications 55 kilobases upstream of complementary DNA AK123120 (P = 3.6 x 10(-6)). Although these variants may be individually rare, they target genes involved in neuronal cell-adhesion or ubiquitin degradation, indicating that these two important gene networks expressed within the central nervous system may contribute to the genetic susceptibility of ASD.	[Glessner, Joseph T.; Wang, Kai; Kim, Cecilia E.; Zhang, Haitao; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Cai, Guiqing; Reichert, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Sakurai, Takeshi; Zurawiecki, Danielle; Kolevzon, Alexander; Silverman, Jeremy M.; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena; Estes, Annette; Munson, Jeffrey; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Seattle, WA 98105 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37235 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37235 USA; [Piven, Joseph] Univ N Carolina, Neurodev Disorders Res Ctr, Greensboro, NC 27412 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Greensboro, NC 27412 USA; [Meyer, Kacie J.; Rudd, Danielle S.; Davis, Lea K.; Wassink, Thomas H.] Univ Iowa, Iowa City, IA 52242 USA; [Miller, Judith; McMahon, William M.; Coon, Hilary] Univ Utah, Salt Lake City, UT 84112 USA; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Indianapolis, IN 46202 USA; [Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Bucan, Maja] Univ Penn, Sch Med, Dept Genet Biol & Biostat, Philadelphia, PA 19104 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Iowa; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	gerardsc@mail.med.upenn.edu; hakonarson@chop.edu	Sutcliffe, James S/C-1348-2012; Silverman, Jeremy M./AAO-4268-2020; Buxbaum, Joseph D/G-6001-2010	Sutcliffe, James S/0000-0001-5200-6007; Sweeney, John/0000-0003-1752-2828; Estes, Annette/0000-0003-2687-4155; Buxbaum, Joseph/0000-0001-8898-8313; Glessner, Joseph/0000-0001-5131-2811; Wassink, Thomas/0000-0002-0952-8333; Nurnberger, John/0000-0002-7674-1767; Munson, Jeffrey A/0000-0003-1798-8927; Grant, Struan/0000-0003-2025-5302; Dawson, Geraldine/0000-0003-1410-2764	Children's Hospital of Philadelphia, Autism Speaks; NICHD [HD35476]; National Institute of Mental Health [1U24MH081810]; Margaret Q. Landenberger Foundation [UL1-RR024134-03]; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; National Institute of Health [HD055782-01]; Utah Autism Foundation [MH0666730, MH061009, NS049261, HD055751, U10MH66766-02S1, MH69359, M01-RR00064]; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK); Health Research Board (Ireland);  [MH64547]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, U19HD035476, P01HD035476, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069359, R01MH064547, U24MH081810, R01MH061009, U54MH066673, R01MH057881, U10MH066766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049261] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia, Autism Speaks; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Margaret Q. Landenberger Foundation; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Utah Autism Foundation; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Board (Ireland); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the ASD children and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia for genetic research purposes. We thank the technical staff in the Center for Applied Genomics, Children's Hospital of Philadelphia for generating the genotypes used in this study. We thank S. Diskin for her contribution to the discussion on the effect of wave artifacts on CNV calling. We also thank S. Kristinsson, L. A. Hermannsson and A. Krisbjornsson for their software design and contribution. This research was financially supported by The Children's Hospital of Philadelphia, Autism Speaks, and NICHD (HD35476). We also gratefully acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). The AGRE data set was genotyped by the Center for Applied Genomics at the Children's Hospital of Philadelphia, which funded all genotyping for this study, and the complete sets of genotyping data have been released to the public domain. AGRE-approved academic researchers can acquire the data sets from AGRE (http://www.agre.org). The study is supported in part by Research Award from the Margaret Q. Landenberger Foundation (H. H.), UL1-RR024134-03 (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), and National Institute of Health grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), U10MH66766-02S1 (C. J. M.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller, and W. M. M.). All genotyping for this study was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) from the Children's Hospital of Philadelphia. We acknowledge the Autism Genome Project Consortium (J. P., C. W. B., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We are grateful for the public access to the Affymetrix 5.0 data available for a subset of AGRE families (http://www.agre.org), which served as important validation of CNV calls made.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; [Anonymous], 2007, AUTISM DEV DISABILIT; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Le Couteur A, 2008, J AUTISM DEV DISORD, V38, P362, DOI 10.1007/s10803-007-0403-3; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	29	973	1018	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					569	573		10.1038/nature07953	http://dx.doi.org/10.1038/nature07953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404257	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000266370500039
J	Mukhtasimova, N; Lee, WY; Wang, HL; Sine, SM				Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.			Detection and trapping of intermediate states priming nicotinic receptor channel opening	NATURE			English	Article							SINGLE-CHANNEL; AGONIST BINDING; ACETYLCHOLINE-RECEPTORS; BC3H-1 CELLS; ION CHANNELS; END-PLATE; ACTIVATION; KINETICS; MUTATION; SUBUNIT	In the course of synaptic transmission in the brain and periphery, acetylcholine receptors (AChRs) rapidly transduce a chemical signal into an electrical impulse. The speed of transduction is facilitated by rapid ACh association and dissociation, suggesting a binding site relatively non-selective for small cations. Selective transduction has been thought to originate from the ability of ACh, over that of other organic cations, to trigger the subsequent channel-opening step. However, transitions to and from the open state were shown to be similar for agonists with widely different efficacies(1-3). By studying mutant AChRs, we show here that the ultimate closed-to-open transition is agonist-independent and preceded by two primed closed states; the first primed state elicits brief openings, whereas the second elicits long-lived openings. Long-lived openings and the associated primed state are detected in the absence and presence of an agonist, and exhibit the same kinetic signatures under both conditions. By covalently locking the agonist-binding sites in the bound conformation, we find that each site initiates a priming step. Thus, a change in binding-site conformation primes the AChR for channel opening in a process that enables selective activation by ACh while maximizing the speed and efficiency of the biological response.	[Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	sine@mayo.edu		Lee, Won Yong/0000-0001-7915-1829	National Institutes of Health [NS031744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Johnson for computer programming, and C. Free for technical contributions. This work was supported by National Institutes of Health grant NS031744 (S. M. S.).	Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LEE BS, 1991, J BIOL CHEM, V266, P11448; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2004, J GEN PHYSIOL, V124, P555, DOI 10.1085/jgp.200409077; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Maconochie DJ, 1998, J PHYSIOL-LONDON, V506, P53, DOI 10.1111/j.1469-7793.1998.053bx.x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1986, J PHYSIOL-LONDON, V370, P357, DOI 10.1113/jphysiol.1986.sp015939; Wang HL, 1997, J GEN PHYSIOL, V109, P757, DOI 10.1085/jgp.109.6.757	25	166	166	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					451	U172		10.1038/nature07923	http://dx.doi.org/10.1038/nature07923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339970	Green Accepted			2022-12-24	WOS:000266243700051
J	North, TE; Goessling, W; Peeters, M; Li, PL; Ceol, C; Lord, AM; Weber, GJ; Harris, J; Cutting, CC; Huang, P; Dzierzak, E; Zon, LI				North, Trista E.; Goessling, Wolfram; Peeters, Marian; Li, Pulin; Ceol, Craig; Lord, Allegra M.; Weber, Gerhard J.; Harris, James; Cutting, Claire C.; Huang, Paul; Dzierzak, Elaine; Zon, Leonard I.			Hematopoietic Stem Cell Development Is Dependent on Blood Flow	CELL			English	Article							NITRIC-OXIDE SYNTHASE; BETA-CATENIN; MOUSE; EXPRESSION; GENE; DISRUPTION; MIGRATION; EMBRYO; DIFFERENTIATION; ACTIVATION	During vertebrate embryogenesis, hematopoietic stem cells (HSCs) arise in the aorta-gonads-mesonephros (AGM) region. We report here that blood flow is a conserved regulator of HSC formation. In zebrafish, chemical blood flow modulators regulated HSC development, and silent heart (sih) embryos, lacking a heartbeat and blood circulation, exhibited severely reduced HSCs. Flow-modifying compounds primarily affected HSC induction after the onset of heartbeat; however, nitric oxide (NO) donors regulated HSC number even when treatment occurred before the initiation of circulation, and rescued HSCs in sih mutants. Morpholino knockdown of nos1 (nnos/enos) blocked HSC development, and its requirement was shown to be cell autonomous. In the mouse, Nos3 (eNos) was expressed in HSCs in the AGM. Intrauterine Nos inhibition or embryonic Nos3 deficiency resulted in a reduction of hematopoietic clusters and transplantable murine HSCs. This work links blood flow to AGM hematopoiesis and identifies NO as a conserved downstream regulator of HSC development.	[North, Trista E.; Goessling, Wolfram; Li, Pulin; Ceol, Craig; Lord, Allegra M.; Weber, Gerhard J.; Zon, Leonard I.] Harvard Univ, Sch Med, Stem Cell Program & Hematol Oncol, Childrens Hosp,Howard Hughes Med Inst,Harvard Ste, Boston, MA 02115 USA; [North, Trista E.; Harris, James] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Goessling, Wolfram; Cutting, Claire C.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Goessling, Wolfram] Dana Farber Canc Inst, Boston, MA 02115 USA; [Peeters, Marian; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, NL-3000 DR Rotterdam, Netherlands; [Huang, Paul] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital	Zon, LI (corresponding author), Harvard Univ, Sch Med, Stem Cell Program & Hematol Oncol, Childrens Hosp,Howard Hughes Med Inst,Harvard Ste, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569; Li, Pulin/0000-0002-8525-4936; Huang, Paul/0000-0002-5436-8658; Harris, James/0000-0002-8995-8324	National Institutes of Health; Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur; Howard Hughes Medical Institute investigator; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur; Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Lin and J. Loscalzo for helpful suggestions, D. Atochin for assistance with Nos knockout mice, and W. Davis for technical support with spinning- disk confocal microscopy. We thank K. R. Kopani, J. Ojeda, and A. Meyers for technical assistance with the zebrafish HSC screen. This work was supported by the National Institutes of Health (T. E. N., W. G., E. D., and L. I. Z) and a Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur award (E. D.). L. I. Z. is a Howard Hughes Medical Institute investigator.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Burggren WW, 2004, PHYSIOL BIOCHEM ZOOL, V77, P333, DOI 10.1086/422230; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DOWNING JR, 1993, BLOOD, V81, P2860; Du QA, 2006, CANCER RES, V66, P7024, DOI 10.1158/0008-5472.CAN-05-4110; Duran-Reyes G, 1999, LIFE SCI, V65, P2259, DOI 10.1016/S0024-3205(99)00491-9; Dzierzak E, 2008, DEVELOPMENT, V135, P2343, DOI 10.1242/dev.021279; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eddy FB, 2005, COMP BIOCHEM PHYS A, V142, P221, DOI 10.1016/j.cbpb.2005.05.038; Epperly MW, 2007, EXP HEMATOL, V35, P137, DOI 10.1016/j.exphem.2006.09.009; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin H, 2009, DEVELOPMENT, V136, P647, DOI 10.1242/dev.029637; Krasnov P, 2008, MOL MED, V14, P141, DOI 10.2119/2007-00011.Krasnov; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Michurina T, 2004, MOL THER, V10, P241, DOI 10.1016/j.ymthe.2004.05.030; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nath AK, 2004, DEVELOPMENT, V131, P2485, DOI 10.1242/dev.01131; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pallares P, 2008, REPRODUCTION, V136, P573, DOI 10.1530/REP-08-0272; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Prevotat L, 2006, GASTROENTEROLOGY, V131, P1142, DOI 10.1053/j.gastro.2006.07.017; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Teichert AM, 2008, CIRC RES, V103, P24, DOI 10.1161/CIRCRESAHA.107.168567; van Haperen R, 2003, AM J PATHOL, V163, P1677, DOI 10.1016/S0002-9440(10)63524-9; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128	51	327	340	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					736	748		10.1016/j.cell.2009.04.023	http://dx.doi.org/10.1016/j.cell.2009.04.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450519	Green Accepted, Bronze			2022-12-24	WOS:000266114100021
J	Adorno, M; Cordenonsi, M; Montagner, M; Dupont, S; Wong, C; Hann, B; Solari, A; Bobisse, S; Rondina, MB; Guzzardo, V; Parenti, AR; Rosato, A; Bicciato, S; Balmain, A; Piccolo, S				Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Wong, Christine; Hann, Byron; Solari, Aldo; Bobisse, Sara; Rondina, Maria Beatrice; Guzzardo, Vincenza; Parenti, Anna R.; Rosato, Antonio; Bicciato, Silvio; Balmain, Allan; Piccolo, Stefano			A Mutant-p53/Smad Complex Opposes p63 to Empower TGF beta-Induced Metastasis	CELL			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; HISTOLOGIC GRADE; MOUSE MODEL; P53; PROGRESSION; MUTANT; GAIN; MICE; P73	TGF beta ligands act as tumor suppressors in early stage tumors but are paradoxically diverted into potent prometastatic factors in advanced cancers. The molecular nature of this switch remains enigmatic. Here, we show that TGF beta-dependent cell migration, invasion and metastasis are empowered by mutant-p53 and opposed by p63. Mechanistically, TGF beta acts in concert with oncogenic Ras and mutant-p53 to induce the assembly of a mutant-p53/p63 protein complex in which Smads serve as essential platforms. Within this ternary complex, p63 functions are antagonized. Downstream of p63, we identified two candidate metastasis suppressor genes associated with metastasis risk in a large cohort of breast cancer patients. Thus, two common oncogenic lesions, mutant-p53 and Ras, selected in early neoplasms to promote growth and survival, also prefigure a cellular set-up with particular metastasis proclivity by TGF beta-dependent inhibition of p63 function.	[Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy; [Wong, Christine; Hann, Byron; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; [Solari, Aldo] Univ Padua, Dept Chem Engn Proc, I-35131 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Ist Oncol Veneto, I-35126 Padua, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy	University of Padua; University of California System; University of California San Francisco; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35100 Padua, Italy.	piccolo@civ.bio.unipd.it	Rosato, Antonio/E-8626-2010; Bicciato, Silvio/C-9825-2009; Dupont, Sirio/AAP-8133-2021; BICCIATO, Silvio/J-4466-2019; Cordenonsi, Michelangelo/K-7692-2016; Montagner, Marco/AAY-3236-2020	Rosato, Antonio/0000-0002-5263-8386; Bicciato, Silvio/0000-0002-1944-7078; BICCIATO, Silvio/0000-0002-1944-7078; Cordenonsi, Michelangelo/0000-0002-8253-5724; Montagner, Marco/0000-0003-3080-2138; SOLARI, ALDO/0000-0003-1243-0385; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	Swiss National Science Foundation; Cariparo; NCI [U01 CA84244]; Italian Association on Cancer Research (AIRC); Fondazione Cariparo; NATIONAL CANCER INSTITUTE [U01CA084244] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cariparo(Fondazione Cariparo); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Association on Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo(Fondazione Cariparo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the memory of Stefano Ferrari. We thank O. Wessely, G. Bressan, D. Volpin, G. Del Sal, and all members of the Piccolo group for invaluable discussions and comments on the manuscript; G. Del Sal and J. Girardini for transgenic MEFs; L. Morsut for data-mining; A. Colombatti and P. Spessotto for training with transwell and invasion assays; G. Gallina for microarrays; and G. Blandino, L. W. Ellisen, M. Tripodi, and L. Naldini for gifts of reagents. C.W. is a Swiss National Science Foundation fellow. This work is supported by grants from Cariparo (Excellence grant) to S.B., from NCI (U01 CA84244) to A.B. and from the Italian Association on Cancer Research (AIRC) and Fondazione Cariparo (Excellence grant) to S.P.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Sobin, 2009, UICC TNM CLASSIFICAT; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200	22	615	634	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					87	98		10.1016/j.cell.2009.01.039	http://dx.doi.org/10.1016/j.cell.2009.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345189	Bronze			2022-12-24	WOS:000264813300016
J	Sohal, VS; Zhang, F; Yizhar, O; Deisseroth, K				Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl			Parvalbumin neurons and gamma rhythms enhance cortical circuit performance	NATURE			English	Article							IN-VIVO; POSITIVE INTERNEURONS; NEURAL CIRCUITRY; TRANSGENIC MICE; PYRAMIDAL CELLS; OSCILLATIONS; SYNCHRONIZATION; NEOCORTEX; CONNECTIONS; MODULATION	Synchronized oscillations and inhibitory interneurons have important and interconnected roles within cortical microcircuits. In particular, interneurons defined by the fast-spiking phenotype and expression of the calcium-binding protein parvalbumin(1,2) have been suggested to be involved in gamma (30-80 Hz) oscillations(3-7), which are hypothesized to enhance information processing(8,9). However, because parvalbumin interneurons cannot be selectively controlled, definitive tests of their functional significance in gamma oscillations, and quantitative assessment of the impact of parvalbumin interneurons and gamma oscillations on cortical circuits, have been lacking despite potentially enormous significance (for example, abnormalities in parvalbumin interneurons may underlie altered gamma-frequency synchronization and cognition in schizophrenia(10) and autism(11)). Here we use a panel of optogenetic technologies(12-14) in mice to selectively modulate multiple distinct circuit elements in neocortex, alone or in combination. We find that inhibiting parvalbumin interneurons suppresses gamma oscillations in vivo, whereas driving these interneurons (even by means of non-rhythmic principal cell activity) is sufficient to generate emergent gamma-frequency rhythmicity. Moreover, gamma-frequency modulation of excitatory input in turn was found to enhance signal transmission in neocortex by reducing circuit noise and amplifying circuit signals, including inputs to parvalbumin interneurons. As demonstrated here, optogenetics opens the door to a new kind of informational analysis of brain function, permitting quantitative delineation of the functional significance of individual elements in the emergent operation and function of intact neural circuitry.	[Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, W083 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Sohal, Vikaas/M-9327-2016; Macrae, Rhiannon/AAX-1536-2020; YIZHAR, OFER/AAV-8497-2021	Sohal, Vikaas/0000-0002-2238-4186; Yizhar, Ofer/0000-0003-4228-1448	President and Provost of Stanford University; BioX; Bioengineering; NIMH; NIDA; CIRM; NSF; Keck, McKnight and Coulter Foundations; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059160] Funding Source: NIH RePORTER	President and Provost of Stanford University(Stanford University); BioX; Bioengineering; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Keck, McKnight and Coulter Foundations; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Arber for her gift of the PV:: Cre mice, and we acknowledge the advice and suggestions of R. C. Malenka, J. Huguenard and S. Baccus on this work. All materials are freely distributed and supported by the Deisseroth laboratory (http://www.optogenetics.org). K. D. is supported by the President and Provost of Stanford University, BioX, Bioengineering, and by NIMH, NIDA, CIRM, NSF, and the Keck, McKnight and Coulter Foundations. F. Z. is supported by NINDS, and V. S. S. is supported by a T32 postdoctoral research training fellowship from NIMH.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Meyer AH, 2002, J NEUROSCI, V22, P7055; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	1670	1722	10	352	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					698	702		10.1038/nature07991	http://dx.doi.org/10.1038/nature07991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396159	Green Accepted			2022-12-24	WOS:000266608600043
J	Delhommeau, F; Dupont, S; Della Valle, V; James, C; Trannoy, S; Masse, A; Kosmider, O; Le Couedic, JP; Robert, F; Alberdi, A; Lecluse, Y; Plo, I; Dreyfus, FJ; Marzac, C; Casadevall, N; Lacombe, C; Romana, SP; Dessen, P; Soulier, J; Viguie, F; Fontenay, M; Vainchenker, W; Bernard, OA				Delhommeau, Francois; Dupont, Sabrina; Della Valle, Veronique; James, Chloe; Trannoy, Severine; Masse, Aline; Kosmider, Olivier; Le Couedic, Jean-Pierre; Robert, Fabienne; Alberdi, Antonio; Lecluse, Yann; Plo, Isabelle; Dreyfus, Francois J.; Marzac, Christophe; Casadevall, Nicole; Lacombe, Catherine; Romana, Serge P.; Dessen, Philippe; Soulier, Jean; Viguie, Franck; Fontenay, Michaela; Vainchenker, William; Bernard, Olivier A.			Mutation in TET2 in Myeloid Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL COMPARTMENT; UNIPARENTAL DISOMY; MYELOPROLIFERATIVE DISORDERS; MYELODYSPLASTIC SYNDROMES; POLYCYTHEMIA-VERA; V617F MUTATION; GENETIC EVENT; JAK2; LEUKEMIA; CLASSIFICATION	BACKGROUND The myelodysplastic syndromes and myeloproliferative disorders are associated with deregulated production of myeloid cells. The mechanisms underlying these disorders are not well defined. METHODS We conducted a combination of molecular, cytogenetic, comparative-genomic-hybridization, and single-nucleotide-polymorphism analyses to identify a candidate tumor-suppressor gene common to patients with myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia (AML). The coding sequence of this gene, TET2, was determined in 320 patients. We analyzed the consequences of deletions or mutations in TET2 with the use of in vitro clonal assays and transplantation of human tumor cells into mice. RESULTS We initially identified deletions or mutations in TET2 in three patients with myelodysplastic syndromes, in three of five patients with myeloproliferative disorders, in two patients with primary AML, and in one patient with secondary AML. We selected the six patients with myelodysplastic syndromes or AML because they carried acquired rearrangements on chromosome 4q24; we selected the five patients with myeloproliferative disorders because they carried a dominant clone in hematopoietic progenitor cells that was positive for the V617F mutation in the Janus kinase 2 (JAK2) gene. TET2 defects were observed in 15 of 81 patients with myelodysplastic syndromes (19%), in 24 of 198 patients with myeloproliferative disorders (12%) (with or without the JAK2 V617F mutation), in 5 of 21 patients with secondary AML (24%), and in 2 of 9 patients with chronic myelomonocytic leukemia (22%). TET2 defects were present in hematopoietic stem cells and preceded the JAK2 V617F mutation in the five samples from patients with myeloproliferative disorders that we analyzed. CONCLUSIONS Somatic mutations in TET2 occur in about 15% of patients with various myeloid cancers.	[Della Valle, Veronique; Trannoy, Severine; Robert, Fabienne; Romana, Serge P.; Bernard, Olivier A.] Hop Necker Enfants Malad, INSERM, E0210, F-75015 Paris, France; [Delhommeau, Francois; Dupont, Sabrina; James, Chloe; Masse, Aline; Le Couedic, Jean-Pierre; Lecluse, Yann; Plo, Isabelle; Casadevall, Nicole; Dessen, Philippe; Vainchenker, William] Inst Gustave Roussy, INSERM, U790, F-94805 Villejuif, France; [Delhommeau, Francois; Dupont, Sabrina; Masse, Aline; Le Couedic, Jean-Pierre; Casadevall, Nicole; Dessen, Philippe; Vainchenker, William] Univ Paris 11, Villejuif, France; [Delhommeau, Francois; Marzac, Christophe; Casadevall, Nicole] Hop St Antoine, F-75571 Paris, France; [Delhommeau, Francois; Casadevall, Nicole] Univ Paris 06, Paris, France; [Della Valle, Veronique; Kosmider, Olivier; Dreyfus, Francois J.; Lacombe, Catherine; Romana, Serge P.; Viguie, Franck; Fontenay, Michaela; Bernard, Olivier A.] Univ Paris 05, Paris, France; [Kosmider, Olivier; Dreyfus, Francois J.; Lacombe, Catherine; Fontenay, Michaela] Hop Cochin, Inst Cochin, INSERM, CNRS UMR8104,U567, F-75674 Paris, France; [Kosmider, Olivier; Lacombe, Catherine; Fontenay, Michaela; Bernard, Olivier A.] Hop Cochin, Hematol Lab, AP HP, F-75674 Paris, France; [Dreyfus, Francois J.] Hop Cochin, Unite Fonct Hematol, F-75674 Paris, France; [James, Chloe] Univ Bordeaux 2, INSERM, U876, F-33076 Bordeaux, France; [Alberdi, Antonio; Soulier, Jean] Univ Paris Diderot, INSERM, Unite MR944, Hop St Louis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bernard, OA (corresponding author), Hop Necker Enfants Malad, INSERM, E0210, 149 Rue Vaugirard, F-75015 Paris, France.	olivier.bernard@inserm.fr	james, chloe/A-2015-2012; Plo, Isabelle/C-9056-2017; Bernard, Olivier A./E-5721-2016; Trannoy, Severine/D-1530-2015; Plo, Isabelle/AAT-6742-2021	Plo, Isabelle/0000-0002-5915-6910; Trannoy, Severine/0000-0002-5059-9846; Vainchenker, William/0000-0003-4705-202X; Romana, Serge Pierrick/0000-0003-3435-239X; James, Chloe/0000-0001-9553-2701; Bernard, Olivier/0000-0002-0463-9747; Delhommeau, Francois/0000-0002-4915-0734; KOSMIDER, olivier/0000-0002-6021-4057; Fontenay, Michaela/0000-0002-5492-6349	INSERM; La Ligue Nationale contre le Cancer; La Fondation de France; Institut National du Cancer; Canceropole Ile de France; L'association Francaise contre les Myopathies; GIS-Institut des Maladies Rares; la Direction Regionale de la Recherche Clinique AP-HP; Ministere de la Recherche et de la Technologie; European Hematology Association	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); La Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France); L'association Francaise contre les Myopathies(Association Francaise contre les Myopathies); GIS-Institut des Maladies Rares; la Direction Regionale de la Recherche Clinique AP-HP; Ministere de la Recherche et de la Technologie; European Hematology Association	Supported by grants from INSERM, La Ligue Nationale contre le Cancer, La Fondation de France, Institut National du Cancer, Canceropole Ile de France (Cellules Souches Cancereuses and Apoptosis 2007), L'association Francaise contre les Myopathies, GIS-Institut des Maladies Rares, la Direction Regionale de la Recherche Clinique AP-HP, Ministere de la Recherche et de la Technologie (to Dr. Dupont), and the European Hematology Association (to Dr. Delhommeau).	Bellanne-Chantelot C, 2006, BLOOD, V108, P346, DOI 10.1182/blood-2005-12-4852; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Braun T, 2006, BLOOD, V107, P1156; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Gondek LP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001225; Greenberg, 1998, BLOOD, V91, P1100; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Morgani KJ, 2008, ANNU REV MED, V59, P213, DOI 10.1146/annurev.med.59.061506.154159; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Ono R, 2002, CANCER RES, V62, P4075; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Robert-Richard E, 2006, HAEMATOLOGICA, V91, P1384; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; Villeval JL, 2006, SEMIN THROMB HEMOST, V32, P341, DOI 10.1055/s-2006-942755	29	1309	1370	4	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2289	2301		10.1056/NEJMoa0810069	http://dx.doi.org/10.1056/NEJMoa0810069			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474426	Bronze			2022-12-24	WOS:000266367300005
J	Mabberley, DJ				Mabberley, David J.			Exploring Terra Incognita	SCIENCE			English	Editorial Material							KORUP NATIONAL-PARK		Royal Bot Gardens, Richmond TW9 3AE, Surrey, England	Royal Botanic Gardens, Kew	Mabberley, DJ (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.	d.mabberley@kew.org						Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; THULIN M, 1989, PLANT SYST EVOL, V166, P249, DOI 10.1007/BF00935953; Thulin M, 2001, NORD J BOT, V21, P393, DOI 10.1111/j.1756-1051.2001.tb00783.x; Thulin M., 2006, FLORA SOMALIA, V3; Thulin Mats, 2008, Kew Bulletin, V63, P617, DOI 10.1007/s12225-008-9060-8; Thulin M, 2008, NORD J BOT, V26, P218, DOI 10.1111/j.1756-1051.2008.00245.x; van der Burgt XM, 2007, ADANSONIA, V29, P59; van der Burgt Xander M., 2006, Kew Bulletin, V61, P79	9	6	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					472	472		10.1126/science.1173323	http://dx.doi.org/10.1126/science.1173323			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390032				2022-12-24	WOS:000265411200031
J	Menuz, V; Howell, KS; Gentina, S; Epstein, S; Riezman, I; Fornallaz-Mulhauser, M; Hengartner, MO; Gomez, M; Riezman, H; Martinou, JC				Menuz, Vincent; Howell, Kate S.; Gentina, Sebastien; Epstein, Sharon; Riezman, Isabelle; Fornallaz-Mulhauser, Monique; Hengartner, Michael O.; Gomez, Marie; Riezman, Howard; Martinou, Jean-Claude			Protection of C-elegans from Anoxia by HYL-2 Ceramide Synthase	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; (DIHYDRO)CERAMIDE SYNTHASE; SUSPENDED ANIMATION; FAMILY-MEMBERS; SPHINGOID BASE; GENE LAG1; PROTEIN; APOPTOSIS; REQUIRES; HYPOXIA	Oxygen deprivation is rapidly deleterious for most organisms. However, Caenorhabditis elegans has developed the ability to survive anoxia for at least 48 hours. Mutations in the DAF-2/DAF-16 insulin-like signaling pathway promote such survival. We describe a pathway involving the HYL-2 ceramide synthase that acts independently of DAF-2. Loss of the ceramide synthase gene hyl-2 results in increased sensitivity of C. elegans to anoxia. C. elegans has two ceramide synthases, hyl-1 and hyl-2, that participate in ceramide biogenesis and affect its ability to survive anoxic conditions. In contrast to hyl-2(lf) mutants, hyl-1(lf) mutants are more resistant to anoxia than normal animals. HYL-1 and HYL-2 have complementary specificities for fatty acyl chains. These data indicate that specific ceramides produced by HYL-2 confer resistance to anoxia.	[Howell, Kate S.; Epstein, Sharon; Riezman, Isabelle; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Menuz, Vincent; Gentina, Sebastien; Fornallaz-Mulhauser, Monique; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Howell, Kate S.] Univ Melbourne, Fac Land & Food Resource, Parkville, Vic 3010, Australia; [Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Gomez, Marie] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Melbourne; University of Zurich; University of Geneva	Riezman, H (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.	Howard.Riezman@unige.ch; Jean-Claude.Martinou@unige.ch	Howell, Kate/M-2370-2013; Hengartner, Michael O/E-6235-2011	Howell, Kate/0000-0001-6498-0472; Hengartner, Michael/0000-0002-7584-596X; Riezman, Howard/0000-0003-4680-9422; martinou, Jean-claude/0000-0002-9847-2051	Swiss National Science Foundation [3100A0-109419/2, 3100A0-114189, 3100A0-105907/1, 3100A0-113889]; Human Frontiers Science Program Organization; Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program Organization(Human Frontier Science Program); Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	We thank F. Solary for help with analysis of aging; Y. Mattenberger and D. Courvoisier from the Clinical Research Center University of Geneva and Geneva University Hospitals for statistical support; S. Herzig for artwork; S. Mitani and the Japanese National Bioresource Project for tm strains; and J. Hodgkin for providing strains CB5670, CB6166, CB5439, and CB5430. Some nematodes were provided by the Caenorhabditis Genome Center, which is funded by the NIH National Center for Research Resources. This work was funded by the Swiss National Science Foundation [subsidies 3100A0-109419/2 (J.-C.M.), 3100A0-114189 (H.R.), 3100A0-105907/1 (M.G.), and 3100A0-113889 (M.O.H.)], the Human Frontiers Science Program Organization (H.R.), the Swiss SystemsX.ch initiative (H.R.) evaluated by the Swiss National Science Foundation, the Roche Foundation (V.M.), Ernest Boninchi subsidy for the purchase of the anoxic chamber, the Canton of Zurich (M.O.H.), the Ernst Hadorm Foundation (M.O.H.), and the Geneva Department of Education.	CHITWOOD DJ, 1995, LIPIDS, V30, P567, DOI 10.1007/BF02537032; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Hajeri VA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nystul TG, 2003, SCIENCE, V302, P1038, DOI 10.1126/science.1089705; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	21	123	134	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					381	384		10.1126/science.1168532	http://dx.doi.org/10.1126/science.1168532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372430	Green Published			2022-12-24	WOS:000265221600040
J	Ashall, L; Horton, CA; Nelson, DE; Paszek, P; Harper, CV; Sillitoe, K; Ryan, S; Spiller, DG; Unitt, JF; Broomhead, DS; Kell, DB; Rand, DA; See, V; White, MRH				Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; Unitt, John F.; Broomhead, David S.; Kell, Douglas B.; Rand, David A.; See, Violaine; White, Michael R. H.			Pulsatile Stimulation Determines Timing and Specificity of NF-kappa B-Dependent Transcription	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; TEMPORAL CONTROL; FEEDBACK LOOP; OSCILLATIONS; DYNAMICS	The nuclear factor kappa B (NF-kappa B) transcription factor regulates cellular stress responses and the immune response to infection. NF-kappa B activation results in oscillations in nuclear NF-kappa B abundance. To define the function of these oscillations, we treated cells with repeated short pulses of tumor necrosis factor-alpha at various intervals to mimic pulsatile inflammatory signals. At all pulse intervals that were analyzed, we observed synchronous cycles of NF-kappa B nuclear translocation. Lower frequency stimulations gave repeated full-amplitude translocations, whereas higher frequency pulses gave reduced translocation, indicating a failure to reset. Deterministic and stochastic mathematical models predicted how negative feedback loops regulate both the resetting of the system and cellular heterogeneity. Altering the stimulation intervals gave different patterns of NF-kappa B-dependent gene expression, which supports the idea that oscillation frequency has a functional role.	[Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; See, Violaine; White, Michael R. H.] Sch Biol Sci, Ctr Cell Imaging, Liverpool L69 7ZB, Merseyside, England; [Unitt, John F.] AstraZeneca R&D Charnwood, Dept Mol Biol, Loughborough LE11 5RH, Leics, England; [Broomhead, David S.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Rand, David A.] Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of Liverpool; AstraZeneca; University of Manchester; University of Manchester; University of Manchester; University of Warwick	White, MRH (corresponding author), Sch Biol Sci, Ctr Cell Imaging, Biosci Res Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	mwhite@liv.ac.uk	Broomhead, David S/C-6836-2009; Nelson, David/AAX-5648-2021; Rand, David A/J-9085-2012; Paszek, Pawel/J-2840-2012; Kell, Douglas/E-8318-2011; Spiller, David G/I-3645-2012	Nelson, David/0000-0002-5034-0885; Rand, David A/0000-0002-2217-3274; Paszek, Pawel/0000-0002-0363-0716; Kell, Douglas/0000-0001-5838-7963; Spiller, David Geoffrey/0000-0003-2502-6787; harper, claire/0000-0001-6228-4078; White, Michael/0000-0002-3617-3232	Biotechnology and Biological Sciences Research Council (BBSRC) [BBD0107481, BBF0059381, BBC0082191, BBC0071581]; Medical Research Council [G0500346]; Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01]; European Union [005137]; Royal Society/Wolfson Merit Award; BBSRC David Phillips Research Fellowship [BBC5204711]; BBSRC [BB/F005938/1, BB/D010748/1, BB/E012965/1, BB/E004210/1] Funding Source: UKRI; EPSRC [EP/C544587/1] Funding Source: UKRI; MRC [G0500346] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E012965/1, BB/C008219/1, BB/F005938/1, BB/E004210/1, BB/C007158/1, BB/C520471/1, BB/D010748/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S29256/01, EP/C544587/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Royal Society/Wolfson Merit Award(Royal Society of London); BBSRC David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank N. Perkins for reading the manuscript and D. Jackson, M. Kimmel, and T. Lipniacki for discussion. The work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grants BBD0107481, BBF0059381, BBC0082191, and BBC0071581; BBSRC studentships to L.A. and K.S. (AstraZeneca Collaborative Awards in Science and Engineering); and Medical Research Council grant G0500346. C.V.H. holds a Professor John Glover Memorial Research Fellowship; D.A.R. held an Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01 and European Union (BioSim Network contract 005137)]; D.B.K. holds a Royal Society/Wolfson Merit Award; and V.S. holds a BBSRC David Phillips Research Fellowship (BBC5204711). Hamamatsu Photonics and Carl Zeiss Limited provided training and technical support.	Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; KEAMS JD, 2006, J CELL BIOL, V173, P659; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Nelson DE, 2005, SCIENCE, V308, DOI 10.1126/science.1108198; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	24	408	416	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					242	246		10.1126/science.1164860	http://dx.doi.org/10.1126/science.1164860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359585	Green Accepted, Green Submitted			2022-12-24	WOS:000265024400044
J	Savva, GM; Wharton, SB; Ince, PG; Forster, G; Matthews, FE; Brayne, C				Savva, George M.; Wharton, Stephen B.; Ince, Paul G.; Forster, Gillian; Matthews, Fiona E.; Brayne, Carol		Med Res Council Cognitive Function	Age, Neuropathology, and Dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COUNCIL COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; SENILE DEMENTIA; OLDER PERSONS; POPULATION; IMPAIRMENT; EPIDEMIOLOGY; PREVALENCE; DISORDERS; DIAGNOSIS	BACKGROUND Research in Alzheimer's disease is focused mainly on younger old persons, whereas studies involving very old persons report attenuated relationships between the pathological features of Alzheimer's disease and dementia. METHODS We assessed 456 brains donated to the population-based Medical Research Council Cognitive Function and Ageing Study from persons 69 to 103 years of age at death. We used a standard neuropathological protocol that included measures of the pathological features of Alzheimer's disease, cerebral atrophy, and cerebrovascular disease. Neuropathological variables were dichotomized to represent no burden or a mild burden of pathological lesions as compared with a moderate or severe burden. Logistic regression was used to estimate the effect of age on the relationship between neuropathological features and dementia. RESULTS The difference in the prevalence of moderate and severe Alzheimer's-type pathological changes between persons with and those without dementia decreased with increasing age. The association between neocortical neuritic plaques and dementia was strong at 75 years of age (odds ratio, 8.63; 95% confidence interval [CI], 3.81 to 19.60) and reduced at 95 years of age (odds ratio, 2.48; 95% CI, 0.92 to 4.14), and similar attenuations with advancing age were observed in the association between other pathological changes related to Alzheimer's disease and dementia in all brain areas. In contrast, neocortical cerebral atrophy maintained a relationship with age in persons with dementia at both 75 years of age (odds ratio, 5.11; 95% CI, 1.94 to 13.46) and 95 years of age (odds ratio, 6.10; 95% CI, 2.80 to 13.28) and thus distinguished the cohort with dementia from the cohort without dementia. CONCLUSIONS The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. Age must be taken into account when assessing the likely effect of interventions against dementia on the population.	[Wharton, Stephen B.] Univ Sheffield, Sch Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England; [Savva, George M.; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge, England; [Matthews, Fiona E.] MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England	University of Sheffield; University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Wharton, SB (corresponding author), Univ Sheffield, Sch Med, Acad Unit Pathol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	s.wharton@sheffield.ac.uk	Savva, George M/E-9670-2011; Brayne, Carol/AAA-4285-2020; Ince, Paul G/A-5064-2009; Matthews, Fiona/O-6932-2015	Savva, George M/0000-0001-9190-124X; Brayne, Carol/0000-0001-5307-663X; Ince, Paul G/0000-0001-6677-8753; Matthews, Fiona/0000-0002-1728-2388; Wharton, Stephen B/0000-0003-2785-333X	Medical Research Council, United Kingdom [G9901400]; MRC [G0502157, MC_U105292687, G9901400, G0300126, G0400074] Funding Source: UKRI; Medical Research Council [G0400074, G0502157, MC_U105292687, G9901400, G0300126] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a grant (G9901400) from the Medical Research Council, United Kingdom.	Alzheimer & Society, 2007, DEMENTIA UK 2 EDITIO; AMADUCCI LA, 1986, NEUROLOGY, V36, P1497, DOI 10.1212/WNL.36.11.1497; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; COPELAND JRM, 1991, EUR ARCH PSY CLIN N, V240, P212, DOI 10.1007/BF02189529; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Esiri MM, 2001, LANCET, V357, P169; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; HACHINSKI VC, 1974, LANCET, V2, P207; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; HUBBARD BM, 1981, J NEUROL SCI, V50, P135, DOI 10.1016/0022-510X(81)90048-4; JELLINGER K, 1990, J NEUROL SCI, V95, P239, DOI 10.1016/0022-510X(90)90072-U; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; MANN DMA, 1985, J NEUROL SCI, V69, P139, DOI 10.1016/0022-510X(85)90129-7; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Matthews FE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-185; PERRY EK, 1992, NEUROBIOL AGING, V13, P393, DOI 10.1016/0197-4580(92)90113-C; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; ROSSOR MN, 1984, BRIT MED J, V288, P961, DOI 10.1136/bmj.288.6422.961; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schoenmaker N, 2004, LANCET NEUROL, V3, P627, DOI 10.1016/S1474-4422(04)00884-1; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Zaccai J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-2	35	634	641	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2009	360	22					2302	2309		10.1056/NEJMoa0806142	http://dx.doi.org/10.1056/NEJMoa0806142			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	449YO	19474427				2022-12-24	WOS:000266367300006
J	Burdon, JJ; Thrall, PH				Burdon, Jeremy J.; Thrall, Peter H.			Coevolution of Plants and Their Pathogens in Natural Habitats	SCIENCE			English	Editorial Material							GENE-FOR-GENE; METAPOPULATION MODEL; LOCAL ADAPTATION; RESISTANCE; HOST; VIRULENCE; EVOLUTION; DYNAMICS; POPULATIONS; INFECTION	Understanding of plant-pathogen coevolution in natural systems continues to develop as new theories at the population and species level are increasingly informed by studies unraveling the molecular basis of interactions between individual plants and their pathogens. The next challenge lies in further integration of these approaches to develop a comprehensive picture of how life history traits of both players interact with the environment to shape evolutionary trajectories.	[Burdon, Jeremy J.; Thrall, Peter H.] CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burdon, JJ (corresponding author), CSIRO Plant Ind, POB 1600, Canberra, ACT 2601, Australia.	Jeremy.Burdon@csiro.au	Burdon, Jeremy J/B-9913-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074265] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074265-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 2002, EVOL ECOL RES, V4, P79; [Anonymous], [No title captured]; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Burdon JJ, 1996, OIKOS, V76, P411, DOI 10.2307/3546214; CHIN KM, 1984, PLANT PATHOL, V33, P535, DOI 10.1111/j.1365-3059.1984.tb02878.x; *CSIRO NIH, 5R01GM07426501A2 CSI; Damgaard C, 1999, J THEOR BIOL, V201, P1, DOI 10.1006/jtbi.1999.1007; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gilpin M.E., 1991, METAPOPULATION DYNAM; Hanski I., 1999, METAPOPULATION ECOLO; Holt BF, 2003, CURR OPIN IMMUNOL, V15, P20, DOI 10.1016/S0952-7915(02)00014-6; Keen N, 2000, P NATL ACAD SCI USA, V97, P8752, DOI 10.1073/pnas.97.16.8752; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Lannou C, 2005, PLANT PATHOL, V54, P699, DOI 10.1111/j.1365-3059.2005.01251.x; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nuismer SL, 2006, EVOLUTION, V60, P24, DOI 10.1111/j.0014-3820.2006.tb01078.x; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2002, PLANT PATHOL, V51, P169, DOI 10.1046/j.1365-3059.2002.00683.x; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 2004, WEED TECHNOL, V18, P1269, DOI 10.1614/0890-037X(2004)018[1269:HLHIAB]2.0.CO;2; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tibayrenc M, 1998, INT J PARASITOL, V28, P85, DOI 10.1016/S0020-7519(97)00180-X; Wichmann G, 2005, APPL ENVIRON MICROB, V71, P2418, DOI 10.1128/AEM.71.5.2418-2432.2005	33	104	109	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					755	756		10.1126/science.1171663	http://dx.doi.org/10.1126/science.1171663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423818	Green Accepted			2022-12-24	WOS:000265832400037
J	Bergmann, O; Bhardwaj, RD; Bernard, S; Zdunek, S; Barnabe-Heider, F; Walsh, S; Zupicich, J; Alkass, K; Buchholz, BA; Druid, H; Jovinge, S; Frisen, J				Bergmann, Olaf; Bhardwaj, Ratan D.; Bernard, Samuel; Zdunek, Sofia; Barnabe-Heider, Fanie; Walsh, Stuart; Zupicich, Joel; Alkass, Kanar; Buchholz, Bruce A.; Druid, Henrik; Jovinge, Stefan; Frisen, Jonas			Evidence for Cardiomyocyte Renewal in Humans	SCIENCE			English	Article							CARDIAC MYOCYTES; NUCLEAR TESTS; HUMAN HEARTS; CELLS; HYPERTROPHY; PROGENITORS; ORIGINS; C-14	It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.	[Bergmann, Olaf; Bhardwaj, Ratan D.; Zdunek, Sofia; Barnabe-Heider, Fanie; Zupicich, Joel; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon 1, Inst Camille Jordan, CNRS, UMR5208, F-69622 Villeurbanne, France; [Walsh, Stuart; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, SE-17177 Stockholm, Sweden; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Jovinge, Stefan] Univ Lund Hosp, Dept Cardiol, SE-22185 Lund, Sweden	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Lund University; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lund University; Skane University Hospital	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bernard, Samuel/A-5623-2009; Buchholz, Bruce A/G-1356-2011; Schick, Joel/ABA-3728-2021; Bergmann, Olaf/A-5706-2009	Bernard, Samuel/0000-0002-8442-9968; Buchholz, Bruce A/0000-0002-9531-551X; Schick, Joel/0000-0002-8623-4910; Bergmann, Olaf/0000-0003-1065-4107; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	Swedish Heart-Lung Foundation; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Human Frontiers Science Program; Swedish Cancer Society; Foundation for Strategic Research; Karolinska Institutet; Juvenile Diabetes Research Foundation; NIH/NCRR [RR13461]; European Commission; Tobias Foundation; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Canadian Institutes of Health Research fellowships; Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Human Frontiers Science Program(Human Frontier Science Program); Swedish Cancer Society(Swedish Cancer Society); Foundation for Strategic Research; Karolinska Institutet(Karolinska Institutet); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Tobias Foundation; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Canadian Institutes of Health Research fellowships(Canadian Institutes of Health Research (CIHR)); Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lee, K. Spalding, and members of the Frisen lab for valuable discussions; M. Toro and K. Hamrin for help with flow cytometry; P. Reimer for assistance with radiocarbon interpretation; R. Cassidy, M. Muller, and E. Klaile for technical advice; M. Stahlberg and T. Bergman for help with high-performance liquid chromatography; and D. Kurdyla and P. Zermeno for producing graphite. This study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, Human Frontiers Science Program, the Swedish Cancer Society, the Foundation for Strategic Research, the Karolinska Institutet, the Juvenile Diabetes Research Foundation, NIH/NCRR (RR13461), European Commission FP7 CardioCell, and the Tobias Foundation. This work was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. R.D.B. and F.B.-H. were supported by fellowships from the Canadian Institutes of Health Research, and F.B.-H. was also supported by a fellowship from the Christopher and Dana Reeve Foundation.	Adler C, 1991, DEV REGENERATIVE POT, P227; Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; PFITZER P, 1971, CURR TOP PATHOL, V54, P125; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Wild EM, 2000, NUCL INSTRUM METH B, V172, P944, DOI 10.1016/S0168-583X(00)00227-5; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002	28	2044	2148	9	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					98	102		10.1126/science.1164680	http://dx.doi.org/10.1126/science.1164680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342590	Green Submitted, Green Accepted			2022-12-24	WOS:000264802100041
J	Adams, RW; Aguilar, JA; Atkinson, KD; Cowley, MJ; Elliott, PIP; Duckett, SB; Green, GGR; Khazal, IG; Lopez-Serrano, J; Williamson, DC				Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Green, Gary G. R.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.			Reversible Interactions with para-Hydrogen Enhance NMR Sensitivity by Polarization Transfer	SCIENCE			English	Article							NOBEL LECTURE; SPECTROSCOPY; CHEMISTRY	The sensitivity of both nuclear magnetic resonance spectroscopy and magnetic resonance imaging is very low because the detected signal strength depends on the small population difference between spin states even in high magnetic fields. Hyperpolarization methods can be used to increase this difference and thereby enhance signal strength. This has been achieved previously by incorporating the molecular spin singlet para-hydrogen into hydrogenation reaction products. We show here that a metal complex can facilitate the reversible interaction of para-hydrogen with a suitable organic substrate such that up to an 800-fold increase in proton, carbon, and nitrogen signal strengths are seen for the substrate without its hydrogenation. These polarized signals can be selectively detected when combined with methods that suppress background signals.	[Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Green, Gary G. R.] Univ York, York Neuroimaging Ctr, Bioctr York Sci Pk, York YO10 5DG, N Yorkshire, England	University of York - UK; University of York - UK	Duckett, SB (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	sbd3@york.ac.uk	Green, Gary GR/D-3543-2009; Cowley, Michael J/C-5169-2014; Adams, Ralph/H-9205-2012; Aguilar, Juan A./B-5315-2015; Lopez-Serrano, Joaquin/A-2267-2011; Cowley, Michael J/H-8512-2012; Cowley, Michael/AAQ-5067-2020; Duckett, Simon/M-1790-2016	Green, Gary GR/0000-0003-1977-7509; Cowley, Michael J/0000-0003-0664-2891; Adams, Ralph/0000-0001-8009-5334; Aguilar, Juan A./0000-0001-9181-8892; Lopez-Serrano, Joaquin/0000-0003-3999-0155; Cowley, Michael/0000-0003-0664-2891; Duckett, Simon/0000-0002-9788-6615; Elliott, Paul/0000-0003-1570-3289	University of York; White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council; Medical Research Council; Biotechnology and Biological Sciences Research Council; Spanish Ministry of Education and Science [CSD 2007-00006]; EPSRC [EP/F022530/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F022530/1] Funding Source: researchfish	University of York(European Commission); White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Education and Science(Spanish Government); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the University of York, the White-Rose Health Innovation Partnership, the Engineering and Physical Sciences Research Council, the Medical Research Council, Biotechnology and Biological Sciences Research Council, the Spanish Ministry of Education and Science [Project Consolider ORFEO (CSD 2007-00006)], and Bruker Bio-Spin. We thank Bruker Bio-Spin, R. Perutz, P. Walton, M. Hymers, S. Johnson, M. Mortimer, and K. Armour for advice and helpful discussions. We have filed a patent application, P115707GB, based on this work	Aguilar JA, 2007, CHEM COMMUN, P1183, DOI 10.1039/b616307f; Anwar MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040501; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Blazina D, 2004, DALTON T, P2601, DOI 10.1039/b409606a; Bouchard LS, 2008, SCIENCE, V319, P442, DOI 10.1126/science.1151787; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; CRABTREE RH, 1986, J AM CHEM SOC, V108, P4032, DOI 10.1021/ja00274a030; Driehuys B, 2006, SCIENCE, V314, P432, DOI 10.1126/science.1134532; ERNST RR, 1992, ANGEW CHEM INT EDIT, V31, P805, DOI 10.1002/anie.199208053; Frydman L, 2007, NAT PHYS, V3, P415, DOI 10.1038/nphys597; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Kemsley J, 2008, CHEM ENG NEWS, V86, P12, DOI 10.1021/cen-v086n043.p012; Kuhn LT, 2007, TOP CURR CHEM, V276, P25, DOI 10.1007/128_064; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Morris P.G., 1986, NUCL MAGNETIC RESONA; OPPELT A, 1986, Electromedica (English Edition), V54, P15; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Wood NJ, 2007, J AM CHEM SOC, V129, P11012, DOI 10.1021/ja074286k; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Zeeman P, 1908, NATURE, V78, P369, DOI 10.1038/078369a0	21	614	621	9	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1708	1711		10.1126/science.1168877	http://dx.doi.org/10.1126/science.1168877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325111	Green Accepted			2022-12-24	WOS:000264559800034
J	Goessling, W; North, TE; Loewer, S; Lord, AM; Lee, S; Stoick-Cooper, CL; Weidinger, G; Puder, M; Daley, GQ; Moon, RT; Zon, LI				Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Puder, Mark; Daley, George Q.; Moon, Randall T.; Zon, Leonard I.			Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration	CELL			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; WNT/BETA-CATENIN; COLON-CANCER; LONG-TERM; PROSTAGLANDIN E-2; GAMMA-CATENIN; ZEBRAFISH; PHOSPHORYLATION	Interactions between developmental signaling pathways govern the formation and function of stem cells. Prostaglandin (PG) E2 regulates vertebrate hematopoietic stem cells (HSC). Similarly, the Wnt signaling pathway controls HSC self-renewal and bone marrow repopulation. Here, we show that wnt reporter activity in zebrafish HSCs is responsive to PGE2 modulation, demonstrating a direct interaction in vivo. Inhibition of PGE2 synthesis blocked wnt-induced alterations in HSC formation. PGE2 modified the wnt signaling cascade at the level of beta-catenin degradation through cAMP/PKA-mediated stabilizing phosphorylation events. The PGE2/Wnt interaction regulated murine stem and progenitor populations in vitro in hematopoietic ES cell assays and in vivo following transplantation. The relationship between PGE2 and Wnt was also conserved during regeneration of other organ systems. Our work provides in vivo evidence that Wnt activation in stem cells requires PGE2, and suggests the PGE2/Wnt interaction is a master regulator of vertebrate regeneration and recovery.	[Goessling, Wolfram; North, Trista E.; Daley, George Q.; Zon, Leonard I.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Puder, Mark; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Daley, George Q.; Zon, Leonard I.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Program, Boston, MA 02115 USA; [Lee, Sang; Puder, Mark] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zon, LI (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	zon@enders.tch.harvard.edu	Moon, Randall/M-5605-2019; Weidinger, Gilbert/A-8342-2010; North, Trista/ABG-4789-2020; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Weidinger, Gilbert/0000-0003-3599-6760; North, Trista/0000-0003-1249-563X; Moon, Randall T/0000-0002-9352-1408; Goessling, Wolfram/0000-0001-9972-1569	National Institutes of Health; American Gastroenterological Association; American Cancer Society; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank: D. Langenau and C. Ceol for critical reading of the manuscript; C. R. Walkley and L. Purton for advice on HSC transplants; and J. Harris and C. C. Cutting for technical assistance. This work was supported by the National Institutes of Health (W. G., G. Q. D., R. T. M., and L. I. Z.), the American Gastroenterological Association (W. G.), the American Cancer Society (T. E. N.), and the Human Frontier Science Program (S. L.). G. Q. D., R. T. M., L. I. Z. are Howard Hughes Medical Institute investigators.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Boolbol SK, 1996, CANCER RES, V56, P2556; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; FISHER JW, 1984, BLOOD CELLS, V10, P241; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; GOLDSTEIN IM, 1997, INFLAMMATION, V2, P309; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; NOCKA KH, 1989, LEUKEMIA RES, V13, P527, DOI 10.1016/0145-2126(89)90119-7; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; WILLIAMS N, 1980, J CELL PHYSIOL, V103, P239, DOI 10.1002/jcp.1041030208; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	44	533	579	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1136	1147		10.1016/j.cell.2009.01.015	http://dx.doi.org/10.1016/j.cell.2009.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303855	Green Accepted, Bronze			2022-12-24	WOS:000264403900018
J	Peterson, TR; Laplante, M; Thoreen, CC; Sancak, Y; Kang, SA; Kuehl, WM; Gray, NS; Sabatini, DM				Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Kuehl, W. Michael; Gray, Nathanael S.; Sabatini, David M.			DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival	CELL			English	Article							C-MAF; PROTEIN; PHOSPHORYLATION; KINASE; COMPLEX; DYSREGULATION; PROLIFERATION; ACTIVATION; DOMAINS; TARGET	The mTORC1 and mTORC2 pathways regulate cell growth, proliferation, and survival. We identify DEPTOR as an mTOR-interacting protein whose expression is negatively regulated by mTORC1 and mTORC2. Loss of DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and activates mTORC1 and mTORC2 kinase activities. DEPTOR overexpression suppresses S6K1 but, by relieving feedback inhibition from mTORC1 to PI3K signaling, activates Akt. Consistent with many human cancers having activated mTORC1 and mTORC2 pathways, DEPTOR expression is low in most cancers. Surprisingly, DEPTOR is highly overexpressed in a subset of multiple myelomas harboring cyclin D1/D3 or c-MAF/MAFB translocations. In these cells, high DEPTOR expression is necessary to maintain PI3K and Akt activation and a reduction in DEPTOR levels leads to apoptosis. Thus, we identify a novel MTOR-interacting protein whose deregulated overexpression in multiple myeloma cells represents a mechanism for activating PI3K/Akt signaling and promoting cell survival.	[Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Peterson, Timothy R.; Laplante, Mathieu; Thoreen, Carson C.; Sancak, Yasemin; Kang, Seong A.; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Kuehl, W. Michael] NCI, Bethesda, MD 20814 USA; [Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [R01 AI47389, R01 CA103866]; Keck Foundation; LAM Foundation; American Diabetes Association; Canadian Institutes of Health Research; American Cancer Society; Intramural Research Program; National Cancer Institute; Center for Cancer Research; Dana Farber Cancer Institute High-Tech Research Fund; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [ZIASC006581, R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); LAM Foundation; American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber Cancer Institute High-Tech Research Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Thijn Brummelkamp for reviewing the manuscript and the following for technical assistance: Leslie Brents, Stephen Carr, Jake Jaffe, Xana Frias, Heather Keys, Stephanie Kinkel, Doug McMillin, Jan Reiling, Eric Spooner, Ed Van Veen, and Marcel Van Vugt. We thank members of the Sabatini lab for helpful discussions. This work was supported by grants from the National Institutes of Health ( NIH; R01 AI47389 and R01 CA103866) to D. M. S.; awards from the Keck Foundation and LAM Foundation to D. M. S.; a fellowship from the American Diabetes Association to T. R. P.; a fellowship from the Canadian Institutes of Health Research to M. L.; and a fellowship from the American Cancer Society to S. A. K. W. M. K was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. N. S. G. is funded in part by the Dana Farber Cancer Institute High-Tech Research Fund. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Bliskovsky V, 2003, P NATL ACAD SCI USA, V100, P14982, DOI 10.1073/pnas.2431627100; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; Chesi M, 1998, BLOOD, V91, P4457, DOI 10.1182/blood.V91.12.4457.412k48_4457_4463; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hurt EM, 2004, CANCER CELL, V5, P191, DOI 10.1016/S1535-6108(04)00019-4; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shapiro-Shelef M, 2004, CURR OPIN IMMUNOL, V16, P226, DOI 10.1016/j.coi.2004.02.001; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	47	883	908	4	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					873	886		10.1016/j.cell.2009.03.046	http://dx.doi.org/10.1016/j.cell.2009.03.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446321	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000266454800018
J	Gore, J; Youk, H; van Oudenaarden, A				Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander			Snowdrift game dynamics and facultative cheating in yeast	NATURE			English	Article							COOPERATION; EVOLUTION; CONFLICT; POPULATIONS; COMPETITION; GENE	The origin of cooperation is a central challenge to our understanding of evolution(1-3). The fact that microbial interactions can be manipulated in ways that animal interactions cannot has led to a growing interest in microbial models of cooperation(4-10) and competition(11,12). For the budding yeast Saccharomyces cerevisiae to grow on sucrose, the disaccharide must first be hydrolysed by the enzyme invertase(13,14). This hydrolysis reaction is performed outside the cytoplasm in the periplasmic space between the plasma membrane and the cell wall. Here we demonstrate that the vast majority ( 99 per cent) of the monosaccharides created by sucrose hydrolysis diffuse away before they can be imported into the cell, serving to make invertase production and secretion a cooperative behaviour(15,16). A mutant cheater strain that does not produce invertase is able to take advantage of and invade a population of wild-type cooperator cells. However, over a wide range of conditions, the wild-type cooperator can also invade a population of cheater cells. Therefore, we observe steady-state coexistence between the two strains in well-mixed culture resulting from the fact that rare strategies outperform common strategies-the defining features of what game theorists call the snowdrift game(17). A model of the cooperative interaction incorporating nonlinear benefits explains the origin of this coexistence. We are able to alter the outcome of the competition by varying either the cost of cooperation or the glucose concentration in the media. Finally, we note that glucose repression of invertase expression in wild-type cells produces a strategy that is optimal for the snowdrift game-wild-type cells cooperate only when competing against cheater cells.	[Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Youk, Hyun/E-2661-2016; van Oudenaarden, Alexander/AAA-1705-2019	Youk, Hyun/0000-0003-1687-5760; 	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence; Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM085279, R01GM068957] Funding Source: NIH RePORTER	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Kim, A. Raj, K. Gora, D. Muzzey and B. Pando for discussions and/or experimental help. This work was supported by grants from the US National Institutes of Health (NIH) and National Science Foundation to A. v. O. J. G. is supported through a Pappalardo Postdoctoral Fellowship and an NIH K99 Pathways to Independence Award. H. Y. was supported by a Lester Wolfe Fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; DICKINSON JR, 2004, METABOLISM MOL PHYSL, P54; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Greig D, 2004, P ROYAL SOC B S, V271, P25, DOI [DOI 10.1098/RSBL.2003.0083), 10.1098/rsbl.2003.0083]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Maclean RC, 2008, J EVOLUTION BIOL, V21, P1836, DOI 10.1111/j.1420-9101.2008.01579.x; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Maynard Smith J., 1982, pi; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Naumov GI, 1996, FEMS MICROBIOL LETT, V135, P31, DOI 10.1016/0378-1097(95)00424-6; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ozcan S, 1997, YEAST, V13, P127; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	29	435	442	3	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					253	256		10.1038/nature07921	http://dx.doi.org/10.1038/nature07921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19349960	Green Accepted			2022-12-24	WOS:000266036100041
J	Hayashi, MK; Tang, CY; Verpelli, C; Narayanan, R; Stearns, MH; Xu, RM; Li, HL; Sala, C; Hayashi, Y				Hayashi, Mariko Kato; Tang, Chunyan; Verpelli, Chiara; Narayanan, Radhakrishnan; Stearns, Marissa H.; Xu, Rui-Ming; Li, Huilin; Sala, Carlo; Hayashi, Yasunori			The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure	CELL			English	Article							CRYSTAL-STRUCTURE; COMPLEX REVEALS; RAT FOREBRAIN; EVH1 DOMAIN; KINASE-II; FAMILY; RECEPTOR; SYNAPSES; BINDS; RECOGNITION	The postsynaptic density (PSD) is crucial for synaptic functions, but the molecular architecture retaining its structure and components remains elusive. Homer and Shank are among the most abundant scaffolding proteins in the PSD, working synergistically for maturation of dendritic spines. Here, we demonstrate that Homer and Shank, together, form a mesh-like matrix structure. Crystallographic analysis of this region revealed a pair of parallel dimeric coiled coils intercalated in a tail-to-tail fashion to form a tetramer, giving rise to the unique configuration of a pair of N-terminal EVH1 domains at each end of the coiled coil. In neurons, the tetramerization is required for structural integrity of the dendritic spines and recruitment of proteins to synapses. We propose that the Homer-Shank complex serves as a structural framework and as an assembly platform for other PSD proteins.	[Hayashi, Mariko Kato; Narayanan, Radhakrishnan; Stearns, Marissa H.; Hayashi, Yasunori] MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hayashi, Mariko Kato; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Tang, Chunyan; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Dept Pharmacol, I-20129 Milan, Italy; [Xu, Rui-Ming] New York Univ, Structural Biol Program, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Sch Med, New York, NY 10016 USA; [Xu, Rui-Ming] New York Univ, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; New York University; New York University	Hayashi, MK (corresponding author), MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	hayashim@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Mariko K/L-1187-2013; Hayashi, Mariko/HHY-7722-2022; Verpelli, Chiara/K-6673-2016; xu, rui/GRX-5734-2022; Verpelli, Chiara/AAH-1140-2020; Hayashi, Yasunori/C-2249-2008; Tang, Chunyan/E-8352-2010; Sala, Carlo/A-2493-2009	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Mariko K/0000-0001-8296-4599; Hayashi, Mariko/0000-0001-8296-4599; Verpelli, Chiara/0000-0003-2949-9725; Verpelli, Chiara/0000-0003-2949-9725; Hayashi, Yasunori/0000-0002-7560-3004; Sala, Carlo/0000-0003-0662-9523; Li, Huilin/0000-0001-8085-8928	NIH [GM68762, R01DA17310]; RIKEN; Ministry of Education, Science, and Culture of Japan; Telethon Italy [GGP06208]; Fondazione Cariplo [2006-0779/109251]; Compagnia di San Paolo [2005-1964];  [NSF-0070319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, P50GM068762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Compagnia di San Paolo(Compagnia di San Paolo); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The crystallographic data were deposited in PDB with accession number 3CVE (Homer1b) and 3CVF (Homer3a). We thank Doctors Amy E. Keating, Robert T. Sauer, Myung Jong Kim, Amanda Mower, Teiichi Furuichi, and Morgan Sheng for helpful discussion and sharing of resources, as well as Ms. Cristina Zucchi and Ms. Valentina Giannini for technical help. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (supported by NSF-0070319 and NIH GM68762) at Massachusetts Institute of Technology is gratefully acknowledged. This work was supported by RIKEN; NIH grant R01DA17310; Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y.H.); Telethon Italy (grant number GGP06208); Fondazione Cariplo (project number 2006-0779/109251); and Compagnia di San Paolo (project number 2005-1964) (C.S.).	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Hayashi MK, 2006, J NEUROSCI, V26, P8492, DOI 10.1523/JNEUROSCI.2731-06.2006; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Minakami R, 2000, BIOCHEM BIOPH RES CO, V272, P466, DOI 10.1006/bbrc.2000.2777; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petersen JD, 2003, J NEUROSCI, V23, P11270; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	35	246	249	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					159	171		10.1016/j.cell.2009.01.050	http://dx.doi.org/10.1016/j.cell.2009.01.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345194	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000264813300022
J	Takeuchi, K; Nakano, Y; Kato, U; Kaneda, M; Aizu, M; Awano, W; Yonemura, S; Kiyonaka, S; Mori, Y; Yamamoto, D; Umeda, M				Takeuchi, Ken-ichi; Nakano, Yoshiro; Kato, Utako; Kaneda, Mizuho; Aizu, Masako; Awano, Wakae; Yonemura, Shigenobu; Kiyonaka, Shigeki; Mori, Yasuo; Yamamoto, Daisuke; Umeda, Masato			Changes in Temperature Preferences and Energy Homeostasis in Dystroglycan Mutants	SCIENCE			English	Article							DEHYDROGENASE COMPLEX; DROSOPHILA; CELLS; EXTINCTION; METABOLISM	Temperature affects the physiology, behavior, and evolution of organisms. We conducted mutagenesis and screens for mutants with altered temperature preference in Drosophila melanogaster and identified a cryophilic (cold-seeking) mutant, named atsugari (atu). Reduced expression of the Drosophila ortholog of dystroglycan (DmDG) induced tolerance to cold as well as preference for the low temperature. A sustained increase in mitochondrial oxidative metabolism caused by the reduced expression of DmDG accounted for the cryophilic phenotype of the atu mutant. Although most ectothermic animals do not use metabolically produced heat to regulate body temperature, our results indicate that their thermoregulatory behavior is closely linked to rates of mitochondrial oxidative metabolism and that a mutation in a single gene can induce a sustained change in energy homeostasis and the thermal responses.	[Takeuchi, Ken-ichi; Kato, Utako; Umeda, Masato] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Takeuchi, Ken-ichi; Kaneda, Mizuho; Aizu, Masako; Umeda, Masato] Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Nakano, Yoshiro] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Awano, Wakae] Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6068501, Japan; [Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Kyoto University; Tokyo Metropolitan Institute of Medical Science; Hyogo College of Medicine; RIKEN; Kyoto University; Tohoku University	Umeda, M (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	umeda@scl.kyoto-u.ac.jp	Kiyonaka, Shigeki/AAM-7303-2021	, Daisuke/0000-0002-4623-0106	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan [1802012]; The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakano for statistical analysis; H. Suzuki and J. Ikenouchi for assistance with electron microscopy; R. Niwa, M. O'Connor, A. P. Gould, and M. Kamakura for providing GAL4 flies; N. Juni for helpful discussions; A. Yamaguchi, Y. Yamaguchi, and M. Nishikawa for technical assistance; and R. Matsuda, H. Takeshima, Y. Nagai, and M. Ui for valuable advice and encouragement. This work was supported in part by Special Coordination Funds for Promoting Science and Technology from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan, and by a research grant from The Novartis Foundation (Japan) for the Promotion of Science. D.Y. was supported by Specially Promoted Research grant 1802012 from MEXT and The Tohoku Neuroscience Global Centers of Excellence program.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bennett A.F., 1996, ANIMALS TEMPERATURE; BULLOCK TH, 1955, BIOL REV, V30, P311, DOI 10.1111/j.1469-185X.1955.tb01211.x; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gisolfi C., 2000, HOT BRAIN SURVIVAL T; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Heinrich B., 1993, HOT BLOODED INSECTS; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; MCCORMACK JG, 1981, BIOCHEM J, V196, P619, DOI 10.1042/bj1960619; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856	19	44	46	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1740	1743		10.1126/science.1165712	http://dx.doi.org/10.1126/science.1165712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325118				2022-12-24	WOS:000264559800043
J	Okuda, S; Tsutsui, H; Shiina, K; Sprunck, S; Takeuchi, H; Yui, R; Kasahara, RD; Hamamura, Y; Mizukami, A; Susaki, D; Kawano, N; Sakakibara, T; Namiki, S; Itoh, K; Otsuka, K; Matsuzaki, M; Nozaki, H; Kuroiwa, T; Nakano, A; Kanaoka, MM; Dresselhaus, T; Sasaki, N; Higashiyama, T				Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Sprunck, Stefanie; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Itoh, Kie; Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Kuroiwa, Tsuneyoshi; Nakano, Akihiko; Kanaoka, Masahiro M.; Dresselhaus, Thomas; Sasaki, Narie; Higashiyama, Tetsuya			Defensin-like polypeptide LUREs are pollen tube attractants secreted from synergid cells	NATURE			English	Article							TORENIA-FOURNIERI; FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; DOUBLE FERTILIZATION; EMBRYO SAC; IN-VITRO; GUIDANCE; ARABIDOPSIS; GENES; PROTEIN	For more than 140 years, pollen tube guidance in flowering plants has been thought to be mediated by chemoattractants derived from target ovules(1). However, there has been no convincing evidence of any particular molecule being the true attractant that actually controls the navigation of pollen tubes towards ovules. Emerging data indicate that two synergid cells on the side of the egg cell emit a diffusible, species-specific signal to attract the pollen tube at the last step of pollen tube guidance(1-3). Here we report that secreted, cysteine-rich polypeptides (CRPs) in a subgroup of defensin-like proteins are attractants derived from the synergid cells. We isolated synergid cells of Torenia fournieri, a unique plant with a protruding embryo sac, to identify transcripts encoding secreted proteins as candidate molecules for the chemoattractant(s). We found two CRPs, abundantly and predominantly expressed in the synergid cell, which are secreted to the surface of the egg apparatus. Moreover, they showed activity in vitro to attract competent pollen tubes of their own species and were named as LUREs. Injection of morpholino antisense oligomers against the LUREs impaired pollen tube attraction, supporting the finding that LUREs are the attractants derived from the synergid cells of T. fournieri.	[Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Kanaoka, Masahiro M.; Sasaki, Narie; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Aichi 4648602, Japan; [Sprunck, Stefanie; Dresselhaus, Thomas] Univ Regensburg, D-93053 Regensburg, Germany; [Itoh, Kie] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroiwa, Tsuneyoshi] Rikkyo St Pauls Univ, Grad Sch Sci, Res Informat Ctr Extremophile, Tokyo 1718501, Japan; [Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	Nagoya University; University of Regensburg; University of Tokyo; University of Tokyo; Rikkyo University; RIKEN	Higashiyama, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp	Matsuzaki, Motomichi/D-4043-2016; KANAOKA, Masahiro/I-7192-2014; Nakano, Akihiko/C-6185-2009; Takeuchi, Hidenori/AFG-8500-2022; Nakano, Akihiko/A-6420-2016; Higashiyama, Tetsuya/C-2882-2012; Nakano, Akihiko/G-4942-2014; Tsutsui, Hiroki/ABC-1564-2021; NOZAKI, HISAYOSHI/G-4926-2014	Matsuzaki, Motomichi/0000-0001-5811-798X; KANAOKA, Masahiro/0000-0003-4913-6278; Takeuchi, Hidenori/0000-0002-0719-3736; Nakano, Akihiko/0000-0003-3635-548X; Higashiyama, Tetsuya/0000-0002-7346-360X; Nakano, Akihiko/0000-0003-3635-548X; Tsutsui, Hiroki/0000-0001-5710-3367; Susaki, Daichi/0000-0002-9465-9222; Nozaki, Hisayoshi/0000-0002-9308-4498	Grant-in-Aid for Young Scientists (Start-up); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [20870020]; Creative Scientific Research, MEXT, Japan [18GS0314-01]; Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan [19370017]; Grant-in-Aid for Scientific Research on Priority Areas [18075004]; PRESTO project; Japan Science and Technology Agency, Japan	Grant-in-Aid for Young Scientists (Start-up)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO project; Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank T. Suzuki for help with the analysis of the EST sequences, S. Takayama for providing chemically synthesized and refolded SP11 peptides, W. Uchida for checking the diameter of the glass needles for microinjection by scanning electron microscopy and N. Iwata for assistance in preparing plant materials. This work was supported in part by a Grant-in-Aid for Young Scientists (Start-up), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (20870020 to M. M. K.); a Grant-in-Aid for Creative Scientific Research, MEXT, Japan (18GS0314-01 to N. S.); a grant from Yamada Science Foundation, Japan (to T. H.); a Grant-in-Aid for Scientific Research (B), MEXT, Japan (19370017 to T. H.); a Grant-in-Aid for Scientific Research on Priority Areas (18075004 to T. H.), and PRESTO project, Japan Science and Technology Agency, Japan (to T. H.).	Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Cheung AY, 2001, SCIENCE, V293, P1441, DOI 10.1126/science.1065051; Cordts S, 2001, PLANT J, V25, P103, DOI 10.1046/j.0960-7412.2000.00944.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Han YZ, 2000, PLANTA, V211, P158, DOI 10.1007/s004250000289; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2002, J PLANT RES, V115, P149, DOI 10.1007/s102650200020; Higashiyama T, 2008, SEX PLANT REPROD, V21, P17, DOI 10.1007/s00497-007-0064-6; Higashiyama T, 2006, PLANT CELL MONOGR, V3, P265, DOI 10.1007/7089_053; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Imre K, 1999, SEX PLANT REPROD, V12, P152, DOI 10.1007/s004970050186; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2008, SEX PLANT REPROD, V21, P37, DOI 10.1007/s00497-007-0062-8; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Punwani JA, 2008, SEX PLANT REPROD, V21, P7, DOI 10.1007/s00497-007-0059-3; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Yang HP, 2006, PLANTA, V224, P1004, DOI 10.1007/s00425-006-0283-3; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	32	429	456	3	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					357	U122		10.1038/nature07882	http://dx.doi.org/10.1038/nature07882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295610				2022-12-24	WOS:000264285600045
J	Dawood, FS; Jain, S; Finelli, L; Shaw, MW; Lindstrom, S; Garten, RJ; Gubareva, LV; Xu, XY; Bridges, CB; Uyeki, TM				Dawood, Fatimah S.; Jain, Seema; Finelli, Lyn; Shaw, Michael W.; Lindstrom, Stephen; Garten, Rebecca J.; Gubareva, Larisa V.; Xu, Xiyan; Bridges, Carolyn B.; Uyeki, Timothy M.			Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINES	BACKGROUND On April 15 and April 17, 2009, novel swine-origin influenza A (H1N1) virus (S-OIV) was identified in specimens obtained from two epidemiologically unlinked patients in the United States. The same strain of the virus was identified in Mexico, Canada, and elsewhere. We describe 642 confirmed cases of human S-OIV infection identified from the rapidly evolving U. S. outbreak. METHODS Enhanced surveillance was implemented in the United States for human infection with influenza A viruses that could not be subtyped. Specimens were sent to the Centers for Disease Control and Prevention for real-time reverse-transcriptase-polymerasechain-reaction confirmatory testing for S-OIV. RESULTS From April 15 through May 5, a total of 642 confirmed cases of S-OIV infection were identified in 41 states. The ages of patients ranged from 3 months to 81 years; 60% of patients were 18 years of age or younger. Of patients with available data, 18% had recently traveled to Mexico, and 16% were identified from school outbreaks of S-OIV infection. The most common presenting symptoms were fever (94% of patients), cough (92%), and sore throat (66%); 25% of patients had diarrhea, and 25% had vomiting. Of the 399 patients for whom hospitalization status was known, 36 (9%) required hospitalization. Of 22 hospitalized patients with available data, 12 had characteristics that conferred an increased risk of severe seasonal influenza, 11 had pneumonia, 8 required admission to an intensive care unit, 4 had respiratory failure, and 2 died. The S-OIV was determined to have a unique genome composition that had not been identified previously. CONCLUSIONS A novel swine-origin influenza A virus was identified as the cause of outbreaks of febrile respiratory infection ranging from self-limited to severe illness. It is likely that the number of confirmed cases underestimates the number of cases that have occurred.	[Dawood, Fatimah S.] Ctr Dis Control & Prevent, Influenza Div, Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Jain, Seema; Finelli, Lyn; Shaw, Michael W.; Lindstrom, Stephen; Garten, Rebecca J.; Gubareva, Larisa V.; Xu, Xiyan; Bridges, Carolyn B.; Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dawood, FS (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Off Workforce & Career Dev, Epidem Intelligence Serv, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	fdawood@cdc.gov; mshaw1@cdc.gov	Fahimifar, Sepideh/M-5303-2019; Chen, Chien Ku/C-6128-2008; Finelli, Lyn/AAK-2360-2020	Cocoros, Noelle/0000-0001-7090-2761; Waddell, Elizabeth/0000-0002-0701-1939; McMorrow, Meredith/0000-0001-6363-4033; Biggerstaff, Matthew/0000-0001-5108-8311; Patel, Minal/0000-0002-8707-7531				[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], 2009, INFL H1N1 UPD 12; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; BLACHERE FM, 2009, CLIN INFECT DIS 0109; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CATE TR, 1977, J INFECT DIS, V136, pS518, DOI 10.1093/infdis/136.Supplement_3.S518; *CDCP, 2008 09 INFL PREV CO; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; DOLIN R, 1977, J INFECT DIS, V136, pS435, DOI 10.1093/infdis/136.Supplement_3.S435; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Hager M. C., 2003, STORMWATER, V4, P12; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; 2009, MMWR MORB MORTAL WKL, V58, P431	23	2103	2250	14	502	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2009	360	25					2605	2615		10.1056/NEJMoa0903810	http://dx.doi.org/10.1056/NEJMoa0903810			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458WR	19423869	Bronze			2022-12-24	WOS:000267060000005
J	Hirschfield, GM; Liu, XD; Xu, C; Lu, Y; Xie, G; Lu, Y; Gu, XJ; Walker, EJ; Jing, KY; Juran, BD; Mason, AL; Myers, RP; Peltekian, KM; Ghent, CN; Coltescu, C; Atkinson, EJ; Heathcote, EJ; Lazaridis, KN; Amos, CI; Siminovitch, KA				Hirschfield, Gideon M.; Liu, Xiangdong; Xu, Chun; Lu, Yue; Xie, Gang; Lu, Yan; Gu, Xiangjun; Walker, Erin J.; Jing, Kaiyan; Juran, Brian D.; Mason, Andrew L.; Myers, Robert P.; Peltekian, Kevork M.; Ghent, Cameron N.; Coltescu, Catalina; Atkinson, Elizabeth J.; Heathcote, E. Jenny; Lazaridis, Konstantinos N.; Amos, Christopher I.; Siminovitch, Katherine A.			Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIMITOCHONDRIAL ANTIBODIES; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCUS; ULCERATIVE-COLITIS; LARGE-SCALE; DISEASE; GENE; POPULATION	BACKGROUND Primary biliary cirrhosis is a chronic granulomatous cholangitis, characteristically associated with antimitochondrial antibodies. Twin and family aggregation data suggest that there is a significant genetic predisposition to primary biliary cirrhosis, but the susceptibility loci are unknown. METHODS To identify genetic loci conferring a risk for primary biliary cirrhosis, we carried out a genomewide association analysis in which DNA samples from 2072 Canadian and U. S. subjects (536 patients with primary biliary cirrhosis and 1536 controls) were genotyped for more than 300,000 single-nucleotide polymorphisms (SNPs). Sixteen of the SNPs most strongly associated with primary biliary cirrhosis were genotyped in two independent replication sets. We carried out fine-mapping studies across three loci associated with primary biliary cirrhosis. RESULTS We found significant associations between primary biliary cirrhosis and 13 loci across the HLA class II region; the HLA-DQB1 locus (encoding the major histocompatibility complex class II, DQ beta chain 1) had the strongest association (P = 1.78x10(-19); odds ratio for patients vs. controls, 1.75). Primary biliary cirrhosis was also significantly and reproducibly associated with two SNPs at the IL12A locus (encoding interleukin-12 alpha), rs6441286 (P = 2.42x10(-14); odds ratio, 1.54) and rs574808 (P = 1.88x10(-13); odds ratio, 1.54), and one SNP at the IL12RB2 locus (encoding interleukin-12 receptor beta 2), rs3790567 (P = 2.76x10(-11); odds ratio, 1.51). Fine-mapping analysis showed that a five-allele haplotype in the 3' flank of IL12A was significantly associated with primary biliary cirrhosis (P = 1.15x10(-34)). We found a modest genomewide association (P<5.0x10(-5)) with the risk of disease for SNPs at the STAT4 locus (encoding signal transducer and activator of transcription 4) and the CTLA4 locus (encoding cytotoxic T-lymphocyte-associated protein 4) and 10 other loci. CONCLUSIONS Our data show significant associations between primary biliary cirrhosis and common genetic variants at the HLA class II, IL12A, and IL12RB2 loci and suggest that the interleukin-12 immunoregulatory signaling axis is relevant to the pathophysiology of primary biliary cirrhosis. (ClinicalTrials.gov number, NCT00242125.)	[Hirschfield, Gideon M.; Liu, Xiangdong; Xu, Chun; Xie, Gang; Lu, Yan; Walker, Erin J.; Heathcote, E. Jenny; Siminovitch, Katherine A.] Univ Toronto, Toronto, ON, Canada; [Hirschfield, Gideon M.; Coltescu, Catalina; Heathcote, E. Jenny] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Mason, Andrew L.] Univ Alberta, Edmonton, AB, Canada; [Myers, Robert P.] Univ Calgary, Calgary, AB, Canada; [Peltekian, Kevork M.] Dalhousie Univ, Halifax, NS, Canada; [Ghent, Cameron N.] London Hlth Sci Ctr, London, ON, Canada; [Lu, Yue; Gu, Xiangjun; Jing, Kaiyan; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Juran, Brian D.; Atkinson, Elizabeth J.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Rochester, MN USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta; University of Calgary; Dalhousie University; London Health Sciences Centre; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic	Siminovitch, KA (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Room 778D, Toronto, ON M5G 1X5, Canada.	ksimin@mshri.on.ca	Peltekian, Kevork M/D-1083-2010; Walker, Erin J/H-5302-2013; Hirschfield, Gideon M/M-2143-2015; Siminovitch, Katherine/K-1475-2013; Mason, Andrew/D-2938-2013	Peltekian, Kevork M/0000-0002-9560-5576; Walker, Erin J/0000-0001-8476-7302; Hirschfield, Gideon M/0000-0002-6736-2255; Mason, Andrew/0000-0002-0470-9522	McLaughlin Centre for Molecular Medicine; Canada Research Chair award; Sherman Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK078527, R01DK080670, K23DK068290] Funding Source: NIH RePORTER	McLaughlin Centre for Molecular Medicine; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Sherman Family Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	support from the Immunogenomics Program of the McLaughlin Centre for Molecular Medicine, from a Canada Research Chair award, and from the Sherman Family Foundation. No other potential conflict of interest relevant to this article was reported.	Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Donaldson P, 2007, CLIN GASTROENTEROL H, V5, P755, DOI 10.1016/j.cgh.2007.02.012; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Filipe-Santos O, 2007, SEMIN IMMUNOL, V19, P136, DOI 10.1016/j.smim.2007.02.002; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Invernizzi P, 2005, CLIN GASTROENTEROL H, V3, P401, DOI 10.1016/S1542-3565(04)00678-0; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; Irie J, 2006, J EXP MED, V203, P1209, DOI 10.1084/jem.20051911; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; Juran BD, 2008, GASTROENTEROLOGY, V135, P1200, DOI 10.1053/j.gastro.2008.06.077; Kaplan MM, 2006, NEW ENGL J MED, V354, P313; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Lazaridis KN, 2007, HEPATOLOGY, V46, P785, DOI 10.1002/hep.21749; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; POUPON RE, 1994, NEW ENGL J MED, V330, P1342, DOI 10.1056/NEJM199405123301903; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulickal AS, 2008, J TROP PEDIATRICS, V54, P269, DOI 10.1093/tropej/fmm119; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Traherne JA, 2006, HUM MOL GENET, V15, P155, DOI 10.1093/hmg/ddi436; Valentonyte R, 2005, NAT GENET, V37, P652, DOI 10.1038/ng0605-652a; Wakabayashi K, 2006, HEPATOLOGY, V44, P1240, DOI 10.1002/hep.21385; Walker EJ, 2009, ARTHRITIS RHEUM-US, V60, P931, DOI 10.1002/art.24412; Watt FE, 2004, QJM-INT J MED, V97, P397, DOI 10.1093/qjmed/hch078	41	458	477	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2009	360	24					2544	2555		10.1056/NEJMoa0810440	http://dx.doi.org/10.1056/NEJMoa0810440			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456BS	19458352	Green Accepted			2022-12-24	WOS:000266813800009
J	Spencer, SL; Gaudet, S; Albeck, JG; Burke, JM; Sorger, PK				Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.			Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis	NATURE			English	Article							TUMOR-CELL; PROTEIN; ACTIVATION; NOISE; ROBUSTNESS; EXPRESSION; FAMILY; KILL	In microorganisms, noise in gene expression gives rise to cell-to-cell variability in protein concentrations(1-7). In mammalian cells, protein levels also vary(8-10) and individual cells differ widely in their responsiveness to uniform physiological stimuli(11-15). In the case of apoptosis mediated by TRAIL (tumour necrosis factor (TNF)related apoptosis-inducing ligand) it is common for some cells in a clonal population to die while others survive-a striking divergence in cell fate. Among cells that die, the time between TRAIL exposure and caspase activation is highly variable. Here we image sister cells expressing reporters of caspase activation and mitochondrial outer membrane permeabilization after exposure to TRAIL. We show that naturally occurring differences in the levels or states of proteins regulating receptor-mediated apoptosis are the primary causes of cell-to-cell variability in the timing and probability of death in human cell lines. Protein state is transmitted from mother to daughter, giving rise to transient heritability in fate, but protein synthesis promotes rapid divergence so that sister cells soon become no more similar to each other than pairs of cells chosen at random. Our results have implications for understanding 'fractional killing' of tumour cells after exposure to chemotherapy, and for variability in mammalian signal transduction in general.	[Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA; [Spencer, Sabrina L.] MIT, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu		Altan-Bonnet, Gregoire/0000-0002-7283-3162; SPENCER, SABRINA/0000-0002-5798-3007; Gaudet, Suzanne/0000-0002-5701-2825; Sorger, Peter/0000-0002-3364-1838	National Institute of Health [GM68762, CA112967]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Flusberg, S. Govind, L. Kleiman, A. Letai, B. Millard, R. Milo, T. Norman, J. Paulsson and R. Ward for their help. This work was supported by National Institute of Health (NIH grants) GM68762 and CA112967.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERENBAUM MC, 1972, CANCER CHEMOTH REP 1, V56, P563; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goldstein JC, 2000, ANN NY ACAD SCI, V926, P132; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	29	697	713	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					428	U144		10.1038/nature08012	http://dx.doi.org/10.1038/nature08012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19363473	Green Accepted			2022-12-24	WOS:000266243700046
J	He, L; Sabet, A; Djedjos, S; Miller, R; Sun, XJ; Hussain, MA; Radovick, S; Wondisford, FE				He, Ling; Sabet, Amin; Djedjos, Stephen; Miller, Ryan; Sun, Xiaojian; Hussain, Mehboob A.; Radovick, Sally; Wondisford, Fredric E.			Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein	CELL			English	Article							KINASE-C; GLUCOSE-PRODUCTION; COACTIVATOR TORC2; PKC-LAMBDA; DOMAIN; LIVER; METABOLISM; ACTIVATION; MECHANISMS; EXPRESSION	Insulin resistance and elevated glucagon levels result in nonsuppressible hepatic glucose production and hyperglycemia in patients with type 2 diabetes. The CREB coactivator complex controls transcription of hepatic gluconeogenic enzyme genes. Here, we show that both the antidiabetic agent metformin and insulin phosphorylate the transcriptional coactivator CREB binding protein (CBP) at serine 436 via PKCL/lambda. This event triggers the dissociation of the CREB-CBP-TORC2 transcription complex and reduces gluconeogenic enzyme gene expression. Mice carrying a germline mutation of this CBP phosphorylation site (S436A) demonstrate resistance to the hypoglycemic effect of both insulin and metformin. Obese, hyperglycemic mice display hepatic insulin resistance, but metformin is still effective in treating the hyperglycemia of these mice since it stimulates CBP phosphorylation by bypassing the block in insulin signaling. Our findings point to CBP phosphorylation at Ser436 by metformin as critical for its therapeutic effect, and as a potential target for pharmaceutical intervention.	[He, Ling; Sabet, Amin; Miller, Ryan; Hussain, Mehboob A.; Wondisford, Fredric E.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [Djedjos, Stephen; Radovick, Sally] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol & Med, Baltimore, MD 21287 USA; [Sun, Xiaojian] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Chicago	Wondisford, FE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA.	fwondis1@jhmi.edu		Sabet, Amin/0000-0001-5876-0502	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK063349]; Baltimore Diabetes Research and Training Center [P60DK079637]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD041859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637, R01DK081472, R01DK063349, P30DK079637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Baltimore Diabetes Research and Training Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK063349 and by the Baltimore Diabetes Research and Training Center Grant P60DK079637 (F. E. W., P. I.).	AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Goodman RH, 2000, GENE DEV, V14, P1553; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	30	345	359	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					635	646		10.1016/j.cell.2009.03.016	http://dx.doi.org/10.1016/j.cell.2009.03.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450513	Bronze, Green Accepted			2022-12-24	WOS:000266114100013
J	Desmurget, M; Reilly, KT; Richard, N; Szathmari, A; Mottolese, C; Sirigu, A				Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Szathmari, Alexandru; Mottolese, Carmine; Sirigu, Angela			Movement Intention After Parietal Cortex Stimulation in Humans	SCIENCE			English	Article							CONSCIOUS INTENTION; MOTOR CORTEX; AWARENESS; REPRESENTATION; ORGANIZATION; DAMAGE	Parietal and premotor cortex regions are serious contenders for bringing motor intentions and motor responses into awareness. We used electrical stimulation in seven patients undergoing awake brain surgery. Stimulating the right inferior parietal regions triggered a strong intention and desire to move the contralateral hand, arm, or foot, whereas stimulating the left inferior parietal region provoked the intention to move the lips and to talk. When stimulation intensity was increased in parietal areas, participants believed they had really performed these movements, although no electromyographic activity was detected. Stimulation of the premotor region triggered overt mouth and contralateral limb movements. Yet, patients firmly denied that they had moved. Conscious intention and motor awareness thus arise from increased parietal activity before movement execution.	[Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Sirigu, Angela] CNRS, UMR 5229, Ctr Neurosci Cognit, F-69500 Bron, France; [Desmurget, Michel; Reilly, Karen T.; Richard, Nathalie; Sirigu, Angela] Univ Lyon 1, F-69100 Villeurbanne, France; [Szathmari, Alexandru; Mottolese, Carmine] Hosp Civils Lyon, Hop Pierre Wertheimer, Neurosurg Unit 500, F-69003 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Sirigu, A (corresponding author), CNRS, UMR 5229, Ctr Neurosci Cognit, F-69500 Bron, France.	sirigu@isc.cnrs.fr	Richard, Nathalie/N-9084-2017; Desmurget, Michel/L-2401-2017; Reilly, Karen T/D-4423-2016; Sirigu, Angela/L-4683-2017	Reilly, Karen T/0000-0002-2840-1610; Richard, Nathalie/0000-0002-2547-6721	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [Neuro-031-02]; Human Frontiers Science Program [RGP0056/2005-C]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontiers Science Program(Human Frontier Science Program)	This study was funded by Centre National de la Recherche Scientifique, Agence Nationale de la Recherche (Neuro-031-02), and by Human Frontiers Science Program (RGP0056/2005-C) to A.S. We thank J. R. Duhamel for helpful discussion. We thank patients for their cooperation and L. Pouga and the clinical staff for help during testing.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Berti A., 2007, SENSORIMOTOR FDN HIG, VXXII; DESCARTES R, 1992, MEDITATIONS METAPHYS; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fotopoulou A, 2008, BRAIN, V131, P3432, DOI 10.1093/brain/awn225; FRIED I, 1991, J NEUROSCI, V11, P3656; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gemba H, 2004, NEUROSCI LETT, V357, P68, DOI 10.1016/j.neulet.2003.12.033; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Rothi U., 1997, APRAXIA NEUROPSYCHOL, P29; Searle John, 1983, INTENTIONALITY; SIRIGU A, 1995, CORTEX, V31, P41, DOI 10.1016/S0010-9452(13)80104-9; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stark E, 2007, J NEUROPHYSIOL, V97, P3351, DOI 10.1152/jn.01328.2006	27	458	477	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					811	813		10.1126/science.1169896	http://dx.doi.org/10.1126/science.1169896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423830				2022-12-24	WOS:000265832400054
J	Kiani, R; Shadlen, MN				Kiani, Roozbeh; Shadlen, Michael N.			Representation of Confidence Associated with a Decision by Neurons in the Parietal Cortex	SCIENCE			English	Article							PROBABILISTIC POPULATION CODES; DORSOLATERAL PREFRONTAL CORTEX; LATERAL INTRAPARIETAL AREA; PERCEPTUAL DECISION; ORBITOFRONTAL CORTEX; DISCRIMINATION TASK; REWARD PREFERENCE; VISUAL-MOTION; NEURAL BASIS; MACAQUE	The degree of confidence in a decision provides a graded and probabilistic assessment of expected outcome. Although neural mechanisms of perceptual decisions have been studied extensively in primates, little is known about the mechanisms underlying choice certainty. We have shown that the same neurons that represent formation of a decision encode certainty about the decision. Rhesus monkeys made decisions about the direction of moving random dots, spanning a range of difficulties. They were rewarded for correct decisions. On some trials, after viewing the stimulus, the monkeys could opt out of the direction decision for a small but certain reward. Monkeys exercised this option in a manner that revealed their degree of certainty. Neurons in parietal cortex represented formation of the direction decision and the degree of certainty underlying the decision to opt out.	[Kiani, Roozbeh] Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kiani, R (corresponding author), Univ Washington, Howard Hughes Med Inst, Natl Primate Res Ctr, Seattle, WA 98195 USA.	roozbeh@u.washington.edu; shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Howard Hughes Medical Institute; National Eye Institute [EY11378]; National Center for Research Resources [RR00166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Howard Hughes Medical Institute, National Eye Institute grant EY11378, and National Center for Research Resources grant RR00166. We thank T. Hanks, A. Pouget, A. Churchland, D. Lee, P. Phillips, J. Palmer, and C. D. Salzman for helpful discussions and comments and A. Boulet and K. Ahl for technical assistance.	AUDLEY RJ, 1964, BRIT MED BULL, V20, P27, DOI 10.1093/oxfordjournals.bmb.a070277; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANKS T, EY11378 H HUGH MED I; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Henmon VAC, 1911, PSYCHOL REV, V18, P186, DOI 10.1037/h0074579; HOWIE D, 2007, INTERPRETING PROBABI; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jaynes E.T., 2003, PROBABILITY THEORY L; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Laming DR, 1968, INFORM THEORY CHOICE; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Link SW, 1992, WAVE THEORY DIFFEREN; Luce RD, 1986, RESPONSE TIMES THEIR; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; McDougall W, 1921, PSYCHOL REV, V28, P315, DOI 10.1037/h0075816; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Petrusic WM, 2003, PSYCHON B REV, V10, P177, DOI 10.3758/BF03196482; PIERCE CS, 1884, P NATL ACAD SCI USA, V3, P75; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shields WE, 1997, J EXP PSYCHOL GEN, V126, P147, DOI 10.1037/0096-3445.126.2.147; Smith JD, 2008, PSYCHON B REV, V15, P679, DOI 10.3758/PBR.15.4.679; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sumner F. B., 1898, PSYCHOL REV, V5, P616, DOI [10.1037/h0073257, DOI 10.1037/H0073257]; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; VICKERS D, 1982, ACTA PSYCHOL, V50, P179, DOI 10.1016/0001-6918(82)90006-3; VICKERS D, 1985, PERCEPTION, V14, P471, DOI 10.1068/p140471; Vickers D., 1979, DECISION PROCESSES V; Volkmann J., 1934, PSYCHOL BULL, V31, P672; Wald A., 1947, SEQUENTIAL ANAL; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	64	556	560	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					759	764		10.1126/science.1169405	http://dx.doi.org/10.1126/science.1169405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442HN	19423820	Green Accepted			2022-12-24	WOS:000265832400039
J	Weston, EM; Lister, AM				Weston, Eleanor M.; Lister, Adrian M.			Insular dwarfism in hippos and a model for brain size reduction in Homo floresiensis	NATURE			English	Article							EVOLUTION; ALLOMETRY; MORPHOLOGY; PLEISTOCENE; PRIMATES; HOMININ; SAPIENS; DMANISI; GEORGIA; RULES	Body size reduction in mammals is usually associated with only moderate brain size reduction, because the brain and sensory organs complete their growth before the rest of the body during ontogeny(1,2). On this basis, 'phyletic dwarfs' are predicted to have a greater relative brain size than 'phyletic giants'(1,3). However, this trend has been questioned in the special case of dwarfism of mammals on islands(4). Here we show that the endocranial capacities of extinct dwarf species of hippopotamus from Madagascar are up to 30% smaller than those of a mainland African ancestor scaled to equivalent body mass. These results show that brain size reduction is much greater than predicted from an intraspecific 'late ontogenetic' model of dwarfism in which brain size scales to body size with an exponent of 0.35. The nature of the proportional change or grade shift(2,5) observed here indicates that selective pressures on brain size are potentially independent of those on body size. This study demonstrates empirically that it is mechanistically possible for dwarf mammals on islands to evolve significantly smaller brains than would be predicted from a model of dwarfing based on the intraspecific scaling of the mainland ancestor. Our findings challenge current understanding of brain-body allometric relationships in mammals and suggest that the process of dwarfism could in principle explain small brain size, a factor relevant to the interpretation of the small-brained hominin found on the Island of Flores, Indonesia(6).	[Weston, Eleanor M.; Lister, Adrian M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Natural History Museum London	Weston, EM (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	e.weston@nhm.ac.uk		Lister, Adrian/0000-0002-7985-138X	NERC [NE/F017936/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522689/1, BB/D522689/2] Funding Source: Medline; Natural Environment Research Council [NE/F017936/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACCORDI FS, 1971, ATTI ACCAD NAZ LIN, V51, P111; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Boisserie JR, 2005, ZOOL J LINN SOC-LOND, V143, P1, DOI 10.1111/j.1096-3642.2004.00138.x; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Eltringham S. K., 1999, HIPPOS NATURAL HIST; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Kohler M, 2008, TRENDS ECOL EVOL, V23, P6, DOI 10.1016/j.tree.2007.10.002; Kohler M, 2004, BRAIN BEHAV EVOLUT, V63, P125, DOI 10.1159/000076239; Kruska DCT, 2005, BRAIN BEHAV EVOLUT, V65, P73, DOI 10.1159/000082979; Lalueza-Fox C, 2002, MOL PHYLOGENET EVOL, V25, P501, DOI 10.1016/S1055-7903(02)00290-7; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Martin R.D., 1985, P147; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin RD, 2006, SCIENCE, V312, DOI 10.1126/science.1121144; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Niven JE, 2008, TRENDS ECOL EVOL, V23, P8, DOI 10.1016/j.tree.2007.10.004; Niven JE, 2007, TRENDS ECOL EVOL, V22, P57, DOI 10.1016/j.tree.2006.11.009; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Roth V.L., 1992, Oxford Surveys in Evolutionary Biology, V8, P259; SHEA BT, 1983, INT J PRIMATOL, V4, P33, DOI 10.1007/BF02739359; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Stanyon R., 1993, Human Evolution, V8, P205, DOI 10.1007/BF02436715; Stuenes S., 1989, Journal of Vertebrate Paleontology, V9, P241; Weston EM, 2003, BIOL J LINN SOC, V80, P625, DOI 10.1111/j.1095-8312.2003.00263.x	30	92	94	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					85	U88		10.1038/nature07922	http://dx.doi.org/10.1038/nature07922			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	441WN	19424156	Green Accepted			2022-12-24	WOS:000265801300034
J	Schweitzer, MH; Zheng, WX; Organ, CL; Avci, R; Suo, ZY; Freimark, LM; Lebleu, VS; Duncan, MB; Heiden, MGV; Neveu, JM; Lane, WS; Cottrell, JS; Horner, JR; Cantley, LC; Kalluri, R; Asara, JM				Schweitzer, Mary H.; Zheng, Wenxia; Organ, Chris L.; Avci, Recep; Suo, Zhiyong; Freimark, Lisa M.; Lebleu, Valerie S.; Duncan, Michael B.; Heiden, Matthew G. Vander; Neveu, John M.; Lane, William S.; Cottrell, John S.; Horner, John R.; Cantley, Lewis C.; Kalluri, Raghu; Asara, John M.			Biomolecular Characterization and Protein Sequences of the Campanian Hadrosaur B. canadensis	SCIENCE			English	Article							SOFT-TISSUE; CELLULAR PRESERVATION; MASTODON; IDENTIFICATION; BONE; BACTERIAL; COLLAGEN	Molecular preservation in non-avian dinosaurs is controversial. We present multiple lines of evidence that endogenous proteinaceous material is preserved in bone fragments and soft tissues from an 80-million-year-old Campanian hadrosaur, Brachylophosaurus canadensis [Museum of the Rockies (MOR) 2598]. Microstructural and immunological data are consistent with preservation of multiple bone matrix and vessel proteins, and phylogenetic analyses of Brachylophosaurus collagen sequenced by mass spectrometry robustly support the bird-dinosaur clade, consistent with an endogenous source for these collagen peptides. These data complement earlier results from Tyrannosaurus rex (MOR 1125) and confirm that molecular preservation in Cretaceous dinosaurs is not a unique event.	[Schweitzer, Mary H.; Zheng, Wenxia] N Carolina State Univ, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Organ, Chris L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Avci, Recep; Suo, Zhiyong] Montana State Univ, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA; [Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Lebleu, Valerie S.; Duncan, Michael B.; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02115 USA; [Lebleu, Valerie S.; Duncan, Michael B.; Kalluri, Raghu] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Heiden, Matthew G. Vander] Dana Farber Canc Inst, Boston, MA 02115 USA; [Neveu, John M.; Lane, William S.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA; [Cottrell, John S.] Matrix Sci Ltd, London W1U 7GB, England; [Horner, John R.] Museum Rockies, Bozeman, MT 59717 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kalluri, Raghu] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02139 USA; [Kalluri, Raghu] Harvard Univ, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of North Carolina; North Carolina State University; Harvard University; Montana State University System; Montana State University Bozeman; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard Medical School	Schweitzer, MH (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu; jasara@bidmc.harvard.edu	schweitzer, mary h/A-6756-2010; LeBleu, Valerie/E-2991-2015; Schweitzer, Mary/V-8143-2019; Cantley, Lewis C/D-1800-2014; Kalluri, Raghu/E-2677-2015	schweitzer, mary h/0000-0002-0427-3829; Cantley, Lewis C/0000-0002-1298-7653; Kalluri, Raghu/0000-0002-2190-547X	NSF [EAR 0722702, EAR 0634136, EAR 0548847, EAR-0541744]; David and Lucile Packard Foundation; United Negro College Fund Merck Postdoctoral Science Research Fellowship; Taplin Funds for Discovery (Harvard Medical School); NASA Expermental Project to Simulate Competitive Research [NCC5-579]; Damon Runyon Cancer Research Foundation; NIH [DK 55001, DK 62987, AA 13913, DK 61866, CA 125550]; Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK061866, R01DK062987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); United Negro College Fund Merck Postdoctoral Science Research Fellowship; Taplin Funds for Discovery (Harvard Medical School); NASA Expermental Project to Simulate Competitive Research; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We acknowledge funding from NSF [awards EAR 0722702 and EAR 0634136 (J.M.A.) and EAR 0548847 and EAR-0541744 (M.H.S.)]; the David and Lucile Packard Foundation (M.H.S.); United Negro College Fund Merck Postdoctoral Science Research Fellowship (M.B.D.); the Taplin Funds for Discovery (Harvard Medical School); partial support by NASA Expermental Project to Simulate Competitive Research under grant NCC5-579 (R.A. and Z.S.); Damon Runyon Cancer Research Foundation (M.G.V.H.); NIH grants DK 55001, DK 62987, AA 13913, DK 61866, and CA 125550; and the Department of Medicine for the Division of Matrix Biology at the Beth Israel Deaconess Medical Center. Correspondence and requests for materials should be addressed to M.H.S. for biochemical and morphological analyses and to J.M.A. for mass spectrometry and molecular phylogenetics analyses.	Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Asara JM, 2008, SCIENCE, V321, DOI 10.1126/science.1157829; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; EBERT PS, 1962, BIOCHEM BIOPH RES CO, V8, P305, DOI 10.1016/0006-291X(62)90283-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625; Mecham R.P., 1991, CELL BIOL EXTRACELLU, V2nd, P79; MENTON DN, 1984, ANAT RECORD, V209, P29, DOI 10.1002/ar.1092090105; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pevzner PA, 2008, SCIENCE, V321, DOI 10.1126/science.1155006; Pisani D, 2002, P ROY SOC B-BIOL SCI, V269, P915, DOI 10.1098/rspb.2001.1942; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107	24	143	151	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					626	631		10.1126/science.1165069	http://dx.doi.org/10.1126/science.1165069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407199				2022-12-24	WOS:000265608800039
J	Kuo, WJ; Sjostrom, T; Chen, YP; Wang, YH; Huang, CY				Kuo, Wen-Jui; Sjoestroem, Tomas; Chen, Yu-Ping; Wang, Yen-Hsiang; Huang, Chen-Ying			Intuition and Deliberation: Two Systems for Strategizing in the Brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; FUNCTIONAL NEUROANATOMY; CORTICAL NETWORK; NEURAL BASIS; SALIENCE; PRECUNEUS; RESPONSES; FEEL; FMRI	Dual-process theories distinguish between intuition (fast and emotional) and reasoning (slow and controlled) as a basis for human decision-making. We contrast dominance-solvable games, which can be solved by step-by-step deliberative reasoning, with pure coordination games, which must be solved intuitively. Using functional magnetic resonance imaging, we found that the middle frontal gyrus, the inferior parietal lobule, and the precuneus were more active in dominance-solvable games than in coordination games. The insula and anterior cingulate cortex showed the opposite pattern. Moreover, precuneus activity correlates positively with how "effortful" a dominance-solvable game is, whereas insula activity correlates positively with how "effortless" a coordination game is.	[Chen, Yu-Ping; Huang, Chen-Ying] Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Sjoestroem, Tomas] Rutgers State Univ, Dept Econ, New Brunswick, NJ 08901 USA; [Wang, Yen-Hsiang] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Rutgers State University New Brunswick; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan.	chenying@ntu.edu.tw	Sjostrom, Tomas/AAB-9239-2020; Huang, Chen-Ying/M-1704-2018	Sjostrom, Tomas/0000-0003-2835-0953; Huang, Chen-Ying/0000-0003-2897-642X	National Science Council of Taiwan [NSC 94-2415-H-002-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank M. Hsu for helpful comments on the manuscript and J.-Y. Leu, J.T.-Y. Wang, D. Niddam, and participants at many seminars for discussions. Technical assistance from C.-R. Chou, C.-T. Chen, C.-H. Lan, S.-C. Lin, K.-L. Chen, Y.-Y. Chung, W.-Y. Lin, S. Hsu, R. Chen, and the National Taiwan University Hospital MRI Laboratory is greatly appreciated. This work was supported by the National Science Council of Taiwan (grant NSC 94-2415-H-002-004).	Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BARDSLEY N, 2008, 200817 CTR DEC RES E; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; CAMERER C, 2003, BEHAV GAME THEORY EX, pCH5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Goel V, 2001, NEUROPSYCHOLOGIA, V39, P901, DOI 10.1016/S0028-3932(01)00024-0; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MEHTA J, 1994, AM ECON REV, V84, P658; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Noveck IA, 2004, CORTEX, V40, P613, DOI 10.1016/S0010-9452(08)70157-6; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Schaeffer J, 2007, SCIENCE, V317, P1518, DOI 10.1126/science.1144079; SCHELLING TC, 1958, J CONFLICT RESOLUT, V2, P203, DOI DOI 10.1177/002200275800200301; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wallentin M, 2008, HUM BRAIN MAPP, V29, P524, DOI 10.1002/hbm.20413; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Woodward J, 2007, J PHYSIOL-PARIS, V101, P179, DOI 10.1016/j.jphysparis.2007.12.003	41	78	82	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					519	522		10.1126/science.1165598	http://dx.doi.org/10.1126/science.1165598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390048	Green Submitted			2022-12-24	WOS:000265411200049
J	Heiman, MG; Shaham, S				Heiman, Maxwell G.; Shaham, Shai			DEX-1 and DYF-7 Establish Sensory Dendrite Length by Anchoring Dendritic Tips during Cell Migration	CELL			English	Article							NERVOUS-SYSTEM; C-ELEGANS; BASEMENT-MEMBRANE; ZONA-PELLUCIDA; EXPRESSION; PROTEIN; MECHANISMS; DOMAIN; MOUSE; GENE	Cells are devices whose structures delimit function. For example, in the nervous system, neuronal and glial shapes dictate paths of information flow. To understand how cells acquire their shapes, we examined the formation of a sense organ in C. elegans. Using time-lapse imaging, we found that sensory dendrites form by stationary anchoring of dendritic tips during cell-body migration. Agenetic screen identified DEX-1 and DYF-7, extracellular proteins required for dendritic tip anchoring, which act cooperatively at the time and place of anchoring. DEX-1 and DYF-7 contain, respectively, zonadhesin and zona pellucida domains, and DYF-7 self-associates into multimers important for anchoring. Thus, unlike other dendrites, amphid dendritic tips are positioned by DEX-1 and DYF-7 without the need for long-range guidance cues. In sequence and function, DEX-1 and DYF-7 resemble tectorins, which anchor stereocilia in the inner ear, suggesting that a sensory dendrite anchor may have evolved into part of a mechanosensor.	[Heiman, Maxwell G.; Shaham, Shai] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu		Heiman, Maxwell/0000-0002-2557-6490	NIH [1R01NS064273]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yun Lu for preparing the electron micrograph in Figure S1B; Valeri Thomson, the Rockefeller University Bio- Imaging Resource Center, and members of Ulrike Gaul's laboratory for technical help; Cori Bargmann, Alison North, and members of the Shaham laboratory for comments on the manuscript; and Myriam Heiman. M. G. H. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. S. S. is a Klingenstein Fellow in the Neurosciences and a Monique Weill-Caulier Scholar. This work was supported in part by a grant from the Patterson Trust and by NIH grant 1R01NS064273 to S. S.	ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Di Schiavi E, 2005, EUR J NEUROSCI, V21, P3291, DOI 10.1111/j.1460-9568.2005.04164.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao FB, 2007, CURR OPIN NEUROBIOL, V17, P525, DOI 10.1016/j.conb.2007.08.004; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Halfter W, 2002, J NEUROSCI, V22, P6029; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kim S, 2000, SCIENCE, V288, P150, DOI 10.1126/science.288.5463.150; Landmann F, 2004, DEV BIOL, V265, P478, DOI 10.1016/j.ydbio.2003.09.009; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Matsushita F, 2000, BIOCHEM BIOPH RES CO, V268, P275, DOI 10.1006/bbrc.2000.2104; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Nguyen CQ, 1999, DEV BIOL, V207, P86, DOI 10.1006/dbio.1998.9173; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Paley W., 1803, NATURAL THEOLOGY EVI; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; STARICH TA, 1995, GENETICS, V139, P171; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wu GY, 2003, J COMP NEUROL, V459, P392, DOI 10.1002/cne.10618; Yaron A, 2007, DEV NEUROBIOL, V67, P1216, DOI 10.1002/dneu.20512; Yu RYL, 2000, EMBO J, V19, P3542, DOI 10.1093/emboj/19.14.3542; Zallen JA, 1999, DEVELOPMENT, V126, P3679	51	113	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					344	355		10.1016/j.cell.2009.01.057	http://dx.doi.org/10.1016/j.cell.2009.01.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19344940	Green Accepted, Bronze			2022-12-24	WOS:000265456800026
J	Fraser, C; Donnelly, CA; Cauchemez, S; Hanage, WP; Van Kerkhove, MD; Hollingsworth, TD; Griffin, J; Baggaley, RF; Jenkins, HE; Lyons, EJ; Jombart, T; Hinsley, WR; Grassly, NC; Balloux, F; Ghani, AC; Ferguson, NM; Rambaut, A; Pybus, OG; Lopez-Gatell, H; Alpuche-Aranda, CM; Chapela, IB; Zavala, EP; Guevara, DME; Checchi, F; Garcia, E; Hugonnet, S; Roth, C				Fraser, Christophe; Donnelly, Christl A.; Cauchemez, Simon; Hanage, William P.; Van Kerkhove, Maria D.; Hollingsworth, T. Deirdre; Griffin, Jamie; Baggaley, Rebecca F.; Jenkins, Helen E.; Lyons, Emily J.; Jombart, Thibaut; Hinsley, Wes R.; Grassly, Nicholas C.; Balloux, Francois; Ghani, Azra C.; Ferguson, Neil M.; Rambaut, Andrew; Pybus, Oliver G.; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel; Espejo Guevara, Dulce Ma.; Checchi, Francesco; Garcia, Erika; Hugonnet, Stephane; Roth, Cathy		WHO Rapid Pandemic Assessment Coll	Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings	SCIENCE			English	Article							TRANSMISSIBILITY; STRATEGIES; MORTALITY; IMPACT	A novel influenza A (H1N1) virus has spread rapidly across the globe. Judging its pandemic potential is difficult with limited data, but nevertheless essential to inform appropriate health responses. By analyzing the outbreak in Mexico, early data on international spread, and viral genetic diversity, we make an early assessment of transmissibility and severity. Our estimates suggest that 23,000 (range 6000 to 32,000) individuals had been infected in Mexico by late April, giving an estimated case fatality ratio (CFR) of 0.4% (range: 0.3 to 1.8%) based on confirmed and suspected deaths reported to that time. In a community outbreak in the small community of La Gloria, Veracruz, no deaths were attributed to infection, giving an upper 95% bound on CFR of 0.6%. Thus, although substantial uncertainty remains, clinical severity appears less than that seen in the 1918 influenza pandemic but comparable with that seen in the 1957 pandemic. Clinical attack rates in children in La Gloria were twice that in adults (<15 years of age: 61%; >= 15 years: 29%). Three different epidemiological analyses gave basic reproduction number (R-0) estimates in the range of 1.4 to 1.6, whereas a genetic analysis gave a central estimate of 1.2. This range of values is consistent with 14 to 73 generations of human-to-human transmission having occurred in Mexico to late April. Transmissibility is therefore substantially higher than that of seasonal flu, and comparable with lower estimates of R0 obtained from previous influenza pandemics.	[Fraser, Christophe; Donnelly, Christl A.; Cauchemez, Simon; Hanage, William P.; Van Kerkhove, Maria D.; Hollingsworth, T. Deirdre; Griffin, Jamie; Baggaley, Rebecca F.; Jenkins, Helen E.; Lyons, Emily J.; Jombart, Thibaut; Hinsley, Wes R.; Grassly, Nicholas C.; Balloux, Francois; Ghani, Azra C.; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Rambaut, Andrew] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Lopez-Gatell, Hugo; Bojorquez Chapela, Ietza; Palacios Zavala, Ethel] FCO De P Miranda, Directorate Gen Epidemiol, Mexico City 01480, DF, Mexico; [Alpuche-Aranda, Celia M.] Natl Inst Epidemiol Diagnosis & Reference, Mexico City 11340, DF, Mexico; [Espejo Guevara, Dulce Ma.] Secretaria Salud Serv Salud Veracruz Soconusco 36, Xalapa, Veracruz, Mexico; [Checchi, Francesco; Garcia, Erika; Hugonnet, Stephane; Roth, Cathy] WHO, Geneva, Switzerland	Imperial College London; University of Edinburgh; University of Oxford; World Health Organization	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008; Balloux, Francois/D-4783-2009; Pybus, Oliver G/B-2640-2012; Hollingsworth, Deirdre/D-2421-2009; Balloux, Francois/X-7856-2019; Hanage, Bill/CAF-1813-2022; Grassly, Nicholas C/C-6381-2008; Rambaut, Andrew/B-2481-2009	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Balloux, Francois/0000-0003-1978-7715; Pybus, Oliver G/0000-0002-8797-2667; Hollingsworth, Deirdre/0000-0001-5962-4238; Balloux, Francois/0000-0003-1978-7715; Grassly, Nicholas C/0000-0001-6067-4507; Rambaut, Andrew/0000-0003-4337-3707; Van Kerkhove, Maria/0000-0002-6135-0018; Baggaley, Rebecca/0000-0002-4688-3924; Jenkins, Helen/0000-0003-4749-1591; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Ghani, Azra/0000-0002-0007-4910; Checchi, Francesco/0000-0001-9030-5382; Donnelly, Christl/0000-0002-0195-2463	Medical Research Council UK Centre; National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS); The Royal Society; Research Councils UK; Bill and Melinda Gates Foundation; The Wellcome Trust [GR082623MA]; Biotechnology and Biological Sciences Research Council UK; Microsoft Research; Medical Research Council; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Medical Research Council UK Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); The Royal Society(Royal Society of London); Research Councils UK(UK Research & Innovation (UKRI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); The Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Microsoft Research(Microsoft); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all those in Mexico and WHO (in particular J. Fitzner, K. Vandemaele and A. Merianos) who helped to collate the data used in this analysis. We also thank A. Borquez for help with translation and data collection and R. Eggo for data collation. We thank R. Anderson, K. Fukada, R. Hatchett, M. Lipsitch, D. Shay and L. Wolfson for useful discussions and comments. We thank the U.S. Centers for Disease Control; the Instituto de Salud Carlos III, Spain; Statens Erum Institut, Denmark; Erasmus MC Rotterdam, Netherlands; University of Regensburg, Germany; and the WHO collaborating centre for Reference and Research on Influenza, Australia, for posting viral sequences on GenBank. The work at Imperial College was funded by the Medical Research Council UK Centre grant. We also acknowledge additional support for individual staff members from the National Institute of General Medical Sciences (NIH) Models of Infectious Disease Agent Study (MIDAS) programme, The Royal Society (C.F., W.P.H., N.C.G., A.R., O.G.P.), Research Councils UK (S.C.), Bill and Melinda Gates Foundation (M.V.K., T.D.H., J.G.), The Wellcome Trust (R.F.B., grant GR082623MA), Biotechnology and Biological Sciences Research Council UK (T.J.), Microsoft Research (W.R.H.), and a studentship from the Medical Research Council (H.E.J.). GenBank accession numbers: GQ117067 [GenBank] , FJ973557 [GenBank] , FJ966082 [GenBank] , FJ966952 [GenBank] , FJ966960 [GenBank] , FJ966974 [GenBank] , FJ966971 [GenBank] , FJ969511 [GenBank] , GQ117040 [GenBank] , FJ985753 [GenBank] , GQ117119 [GenBank] , FJ982430 [GenBank] , GQ117097 [GenBank] , GQ117059 [GenBank] , GQ117103 [GenBank] , GQ117112 [GenBank] , CY039527 [GenBank] , FJ984364 [GenBank] , FJ984397 [GenBank] , FJ985763 [GenBank] , FJ974021 [GenBank] , GQ117056 [GenBank] , and FJ966982 [GenBank] for the main analysis and CY039527 [GenBank] , FJ966082 [GenBank] , FJ966959 [GenBank] , FJ966960 [GenBank] , FJ966974 [GenBank] , FJ969509 [GenBank] , FJ969511 [GenBank] , FJ966952 [GenBank] , FJ966982 [GenBank] , FJ971076 [GenBank] , and FJ973557 [GenBank] for the preliminary analysis.	Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Frost W.H., 1919, PUBLIC HLTH REPORTS, V34, P491, DOI [10.2307/4575056, DOI 10.2307/4575056]; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; GLEZEN WP, 1982, J INFECT DIS, V146, P313, DOI 10.1093/infdis/146.3.313; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; HUDMAN LE, 2002, GEOGRAPHY TRAVEL TOU; Lackenby A, 2008, EURO SURVEILL, V13; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; *MEX DIR GEN ADJ E, 2009, BROT INFL PORC MEX; *MEX DIR GEN ADJ E, 2009, BROT INFL HUM A H1N1; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; *WHO, SWIN INFL UPD 15	22	1354	1437	9	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2009	324	5934					1557	1561		10.1126/science.1176062	http://dx.doi.org/10.1126/science.1176062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459SU	19433588	Green Accepted			2022-12-24	WOS:000267130600043
J	Makarov, V; Manina, G; Mikusova, K; Mollmann, U; Ryabova, O; Saint-Joanis, B; Dhar, N; Pasca, MR; Buroni, S; Lucarelli, AP; Milano, A; De Rossi, E; Belanova, M; Bobovska, A; Dianiskova, P; Kordulakova, J; Sala, C; Fullam, E; Schneider, P; McKinney, JD; Brodin, P; Christophe, T; Waddell, S; Butcher, P; Albrethsen, J; Rosenkrands, I; Brosch, R; Nandi, V; Bharath, S; Gaonkar, S; Shandil, RK; Balasubramanian, V; Balganesh, T; Tyagi, S; Grosset, J; Riccardi, G; Cole, ST				Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.			Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis	SCIENCE			English	Article							CELL-WALL; IDENTIFICATION	New drugs are required to counter the tuberculosis (TB) pandemic. Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB. Using genetics and biochemistry, we identified the enzyme decaprenylphosphoryl-beta-D-ribose 2'-epimerase as a major BTZ target. Inhibition of this enzymatic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death. The most advanced compound, BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.	[Makarov, Vadim; Ryabova, Olga] Russian Acad Sci, AN Bakh Biochem Inst, Moscow 119071, Russia; [Manina, Giulia; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Riccardi, Giovanna] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Mikusova, Katarina; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Moellmann, Ute] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Saint-Joanis, Brigitte; Brosch, Roland] Inst Pasteur, F-75724 Paris 15, France; [Dhar, Neeraj; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Brodin, Priscille; Christophe, Thierry] Inst Pasteur Korea, Inserm Avenir Grp, Seoul 136791, South Korea; [Waddell, Simon; Butcher, Philip] Univ London St Georges Hosp, Div Cellular & Mol Med, London SE17 ORE, England; [Albrethsen, Jakob; Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; [Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore] AstraZeneca India, Bangalore, Karnataka, India; [Tyagi, Sandeep; Grosset, Jacques] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21231 USA	Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Pavia; Comenius University Bratislava; Hans Knoll Institute (HKI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut Pasteur Korea; St Georges University London; Statens Serum Institut; AstraZeneca; Johns Hopkins University		stewart.cole@epfl.ch	Makarov, Vadim/AAE-5483-2021; riccardi, gabriele/A-9269-2012; Buroni, Silvia/AAX-5454-2020; Brodin, Priscille/E-5802-2014; Brosch, Roland/AAZ-3850-2021; Manina, Giulia/AAI-5496-2020; Sala, Claudia/AAM-8395-2020; Brosch, Roland/ABB-4108-2021; Waddell, Simon J/A-9170-2013; Mikusova, Katarina/I-3622-2014; Pasca, Maria Rosalia/J-8752-2016; Kordulakova, Jana/I-3887-2014; Sala, Claudia/R-6037-2017; Brodin, Priscille/N-6979-2019; Riabova, Olga/K-6030-2015; Dhar, Neeraj/K-8171-2013; Makarov, Vadim/HGB-7756-2022	Makarov, Vadim/0000-0001-8746-2694; Brodin, Priscille/0000-0003-0991-7344; Brosch, Roland/0000-0003-2587-3863; Sala, Claudia/0000-0003-4031-4648; Waddell, Simon J/0000-0002-3684-9116; Pasca, Maria Rosalia/0000-0002-8906-4937; Kordulakova, Jana/0000-0003-2834-0165; Sala, Claudia/0000-0003-4031-4648; Brodin, Priscille/0000-0003-0991-7344; Riabova, Olga/0000-0002-3794-6495; Dhar, Neeraj/0000-0002-5887-8137; Makarov, Vadim/0000-0001-8746-2694; Mikusova, Katarina/0000-0002-0100-4877; Buroni, Silvia/0000-0002-6979-2275; deboosere, Nathalie/0000-0002-2873-5485; Butcher, Philip/0000-0003-1223-9097; Albrethsen, Jakob/0000-0002-2842-1128; RICCARDI, Giovanna/0000-0003-3295-0070; MANINA, GIULIA/0000-0001-9905-6095	European Commission [LHSP-CT-2005-018923]; Wellcome Trust [062511]	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Deshpande, I. Heinemann, P. Hojrup, K. Johnsson, M. K. N. Kumar, N. Kumar, L. Pagani, P. Marone, M. R. McNeil, I. Old, J. Reddy, S. Schmitt, P. Vachaspati, and C. Weigel for their help and support. Patents related to this work have been filed (WO/2007/134625, WO/2009/010163, and PCT/EP2008/001088). The NM4TB Consortium is funded by the European Commission (LHSP-CT-2005-018923), and microarray work at St Georges Hospital, University of London, is supported by the Wellcome Trust (grant 062511). Microarray data are Minimum Information About a Microarray Experiment (MIAME) compliant and deposited under accession number E-BUGS-80 at http://bugs.sgul.ac.uk/E-BUGS-80.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Makarov V., 2007, [No title captured], Patent No. [2029583, EP 2029583]; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MARKAROV V, 2006, J ANTIMICROB CHEMOTH, V57, P1134; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	24	523	558	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					801	804		10.1126/science.1171583	http://dx.doi.org/10.1126/science.1171583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19299584	Green Accepted			2022-12-24	WOS:000265832400051
J	Kim, J; Guermah, M; McGinty, RK; Lee, JS; Tang, ZY; Milne, TA; Shilatifard, A; Muir, TW; Roeder, RG				Kim, Jaehoon; Guermah, Mohamed; McGinty, Robert K.; Lee, Jung-Shin; Tang, Zhanyun; Milne, Thomas A.; Shilatifard, Ali; Muir, Tom W.; Roeder, Robert G.			RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human Cells	CELL			English	Article							RNA-POLYMERASE-II; UBIQUITIN-CONJUGATING ENZYME; HISTONE H2B; DNA-REPAIR; PAF1 COMPLEX; ELONGATION; CHROMATIN; YEAST; MONOUBIQUITINATION; EXPRESSION	H2B ubiquitylation has been implicated in active transcription but is not well understood in mammalian cells. Beyond earlier identification of hBRE1 as the E3 ligase for H2B ubiquitylation in human cells, we now show (1) that hRAD6 serves as the cognate E2-conjugating enzyme; (2) that hRAD6, through direct interaction with hPAF-bound hBRE1, is recruited to transcribed genes and ubiquitylates chromatinized H2B at lysine 120; (3) that hPAF-mediated transcription is required for efficient H2B ubiquitylation as a result of hPAF-dependent recruitment of hBRE1-hRAD6 to the Pol II transcription machinery; (4) that H2B ubiquitylation per se does not affect the level of hPAF-, SII-, and p300-dependent transcription and likely functions downstream; and (5) that H2B ubiquitylation directly stimulates hSET1-dependent H3K4 di- and trimethylation. These studies establish the natural H2B ubiquitylation factors in human cells and also detail the mechanistic basis for H2B ubiquitylation and function during transcription.	[Kim, Jaehoon; Guermah, Mohamed; Tang, Zhanyun; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Milne, Thomas A.] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Lee, Jung-Shin; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Rockefeller University; Rockefeller University; Rockefeller University; Stowers Institute for Medical Research	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Muir, Tom/AHD-0860-2022; Kim, Jaehoon/G-2711-2011; Milne, Tom/E-1872-2016	Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438; Milne, Tom/0000-0002-0413-4271	NIH [CA129325, DK071900, CA113872]; Leukemia and Lymphoma Society SCOR; NATIONAL CANCER INSTITUTE [R01CA089455, R01CA129325, R01CA113872, R01CA150265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM069905] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. C. D. Allis for helpful discussion; Drs. N. Minsky and M. Oren for anti-ubH2B antibody; Drs. O. Rozenblatt-Rosen and M. Meyerson for anti-hCTR9 antibody; and Dr. D. Reinberg for anti-hSKI8 antibody and the FLAG-hBRE1A/RNF20 cell line. This work was supported by NIH grants (CA129325, DK071900, and CA113872) to R. G. R. and by a Leukemia and Lymphoma Society SCOR grant.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	32	359	371	4	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					459	471		10.1016/j.cell.2009.02.027	http://dx.doi.org/10.1016/j.cell.2009.02.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19410543	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000265677200016
J	Bos, PD; Zhang, XHF; Nadal, C; Shu, WP; Gomis, RR; Nguyen, DX; Minn, AJ; van de Vijver, MJ; Gerald, WL; Foekens, JA; Massague, J				Bos, Paula D.; Zhang, Xiang H. -F.; Nadal, Cristina; Shu, Weiping; Gomis, Roger R.; Nguyen, Don X.; Minn, Andy J.; van de Vijver, Marc J.; Gerald, William L.; Foekens, John A.; Massague, Joan			Genes that mediate breast cancer metastasis to the brain	NATURE			English	Article							LUNG METASTASIS; GROWTH-FACTOR; IN-VITRO; EXPRESSION; CELLS; BONE; BETA; PROGRESSION; BARRIER; TISSUES	The molecular basis for breast cancer metastasis to the brain is largely unknown(1,2). Brain relapse typically occurs years after the removal of a breast tumour(2-4), suggesting that disseminated cancer cells must acquire specialized functions to take over this organ. Here we show that breast cancer metastasis to the brain involves mediators of extravasation through non-fenestrated capillaries, complemented by specific enhancers of blood-brain barrier crossing and brain colonization. We isolated cells that preferentially infiltrate the brain from patients with advanced disease. Gene expression analysis of these cells and of clinical samples, coupled with functional analysis, identified the cyclooxygenase COX2 (also known as PTGS2), the epidermal growth factor receptor (EGFR) ligand HBEGF, and the alpha 2,6-sialyltransferase ST6GALNAC5 as mediators of cancer cell passage through the blood-brain barrier. EGFR ligands and COX2 were previously linked to breast cancer infiltration of the lungs, but not the bones or liver(5,6), suggesting a sharing of these mediators in cerebral and pulmonary metastases. In contrast, ST6GALNAC5 specifically mediates brain metastasis. Normally restricted to the brain(7), the expression of ST6GALNAC5 in breast cancer cells enhances their adhesion to brain endothelial cells and their passage through the blood-brain barrier. This co-option of a brain sialyltransferase highlights the role of cell-surface glycosylation in organ-specific metastatic interactions.	[Bos, Paula D.; Zhang, Xiang H. -F.; Nadal, Cristina; Shu, Weiping; Gomis, Roger R.; Nguyen, Don X.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Minn, Andy J.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Minn, Andy J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Gerald, William L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Foekens, John A.] Erasmus MC, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Foekens, John A.] Canc Genom Ctr, Rotterdam, Netherlands; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Memorial Sloan Kettering Cancer Center; University of Chicago; University of Chicago; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gomis, Roger R/E-9788-2016	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670; Minn, Andy/0000-0003-1418-0906; van de Vijver, Marc/0000-0002-0385-4787	National Institutes of Health [U54 CA126518]; Kleberg Foundation and the Hearst Foundation; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO); Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA126518, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleberg Foundation and the Hearst Foundation; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the memory of our colleague W. Gerald. We thank E. Eugenin, E. Brogi, M. Drobnjac, K. LaPerle, M. Smid, A. Viale and K. Manova-Todorova for advice and support. We thank L. DeAngelis, A. Lassman, E. Holland, J. Posner and members of the Massague laboratory for discussions. This work was supported by grants from the National Institutes of Health (U54 CA126518), the Kleberg Foundation and the Hearst Foundation, and the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). J. M. is an investigator of the Howard Hughes Medical Institute.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Kamar FG, 2004, SEMIN NEUROL, V24, P347, DOI 10.1055/s-2004-861530; Eugenin EA, 2003, METHODS, V29, P351, DOI 10.1016/S1046-2023(02)00359-6; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Inoue S, 2001, ANAT RECORD, V264, P294, DOI 10.1002/ar.1166; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Lassman AB, 2003, NEUROL CLIN, V21, P1, DOI 10.1016/S0733-8619(02)00035-X; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paku S, 2001, CLIN EXP METASTAS, V18, P481, DOI 10.1023/A:1011858925376; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Slimane K, 2004, ANN ONCOL, V15, P1640, DOI 10.1093/annonc/mdh432; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	35	1228	1272	9	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2009	459	7249					1005	U137		10.1038/nature08021	http://dx.doi.org/10.1038/nature08021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458XS	19421193	Green Accepted			2022-12-24	WOS:000267063500047
J	Wang, K; Zhang, HT; Ma, DQ; Bucan, M; Glessner, JT; Abrahams, BS; Salyakina, D; Imielinski, M; Bradfield, JP; Sleiman, PMA; Kim, CE; Hou, CP; Frackelton, E; Chiavacci, R; Takahashi, N; Sakurai, T; Rappaport, E; Lajonchere, CM; Munson, J; Estes, A; Korvatska, O; Piven, J; Sonnenblick, LI; Retuerto, AIA; Herman, EI; Dong, HM; Hutman, T; Sigman, M; Ozonoff, S; Klin, A; Owley, T; Sweeney, JA; Brune, CW; Cantor, RM; Bernier, R; Gilbert, JR; Cuccaro, ML; McMahon, WM; Miller, J; State, MW; Wassink, TH; Coon, H; Levy, SE; Schultz, RT; Nurnberger, JI; Haines, JL; Sutcliffe, JS; Cook, EH; Minshew, NJ; Buxbaum, JD; Dawson, G; Grant, SFA; Geschwind, DH; Pericak-Vance, MA; Schellenberg, GD; Hakonarson, H				Wang, Kai; Zhang, Haitao; Ma, Deqiong; Bucan, Maja; Glessner, Joseph T.; Abrahams, Brett S.; Salyakina, Daria; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Takahashi, Nagahide; Sakurai, Takeshi; Rappaport, Eric; Lajonchere, Clara M.; Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Piven, Joseph; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Ozonoff, Sally; Klin, Ami; Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cantor, Rita M.; Bernier, Raphael; Gilbert, John R.; Cuccaro, Michael L.; McMahon, William M.; Miller, Judith; State, Matthew W.; Wassink, Thomas H.; Coon, Hilary; Levy, Susan E.; Schultz, Robert T.; Nurnberger, John I., Jr.; Haines, Jonathan L.; Sutcliffe, James S.; Cook, Edwin H.; Minshew, Nancy J.; Buxbaum, Joseph D.; Dawson, Geraldine; Grant, Struan F. A.; Geschwind, Daniel H.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Hakonarson, Hakon			Common genetic variants on 5p14.1 associate with autism spectrum disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; FAMILIAL RISK; LINKAGE; LOCI; UNDERCONNECTIVITY; DISCONNECTION; EXPRESSION; IDENTIFICATION; CHROMOSOME	Autism spectrum disorders (ASDs) represent a group of childhood neurodevelopmental and neuropsychiatric disorders characterized by deficits in verbal communication, impairment of social interaction, and restricted and repetitive patterns of interests and behaviour. To identify common genetic risk factors underlying ASDs, here we present the results of genome-wide association studies on a cohort of 780 families (3,101 subjects) with affected children, and a second cohort of 1,204 affected subjects and 6,491 control subjects, all of whom were of European ancestry. Six single nucleotide polymorphisms between cadherin 10 (CDH10) and cadherin 9 (CDH9)-two genes encoding neuronal cell-adhesion molecules-revealed strong association signals, with the most significant SNP being rs4307059 (P = 3.4 x 10(-8), odds ratio = 1.19). These signals were replicated in two independent cohorts, with combined P values ranging from 7.4 x 10(-8) to 2.1 x 10(-10). Our results implicate neuronal cell-adhesion molecules in the pathogenesis of ASDs, and represent, to our knowledge, the first demonstration of genome-wide significant association of common variants with susceptibility to ASDs.	[Wang, Kai; Zhang, Haitao; Glessner, Joseph T.; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miami Inst Human Genom, Miami, FL 33101 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Dept Human Genet, Miami, FL 33101 USA; [Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19014 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Takahashi, Nagahide; Sakurai, Takeshi; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Rappaport, Eric; Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19014 USA; [Lajonchere, Clara M.] Univ So Calif & Autism Speaks, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Dept Psychiat, Seattle, WA 98105 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Piven, Joseph] Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ozonoff, Sally] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Ozonoff, Sally] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [McMahon, William M.; Miller, Judith; Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Iowa City, IA USA; [Nurnberger, John I., Jr.] Indiana Univ, Inst Psychiat Res, Indianapolis, IN 46202 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Miami; University of Miami; University of Pennsylvania; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; University of California System; University of California Davis; Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Haines, Jonathan/C-3374-2012; Takahashi, Nagahide/AAR-6268-2020; State, Matthew/W-2256-2019; Sutcliffe, James S/C-1348-2012; Buxbaum, Joseph D/G-6001-2010; Rappaport, Eric/GRO-4051-2022	Haines, Jonathan/0000-0002-4351-4728; Takahashi, Nagahide/0000-0002-7711-0297; Sutcliffe, James S/0000-0001-5200-6007; Dawson, Geraldine/0000-0003-1410-2764; Buxbaum, Joseph/0000-0001-8898-8313; State, Matthew/0000-0003-1624-8302; Glessner, Joseph/0000-0001-5131-2811; Estes, Annette/0000-0003-2687-4155; Nurnberger, John/0000-0002-7674-1767; Grant, Struan/0000-0003-2025-5302; Wassink, Thomas/0000-0002-0952-8333; Sweeney, John/0000-0003-1752-2828; Munson, Jeffrey A/0000-0003-1798-8927; Salyakina, Daria/0000-0003-3283-3691	National Institute of Mental Health [1U24MH081810]; National Institute of Child Health and Human Development [NO1-HD-4-3368, NO1-HD-4-3383]; Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation [UL1-RR024134-03]; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; NIH [MH64547, HD055782-01, MH0666730, MH061009, NS049261, HD055751, MH69359, M01-RR00064, MH081754, HD055784, NS26630, NS36768, MH080647]; Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055782, P50HD055751, P50HD055748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066673, R01MH080647, R01MH069359, R01MH081754, R01MH061009, R01MH064547, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036768, P01NS026630, R01NS049261] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the children with ASDs and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia (CHOP) for genetic research purposes. We also acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). We thank the technical staff at the Center for Applied Genomics at CHOP for producing the genotypes used for analyses, and the nursing, medical assistant and medical staff for their help with recruitment of patient and control subjects for the study. We thank R. Liu and I. Lindquist for helping with CNV validation. We thank D. J. Hedges, H. N. Cukier, J. L. McCauley, G. W. Beecham, H. H. Wright, R. K. Abramson, E. R. Martin and J. P. Hussman for their comments, advice and statistical support, and the laboratory core and the autism clinical personnel at the Miami Institute for Human Genomics and the autism clinical staff at the Vanderbilt Center for Human Genetics Research. A subset of the CAP participants was ascertained while M. A. P.-V. was a faculty member at Duke University. We thank the National Institutes of Health (NIH)-funded Developmental Brain and Tissue Bank at University of Maryland for access to the fetal brain tissues used in these studies (National Institute of Child Health and Human Development Contract no. NO1-HD-4-3368 and NO1-HD-4-3383). All genotyping of the AGRE and ACC cohort was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) at the Children's Hospital of Philadelphia. The study was supported in part by a Research Award from the Margaret Q. Landenberger Foundation (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G), UL1-RR024134-03 (H. H.), an Alavi-Dabiri fellowship from Mental Retardation and Developmental Disability Research Center at CHOP (K. W.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), NIH grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller and W. M. M.), MH64547, MH081754 (D. H. G.), HD055784 (D. H. G. and M. S.), NS26630, NS36768, MH080647 and a gift from the Hussman Foundation (M. A. P.-V.), the Autism Genome Project Consortium (B. S. A., J. P., C. W. B., D. H. G., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We also acknowledge the partial support to CAP cohort from the Autism Genome Project.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; ALKELAI A, 2008, AM J MED GENET B, V174, P233; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Frith C, 2004, LANCET NEUROL, V3, P577, DOI 10.1016/S1474-4422(04)00875-0; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kools P, 1999, FEBS LETT, V452, P328, DOI 10.1016/S0014-5793(99)00672-9; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MA DQ, ANN HUM GEN IN PRESS, DOI DOI 10.1111/J.1469-1809.2008.00523.X; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sykes Nuala H., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000452; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; 2009, AUTISM DEV DISABILIT	51	706	732	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					528	533		10.1038/nature07999	http://dx.doi.org/10.1038/nature07999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404256	Green Accepted, Green Published			2022-12-24	WOS:000266370500030
J	Munoz, MJ; Santangelo, MSP; Paronetto, MP; de la Mata, M; Pelisch, F; Boireau, S; Glover-Cutter, K; Ben-Dov, C; Blaustein, M; Lozano, JJ; Bird, G; Bentley, D; Bertrand, E; Kornblihtt, AR				Munoz, Manuel J.; Perez Santangelo, M. Soledad; Paronetto, Maria P.; de la Mata, Manuel; Pelisch, Federico; Boireau, Stephanie; Glover-Cutter, Kira; Ben-Dov, Claudia; Blaustein, Matias; Lozano, Juan J.; Bird, Gregory; Bentley, David; Bertrand, Edouard; Kornblihtt, Alberto R.			DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation	CELL			English	Article							PRE-MESSENGER-RNA; SUBCELLULAR-DISTRIBUTION; PROCESSING FACTORS; GENOTOXIC STRESS; IN-VIVO; TRANSCRIPTION; GENE; P53; PHOSPHORYLATION; ALTERS	DNA damage induces apoptosis and many apoptotic genes are regulated via alternative splicing (AS), but little is known about the control mechanisms. Here we show that ultraviolet irradiation (UV) affects cotranscriptional AS in a p53-independent way, through the hyperphosphorylation of RNA polymerase II carboxy-terminal domain (CTD) and a subsequent inhibition of transcriptional elongation, estimated in vivo and in real time. Phosphomimetic CTD mutants not only display lower elongation but also duplicate the UV effect on AS. Consistently, nonphosphorylatable mutants prevent the UV effect. Apoptosis promoted by UV in cells lacking p53 is prevented when the change in AS of the apoptotic gene bcl-x is reverted, confirming the relevance of this mechanism. Splicing-sensitive microarrays revealed a significant overlap of the subsets of genes that have changed AS with UV and those that have reduced expression, suggesting that transcriptional coupling to AS is a key feature of the DNA-damage response.	[Munoz, Manuel J.; Perez Santangelo, M. Soledad; de la Mata, Manuel; Pelisch, Federico; Blaustein, Matias; Kornblihtt, Alberto R.] Univ Buenos Aires, Lab Fisiologia & Biologia Mol, Dept Fisiologia Biologia Mol & Celular, IFIBYNE CONICET,Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Glover-Cutter, Kira; Bird, Gregory; Bentley, David] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Paronetto, Maria P.; Ben-Dov, Claudia; Lozano, Juan J.] Ctr Regulacio Genom, Barcelona 08003, Spain; [Boireau, Stephanie; Bertrand, Edouard] IGMM CNRS UMR 5535, F-34293 Montpellier, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Lab Fisiologia & Biologia Mol, Dept Fisiologia Biologia Mol & Celular, IFIBYNE CONICET,Fac Ciencias Exactas & Nat, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar	Paronetto, Maria Paola/A-9578-2012; Blaustein, Matías/ABF-7951-2020; Pelisch, Federico/C-3815-2011; Pelisch, Federico/H-9219-2013; Glover-Cutter, Kira/S-9046-2016	Paronetto, Maria Paola/0000-0001-5324-0903; Blaustein, Matías/0000-0001-6309-6888; Perez-Santangelo, Maria Soledad/0000-0002-3497-9603; Kornblihtt, Alberto/0000-0003-4322-0831; Lozano, Juan Jose/0000-0001-7613-3908; bertrand, edouard/0000-0002-9642-7994; Pelisch, Federico/0000-0003-4575-1492; Glover-Cutter, Kira/0000-0002-7321-8604; Munoz, Manuel J./0000-0002-1152-5449; de la Mata, Manuel/0000-0003-0631-4038	Fundacion Antorchas; ANPCYT of Argentina; European AS Network (EURASNET); Howard Hughes Medical Institute; NIH [GM58613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058613] Funding Source: NIH RePORTER	Fundacion Antorchas; ANPCYT of Argentina(ANPCyT); European AS Network (EURASNET); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wang for providing PD166326 and V. Gottifredi, S. Kim, M. Raices, M. D'Angelo, R. Verdun, N. Lavagnino, V. Buggiano, G. Soria, and the members of the Srebrow and Kornblihtt labs for help and support. This work was supported by grants to A. R. K. from the Fundacion Antorchas, the ANPCYT of Argentina, and the European AS Network (EURASNET); M. J. M., M. B., and M. d. l. M. are recipients of fellowships and A. R. K. is a career investigator of the CONICET. A. R. K. is an international research scholar of the Howard Hughes Medical Institute. Work in D.B.'s lab is supported by NIH grant GM58613. M. J. M. designed, performed, and interpreted the results of most experiments. M. S. P. S., M. d. l. M., M. B., and F. P. helped perform some experiments. S. B. and E. B. performed the FRAP experiments. G. B., K. G. C., and D. B. generated the CTD mutants and performed the ChIP experiments. M. P. P. and C. B-D. performed the microarray experiments. A. R. K. coordinated the work and prepared the manuscript.	Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Fededa JP, 2005, MOL CELL, V19, P393, DOI 10.1016/j.molcel.2005.06.035; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Lazarev D, 2007, RNA, V13, P1546, DOI 10.1261/rna.595907; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nicholls CD, 2004, J BIOL CHEM, V279, P24171, DOI 10.1074/jbc.M401049200; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shomron N, 2005, J CELL SCI, V118, P1151, DOI 10.1242/jcs.01720; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200	40	224	228	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 15	2009	137	4					708	720		10.1016/j.cell.2009.03.010	http://dx.doi.org/10.1016/j.cell.2009.03.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	446IA	19450518	Bronze			2022-12-24	WOS:000266114100019
J	Nowacki, M; Higgins, BP; Maquilan, GM; Swart, EC; Doak, TG; Landweber, LF				Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Doak, Thomas G.; Landweber, Laura F.			A Functional Role for Transposases in a Large Eukaryotic Genome	SCIENCE			English	Article							INTERNAL ELIMINATED SEQUENCES; CILIATED PROTOZOA; OXYTRICHA-FALLAX; PRECISE EXCISION; ELEMENTS; DNA; REARRANGEMENT; TETRAHYMENA; TRIFALLAX; EVOLUTION	Despite comprising much of the eukaryotic genome, few transposons are active, and they usually confer no benefit to the host. Through an exaggerated process of genome rearrangement, Oxytricha trifallax destroys 95% of its germline genome during development. This includes the elimination of all transposon DNA. We show that germline-limited transposase genes play key roles in this process of genome-wide DNA excision, which suggests that transposases function in large eukaryotic genomes containing thousands of active transposons. We show that transposase gene expression occurs during germline-soma differentiation and that silencing of transposase by RNA interference leads to abnormal DNA rearrangement in the offspring. This study suggests a new important role in Oxytricha for this large portion of genomic DNA that was previously thought of as junk.	[Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Doak, Thomas G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Princeton University; Indiana University System; Indiana University Bloomington	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Doak, Thomas/0000-0001-5487-553X	NSF [0622112]; NIH [GM59708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant 0622112 and NIH grant GM59708. We thank J. Wang for technical assistance. DNA sequences have been deposited in GenBank under accession numbers FJ666213 [GenBank] -FJ666314 [GenBank] (TBE transposases), FJ545743 [GenBank] [ribosomal DNA (rDNA) macronucleus], and FJ545744 [GenBank] (rDNA micronucleus).	Chalker DL, 1996, MOL CELL BIOL, V16, P3658; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Doak TG, 1997, GENETICA, V101, P75, DOI 10.1023/A:1018331118647; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; HERRICK G, 1985, CELL, V43, P759, DOI 10.1016/0092-8674(85)90249-1; HUNTER DJ, 1989, GENE DEV, V3, P2101, DOI 10.1101/gad.3.12b.2101; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Seegmiller A, 1996, MOL BIOL EVOL, V13, P1351, DOI 10.1093/oxfordjournals.molbev.a025581; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809	20	84	86	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					935	938		10.1126/science.1170023	http://dx.doi.org/10.1126/science.1170023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372392	Green Accepted			2022-12-24	WOS:000266048800038
J	Tahiliani, M; Koh, KP; Shen, YH; Pastor, WA; Bandukwala, H; Brudno, Y; Agarwal, S; Iyer, LM; Liu, DR; Aravind, L; Rao, A				Tahiliani, Mamta; Koh, Kian Peng; Shen, Yinghua; Pastor, William A.; Bandukwala, Hozefa; Brudno, Yevgeny; Agarwal, Suneet; Iyer, Lakshminarayan M.; Liu, David R.; Aravind, L.; Rao, Anjana			Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; GLYCOSYLASE ACTIVITY; CXXC DOMAIN; BASE-J; DEMETHYLATION; CYTOSINE; METHYLATION; PROTEIN; METHYLTRANSFERASE; T(10/11)(Q22,Q23)	DNA cytosine methylation is crucial for retrotransposon silencing and mammalian development. In a computational search for enzymes that could modify 5-methylcytosine (5mC), we identified TET proteins as mammalian homologs of the trypanosome proteins JBP1 and JBP2, which have been proposed to oxidize the 5-methyl group of thymine. We show here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. hmC is present in the genome of mouse embryonic stem cells, and hmC levels decrease upon RNA interference-mediated depletion of TET1. Thus, TET proteins have potential roles in epigenetic regulation through modification of 5mC to hmC.	[Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Agarwal, Suneet] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet] Dana Farber Canc Inst, Boston, MA 02115 USA; [Iyer, Lakshminarayan M.; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu; aravind@ncbi.nlm.nih.gov; arao@idi.harvard.edu	Koh, Kian Peng/S-6279-2016; Liu, David R./HCH-3132-2022; Erlitzki, Noa/AHC-5346-2022; Iyer, Lakshminarayan M./H-2996-2019	Koh, Kian Peng/0000-0003-2523-5175; Aravind, L/0000-0003-0771-253X; Brudno, Yevgeny/0000-0003-2963-3293	NIH [AI44432, K08 HL089150]; a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute [Seed]; Howard Hughes Medical Institute; NIH/NIGMS [R01GM065865]; American Heart Association postdoctoral fellowship; National Library of Medicine, NIH; Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association postdoctoral fellowship(American Heart Association); National Library of Medicine, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank K. Kreuzer for the gift of the T4 phage and E. coli ER1656 and CR63; Charles Richardson, Udi Qimron, and Ben Beauchamp for advice and assistance in culturing T4 phage; Melissa Call for advice on production of recombinant proteins in insect cells; and Patrick Hogan for many helpful discussions. This work was supported by NIH grant AI44432, a Scholar Award from the Juvenile Diabetes Research Foundation, and a Seed grant from the Harvard Stem Cell Institute (to A.R.); Howard Hughes Medical Institute and NIH/NIGMS (R01GM065865) funding (to D.R.L.); an American Heart Association postdoctoral fellowship (to K.P.K.); intramural funds of the National Library of Medicine, NIH (to L.A. and L.M.I.); a Lady Tata Memorial postdoctoral fellowship (to H.B.); NIH award K08 HL089150 (to S.A.); NSF Graduate Fellowships (to W.A.P. and Y.B.); and a Department of Defense graduate fellowship (to W.A.P.).	ALEGRIA AH, 1967, BIOCHIM BIOPHYS ACTA, V149, P317, DOI 10.1016/0005-2787(67)90159-1; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; ARAVIND L, 2001, GENOME BIOL, V2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; DELHOMMEAU F, 2008, AM SOC HEM ANN M EXP; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FLAKS JG, 1959, J BIOL CHEM, V234, P1501; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	33	3966	4175	13	606	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					930	935		10.1126/science.1170116	http://dx.doi.org/10.1126/science.1170116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372391	Green Submitted, Green Accepted			2022-12-24	WOS:000266048800037
J	Ma, Y; Szostkiewicz, I; Korte, A; Moes, D; Yang, Y; Christmann, A; Grill, E				Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin			Regulators of PP2C Phosphatase Activity Function as Abscisic Acid Sensors	SCIENCE			English	Article							EARLY SEEDLING DEVELOPMENT; CRYSTAL-STRUCTURE; ABA CONTROL; ARABIDOPSIS; PROTEIN; ABI1; GERMINATION; RECEPTOR; SIGNAL; TRANSDUCTION	The plant hormone abscisic acid (ABA) acts as a developmental signal and as an integrator of environmental cues such as drought and cold. Key players in ABA signal transduction include the type 2C protein phosphatases (PP2Cs) ABI1 and ABI2, which act by negatively regulating ABA responses. In this study, we identify interactors of ABI1 and ABI2, which we have named regulatory components of ABA receptor (RCARs). In Arabidopsis, RCARs belong to a family with 14 members that share structural similarity with class 10 pathogen-related proteins. RCAR1 was shown to bind ABA, to mediate ABA-dependent inactivation of ABI1 or ABI2 in vitro, and to antagonize PP2C action in planta. Other RCARs also mediated ABA-dependent regulation of ABI1 and ABI2, consistent with a combinatorial assembly of receptor complexes.	[Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin] Tech Univ Munich, Lehrstuhl Bot, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Grill, E (corresponding author), Tech Univ Munich, Lehrstuhl Bot, Hochanger 4, D-85354 Freising Weihenstephan, Germany.	erwin.grill@wzw.tum.de	Christmann, Alexander/I-2655-2017; Korte, Arthur/H-3190-2019	Christmann, Alexander/0000-0002-3242-0814; Korte, Arthur/0000-0003-0831-1463; Yang, Yi/0000-0001-6051-4992	Deutsche Forschungsgemeinschaft [CH-182/5]; European Union Marie-Curie-Program [MEST-CT-2005-020232]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Marie-Curie-Program(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This study was funded by the Deutsche Forschungsgemeinschaft CH-182/5, European Union Marie-Curie-Program MEST-CT-2005-020232, and the Fonds der Chemischen Industrie. We thank J. Berger, C. Heidersberger, and C. Kornbauer for technical assistance. We are grateful to D. Weinfurtner, Chemistry Department TUM, and K. Berendzen, University of Tubingen, for help in conducting the ITC and FACS analysis, respectively. The cytokinin reporter and the At5g46790 cDNA clone were kindly provided by J. Sheen, Harvard University, and the Arabidopsis Biological Resource Center, USA, respectively. We thank F. Assaad for critical reading of the manuscript. This contribution is dedicated to Hubert Ziegler, who passed away on 17 April 2009.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Leube MP, 1998, FEBS LETT, V424, P100, DOI 10.1016/S0014-5793(98)00149-5; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Yang Y, 2006, P NATL ACAD SCI USA, V103, P6061, DOI 10.1073/pnas.0501720103; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128	31	1518	1674	11	449	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1064	1068		10.1126/science.1172408	http://dx.doi.org/10.1126/science.1172408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407143				2022-12-24	WOS:000266246700040
J	Tsai, HC; Zhang, F; Adamantidis, A; Stuber, GD; Bonci, A; de Lecea, L; Deisseroth, K				Tsai, Hsing-Chen; Zhang, Feng; Adamantidis, Antoine; Stuber, Garret D.; Bonci, Antonello; de Lecea, Luis; Deisseroth, Karl			Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning	SCIENCE			English	Article							PLACE PREFERENCE; DEFICIENT MICE; REWARD; ADDICTION; SYSTEMS; CHANNELRHODOPSIN-2; DYSREGULATION; MOTIVATION; CIRCUIT; HABITS	Natural rewards and drugs of abuse can alter dopamine signaling, and ventral tegmental area (VTA) dopaminergic neurons are known to fire action potentials tonically or phasically under different behavioral conditions. However, without technology to control specific neurons with appropriate temporal precision in freely behaving mammals, the causal role of these action potential patterns in driving behavioral changes has been unclear. We used optogenetic tools to selectively stimulate VTA dopaminergic neuron action potential firing in freely behaving mammals. We found that phasic activation of these neurons was sufficient to drive behavioral conditioning and elicited dopamine transients with magnitudes not achieved by longer, lower-frequency spiking. These results demonstrate that phasic dopaminergic activity is sufficient to mediate mammalian behavioral conditioning.	[Tsai, Hsing-Chen] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Adamantidis, Antoine; de Lecea, Luis; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Stuber, Garret D.; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Deisseroth, K (corresponding author), Stanford Univ, Neurosci Program, W080 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Stuber, Garret/E-1160-2011; de Lecea, Luis/ABE-4005-2021; de Lecea, Luis/B-3171-2009; Macrae, Rhiannon/AAX-1536-2020	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Stuber, Garret/0000-0003-1730-4855; Adamantidis, Antoine/0000-0003-2531-5175	Stanford Graduate Fellowship; NIH National Research Service award; Fonds National de la Recherche Scientifique; NARSAD; Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA); Defense Advanced Research Projects Agency; NSF; National Institute of Mental Health; McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS065009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021880] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NIH National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NARSAD(NARSAD); Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Wightman, P. Phillips, and the entire Deisseroth laboratory for their support. All reagents and protocols are freely distributed and supported by the authors (www.optogenetics.org); because these tools are not protected by patents, Stanford University has applied for a patent to ensure perpetual free distribution to the international academic nonprofit community. H.C.T. is supported by a Stanford Graduate Fellowship. F.Z. and G.D.S. are supported by NIH National Research Service award. A.R.A. is supported by the Fonds National de la Recherche Scientifique, NARSAD, and the Fondation Leon Fredericq. L.d.L. is supported by National Institute on Drug Abuse (NIDA), Defense Advanced Research Projects Agency, and NARSAD. K.D. is supported by NSF; National Institute of Mental Health; NIDA; and the McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cannon CM, 2003, J NEUROSCI, V23, P10827; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Picciotto MR, 2002, J NEUROSCI, V22, P3338; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Williams J, 2005, J CHILD ADOL PSYCHOP, V15, P160, DOI 10.1089/cap.2005.15.160; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang F., 2008, COLD SPRING HARB LAB; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	29	828	877	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1080	1084		10.1126/science.1168878	http://dx.doi.org/10.1126/science.1168878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389999	Green Accepted			2022-12-24	WOS:000266246700044
J	Heintzman, ND; Hon, GC; Hawkins, RD; Kheradpour, P; Stark, A; Harp, LF; Ye, Z; Lee, LK; Stuart, RK; Ching, CW; Ching, KA; Antosiewicz-Bourget, JE; Liu, H; Zhang, XM; Green, RD; Lobanenkov, VV; Stewart, R; Thomson, JA; Crawford, GE; Kellis, M; Ren, B				Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Kheradpour, Pouya; Stark, Alexander; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Antosiewicz-Bourget, Jessica E.; Liu, Hui; Zhang, Xinmin; Green, Roland D.; Lobanenkov, Victor V.; Stewart, Ron; Thomson, James A.; Crawford, Gregory E.; Kellis, Manolis; Ren, Bing			Histone modifications at human enhancers reflect global cell-type-specific gene expression	NATURE			English	Article							HUMAN GENOME; BINDING-SITES; TRANSCRIPTION; PROMOTERS; ELEMENTS; SEQUENCE; RECEPTOR; MAP	The human body is composed of diverse cell types with distinct functions. Although it is known that lineage specification depends on cell-specific gene expression, which in turn is driven by promoters, enhancers, insulators and other cis-regulatory DNA sequences for each gene(1-3), the relative roles of these regulatory elements in this process are not clear. We have previously developed a chromatin-immunoprecipitation-based microarray method (ChIP-chip) to locate promoters, enhancers and insulators in the human genome(4-6). Here we use the same approach to identify these elements in multiple cell types and investigate their roles in cell-type-specific gene expression. We observed that the chromatin state at promoters and CTCF-binding at insulators is largely invariant across diverse cell types. In contrast, enhancers are marked with highly cell-type-specific histone modification patterns, strongly correlate to cell-type-specific gene expression programs on a global scale, and are functionally active in a cell-type-specific manner. Our results define over 55,000 potential transcriptional enhancers in the human genome, significantly expanding the current catalogue of human enhancers and highlighting the role of these elements in cell-type-specific gene expression.	[Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Heintzman, Nathaniel D.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hon, Gary C.] Univ Calif San Diego, Sch Med, Bioinformat Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kheradpour, Pouya; Stark, Alexander; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Stark, Alexander; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Antosiewicz-Bourget, Jessica E.; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Liu, Hui; Zhang, Xinmin; Green, Roland D.] Roche NimbleGen Inc, Madison, WI 53719 USA; [Lobanenkov, Victor V.] NIAID, Rockville, MD 20852 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Crawford, Gregory E.] Duke Univ, Dept Pediat, Durham, NC 27708 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; Roche Holding; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Lobanenkov, Victor/ABD-5710-2021; Stark, Alexander/D-1473-2012; Kellis, Manolis/ABE-7385-2020; Lobanenkov, Victor V./AGQ-8903-2022	Stark, Alexander/0000-0003-2611-0841; Kellis, Manolis/0000-0001-7113-9630; Lobanenkov, Victor/0000-0001-6665-3635; Stuart, Rhona/0000-0001-5916-9693	American Cancer Society; NIAID; LICR; NHGRI; NCI; CIRM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000860] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LICR; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Ren laboratory for comments. This work was supported by funding from American Cancer Society (R. D. H.), NIAID Intramural Research Program (V. V. L.), LICR (B. R.), NHGRI (B. R.), NCI (B. R.) and CIRM (B. R.).	Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wolf AT, 2005, BLOOD, V105, P1060, DOI 10.1182/blood-2003-12-4383; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	25	1711	1752	2	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					108	112		10.1038/nature07829	http://dx.doi.org/10.1038/nature07829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19295514	Green Accepted, Green Submitted			2022-12-24	WOS:000265801300039
J	Kim, T; Buratowski, S				Kim, TaeSoo; Buratowski, Stephen			Dimethylation of H3K4 by Set1 Recruits the Set3 Histone Deacetylase Complex to 5 ' Transcribed Regions	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHD FINGER; TRANSCRIPTIONAL ELONGATION; H2B MONOUBIQUITINATION; LYSINE-4 METHYLATION; GENE-EXPRESSION; BINDING MODULES; YEAST	Cotranscriptional histone methylations by Set1 and Set2 have been shown to affect histone acetylation at promoters and 3' regions of genes, respectively. While histone H3K4 trimethylation (H3K4me3) is thought to promote nucleosome acetylation and remodeling near promoters, we show here that H3K4 dimethylation (H3K4me2) by Set1 leads to reduced histone acetylation levels near 5' ends of genes. H3K4me2 recruits the Set3 complex via the Set3 PHD finger, localizing the Hos2 and Hst1 subunits to deacetylate histones in 5' transcribed regions. Cells lacking the Set1-Set3 complex pathway are sensitive to mycophenolic acid and have reduced polymerase levels at a Set3 target gene, suggesting a positive role in transcription. We propose that Set1 establishes two distinct chromatin zones on genes: H3K4me3 leads to high levels of acetylation and low nucleosome density at promoters, while H3K4me2 just downstream recruits the Set3 complex to suppress nucleosome acetylation and remodeling.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Kim, TaeSoo/0000-0002-3902-1058	United States National Institutes of Health [GM46498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R29GM046498] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Gozani (Stanford) for histone peptides, S. Briggs (Purdue) for plasmids, L. Howe (University of British Columbia) and M. Keogh (Albert Einstein College of Medicine) for strains, and N. Krogan (University of California, San Francisco), O. Rando (University of Massachusetts, Worcester), and all members of the Buratowski lab for helpful advice and discussions. T. K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grant GM46498 to S.B. from the United States National Institutes of Health.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Flanagan JF, 2007, J MOL BIOL, V369, P334, DOI 10.1016/j.jmb.2007.03.024; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okuda M, 2007, J MOL BIOL, V365, P1047, DOI 10.1016/j.jmb.2006.10.039; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	59	228	233	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					259	272		10.1016/j.cell.2009.02.045	http://dx.doi.org/10.1016/j.cell.2009.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379692	Green Accepted, Bronze			2022-12-24	WOS:000265456800019
J	Xu, P; Duong, DM; Seyfried, NT; Cheng, DM; Xie, Y; Robert, J; Rush, J; Hochstrasser, M; Finley, D; Peng, J				Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Xie, Yang; Robert, Jessica; Rush, John; Hochstrasser, Mark; Finley, Daniel; Peng, Junmin			Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation	CELL			English	Article							DOA4 DEUBIQUITINATING ENZYME; MASS-SPECTROMETRY; POLYUBIQUITIN CHAINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN LIGASES; 26S PROTEASOME; IN-VITRO; YEAST; COMPLEX	All seven lysine residues in ubiquitin contribute to the synthesis of polyubiquitin chains on protein substrates. Whereas K48-linked chains are well established as mediators of proteasomal degradation, and K63-linked chains act in nonproteolytic events, the roles of unconventional polyubiquitin chains linked through K6, K11, K27, K29, or K33 are not well understood. Here, we report that the unconventional linkages are abundant in vivo and that all non-K63 linkages may target proteins for degradation. Ubiquitin with K48 as the single lysine cannot support yeast viability, and different linkages have partially redundant functions. By profiling both the entire yeast proteome and ubiquitinated proteins in wild-type and ubiquitin K11R mutant strains using mass spectrometry, we identified K11 linkage-specific substrates, including Ubc6, a ubiquitin-conjugating enzyme involved in endoplasmic reticulum-associated degradation (ERAD). Ubc6 primarily synthesizes K11-linked chains, and K11 linkages function in the ERAD pathway. Thus, unconventional polyubiquitin chains are critical for ubiquitin-proteasome system function.	[Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Xie, Yang; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Robert, Jessica; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Beverly, MA 01915 USA	Emory University; Yale University; Harvard University; Harvard Medical School	Peng, J (corresponding author), Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jpeng@emory.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Hochstrasser, Mark/0000-0002-1131-5484; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [GM046904, GM043601, DK069580, CA126222, AG025688]; NATIONAL CANCER INSTITUTE [R21CA126222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM046904, R37GM046904, R01GM043601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Coffino, A. Corbett, G. Crouse, R. Cohen, E. Dammer, J. Fridovich-Keil, M. Hoyt, M. Jonikas, C. Kahana, C.-W. Liu, J. Mullally, P. Philippsen, D. Reines, J. Roelofs, R. Rothstein, T. Sommer, Y. Tone, P. Walter, J. Weissman, K. Wilkinson, Q. Xia, and T. Yao for reagents and discussion. We also thank D. Kirkpatrick and K. Wilkinson for critical reading and H. Boldt and C. Strauss for editing. This work was funded by National Institutes of Health grants (GM046904 to M.H.; GM043601 to D.F.; and DK069580, CA126222, and AG025688 to J.P.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE	43	796	831	4	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					133	145		10.1016/j.cell.2009.01.041	http://dx.doi.org/10.1016/j.cell.2009.01.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345192	Green Accepted, Bronze			2022-12-24	WOS:000264813300020
J	Jonikas, MC; Collins, SR; Denic, V; Oh, E; Quan, EM; Schmid, V; Weibezahn, J; Schwappach, B; Walter, P; Weissman, JS; Schuldiner, M				Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Schmid, Volker; Weibezahn, Jimena; Schwappach, Blanche; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya			Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; TAIL-ANCHORED PROTEINS; QUALITY-CONTROL; MISFOLDED PROTEINS; SECRETORY PATHWAY; YEAST; ER; DEGRADATION; INSERTION; MEMBRANE	Protein folding in the endoplasmic reticulum is a complex process whose malfunction is implicated in disease and aging. By using the cell's endogenous sensor (the unfolded protein response), we identified several hundred yeast genes with roles in endoplasmic reticulum folding and systematically characterized their functional interdependencies by measuring unfolded protein response levels in double mutants. This strategy revealed multiple conserved factors critical for endoplasmic reticulum folding, including an intimate dependence on the later secretory pathway, a previously uncharacterized six-protein transmembrane complex, and a co-chaperone complex that delivers tail-anchored proteins to their membrane insertion machinery. The use of a quantitative reporter in a comprehensive screen followed by systematic analysis of genetic dependencies should be broadly applicable to functional dissection of complex cellular processes from yeast to human.	[Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Schmid, Volker; Schwappach, Blanche] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Manchester	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Schuldiner, Maya/C-9488-2009	Schwappach, Blanche/0000-0003-0225-6432; Schuldiner, Maya/0000-0001-9947-115X; Weissman, Jonathan/0000-0003-2445-670X; Oh, Eugene/0000-0003-1970-8423; Collins, Sean/0000-0002-4276-5840	Howard Hughes Medical Institute; NSF; International Human Frontier Science Program; NIH [K99/R00]; European Molecular Biology Organization long-term fellowship; Deutsche Forschungsgemeinschaft; Wellcome Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); International Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C.-S. Chin for flow cytometry software development; C. Boone, D. Breslow, N. Krogan, D. Ng, and C. Wang for reagents; K. Thorn for microscopy assistance; S. Zhou, D. King, G. Cagney, and N. Krogan for mass spectrometry analyses; J. Metz, P. Nittler, A. Carroll, J. Hill, J. Ihmels, S. Wang, and C. Chu for technical help; R. Andino, T. Aragon, A. Battle, N. Bradshaw, J. DeRisi, N. Friedman, J. Hollien, J. Newman, D. Koller, R. Kupferman, H. Madhani, L. Osherovich, F. Papa, and members of the Weissman, Walter, and Schwappach labs for stimulating discussion; B. Toyama for graphics; and M. Bassik, D. Breslow, O. Brandman, S. Churchman, and S. Neher for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute (J.S.W. and P.W.), the NSF (M.C.J. and E.M.Q.), the International Human Frontier Science Program (M.S. and J.W.), an NIH K99/R00 award (M.S.), a European Molecular Biology Organization long-term fellowship (J.W.), the Deutsche Forschungsgemeinschaft (V.S.), and the Wellcome Trust (B.S.).	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	33	503	521	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1693	1697		10.1126/science.1167983	http://dx.doi.org/10.1126/science.1167983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325107	Green Accepted			2022-12-24	WOS:000264559800030
J	Baek, KH; Zaslavsky, A; Lynch, RC; Britt, C; Okada, Y; Siarey, RJ; Lensch, MW; Park, IH; Yoon, SS; Minami, T; Korenberg, JR; Folkman, J; Daley, GQ; Aird, WC; Galdzicki, Z; Ryeom, S				Baek, Kwan-Hyuck; Zaslavsky, Alexander; Lynch, Ryan C.; Britt, Carmella; Okada, Yoshiaki; Siarey, Richard J.; Lensch, M. William; Park, In-Hyun; Yoon, Sam S.; Minami, Takashi; Korenberg, Julie R.; Folkman, Judah; Daley, George Q.; Aird, William C.; Galdzicki, Zygmunt; Ryeom, Sandra			Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1	NATURE			English	Article							CRITICAL REGION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; CYCLOSPORINE-A; MOUSE MODEL; ANGIOGENESIS; VEGF; TARGET; CHROMOSOME-21; REGRESSION	The incidence of many cancer types is significantly reduced in individuals with Down's syndrome(1-4), and it is thought that this broad cancer protection is conferred by the increased expression of one or more of the 231 supernumerary genes on the extra copy of chromosome 21. One such gene is Down's syndrome candidate region-1 (DSCR1, also known as RCAN1), which encodes a protein that suppresses vascular endothelial growth factor ( VEGF)mediated angiogenic signalling by the calcineurin pathway(5-10). Here we show that DSCR1 is increased in Down's syndrome tissues and in a mouse model of Down's syndrome. Furthermore, we show that the modest increase in expression afforded by a single extra transgenic copy of Dscr1 is sufficient to confer significant suppression of tumour growth in mice, and that such resistance is a consequence of a deficit in tumour angiogenesis arising from suppression of the calcineurin pathway. We also provide evidence that attenuation of calcineurin activity by DSCR1, together with another chromosome 21 gene Dyrk1a, may be sufficient to markedly diminish angiogenesis. These data provide a mechanism for the reduced cancer incidence in Down's syndrome and identify the calcineurin signalling pathway, and its regulators DSCR1 and DYRK1A, as potential therapeutic targets in cancers arising in all individuals.	[Baek, Kwan-Hyuck; Zaslavsky, Alexander; Lynch, Ryan C.; Britt, Carmella; Folkman, Judah; Ryeom, Sandra] Childrens Hosp Boston, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Okada, Yoshiaki; Aird, William C.] Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Siarey, Richard J.; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Serv, Sch Med, Mol & Cellular Biol Program, Dept Anat Physiol & Genet Neurosci, Bethesda, MD 20814 USA; [Lensch, M. William; Park, In-Hyun; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Dept Med, Boston, MA 02115 USA; [Lensch, M. William; Park, In-Hyun; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA; [Minami, Takashi] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Korenberg, Julie R.] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA; [Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA	Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; University of Tokyo; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ryeom, S (corresponding author), Childrens Hosp Boston, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.	sandra.ryeom@childrens.harvard.edu	Okada, Yoshiaki/M-8718-2017		Howard Hughes Medical Institute; Harvard Stem Cell Institute; National Institute of Health Director's Pioneer Award; NHLBI; Jerome Lejeune Foundation; USUHS; Smith Family Medical Foundation; Garrett B. Smith Foundation; Annie's Fun Foundation; NATIONAL CANCER INSTITUTE [R01CA118374] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; National Institute of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jerome Lejeune Foundation; USUHS; Smith Family Medical Foundation; Garrett B. Smith Foundation; Annie's Fun Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Evan, C. Kim, K. Cichowski and J. Italiano for critical discussions and advice. This work was supported by the Howard Hughes Medical Institute ( G. Q. D.), Harvard Stem Cell Institute ( G. Q. D.), the National Institute of Health Director's Pioneer Award ( G. Q. D.), NHLBI ( W. C. A.), Jerome Lejeune Foundation ( Z. G.), USUHS ( Z. G.), the Smith Family Medical Foundation ( S. R.), the Garrett B. Smith Foundation ( S. R.) and Annie's Fun Foundation ( S. R.).	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fulcher T, 1998, BRIT J OPHTHALMOL, V82, P407, DOI 10.1136/bjo.82.4.407; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harashima C, 2006, CELL MOL NEUROBIOL, V26, P719, DOI 10.1007/s10571-006-9066-4; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Satge D, 1998, CANCER RES, V58, P448; SHI YP, 1994, MAMM GENOME, V5, P337, DOI 10.1007/BF00356551; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176	30	264	270	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2009	459	7250					1126	U113		10.1038/nature08062	http://dx.doi.org/10.1038/nature08062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	466BX	19458618	Green Accepted			2022-12-24	WOS:000267636700043
J	Kato, M; Sanada, M; Kato, I; Sato, Y; Takita, J; Takeuchi, K; Niwa, A; Chen, YY; Nakazaki, K; Nomoto, J; Asakura, Y; Muto, S; Tamura, A; Iio, M; Akatsuka, Y; Hayashi, Y; Mori, H; Igarashi, T; Kurokawa, M; Chiba, S; Mori, S; Ishikawa, Y; Okamoto, K; Tobinai, K; Nakagama, H; Nakahata, T; Yoshino, T; Kobayashi, Y; Ogawa, S				Kato, Motohiro; Sanada, Masashi; Kato, Itaru; Sato, Yasuharu; Takita, Junko; Takeuchi, Kengo; Niwa, Akira; Chen, Yuyan; Nakazaki, Kumi; Nomoto, Junko; Asakura, Yoshitaka; Muto, Satsuki; Tamura, Azusa; Iio, Mitsuru; Akatsuka, Yoshiki; Hayashi, Yasuhide; Mori, Hiraku; Igarashi, Takashi; Kurokawa, Mineo; Chiba, Shigeru; Mori, Shigeo; Ishikawa, Yuichi; Okamoto, Koji; Tobinai, Kensei; Nakagama, Hitoshi; Nakahata, Tatsutoshi; Yoshino, Tadashi; Kobayashi, Yukio; Ogawa, Seishi			Frequent inactivation of A20 in B-cell lymphomas	NATURE			English	Article							NF-KAPPA-B; CLASSICAL HODGKIN LYMPHOMA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS FACTOR-ALPHA; ZINC-FINGER PROTEIN; EPSTEIN-BARR-VIRUS; ACTIVATION; TNFAIP3; GENE; INHIBITOR	A20 is a negative regulator of the NF-kappa B pathway and was initially identified as being rapidly induced after tumour-necrosis factor-alpha stimulation(1). It has a pivotal role in regulation of the immune response and prevents excessive activation of NF-kappa B in response to a variety of external stimuli(2-7); recent genetic studies have disclosed putative associations of polymorphic A20 (also called TNFAIP3) alleles with autoimmune disease risk(8,9). However, the involvement of A20 in the development of human cancers is unknown. Here we show, using a genome-wide analysis of genetic lesions in 238 B-cell lymphomas, that A20 is a common genetic target in B-lineage lymphomas. A20 is frequently inactivated by somatic mutations and/or deletions in mucosa-associated tissue lymphoma (18 out of 87; 21.8%) and Hodgkin's lymphoma of ;nodular sclerosis histology (5 out of 15; 33.3%), and, to a lesser extent, in other B-lineage lymphomas. When re-expressed in a lymphoma-derived cell line with no functional A20 alleles, wildtype A20, but not mutant A20, resulted in suppression of cell growth and induction of apoptosis, accompanied by down-regulation of NF-kappa B activation. The A20-deficient cells stably generated tumours in immunodeficient mice, whereas the tumorigenicity was effectively suppressed by re-expression of A20. In A20-deficient cells, suppression of both cell growth and NF-kappa B activity due to re-expression of A20 depended, at least partly, on cell-surface-receptor signalling, including the tumour-necrosis factor receptor. Considering the physiological function of A20 in the negative modulation of NF-kappa B activation induced by multiple upstream stimuli, our findings indicate that uncontrolled signalling of NF-kappa B caused by loss of A20 function is involved in the pathogenesis of subsets of B-lineage lymphomas.	[Kato, Motohiro; Sanada, Masashi; Takita, Junko; Chen, Yuyan; Nakazaki, Kumi; Muto, Satsuki; Tamura, Azusa; Iio, Mitsuru; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Kato, Motohiro; Takita, Junko; Chen, Yuyan; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Takita, Junko; Chiba, Shigeru] Univ Tokyo, Dept Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nakazaki, Kumi; Kurokawa, Mineo] Univ Tokyo, Dept Hematol & Oncol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Sanada, Masashi; Nakazaki, Kumi; Ogawa, Seishi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Kato, Itaru; Niwa, Akira; Nakahata, Tatsutoshi] Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan; [Sato, Yasuharu; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Kita Ku, Okayama 7008558, Japan; [Takeuchi, Kengo; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Koto Ku, Tokyo 1358550, Japan; [Nomoto, Junko; Asakura, Yoshitaka; Tobinai, Kensei; Kobayashi, Yukio] Natl Canc Ctr, Div Hematol, Chuo Ku, Tokyo 1040045, Japan; [Okamoto, Koji; Nakagama, Hitoshi] Natl Canc Ctr, Early Oncogenesis Res Project, Res Inst, Chuo Ku, Tokyo 1040045, Japan; [Asakura, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Immunol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa 3778577, Japan; [Mori, Hiraku] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan; [Mori, Shigeo] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Okayama University; Japanese Foundation for Cancer Research; National Cancer Center - Japan; National Cancer Center - Japan; Aichi Cancer Center; Gunma Children's Medical Centre; Showa University; Teikyo University	Ogawa, S (corresponding author), Univ Tokyo, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ykkobaya@ncc.go.jp; sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; Chen, Yuyan/V-7279-2019; Kobayahi, Yukio/E-9081-2017; Takeuchi, Kengo/C-3614-2008	Chen, Yuyan/0000-0002-2894-1430; Kobayahi, Yukio/0000-0003-2378-7865; Takeuchi, Kengo/0000-0002-1599-5800; akatsuka, yoshiki/0000-0003-3623-2826; Kato, Motohiro/0000-0001-5145-1774	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [21390316] Funding Source: KAKEN	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, by the 21 st century centre of excellence program 'Study on diseases caused by environment/genome interactions', and by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor and Welfare of Japan for the 3rd- term Comprehensive 10-year Strategy for Cancer Control. We also thank Y. Ogino, E. Matsui and M. Matsumura for their technical assistance.	Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Durkop H, 2003, J PATHOL, V200, P229, DOI 10.1002/path.1351; Fries KL, 1999, VIROLOGY, V264, P159, DOI 10.1006/viro.1999.9980; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; HSU PL, 1989, AM J PATHOL, V135, P735; Jaffe ES, 2001, WHO CLASSIFICATION T; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; SARMA V, 1995, J BIOL CHEM, V270, P12343, DOI 10.1074/jbc.270.21.12343; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6	29	419	435	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					712	U118		10.1038/nature07969	http://dx.doi.org/10.1038/nature07969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19412163				2022-12-24	WOS:000266608600046
J	Saeki, Y; Toh-e, A; Kudo, T; Kawamura, H; Tanaka, K				Saeki, Yasushi; Toh-e, Akio; Kudo, Tai; Kawamura, Hitomi; Tanaka, Keiji			Multiple Proteasome-Interacting Proteins Assist the Assembly of the Yeast 19S Regulatory Particle	CELL			English	Article							26 S-PROTEASOME; SACCHAROMYCES-CEREVISIAE; UBIQUITIN SYSTEM; 20S PROTEASOMES; CDNA CLONING; HSM3 GENE; GANKYRIN; DEGRADATION; SUBUNITS; ATPASES	The 26S proteasomeis a highly conserved multisubunit protease that degrades ubiquitinated proteins in eukaryotic cells. The 26S proteasome consists of the proteolytic core particle (CP) and one or two 19S regulatory particles (RPs). Although the mechanisms of CP assembly are well described, the mechanism of RP assembly is largely unknown. Here, we show that four proteasome-interacting proteins (PIPs), Nas2/p27, Nas6/gankyrin, Rpn14/PAAF1, and Hsm3/S5b, bind specific Rpt subunits of the RP and interact each other genetically. Lack of these PIPs resulted in defective assembly of the 26S proteasome at an early stage, suggesting that these proteins are bona fide RP chaperones. Each of the RP chaperones formed distinct specific subassemblies of the base components and escorted them to mature RPs. Our results indicate that the RP assembly is a highly organized and elaborate process orchestrated by multiple proteasome-dedicated chaperones.	[Saeki, Yasushi; Toh-e, Akio; Kudo, Tai; Kawamura, Hitomi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Toh-e, A (corresponding author), Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	toue-ak@igakuken.or.jp; tanaka-kj@igakuken.or.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453	Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan; Target Protein Project of MEXT	Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Target Protein Project of MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank B. P. Cormack for kindly providing the yEGFP1 plasmid. We are grateful to all members of K.T.'s laboratory for the useful discussions. This work was supported by grants from the Ministry of Education, Science, Sports, Culture, and Technology ( MEXT) of Japan ( to A. T. and K. T.) and the Target Protein Project of MEXT ( Y. S. and K. T.).	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fatica A, 2003, MOL CELL BIOL, V23, P1798, DOI 10.1128/MCB.23.5.1798-1807.2003; Fedorova IV, 2004, MUTAT RES-FUND MOL M, V554, P67, DOI 10.1016/j.mrfmmm.2004.03.003; Fedorova IV, 1998, GENETICS, V148, P963; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hori T, 1998, GENE, V216, P113, DOI 10.1016/S0378-1119(98)00309-6; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2008, EMBO REP, V9, P1237, DOI 10.1038/embor.2008.190; Lozano G, 2005, CANCER CELL, V8, P3, DOI 10.1016/j.ccr.2005.06.014; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Rencus-Lazar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002239; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Yahalom A, 2008, PLANT J, V53, P300, DOI 10.1111/j.1365-313X.2007.03347.x; Yen HCS, 2003, CELL CYCLE, V2, P81, DOI 10.4161/cc.2.2.340	52	125	132	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 29	2009	137	5					900	913		10.1016/j.cell.2009.05.005	http://dx.doi.org/10.1016/j.cell.2009.05.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	451EZ	19446323	Bronze			2022-12-24	WOS:000266454800020
J	Panstruga, R; Dodds, PN				Panstruga, Ralph; Dodds, Peter N.			Terrific Protein Traffic: The Mystery of Effector Protein Delivery by Filamentous Plant Pathogens	SCIENCE			English	Editorial Material							PHYTOPHTHORA-INFESTANS; CELL-DEATH; DISEASE RESISTANCE; MAGNAPORTHE-GRISEA; SECRETED PROTEINS; AVIRULENCE GENES; POWDERY MILDEW; RXLR EFFECTORS; RUST; FUNGI	Many biotrophic fungal and oomycete plant pathogens deliver effector proteins directly into host cells during infection. Recent advances are revealing the extensive effector repertoires of these pathogens and are beginning to shed light on how they manipulate host cells to establish a parasitic relationship. Surprisingly, oomycete effectors seem to share a common uptake system with those from the human malaria pathogen. The current explosion of information is opening new research avenues in molecular plant pathology and is providing new opportunities to limit the impact of plant disease on food production.	[Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Dodds, Peter N.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia	Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de; peter.dodds@csiro.au	Panstruga, Ralph/F-3340-2011; Dodds, Peter/D-1181-2009	Panstruga, Ralph/0000-0002-3756-8957; Dodds, Peter/0000-0003-0620-5923	NIGMS NIH HHS [R01 GM074265-01A2, GM074265-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RL, 1957, SCIENCE, V306, P2004; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; DOU DL, 1930, PLANT CELL, V20, P2008; Ellis JG, 2007, CURR OPIN MICROBIOL, V10, P326, DOI 10.1016/j.mib.2007.05.015; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAMOUN S, SFB670 DFG M PLANCK; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mims CW, 2002, PROTOPLASMA, V219, P221, DOI 10.1007/s007090200023; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	31	129	137	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 8	2009	324	5928					748	750		10.1126/science.1171652	http://dx.doi.org/10.1126/science.1171652			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19423815	Green Accepted			2022-12-24	WOS:000265832400034
J	Li, CYT; Poo, MM; Dan, Y				Li, Cheng-yu T.; Poo, Mu-ming; Dan, Yang			Burst Spiking of a Single Cortical Neuron Modifies Global Brain State	SCIENCE			English	Article							NEOCORTICAL NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; SLEEP STATES; OSCILLATIONS; MECHANISMS; RHYTHMS; TRANSITIONS; CIRCUITS; WAKING	Different global patterns of brain activity are associated with distinct arousal and behavioral states of an animal, but how the brain rapidly switches between different states remains unclear. We here report that repetitive high-frequency burst spiking of a single rat cortical neuron could trigger a switch between the cortical states resembling slow-wave and rapid-eye-movement sleep. This is reflected in the switching of the membrane potential of the stimulated neuron from slow UP/DOWN oscillations to a persistent-UP state or vice versa, with concurrent changes in the temporal pattern of cortical local field potential (LFP) recorded several millimeters away. These results point to the power of single cortical neurons in modulating the behavioral state of an animal.	[Li, Cheng-yu T.; Poo, Mu-ming; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Li, Cheng-yu T.; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Li, Chengyu/0000-0001-6829-0209; Dan, Yang/0000-0002-3818-877X	NIH; NSF [SBE-0542013]; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from NIH and NSF (SBE-0542013 to Temporal Dynamics of Learning Center, TDLC). We thank W. Sun for technical help.	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 1990, BRAINSTEM CONTROL WA; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	26	157	158	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					643	646		10.1126/science.1169957	http://dx.doi.org/10.1126/science.1169957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407203	Green Accepted			2022-12-24	WOS:000265608800044
J	Bastolla, U; Fortuna, MA; Pascual-Garcia, A; Ferrera, A; Luque, B; Bascompte, J				Bastolla, Ugo; Fortuna, Miguel A.; Pascual-Garcia, Alberto; Ferrera, Antonio; Luque, Bartolo; Bascompte, Jordi			The architecture of mutualistic networks minimizes competition and increases biodiversity	NATURE			English	Article							COEVOLUTIONARY NETWORKS; POLLINATION NETWORKS; MODEL-ECOSYSTEMS; MAINTENANCE; DIVERSITY; STABILITY; COMPLEX	The main theories of biodiversity either neglect species interactions(1,2) or assume that species interact randomly with each other(3,4). However, recent empirical work has revealed that ecological networks are highly structured(5-7), and the lack of a theory that takes into account the structure of interactions precludes further assessment of the implications of such network patterns for biodiversity. Here we use a combination of analytical and empirical approaches to quantify the influence of network architecture on the number of coexisting species. As a case study we consider mutualistic networks between plants and their animal pollinators or seed dispersers(5,8-11). These networks have been found to be highly nested(5), with the more specialist species interacting only with proper subsets of the species that interact with the more generalist. We show that nestedness reduces effective interspecific competition and enhances the number of coexisting species. Furthermore, we show that a nested network will naturally emerge if new species are more likely to enter the community where they have minimal competitive load. Nested networks seem to occur in many biological and social contexts(12-14), suggesting that our results are relevant in a wide range of fields.	[Fortuna, Miguel A.; Bascompte, Jordi] CSIC, Estac Biol Donana, Integrat Ecol Grp, Seville 41092, Spain; [Bastolla, Ugo; Pascual-Garcia, Alberto] Univ Autonoma Madrid, CSIC, Ctr Mol Biol, E-28049 Madrid, Spain; [Ferrera, Antonio; Luque, Bartolo] Univ Politecn Madrid, Dept Matemat Aplicada & Estadist, ETSI Aeronaut, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, C Amer Vespucio S-N, Seville 41092, Spain.	bascompte@ebd.csic.es	Bastolla, Ugo/H-6330-2015; Bascompte, Jordi/B-7596-2008; Fortuna, Miguel A/D-4154-2013; Luque, Bartolo/B-3646-2018	Bastolla, Ugo/0000-0001-9342-4678; Bascompte, Jordi/0000-0002-0108-6411; Fortuna, Miguel A/0000-0002-8374-1941; Luque, Bartolo/0000-0002-0396-4396; Pascual Garcia, Alberto/0000-0002-8444-3196	Spanish Ministry of Science and Technology; European Heads of Research Councils; European Science Foundation; EC; Ramon Areces Foundation	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Heads of Research Councils; European Science Foundation(European Science Foundation (ESF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Ramon Areces Foundation	We thank P. Jordano and J. Olesen for providing data and insight, A. Ramirez Ortiz for discussions and P. Buston and D. Stouffer for comments on a previous draft. J. Olesen provided the drawings in Fig. 1. Funding was provided by the Spanish Ministry of Science and Technology (through a Ramon y Cajal Contract and a Consolider Ingenio Project to U. B., a PhD Fellowship to M. A. F. and a grant to B. L.) and by the European Heads of Research Councils, the European Science Foundation, and the EC Sixth Framework Programme through a European Young Investigator Award (J. B.). Research at the Centro de Biologia Molecular Severo Ochoa is facilitated by an institutional grant from the Ramon Areces Foundation.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2005, J THEOR BIOL, V235, P531, DOI 10.1016/j.jtbi.2005.02.006; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; May R.M., 1974, STABILITY COMPLEXITY; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pachepsky E, 2002, ARTIF LIFE, V8, P5, DOI 10.1162/106454602753694747; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rikvold PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031913; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Sugihara G., 1984, P S APPL MATH, V30, P83, DOI DOI 10.1090/PSAPM/030/738641; SUGIHARA G, 1982, THESIS PRINCETON U; Tokita K, 2003, THEOR POPUL BIOL, V63, P131, DOI 10.1016/S0040-5809(02)00038-2; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	30	657	671	17	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1018	U91		10.1038/nature07950	http://dx.doi.org/10.1038/nature07950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396144				2022-12-24	WOS:000265412900040
J	Ezhkova, E; Pasolli, HA; Parker, JS; Stokes, N; Su, IH; Hannon, G; Tarakhovsky, A; Fuchs, E				Ezhkova, Elena; Pasolli, H. Amalia; Parker, Joel S.; Stokes, Nicole; Su, I-hsin; Hannon, Gregory; Tarakhovsky, Alexander; Fuchs, Elaine			Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells	CELL			English	Article							POLYCOMB GROUP PROTEINS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; CORNIFIED ENVELOPE; PROXIMAL PROMOTER; BMI-1; SKIN; METHYLATION; CHROMATIN; BARRIER	Although in vitro studies of embryonic stem cells have identified polycomb repressor complexes (PRCs) as key regulators of differentiation, it remains unclear as to how PRC-mediated mechanisms control fates of multipotent progenitors in developing tissues. Here, we show that an essential PRC component, Ezh2, is expressed in epidermal progenitors but diminishes concomitant with embryonic differentiation and with postnatal decline in proliferative activity. We show that Ezh2 controls proliferative potential of basal progenitors by repressing the Ink4A-Ink4B locus and tempers the developmental rate of differentiation by preventing premature recruitment of AP1 transcriptional activator to the structural genes that are required for epidermal differentiation. Together, our studies reveal that PRCs control epigenetic modifications temporally and spatially in tissue-restricted stem cells. They maintain their proliferative potential and globally repressing undesirable differentiation programs while selectively establishing a specific terminal differentiation program in a stepwise fashion.	[Ezhkova, Elena; Pasolli, H. Amalia; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Su, I-hsin; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27502 USA; [Su, I-hsin] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore 637551, Singapore; [Hannon, Gregory] Cold Spring Harbor Lab, Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Hannon, Gregory/AAB-3568-2019; Parker, Joel/AAG-1108-2019; Fuchs, Elaine/G-1565-2016; Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Pasolli, Hilda Amalia/0000-0003-3899-3530; Ezhkova, Elena/0000-0003-4154-1615	Life Sciences Research Foundation; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	Life Sciences Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Markus Schober, Scott Williams, Greg Wang (Allis's lab), Maria Nikolova, June Racelis, Svetlana Mazel, Christopher Bare, Xiaoxuan Fan, and Agnes Viale for technical assistance and our colleagues in the Fuchs laboratory, especially Jonathan Nowak, Rui Yi, and Valerie Horsley, for constructive discussion and criticisms. E. E. is a NY Stem Cell Foundation postdoctoral fellow of the Life Sciences Research Foundation. E. F. is an HHMI Investigator. This work was supported by a grant (E. F.) from the NIH.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006	49	447	455	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1122	1135		10.1016/j.cell.2008.12.043	http://dx.doi.org/10.1016/j.cell.2008.12.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303854	Green Accepted, Bronze			2022-12-24	WOS:000264403900017
J	Costello, A; Abbas, M; Allen, A; Ball, S; Bell, S; Bellamy, R; Friel, S; Groce, N; Johnson, A; Kett, M; Lee, M; Levy, C; Maslin, M; Mccoy, D; McGuire, B; Montgomery, H; Napier, D; Pagel, C; Patel, J; Antonio, J; de Oliveira, P; Redclift, N; Rees, H; Rogger, D; Scott, J; Stephenson, J; Twigg, J; Wolff, J; Patterson, C				Costello, Anthony; Abbas, Mustafa; Allen, Adriana; Ball, Sarah; Bell, Sarah; Bellamy, Richard; Friel, Sharon; Groce, Nora; Johnson, Anne; Kett, Maria; Lee, Maria; Levy, Caren; Maslin, Mark; McCoy, David; McGuire, Bill; Montgomery, Hugh; Napier, David; Pagel, Christina; Patel, Jinesh; Antonio, Jose; de Oliveira, Puppim; Redclift, Nanneke; Rees, Hannah; Rogger, Daniel; Scott, Joanne; Stephenson, Judith; Twigg, John; Wolff, Jonathan; Patterson, Craig			Managing the health effects of climate change	LANCET			English	Review							PUBLIC-HEALTH; AFRICAN HIGHLANDS; HUMAN-SETTLEMENTS; FOOD SECURITY; GLOBAL HEALTH; HEAT-WAVE; MALARIA; ADAPTATION; IMPACTS; DISEASE		[Costello, Anthony; Ball, Sarah; Patterson, Craig] UCL, Inst Global Hlth, London WC1N 1EH, England; [Abbas, Mustafa; Patel, Jinesh] UCL, Sch Med, London WC1N 1EH, England; [Allen, Adriana; Levy, Caren; de Oliveira, Puppim] UCL, Dev Planning Unit, London WC1N 1EH, England; [Bell, Sarah] UCL, Dept Civil Environm & Geomat Engn, London WC1N 1EH, England; [Bellamy, Richard] UCL, Dept Polit Sci, London WC1N 1EH, England; [Friel, Sharon] UCL, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England; [Groce, Nora; Kett, Maria] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London WC1N 1EH, England; [Johnson, Anne] UCL, Div Populat Hlth, London WC1N 1EH, England; [Lee, Maria; Scott, Joanne] UCL, Fac Laws, London WC1N 1EH, England; [Maslin, Mark] UCL, Inst Environm, London WC1N 1EH, England; [McCoy, David] UCL, Ctr Int Hlth & Dev, London WC1N 1EH, England; [McGuire, Bill; Twigg, John] UCL, Aon Benfield UCL Hazard Res Ctr, London WC1N 1EH, England; [Montgomery, Hugh] UCL, Inst Human Hlth & Performance, London WC1N 1EH, England; [Napier, David; Redclift, Nanneke] UCL, Dept Anthropol, London WC1N 1EH, England; [Pagel, Christina] UCL, Clin Operat Res Unit, London WC1N 1EH, England; [Rees, Hannah] UCL, Dept Life Sci, London WC1N 1EH, England; [Rogger, Daniel] UCL, Dept Econ, London WC1N 1EH, England; [Stephenson, Judith] UCL, Inst Womens Hlth, London WC1N 1EH, England; [Wolff, Jonathan] UCL, Dept Philosophy, London WC1N 1EH, England	University of London; University College London; University of London; University College London; UCL Medical School; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Costello, A (corresponding author), UCL, Inst Global Hlth, 30 Guilford St, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk	Kett, Maria/AAA-3421-2022; de Oliveira, Jose Antonio Puppim/J-2824-2014; Chesters, Heather/C-6089-2009; Montgomery, Hugh/L-1229-2019; Bellamy, Richard P/A-2728-2013; Montgomery, Hugh/C-2592-2008	Kett, Maria/0000-0002-1975-7674; de Oliveira, Jose Antonio Puppim/0000-0001-5000-6265; Bellamy, Richard P/0000-0002-9823-0626; lee, maria/0000-0001-7778-2766; Wolff, Jonathan/0000-0003-2608-5674; Bell, Sarah/0000-0001-5289-4358; Maslin, Mark/0000-0001-9957-3463; Friel, Sharon/0000-0002-8345-5435; Montgomery, Hugh/0000-0001-8797-5019; Pagel, Christina/0000-0002-2857-1628; Groce, Nora/0000-0002-7885-7042	National Institute for Health Research [NF-SI-0508-10244] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ACTIONAID, 2008, CER OFF ACTIONAID PO; *ACTIONAID INT, 2008, UNJ WAT CLIM CHANG F; Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Allen A., 2002, SUSTAINABLE URBANISA; ALLEN A, BUILT IN RE IN PRESS; Allen KM, 2006, DISASTERS, V30, P81, DOI 10.1111/j.1467-9523.2006.00308.x; Altieri M. A., 1990, Agroecology., P551; [Anonymous], ECONOMIST; de Oliveira JAP, 2009, HABITAT INT, V33, P253, DOI 10.1016/j.habitatint.2008.10.006; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409; Baer H, 2008, GLOBAL WARMING POLIT; Barnett J, 2003, GLOBAL ENVIRON CHANG, V13, P7, DOI 10.1016/S0959-3780(02)00080-8; BARNETT J, 2007, POLITICAL GEOGRAPHY, V26, P627; Bates B.C., 2008, CLIMATE CHANGE WATER; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Benthall J., 1993, DISASTERS RELIEF MED; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLAIR T, 2008, CLIMATE GROUP BREAKI; BRIDSALL N, 2001, POPULATION MATTERS D, P6; BROWN C, 2007, CLIMATE CHANGE FORCE; Brown ME, 2008, SCIENCE, V319, P580, DOI 10.1126/science.1154102; Brown RA, 1997, AGR FOREST METEOROL, V83, P171, DOI 10.1016/S0168-1923(96)02352-0; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Campbell-Lendrum DH, 2003, CLIMATE CHANGE HUMAN; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P235, DOI 10.2471/BLT.06.039503; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cardenas R, 2008, ANN NY ACAD SCI, V1149, P326, DOI 10.1196/annals.1428.094; Castles S, 2002, 70 UNHCR; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chivian E, 2008, SUSTAINING LIFE HUMA; Cleland J, 2009, BEST PRACT RES CL OB, V23, P165, DOI 10.1016/j.bpobgyn.2008.11.002; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Cohen M. J., 2008, IMPACT CLIMATE CHANG; *COMM AFR, 2009, OUR COMM INT REP COM; CONE R, 2003, SOCIAL CULTURAL LIVE, P232; COTTER J, 2008, FOOD SECURITY CLIMAT; De US, 2004, NAT HAZARDS, V31, P487, DOI 10.1023/B:NHAZ.0000023363.93647.c7; *DEV IN, 2005, AID DAT REP; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; European Commission, 2007, AD CLIM CHANG EUR OP; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; FRIMAN RN, 2007, HUMAN TRAFFICKING HU; Fritze Jessica G, 2008, Int J Ment Health Syst, V2, P13, DOI 10.1186/1752-4458-2-13; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Gilbert M, 2008, REV SCI TECH OIE, V27, P459, DOI 10.20506/rst.27.2.1821; *GLOB ENV FAC, 2 AIACC REG WORKSH L; GOLDSTONE J, 2001, ENV CONFLICT; Grant R. W., 2004, ACCOUNTABILITY ABUSE; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Green D, 2009, MED J AUSTRALIA, V190, P4, DOI 10.5694/j.1326-5377.2009.tb02250.x; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; HAILS C, LIVING PLANET REPORT; Hajjar R, 2008, AGR ECOSYST ENVIRON, V123, P261, DOI 10.1016/j.agee.2007.08.003; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hales Simon, 2007, Reviews on Environmental Health, V22, P295; Handmer J., 2007, HDB DISASTER EMERGEN; HANEY TJ, 2007, SOCIOLOGY KATRINA PE, P8; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; HAY SI, 2006, FORESIGHT POPULATION, P40; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hoffmann B, 2008, J TOXICOL ENV HEAL A, V71, P759, DOI 10.1080/15287390801985539; Houghton J., 2004, GLOBAL WARMING COMPL; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; Husain Tahir, 2008, Int J Environ Res Public Health, V5, P204, DOI 10.3390/ijerph5040204; *IAASTD, INT ASS AGR KNOWL SC; *IFRC, 2008, WORLD DIS REP 2008; IPCC, 2000, SPECIAL REPORT EMISS; Jiang J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008749; JOHANSSON TB, 2004, WORLD ENERGY ASSESSM; JOWITT J, UN SAYS EAT LESS MEA; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keim ME, 2008, AM J PREV MED, V35, P508, DOI 10.1016/j.amepre.2008.08.022; Klein R.J.T., 2003, ENVIRON HAZARDS-UK, V5, P35, DOI [10.1016/j.hazards.2004.02.001, DOI 10.1016/J.HAZARDS.2004.02.001]; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2003, SCIENCE, V299, P1032, DOI 10.1126/science.1077838; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Manyena SB, 2006, DISASTERS, V30, P433; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; MASLIN M, 2008, GLOBAL WARMING VERY; McCoy D., 2009, MAKING SENSE GLOBAL; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Menne B., 2002, International Journal of Global Environmental Issues, V2, P181, DOI 10.1504/IJGENVI.2002.002399; Metz B., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1017/CBO9780511546013; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; MUNICH RE, 2008, NATURAL CATASTROPHES; Myers N., 2005, ENV REFUGEES EMERGEN; *OECD, 2007, AGR POL OECD COUNTR; Orr Jackie, 2006, PANIC DIARIES GENEAL; Pace N, 2008, LANCET, V371, P1648, DOI 10.1016/S0140-6736(08)60707-2; Parry M., 2008, NATURE REPORTS CLIMA, DOI [DOI 10.1038/CLIMATE.2008.50, 10.1038/climate.2008.50]; Parry ML, 2007, CLIMATE CHANGE 2007; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; Pelling Mark, 2003, VULNERABILITY CITIES; Pielke R, 2008, NATURE, V452, P531, DOI 10.1038/452531a; Pinto RF, 2008, PUBLIC ADMIN DEVELOP, V28, P340, DOI 10.1002/pad.516; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Randolph SE, 2008, REV SCI TECH OIE, V27, P367, DOI 10.20506/rst.27.2.1805; Randolph SE, 2008, CURR OPIN INFECT DIS, V21, P462, DOI 10.1097/QCO.0b013e32830ce74b; Reiter P, 2004, LANCET INFECT DIS, V4, P323, DOI 10.1016/S1473-3099(04)01038-2; Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001; Revi A, 2008, ENVIRON URBAN, V20, P207, DOI 10.1177/0956247808089157; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Rockel B, 2007, CLIMATIC CHANGE, V81, P267, DOI 10.1007/s10584-006-9227-y; Romero Lankao P, 2007, ENVIRON URBAN, V19, P157; Rweyemamu M., 2006, INFECT DIS PREPARING; Satterthwaite David, 2007, HUMAN SETTLEMENTS DI; Schellnhuber H J, 2006, AVOIDING DANGEROUS C; Scherr S. J., 1999, Food, Agriculture and the Environment Discussion Paper - International Food Policy Research Institute; Sen A., 1983, POVERTY FAMINES ESSA; Sheeran J, 2008, LANCET, V371, P180, DOI 10.1016/S0140-6736(07)61870-4; *SIWI IFPRI IUCN I, 2005, CSD13 SIWI IFPRI IUC; Smith MC, 2008, AM BOOK REV, V29, P25, DOI 10.1353/abr.2008.0001; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STAHL T, 2006, HLTH POLICIES PROSPE; Sterl A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034071; Stern Nicholas, 2006, STERN REV EC CLIMATE; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; TAYLOR RG, EOS T AM GE IN PRESS; TELLEZ VM, LESSONS FOOD CRISIS; Twigg J., 2004, Disaster risk reduction: mitigation and preparedness in development and emergency programming; Twigg J., 2007, CHARACTERISTICS DISA; Ulbrich U, 2008, J CLIMATE, V21, P1669, DOI 10.1175/2007JCLI1992.1; [UN Department of Economic and Social Affairs Population Division], 2006, ESAPWP200 UN DEP EC; UN Department of Economic and Social Affairs Population Division, 2006, WORLD POP PROSP 2006; *UN FRAM CONV CLIM, AD FUND; *UN INT STRAT DIS, 2008, IND PROGR GUID MEAS; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UN STAT DIV, MILL DEV GOALS IND; UNDP, 2004, GLOB REP RED DIS RIS; *UNDP GLOB ENV FAC, 2004, RECL LAND SUST LIV; *UNEP, UNEP ANN REP 2007; UNFCCC, 2007, P NAME C 2 INT C GRE; UNFPA, 2008, STAT WORLD POP 2008; *UNFPA, 2002, STAT WORLD POP 2002; *UNFPA AL GUTTM I, 2004, ADD IT BEN INV SEX R; United Nations Development Programme, 2007, 20072008 UN DEV PROG; United Nations International Strategy for Disaster Reduction, 2004, LIV RISK GLOB REV DI; Venton P., 2008, Linking climate change adaptation and disaster risk reduction; Von Braun J, 2007, WORLD FOOD SITUATION; Washington R., 2004, AFRICAN CLIMATE REPO; Weart S.R, 2004, DISCOVERY GLOBAL WAR; WEDO, 2008, GEND CLIM CHANG HUM; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson R., 2009, SPIRIT LEVEL; Wisner B., 2004, At risk: natural hazards, people's vulnerability and disasters; *WORLD BANK, CLIM INV FUNDS; *WORLD TRAD ORG, TRIPS PUBL HLTH; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; UN WORLD C DIS RED H; REGIONAL GREENHOUSE; 2009, CLIMATE CHANGE GLOBA; ANN REPORT UK CLIMAT; 2008, WASHINGTON POST 0415	170	1447	1490	29	578	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2009	373	9676					1693	1733		10.1016/S0140-6736(09)60935-1	http://dx.doi.org/10.1016/S0140-6736(09)60935-1			41	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	447RP	19447244				2022-12-24	WOS:000266209800017
J	Brownstein, JS; Freifeld, CC; Madoff, LC				Brownstein, John S.; Freifeld, Clark C.; Madoff, Lawrence C.			Digital Disease Detection - Harnessing the Web for Public Health Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownstein, John S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Freifeld, Clark C.] Childrens Hosp Informat Program, Boston, MA USA; [Freifeld, Clark C.] MIT, Media Lab, New Media Med Grp, Cambridge, MA 02139 USA; [Madoff, Lawrence C.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Madoff, Lawrence C.] Massachusetts Dept Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Department of Public Health	Brownstein, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Brownstein, John S/A-1438-2011		NLM NIH HHS [G08 LM009776, G08 LM009776-01A2] Funding Source: Medline; NLM NIH HHS [G08 LM009776-01A2S1, G08 LM009776, G08 LM009776-01A2] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; HARRIS G, 2009, NY TIMES        0501; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; MARTINEZ R, 2009, PROCESO         0402; MORALES AT, 2009, JORNADA         0401; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098	9	480	495	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2009	360	21					2153	2157		10.1056/NEJMp0900702	http://dx.doi.org/10.1056/NEJMp0900702			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	447QI	19423868	Green Accepted			2022-12-24	WOS:000266206000001
